data_2mxc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mxc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.897 0.38 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.36 -179.97 45.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.375 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -55.69 157.61 15.38 Favored 'Trans proline' 0 C--O 1.225 -0.134 0 C-N-CA 124.142 3.228 . . . . 0.0 111.963 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.49 -9.03 3.23 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.916 3.078 . . . . 0.0 114.462 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.5 t -73.32 -54.28 8.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.627 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.6 m120 58.14 -178.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.434 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -97.36 138.52 34.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -148.17 132.95 17.95 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.552 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -146.92 106.87 3.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.645 HG12 ' HB ' ' A' ' 53' ' ' VAL . 36.0 mt -115.36 147.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.209 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.62 111.61 7.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 33' ' ' VAL . 1.2 m -88.97 131.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -179.33 -165.7 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 58.21 67.36 2.24 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-O 121.123 0.487 . . . . 0.0 110.388 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HG3' HG23 ' A' ' 115' ' ' ILE . 72.4 Cg_endo -72.74 152.77 53.42 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.933 2.422 . . . . 0.0 113.532 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.8 tp60 -138.93 111.57 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.322 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.0 m -78.92 90.22 4.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.856 0.836 . . . . 0.0 110.25 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 37' ' ' GLN . 1.0 OUTLIER -116.9 96.82 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.353 -174.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.64 -167.53 31.97 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.525 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.6 t -98.7 152.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-O 119.419 -0.324 . . . . 0.0 110.52 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.16 -46.57 8.15 Favored Glycine 0 N--CA 1.46 0.248 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.321 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -100.2 84.84 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.23 0.538 . . . . 0.0 109.852 172.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.58 37.29 0.79 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.274 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 21.1 ttt180 -83.38 130.32 35.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.8 0.333 . . . . 0.0 110.379 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -122.52 159.17 28.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.1 m -111.95 127.32 55.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.483 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 43.4 p -92.5 152.36 19.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.293 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -119.62 140.5 50.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 32.9 tt0 -90.89 119.48 31.12 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.67 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.39 111.98 26.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.069 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 58.9 mtp85 -104.79 134.86 47.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -144.64 141.57 23.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.1 ttmt -127.39 135.95 51.19 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.072 169.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 63' ' ' LYS . 15.0 t -171.23 163.86 7.17 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.514 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.514 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.98 27.25 9.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.836 169.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.627 HD23 ' OD1' ' A' ' 27' ' ' ASN . 23.1 mt -61.38 139.06 94.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.029 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.13 -12.27 19.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.151 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.49 HD13 HG13 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -89.67 -41.22 13.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.432 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.3 m-85 -65.37 -13.53 58.81 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 71.35 -66.5 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.77 -2.85 58.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 122.174 -0.329 . . . . 0.0 110.462 -172.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 55' ' ' THR . 4.5 mmpp? 70.45 -46.18 0.61 Allowed 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.129 0.893 . . . . 0.0 111.545 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -158.41 118.98 3.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.893 0.854 . . . . 0.0 110.905 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 t -155.58 179.33 9.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.517 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.457 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 14.2 m -141.36 137.02 32.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 m -125.96 175.62 7.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.452 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -145.72 118.59 8.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.729 0.3 . . . . 0.0 110.855 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -151.9 173.53 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HG2' ' OD2' ' A' ' 73' ' ' ASP . 20.6 ptt180 -99.32 170.54 8.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -164.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.468 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 33.7 t80 -53.88 -38.71 65.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.488 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.598 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 29.9 m -59.38 -25.24 64.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.776 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.655 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 20.7 m-20 -80.5 -35.18 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.446 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 57.0 m-85 -59.48 -38.86 81.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.445 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.598 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 20.1 mt-10 -61.68 -53.24 58.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.56 0.695 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.509 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -68.25 -23.46 64.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.206 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.73 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -71.95 -42.95 65.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -55.31 -60.58 3.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.815 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.721 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.5 p -64.2 -35.37 80.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.371 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 4.6 mm-40 -59.37 -37.25 77.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.404 HD13 HG11 ' A' ' 87' ' ' VAL . 95.2 mt -73.36 -27.8 61.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.058 0.456 . . . . 0.0 110.656 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 89' ' ' VAL . 49.8 mt-10 -84.38 -18.33 36.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.355 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.0 mmm180 -58.84 -61.7 2.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -119.64 0.05 10.88 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.512 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 73.7 m -125.43 166.99 15.6 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.778 0.799 . . . . 0.0 111.911 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.51 30.41 3.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.47 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 89' ' ' VAL . 97.2 t -52.49 141.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.873 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 88' ' ' VAL . 4.0 p -66.42 27.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.882 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.532 ' HA ' HG13 ' A' ' 129' ' ' VAL . 0.5 OUTLIER -57.88 120.33 41.31 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 121.809 -0.557 . . . . 0.0 111.777 -174.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG3' ' CD ' ' A' ' 128' ' ' LYS . 97.4 Cg_endo -88.58 168.25 5.99 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.005 2.47 . . . . 0.0 112.147 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 146.06 75.81 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 112.184 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 75' ' ' GLU . 80.1 mt -69.26 152.02 96.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.15 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.53 109.98 2.97 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.965 2.443 . . . . 0.0 111.932 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.61 176.82 44.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.081 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.2 31.49 16.56 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.567 0.699 . . . . 0.0 110.346 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.7 -85.23 0.59 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.912 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.515 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -61.76 -18.19 58.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.327 -177.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.9 mm? -69.6 -44.14 71.34 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 -174.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 17.88 6.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 109.844 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.2 tt0 -118.5 -39.88 2.97 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.689 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 mt -92.83 171.76 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.998 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.14 -172.86 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.737 2.291 . . . . 0.0 111.732 171.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 61.5 m-85 -105.65 -86.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.655 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 65.19 -75.57 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.677 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.78 64.82 3.62 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.376 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.2 t70 65.93 -69.96 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.324 1.05 . . . . 0.0 110.331 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.53 -23.97 12.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.128 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 113.78 7.28 20.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.124 -174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.754 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.8 pt -71.95 -19.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.886 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.92 -12.04 60.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.791 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.37 135.19 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.471 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.69 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 48.3 m-80 -73.52 -58.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.754 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -50.65 -48.18 58.31 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.526 0.516 . . . . 0.0 111.192 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 36' ' ' PRO . 37.5 mt -51.76 -48.38 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.433 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.14 -20.51 59.36 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.262 -177.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.625 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 29.9 mm-40 -71.88 -32.79 67.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.209 0.528 . . . . 0.0 109.762 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 43.5 ttp180 -81.93 -34.34 29.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.237 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.02 -50.05 71.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.524 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.748 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -59.47 -39.97 85.42 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.166 -175.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.5 -36.54 23.08 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.443 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 4.6 tp -64.24 -36.61 84.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.435 0.16 . . . . 0.0 111.037 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.1 pt-20 -75.65 -29.99 59.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.7 mm-40 -64.01 -53.61 47.32 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.6 t80 -49.9 -54.55 18.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.287 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.544 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.1 tp -64.67 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.865 -172.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -62.21 -16.96 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.16 -0.338 . . . . 0.0 111.825 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.439 ' CD ' ' HG3' ' A' ' 90' ' ' PRO . 32.1 mttm -89.92 -58.65 2.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.038 0.923 . . . . 0.0 110.568 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 89' ' ' VAL . 1.3 m -66.05 -13.51 15.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.027 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 126' ' ' ILE . . . -111.92 10.28 20.62 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -136.16 2.25 3.54 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.436 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.69 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 35.1 t60 -99.91 144.36 28.22 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 117.185 0.492 . . . . 0.0 111.74 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.8 Cg_exo -39.64 -50.52 3.1 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.578 3.519 . . . . 0.0 113.879 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.37 -30.14 68.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.521 ' O ' HD21 ' A' ' 141' ' ' LEU . . . -78.03 -39.99 40.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.25 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.462 ' OE1' HG22 ' A' ' 59' ' ' ILE . 53.8 mm-40 -65.56 -6.38 10.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.584 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -108.7 6.07 25.39 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.974 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.512 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 5.1 mm-40 -118.48 129.18 55.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.824 0.345 . . . . 0.0 111.128 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -54.21 -20.41 6.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.518 -176.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.5 m -53.45 -35.81 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.432 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 135' ' ' ALA . 5.5 mp -69.95 -33.53 72.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.238 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 37.1 t-80 -56.88 -39.72 74.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.132 0.491 . . . . 0.0 110.249 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 150' ' ' ILE . 2.5 ptm -79.96 -28.57 39.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.081 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.73 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.26 -47.81 14.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.518 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -93.98 -19.91 20.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.113 -174.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 7.6 mt-30 -119.95 -172.61 2.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.151 -168.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 53.06 -116.75 1.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.257 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -134.89 -35.15 0.87 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.701 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.98 162.65 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.75 0.786 . . . . 0.0 112.868 -167.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -74.82 115.65 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.895 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.32 112.89 24.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.844 0.354 . . . . 0.0 110.186 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.509 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 27.1 mmtp -75.69 11.04 1.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -172.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.0 m -129.08 19.21 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.212 0.53 . . . . 0.0 110.297 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.509 ' CD1' ' HE3' ' A' ' 143' ' ' MET . 0.6 OUTLIER -65.57 -174.2 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.16 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.0 m -90.89 112.49 53.79 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.161 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.72 76.68 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 123.453 2.768 . . . . 0.0 112.111 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -146.82 -161.78 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.442 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.1 mmmt -85.93 165.07 17.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.49 HG13 HD13 ' A' ' 59' ' ' ILE . 12.1 mm -60.54 -40.92 85.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.217 0.532 . . . . 0.0 110.261 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.41 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 79.6 m-85 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.44 174.75 46.95 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.602 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.69 158.62 19.51 Favored 'Trans proline' 0 C--O 1.222 -0.276 0 C-N-CA 124.336 3.358 . . . . 0.0 111.174 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.63 -14.67 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.418 3.412 . . . . 0.0 115.206 -171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 p -68.63 -62.45 1.38 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 58.13 -177.37 0.07 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.262 0.553 . . . . 0.0 111.902 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -99.47 138.17 36.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.557 HD23 HD11 ' A' ' 57' ' ' LEU . 15.9 tp -145.58 132.33 20.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.057 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.73 106.05 3.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.174 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.656 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.2 mt -114.55 142.87 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.058 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -136.55 118.47 15.24 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -100.23 135.04 37.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t 178.85 -161.97 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 31.7 m-80 62.5 73.42 0.54 Allowed Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 110.46 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HG3' HG22 ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.01 131.85 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.802 2.335 . . . . 0.0 112.865 -173.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 47.6 tp60 -117.02 112.34 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.14 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.9 m -73.17 104.04 4.1 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.42 90.66 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.268 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.22 -167.57 33.24 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.814 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.4 t -100.71 147.98 7.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 119.278 -0.392 . . . . 0.0 110.134 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.34 5.55 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 121.59 -0.338 . . . . 0.0 113.152 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -103.96 88.62 3.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.462 0.649 . . . . 0.0 109.416 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.37 32.35 0.98 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.725 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.554 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 8.9 ttp180 -84.34 152.21 24.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.403 0.281 . . . . 0.0 110.304 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.14 162.3 35.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.747 0.308 . . . . 0.0 110.359 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -113.92 131.35 56.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.608 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 15.9 p -99.64 153.39 19.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.54 144.97 43.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.237 0.541 . . . . 0.0 110.627 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 35.9 tt0 -95.79 123.2 39.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.347 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.5 mp -96.72 117.84 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.276 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.5 109.81 20.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.407 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.656 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -119.46 137.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.013 0.435 . . . . 0.0 111.993 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -125.89 134.97 51.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.307 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.512 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.4 t -170.31 165.95 8.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.288 0.566 . . . . 0.0 111.626 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -120.45 26.26 9.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.119 168.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD11 HD23 ' A' ' 29' ' ' LEU . 20.9 mt -60.62 143.36 90.54 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.192 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.84 -29.64 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.431 2.088 . . . . 0.0 111.711 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 136' ' ' GLN . 0.4 OUTLIER -69.29 -40.19 79.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.95 178.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.612 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.4 m-30 -69.1 -19.98 64.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.49 -64.33 0.39 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -80.11 -7.66 59.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 122.182 -0.324 . . . . 0.0 110.833 -172.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp 70.68 -43.43 0.55 Allowed 'General case' 0 C--O 1.218 -0.578 0 O-C-N 124.014 0.822 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.6 pp20? -160.58 130.82 5.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 109.998 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.2 t -160.43 165.85 30.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.609 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 37.7 m -140.5 130.4 24.58 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.292 0.568 . . . . 0.0 110.853 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 147' ' ' ASP . 5.8 m -133.47 174.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -144.06 122.88 12.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.197 0.522 . . . . 0.0 111.567 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.05 -177.66 5.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 167.57 10.25 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -169.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.7 t80 -55.09 -34.38 63.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.42 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.514 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 16.9 m -55.03 -33.58 62.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.738 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -75.06 -38.14 61.45 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 59.9 m-85 -60.12 -37.47 80.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.644 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 25.7 mt-10 -62.52 -55.07 30.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.752 0.787 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.415 ' CD1' HG21 ' A' ' 150' ' ' ILE . 1.1 t-105 -64.9 -28.64 69.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.436 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.636 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -69.35 -40.73 77.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.523 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 63.9 ttt180 -57.95 -64.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.446 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.721 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -61.28 -37.17 82.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.014 -172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.19 -44.73 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.373 0.42 . . . . 0.0 111.431 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.37 -37.06 85.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.73 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -73.82 -24.95 59.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.138 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 79' ' ' SER . 25.1 mmt180 -67.98 -62.53 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.063 0.459 . . . . 0.0 111.816 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -85.46 -30.05 23.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.323 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.503 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 29.5 m -120.66 175.03 6.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.654 0.74 . . . . 0.0 112.004 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -105.0 23.6 13.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.738 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 89' ' ' VAL . 97.6 t -42.6 140.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.846 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' VAL . 5.6 p -69.19 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.371 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.2 t -56.07 121.65 42.65 Favored Pre-proline 0 N--CA 1.464 0.268 0 O-C-N 121.945 -0.472 . . . . 0.0 110.836 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.483 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 89.0 Cg_endo -88.28 166.4 6.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.904 2.403 . . . . 0.0 112.302 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.66 150.82 87.55 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.867 2.378 . . . . 0.0 112.459 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 75' ' ' GLU . 49.6 mt -80.51 153.39 73.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.436 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -88.44 109.27 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.912 2.408 . . . . 0.0 112.289 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.12 59.15 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.443 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -144.55 -25.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.778 0.323 . . . . 0.0 111.4 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.85 -82.32 0.29 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.499 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -49.94 -24.5 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.951 1.3 . . . . 0.0 114.14 -171.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.6 mm? -59.34 -45.16 92.15 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.915 0.388 . . . . 0.0 111.221 -173.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 20.65 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.716 0.769 . . . . 0.0 109.432 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -118.1 -28.31 5.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.866 -176.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 mt -101.67 169.16 8.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.25 -161.38 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.898 2.399 . . . . 0.0 112.484 173.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 37.9 m-85 -106.97 -80.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.608 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 68.38 -64.99 0.28 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.538 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -113.86 79.07 0.27 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.431 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.64 -71.41 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.056 0.943 . . . . 0.0 111.911 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.9 -32.11 7.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.842 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 123.3 4.42 8.35 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.936 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 45.8 pt -73.09 -15.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 54.5 m-85 -79.88 -15.1 58.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.402 ' OD1' ' HB2' ' A' ' 113' ' ' ASN . 16.6 t70 -78.97 134.48 36.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.992 0.425 . . . . 0.0 110.245 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.97 -24.7 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.67 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.592 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 42.7 m-80 -65.64 -57.71 7.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -51.34 -51.03 58.08 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.661 0.601 . . . . 0.0 110.879 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.409 HG22 ' HG3' ' A' ' 36' ' ' PRO . 23.7 mt -50.59 -50.35 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.995 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.55 -20.59 58.55 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.883 -177.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 37.3 mm-40 -74.25 -33.64 63.38 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.166 0.508 . . . . 0.0 109.95 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 37.5 ttm180 -80.63 -33.68 35.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -55.89 -50.88 69.45 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.551 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.73 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.6 -41.91 95.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.844 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.0 -34.5 33.47 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.439 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.571 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 4.2 tp -67.52 -36.59 81.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.025 -0.103 . . . . 0.0 111.243 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HA ' HG21 ' A' ' 126' ' ' ILE . 12.8 pt-20 -72.77 -33.33 66.24 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.73 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 15.6 mm-40 -60.45 -58.44 8.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' O ' HG12 ' A' ' 129' ' ' VAL . 15.0 t80 -47.57 -55.43 9.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.443 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.543 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -63.93 -39.49 85.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.83 -172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -61.62 -20.27 63.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.017 0.437 . . . . 0.0 111.986 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.483 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 35.1 mttm -90.18 -56.36 3.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.939 0.876 . . . . 0.0 110.641 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 125' ' ' PHE . 1.2 m -65.84 -13.15 15.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.002 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -110.11 7.61 23.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.088 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.419 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -141.14 12.36 2.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.463 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 57.7 t60 -100.32 139.8 20.96 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 122.397 -0.472 . . . . 0.0 110.499 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.635 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 6.8 Cg_exo -41.38 -47.1 5.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.21 3.273 . . . . 0.0 113.888 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -70.81 -32.55 69.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.102 -176.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.62 -42.47 51.61 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.716 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -66.0 -6.57 13.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.141 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.568 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -99.61 -10.04 22.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.464 179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.503 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 5.5 mm-40 -106.61 131.87 53.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 111.967 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 159' ' ' ILE . 16.3 tpt180 -58.24 -19.08 31.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.852 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 143' ' ' MET . 0.7 OUTLIER -63.97 -24.17 67.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.0 110.965 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.613 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.1 mp -75.55 -31.23 59.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.553 -0.717 . . . . 0.0 110.999 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 65.0 t-80 -57.61 -38.3 74.7 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 4.0 ptm -80.47 -26.76 38.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.559 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.636 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.14 -53.74 6.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.613 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -78.78 -36.31 43.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.357 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 11.6 mt-30 -95.3 166.67 11.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' VAL . 46.1 m-20 61.96 -179.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.638 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.17 -35.25 14.65 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.048 0.928 . . . . 0.0 110.392 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.503 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -134.8 152.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.182 -165.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.575 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.2 mp -81.72 116.05 25.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.64 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.19 101.58 6.24 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.054 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -71.77 11.34 0.52 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.0 m -130.28 19.17 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 110.657 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.426 ' CD1' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.18 -171.43 0.05 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.534 0.683 . . . . 0.0 112.122 -179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 87.4 m -88.48 113.01 53.64 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.161 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.65 65.64 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.442 2.761 . . . . 0.0 112.303 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -140.59 -154.04 0.5 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.626 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.568 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 20.9 mmmt -86.24 158.98 19.59 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.475 -0.14 . . . . 0.0 110.75 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 139' ' ' ARG . 16.7 mm -51.41 -52.44 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.422 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.337 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 2.6 m-85 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.52 175.5 43.91 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.425 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.33 154.71 10.73 Favored 'Trans proline' 0 C--O 1.224 -0.224 0 C-N-CA 124.0 3.133 . . . . 0.0 111.34 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.98 -11.82 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 124.483 3.455 . . . . 0.0 115.161 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -74.06 -61.89 1.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 32.2 m-80 58.84 -178.58 0.08 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.489 0.493 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -91.43 125.52 36.21 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.584 HD21 HD12 ' A' ' 57' ' ' LEU . 13.1 tp -138.14 129.09 27.06 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.88 -176.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -140.32 104.36 4.77 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.093 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.636 HG12 ' HB ' ' A' ' 53' ' ' VAL . 47.9 mt -114.69 141.49 31.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.182 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.8 117.57 14.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.996 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -98.62 132.42 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t 179.52 -162.56 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.2 m-80 63.58 77.44 0.32 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.98 142.17 30.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.392 2.061 . . . . 0.0 113.051 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -131.9 111.22 11.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.059 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.0 101.57 4.52 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.3 88.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.426 0.632 . . . . 0.0 110.235 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.44 -167.62 33.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.837 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.2 t -111.35 156.28 12.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.144 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.41 -49.04 6.98 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.465 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -99.08 85.1 3.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.084 0.469 . . . . 0.0 109.744 171.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.42 38.99 0.64 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.565 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 10.1 ttt180 -89.49 140.46 29.5 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.24 154.82 42.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.844 0.355 . . . . 0.0 110.759 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 m -110.57 122.97 49.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 p -92.55 155.91 17.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.859 0.361 . . . . 0.0 110.829 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 80.5 m-85 -119.12 141.42 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.728 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 31.3 tt0 -90.64 123.62 34.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.349 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -102.73 115.6 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.41 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 57.4 mtp180 -105.52 139.41 40.17 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.556 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.636 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -146.39 140.7 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -128.83 143.08 50.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.039 165.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.405 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 15.0 t -172.9 164.46 5.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.912 0.387 . . . . 0.0 111.964 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.52 31.12 6.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.628 0.728 . . . . 0.0 110.137 166.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.584 HD12 HD21 ' A' ' 29' ' ' LEU . 23.2 mt -67.86 145.2 97.83 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.273 174.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.53 -28.53 5.38 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.598 2.199 . . . . 0.0 111.777 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.4 OUTLIER -69.94 -41.36 79.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.878 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 145' ' ' LEU . 2.3 m-30 -69.96 -33.0 71.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.593 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.1 tmmm? 75.11 -58.13 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.582 0.551 . . . . 0.0 112.101 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.75 -14.83 60.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 122.284 -0.26 . . . . 0.0 111.039 -172.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp 73.66 -38.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.851 0.719 . . . . 0.0 110.857 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.62 140.25 30.04 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.411 0.624 . . . . 0.0 109.956 174.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -160.28 151.55 19.37 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.109 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.9 m -140.39 133.95 30.14 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.021 0.439 . . . . 0.0 109.935 173.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 21.0 m -129.96 179.52 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.624 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 36.3 ttm180 -145.96 101.83 3.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 mmp_? -122.95 172.61 8.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.137 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -88.83 161.83 16.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.539 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 38.5 t80 -55.26 -37.53 67.37 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.437 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 35.5 m -61.99 -26.17 68.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.648 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.8 -36.42 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.65 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 52.1 m-85 -66.46 -39.89 89.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.998 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 32.9 mt-10 -57.06 -56.94 15.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.585 0.707 . . . . 0.0 110.826 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.46 ' CD1' HG23 ' A' ' 150' ' ' ILE . 4.7 t-105 -63.33 -34.09 76.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.733 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.629 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -69.19 -43.97 73.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 31.8 ttt180 -57.54 -59.52 5.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.797 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -60.58 -32.95 72.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.301 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.7 mm-40 -63.14 -46.37 87.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.014 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 85' ' ' SER . 88.8 mt -71.06 -16.31 62.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.0 110.755 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 47.5 mt-10 -87.73 -50.08 6.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.107 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 1.5 ppt_? -62.2 -21.79 65.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -165.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 9.5 pt-20 -138.12 -34.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.282 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.92 158.85 33.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.203 0.525 . . . . 0.0 110.476 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -96.53 17.86 15.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.238 0.542 . . . . 0.0 109.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 135' ' ' ALA . 90.7 t -56.06 140.24 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.93 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' VAL . 9.8 p -75.53 37.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.611 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.519 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -51.69 118.72 12.01 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.411 -175.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 6.3 Cg_exo -72.43 160.56 46.53 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.495 2.797 . . . . 0.0 112.525 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 142.2 42.3 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.876 2.384 . . . . 0.0 111.983 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.1 mt -69.37 150.57 97.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -86.49 109.65 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.881 2.388 . . . . 0.0 111.957 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.63 -174.53 27.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.078 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.43 ' N ' HD23 ' A' ' 98' ' ' LEU . 51.8 tttp 71.09 -55.25 0.65 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.824 . . . . 0.0 112.035 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.61 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -73.36 -18.17 61.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.482 -170.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mm? -69.14 -44.34 72.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.772 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 26.48 4.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.536 0.684 . . . . 0.0 110.178 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -116.69 -41.51 3.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 62.6 mt -80.57 163.6 55.7 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.62 147.35 86.15 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.961 2.441 . . . . 0.0 111.499 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -104.76 94.82 5.49 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -125.76 -30.88 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.094 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.65 -167.31 43.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.439 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.9 -47.89 76.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.273 0.558 . . . . 0.0 110.936 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -136.41 -51.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.997 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.36 -10.38 1.3 Allowed Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.206 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.775 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.8 pt -65.53 -16.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 111.928 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -81.22 -16.12 53.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.357 0.599 . . . . 0.0 110.119 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.42 122.16 28.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.68 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.64 -27.0 64.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.581 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 14.3 m120 -55.09 -60.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.487 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.775 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -54.84 -47.71 73.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.51 0.506 . . . . 0.0 110.895 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 mt -51.47 -51.27 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.275 -173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -73.11 -22.33 60.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.48 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 66.2 mm-40 -74.87 -32.45 61.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.802 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 14.7 tpp180 -78.97 -35.49 42.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.58 -54.01 51.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.467 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.708 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -59.33 -40.41 86.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.998 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -34.84 32.91 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.133 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.65 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -67.12 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.732 0.266 . . . . 0.0 111.298 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.597 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -73.43 -32.43 64.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.708 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.4 mm-40 -62.31 -58.17 8.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 7.1 t80 -48.89 -53.27 20.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.613 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.34 -41.05 90.36 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.776 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.97 -19.72 45.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 111.809 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 124' ' ' GLN . 31.8 mttm -90.72 -58.83 2.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.76 0.791 . . . . 0.0 110.66 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.628 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.32 -13.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.023 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 126' ' ' ILE . . . -111.18 10.93 21.85 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.981 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.89 8.64 1.3 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.796 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.786 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 59.2 t60 -98.42 144.97 29.06 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 117.217 0.509 . . . . 0.0 110.214 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.786 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.0 Cg_exo -41.9 -48.86 5.89 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.23 3.286 . . . . 0.0 113.775 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.633 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -71.09 -38.91 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.777 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -69.14 -41.49 77.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.359 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 59' ' ' ILE . 6.1 mm-40 -65.93 -4.13 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.194 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 0.3 OUTLIER -106.46 -7.95 17.34 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.875 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.2 mm-40 -106.51 135.14 48.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.01 -0.431 . . . . 0.0 110.998 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -57.02 -17.68 10.89 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.616 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.3 m -58.3 -30.0 66.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.317 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 135' ' ' ALA . 6.5 mp -74.78 -29.97 61.29 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.22 -0.3 . . . . 0.0 111.357 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -58.51 -43.57 89.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.308 0.575 . . . . 0.0 109.864 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.3 ptm -77.84 -31.22 51.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.188 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.629 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 5.0 t80 -77.45 -41.31 40.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.109 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.9 mt -98.29 -47.5 5.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 112.005 -169.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -81.03 -46.39 15.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.014 -171.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.65 154.96 20.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.182 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.7 pm0 -66.42 -29.51 69.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.739 0.781 . . . . 0.0 110.164 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.524 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -134.22 132.37 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.07 -167.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.483 HG21 ' HE3' ' A' ' 143' ' ' MET . 3.3 mp -70.66 105.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.282 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 153' ' ' SER . 14.2 t70 -83.51 99.41 10.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.048 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -71.86 11.61 0.5 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 112.309 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 151' ' ' ASP . 22.1 t -111.99 11.28 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.665 175.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 0.4 OUTLIER -62.8 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.281 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 50.4 m -94.3 114.32 63.02 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.784 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 21.9 Cg_exo -68.88 68.44 1.22 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.432 2.755 . . . . 0.0 112.067 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -140.24 -159.39 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.626 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 6.6 mmmm -88.25 158.91 18.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 59' ' ' ILE . 16.5 mm -50.35 -46.29 25.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.679 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 110.28 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.17 172.0 15.48 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.725 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.04 159.43 9.68 Favored 'Trans proline' 0 C--O 1.222 -0.31 0 C-N-CA 124.201 3.267 . . . . 0.0 111.591 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.99 -24.87 0.47 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.421 3.414 . . . . 0.0 115.452 -170.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -70.53 -62.29 1.44 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.26 0.224 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.8 m-80 61.81 -178.67 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.212 0.53 . . . . 0.0 111.632 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -97.3 140.49 31.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.551 HD22 HD12 ' A' ' 57' ' ' LEU . 13.4 tp -147.11 130.58 16.73 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.429 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.87 103.64 4.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.637 HG12 ' HB ' ' A' ' 53' ' ' VAL . 32.8 mt -115.43 143.29 25.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.01 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.84 115.68 10.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.769 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.2 m -99.25 132.52 44.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.8 t 179.31 -163.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.4 m-80 61.94 81.6 0.23 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 121.124 0.488 . . . . 0.0 110.47 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.67 152.92 59.57 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.724 2.283 . . . . 0.0 113.541 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.1 tp60 -144.84 107.78 4.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.007 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.1 m -76.52 104.3 6.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.4 p -130.86 88.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.706 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.5 -168.17 34.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.0 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.4 t -102.11 158.32 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.068 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.91 -49.78 6.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.972 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.82 87.03 4.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.118 0.485 . . . . 0.0 109.803 169.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.26 34.54 0.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.971 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.6 ttt180 -89.46 126.12 35.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -131.76 156.7 45.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.5 m -107.72 124.74 50.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.368 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 32.0 p -92.09 162.43 14.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.52 139.43 53.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.4 tt0 -91.11 118.35 30.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.571 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.8 mp -93.0 116.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 76.0 mtp180 -105.87 131.87 52.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.971 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.637 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.99 138.39 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.81 137.01 52.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.133 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 63' ' ' LYS . 13.3 t -170.31 163.74 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.272 0.558 . . . . 0.0 112.147 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HA ' ' CD ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -118.91 22.54 11.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.203 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD12 HD22 ' A' ' 29' ' ' LEU . 21.4 mt -56.3 146.71 51.11 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.723 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -9.7 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.503 2.135 . . . . 0.0 111.918 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -88.49 -40.56 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.416 -177.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.541 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.9 m-30 -69.86 -17.36 63.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HB3' HD12 ' A' ' 62' ' ' LEU . 35.7 ttpt 75.21 -71.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -75.91 -1.45 25.5 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -169.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' HG21 ' A' ' 55' ' ' THR . 4.4 mmtm 68.31 -48.09 0.54 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.092 0.87 . . . . 0.0 111.6 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.7 pp20? -156.59 140.36 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.833 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -168.71 174.97 6.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.345 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.0 m -141.12 135.62 31.1 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.238 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 HH21 ' A' ' 69' ' ' ARG . 0.2 OUTLIER -145.4 130.62 13.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.926 -173.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 31.6 ttm180 -97.93 110.89 23.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.39 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.603 HH11 HD11 ' A' ' 150' ' ' ILE . 41.4 mtt-85 -125.64 177.01 6.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.158 -172.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -92.81 156.5 16.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.823 0.344 . . . . 0.0 111.779 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.581 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.5 t80 -59.63 -34.13 72.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t -58.26 -33.4 69.36 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.924 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 150' ' ' ILE . 25.5 m-20 -65.13 -45.24 85.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.412 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 60.6 m-85 -59.81 -40.55 88.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.514 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 32.1 mt-10 -57.04 -56.3 23.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.391 0.615 . . . . 0.0 111.096 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.464 ' CD1' HG23 ' A' ' 150' ' ' ILE . 0.6 OUTLIER -68.41 -28.98 67.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.525 -178.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -68.23 -42.77 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.484 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 55.8 ttt180 -57.89 -62.52 1.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.278 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -63.15 -27.42 69.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.545 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.96 -42.06 77.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 85' ' ' SER . 97.1 mt -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.632 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -90.18 -41.44 11.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.693 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 3.4 ppt_? -78.67 -35.21 45.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 6.0 mm-40 -101.73 -26.82 13.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.986 0.422 . . . . 0.0 111.779 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -112.38 167.8 10.15 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.451 -169.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -105.33 21.14 17.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.439 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG23 HD21 ' A' ' 81' ' ' LEU . 87.3 t -53.68 144.91 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.907 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 88' ' ' VAL . 5.4 p -72.64 31.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.081 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.484 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -52.42 119.51 15.32 Favored Pre-proline 0 N--CA 1.467 0.407 0 O-C-N 122.228 -0.295 . . . . 0.0 111.367 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HG3' ' CD ' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -88.21 168.37 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.868 2.379 . . . . 0.0 111.884 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 148.65 84.02 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.503 2.136 . . . . 0.0 112.495 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 75' ' ' GLU . 67.6 mt -77.22 154.83 82.33 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.641 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 61.0 Cg_endo -83.06 142.12 10.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.73 -163.35 36.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.277 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 68.06 -60.53 0.41 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 112.234 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.29 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -62.09 -16.1 49.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.471 -168.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 98' ' ' LEU . 2.2 mm? -69.5 -37.47 77.22 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.597 -174.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 12.81 32.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.316 0.579 . . . . 0.0 109.931 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.558 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.4 tp-100 -97.58 -38.97 9.34 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.771 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.07 166.87 32.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.859 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.2 142.0 90.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.804 2.336 . . . . 0.0 111.553 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.26 5.5 37.98 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.261 0.553 . . . . 0.0 110.876 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -70.33 -14.25 62.5 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.358 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.4 -178.49 38.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.571 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.08 -45.3 94.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -151.38 -27.98 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.884 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 -0.34 12.97 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.723 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.6 pt -74.81 -15.39 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -84.22 -7.3 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.382 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.25 135.84 36.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.312 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -30.81 71.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.31 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.63 -58.5 6.74 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.723 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -51.5 -48.25 62.97 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.412 0.445 . . . . 0.0 111.101 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.8 mt -50.57 -51.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.218 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.76 -20.62 56.27 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.642 -177.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.562 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 21.2 mm-40 -75.09 -33.27 61.62 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.229 0.538 . . . . 0.0 109.878 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 9.8 tpp180 -78.7 -38.22 39.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.03 -52.27 59.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 -178.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.771 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.62 -41.65 95.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.111 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -80.34 -32.25 35.37 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.5 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.5 tp -67.55 -40.45 84.96 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.799 -0.201 . . . . 0.0 111.156 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.527 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 12.6 pt-20 -72.09 -32.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.771 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.7 mm-40 -61.34 -57.75 11.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.449 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.3 t80 -50.12 -52.1 37.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.758 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.504 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -64.7 -42.04 93.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.928 -170.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -60.64 -17.78 49.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.476 ' CD ' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -88.2 -57.98 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.869 0.842 . . . . 0.0 110.395 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.515 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -65.36 -12.83 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.181 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.32 6.25 28.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.366 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.09 15.94 1.52 Allowed Glycine 0 C--N 1.332 0.352 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.883 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.731 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 50.1 t60 -100.26 144.38 28.31 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 117.328 0.564 . . . . 0.0 110.385 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.731 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 21.2 Cg_exo -38.95 -49.12 2.8 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.403 3.402 . . . . 0.0 113.827 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.677 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -70.94 -39.5 72.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.138 -175.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' ASN . . . -68.02 -41.01 82.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.716 -175.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -70.8 4.82 2.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.735 0.779 . . . . 0.0 109.846 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.7 t-20 -119.24 4.3 11.29 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.1 mm-40 -117.26 128.14 54.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.446 ' HA ' HD12 ' A' ' 159' ' ' ILE . 20.0 tpt180 -54.81 -16.56 2.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.817 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.672 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.9 m -55.5 -28.73 56.38 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.075 0.55 . . . . 0.0 111.461 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.593 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.0 mp -78.75 -29.42 45.19 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.341 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 52.6 t-80 -56.79 -39.55 74.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.7 ptm -79.59 -31.41 41.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.685 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -81.39 -36.12 29.93 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -94.02 -37.7 11.52 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.137 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.2 mt-30 -94.59 174.12 7.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.54 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.0 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -102.72 -30.71 10.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.55 0.691 . . . . 0.0 110.666 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -138.69 158.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.132 -167.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.603 HD11 HH11 ' A' ' 69' ' ' ARG . 2.2 mp -86.85 123.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.638 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.7 106.53 18.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.215 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.458 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 9.4 mptt -77.2 11.24 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.213 0.53 . . . . 0.0 112.158 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 t -126.33 18.01 7.63 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -170.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.277 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.5 m -82.26 112.65 37.8 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.458 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.87 61.34 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.358 2.705 . . . . 0.0 112.675 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.0 m -136.86 -157.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 122.309 -0.244 . . . . 0.0 110.841 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -87.08 158.82 19.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 119.907 -0.092 . . . . 0.0 110.83 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 59' ' ' ILE . 17.5 mm -52.2 -49.95 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.287 0.565 . . . . 0.0 110.539 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.875 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.419 ' CB ' ' HB2' ' A' ' 56' ' ' ASN . 38.6 m-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.52 172.36 45.39 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.88 157.47 10.34 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.859 3.039 . . . . 0.0 112.48 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.29 -18.36 0.73 Allowed 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.997 3.798 . . . . 0.0 115.439 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -69.91 -61.58 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.564 ' OD1' HD22 ' A' ' 57' ' ' LEU . 26.8 m120 61.44 164.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.311 0.644 . . . . 0.0 112.675 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -89.65 143.43 26.81 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.599 HD21 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -147.77 126.66 12.72 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.08 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.2 pt-20 -133.29 100.04 4.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.12 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.646 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.1 mt -113.08 137.55 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.235 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.82 112.9 11.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.345 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.562 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -92.68 130.97 40.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 t -179.9 -163.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.1 m-80 60.32 77.22 0.38 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.477 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.58 150.67 86.35 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' THR . 46.8 tp60 -135.75 110.66 8.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.955 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 m -74.56 98.21 3.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 109.41 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.12 91.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.51 -167.58 32.72 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.86 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -109.77 148.89 13.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 119.41 -0.328 . . . . 0.0 110.36 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.91 -49.93 4.2 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 121.599 -0.334 . . . . 0.0 112.841 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.59 85.34 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.991 0.425 . . . . 0.0 109.89 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.92 39.02 0.67 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.914 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.3 ttp180 -85.94 150.01 24.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 122.487 0.315 . . . . 0.0 110.252 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -149.83 171.27 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.826 0.346 . . . . 0.0 110.798 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 74.0 m -124.63 126.56 45.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.711 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 21.1 p -92.69 161.53 14.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.66 0.267 . . . . 0.0 110.35 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -123.26 140.98 52.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.297 0.57 . . . . 0.0 110.838 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.1 tt0 -92.4 121.06 33.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.073 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -97.52 119.07 45.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.612 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 93.6 mtt180 -109.18 142.05 40.53 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.36 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.646 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.71 142.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 25.2 ttmt -133.81 142.35 47.82 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.527 168.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.591 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 10.1 t -170.12 163.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.72 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.581 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -112.69 20.22 16.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.81 169.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.599 HD11 HD21 ' A' ' 29' ' ' LEU . 30.6 mt -58.71 147.85 69.67 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.4 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -84.6 -30.75 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.808 1.672 . . . . 0.0 112.075 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -61.26 -43.16 95.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 178.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.574 ' CE1' HD12 ' A' ' 57' ' ' LEU . 2.8 m-30 -65.7 -33.56 76.17 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 75.54 -53.72 0.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -81.1 -12.12 59.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 122.017 -0.427 . . . . 0.0 110.392 -176.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 55' ' ' THR . 10.6 mmmm 68.51 -44.55 0.51 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 124.094 0.871 . . . . 0.0 111.09 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -141.36 141.78 33.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 t -170.48 157.48 5.97 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.129 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.5 m -141.85 130.06 22.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 0.0 110.873 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.7 173.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.599 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -137.26 109.93 7.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.433 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 21.4 mmm180 -127.67 179.6 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.586 -175.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -100.22 165.72 11.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.787 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.545 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.1 t80 -53.72 -39.63 65.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.062 174.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.419 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 34.1 m -53.18 -36.65 61.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.622 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' CG ' ' HB3' ' A' ' 69' ' ' ARG . 4.2 m-20 -64.37 -41.64 96.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -64.44 -37.79 88.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.411 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 27.6 mt-10 -60.12 -55.65 31.24 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.38 0.61 . . . . 0.0 111.19 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.408 ' CD1' HG23 ' A' ' 150' ' ' ILE . 3.5 t-105 -67.74 -27.54 66.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.25 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -69.04 -47.47 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.6 ttt180 -55.68 -61.35 2.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.359 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 t -61.63 -27.71 68.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.382 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.6 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.8 tp10 -73.38 -47.23 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.339 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.96 -35.65 73.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 110.751 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 37.6 mt-10 -64.61 -37.58 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.439 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.5 ppt_? -91.36 -28.39 17.74 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.39 -30.87 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.515 ' HB3' HG22 ' A' ' 87' ' ' VAL . 24.3 t -144.32 -175.11 4.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 110.921 -171.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -100.36 26.81 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.204 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 85' ' ' SER . 74.7 t -52.46 139.68 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.308 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.401 ' O ' HG11 ' A' ' 88' ' ' VAL . 8.7 p -73.41 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.988 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -53.15 121.32 23.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 O-C-N 122.023 -0.423 . . . . 0.0 110.565 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.0 Cg_endo -85.77 162.94 10.61 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.605 2.203 . . . . 0.0 112.401 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 29.6 Cg_endo -63.57 146.24 92.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.765 2.31 . . . . 0.0 112.191 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 75' ' ' GLU . 97.6 mt -74.3 142.9 79.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.9 Cg_exo -73.94 117.56 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.885 2.39 . . . . 0.0 111.224 176.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.09 61.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.257 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.43 -45.35 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.01 -85.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -49.45 -32.03 11.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.579 1.152 . . . . 0.0 113.979 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -57.46 -47.3 82.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.07 27.83 8.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.618 0.723 . . . . 0.0 110.145 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -122.96 -32.73 3.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.871 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.53 168.12 12.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.31 156.26 66.96 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.865 2.376 . . . . 0.0 111.551 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -79.2 -90.42 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.498 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 64.97 -72.0 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.637 0.586 . . . . 0.0 111.344 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.02 65.16 4.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 66.57 -71.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.297 1.039 . . . . 0.0 111.326 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.83 -19.18 12.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.338 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.28 8.47 31.09 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 50.3 pt -75.56 -17.39 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.819 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -79.35 -15.43 57.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.031 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.8 132.41 41.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.155 0.503 . . . . 0.0 109.884 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.48 -27.3 69.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.717 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 50.2 m-80 -65.83 -52.43 50.63 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -53.95 -49.4 68.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.522 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.6 mt -52.57 -48.7 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.925 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.13 -21.85 59.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.605 -178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 46.8 mm-40 -73.66 -33.86 64.67 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.621 0.724 . . . . 0.0 109.634 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.79 -35.82 43.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.433 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -57.24 -53.12 61.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.11 -178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -61.17 -45.0 96.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.605 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.17 -43.41 95.52 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.804 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -32.14 70.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.629 0.715 . . . . 0.0 111.599 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.563 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 14.9 pt-20 -74.92 -33.3 61.98 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.0 mm-40 -59.88 -57.64 12.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.513 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.2 t80 -51.68 -53.31 40.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.499 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.532 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.9 tp -64.41 -39.95 87.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.018 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.58 -20.49 60.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 112.026 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.0 mttm -88.46 -56.26 3.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.667 0.746 . . . . 0.0 110.899 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.5 m -66.9 -11.73 14.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.025 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.07 -11.7 16.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.499 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.482 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -122.65 -6.17 8.04 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.936 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.734 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.6 t60 -84.09 143.55 42.85 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 117.328 0.564 . . . . 0.0 110.633 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.734 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 17.2 Cg_exo -39.33 -50.03 2.95 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.514 3.476 . . . . 0.0 113.813 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.42 -30.71 66.38 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.352 -174.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -77.0 -44.54 30.55 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.45 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.57 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.14 -0.76 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.421 176.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.575 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 2.5 t30 -104.11 -21.13 13.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.409 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 17.9 mm-40 -102.11 143.12 32.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.905 0.775 . . . . 0.0 112.627 -166.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -62.85 -21.25 65.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.513 -166.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.545 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 1.9 t -60.41 -26.15 66.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.23 0.538 . . . . 0.0 110.076 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 135' ' ' ALA . 4.6 mp -71.48 -28.51 63.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.342 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.82 -47.18 86.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.5 ptm -72.44 -30.64 64.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.521 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t80 -75.92 -48.37 21.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.651 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 1.6 mt -96.97 -43.68 7.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.558 . . . . 0.0 111.545 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 62' ' ' LEU . 54.4 mt-30 -91.43 -15.51 28.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.573 -166.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -111.43 174.64 5.77 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -79.15 -32.72 44.43 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.089 0.947 . . . . 0.0 110.013 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.465 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -139.9 143.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.132 -167.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.509 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.9 mp -71.58 106.67 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.036 173.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 104.02 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.897 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -69.16 -1.01 6.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.9 p -113.24 18.03 18.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.471 0.653 . . . . 0.0 110.596 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.441 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -64.3 -171.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.604 178.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.7 m -86.45 112.12 44.06 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.14 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 22.1 Cg_exo -69.38 82.43 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.403 2.735 . . . . 0.0 111.621 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 m -156.73 -153.58 0.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -105.02 177.65 4.79 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.697 177.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 59' ' ' ILE . 17.1 mm -66.78 -36.16 76.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.589 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.496 -174.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.185 0.517 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 -179.68 43.01 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.44 154.92 7.82 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.531 2.821 . . . . 0.0 111.499 173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.49 -7.71 2.27 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.798 2.998 . . . . 0.0 113.953 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 p -77.12 -53.58 7.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.589 ' OD1' HD23 ' A' ' 57' ' ' LEU . 28.7 m120 62.85 170.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.671 0.607 . . . . 0.0 111.494 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.65 134.9 33.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.543 HD22 HD11 ' A' ' 57' ' ' LEU . 14.9 tp -142.17 130.25 22.01 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.114 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -141.46 101.11 3.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.824 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.645 HG12 ' HB ' ' A' ' 53' ' ' VAL . 42.9 mt -115.07 140.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -132.59 106.92 8.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.938 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -84.6 130.64 35.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 170.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -179.1 -164.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 59.2 71.75 0.9 Allowed Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 110.284 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.39 133.37 37.15 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.088 2.525 . . . . 0.0 113.487 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 44.0 tp60 -117.65 106.96 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.686 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -78.22 90.1 4.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.554 0.692 . . . . 0.0 109.953 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -117.29 91.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.612 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.45 -166.28 31.53 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.399 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.1 t -101.2 146.94 8.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.346 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.34 -48.13 4.6 Favored Glycine 0 N--CA 1.465 0.584 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.245 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -102.22 88.21 3.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.39 0.614 . . . . 0.0 109.713 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.9 0.93 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.575 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 13.8 ttt180 -85.31 139.86 31.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 39.3 p90 -129.72 153.57 48.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 86.7 m -111.31 124.08 51.5 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.0 p -92.74 153.58 18.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.117 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.26 136.45 51.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.02 0.438 . . . . 0.0 110.765 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 29.3 tt0 -90.58 116.6 28.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 mp -94.27 113.75 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.865 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HG2' ' OG1' ' A' ' 66' ' ' THR . 66.4 mtt180 -105.53 121.98 45.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.843 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -128.9 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.0 111.882 -177.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -127.92 133.74 49.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 63' ' ' LYS . 7.1 t -168.27 165.44 12.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.595 0.712 . . . . 0.0 112.121 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.493 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.94 21.63 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.752 167.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.589 HD23 ' OD1' ' A' ' 27' ' ' ASN . 26.7 mt -56.14 131.96 74.81 Favored Pre-proline 0 CA--C 1.521 -0.163 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.801 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 11.7 Cg_exo -66.82 -37.94 18.97 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.413 2.076 . . . . 0.0 111.186 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 HG23 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -58.2 -42.43 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.448 176.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CE1' HD12 ' A' ' 57' ' ' LEU . 3.8 m-30 -68.87 -23.69 64.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.47 -64.57 0.34 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -73.44 -25.68 60.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -174.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 55' ' ' THR . 19.2 mmtp 82.02 -34.24 0.1 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.822 171.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.32 125.19 1.82 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.546 0.688 . . . . 0.0 110.08 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.7 t -170.71 176.13 4.34 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.751 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.549 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 27.9 m -141.73 133.19 26.72 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.3 178.35 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.301 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -143.24 106.08 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -127.41 167.59 16.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.449 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.584 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 58.0 ttp180 -94.82 165.13 12.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.002 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.507 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.2 t80 -52.52 -40.73 62.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.621 0.248 . . . . 0.0 110.809 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -54.17 -35.5 62.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.7 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.65 -41.51 96.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.97 -38.02 89.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 22.3 mt-10 -60.71 -52.12 66.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.376 0.607 . . . . 0.0 110.935 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.518 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 8.3 t-105 -67.26 -27.53 67.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.283 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -71.32 -46.58 60.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 53.5 ttt180 -58.17 -58.63 7.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.266 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 p -62.74 -32.28 73.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.453 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 1.1 tm-20 -59.4 -48.0 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.0 110.264 176.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.556 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 92.5 mt -65.4 -30.05 70.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.942 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 40.0 mt-10 -82.03 -35.53 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.988 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 2.6 ppt_? -69.59 -25.14 63.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.53 -55.06 2.14 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.056 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.495 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 75.7 m -87.21 171.09 10.91 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.754 0.787 . . . . 0.0 112.221 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -102.66 30.61 4.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 134' ' ' LEU . 99.0 t -50.8 142.23 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.699 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 88' ' ' VAL . 6.5 p -72.01 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.726 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -58.74 119.66 39.06 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.435 . . . . 0.0 110.882 -176.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 91.9 Cg_endo -85.5 162.12 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.882 2.388 . . . . 0.0 112.288 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 135.03 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.988 2.458 . . . . 0.0 112.661 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 75' ' ' GLU . 93.5 mt -66.19 151.26 95.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.401 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.49 113.01 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.635 2.223 . . . . 0.0 111.248 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.48 166.57 37.08 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.635 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.59 25.7 10.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.536 0.684 . . . . 0.0 110.925 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -116.63 -74.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.016 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -69.96 -22.29 63.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.02 -176.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -66.83 -47.0 73.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.517 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -92.98 28.74 2.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.842 0.829 . . . . 0.0 110.051 176.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.6 tp-100 -124.7 -41.29 2.14 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.854 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.74 165.63 20.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.08 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 179.54 3.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.2 2.6 . . . . 0.0 111.966 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.94 -75.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.009 0.433 . . . . 0.0 110.2 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 68.06 -57.48 0.47 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.063 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.31 -159.26 25.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.717 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.09 -48.24 82.34 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.407 0.622 . . . . 0.0 110.719 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.88 -21.85 2.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.438 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.82 11.15 38.4 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 49.8 pt -90.96 -17.93 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.723 -173.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -82.9 10.44 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.357 0.599 . . . . 0.0 109.789 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.88 126.94 40.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.332 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.0 -21.16 65.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.628 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.4 m-80 -71.45 -55.14 8.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -50.82 -50.06 57.31 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.616 0.572 . . . . 0.0 111.129 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.96 -48.99 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.653 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -81.69 -14.84 56.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.913 -177.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 35.7 mm-40 -69.44 -35.13 75.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.3 0.571 . . . . 0.0 109.698 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.6 ttp180 -79.44 -34.32 41.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.212 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -57.41 -51.29 70.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.631 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -61.2 -37.63 83.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.311 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.6 -33.3 25.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.388 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.8 tp -66.6 -38.02 86.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.181 0.192 . . . . 0.0 110.945 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.564 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.8 pt-20 -71.28 -30.87 66.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.776 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 22.0 mm-40 -61.16 -59.64 5.01 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.44 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.5 t80 -48.47 -52.52 21.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.963 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.515 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -64.08 -40.28 88.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.79 -172.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.09 -18.02 44.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.1 -59.24 2.28 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.827 0.822 . . . . 0.0 110.396 175.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 81' ' ' LEU . 1.3 m -63.45 -12.46 10.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.64 -0.89 27.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.436 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.46 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.73 11.94 2.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.685 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.711 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 38.3 t60 -101.57 141.34 22.39 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.474 -0.427 . . . . 0.0 110.82 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.711 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 7.9 Cg_exo -41.27 -50.47 4.42 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.365 3.377 . . . . 0.0 113.79 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.447 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.64 -26.24 64.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.16 -174.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -84.47 -41.67 16.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.651 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.3 mm100 -66.29 -4.68 8.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.201 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.9 t-20 -106.26 0.77 25.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.438 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.495 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 5.1 mm-40 -112.26 127.46 55.98 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.999 -0.438 . . . . 0.0 110.986 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' HA ' HD13 ' A' ' 159' ' ' ILE . 13.7 tpp85 -57.98 -21.53 45.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.42 -172.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.797 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 4.3 t -61.88 -22.78 65.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 110.537 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.506 ' O ' HD21 ' A' ' 145' ' ' LEU . 7.3 mp -72.76 -32.46 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.096 -0.378 . . . . 0.0 111.441 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.625 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 18.8 t60 -58.0 -44.1 87.0 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.363 0.602 . . . . 0.0 109.643 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.797 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -77.83 -24.4 48.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.174 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.4 t80 -80.37 -57.18 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.83 -24.81 26.59 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.686 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.625 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.4 mt-30 -109.16 158.76 17.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.375 -168.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 62.51 -107.06 0.22 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.258 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -146.26 -39.78 0.22 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -139.85 151.78 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -161.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.517 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -77.59 109.11 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.314 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.59 102.3 15.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.931 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 31.6 mmtp -66.25 -5.42 10.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -106.9 18.19 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.311 0.577 . . . . 0.0 110.123 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.32 -170.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.951 -179.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.6 m -87.84 111.6 43.41 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.136 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.7 Cg_exo -70.72 81.68 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.247 2.631 . . . . 0.0 111.785 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.6 m -155.56 -159.24 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.264 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 18.1 mmmt -84.92 167.31 16.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.475 HG23 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.77 -45.17 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.661 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.3 m-85 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.66 172.23 38.18 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.753 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.92 156.56 6.93 Favored 'Trans proline' 0 C--O 1.224 -0.207 0 C-N-CA 124.16 3.24 . . . . 0.0 112.223 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -42.64 -22.51 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 124.81 3.673 . . . . 0.0 115.728 -171.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -72.0 -61.51 1.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.1 m-80 60.95 -178.26 0.11 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.932 0.396 . . . . 0.0 111.523 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.42 130.52 35.76 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 57' ' ' LEU . 18.6 tp -145.1 129.56 17.89 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.041 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -143.04 100.09 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.9 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.657 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.8 mt -111.07 146.05 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.442 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.2 114.99 11.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.719 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.1 m -97.14 132.36 41.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.53 -161.73 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.94 71.87 0.7 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.738 0.304 . . . . 0.0 110.524 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HG3' HG22 ' A' ' 115' ' ' ILE . 51.3 Cg_endo -67.19 132.66 28.39 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.777 2.318 . . . . 0.0 113.183 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.1 tp60 -122.25 111.65 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.569 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.9 m -75.87 98.14 4.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 109.541 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -130.04 94.45 2.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.873 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -170.64 -167.77 31.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.515 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 4.0 t -110.23 151.48 12.44 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.171 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.27 -49.1 4.58 Favored Glycine 0 N--CA 1.46 0.272 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.465 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.23 78.68 3.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.351 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.61 41.12 0.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.945 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.532 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 6.2 ttp180 -82.28 145.85 29.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -146.95 159.67 43.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.069 0.462 . . . . 0.0 111.072 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.6 m -112.36 128.79 56.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.928 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 20.1 p -92.29 146.22 23.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.002 0.429 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 78.9 m-85 -108.18 132.56 53.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.996 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 32.0 tt0 -87.14 119.06 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.73 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.467 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 3.1 mp -94.09 111.67 25.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.104 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 91.6 mtt180 -104.66 132.64 50.67 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.141 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.9 138.44 34.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -125.74 133.91 51.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.596 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.481 HG22 ' CD2' ' A' ' 60' ' ' PHE . 15.0 t -166.3 164.24 17.6 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.422 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.84 25.78 10.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.682 167.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 29' ' ' LEU . 29.4 mt -61.42 133.58 93.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.496 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.8 Cg_exo -70.66 -32.01 15.56 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.462 2.108 . . . . 0.0 111.262 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -63.62 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.963 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.519 ' O ' HD21 ' A' ' 62' ' ' LEU . 3.8 m-30 -71.07 -19.16 62.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 tttp 71.19 -64.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 170.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.29 -5.52 56.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -174.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' O ' HG21 ' A' ' 55' ' ' THR . 4.9 mmpp? 71.22 -38.41 0.42 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.769 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -160.35 135.94 8.22 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.014 0.435 . . . . 0.0 110.038 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -170.08 175.45 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.585 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.8 m -140.83 141.67 34.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.776 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.86 -179.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 40.7 ptt180 -150.37 126.97 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.14 0.495 . . . . 0.0 111.106 171.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.492 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.0 mmp_? -139.36 167.24 22.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.802 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.41 156.6 20.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -51.72 -39.34 58.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.723 0.297 . . . . 0.0 110.744 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.9 m -54.17 -32.77 56.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.863 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.13 -35.85 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CZ ' HD12 ' A' ' 51' ' ' ILE . 51.5 m-85 -64.52 -39.59 94.06 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' HD13 ' A' ' 92' ' ' LEU . 15.7 mt-10 -60.09 -51.6 68.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -65.44 -27.46 68.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.256 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.582 HD21 ' CD2' ' A' ' 144' ' ' PHE . 34.4 tp -72.08 -48.46 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 43.3 ttt180 -53.98 -59.38 4.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.839 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.626 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 p -60.06 -40.3 89.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.033 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.6 -52.57 59.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.594 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 87.6 mt -65.51 -34.8 79.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.383 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 35.0 mt-10 -70.06 -43.96 70.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 79' ' ' SER . 20.6 mmt180 -76.73 -48.07 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.177 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.81 -23.07 31.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.044 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.6 t -132.79 -177.52 4.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.408 0.623 . . . . 0.0 111.237 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -108.54 18.24 21.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.217 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 89' ' ' VAL . 90.1 t -48.89 141.13 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.287 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.1 p -71.91 38.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.466 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.517 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -55.99 118.88 22.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.163 -0.335 . . . . 0.0 110.774 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 161.62 14.17 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.845 2.363 . . . . 0.0 111.976 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.62 139.22 62.77 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.716 2.277 . . . . 0.0 112.223 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 75' ' ' GLU . 90.9 mt -70.27 154.96 94.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.857 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.06 110.07 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 0.0 110.919 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.3 171.32 39.8 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.297 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 56.91 51.28 10.92 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.445 0.64 . . . . 0.0 110.125 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.29 -83.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.543 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.531 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -64.1 -17.96 63.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.814 -174.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 97' ' ' PHE . 2.0 mm? -65.85 -41.58 91.53 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.983 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 24.97 7.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.882 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -96.64 -48.92 5.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.446 -177.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -92.85 165.34 19.04 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.696 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.554 ' N ' HD23 ' A' ' 101' ' ' LEU . 24.0 Cg_exo -59.96 -78.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.489 2.793 . . . . 0.0 113.217 -175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -149.36 -88.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.457 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 67.3 -56.12 0.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.694 0.798 . . . . 0.0 112.632 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.68 170.01 20.02 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.546 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.71 -53.52 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.049 0.54 . . . . 0.0 111.051 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.61 -4.86 19.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.94 58.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.766 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.4 pt -73.57 -14.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.205 -0.498 . . . . 0.0 111.673 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -84.34 1.07 46.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.756 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -103.8 136.59 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.27 -25.57 65.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.638 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -61.85 -61.4 2.52 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.766 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.2 -50.43 38.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.354 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.403 HG22 ' HG3' ' A' ' 36' ' ' PRO . 55.5 mt -51.59 -53.89 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -174.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.18 -20.1 60.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.494 -177.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 65.2 mm-40 -74.26 -33.62 63.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.27 0.557 . . . . 0.0 109.639 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.1 tpp180 -76.64 -40.12 50.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -53.02 -51.44 61.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.859 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.747 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -61.46 -36.26 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.819 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.65 -33.1 10.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.699 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.1 tp -67.39 -36.35 81.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.978 -0.13 . . . . 0.0 111.083 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.624 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.7 pt-20 -72.37 -28.84 63.27 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.747 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 18.2 mm-40 -65.18 -61.34 2.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' O ' HG12 ' A' ' 129' ' ' VAL . 5.5 t80 -44.01 -52.98 6.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.89 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -62.81 -41.15 91.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.476 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -59.29 -17.42 28.77 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -90.47 -58.08 2.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.734 0.778 . . . . 0.0 110.452 175.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -64.47 -12.5 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.884 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.63 0.45 26.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.376 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.477 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.33 13.89 2.29 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.026 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.684 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 55.2 t60 -101.21 141.83 23.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 117.156 0.478 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.684 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.72 -49.49 5.36 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 124.014 3.143 . . . . 0.0 113.523 -173.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.31 -33.17 73.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.331 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -74.08 -41.29 61.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.822 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -70.3 0.13 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.187 0.994 . . . . 0.0 109.36 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -117.28 14.86 14.85 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.242 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.58 130.52 47.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.798 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -49.51 -22.38 1.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.795 0.838 . . . . 0.0 113.002 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.692 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 2.8 m -55.4 -28.0 51.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.21 0.604 . . . . 0.0 112.13 -174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.502 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.2 mp -78.26 -34.39 49.06 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.784 -0.573 . . . . 0.0 111.735 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.8 t60 -63.12 -35.69 81.11 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.45 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.6 ptm -77.47 -28.94 52.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.452 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CD2' HD21 ' A' ' 77' ' ' LEU . 2.1 t80 -80.7 -58.57 3.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.199 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.502 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -83.12 -22.71 33.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.077 -172.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.507 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 42.6 mt-30 -120.98 179.19 4.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.711 -169.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.5 t70 65.73 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.831 0.707 . . . . 0.0 110.542 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.81 -56.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.68 0.752 . . . . 0.0 110.044 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.511 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.49 143.29 40.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.05 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.538 HG21 ' HE1' ' A' ' 143' ' ' MET . 2.9 mp -65.44 119.35 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.585 173.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.4 106.68 18.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -73.89 10.0 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -129.93 19.22 5.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -63.71 -172.31 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.015 -177.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 89.7 m -87.31 112.24 46.66 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -69.94 77.92 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.167 2.578 . . . . 0.0 111.105 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -153.73 -161.61 1.29 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 4.5 mmmm -86.83 158.72 19.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.414 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -57.16 -39.63 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.209 0.528 . . . . 0.0 110.524 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.681 -173.175 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 5.2 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.198 0.523 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.14 174.25 46.61 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -54.33 154.27 19.57 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.988 3.126 . . . . 0.0 111.486 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.47 -19.25 0.63 Allowed 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.42 3.413 . . . . 0.0 115.379 -170.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -70.46 -57.44 4.79 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.453 ' HB2' HD21 ' A' ' 57' ' ' LEU . 36.9 m-80 59.07 -178.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.469 0.481 . . . . 0.0 111.765 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -95.46 136.4 35.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 57' ' ' LEU . 13.9 tp -145.79 131.28 18.73 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.09 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.9 pt-20 -140.81 99.72 3.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.063 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.63 HG12 ' HB ' ' A' ' 53' ' ' VAL . 22.4 mt -112.06 138.81 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.24 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.09 107.72 6.23 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -83.89 136.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -179.9 -167.17 0.09 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.2 84.88 0.2 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.61 0.569 . . . . 0.0 111.479 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HG3' HG21 ' A' ' 115' ' ' ILE . 94.4 Cg_endo -76.35 119.9 5.44 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 113.738 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -102.55 106.26 16.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.386 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.459 HG22 ' HE ' ' A' ' 45' ' ' ARG . 28.5 m -78.75 89.28 4.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.685 0.755 . . . . 0.0 110.115 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 94.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.7 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.61 -167.48 32.67 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.558 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 10.1 t -104.32 152.59 6.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.177 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.1 -51.81 6.01 Favored Glycine 0 N--CA 1.461 0.347 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.188 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.56 83.15 4.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.884 0.373 . . . . 0.0 110.171 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 39.73 0.72 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.384 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.558 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 23.5 ttt180 -84.09 141.12 31.35 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 43.5 p90 -131.1 164.3 25.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.6 m -117.45 127.14 53.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.232 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.594 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 16.6 p -92.15 128.22 37.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 91.8 m-85 -90.63 131.87 36.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.458 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 29.6 tt0 -81.74 116.37 21.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.314 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.46 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 mp -92.83 109.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.707 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 27.5 mtp180 -100.29 136.09 40.72 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.765 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.63 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.49 135.67 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 112.337 -178.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -124.39 139.82 53.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.024 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.462 HG22 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -170.55 164.32 8.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.4 0.619 . . . . 0.0 112.317 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.55 27.35 8.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.949 167.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.586 HD12 HD21 ' A' ' 29' ' ' LEU . 23.0 mt -60.98 141.88 93.19 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.751 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.5 Cg_exo -76.04 -33.04 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.569 2.179 . . . . 0.0 111.524 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.6 OUTLIER -63.05 -41.91 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.807 177.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 145' ' ' LEU . 3.5 m-30 -68.95 -26.52 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.9 tmmm? 73.81 -60.64 0.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -79.69 -7.83 58.84 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.126 -0.359 . . . . 0.0 110.684 -173.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' O ' HG21 ' A' ' 55' ' ' THR . 5.4 mmtp 70.25 -40.83 0.48 Allowed 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.063 0.852 . . . . 0.0 111.24 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.9 pp20? -161.16 136.48 7.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 167.79 13.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.454 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 19.0 m -141.81 137.17 31.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.191 0.52 . . . . 0.0 111.559 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -132.74 -176.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.088 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 8.3 ptp180 -150.33 116.21 5.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.929 173.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 24.4 mmm180 -135.01 160.44 38.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.874 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 32.9 ptt180 -89.8 172.63 8.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -169.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.474 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 26.7 t80 -54.46 -41.88 69.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.247 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 t -55.42 -33.98 64.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.314 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.66 -37.47 73.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 61.7 m-85 -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.0 mt-10 -60.08 -53.48 57.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.754 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.424 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 3.1 t-105 -67.57 -27.9 67.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.403 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.0 tm? -70.49 -41.71 72.34 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 57.2 ttt180 -59.06 -60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 7.5 p -61.45 -37.13 82.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.373 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.96 -49.99 72.01 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.132 0.27 . . . . 0.0 110.755 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.6 mt -61.44 -34.36 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.909 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 32.2 mt-10 -75.22 -18.54 60.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.805 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 79' ' ' SER . 31.7 mmt180 -80.28 -62.99 1.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.208 0.528 . . . . 0.0 111.81 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -88.73 -21.52 23.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.264 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.511 ' HB2' HG22 ' A' ' 87' ' ' VAL . 16.2 m -123.75 169.39 11.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.314 0.578 . . . . 0.0 111.263 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -100.45 32.36 3.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.219 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 85' ' ' SER . 80.8 t -53.08 142.04 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.145 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.7 p -71.21 36.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.737 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.54 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -59.51 116.37 16.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 O-C-N 122.055 -0.403 . . . . 0.0 110.953 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.3 Cg_endo -85.36 162.72 11.2 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.783 2.322 . . . . 0.0 112.606 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 131.86 33.94 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.898 2.399 . . . . 0.0 112.112 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 75' ' ' GLU . 62.5 mt -63.99 152.0 88.41 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.555 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.52 129.74 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.689 2.26 . . . . 0.0 111.202 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -179.23 48.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.3 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 66.58 -58.12 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.088 0.955 . . . . 0.0 112.185 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -71.75 -22.03 61.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.499 -170.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 mm? -65.71 -45.61 82.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.005 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 22.19 8.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.388 0.613 . . . . 0.0 110.38 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -115.97 -45.56 2.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.638 -177.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 46.5 mt -82.26 169.4 18.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.521 -174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.04 145.41 73.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.743 2.295 . . . . 0.0 111.054 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.5 -71.19 0.38 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.075 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 68.83 -56.37 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.887 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.27 -169.15 37.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -53.0 -50.33 64.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.34 0.59 . . . . 0.0 111.246 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.92 -26.44 5.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.62 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.26 -13.8 8.92 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.715 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 24.9 pt -68.75 -16.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.743 -0.729 . . . . 0.0 111.44 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.94 2.15 27.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -116.08 145.31 43.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.13 0.491 . . . . 0.0 110.421 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.84 -17.5 59.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.513 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 93.2 m-20 -66.73 -60.28 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.475 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.715 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -51.42 -48.29 62.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.405 HG21 ' HG3' ' A' ' 36' ' ' PRO . 39.0 mt -50.94 -53.32 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.355 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.24 -20.14 60.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.768 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.612 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 45.4 mm-40 -73.36 -32.96 64.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.057 0.456 . . . . 0.0 110.301 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.474 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 33.4 ttm180 -80.8 -36.45 31.71 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.48 -49.83 66.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.144 -178.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.732 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.4 pt20 -58.0 -36.75 73.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 -174.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.41 -32.67 9.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.441 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.7 tp -66.35 -35.45 80.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.1 pt-20 -72.46 -35.54 68.27 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 17.8 mm-40 -56.49 -53.84 52.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.565 ' O ' HG11 ' A' ' 129' ' ' VAL . 2.6 t80 -53.39 -52.71 58.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.296 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.0 tp -64.41 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.836 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -62.11 -23.56 66.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 111.668 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.488 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 42.9 mttm -81.35 -56.19 4.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.943 0.878 . . . . 0.0 110.367 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 125' ' ' PHE . 1.5 m -68.24 -11.84 14.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.332 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.21 -2.75 19.1 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.832 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.29 -1.12 5.75 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.166 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.708 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 42.6 t60 -89.64 142.03 29.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 122.65 -0.323 . . . . 0.0 110.736 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.708 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.7 Cg_exo -41.52 -48.86 5.38 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.436 3.424 . . . . 0.0 113.659 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.431 ' C ' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.92 -26.63 64.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.347 -174.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.67 -47.75 10.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.86 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.529 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.71 -6.16 1.11 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.236 172.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.613 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -83.54 -33.72 25.41 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.519 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 7.8 pt-20 -113.57 149.98 33.69 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 117.622 -1.631 . . . . 0.0 114.547 -164.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.1 tpt180 -58.14 -21.38 46.62 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 113.138 -1.846 . . . . 0.0 112.026 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 143' ' ' MET . 7.8 t -60.97 -27.68 68.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.545 0.688 . . . . 0.0 109.896 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 145' ' ' LEU . 1.2 tp -71.56 -31.64 67.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.251 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.484 ' HA ' ' CD ' ' A' ' 146' ' ' GLN . 57.3 t60 -69.52 -29.57 67.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.636 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.55 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.7 ptm -79.68 -29.08 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.661 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.447 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 12.8 t80 -80.15 -53.62 6.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.954 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 141' ' ' LEU . 1.2 mp -105.41 -27.74 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.174 0.512 . . . . 0.0 111.792 -172.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.484 ' CD ' ' HA ' ' A' ' 142' ' ' HIS . 31.2 mt-30 -106.43 9.7 31.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.357 -164.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.2 t70 -137.86 -177.56 4.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -83.5 -33.74 25.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 119.475 1.034 . . . . 0.0 110.257 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -143.62 143.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.643 -167.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.55 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.4 mp -75.04 108.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.924 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.8 108.36 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.424 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 28.8 mmtp -73.53 10.68 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -130.92 19.71 5.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.032 0.444 . . . . 0.0 110.142 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.453 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 0.5 OUTLIER -65.15 -174.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.308 -176.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 96.4 m -79.46 112.47 29.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -71.56 43.94 0.57 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.762 2.975 . . . . 0.0 113.143 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 31.9 m -115.01 -158.96 0.69 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 23.3 mmmt -101.07 170.02 8.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.216 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.525 HG12 ' C ' ' A' ' 138' ' ' GLU . 20.1 mm -60.15 -42.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.6 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 32.5 m-85 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.66 175.29 36.54 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.74 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 158.92 21.53 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.823 3.015 . . . . 0.0 110.792 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.45 -19.42 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 124.635 3.557 . . . . 0.0 115.49 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 p -71.97 -59.94 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.441 0.296 . . . . 0.0 110.446 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.506 ' HB2' HD22 ' A' ' 57' ' ' LEU . 45.7 m-80 61.7 -178.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.357 0.598 . . . . 0.0 112.153 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -98.35 145.37 26.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 57' ' ' LEU . 16.6 tp -150.02 130.19 13.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.835 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.8 pt-20 -139.06 112.39 8.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.987 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.599 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.7 mt -122.27 135.81 61.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.793 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.31 117.37 18.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.334 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t 178.98 -162.11 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.5 m-80 63.87 83.5 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-O 120.969 0.414 . . . . 0.0 110.322 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.6 123.76 9.29 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.424 2.082 . . . . 0.0 113.329 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.567 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 27.2 tp60 -110.63 102.71 11.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 HG21 ' NE ' ' A' ' 45' ' ' ARG . 27.9 m -77.5 102.06 6.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.342 0.591 . . . . 0.0 109.748 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -132.36 89.83 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.735 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.01 -166.76 31.96 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.883 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.5 t -98.69 154.96 3.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.442 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.61 -54.3 4.93 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.508 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -95.01 85.38 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 32.04 1.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.588 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.557 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 15.5 ttt180 -77.42 136.91 38.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.71 167.09 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.724 0.297 . . . . 0.0 110.41 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 m -119.56 132.3 55.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 23.4 p -92.52 127.66 38.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -93.74 131.33 39.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.976 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 20.3 tt0 -91.2 120.77 32.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.719 -173.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 mp -93.38 118.21 38.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.672 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 37.7 mtp180 -107.24 130.04 54.79 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.168 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.599 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.96 138.14 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 112.439 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -118.69 140.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.693 167.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.457 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.36 164.29 7.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.243 0.544 . . . . 0.0 111.328 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.6 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -122.36 26.75 8.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.872 168.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.579 HD12 HD21 ' A' ' 29' ' ' LEU . 18.8 mt -62.63 139.22 96.89 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.973 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.76 -41.68 5.51 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.427 2.085 . . . . 0.0 111.408 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -57.26 -42.7 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.3 m-85 -69.33 -22.44 63.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.24 -60.14 0.54 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 171.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -83.62 -11.06 57.77 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.239 0.472 . . . . 0.0 111.448 -171.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp 71.46 -43.05 0.55 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.001 0.813 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -153.23 135.16 14.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.061 178.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -170.57 172.47 5.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.658 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.57 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 8.0 m -140.79 136.38 32.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.203 0.525 . . . . 0.0 111.079 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 26.4 m -135.12 175.15 11.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.692 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 22.1 ptt180 -148.84 133.05 17.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.544 0.688 . . . . 0.0 111.864 172.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.467 ' HB3' ' CB ' ' A' ' 73' ' ' ASP . 3.1 mmp_? -136.69 158.02 45.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.4 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 13.6 ptm180 -79.27 167.41 20.97 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.65 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.55 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 34.7 t80 -52.32 -42.65 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.538 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 15.0 m -58.24 -29.62 65.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.038 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.677 ' OD1' ' HG2' ' A' ' 70' ' ' ARG . 2.2 m-20 -68.46 -38.91 81.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 51' ' ' ILE . 52.6 m-85 -66.65 -36.97 83.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 26.8 mt-10 -61.83 -51.46 68.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.947 0.88 . . . . 0.0 110.071 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.56 -29.54 70.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.406 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.632 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -74.18 -44.71 52.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 45.8 ttt180 -55.59 -57.07 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.752 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.713 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 25.0 p -62.89 -40.66 98.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.142 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 5.9 mm-40 -57.41 -38.61 74.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.457 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.0 mt -72.63 -34.34 67.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.839 0.352 . . . . 0.0 110.586 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 36.2 mt-10 -73.49 -26.33 60.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.197 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 79' ' ' SER . 28.0 mmm180 -55.24 -62.52 1.62 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.73 -2.82 10.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 26.5 t -114.02 173.97 6.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.411 0.624 . . . . 0.0 111.162 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -107.55 20.36 18.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.222 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.6 t -51.77 141.59 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.476 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' O ' HG11 ' A' ' 88' ' ' VAL . 10.0 p -73.48 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.532 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -56.38 120.18 33.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.873 -0.517 . . . . 0.0 110.9 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.442 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 92.3 Cg_endo -85.62 163.03 10.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.354 2.703 . . . . 0.0 112.269 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.55 138.18 44.95 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.793 2.329 . . . . 0.0 112.339 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 75' ' ' GLU . 90.8 mt -67.33 156.42 88.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.558 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -90.26 109.37 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.146 2.564 . . . . 0.0 111.876 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.81 70.51 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -143.01 -8.59 0.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.78 0.324 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -115.21 -84.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -171.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.79 -32.85 9.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.518 1.127 . . . . 0.0 113.688 -171.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -49.42 76.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.832 0.349 . . . . 0.0 111.568 -172.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -102.31 20.24 17.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.49 0.662 . . . . 0.0 110.483 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -113.61 -34.3 5.58 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.446 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' CD ' ' A' ' 102' ' ' PRO . 86.5 mt -83.95 176.74 3.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.471 ' CD ' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -66.27 -146.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.654 2.236 . . . . 0.0 112.238 172.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 104' ' ' ARG . 79.9 m-85 -121.0 -89.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.141 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 103' ' ' PHE . 63.1 mtt180 68.35 -48.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.799 0.687 . . . . 0.0 111.429 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.2 -150.01 8.64 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -90.08 -30.87 17.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.134 0.492 . . . . 0.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HB2' HG21 ' A' ' 109' ' ' ILE . 12.4 m-20 -111.99 -27.76 8.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.733 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 105.37 25.34 6.71 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.398 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.582 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 26.3 pt -73.23 -14.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.482 . . . . 0.0 111.749 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -77.61 -8.15 57.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.771 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.32 119.9 32.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.392 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.32 -33.03 71.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.949 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 94.4 m-20 -55.38 -56.16 23.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.236 0.335 . . . . 0.0 110.354 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -46.75 -50.75 17.62 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.564 0.54 . . . . 0.0 111.057 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.66 -51.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.07 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.54 -18.81 47.31 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.78 -177.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 33.4 mt-10 -76.36 -30.94 57.78 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 109.713 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 16.3 tpp180 -74.81 -42.57 57.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 170.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -53.95 -52.06 61.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.328 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.755 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -59.11 -36.93 76.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 -175.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 124' ' ' GLN . . . -88.85 -32.92 10.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.051 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.439 ' HB3' HG23 ' A' ' 33' ' ' VAL . 7.4 tp -67.74 -34.9 77.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.864 -0.198 . . . . 0.0 110.945 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' HG23 ' A' ' 126' ' ' ILE . 13.2 pt-20 -71.79 -31.93 67.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.755 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 21.1 mm-40 -59.07 -58.21 9.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.415 ' O ' HG12 ' A' ' 129' ' ' VAL . 1.8 t80 -51.08 -51.86 49.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.011 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -62.92 -39.68 86.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -62.5 -19.91 64.07 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 2.9 mptp? -83.36 -58.69 2.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.834 0.826 . . . . 0.0 110.063 173.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.643 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.1 m -64.84 -11.84 11.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.281 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.17 -12.12 15.45 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.433 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -128.85 3.92 6.47 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.964 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.725 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.9 t60 -91.89 142.42 26.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 117.133 0.466 . . . . 0.0 110.216 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.725 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.1 Cg_exo -41.23 -47.34 5.36 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.173 3.248 . . . . 0.0 113.364 -174.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -70.41 -34.25 72.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.098 -175.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -75.8 -45.9 33.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.348 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.587 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.49 -6.53 1.1 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 173.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.77 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t30 -95.9 -20.01 19.11 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.869 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 29.7 mm-40 -103.49 136.79 42.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -165.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HA ' HD11 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -56.98 -20.18 22.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.854 -171.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.3 m -54.76 -33.99 62.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.891 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.573 ' O ' HD22 ' A' ' 145' ' ' LEU . 8.0 mp -73.43 -34.03 65.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.109 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 27.9 t-80 -57.45 -34.9 69.46 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.185 0.517 . . . . 0.0 110.345 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.562 ' HG3' HG12 ' A' ' 150' ' ' ILE . 4.2 ptm -83.24 -30.03 28.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.632 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.0 t80 -72.7 -49.49 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -94.02 -42.74 8.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.079 -175.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 21.1 mp0 -88.01 0.75 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.849 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.516 ' OD1' HD12 ' A' ' 149' ' ' ILE . 8.8 t70 -141.8 150.89 42.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.909 0.385 . . . . 0.0 110.138 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.9 pm0 -75.11 -31.85 61.25 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.108 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.577 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -136.73 120.78 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.645 -170.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.595 HD12 ' CD2' ' A' ' 144' ' ' PHE . 11.0 mt -63.82 122.47 14.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.356 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.31 99.57 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.697 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -68.27 -3.98 12.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.866 0.365 . . . . 0.0 111.516 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.4 m -116.58 20.62 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.482 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -64.42 -171.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.93 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.3 m -82.26 111.72 30.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.448 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 19.2 Cg_exo -71.62 73.85 2.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.579 2.853 . . . . 0.0 111.987 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -152.36 -148.62 0.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.77 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -99.73 -178.0 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.93 0.871 . . . . 0.0 112.091 -176.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.48 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -76.71 -35.23 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.616 175.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.173 -171.187 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.533 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 7.6 m-85 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 121.158 0.504 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.54 43.99 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.678 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 156.23 4.96 Favored 'Trans proline' 0 CA--C 1.526 0.103 0 C-N-CA 124.32 3.347 . . . . 0.0 112.33 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.29 -8.87 0.24 Allowed 'Trans proline' 0 N--CA 1.482 0.82 0 C-N-CA 124.504 3.469 . . . . 0.0 115.213 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -71.42 -63.92 1.02 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.606 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.1 m120 59.54 172.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.669 0.605 . . . . 0.0 111.979 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -95.63 140.93 29.75 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.608 HD21 HD12 ' A' ' 57' ' ' LEU . 13.5 tp -144.88 131.26 19.68 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.343 0.592 . . . . 0.0 110.956 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.23 102.4 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.024 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.633 HG12 ' HB ' ' A' ' 53' ' ' VAL . 54.8 mt -113.49 140.01 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -139.05 112.8 8.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.174 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.1 m -96.99 133.45 38.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t 178.75 -161.64 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 66.96 78.87 0.24 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.187 0.518 . . . . 0.0 110.227 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.48 119.44 5.23 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.688 2.258 . . . . 0.0 113.355 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' THR . 43.7 tp60 -107.73 113.58 26.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.964 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 m -76.04 98.56 4.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.411 0.624 . . . . 0.0 109.478 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.34 91.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.976 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.41 -167.04 31.91 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.702 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.4 t -110.71 154.67 12.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 CA-C-O 119.28 -0.391 . . . . 0.0 109.996 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.6 3.24 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.625 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.86 88.53 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.283 0.563 . . . . 0.0 109.837 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.64 36.35 0.79 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.497 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 5.5 ttp180 -86.23 130.45 34.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.38 171.72 14.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.054 0.454 . . . . 0.0 111.361 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 98.3 m -121.79 129.64 52.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.576 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.411 ' HG1' ' HB3' ' A' ' 37' ' ' GLN . 29.2 p -92.57 130.0 38.34 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -93.43 131.5 38.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.564 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 9.8 tt0 -88.29 118.02 27.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.562 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 mp -93.18 108.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 66.7 mtp180 -92.96 135.88 33.76 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.069 173.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.633 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.56 135.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 111.868 177.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -123.88 134.87 53.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.452 HG22 ' CD2' ' A' ' 60' ' ' PHE . 13.3 t -169.48 164.45 10.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.499 0.666 . . . . 0.0 112.01 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.535 HD21 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -118.76 23.19 11.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.285 171.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.608 HD12 HD21 ' A' ' 29' ' ' LEU . 24.7 mt -57.91 141.11 81.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.955 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.56 -16.25 21.49 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.709 2.272 . . . . 0.0 111.463 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -86.12 -40.99 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.557 -178.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD2' HG22 ' A' ' 55' ' ' THR . 3.2 m-85 -70.05 -8.31 48.29 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -166.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.87 -69.79 0.17 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 167.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -84.25 -5.81 59.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.968 -0.457 . . . . 0.0 110.682 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HD2' ' CE1' ' A' ' 22' ' ' TYR . 5.0 mmtp 70.68 -43.89 0.57 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.122 0.889 . . . . 0.0 111.418 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.1 pp20? -158.86 130.03 6.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.231 0.538 . . . . 0.0 110.063 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.7 t -170.24 173.74 5.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.486 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 28.6 m -141.86 123.05 14.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.416 0.627 . . . . 0.0 111.469 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.17 179.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.105 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 30.9 ptt180 -150.45 126.85 10.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.25 0.548 . . . . 0.0 111.204 171.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -138.53 177.25 8.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.247 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -83.65 167.34 17.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.258 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.6 t80 -60.29 -39.66 87.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.531 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 18.5 m -58.55 -27.08 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.679 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -77.31 -34.22 55.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 35.8 m-85 -63.95 -38.79 92.37 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 26.2 mt-10 -57.12 -56.25 24.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.158 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -65.15 -28.39 69.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.392 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 2.9 tm? -71.63 -38.99 70.71 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 49.6 ttt180 -62.16 -61.47 2.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.042 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.534 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 8.8 p -57.52 -38.03 73.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.278 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.615 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 1.0 OUTLIER -58.31 -47.62 83.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.33 -36.67 84.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.186 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 62.5 mt-10 -69.04 -30.74 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.497 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 79' ' ' SER . 27.8 mmt180 -80.26 -58.93 2.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.661 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.85 -25.48 63.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.511 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.493 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -144.52 -178.72 6.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.725 0.774 . . . . 0.0 112.323 -177.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.86 23.38 8.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.526 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 89' ' ' VAL . 94.5 t -45.89 139.71 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.6 p -70.09 33.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.074 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.548 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -54.86 120.55 29.29 Favored Pre-proline 0 CA--C 1.531 0.241 0 O-C-N 122.134 -0.354 . . . . 0.0 111.0 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 90.1 Cg_endo -85.85 164.29 10.38 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.953 2.435 . . . . 0.0 112.584 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.6 132.1 29.86 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 75' ' ' GLU . 84.5 mt -66.97 143.81 98.18 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.452 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.11 108.63 2.52 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.416 2.077 . . . . 0.0 111.014 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . -172.68 30.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.814 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -131.89 7.64 4.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 110.503 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.16 -90.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -53.7 -29.64 40.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.459 HD21 ' HA2' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -60.85 -49.13 78.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.041 0.448 . . . . 0.0 110.58 -174.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.58 26.18 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.496 0.665 . . . . 0.0 109.922 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.3 tt0 -123.02 -36.91 2.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -176.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.9 mt -92.49 165.39 19.52 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.28 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.58 164.31 35.98 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.328 2.685 . . . . 0.0 111.257 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.17 -76.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.697 0.284 . . . . 0.0 111.474 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 69.13 -63.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.205 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.07 -150.61 26.84 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.514 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.23 -41.79 96.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.941 0.401 . . . . 0.0 110.389 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -138.28 -17.45 1.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.692 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.9 10.92 23.72 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.324 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.642 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.2 pt -83.34 -18.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 0.0 111.872 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -85.8 -2.01 57.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.252 0.549 . . . . 0.0 110.439 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.47 127.45 34.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.851 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.34 -30.83 67.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.1 m-20 -56.1 -60.29 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -53.78 -47.82 70.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.092 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.52 -47.33 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.105 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -75.05 -21.89 58.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -178.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 73.5 mm-40 -71.53 -35.57 70.74 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.262 0.553 . . . . 0.0 109.761 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 10.9 tpp180 -76.89 -35.8 57.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.4 -53.8 54.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.458 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -58.75 -40.79 84.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.067 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.16 -37.34 28.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.963 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -65.6 -34.19 77.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.564 0.182 . . . . 0.0 111.272 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 126' ' ' ILE . 7.4 pt-20 -78.09 -31.47 50.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.441 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.707 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 16.3 mm-40 -59.59 -58.58 7.98 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.517 ' O ' HG11 ' A' ' 129' ' ' VAL . 7.5 t80 -49.2 -53.32 21.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.906 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' A' ' 123' ' ' GLU . 11.0 tp -65.04 -40.75 90.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.19 -19.91 62.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 111.65 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.3 mttm -87.21 -56.61 3.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.661 0.743 . . . . 0.0 110.731 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.563 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.24 -11.65 14.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.974 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.93 -6.29 17.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.291 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.42 10.58 5.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.307 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.689 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.2 t60 -98.19 140.62 21.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.511 -0.405 . . . . 0.0 110.41 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.689 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.51 -48.86 5.36 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.306 3.337 . . . . 0.0 113.672 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.83 -33.16 73.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.323 -175.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.74 -44.41 41.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.912 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -63.82 -0.74 1.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.005 173.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.488 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -111.16 -2.87 15.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.493 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 47.1 mm-40 -112.84 132.31 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.111 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.4 tpp85 -53.82 -25.81 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.418 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 m -51.26 -34.46 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.459 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -67.4 -33.1 74.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.413 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 146' ' ' GLN . 9.5 t60 -62.5 -40.12 95.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.098 0.475 . . . . 0.0 109.748 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.6 ptm -77.95 -26.18 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.975 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.462 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 21.4 t80 -79.75 -63.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.116 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -110.83 -4.29 15.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 142' ' ' HIS . 12.0 mt-30 -117.92 23.59 11.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.853 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 148' ' ' GLU . 8.9 t70 -148.55 -142.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 147' ' ' ASP . 7.3 tp10 -121.08 -56.76 1.91 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.85 0.834 . . . . 0.0 109.511 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.479 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -129.65 139.77 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.107 -176.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.514 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -66.26 112.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 100.73 13.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.21 -7.96 10.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.1 m -108.91 17.88 21.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.415 ' CD1' ' HE3' ' A' ' 143' ' ' MET . 0.3 OUTLIER -66.49 -172.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.658 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.4 m -92.06 114.82 63.3 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.68 83.1 1.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.923 2.415 . . . . 0.0 111.251 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 89.3 p -145.85 -150.17 0.32 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.636 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.488 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 13.1 mmmt -95.4 164.07 12.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.541 HG22 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -63.89 -34.56 69.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.056 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.44 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 7.5 m-85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.01 174.98 45.42 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.162 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.14 158.37 14.99 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 124.304 3.336 . . . . 0.0 111.696 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.82 -24.99 0.89 Allowed 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.704 3.602 . . . . 0.0 115.267 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -68.81 -58.51 4.08 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' ND2' HD21 ' A' ' 57' ' ' LEU . 33.7 m-80 57.96 -170.59 0.11 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.953 0.406 . . . . 0.0 111.663 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -103.34 139.41 38.79 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.579 HD22 HD12 ' A' ' 57' ' ' LEU . 16.9 tp -150.3 131.88 14.85 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.675 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.48 99.43 3.49 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.015 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.658 HG12 ' HB ' ' A' ' 53' ' ' VAL . 29.1 mt -111.81 140.74 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.605 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.92 129.15 29.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.653 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.6 m -112.96 134.13 56.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 t 179.32 -162.58 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.3 m-80 62.77 68.86 0.94 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-O 121.132 0.491 . . . . 0.0 109.837 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.25 138.04 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.794 2.329 . . . . 0.0 113.162 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.4 tp60 -121.93 108.34 13.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.8 m -75.25 95.27 3.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.52 0.676 . . . . 0.0 109.646 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -121.9 92.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.232 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -167.23 32.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.524 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -101.34 150.17 6.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.589 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.05 -48.38 5.35 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.673 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -97.96 83.36 3.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.126 0.489 . . . . 0.0 110.01 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.35 35.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.468 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 19.7 ttt180 -83.35 127.89 34.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.679 0.276 . . . . 0.0 110.367 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -117.38 169.74 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.266 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.3 m -125.88 129.11 48.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.742 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 34.2 p -92.92 146.44 23.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.267 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 83.7 m-85 -118.5 142.64 47.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.133 0.492 . . . . 0.0 110.403 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 38.5 tt0 -90.15 117.96 29.31 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.565 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.4 mp -93.06 120.47 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.864 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 51.7 mtp180 -109.53 131.73 54.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.936 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.658 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.82 136.71 43.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.848 0.356 . . . . 0.0 111.575 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -125.93 135.07 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' O ' ' A' ' 63' ' ' LYS . 14.9 t -169.62 165.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.701 0.762 . . . . 0.0 112.763 -176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.11 26.16 9.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.768 167.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.638 HD13 ' CE1' ' A' ' 60' ' ' PHE . 18.6 mt -61.06 135.89 93.52 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.379 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -68.79 -38.01 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.405 2.07 . . . . 0.0 111.351 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 136' ' ' GLN . 0.4 OUTLIER -61.49 -40.82 87.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.14 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.638 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.0 m-85 -68.77 -25.26 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 73.25 -64.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.77 -6.03 50.6 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.899 -0.501 . . . . 0.0 110.282 -175.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.415 ' O ' HG21 ' A' ' 55' ' ' THR . 4.0 mmpp? 70.91 -37.94 0.41 Allowed 'General case' 0 C--O 1.22 -0.487 0 O-C-N 123.936 0.772 . . . . 0.0 111.452 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.8 pp20? -162.04 142.93 10.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -170.24 169.2 7.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 13.6 m -141.4 135.57 30.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.706 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.537 HG21 HH21 ' A' ' 69' ' ' ARG . 0.5 OUTLIER -147.09 134.87 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.408 -171.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 41.0 ttp180 -99.1 111.25 23.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.936 0.398 . . . . 0.0 110.139 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.539 HH11 HD12 ' A' ' 150' ' ' ILE . 56.2 mtt-85 -124.99 178.1 5.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.476 -173.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -95.23 155.98 16.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.754 0.311 . . . . 0.0 111.306 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.41 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 32.5 t80 -59.59 -37.98 79.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 109.924 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.46 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 34.4 t -59.64 -30.06 68.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.854 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.87 -39.51 83.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.525 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 51.4 m-85 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 12.8 mt-10 -71.97 -49.11 40.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.503 0.668 . . . . 0.0 110.539 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.426 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 8.8 t-105 -65.82 -28.27 68.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.71 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.49 -42.0 59.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 64.2 ttt180 -57.72 -59.2 5.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 6.4 p -60.04 -41.47 92.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.573 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.09 -45.99 79.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.674 0.273 . . . . 0.0 111.253 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.89 -40.72 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.06 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 73.5 mt-10 -65.53 -45.13 84.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.466 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.6 mmt180 -66.96 -60.78 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.92 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -77.73 -18.93 56.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.463 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 t -134.8 -175.82 4.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.472 0.653 . . . . 0.0 111.315 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -109.58 13.44 23.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.29 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 89' ' ' VAL . 99.0 t -42.09 140.16 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.518 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.8 p -71.17 36.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.857 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.513 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -57.48 119.71 34.72 Favored Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 122.046 -0.409 . . . . 0.0 111.014 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.523 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 96.1 Cg_endo -87.71 167.1 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.93 2.42 . . . . 0.0 112.488 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.5 Cg_endo -66.5 146.87 81.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.699 2.266 . . . . 0.0 112.756 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 HD12 ' HG2' ' A' ' 75' ' ' GLU . 50.0 mt -73.44 158.87 85.96 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 67.6 Cg_endo -87.5 108.86 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.754 2.303 . . . . 0.0 111.466 174.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.54 38.71 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.433 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -145.28 42.24 1.28 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.63 -83.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.158 0.504 . . . . 0.0 112.181 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -52.05 -24.78 7.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.339 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.3 mm? -61.14 -43.53 98.74 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 24.64 8.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.809 0.814 . . . . 0.0 109.686 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -120.42 -40.08 2.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.045 -177.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.65 166.24 26.03 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.356 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HG2' ' NH1' ' A' ' 104' ' ' ARG . 15.0 Cg_exo -70.4 -163.62 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.411 2.741 . . . . 0.0 112.726 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.89 -91.09 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.538 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 102' ' ' PRO . 73.1 mtm-85 65.31 -70.86 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.503 0.721 . . . . 0.0 111.855 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.53 77.15 0.32 Allowed Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.603 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.4 t0 67.84 -69.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 110.857 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -125.17 -7.21 7.1 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.17 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.22 8.53 35.76 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.704 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 48.5 pt -82.62 -18.25 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.78 -175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.18 -8.72 59.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.538 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.84 139.27 30.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.83 -22.59 64.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.69 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.579 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 12.5 m120 -63.25 -59.02 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.704 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -54.28 -48.37 71.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.728 0.299 . . . . 0.0 110.753 177.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.3 mt -52.77 -45.54 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.786 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -73.53 -23.32 59.98 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.327 -178.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 39.4 mm-40 -70.78 -32.62 69.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.447 0.641 . . . . 0.0 109.78 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.3 ttm180 -79.89 -39.65 30.02 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -54.22 -49.91 68.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.825 -178.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.703 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -59.92 -40.36 88.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.439 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -84.08 -31.82 24.93 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.065 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.541 ' N ' ' HG3' ' A' ' 93' ' ' PRO . 6.7 tp -65.61 -35.69 81.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.297 0.239 . . . . 0.0 111.063 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.549 ' HA ' HG21 ' A' ' 126' ' ' ILE . 12.9 pt-20 -76.73 -35.39 57.83 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.5 mm-40 -56.71 -55.46 33.86 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' O ' HG11 ' A' ' 129' ' ' VAL . 7.4 t80 -51.23 -54.05 29.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.732 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.3 tp -64.35 -38.22 81.99 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.161 -170.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -64.03 -21.67 66.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.523 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 39.7 mttm -85.15 -55.03 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.757 0.789 . . . . 0.0 110.763 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.38 -12.4 15.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.816 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.33 8.81 21.51 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.332 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.6 9.24 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 47.7 t60 -100.87 140.91 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.637 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.671 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.3 Cg_endo -46.17 -48.03 13.73 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.709 2.939 . . . . 0.0 112.936 -172.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.554 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.66 -30.01 69.44 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.039 -176.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -79.08 -43.79 23.45 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.655 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.9 mm100 -66.85 -7.69 23.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.245 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.59 ' ND2' ' HE2' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -92.23 -15.37 27.61 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.632 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 45.7 mm-40 -105.73 130.84 53.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.608 -170.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 159' ' ' ILE . 19.2 tpt180 -56.7 -25.87 55.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.592 -172.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 143' ' ' MET . 1.2 p -60.32 -21.24 61.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.7 mp -70.01 -35.6 74.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.878 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.593 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 36.1 t60 -56.65 -35.35 68.26 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.122 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.575 ' HG3' HG13 ' A' ' 150' ' ' ILE . 3.8 ptm -82.66 -34.0 27.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.639 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.464 ' N ' ' HG2' ' A' ' 143' ' ' MET . 11.2 t80 -82.11 -26.71 33.33 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 60' ' ' PHE . 2.3 mt -99.48 -46.89 5.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.37 0.605 . . . . 0.0 109.837 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 34.4 mt-30 -91.75 175.89 6.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.852 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 59.59 -168.92 0.15 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -98.31 -34.11 10.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.556 0.693 . . . . 0.0 110.768 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.72 166.1 15.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.35 -166.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.575 HG13 ' HG3' ' A' ' 143' ' ' MET . 1.9 mp -85.18 119.91 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.124 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -90.52 99.48 12.5 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.426 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 31.8 mmtp -67.31 -3.21 7.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.73 0.3 . . . . 0.0 111.684 -172.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.7 m -113.79 18.59 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.5 OUTLIER -66.53 -171.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.798 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.2 m -90.64 113.06 56.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.207 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.75 83.82 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.153 2.569 . . . . 0.0 111.69 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.4 m -153.36 -145.26 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.327 -0.233 . . . . 0.0 110.801 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.59 ' HE2' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -100.67 155.6 17.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 139' ' ' ARG . 19.5 mm -57.7 -41.07 78.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.516 . . . . 0.0 109.909 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.523 175.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.265 0.555 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.88 174.56 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.745 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.87 159.14 9.75 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.763 2.975 . . . . 0.0 111.533 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.65 -9.21 1.02 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.17 3.247 . . . . 0.0 114.569 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -73.49 -55.75 5.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.619 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.7 m120 61.48 169.94 0.11 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.7 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.49 130.9 34.71 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 57' ' ' LEU . 21.9 tp -141.69 129.31 21.5 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.501 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -137.81 99.36 3.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.024 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.655 HG12 ' HB ' ' A' ' 53' ' ' VAL . 44.4 mt -110.57 134.62 52.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.718 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -134.36 113.98 12.47 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -95.52 134.34 33.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t 178.43 -161.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 28.0 m-80 68.09 76.78 0.26 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HB3' HG23 ' A' ' 115' ' ' ILE . 57.6 Cg_endo -71.76 119.27 6.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.069 1.846 . . . . 0.0 112.981 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' HB3' ' HG1' ' A' ' 48' ' ' THR . 49.4 tp60 -111.89 104.71 13.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.6 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.2 m -76.03 106.51 7.67 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -133.51 89.61 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.025 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.93 -167.5 32.94 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.513 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.5 t -101.08 146.89 8.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 119.324 -0.369 . . . . 0.0 110.409 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.72 -51.42 3.96 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.13 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -98.77 89.96 4.52 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.405 0.621 . . . . 0.0 109.554 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.14 29.81 1.43 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.791 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 16.2 ttt180 -82.46 143.12 31.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.527 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 35.0 p90 -137.66 156.62 47.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.695 0.283 . . . . 0.0 110.81 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.2 m -113.78 125.15 53.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.462 . . . . 0.0 110.879 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.459 ' HG1' ' HB3' ' A' ' 37' ' ' GLN . 37.2 p -92.79 143.85 25.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.397 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -103.89 141.58 35.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.377 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 20.1 tt0 -96.19 115.42 27.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.816 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -94.27 111.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 38.0 mtp180 -96.7 141.61 29.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -147.84 136.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.179 0.514 . . . . 0.0 112.174 177.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.97 142.22 51.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.734 167.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 60' ' ' PHE . 14.0 t -171.49 164.68 6.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 111.261 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.508 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.57 21.47 13.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.766 167.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.619 HD23 ' OD1' ' A' ' 27' ' ' ASN . 28.6 mt -55.76 133.3 72.5 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.685 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 7.6 Cg_exo -68.83 -34.65 17.62 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.475 2.117 . . . . 0.0 111.39 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.488 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.53 -42.53 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CD2' HG23 ' A' ' 55' ' ' THR . 3.7 m-30 -68.29 -23.66 64.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 71.1 -61.91 0.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.8 -14.3 59.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.876 0.307 . . . . 0.0 111.021 -173.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp 71.46 -35.09 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.778 0.674 . . . . 0.0 111.302 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -144.32 145.9 32.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.0 t -169.58 153.41 5.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 7.5 m -141.11 130.56 23.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.138 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -127.1 172.9 13.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 32.5 ttp180 -138.24 109.8 7.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.963 0.411 . . . . 0.0 110.229 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' CZ ' HG21 ' A' ' 149' ' ' ILE . 7.4 tpp180 -135.7 171.82 13.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -171.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 56.6 ttp180 -96.45 158.18 15.55 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.472 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.5 t80 -51.35 -41.16 60.42 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.539 0.336 . . . . 0.0 111.0 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.49 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 33.3 p -56.57 -29.62 62.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.8 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 28.3 m-20 -77.55 -30.39 52.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.22 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 46.1 m-85 -64.04 -38.74 92.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 109.679 173.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 92' ' ' LEU . 10.9 mt-10 -65.94 -47.97 72.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.633 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.472 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 6.1 t-105 -62.34 -35.29 78.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.703 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -65.64 -44.33 86.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.2 ttt180 -58.53 -61.33 2.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.24 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -60.12 -35.12 74.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.856 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 5.5 tp10 -66.54 -44.88 81.22 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.297 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.61 -42.36 96.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.858 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 30.8 mt-10 -64.53 -33.12 75.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.953 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.6 ppt_? -90.18 -23.34 21.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -172.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.32 -41.61 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.033 0.444 . . . . 0.0 111.648 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -130.67 174.87 9.5 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.532 0.682 . . . . 0.0 111.227 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -97.12 32.5 2.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.702 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 89' ' ' VAL . 94.6 t -51.54 142.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.958 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.5 p -71.28 35.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -56.5 119.31 27.65 Favored Pre-proline 0 N--CA 1.467 0.406 0 O-C-N 121.873 -0.517 . . . . 0.0 111.167 -176.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 163.31 10.7 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.146 2.564 . . . . 0.0 112.411 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.22 135.15 39.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.886 2.391 . . . . 0.0 112.304 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 75' ' ' GLU . 81.8 mt -64.58 152.02 90.56 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.91 124.31 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.46 2.107 . . . . 0.0 110.811 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.0 175.9 47.74 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 68.91 -54.41 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.659 0.784 . . . . 0.0 112.162 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -47.57 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -172.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.475 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -65.31 -24.08 67.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.669 -170.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.3 mm? -67.4 -46.62 72.69 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.972 0.415 . . . . 0.0 110.602 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.1 ppt_? -95.89 27.26 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.469 0.652 . . . . 0.0 110.395 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -123.27 -42.39 2.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.12 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.79 168.51 11.1 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.471 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.8 140.45 46.47 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.252 2.635 . . . . 0.0 111.151 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -82.48 -75.47 0.3 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 69.78 -56.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.98 -175.91 48.9 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.516 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.44 -51.4 27.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.388 0.613 . . . . 0.0 110.656 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 109' ' ' ILE . 6.8 t70 -117.33 -32.97 4.79 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.53 176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.11 -6.55 7.72 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.289 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.707 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 33.5 pt -66.53 -15.15 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.176 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -78.04 -13.03 60.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.666 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 -17.45 63.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.934 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 47.6 m-80 -73.89 -57.87 3.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.707 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -48.51 -50.56 31.33 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.343 0.402 . . . . 0.0 110.911 178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 36' ' ' PRO . 49.4 mt -49.65 -54.81 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.331 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.69 -17.89 58.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.791 -175.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 67.9 mm-40 -73.27 -35.15 66.14 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.935 0.398 . . . . 0.0 110.481 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 32.7 ttp180 -81.2 -32.48 33.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.99 -50.67 71.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.711 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -60.43 -32.65 71.56 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.544 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 -33.58 10.01 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.734 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.3 tp -66.35 -33.36 75.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.206 0.203 . . . . 0.0 111.223 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' A' ' 126' ' ' ILE . 11.9 pt-20 -75.29 -31.85 60.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.711 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.4 mm-40 -59.97 -59.66 5.07 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.487 ' O ' HG11 ' A' ' 129' ' ' VAL . 2.6 t80 -45.84 -51.63 12.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.033 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.5 tp -65.36 -39.53 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.984 -172.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.85 -16.14 60.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -87.68 -57.8 2.81 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.914 0.864 . . . . 0.0 110.01 174.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 m -64.49 -13.12 13.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.043 -177.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.75 4.68 23.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.32 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.459 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.07 10.91 2.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.71 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.692 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 51.4 t60 -101.19 141.39 22.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 117.176 0.488 . . . . 0.0 110.665 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.692 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.4 Cg_exo -40.87 -49.01 4.51 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.131 3.221 . . . . 0.0 113.822 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.84 -25.73 63.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.441 -174.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -84.11 -40.78 17.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.926 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -68.78 -0.13 5.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.103 176.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.9 t-20 -112.14 10.9 20.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.07 131.79 50.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.002 -0.437 . . . . 0.0 111.013 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -55.67 -17.49 5.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -175.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.72 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.2 m -55.33 -31.14 61.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.699 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.57 ' O ' HD21 ' A' ' 145' ' ' LEU . 5.7 mp -73.63 -35.32 65.3 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.667 -0.646 . . . . 0.0 111.484 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 9.9 t60 -58.53 -39.22 79.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.72 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -76.02 -27.71 57.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.795 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t80 -81.03 -57.87 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -84.47 -26.21 28.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.149 -172.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 9.2 mt-30 -113.83 167.24 10.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.531 -166.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.07 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.885 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -175.04 -60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.577 0.703 . . . . 0.0 111.316 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.541 HG21 ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -121.9 144.49 30.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.868 -171.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.484 HG22 ' HE3' ' A' ' 143' ' ' MET . 3.0 mp -65.85 100.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.28 102.23 5.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.416 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.472 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 32.2 mmtp -69.88 6.55 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.707 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.4 m -120.81 18.19 11.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.357 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.74 -171.32 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.267 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.3 m -87.51 114.16 57.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.901 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -71.06 78.52 1.44 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.751 2.301 . . . . 0.0 110.951 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -155.56 -168.74 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.886 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.477 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 4.6 mmmm -80.85 157.98 25.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.92 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.488 HG13 HD12 ' A' ' 59' ' ' ILE . 15.2 mm -50.57 -42.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.155 0.502 . . . . 0.0 110.069 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.83 177.17 46.24 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.607 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.76 153.92 13.67 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 124.098 3.198 . . . . 0.0 112.307 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.92 -14.75 2.61 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.495 3.463 . . . . 0.0 115.431 -172.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -51.07 13.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.596 ' OD1' HD21 ' A' ' 57' ' ' LEU . 27.9 m120 61.27 176.83 0.11 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.021 175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -90.63 137.64 32.2 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -145.15 130.54 18.7 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.978 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.41 100.45 4.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.651 HG12 ' HB ' ' A' ' 53' ' ' VAL . 48.0 mt -111.76 142.27 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.487 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -132.86 119.39 20.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -101.21 130.44 50.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t 178.96 -162.35 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.9 m-80 64.93 76.22 0.33 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.25 147.26 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.86 2.373 . . . . 0.0 113.465 -171.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -130.99 118.85 21.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.572 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -77.56 95.9 4.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.63 0.729 . . . . 0.0 109.341 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.02 91.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.159 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.29 -167.38 33.03 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.355 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.0 t -104.3 145.14 13.39 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -37.97 -53.63 2.01 Favored Glycine 0 N--CA 1.463 0.472 0 O-C-N 123.182 0.301 . . . . 0.0 113.445 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -100.62 89.94 4.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.498 0.666 . . . . 0.0 109.435 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.48 35.26 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.573 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.77 147.31 25.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 122.957 0.503 . . . . 0.0 110.67 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -140.01 167.71 21.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.5 m -123.47 131.9 53.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 p -94.67 148.84 21.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.878 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.13 146.67 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.384 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 32.8 tt0 -103.48 121.56 43.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.366 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.0 mp -94.39 118.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.227 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 27.1 mtt180 -108.97 126.08 52.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.093 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.651 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -130.66 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.035 0.445 . . . . 0.0 112.123 -177.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.67 137.23 53.85 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.442 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.65 165.18 6.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.364 0.602 . . . . 0.0 112.227 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.61 26.07 9.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.971 168.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 60' ' ' PHE . 19.9 mt -60.88 140.33 93.58 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.38 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.4 -23.21 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.824 2.349 . . . . 0.0 111.688 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.06 -41.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.375 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.663 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 3.0 m-85 -67.26 -27.26 67.06 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -60.2 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.15 -11.12 59.77 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.282 -0.261 . . . . 0.0 111.301 -174.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp 70.9 -33.5 0.27 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.798 0.686 . . . . 0.0 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.22 139.11 25.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 48.5 t -155.59 154.09 31.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.665 -176.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 5.8 m -140.77 129.28 22.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.147 0.498 . . . . 0.0 110.427 171.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' A' ' 69' ' ' ARG . 2.7 m -139.98 145.46 26.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.04 -175.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -115.35 116.27 28.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.582 ' NH1' ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -140.13 169.02 18.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.533 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.98 170.1 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.587 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 36.9 t80 -51.76 -40.59 60.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.575 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.557 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 21.7 m -54.34 -31.87 55.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.048 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 69' ' ' ARG . 44.9 m-20 -74.38 -35.63 63.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 58.5 m-85 -66.36 -36.55 83.16 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 31.4 mt-10 -60.09 -56.05 26.45 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -64.7 -28.06 69.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.372 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.52 -46.03 56.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 46.3 ttt180 -57.29 -58.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.361 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.674 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 14.4 p -60.82 -37.47 82.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.472 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -63.3 -39.01 93.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.951 0.405 . . . . 0.0 110.731 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.573 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.3 mt -62.99 -34.07 76.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.63 -22.79 53.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 79' ' ' SER . 38.9 mmt180 -68.82 -62.23 1.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.01 0.433 . . . . 0.0 111.948 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -98.63 -18.05 18.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.236 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -126.61 166.37 17.45 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.49 0.662 . . . . 0.0 111.117 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -98.51 32.78 2.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.526 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.9 t -51.81 141.33 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.864 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.3 p -71.11 35.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.929 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.517 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -59.81 120.69 52.04 Favored Pre-proline 0 C--O 1.236 0.346 0 O-C-N 121.816 -0.553 . . . . 0.0 111.144 -176.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 72.9 Cg_endo -85.65 165.32 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.843 2.362 . . . . 0.0 112.249 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.86 141.51 65.44 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.6 2.2 . . . . 0.0 111.883 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 75' ' ' GLU . 86.8 mt -69.05 145.48 96.52 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.18 109.33 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.744 2.296 . . . . 0.0 111.479 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.32 46.94 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.003 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 59.08 18.62 6.54 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.913 0.485 . . . . 0.0 111.642 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.526 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -118.62 -81.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 0.0 111.627 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.685 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.72 -23.47 67.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.165 -176.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.486 ' H ' ' CD2' ' A' ' 98' ' ' LEU . 1.1 mm? -62.93 -48.1 80.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.942 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -94.05 20.03 8.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.138 177.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -115.22 -41.9 3.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.322 -177.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 4.5 pp -107.53 169.1 7.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.463 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.2 Cg_exo -69.47 132.07 23.01 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.482 2.788 . . . . 0.0 112.66 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.568 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 13.6 m-85 -55.92 -63.47 1.17 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.78 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 73.85 -56.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.566 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -110.98 -165.95 18.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.196 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -50.85 -47.53 60.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.22 0.533 . . . . 0.0 111.611 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 109' ' ' ILE . 4.7 t70 -120.62 -29.78 4.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.68 -13.95 6.81 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.638 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 38.2 pt -64.54 -16.31 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.571 -0.814 . . . . 0.0 112.105 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.426 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 91.5 m-85 -80.06 -9.36 59.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.677 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.33 137.29 40.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.45 -17.4 61.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.224 -173.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -69.34 -52.43 27.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.227 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.638 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -50.1 -50.63 47.76 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.478 0.486 . . . . 0.0 111.083 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.19 -52.2 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.27 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -73.48 -20.58 60.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.359 -176.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 63.3 mm-40 -72.07 -35.47 69.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 110.036 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 36.7 ttm180 -80.92 -34.98 33.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -54.44 -50.98 66.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.24 -178.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -62.19 -37.46 85.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.481 -174.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.33 -34.94 12.86 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.594 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.4 tp -67.78 -32.39 72.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 122.14 0.176 . . . . 0.0 111.228 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.553 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -75.81 -29.79 58.82 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.2 mm-40 -64.41 -54.17 36.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.1 t80 -48.85 -53.7 18.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.399 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.522 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -65.57 -40.23 87.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.878 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -61.46 -16.99 52.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.109 0.48 . . . . 0.0 111.891 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.488 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 67.2 mttt -90.45 -58.75 2.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.018 0.914 . . . . 0.0 110.69 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.3 m -66.22 -11.73 13.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.337 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.59 -0.07 20.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -132.67 6.13 5.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.407 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.704 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 30.3 t60 -100.71 143.42 26.54 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 117.028 0.414 . . . . 0.0 110.921 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.704 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 4.5 Cg_exo -43.17 -50.17 6.67 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.105 3.203 . . . . 0.0 113.266 -174.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.409 ' C ' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -67.91 -28.08 67.19 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.249 -174.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -81.28 -42.7 20.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.857 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 7.6 mm-40 -62.29 -6.25 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.932 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.8 t-20 -108.75 10.1 26.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.824 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.489 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 51.0 mm-40 -115.71 126.08 53.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.951 0.405 . . . . 0.0 111.206 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.454 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -56.14 -26.18 49.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.847 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.751 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.3 p -62.2 -24.72 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.488 ' HG ' HD11 ' A' ' 145' ' ' LEU . 2.7 mp -66.52 -33.81 76.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.653 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.519 ' HA ' ' OE1' ' A' ' 146' ' ' GLN . 33.4 t-80 -62.77 -34.85 78.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.384 -175.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.751 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -85.04 -28.16 25.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.376 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.459 ' N ' ' HG2' ' A' ' 143' ' ' MET . 31.9 t80 -81.17 -44.81 17.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.532 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.663 HD12 ' CZ ' ' A' ' 60' ' ' PHE . 4.0 mt -93.05 -45.41 7.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.625 0.726 . . . . 0.0 110.574 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.519 ' OE1' ' HA ' ' A' ' 142' ' ' HIS . 30.6 mt-30 -97.87 -172.71 2.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.652 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.13 -132.62 1.76 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.537 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.414 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -130.01 -37.56 1.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.414 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -148.33 161.35 6.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.53 0.681 . . . . 0.0 112.515 -168.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.494 ' CG2' ' HE3' ' A' ' 152' ' ' LYS . 3.8 mp -87.14 105.59 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.626 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 153' ' ' SER . 25.7 t70 -90.46 109.03 20.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.802 175.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 10.7 mptt -76.45 10.8 1.87 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.724 0.774 . . . . 0.0 111.325 -173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 151' ' ' ASP . 12.5 m -115.19 14.61 16.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.82 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -65.74 -171.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.493 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.3 m -89.38 114.0 58.68 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 23.0 Cg_exo -67.02 95.62 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.984 2.456 . . . . 0.0 110.835 174.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 9.4 t -165.95 -155.73 0.24 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.384 0.611 . . . . 0.0 110.501 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.491 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.4 mmmt -97.92 161.94 13.49 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.506 HG22 HG13 ' A' ' 59' ' ' ILE . 22.2 mm -53.74 -47.57 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.402 ' N ' ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.833 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.343 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.443 ' CD2' ' HB2' ' A' ' 56' ' ' ASN . 1.9 m-85 . . . . . 0 CA--C 1.518 -0.27 0 CA-C-O 120.447 0.165 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.66 178.37 47.95 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.42 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.92 157.36 8.09 Favored 'Trans proline' 0 C--N 1.335 -0.17 0 C-N-CA 124.288 3.326 . . . . 0.0 112.392 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.96 -19.66 0.88 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.947 3.765 . . . . 0.0 115.441 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -75.22 -53.41 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.593 ' OD1' HD21 ' A' ' 57' ' ' LEU . 26.8 m120 61.11 178.4 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.588 0.355 . . . . 0.0 111.928 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -92.96 139.27 30.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.552 HD21 HD12 ' A' ' 57' ' ' LEU . 18.3 tp -145.56 131.51 19.2 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.159 -176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 7.8 pt-20 -140.31 102.57 4.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.254 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.614 HG12 ' HB ' ' A' ' 53' ' ' VAL . 51.6 mt -114.05 140.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.345 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -137.12 108.91 7.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.6 m -85.85 129.52 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t 179.95 -164.3 0.06 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.4 m-80 53.34 67.81 3.42 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.51 164.51 14.42 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.96 2.44 . . . . 0.0 113.41 -168.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -142.82 116.26 9.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.797 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.429 HG21 ' NE ' ' A' ' 45' ' ' ARG . 45.6 m -80.17 89.22 5.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.561 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.1 98.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.145 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.9 -167.07 31.53 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.964 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.8 t -102.29 148.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.123 -176.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.73 -49.81 5.97 Favored Glycine 0 N--CA 1.461 0.351 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.51 85.27 3.58 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.51 36.27 0.86 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.699 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.564 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 18.0 ttt180 -81.31 150.07 28.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.82 168.64 19.31 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 m -124.61 126.57 45.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 111.143 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 p -93.62 153.84 18.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.233 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -124.02 142.01 51.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.877 0.37 . . . . 0.0 110.5 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.4 tt0 -94.26 121.45 35.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.133 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.7 mp -97.61 108.96 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 110.623 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 34.0 mtp180 -97.97 136.53 38.11 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.703 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.24 136.99 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -125.46 138.31 54.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.812 168.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.539 HG23 ' CD2' ' A' ' 60' ' ' PHE . 15.3 t -168.5 165.53 12.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 111.834 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.487 HD21 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -119.1 24.34 10.84 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.812 169.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.593 HD21 ' OD1' ' A' ' 27' ' ' ASN . 28.4 mt -60.82 135.02 92.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.89 174.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.85 -30.88 21.18 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.375 2.05 . . . . 0.0 111.404 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -65.22 -42.27 93.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.393 175.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CD2' HG23 ' A' ' 55' ' ' THR . 3.4 m-30 -68.5 -12.47 61.29 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -168.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 72.01 -66.78 0.29 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 169.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.442 HD12 ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -83.1 -7.56 59.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 122.368 -0.208 . . . . 0.0 110.869 -173.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' O ' HG22 ' A' ' 55' ' ' THR . 4.8 mmpp? 70.93 -39.41 0.45 Allowed 'General case' 0 C--O 1.218 -0.592 0 O-C-N 123.873 0.733 . . . . 0.0 111.205 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.0 pp20? -157.77 141.5 15.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.094 0.473 . . . . 0.0 109.989 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.9 t -170.2 172.13 6.47 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.23 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 22.3 m -141.59 127.96 19.95 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.192 0.52 . . . . 0.0 110.492 174.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.61 173.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 68' ' ' ARG . 18.5 ttm180 -137.69 115.24 11.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.117 0.484 . . . . 0.0 110.511 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 3.4 mmp_? -140.92 167.44 22.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.846 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG2' ' N ' ' A' ' 71' ' ' TYR . 46.9 ttt180 -98.52 165.48 11.81 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.068 -173.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.515 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 40.4 t80 -50.58 -39.86 50.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.6 0.238 . . . . 0.0 111.433 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.8 p -57.03 -31.35 65.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.72 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -71.43 -38.59 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 51.2 m-85 -61.73 -42.39 98.89 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 0.0 109.949 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 92' ' ' LEU . 29.1 mt-10 -55.9 -55.05 37.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.321 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -61.93 -33.23 73.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.312 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 2.8 tm? -71.68 -42.89 66.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.579 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.5 ttt180 -56.06 -63.95 1.02 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.139 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.584 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -59.86 -34.49 73.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.049 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.62 -43.95 96.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.098 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.51 -37.66 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.737 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 56.5 mt-10 -67.37 -33.73 75.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.277 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 79' ' ' SER . 24.4 mmt180 -76.34 -61.15 2.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.255 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -66.99 -31.51 72.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.277 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.419 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 1.5 m -139.16 179.68 6.37 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.67 0.748 . . . . 0.0 112.069 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -97.86 22.42 9.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.696 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 89' ' ' VAL . 84.8 t -44.54 140.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.103 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.42 33.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.98 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -54.88 119.8 24.42 Favored Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 122.161 -0.337 . . . . 0.0 110.697 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.478 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 93.6 Cg_endo -85.5 163.53 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.697 2.265 . . . . 0.0 112.398 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 136.05 52.55 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.841 2.36 . . . . 0.0 112.097 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 75' ' ' GLU . 89.3 mt -69.23 149.08 97.56 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.723 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.9 Cg_exo -72.7 109.28 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.446 2.097 . . . . 0.0 110.966 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.616 ' O ' HD21 ' A' ' 98' ' ' LEU . . . -166.45 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.559 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.58 45.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.1 -0.647 . . . . 0.0 110.35 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.8 -103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.552 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -53.54 -30.25 40.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.616 HD21 ' O ' ' A' ' 94' ' ' GLY . 1.8 mm? -66.74 -44.97 80.1 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.179 -0.326 . . . . 0.0 111.299 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 8.42 42.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.771 0.796 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.6 tp-100 -97.11 -38.75 9.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.328 176.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 42.5 mt -94.32 163.69 22.39 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.58 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.11 175.94 9.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.388 2.726 . . . . 0.0 111.432 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -76.07 -79.28 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 60.62 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.585 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.87 75.53 1.08 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.874 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 69.16 -63.22 0.38 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.885 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.42 -29.84 1.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.375 0.607 . . . . 0.0 110.356 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.75 15.76 3.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.966 -173.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.699 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.1 pt -83.53 -18.95 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.387 . . . . 0.0 112.037 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.24 -9.42 59.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 109.794 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.03 118.7 23.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.653 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.06 -17.01 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.835 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.656 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 85.9 m-20 -63.35 -61.58 2.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.699 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -47.78 -51.47 22.3 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.635 0.584 . . . . 0.0 111.441 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.1 mt -50.13 -50.31 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.314 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.495 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -83.74 -14.31 51.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.817 -177.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 30.2 mt-10 -80.16 -28.12 38.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -75.71 -37.6 59.32 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.98 -52.04 67.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.055 -178.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.689 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -59.13 -43.3 91.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 -36.26 38.68 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.062 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -64.01 -38.6 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.811 0.306 . . . . 0.0 111.62 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HA ' HG23 ' A' ' 126' ' ' ILE . 12.3 pt-20 -73.0 -31.13 64.3 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.689 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.9 mm-40 -61.58 -59.36 5.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.543 ' O ' HG12 ' A' ' 129' ' ' VAL . 8.5 t80 -48.82 -54.09 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.756 -1.565 . . . . 0.0 111.383 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -64.04 -41.03 91.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.031 -170.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.32 0.509 . . . . 0.0 111.836 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.478 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -90.49 -58.59 2.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.849 0.833 . . . . 0.0 110.248 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.3 m -64.75 -12.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.256 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -109.74 3.0 20.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.08 -8.01 2.44 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.327 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.661 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 58.9 t60 -82.49 139.81 44.58 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.661 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.8 Cg_endo -44.15 -47.31 10.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.096 3.197 . . . . 0.0 113.292 -172.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.415 ' CB ' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -68.61 -33.16 73.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.125 -176.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -76.74 -43.84 35.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.745 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.492 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.67 -6.41 3.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.229 172.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.531 HD21 ' HE3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -99.79 -6.35 27.1 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.164 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.443 ' C ' HG12 ' A' ' 159' ' ' ILE . 30.1 mm-40 -107.43 129.93 54.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.693 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.466 ' HA ' HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -56.04 -20.34 16.43 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.584 -174.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.52 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.0 m -59.25 -30.31 68.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.359 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 135' ' ' ALA . 1.1 mp -69.79 -35.33 74.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.172 -0.33 . . . . 0.0 111.208 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.681 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 11.9 t-80 -54.25 -41.36 68.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.626 0.727 . . . . 0.0 109.691 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.52 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 3.3 ptm -81.0 -27.93 35.68 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.446 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.516 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 20.3 t80 -79.87 -59.17 2.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.154 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 144' ' ' PHE . 0.0 OUTLIER -106.38 7.09 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -175.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.681 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.5 mt-30 -121.33 -176.1 3.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.65 -111.64 0.58 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.408 0.443 . . . . 0.0 110.889 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -145.42 -39.13 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 112.027 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.06 148.69 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.161 -166.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.51 ' CG2' ' HE3' ' A' ' 152' ' ' LYS . 3.4 mp -72.25 102.84 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.812 172.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -89.74 102.94 15.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.25 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 5.4 mptt -74.74 11.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.296 0.57 . . . . 0.0 111.913 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -111.79 12.53 20.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.166 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -171.84 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.679 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.2 m -92.52 113.71 60.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.54 89.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.018 2.479 . . . . 0.0 110.941 174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 t -159.7 -154.63 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.395 0.617 . . . . 0.0 110.868 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.531 ' HE3' HD21 ' A' ' 137' ' ' ASN . 14.8 mmmt -96.8 157.78 15.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.474 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 59' ' ' ILE . 19.6 mm -57.77 -41.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.0 109.922 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.01 -179.336 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.7 40.15 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.041 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.38 153.45 13.4 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 124.088 3.192 . . . . 0.0 111.608 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -41.13 -30.26 0.65 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 124.6 3.533 . . . . 0.0 115.504 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -70.75 -52.21 22.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 30.9 m-80 61.53 -179.42 0.12 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 112.135 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.39 132.41 36.22 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 57' ' ' LEU . 13.2 tp -143.0 127.21 17.56 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.58 0.705 . . . . 0.0 111.188 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.15 100.79 3.79 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.688 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.644 HG12 ' HB ' ' A' ' 53' ' ' VAL . 46.7 mt -111.82 138.71 39.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.116 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -131.77 103.24 6.23 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -79.35 131.51 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -178.03 -165.13 0.09 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 63.06 81.73 0.22 Allowed Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 121.375 0.607 . . . . 0.0 110.432 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.13 119.59 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.123 2.549 . . . . 0.0 112.527 -175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.487 ' HB3' ' HG1' ' A' ' 48' ' ' THR . 50.0 tp60 -108.81 106.47 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.541 174.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.8 m -77.84 103.15 7.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -134.07 89.9 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.05 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.42 -167.86 33.02 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.218 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 t -104.37 149.91 7.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.337 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.86 3.19 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 121.549 -0.357 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -96.67 86.9 4.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.647 . . . . 0.0 109.858 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.94 34.85 0.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.975 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.9 ttt180 -82.71 146.84 28.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -143.47 165.76 26.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.901 0.381 . . . . 0.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 36.5 m -121.78 129.02 52.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.481 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.487 ' HG1' ' HB3' ' A' ' 37' ' ' GLN . 44.0 p -92.73 140.86 29.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.439 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 98.6 m-85 -100.22 126.75 46.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.07 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.626 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 15.5 tt0 -86.17 120.34 27.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.289 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -93.34 106.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.691 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -95.44 112.03 23.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.424 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.644 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -122.66 140.68 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -126.86 136.87 52.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.244 168.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.562 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.1 t -170.65 164.54 8.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.31 0.576 . . . . 0.0 112.152 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.04 26.02 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.824 168.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 29' ' ' LEU . 26.5 mt -60.4 136.42 91.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.543 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -68.34 -32.87 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.227 1.952 . . . . 0.0 111.162 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 159' ' ' ILE . 1.1 tt -66.69 -37.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.411 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.691 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 4.0 m-30 -75.07 -5.37 43.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -169.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 tttt 67.16 -74.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.18 -4.38 55.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 120.518 0.199 . . . . 0.0 110.502 -171.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 5.5 mmtp 70.31 -42.38 0.52 Allowed 'General case' 0 C--O 1.221 -0.417 0 O-C-N 124.122 0.889 . . . . 0.0 111.496 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.1 pp20? -158.19 127.27 5.67 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.408 0.623 . . . . 0.0 110.121 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 t -166.97 176.22 7.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.547 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.626 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 21.5 m -140.68 122.74 15.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 111.947 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.49 -178.1 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.866 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 38.6 ptt180 -150.53 133.1 15.72 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.109 170.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 4.0 mmp_? -136.11 177.99 7.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.624 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' O ' ' HD1' ' A' ' 74' ' ' PHE . 61.6 mtp180 -93.13 173.2 7.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.282 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.545 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.9 t80 -60.48 -40.52 91.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 p -60.49 -26.78 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' HB3' HD13 ' A' ' 150' ' ' ILE . 9.3 m-20 -73.23 -37.02 66.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.913 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.607 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 34.9 m-85 -65.98 -41.36 91.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.8 mt-10 -55.91 -53.53 55.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.021 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.443 ' CD1' HG23 ' A' ' 150' ' ' ILE . 8.5 t-105 -64.07 -30.27 71.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.331 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -73.44 -43.96 59.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 35.5 ttt180 -56.59 -61.82 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.176 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 32.7 t -59.62 -38.54 81.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.586 -173.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -48.48 75.93 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.2 mt -63.79 -40.37 96.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.201 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.9 mt-10 -66.94 -41.84 86.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.824 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.3 mmm180 -74.96 -53.6 8.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.791 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -82.86 -25.83 32.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.101 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 m -130.46 175.3 9.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.717 0.77 . . . . 0.0 111.569 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -99.13 29.96 3.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.581 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 134' ' ' LEU . 60.3 t -54.61 142.31 8.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.0 p -73.15 34.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.037 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -57.05 122.9 56.65 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 121.886 -0.509 . . . . 0.0 111.206 -175.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.62 167.82 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.926 2.418 . . . . 0.0 111.868 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 150.31 64.66 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.478 2.119 . . . . 0.0 112.244 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD11 ' HA ' ' A' ' 75' ' ' GLU . 92.6 mt -78.41 151.99 78.21 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.255 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.32 110.8 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.778 2.319 . . . . 0.0 111.154 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.415 ' HA2' HD22 ' A' ' 98' ' ' LEU . . . -176.3 43.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.724 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -153.18 58.74 0.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.489 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -165.43 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.626 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -59.47 -29.0 67.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.945 -173.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD22 ' HA2' ' A' ' 94' ' ' GLY . 1.1 mm? -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.444 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.3 ppt_? -99.81 29.33 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 0.0 110.196 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -124.83 -41.43 2.12 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.405 -177.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 54.1 mt -85.23 166.76 29.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.18 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 33.5 Cg_exo -60.06 143.07 99.58 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.986 2.457 . . . . 0.0 112.254 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.604 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 6.9 m-85 -73.65 -62.95 1.31 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 69.77 -60.49 0.47 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.886 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.31 -145.83 7.29 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.954 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.96 -42.47 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 111.432 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -127.87 -53.26 1.32 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -173.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 141.43 -12.57 2.74 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.599 -171.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.636 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 39.3 pt -56.12 -19.84 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -76.22 -7.29 54.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.434 . . . . 0.0 110.834 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.01 125.7 34.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -69.45 -17.94 63.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.122 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.9 m-80 -72.58 -47.41 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.636 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -49.03 -49.57 40.52 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.5 0.5 . . . . 0.0 110.71 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.95 -50.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.618 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -79.18 -16.31 56.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.849 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 65.4 mm-40 -73.31 -35.32 66.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HD2' ' OH ' ' A' ' 49' ' ' TYR . 33.0 ttm180 -79.04 -31.89 44.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.91 -50.96 72.06 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.652 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.683 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -61.45 -37.56 84.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 -40.49 16.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.136 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.607 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -62.11 -35.43 78.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.9 0.35 . . . . 0.0 111.281 178.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 15.9 pt-20 -75.52 -33.18 60.7 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.6 mm-40 -61.67 -56.1 23.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.481 ' O ' HG11 ' A' ' 129' ' ' VAL . 6.1 t80 -51.15 -52.77 40.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.433 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.44 -41.06 90.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.055 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -60.41 -17.99 47.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 0.0 111.981 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -88.25 -59.39 2.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.111 0.957 . . . . 0.0 110.593 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 125' ' ' PHE . 1.4 m -65.35 -13.13 14.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.398 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.41 -5.64 23.89 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.443 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.36 14.3 4.82 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.004 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.669 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 45.1 t60 -100.19 139.45 20.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.796 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.1 Cg_exo -41.32 -49.53 4.84 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.516 3.477 . . . . 0.0 113.706 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.432 ' CB ' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.68 -26.63 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.386 -174.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 137' ' ' ASN . . . -86.76 -42.16 13.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.423 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.39 -2.66 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.182 170.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t-20 -111.3 7.83 21.19 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.937 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -116.03 126.98 54.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.0 0.429 . . . . 0.0 111.199 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -52.46 -29.31 24.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.041 -173.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.657 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 15.5 t -63.75 -22.47 66.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.83 0.347 . . . . 0.0 111.434 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -68.45 -30.85 69.81 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.793 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 7.3 t60 -67.09 -38.09 85.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 6.3 ptm -79.61 -25.28 41.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.826 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' HD11 ' A' ' 150' ' ' ILE . 24.7 t80 -80.17 -52.54 7.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.192 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.691 ' HG ' ' CZ ' ' A' ' 60' ' ' PHE . 3.2 mm? -78.36 -25.83 46.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.921 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.677 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 28.1 mt-30 -129.48 176.7 7.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.068 -164.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.49 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HG3' HG13 ' A' ' 149' ' ' ILE . 9.3 tp10 177.18 -58.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.656 0.741 . . . . 0.0 110.862 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -116.24 135.85 55.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.824 -171.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.528 ' CG2' ' HE1' ' A' ' 143' ' ' MET . 46.6 mt -72.98 111.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.621 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 153' ' ' SER . 10.3 t70 -91.82 99.86 12.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.0 mptt -70.85 11.64 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 151' ' ' ASP . 25.4 m -116.06 14.03 15.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.2 174.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.447 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -61.2 -170.93 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.611 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 93.7 m -91.66 112.21 53.29 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -70.57 88.7 0.62 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.325 2.683 . . . . 0.0 111.724 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 50.1 m -156.95 -159.56 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.175 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.538 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.5 mmmt -91.23 160.02 15.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.479 HG22 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.29 -44.27 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.716 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.088 0.47 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.87 45.42 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.807 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 155.24 14.42 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 C-N-CA 123.889 3.06 . . . . 0.0 112.334 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -49.35 -18.67 2.35 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.853 3.702 . . . . 0.0 114.698 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.2 m -70.84 -54.19 12.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.535 HD21 ' ND2' ' A' ' 56' ' ' ASN . 27.4 m120 61.29 163.24 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.588 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -87.07 139.06 30.96 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 57' ' ' LEU . 18.6 tp -143.79 129.75 19.51 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.545 -177.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -142.03 101.43 3.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.72 0.771 . . . . 0.0 110.237 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.654 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.6 mt -111.04 133.68 55.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.223 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.36 100.79 6.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.279 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -78.01 128.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 106.716 -1.586 . . . . 0.0 106.716 171.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 p -176.8 -163.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 27.3 m-80 58.26 70.76 1.15 Allowed Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.398 . . . . 0.0 110.271 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' A' ' 115' ' ' ILE . 97.4 Cg_endo -77.15 132.34 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.796 2.331 . . . . 0.0 113.414 -172.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.3 tp60 -119.92 107.78 13.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.546 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.481 HG23 ' NE ' ' A' ' 45' ' ' ARG . 54.6 m -78.02 96.12 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.569 0.7 . . . . 0.0 109.896 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.2 p -123.82 94.39 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.379 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.65 -165.82 30.26 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.078 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.9 t -97.22 146.43 7.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.166 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.16 -48.18 6.59 Favored Glycine 0 N--CA 1.46 0.263 0 C-N-CA 121.521 -0.371 . . . . 0.0 113.144 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.91 89.85 3.43 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.57 0.7 . . . . 0.0 109.222 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.74 33.09 0.95 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.474 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 27.8 ttt180 -85.66 146.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.057 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.43 149.47 51.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.54 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.5 m -105.19 128.29 53.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.347 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 35.9 p -93.16 144.3 25.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.87 138.75 49.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 110.767 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 34.8 tt0 -96.79 120.79 37.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.204 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.9 mp -98.64 109.82 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -96.1 145.02 25.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.699 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.654 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.68 138.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.497 . . . . 0.0 112.175 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -127.54 143.61 51.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.009 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -171.75 164.58 6.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.022 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.535 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.62 23.94 11.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.596 167.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.551 HD13 HD21 ' A' ' 29' ' ' LEU . 28.2 mt -58.57 138.58 85.87 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.713 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 2.4 Cg_endo -77.0 -24.99 9.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.5 2.134 . . . . 0.0 111.424 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.552 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.41 -42.27 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 57' ' ' LEU . 3.5 m-30 -68.46 -25.59 65.07 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -170.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.63 -60.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -80.77 -9.02 59.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.831 0.287 . . . . 0.0 111.293 -172.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 70.0 -41.7 0.49 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.839 0.712 . . . . 0.0 110.994 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.53 144.93 36.22 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -163.81 158.12 19.7 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.5 m -142.31 136.61 29.89 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.534 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.85 176.04 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.655 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 35.2 ttp180 -137.89 113.8 9.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.03 0.443 . . . . 0.0 110.438 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 12.1 mmm180 -131.44 177.4 7.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -100.23 172.08 7.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.29 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.622 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.6 t80 -61.81 -38.18 87.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.494 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 17.0 p -57.77 -28.62 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.248 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.482 ' HB3' HD11 ' A' ' 150' ' ' ILE . 5.0 m-20 -70.88 -40.13 72.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.128 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.27 -40.27 95.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 109.892 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 19.9 mt-10 -61.76 -44.98 95.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.826 0.822 . . . . 0.0 110.138 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CE2' ' HG3' ' A' ' 152' ' ' LYS . 7.3 t-105 -64.03 -36.31 83.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.521 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.672 HD22 ' CD2' ' A' ' 144' ' ' PHE . 32.3 tp -70.77 -48.03 56.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.144 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 56.8 ttt180 -50.61 -60.11 3.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.72 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.2 p -61.86 -42.21 98.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.959 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.43 -49.28 64.87 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.332 0.395 . . . . 0.0 111.149 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.21 -38.4 90.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.6 mt-10 -70.89 -20.19 62.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.752 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.72 ' HG2' ' O ' ' A' ' 79' ' ' SER . 26.5 mmt180 -80.21 -61.77 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.499 . . . . 0.0 112.113 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' OE2' ' A' ' 138' ' ' GLU . 43.7 mm-40 -84.74 -22.98 29.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.054 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.468 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 46.7 m -131.98 171.88 13.04 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.687 0.756 . . . . 0.0 112.005 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -97.99 33.46 2.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.402 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 89' ' ' VAL . 66.6 t -54.3 140.0 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.535 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 88' ' ' VAL . 6.1 p -72.41 32.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.99 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.501 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -53.56 122.36 31.88 Favored Pre-proline 0 N--CA 1.466 0.334 0 O-C-N 122.126 -0.359 . . . . 0.0 111.258 -175.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 87.2 Cg_endo -85.75 165.17 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.175 2.583 . . . . 0.0 112.514 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.8 Cg_endo -65.76 142.95 72.12 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.852 2.368 . . . . 0.0 112.285 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.7 mt -69.8 154.17 94.93 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.775 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.52 109.11 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.506 2.137 . . . . 0.0 110.953 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.88 -177.12 37.2 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.073 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.423 ' N ' HD21 ' A' ' 98' ' ' LEU . 12.5 mptt 68.15 -63.18 0.34 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.605 0.762 . . . . 0.0 112.202 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.71 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -76.16 -22.37 55.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.542 -169.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 97' ' ' PHE . 1.7 mm? -64.82 -42.82 94.67 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 30.11 3.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.621 0.724 . . . . 0.0 110.064 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.7 tt0 -130.06 -38.78 1.41 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.293 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.481 HD12 ' HG3' ' A' ' 117' ' ' GLU . 54.0 mt -90.03 169.21 12.82 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.104 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.34 140.43 70.21 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.636 2.224 . . . . 0.0 111.527 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 45.2 m-85 -83.15 -83.13 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.208 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 66.87 -69.4 0.13 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.862 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 110' ' ' PHE . . . -88.85 71.13 2.45 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.636 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.15 -71.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.29 1.036 . . . . 0.0 111.366 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.01 -36.4 9.03 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.827 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.73 -5.01 7.51 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.521 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.682 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.6 pt -68.92 -17.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.461 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 58.1 m-85 -81.25 -4.62 56.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.836 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -100.01 131.47 45.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.268 0.556 . . . . 0.0 109.904 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.51 -25.65 64.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.4 m-20 -64.21 -59.98 3.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.682 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.66 -47.23 58.71 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.419 0.449 . . . . 0.0 111.044 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.424 HG23 ' HG3' ' A' ' 36' ' ' PRO . 65.4 mt -52.72 -52.98 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.617 -174.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.93 -19.52 61.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.291 -177.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 40.6 mm-40 -75.63 -31.23 59.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.437 0.637 . . . . 0.0 109.64 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.03 -39.89 32.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.7 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.64 -51.34 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.795 -178.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.659 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.8 pt20 -61.25 -41.18 96.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.18 -38.67 59.02 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.563 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.12 -35.64 80.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.205 0.502 . . . . 0.0 111.236 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.513 ' HA ' HG22 ' A' ' 126' ' ' ILE . 8.2 pt-20 -76.12 -29.04 57.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.3 mm-40 -62.52 -58.86 6.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.419 ' O ' HG11 ' A' ' 129' ' ' VAL . 6.2 t80 -51.3 -52.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.074 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG22 ' HA ' ' A' ' 123' ' ' GLU . 9.7 tp -63.35 -43.8 98.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -170.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -59.78 -20.12 54.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.488 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 38.3 mttm -84.0 -58.25 2.85 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.987 0.898 . . . . 0.0 110.14 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.3 m -65.3 -11.96 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.338 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.626 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.425 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -123.68 1.89 9.38 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.281 -0.961 . . . . 0.0 114.044 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.7 t60 -89.67 141.94 28.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 117.321 0.561 . . . . 0.0 110.758 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.3 Cg_exo -40.55 -50.57 3.76 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.356 3.37 . . . . 0.0 113.774 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.34 -23.85 62.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.422 -174.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -88.36 -42.22 12.34 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.439 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.57 -4.26 1.88 Allowed 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.523 0.678 . . . . 0.0 110.256 172.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -105.6 2.1 27.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.269 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 138' ' ' GLU . 4.9 mm-40 -114.29 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.879 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -55.48 -20.88 14.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.421 -175.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' MET . 6.0 t -65.51 -24.23 67.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.579 ' O ' HD21 ' A' ' 145' ' ' LEU . 5.3 mp -71.6 -31.11 66.57 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.7 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.532 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 6.3 t60 -61.73 -34.18 75.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.1 ptm -84.43 -26.16 28.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.672 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.5 t80 -78.98 -54.13 6.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.552 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.579 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.29 -33.84 22.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 0.0 110.713 -174.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 8.5 mt-30 -107.54 -175.44 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.329 -170.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 54.75 -145.05 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -117.92 -32.83 4.66 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 111.543 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -145.42 156.76 13.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.874 0.845 . . . . 0.0 113.132 -166.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 144' ' ' PHE . 81.3 mt -89.12 111.99 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.02 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 153' ' ' SER . 25.2 t70 -99.78 106.24 18.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.781 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 76' ' ' TRP . 9.5 mptt -71.39 5.55 2.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 111.773 -171.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 151' ' ' ASP . 15.4 m -109.31 13.74 24.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.834 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.455 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 1.2 p90 -63.48 -172.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.499 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 99.0 m -95.45 112.83 60.19 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -69.82 50.21 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.916 3.078 . . . . 0.0 113.262 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 71.2 m -108.69 -160.59 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.82 0.343 . . . . 0.0 110.536 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 18.5 mmmt -86.78 160.31 18.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.552 HG21 HG13 ' A' ' 59' ' ' ILE . 17.5 mm -52.78 -45.87 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.547 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.306 174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.4 m-85 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.2 178.78 41.2 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.28 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.02 154.43 13.37 Favored 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 124.314 3.343 . . . . 0.0 111.866 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.39 -27.01 4.5 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 124.078 3.185 . . . . 0.0 115.354 -169.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.413 ' O ' HD21 ' A' ' 57' ' ' LEU . 9.0 t -87.72 -33.55 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.794 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.52 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 22.0 m-80 57.41 -173.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.96 128.99 34.87 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD22 HD12 ' A' ' 57' ' ' LEU . 16.7 tp -141.36 130.47 23.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.129 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -139.19 109.0 6.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.245 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.656 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.9 mt -120.84 137.8 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 115.75 14.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.2 m -98.08 133.79 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 31.2 t 179.16 -161.54 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 62.22 68.66 1.04 Allowed Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 0.0 110.271 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.84 134.57 23.97 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.797 2.331 . . . . 0.0 113.832 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.627 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.6 tp60 -117.36 106.52 13.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.006 170.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.542 HG21 ' HE ' ' A' ' 45' ' ' ARG . 32.4 m -78.95 97.12 5.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.0 110.037 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -125.81 90.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.973 -170.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -165.41 29.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.9 t -97.02 149.13 5.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.649 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.09 -48.1 6.48 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 121.508 -0.377 . . . . 0.0 113.299 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -101.9 87.99 3.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 34.2 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.5 ttt180 -84.36 140.27 31.7 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -125.24 157.31 36.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.938 0.399 . . . . 0.0 110.408 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 m -110.35 127.72 55.2 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.079 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.2 p -92.82 128.55 38.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 87.6 m-85 -101.9 134.84 44.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 37.2 tt0 -86.91 121.76 29.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.897 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.6 mp -95.55 116.26 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 35.0 mtt180 -109.82 119.33 39.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.55 175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.656 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -123.57 142.5 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 111.953 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -127.49 138.16 52.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -171.12 165.24 7.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.5 0.667 . . . . 0.0 111.899 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -121.79 28.46 7.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.397 169.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.679 HD13 ' CE1' ' A' ' 60' ' ' PHE . 17.8 mt -62.82 145.24 96.17 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.575 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.8 -15.68 13.29 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.726 2.284 . . . . 0.0 112.345 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 HG22 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -85.06 -41.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.75 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.679 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.3 m-30 -68.51 -29.69 68.34 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 74.25 -57.52 0.61 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.421 0.451 . . . . 0.0 112.023 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.11 -12.44 59.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.648 0.204 . . . . 0.0 111.099 -173.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp 71.93 -38.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.809 0.693 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.44 146.36 26.61 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.176 0.512 . . . . 0.0 109.911 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -170.09 159.14 7.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.196 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.4 m -140.84 136.55 32.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.416 0.627 . . . . 0.0 111.462 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 4.6 m -143.71 179.92 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.765 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 7.1 ptp180 -140.31 126.01 19.26 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.446 173.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.552 HH11 HG13 ' A' ' 150' ' ' ILE . 22.2 mmt85 -125.58 161.39 27.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.487 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -82.09 159.84 23.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.553 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 24.7 t80 -55.26 -38.31 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -59.26 -28.05 66.36 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.461 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB3' HD13 ' A' ' 150' ' ' ILE . 52.2 m-20 -74.72 -37.24 62.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.187 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -65.02 -36.16 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.937 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.1 mt-10 -63.45 -51.77 64.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 5.0 t-105 -61.64 -34.93 76.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.945 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.645 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -67.79 -44.24 77.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 66.4 ttt180 -57.14 -59.61 4.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.973 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.674 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 t -62.33 -36.01 80.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.973 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -53.93 -56.45 17.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 109.758 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.16 -35.28 76.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.296 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 20.3 mt-10 -69.37 -38.84 78.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 79' ' ' SER . 33.3 mmt180 -69.29 -60.36 2.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 0.0 111.443 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.66 -22.29 29.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.929 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -126.64 175.21 8.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.208 0.528 . . . . 0.0 112.112 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -103.0 21.03 16.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.874 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 89' ' ' VAL . 89.9 t -48.01 142.0 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.125 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 88' ' ' VAL . 9.8 p -72.89 36.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.787 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -55.61 119.6 26.05 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -175.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 86.0 Cg_endo -85.9 168.37 9.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.13 2.553 . . . . 0.0 112.325 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 147.3 70.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.697 2.265 . . . . 0.0 112.554 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 75' ' ' GLU . 78.2 mt -73.97 157.67 86.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.418 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.4 109.03 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.577 2.185 . . . . 0.0 111.439 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.5 -171.46 38.07 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.602 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 68.03 -2.75 1.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.785 0.434 . . . . 0.0 111.733 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.57 -89.98 0.46 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -52.6 -23.57 6.7 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 113.296 -174.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 mm? -60.86 -41.55 96.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.994 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 18.24 21.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.692 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.0 tp-100 -113.71 -40.24 3.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.96 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.448 ' CD1' ' HB2' ' A' ' 114' ' ' PHE . 35.8 mt -89.7 165.87 23.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.515 -175.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.02 164.15 28.57 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.081 2.521 . . . . 0.0 111.962 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -83.23 -100.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 65.78 -65.87 0.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 111.577 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.96 52.18 4.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.146 -0.55 . . . . 0.0 111.952 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 63.9 -71.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.69 1.196 . . . . 0.0 110.391 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.01 -20.06 17.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.933 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.7 14.03 20.59 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.631 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.9 pt -83.21 -16.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.989 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 70.0 m-85 -79.69 1.24 27.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.453 175.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 113' ' ' ASN . 24.9 t70 -86.45 129.92 34.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.64 -19.76 63.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.88 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.553 ' HB2' ' OD2' ' A' ' 111' ' ' ASP . 46.4 m-80 -74.14 -54.37 7.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.631 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -49.87 -50.05 47.11 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.748 0.655 . . . . 0.0 111.158 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.7 mt -52.26 -45.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.278 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.0 -15.24 57.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.742 -178.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 42.4 mm-40 -70.78 -34.69 72.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.302 0.573 . . . . 0.0 109.767 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.48 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 36.5 ttm180 -78.52 -36.37 45.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -55.13 -49.32 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.827 -178.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.713 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -61.46 -33.72 74.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.496 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.02 -33.66 9.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.992 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 7.4 tp -66.32 -33.61 76.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.138 0.175 . . . . 0.0 111.018 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 10.5 pt-20 -75.22 -32.47 61.16 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.713 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.9 mm-40 -59.96 -59.85 4.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 4.7 t80 -45.63 -51.72 11.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.022 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.12 -39.05 84.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.83 -172.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.17 -12.53 28.65 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD3' ' HG3' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -90.78 -59.46 2.17 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.734 0.778 . . . . 0.0 110.177 172.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.543 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.1 m -65.03 -12.19 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.056 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.02 1.5 22.49 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.354 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.87 12.95 2.4 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.509 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 54.8 t60 -100.26 140.32 21.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.987 0.394 . . . . 0.0 110.19 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 3.8 Cg_exo -43.94 -43.91 12.15 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.936 3.091 . . . . 0.0 113.54 -171.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -28.72 61.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.454 -175.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -80.35 -41.21 25.16 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.551 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.2 mm100 -67.55 -0.67 4.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.528 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -100.71 -7.01 24.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.386 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -117.52 132.7 56.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -49.44 -31.86 10.67 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.556 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.447 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.6 p -58.83 -25.2 62.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 111.6 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -70.52 -33.88 71.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -55.51 -41.17 72.72 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.303 0.573 . . . . 0.0 109.7 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.605 ' HE2' ' O ' ' A' ' 151' ' ' ASP . 1.8 mpp? -66.81 -56.66 9.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.61 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.645 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.053 -1.43 . . . . 0.0 112.856 -173.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 60' ' ' PHE . 1.5 mt -99.2 -40.73 7.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.054 0.454 . . . . 0.0 112.117 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.4 -49.44 5.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -168.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 67' ' ' VAL . 74.8 m-20 -73.66 -178.67 3.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -83.74 -30.95 26.26 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.459 0.647 . . . . 0.0 110.246 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.495 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -149.5 158.86 5.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.237 -169.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.58 HG22 ' HE3' ' A' ' 143' ' ' MET . 70.9 mt -86.4 111.81 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.103 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.605 ' O ' ' HE2' ' A' ' 143' ' ' MET . 52.2 t0 -82.48 113.86 20.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.018 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.4 mptt -77.13 -3.13 37.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.91 0.862 . . . . 0.0 110.234 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.5 t -108.7 19.6 19.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.342 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 6.2 p90 -61.16 -174.18 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.959 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.589 HG23 ' OG ' ' A' ' 157' ' ' SER . 73.6 m -93.02 108.26 31.14 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.404 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 35.6 Cg_exo -65.87 92.54 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.321 2.68 . . . . 0.0 111.734 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.589 ' OG ' HG23 ' A' ' 155' ' ' THR . 4.9 p -164.68 -169.62 1.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -174.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.6 mmmm -81.61 152.2 27.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.004 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.475 HG22 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -52.56 -42.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.373 0.606 . . . . 0.0 110.328 173.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.795 -173.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 120.614 0.245 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.03 178.27 48.21 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.049 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.17 156.2 8.02 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 124.145 3.23 . . . . 0.0 112.323 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.53 -17.32 2.79 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 124.496 3.464 . . . . 0.0 114.831 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.9 m -76.29 -51.21 12.45 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.615 ' OD1' HD21 ' A' ' 57' ' ' LEU . 26.7 m120 60.95 176.08 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.555 0.535 . . . . 0.0 111.382 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -88.95 135.43 33.55 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 57' ' ' LEU . 15.3 tp -142.85 132.89 24.33 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.097 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.5 99.41 3.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.147 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.618 HG12 ' HB ' ' A' ' 53' ' ' VAL . 34.5 mt -110.67 141.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.058 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -140.43 118.26 11.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -99.5 136.6 29.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.24 -163.19 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 60.39 77.22 0.38 Allowed Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 110.574 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.29 148.18 38.36 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.633 2.222 . . . . 0.0 112.996 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.2 tp60 -134.51 108.91 8.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.688 175.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -76.7 94.1 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.407 0.623 . . . . 0.0 109.75 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -122.97 92.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.269 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.07 -165.35 29.89 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.878 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.0 t -101.99 145.42 11.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.246 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.0 -48.2 5.29 Favored Glycine 0 N--CA 1.463 0.498 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.008 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.4 86.29 2.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.69 36.11 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.492 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 11.3 ttt180 -87.34 140.95 29.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -129.19 142.25 50.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.91 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -100.48 124.32 45.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.275 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 40.4 p -93.09 152.33 19.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.545 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.07 143.89 46.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.446 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 33.6 tt0 -96.35 120.57 36.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.461 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.5 mp -93.95 117.96 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 13.3 mtp180 -105.52 136.95 44.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.25 139.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -126.69 138.93 53.47 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.564 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 60' ' ' PHE . 14.1 t -170.91 164.02 7.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.219 0.533 . . . . 0.0 111.48 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.51 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.93 23.42 11.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.255 168.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.615 HD21 ' OD1' ' A' ' 27' ' ' ASN . 27.0 mt -57.44 139.93 80.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.705 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 -25.84 13.52 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -75.84 -40.97 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.07 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.592 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.39 -18.43 64.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HD3' ' NE2' ' A' ' 146' ' ' GLN . 57.4 tttt 72.22 -66.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 171.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.7 -11.8 58.9 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 122.24 -0.288 . . . . 0.0 110.314 -172.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 72.21 -42.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.053 0.845 . . . . 0.0 110.762 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -149.57 138.26 20.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.581 0.705 . . . . 0.0 110.755 176.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -171.33 162.63 6.83 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.823 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.5 m -137.95 129.95 28.69 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.116 0.484 . . . . 0.0 111.015 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -127.1 169.22 18.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.153 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -134.18 121.35 21.27 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.782 ' NH1' ' HA ' ' A' ' 144' ' ' PHE . 16.7 ptp180 -151.26 163.47 38.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 111.316 -173.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.591 ' HG3' ' H ' ' A' ' 72' ' ' SER . 30.1 tpt180 -86.6 148.0 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.127 -170.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 38.6 t80 -48.03 -37.33 14.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.004 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.591 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 5.5 m -54.13 -34.24 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 111.244 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.22 -33.94 63.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 33.6 m-85 -60.21 -36.24 77.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.044 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.489 ' OE2' ' HA ' ' A' ' 72' ' ' SER . 18.6 mt-10 -64.9 -53.3 48.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.743 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -28.92 66.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.786 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.4 tm? -71.73 -43.84 65.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 60.0 ttt180 -59.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.631 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.541 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.1 p -62.85 -33.49 75.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.76 -47.97 82.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.56 -42.15 91.78 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.846 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 33.0 mt-10 -66.03 -32.83 74.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.616 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.1 mmt180 -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.083 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -75.67 -33.09 60.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.961 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 m -124.62 177.46 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.314 0.578 . . . . 0.0 111.037 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -101.98 29.3 5.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.491 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 89' ' ' VAL . 57.3 t -51.13 140.18 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.038 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 88' ' ' VAL . 5.6 p -71.22 31.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.279 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -51.72 123.05 23.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 111.354 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.4 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 92.6 Cg_endo -86.12 166.51 9.62 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.171 2.581 . . . . 0.0 112.192 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 43.5 Cg_endo -67.8 142.6 58.23 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.764 2.309 . . . . 0.0 112.477 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 75' ' ' GLU . 91.4 mt -69.69 150.72 96.65 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.293 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.79 116.95 2.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.551 2.168 . . . . 0.0 110.571 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.38 48.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.554 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -149.95 42.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.436 0.636 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.531 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -151.48 -81.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.016 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.54 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -56.53 -26.22 54.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.087 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' H ' ' CD2' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.63 -47.67 84.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -174.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 3.4 ppt_? -97.12 24.52 6.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.401 0.62 . . . . 0.0 110.689 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -112.84 -47.18 3.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.879 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.75 HD11 ' C ' ' A' ' 101' ' ' LEU . 3.2 pp -91.04 173.03 5.9 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.671 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.56 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.4 Cg_exo -71.93 -143.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 124.115 3.21 . . . . 0.0 113.292 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -116.95 -83.81 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 65.27 -74.42 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.834 0.708 . . . . 0.0 111.61 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -107.09 75.82 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.366 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.29 -72.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.026 0.93 . . . . 0.0 111.852 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.21 -34.15 8.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.113 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.62 3.02 10.41 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.606 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 114' ' ' PHE . 47.8 pt -70.18 -17.86 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.441 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 49.4 m-85 -76.76 -7.72 55.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.24 129.37 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.101 0.477 . . . . 0.0 110.009 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.74 -26.03 68.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.05 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.647 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 43.3 m-80 -69.56 -56.87 6.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -46.75 -47.94 20.6 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 123.673 0.608 . . . . 0.0 111.091 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 mt -53.37 -46.65 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.368 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -78.53 -19.17 53.53 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.116 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 32.1 mm-40 -72.98 -34.65 66.59 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.64 -42.35 61.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.659 174.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.85 -50.89 71.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.612 -176.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -60.28 -35.19 74.98 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.984 -173.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.62 -31.96 9.78 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.13 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.3 tp -64.86 -35.36 80.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.807 -0.231 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.493 ' HA ' HG22 ' A' ' 126' ' ' ILE . 10.5 pt-20 -69.88 -31.35 69.12 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.738 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 65.4 mm-40 -65.83 -58.78 4.82 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.511 ' O ' HG11 ' A' ' 129' ' ' VAL . 5.2 t80 -45.45 -53.38 8.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.641 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.7 tp -64.23 -38.67 83.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.644 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -60.48 -19.34 56.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -89.6 -56.98 3.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.882 0.849 . . . . 0.0 110.449 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 m -63.85 -12.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.898 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.8 3.83 24.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.479 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.28 12.02 2.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.551 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 39.4 t60 -101.43 140.47 21.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 122.483 -0.422 . . . . 0.0 110.875 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 14.5 Cg_exo -40.59 -47.14 4.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.242 3.294 . . . . 0.0 114.058 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.19 -26.54 61.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.333 -174.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -83.16 -40.13 20.13 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.989 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.0 mm100 -67.61 -3.01 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.225 176.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.5 t-20 -112.56 12.35 19.87 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.231 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -122.67 126.53 47.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.673 0.273 . . . . 0.0 110.929 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 159' ' ' ILE . 15.7 tpt180 -57.36 -15.7 7.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.486 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.714 ' O ' ' HG2' ' A' ' 143' ' ' MET . 3.2 m -56.07 -29.39 60.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.095 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.534 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.5 mp -74.5 -28.97 61.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.199 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 60.9 t-80 -57.28 -43.29 82.99 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.913 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.737 ' SD ' HG22 ' A' ' 150' ' ' ILE . 3.9 ptp -70.89 -35.24 72.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.782 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -77.61 -46.01 23.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -88.79 -36.47 16.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.388 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.468 ' NE2' ' HD3' ' A' ' 61' ' ' LYS . 7.1 mt-30 -100.82 -174.01 2.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.394 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 57.41 -165.21 0.16 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.363 0.414 . . . . 0.0 110.274 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -100.17 -32.38 10.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.428 0.632 . . . . 0.0 110.773 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.465 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -155.44 173.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.163 -169.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.737 HG22 ' SD ' ' A' ' 143' ' ' MET . 2.1 mp -78.35 120.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.556 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 154' ' ' TYR . 9.6 t0 -96.24 99.88 11.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HG2' ' CG2' ' A' ' 150' ' ' ILE . 81.6 mttt -74.63 -2.59 26.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.624 0.726 . . . . 0.0 111.966 -170.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.8 m -108.37 18.88 20.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.318 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -62.71 -170.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.141 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 56.1 m -84.1 110.84 28.88 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.948 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.2 Cg_exo -71.06 77.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.611 2.874 . . . . 0.0 112.227 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -151.44 -162.92 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.449 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.9 mmmt -81.37 163.25 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.925 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 139' ' ' ARG . 17.0 mm -56.25 -39.39 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.2 0.524 . . . . 0.0 109.612 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.842 -179.698 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.36 169.2 38.18 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.329 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.99 160.24 13.0 Favored 'Trans proline' 0 C--O 1.224 -0.214 0 C-N-CA 123.911 3.074 . . . . 0.0 111.282 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.14 -21.6 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 124.839 3.693 . . . . 0.0 115.571 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -70.67 -63.59 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.522 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.4 m-80 60.24 177.41 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.108 0.48 . . . . 0.0 111.709 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -91.21 134.82 34.24 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD23 HD13 ' A' ' 57' ' ' LEU . 14.2 tp -146.46 131.82 18.58 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.368 -175.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -144.11 100.42 3.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.079 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.649 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.5 mt -109.99 140.1 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -139.29 108.21 5.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.106 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.83 133.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t 179.74 -163.15 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 56.31 64.46 4.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.315 0.578 . . . . 0.0 109.685 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.82 154.19 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.026 2.484 . . . . 0.0 113.408 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.512 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.5 tp60 -135.09 112.2 10.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.557 173.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.487 HG23 ' HE ' ' A' ' 45' ' ' ARG . 45.5 m -76.38 92.4 3.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.738 . . . . 0.0 109.9 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -119.93 94.74 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.549 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.59 -166.3 30.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.356 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.3 t -95.9 147.55 5.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.26 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.53 -48.96 5.87 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.333 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -102.25 88.63 3.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.487 0.661 . . . . 0.0 109.484 170.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.75 34.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.783 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.8 ttt180 -85.16 132.67 34.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.862 0.363 . . . . 0.0 110.449 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -117.17 174.51 6.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.993 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.4 m -129.0 133.38 47.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.282 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.512 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.6 p -92.83 129.92 38.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -105.92 133.01 51.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.978 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 35.7 tt0 -86.36 118.15 25.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.327 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.491 HD13 ' CZ ' ' A' ' 74' ' ' PHE . 3.8 mp -94.39 109.45 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 42.6 mtp180 -96.02 132.41 41.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.236 173.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.649 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.4 137.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 0.0 111.262 177.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -125.32 137.0 54.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.549 HG21 ' O ' ' A' ' 63' ' ' LYS . 11.8 t -170.51 165.22 8.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.363 0.601 . . . . 0.0 112.394 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HA ' ' CD ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -115.89 24.4 11.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.276 166.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.587 HD11 ' CE1' ' A' ' 60' ' ' PHE . 23.1 mt -61.09 134.48 93.0 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 173.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 -39.97 12.48 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.645 2.23 . . . . 0.0 111.797 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -60.07 -41.61 87.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.285 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CE1' HD11 ' A' ' 57' ' ' LEU . 3.3 m-30 -66.32 -16.28 63.92 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 tttt 71.77 -65.69 0.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -86.04 -5.68 59.17 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.415 -0.178 . . . . 0.0 110.717 -174.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.549 ' O ' HG21 ' A' ' 55' ' ' THR . 14.7 mmtp 71.64 -41.61 0.51 Allowed 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.849 0.718 . . . . 0.0 111.715 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -160.05 122.41 3.34 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.429 0.633 . . . . 0.0 109.896 -177.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -160.89 176.89 10.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.525 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 20.1 m -141.84 132.5 25.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.125 0.488 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.06 179.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.436 176.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 35.0 ttt180 -145.29 111.23 5.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.619 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -138.16 152.68 48.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.806 0.813 . . . . 0.0 112.716 -173.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' A' ' 72' ' ' SER . 28.9 ttp180 -74.02 144.31 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.705 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.41 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 40.3 t80 -50.98 -36.47 39.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.484 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.575 ' H ' ' HG2' ' A' ' 70' ' ' ARG . 11.0 m -61.87 -21.81 65.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.767 0.318 . . . . 0.0 111.777 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -89.03 -24.49 22.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 51' ' ' ILE . 23.6 m-85 -61.78 -34.15 75.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.8 mt-10 -64.4 -50.92 65.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.485 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 6.6 t-105 -62.02 -30.45 70.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.586 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -70.2 -45.65 66.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.549 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 47.4 ttt180 -56.83 -61.68 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.717 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 11.1 p -59.3 -34.85 72.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.043 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.598 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 3.2 mm-40 -62.36 -37.11 84.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 85' ' ' SER . 97.7 mt -75.7 -17.99 59.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.102 0.477 . . . . 0.0 110.45 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 41.2 mt-10 -88.02 -26.36 22.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.284 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 79' ' ' SER . 41.5 mmt180 -58.43 -64.2 1.0 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -118.86 5.78 11.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 33.5 t -119.54 167.5 11.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.612 0.72 . . . . 0.0 111.169 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -101.2 19.45 17.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.535 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 89' ' ' VAL . 89.2 t -51.24 139.07 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.421 0.629 . . . . 0.0 111.762 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.25 35.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.815 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.549 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -55.45 120.26 30.06 Favored Pre-proline 0 N--CA 1.465 0.286 0 O-C-N 122.042 -0.411 . . . . 0.0 111.159 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.3 Cg_endo -87.52 165.22 7.9 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.978 2.452 . . . . 0.0 112.249 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 38.1 Cg_endo -66.23 144.75 76.01 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.76 2.307 . . . . 0.0 112.65 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 75' ' ' GLU . 74.0 mt -70.92 150.39 95.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.111 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -84.93 114.55 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.8 2.333 . . . . 0.0 111.192 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.29 32.78 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.8 18.21 2.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.218 0.509 . . . . 0.0 110.935 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -110.49 -83.31 0.57 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.078 0.466 . . . . 0.0 111.891 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.549 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -58.01 -27.18 63.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.323 -173.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 97' ' ' PHE . 1.5 mm? -60.93 -46.94 88.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.023 0.439 . . . . 0.0 111.128 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.26 29.95 4.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.49 0.662 . . . . 0.0 109.948 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.9 tt0 -128.46 -36.83 1.85 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.432 -173.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 74.7 mt -85.08 172.17 9.4 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.947 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 Cg_exo -66.42 -157.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.929 2.419 . . . . 0.0 112.671 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -87.76 -74.65 0.44 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.43 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 64.31 -81.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.743 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.58 108.78 0.44 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.822 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.3 t70 69.43 -65.27 0.31 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 111.836 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -139.22 -5.82 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.085 0.469 . . . . 0.0 110.45 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.86 9.63 22.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.779 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 42.7 pt -76.05 -18.0 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.131 0.491 . . . . 0.0 111.182 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.468 ' CE2' ' HD3' ' A' ' 45' ' ' ARG . 84.0 m-85 -87.47 18.19 4.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.625 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.66 134.97 54.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.692 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.04 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.734 -174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.501 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -64.67 -60.06 3.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.268 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.779 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -52.88 -46.89 68.15 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.041 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.69 -46.41 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.157 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -18.54 47.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.549 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 56.5 mm-40 -67.55 -38.83 84.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.542 0.687 . . . . 0.0 109.177 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -67.78 -43.35 79.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.835 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -55.77 -52.54 63.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.174 -175.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.693 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -62.52 -35.24 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.581 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.71 -34.02 17.15 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.413 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.7 tp -66.76 -36.59 82.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 122.043 0.137 . . . . 0.0 111.181 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 5.1 pt-20 -72.23 -31.7 66.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.693 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.3 mm-40 -60.32 -59.75 4.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 129' ' ' VAL . 3.5 t80 -47.22 -52.73 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.944 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.32 -40.15 87.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.918 -171.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.51 -21.06 59.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.1 0.476 . . . . 0.0 111.87 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 124' ' ' GLN . 36.7 mttm -87.86 -55.22 3.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.719 0.771 . . . . 0.0 110.453 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.587 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -69.08 -12.58 16.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.605 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 126' ' ' ILE . . . -114.35 12.15 17.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -136.23 -9.51 1.42 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.534 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.745 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.8 t60 -87.15 146.38 40.15 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.446 -0.311 . . . . 0.0 111.282 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.745 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.3 Cg_exo -43.08 -51.24 5.74 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.915 3.077 . . . . 0.0 113.337 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.528 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -66.5 -32.59 74.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.151 -174.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.16 -44.91 35.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.152 -177.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.569 ' O ' HD12 ' A' ' 59' ' ' ILE . 43.2 mm-40 -61.52 -6.49 2.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.016 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -98.87 -21.44 16.31 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.066 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 13.0 mm-40 -99.91 137.38 38.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.634 0.652 . . . . 0.0 112.352 -168.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 3.5 mmt180 -50.46 -24.45 3.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.023 0.929 . . . . 0.0 112.716 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.647 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.1 m -56.86 -29.94 63.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.464 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.527 HD21 ' O ' ' A' ' 135' ' ' ALA . 5.9 mp -75.36 -35.26 61.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 110.662 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -64.33 -35.32 80.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.4 ptm -81.74 -31.79 31.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.513 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 22.3 t80 -80.29 -43.36 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.332 -175.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.429 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 11.0 mt -92.02 -26.46 18.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.361 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -117.16 178.3 4.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.364 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.88 -82.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.053 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 176.92 -55.01 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.797 0.808 . . . . 0.0 109.576 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.485 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.1 OUTLIER -130.66 154.16 40.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.894 -175.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.51 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -71.15 113.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.855 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.78 97.71 4.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.756 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -66.46 -6.91 16.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.881 0.372 . . . . 0.0 111.322 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.2 m -112.96 19.68 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.366 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -64.21 -170.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.997 -178.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.5 m -86.31 113.2 51.09 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.7 Cg_exo -69.83 71.94 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.42 2.747 . . . . 0.0 111.589 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -161.56 1.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -92.85 168.27 11.29 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.799 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.444 HG13 HD12 ' A' ' 59' ' ' ILE . 8.6 mm -54.71 -48.72 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 122.781 0.432 . . . . 0.0 111.076 -174.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.488 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 8.4 m-85 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 121.144 0.497 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.93 173.98 46.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.368 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.2 155.53 9.05 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 C-N-CA 124.124 3.216 . . . . 0.0 111.882 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.28 -21.08 0.36 Allowed 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.769 3.646 . . . . 0.0 115.737 -170.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.5 m -75.16 -59.44 2.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.458 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.0 m-80 62.29 -178.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 111.812 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.4 132.11 37.03 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 57' ' ' LEU . 19.2 tp -147.02 128.82 15.29 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.791 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 4.3 pt-20 -138.01 99.78 3.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.89 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.649 HG12 ' HB ' ' A' ' 53' ' ' VAL . 30.9 mt -113.34 142.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.801 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -142.21 111.74 6.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.646 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.48 136.37 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 171.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 22.9 t 179.79 -163.08 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 38.6 m-80 62.44 79.7 0.26 Allowed Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.191 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -64.83 143.69 80.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.187 2.591 . . . . 0.0 112.574 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -134.15 108.31 8.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.905 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 m -76.11 93.11 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 109.535 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.2 89.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.04 -166.98 32.31 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.955 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 9.9 t -117.41 152.17 19.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.638 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.54 -46.63 4.66 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 121.771 -0.252 . . . . 0.0 113.019 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.18 83.06 2.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.82 40.8 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.316 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.6 ttt180 -89.17 142.05 27.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.76 162.4 36.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.916 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 22.4 m -114.56 126.08 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.9 p -92.22 154.82 18.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.78 136.24 53.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.243 0.544 . . . . 0.0 110.836 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.582 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 28.6 tt0 -93.13 119.4 32.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.769 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.5 mp -93.75 115.37 32.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.96 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 29.6 mtp180 -102.37 128.19 49.06 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.649 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -137.49 140.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 11.4 ttmt -128.97 136.28 50.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' LYS . 10.4 t -170.21 164.63 9.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.401 0.619 . . . . 0.0 112.493 -175.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.45 ' HA ' ' CD ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.29 25.21 10.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.08 164.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.57 HD12 HD21 ' A' ' 29' ' ' LEU . 30.3 mt -58.55 134.38 85.79 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.493 171.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 8.5 Cg_exo -67.79 -36.26 19.06 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.727 2.284 . . . . 0.0 111.475 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.457 HD12 HG13 ' A' ' 159' ' ' ILE . 1.3 tt -61.03 -40.54 85.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.202 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.644 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 4.9 m-30 -71.1 -18.33 62.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.46 -67.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.28 -1.72 31.13 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.432 -0.167 . . . . 0.0 111.389 -171.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.557 ' O ' HG23 ' A' ' 55' ' ' THR . 4.5 mmtm 68.06 -45.54 0.51 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.07 0.856 . . . . 0.0 112.045 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.1 pp20? -159.79 138.96 10.99 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.659 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -170.52 177.54 3.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.582 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 23.9 m -142.26 127.27 18.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.63 172.09 7.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.775 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -140.83 129.1 22.32 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.646 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.1 177.06 9.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.361 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 85.5 mtt180 -85.54 168.5 14.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.441 -172.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.482 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 46.5 t80 -60.77 -40.56 92.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.529 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 55.0 m -61.32 -23.3 65.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 150' ' ' ILE . 6.3 m-20 -72.94 -36.7 67.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 51' ' ' ILE . 70.9 m-85 -64.54 -40.15 95.08 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 28.9 mt-10 -59.17 -53.43 58.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.608 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -60.65 -31.32 70.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -73.23 -44.67 59.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 39.3 ttt180 -55.82 -61.04 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.017 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -59.42 -35.11 73.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.629 -174.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 6.4 tp10 -64.3 -44.77 90.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.811 0.338 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.455 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.1 mt -62.64 -40.59 97.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.581 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.39 -34.66 78.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.209 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 3.2 ppt_? -90.24 -28.76 18.62 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -172.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 83' ' ' ARG . 4.8 mm-40 -95.35 -17.29 21.72 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.956 -0.465 . . . . 0.0 112.189 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB3' HG22 ' A' ' 87' ' ' VAL . 22.7 t -144.95 178.71 7.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.745 0.783 . . . . 0.0 111.685 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -103.64 19.78 19.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.423 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 85' ' ' SER . 79.3 t -45.41 140.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.563 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' O ' HG11 ' A' ' 88' ' ' VAL . 9.8 p -72.73 37.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.883 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.502 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -54.95 121.16 33.73 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.128 -0.358 . . . . 0.0 111.075 -176.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 71.9 Cg_endo -83.47 165.9 14.09 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.324 2.682 . . . . 0.0 113.188 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.19 143.92 79.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.192 2.595 . . . . 0.0 112.686 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.473 HD13 ' HG2' ' A' ' 75' ' ' GLU . 95.8 mt -81.55 141.43 48.72 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.769 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.0 Cg_exo -73.79 114.22 3.98 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.173 2.582 . . . . 0.0 111.998 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.83 38.26 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.72 -34.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 111.428 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.21 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.521 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -53.99 -26.78 27.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.094 0.958 . . . . 0.0 113.542 -170.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.455 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.2 mm? -62.7 -48.03 81.06 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.82 13.64 23.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -102.15 -29.2 11.87 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.001 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 mt -99.99 165.69 14.11 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.073 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 -153.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.542 2.828 . . . . 0.0 112.231 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -103.05 -78.79 0.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.144 172.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 68.05 -65.81 0.24 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.135 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.8 -155.51 30.92 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.053 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -62.54 -30.83 71.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 111.143 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.65 -47.08 0.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.32 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.93 -9.57 1.8 Allowed Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.406 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.423 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 30.8 pt -65.46 -17.58 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.175 -0.512 . . . . 0.0 112.169 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -86.92 39.49 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.375 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.99 136.12 54.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.76 -21.52 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -170.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 38.2 m-80 -71.05 -60.42 2.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -45.77 -49.98 14.43 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.646 0.591 . . . . 0.0 111.263 178.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.05 -46.84 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.456 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -83.42 -17.85 40.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.519 -178.329 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 28.5 mt-10 -80.51 -30.35 37.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 109.89 -176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -80.02 -29.37 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.69 -52.5 63.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.108 178.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.667 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -59.92 -38.5 82.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.312 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.44 -42.2 65.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.882 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -69.54 -30.77 68.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 117.794 0.797 . . . . 0.0 111.313 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 10.8 pt-20 -74.05 -33.74 63.81 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 9.4 mm-40 -59.84 -60.56 3.64 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' O ' HG11 ' A' ' 129' ' ' VAL . 9.7 t80 -48.34 -52.76 20.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.577 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.519 HG23 ' HA ' ' A' ' 123' ' ' GLU . 11.2 tp -66.11 -34.76 72.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.625 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.553 ' ND2' ' HB ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -61.37 -21.23 63.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -88.02 -59.42 2.25 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.689 0.757 . . . . 0.0 110.33 175.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.75 -11.94 11.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.477 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.01 8.08 20.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.64 15.66 1.61 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.977 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.684 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 69.8 t60 -101.09 142.07 23.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.684 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.1 Cg_endo -47.93 -44.03 28.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.375 2.717 . . . . 0.0 113.193 -170.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -73.56 -25.67 60.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.161 -175.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -82.44 -42.81 18.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.632 -176.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.4 mm100 -65.21 -7.08 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.468 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -91.11 -18.87 23.81 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.969 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 36.5 mm-40 -105.01 129.81 53.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.724 -168.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 159' ' ' ILE . 21.1 tpt180 -54.59 -28.54 46.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.653 -172.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 143' ' ' MET . 2.3 p -60.71 -18.6 55.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.512 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -72.13 -32.58 67.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.935 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 58.8 t-80 -66.33 -34.05 77.12 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.484 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -81.35 -27.31 34.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.344 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.535 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 32.5 t80 -73.91 -52.31 13.33 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.552 HD23 ' CE2' ' A' ' 60' ' ' PHE . 4.3 mp -96.41 -24.43 16.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.438 -173.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.644 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 29.1 mt-30 -118.92 -169.79 1.79 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.015 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 61.66 -88.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.604 0.565 . . . . 0.0 110.493 -174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.426 ' HG3' HG13 ' A' ' 149' ' ' ILE . 5.8 tp10 -179.41 -58.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.687 0.756 . . . . 0.0 109.509 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.496 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.11 154.27 35.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.562 -175.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.518 HG12 ' HG3' ' A' ' 143' ' ' MET . 90.7 mt -85.75 115.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -98.05 105.3 17.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.829 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -73.07 3.03 5.96 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.601 0.715 . . . . 0.0 111.43 -171.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.6 m -110.45 15.62 22.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.126 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.7 OUTLIER -67.65 -171.61 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.824 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 52.4 m -83.13 111.68 32.52 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.347 177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -72.83 77.01 2.36 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 123.329 2.686 . . . . 0.0 111.801 175.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -147.69 -154.34 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.694 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 15.7 mmmt -95.6 161.72 13.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.594 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 139' ' ' ARG . 19.5 mm -56.41 -48.75 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.825 0.345 . . . . 0.0 110.167 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.24 11.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 110.127 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -89.53 118.99 29.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.33 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -149.92 138.1 20.43 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.01 0.433 . . . . 0.0 110.505 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -110.3 2.59 19.25 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.475 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.38 138.31 38.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.514 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -157.53 133.78 9.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.072 0.463 . . . . 0.0 111.067 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -129.05 42.46 3.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.491 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.33 141.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.83 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 63.82 -147.63 50.71 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.776 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.3 p -81.31 107.45 14.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.12 127.77 32.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.934 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.46 -52.79 0.82 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.014 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -85.77 147.25 26.41 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.249 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.35 165.8 3.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.823 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.38 77.32 3.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.288 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -102.53 -164.93 1.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -113.42 -52.5 2.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.139 0.495 . . . . 0.0 109.801 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 62.23 -87.94 0.02 OUTLIER 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.274 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -157.32 -94.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.406 ' O ' ' HB ' ' A' ' 12' ' ' ILE . 12.8 tp 64.19 -82.18 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.828 0.705 . . . . 0.0 112.623 173.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 22.1 mt 71.5 146.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.0 111.761 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 p -121.97 84.31 2.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.802 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -111.89 152.45 44.23 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.989 -177.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.58 103.17 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.551 2.834 . . . . 0.0 111.869 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -98.04 29.17 3.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.066 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 62.14 -168.65 0.19 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.473 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.52 149.13 50.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 110.817 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -108.03 -173.22 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.532 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -118.67 140.98 49.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.999 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.83 -58.96 0.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -114.43 -50.74 2.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.541 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.36 -179.97 45.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.375 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -55.69 157.61 15.38 Favored 'Trans proline' 0 C--O 1.225 -0.134 0 C-N-CA 124.142 3.228 . . . . 0.0 111.963 174.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.49 -9.03 3.23 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.916 3.078 . . . . 0.0 114.462 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.5 t -73.32 -54.28 8.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.627 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.6 m120 58.14 -178.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.434 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -97.36 138.52 34.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -148.17 132.95 17.95 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.552 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -146.92 106.87 3.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.645 HG12 ' HB ' ' A' ' 53' ' ' VAL . 36.0 mt -115.36 147.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.209 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.62 111.61 7.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 33' ' ' VAL . 1.2 m -88.97 131.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -179.33 -165.7 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 58.21 67.36 2.24 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-O 121.123 0.487 . . . . 0.0 110.388 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HG3' HG23 ' A' ' 115' ' ' ILE . 72.4 Cg_endo -72.74 152.77 53.42 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.933 2.422 . . . . 0.0 113.532 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.8 tp60 -138.93 111.57 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.322 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.0 m -78.92 90.22 4.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.856 0.836 . . . . 0.0 110.25 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 37' ' ' GLN . 1.0 OUTLIER -116.9 96.82 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.353 -174.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.64 -167.53 31.97 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.525 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.6 t -98.7 152.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-O 119.419 -0.324 . . . . 0.0 110.52 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.16 -46.57 8.15 Favored Glycine 0 N--CA 1.46 0.248 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.321 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -100.2 84.84 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.23 0.538 . . . . 0.0 109.852 172.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.58 37.29 0.79 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.274 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 21.1 ttt180 -83.38 130.32 35.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.8 0.333 . . . . 0.0 110.379 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -122.52 159.17 28.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.1 m -111.95 127.32 55.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.483 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 43.4 p -92.5 152.36 19.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.293 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -119.62 140.5 50.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 32.9 tt0 -90.89 119.48 31.12 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.67 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.39 111.98 26.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.069 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 58.9 mtp85 -104.79 134.86 47.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -144.64 141.57 23.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.1 ttmt -127.39 135.95 51.19 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.072 169.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 63' ' ' LYS . 15.0 t -171.23 163.86 7.17 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.514 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.514 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.98 27.25 9.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.836 169.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.627 HD23 ' OD1' ' A' ' 27' ' ' ASN . 23.1 mt -61.38 139.06 94.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.029 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.13 -12.27 19.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.151 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.49 HD13 HG13 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -89.67 -41.22 13.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.432 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.3 m-85 -65.37 -13.53 58.81 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 71.35 -66.5 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.77 -2.85 58.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 122.174 -0.329 . . . . 0.0 110.462 -172.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 55' ' ' THR . 4.5 mmpp? 70.45 -46.18 0.61 Allowed 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.129 0.893 . . . . 0.0 111.545 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -158.41 118.98 3.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.893 0.854 . . . . 0.0 110.905 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 t -155.58 179.33 9.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.517 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.457 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 14.2 m -141.36 137.02 32.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 m -125.96 175.62 7.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.452 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -145.72 118.59 8.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.729 0.3 . . . . 0.0 110.855 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -151.9 173.53 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HG2' ' OD2' ' A' ' 73' ' ' ASP . 20.6 ptt180 -99.32 170.54 8.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -164.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.468 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 33.7 t80 -53.88 -38.71 65.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.488 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.598 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 29.9 m -59.38 -25.24 64.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.776 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.655 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 20.7 m-20 -80.5 -35.18 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.446 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 57.0 m-85 -59.48 -38.86 81.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.445 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.598 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 20.1 mt-10 -61.68 -53.24 58.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.56 0.695 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.509 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -68.25 -23.46 64.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.206 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.73 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -71.95 -42.95 65.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -55.31 -60.58 3.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.815 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.721 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.5 p -64.2 -35.37 80.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.371 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.533 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 4.6 mm-40 -59.37 -37.25 77.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.404 HD13 HG11 ' A' ' 87' ' ' VAL . 95.2 mt -73.36 -27.8 61.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.058 0.456 . . . . 0.0 110.656 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HG3' HG22 ' A' ' 89' ' ' VAL . 49.8 mt-10 -84.38 -18.33 36.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.355 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.0 mmm180 -58.84 -61.7 2.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -119.64 0.05 10.88 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.512 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 73.7 m -125.43 166.99 15.6 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.778 0.799 . . . . 0.0 111.911 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.51 30.41 3.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.47 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 89' ' ' VAL . 97.2 t -52.49 141.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.873 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 88' ' ' VAL . 4.0 p -66.42 27.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.882 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.532 ' HA ' HG13 ' A' ' 129' ' ' VAL . 0.5 OUTLIER -57.88 120.33 41.31 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 121.809 -0.557 . . . . 0.0 111.777 -174.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG3' ' CD ' ' A' ' 128' ' ' LYS . 97.4 Cg_endo -88.58 168.25 5.99 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.005 2.47 . . . . 0.0 112.147 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 146.06 75.81 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 112.184 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 75' ' ' GLU . 80.1 mt -69.26 152.02 96.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.15 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.53 109.98 2.97 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.965 2.443 . . . . 0.0 111.932 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.61 176.82 44.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.081 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.2 31.49 16.56 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.567 0.699 . . . . 0.0 110.346 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.7 -85.23 0.59 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.912 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.515 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -61.76 -18.19 58.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.327 -177.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.9 mm? -69.6 -44.14 71.34 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 -174.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 17.88 6.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 109.844 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.2 tt0 -118.5 -39.88 2.97 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.689 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 mt -92.83 171.76 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.998 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.14 -172.86 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.737 2.291 . . . . 0.0 111.732 171.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 61.5 m-85 -105.65 -86.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.655 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 65.19 -75.57 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.677 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.78 64.82 3.62 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.376 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.2 t70 65.93 -69.96 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.324 1.05 . . . . 0.0 110.331 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.53 -23.97 12.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.128 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 113.78 7.28 20.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.124 -174.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.754 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.8 pt -71.95 -19.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.886 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.92 -12.04 60.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.791 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.37 135.19 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.471 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.69 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 48.3 m-80 -73.52 -58.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.754 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -50.65 -48.18 58.31 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.526 0.516 . . . . 0.0 111.192 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.441 HG23 ' HG3' ' A' ' 36' ' ' PRO . 37.5 mt -51.76 -48.38 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.433 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.14 -20.51 59.36 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.262 -177.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.625 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 29.9 mm-40 -71.88 -32.79 67.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.209 0.528 . . . . 0.0 109.762 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 43.5 ttp180 -81.93 -34.34 29.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.237 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.02 -50.05 71.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.524 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.748 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -59.47 -39.97 85.42 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.166 -175.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.5 -36.54 23.08 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.443 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 4.6 tp -64.24 -36.61 84.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.435 0.16 . . . . 0.0 111.037 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.1 pt-20 -75.65 -29.99 59.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.7 mm-40 -64.01 -53.61 47.32 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.6 t80 -49.9 -54.55 18.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.287 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.544 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.1 tp -64.67 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.865 -172.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -62.21 -16.96 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.16 -0.338 . . . . 0.0 111.825 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.439 ' CD ' ' HG3' ' A' ' 90' ' ' PRO . 32.1 mttm -89.92 -58.65 2.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.038 0.923 . . . . 0.0 110.568 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 89' ' ' VAL . 1.3 m -66.05 -13.51 15.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.027 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 126' ' ' ILE . . . -111.92 10.28 20.62 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -136.16 2.25 3.54 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.436 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.69 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 35.1 t60 -99.91 144.36 28.22 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 117.185 0.492 . . . . 0.0 111.74 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.8 Cg_exo -39.64 -50.52 3.1 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.578 3.519 . . . . 0.0 113.879 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.37 -30.14 68.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.521 ' O ' HD21 ' A' ' 141' ' ' LEU . . . -78.03 -39.99 40.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.25 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.462 ' OE1' HG22 ' A' ' 59' ' ' ILE . 53.8 mm-40 -65.56 -6.38 10.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.584 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.442 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -108.7 6.07 25.39 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.974 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.512 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 5.1 mm-40 -118.48 129.18 55.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.824 0.345 . . . . 0.0 111.128 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -54.21 -20.41 6.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.518 -176.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.5 m -53.45 -35.81 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.432 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 135' ' ' ALA . 5.5 mp -69.95 -33.53 72.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.238 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 37.1 t-80 -56.88 -39.72 74.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.132 0.491 . . . . 0.0 110.249 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.52 ' HG3' HG13 ' A' ' 150' ' ' ILE . 2.5 ptm -79.96 -28.57 39.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.081 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.73 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.26 -47.81 14.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.518 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -93.98 -19.91 20.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.113 -174.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 7.6 mt-30 -119.95 -172.61 2.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.151 -168.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 53.06 -116.75 1.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.257 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -134.89 -35.15 0.87 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.701 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.98 162.65 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.75 0.786 . . . . 0.0 112.868 -167.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -74.82 115.65 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.895 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.32 112.89 24.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.844 0.354 . . . . 0.0 110.186 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.509 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 27.1 mmtp -75.69 11.04 1.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -172.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.0 m -129.08 19.21 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.212 0.53 . . . . 0.0 110.297 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.509 ' CD1' ' HE3' ' A' ' 143' ' ' MET . 0.6 OUTLIER -65.57 -174.2 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.16 -178.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.0 m -90.89 112.49 53.79 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.161 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.72 76.68 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 123.453 2.768 . . . . 0.0 112.111 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -146.82 -161.78 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.442 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.1 mmmt -85.93 165.07 17.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.49 HG13 HD13 ' A' ' 59' ' ' ILE . 12.1 mm -60.54 -40.92 85.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.217 0.532 . . . . 0.0 110.261 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 120.45 25.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.52 20.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 111.014 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.758 177.458 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 20.8 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.214 0.53 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . 55.65 40.91 30.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.642 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -122.89 80.9 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.175 0.512 . . . . 0.0 109.797 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -129.36 165.48 21.42 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.134 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -88.64 -30.77 18.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.767 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 4.4 t60 63.82 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.359 0.664 . . . . 0.0 110.725 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -145.9 33.19 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.76 0.79 . . . . 0.0 108.912 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -123.02 112.27 17.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.706 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.0 124.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 109.835 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -79.47 -170.13 39.21 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.805 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 m -86.24 10.99 13.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.291 1.043 . . . . 0.0 110.182 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.37 128.42 4.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.065 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -159.29 -58.8 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.12 144.9 30.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.623 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.4 -157.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 124.302 1.001 . . . . 0.0 111.56 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.56 67.05 0.75 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.238 0.542 . . . . 0.0 112.2 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.4 155.92 33.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.896 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.1 p -56.13 -54.19 48.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.806 0.336 . . . . 0.0 110.433 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 70.82 143.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.504 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.706 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 5.7 ppt_? -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.704 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.625 ' C ' HG13 ' A' ' 12' ' ' ILE . 16.4 tp -153.68 -71.41 0.14 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.066 0.46 . . . . 0.0 110.732 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.625 HG13 ' C ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER 63.4 -159.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.712 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.464 ' H ' HG21 ' A' ' 12' ' ' ILE . 13.1 p 72.81 112.59 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.0 111.682 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.5 mptt -76.79 170.99 13.56 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.344 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 82.9 Cg_exo -48.32 118.53 3.31 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.192 1.928 . . . . 0.0 112.448 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.23 144.04 29.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.94 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.8 127.88 44.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' HG ' ' CZ ' ' A' ' 160' ' ' ARG . 3.5 mm? -105.78 -173.32 2.27 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.148 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -77.51 176.15 9.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.97 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -159.12 162.97 36.52 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.855 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.0 -46.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.162 0.505 . . . . 0.0 111.061 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.41 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 79.6 m-85 -121.45 -20.05 6.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.592 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.44 174.75 46.95 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.602 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.69 158.62 19.51 Favored 'Trans proline' 0 C--O 1.222 -0.276 0 C-N-CA 124.336 3.358 . . . . 0.0 111.174 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.63 -14.67 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.418 3.412 . . . . 0.0 115.206 -171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 p -68.63 -62.45 1.38 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 58.13 -177.37 0.07 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.262 0.553 . . . . 0.0 111.902 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -99.47 138.17 36.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.557 HD23 HD11 ' A' ' 57' ' ' LEU . 15.9 tp -145.58 132.33 20.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.057 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.73 106.05 3.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.174 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.656 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.2 mt -114.55 142.87 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.058 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -136.55 118.47 15.24 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -100.23 135.04 37.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t 178.85 -161.97 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 31.7 m-80 62.5 73.42 0.54 Allowed Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 110.46 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HG3' HG22 ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.01 131.85 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.802 2.335 . . . . 0.0 112.865 -173.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 47.6 tp60 -117.02 112.34 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.14 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.9 m -73.17 104.04 4.1 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.42 90.66 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.268 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.22 -167.57 33.24 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.814 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.4 t -100.71 147.98 7.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 119.278 -0.392 . . . . 0.0 110.134 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.34 5.55 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 121.59 -0.338 . . . . 0.0 113.152 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -103.96 88.62 3.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.462 0.649 . . . . 0.0 109.416 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.37 32.35 0.98 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.725 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.554 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 8.9 ttp180 -84.34 152.21 24.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.403 0.281 . . . . 0.0 110.304 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.14 162.3 35.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.747 0.308 . . . . 0.0 110.359 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -113.92 131.35 56.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.608 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 15.9 p -99.64 153.39 19.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.54 144.97 43.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.237 0.541 . . . . 0.0 110.627 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 35.9 tt0 -95.79 123.2 39.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.347 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.5 mp -96.72 117.84 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.276 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -110.5 109.81 20.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.407 176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.656 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -119.46 137.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.013 0.435 . . . . 0.0 111.993 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -125.89 134.97 51.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.307 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.512 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.4 t -170.31 165.95 8.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.288 0.566 . . . . 0.0 111.626 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -120.45 26.26 9.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.119 168.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD11 HD23 ' A' ' 29' ' ' LEU . 20.9 mt -60.62 143.36 90.54 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.192 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.84 -29.64 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.431 2.088 . . . . 0.0 111.711 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.477 HD11 ' O ' ' A' ' 136' ' ' GLN . 0.4 OUTLIER -69.29 -40.19 79.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.95 178.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.612 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.4 m-30 -69.1 -19.98 64.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.49 -64.33 0.39 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -80.11 -7.66 59.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 122.182 -0.324 . . . . 0.0 110.833 -172.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.6 mmtp 70.68 -43.43 0.55 Allowed 'General case' 0 C--O 1.218 -0.578 0 O-C-N 124.014 0.822 . . . . 0.0 111.163 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.6 pp20? -160.58 130.82 5.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 109.998 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.2 t -160.43 165.85 30.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.609 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 37.7 m -140.5 130.4 24.58 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.292 0.568 . . . . 0.0 110.853 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 147' ' ' ASP . 5.8 m -133.47 174.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -144.06 122.88 12.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.197 0.522 . . . . 0.0 111.567 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.05 -177.66 5.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 167.57 10.25 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -169.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.547 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.7 t80 -55.09 -34.38 63.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.42 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.514 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 16.9 m -55.03 -33.58 62.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.738 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -75.06 -38.14 61.45 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 59.9 m-85 -60.12 -37.47 80.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.644 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 25.7 mt-10 -62.52 -55.07 30.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.752 0.787 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.415 ' CD1' HG21 ' A' ' 150' ' ' ILE . 1.1 t-105 -64.9 -28.64 69.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.436 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.636 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -69.35 -40.73 77.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 63.9 ttt180 -57.95 -64.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.446 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.721 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -61.28 -37.17 82.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.014 -172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.19 -44.73 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.373 0.42 . . . . 0.0 111.431 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.37 -37.06 85.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.73 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -73.82 -24.95 59.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.138 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HG2' ' O ' ' A' ' 79' ' ' SER . 25.1 mmt180 -67.98 -62.53 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.063 0.459 . . . . 0.0 111.816 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -85.46 -30.05 23.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.323 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.503 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 29.5 m -120.66 175.03 6.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.654 0.74 . . . . 0.0 112.004 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -105.0 23.6 13.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.738 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 89' ' ' VAL . 97.6 t -42.6 140.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.846 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 88' ' ' VAL . 5.6 p -69.19 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.371 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.2 t -56.07 121.65 42.65 Favored Pre-proline 0 N--CA 1.464 0.268 0 O-C-N 121.945 -0.472 . . . . 0.0 110.836 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.483 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 89.0 Cg_endo -88.28 166.4 6.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.904 2.403 . . . . 0.0 112.302 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.66 150.82 87.55 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.867 2.378 . . . . 0.0 112.459 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 75' ' ' GLU . 49.6 mt -80.51 153.39 73.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.436 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -88.44 109.27 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.912 2.408 . . . . 0.0 112.289 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.12 59.15 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.443 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -144.55 -25.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.778 0.323 . . . . 0.0 111.4 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.85 -82.32 0.29 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.499 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -49.94 -24.5 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.951 1.3 . . . . 0.0 114.14 -171.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.6 mm? -59.34 -45.16 92.15 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.915 0.388 . . . . 0.0 111.221 -173.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 20.65 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.716 0.769 . . . . 0.0 109.432 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -118.1 -28.31 5.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.866 -176.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 mt -101.67 169.16 8.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.25 -161.38 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.898 2.399 . . . . 0.0 112.484 173.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 37.9 m-85 -106.97 -80.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.608 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 68.38 -64.99 0.28 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.538 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.474 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -113.86 79.07 0.27 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.431 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.64 -71.41 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.056 0.943 . . . . 0.0 111.911 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.9 -32.11 7.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.842 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 123.3 4.42 8.35 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.936 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 45.8 pt -73.09 -15.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 54.5 m-85 -79.88 -15.1 58.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.402 ' OD1' ' HB2' ' A' ' 113' ' ' ASN . 16.6 t70 -78.97 134.48 36.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.992 0.425 . . . . 0.0 110.245 -178.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.97 -24.7 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.67 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.592 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 42.7 m-80 -65.64 -57.71 7.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -51.34 -51.03 58.08 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.661 0.601 . . . . 0.0 110.879 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.409 HG22 ' HG3' ' A' ' 36' ' ' PRO . 23.7 mt -50.59 -50.35 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.995 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.55 -20.59 58.55 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.883 -177.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 37.3 mm-40 -74.25 -33.64 63.38 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.166 0.508 . . . . 0.0 109.95 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 37.5 ttm180 -80.63 -33.68 35.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -55.89 -50.88 69.45 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.551 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.73 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.6 -41.91 95.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.844 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.0 -34.5 33.47 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.439 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.571 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 4.2 tp -67.52 -36.59 81.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.025 -0.103 . . . . 0.0 111.243 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.543 ' HA ' HG21 ' A' ' 126' ' ' ILE . 12.8 pt-20 -72.77 -33.33 66.24 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.73 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 15.6 mm-40 -60.45 -58.44 8.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' O ' HG12 ' A' ' 129' ' ' VAL . 15.0 t80 -47.57 -55.43 9.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.443 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.543 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -63.93 -39.49 85.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.83 -172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -61.62 -20.27 63.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.017 0.437 . . . . 0.0 111.986 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.483 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 35.1 mttm -90.18 -56.36 3.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.939 0.876 . . . . 0.0 110.641 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 125' ' ' PHE . 1.2 m -65.84 -13.15 15.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.002 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -110.11 7.61 23.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.088 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.419 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -141.14 12.36 2.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.463 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 57.7 t60 -100.32 139.8 20.96 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 122.397 -0.472 . . . . 0.0 110.499 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.635 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 6.8 Cg_exo -41.38 -47.1 5.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.21 3.273 . . . . 0.0 113.888 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -70.81 -32.55 69.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.102 -176.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.527 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.62 -42.47 51.61 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.716 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -66.0 -6.57 13.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.141 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.568 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -99.61 -10.04 22.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.464 179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 5.5 mm-40 -106.61 131.87 53.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 111.967 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 159' ' ' ILE . 16.3 tpt180 -58.24 -19.08 31.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.852 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 143' ' ' MET . 0.7 OUTLIER -63.97 -24.17 67.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.0 110.965 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.613 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.1 mp -75.55 -31.23 59.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.553 -0.717 . . . . 0.0 110.999 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.519 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 65.0 t-80 -57.61 -38.3 74.7 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 4.0 ptm -80.47 -26.76 38.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.559 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.636 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.14 -53.74 6.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.613 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -78.78 -36.31 43.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.357 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 11.6 mt-30 -95.3 166.67 11.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' VAL . 46.1 m-20 61.96 -179.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.638 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.17 -35.25 14.65 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.048 0.928 . . . . 0.0 110.392 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.503 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -134.8 152.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.182 -165.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.575 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.2 mp -81.72 116.05 25.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.64 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.19 101.58 6.24 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.054 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -71.77 11.34 0.52 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.0 m -130.28 19.17 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 110.657 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.426 ' CD1' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.18 -171.43 0.05 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.534 0.683 . . . . 0.0 112.122 -179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 87.4 m -88.48 113.01 53.64 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.161 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.65 65.64 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.442 2.761 . . . . 0.0 112.303 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -140.59 -154.04 0.5 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.626 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.568 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 20.9 mmmt -86.24 158.98 19.59 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.475 -0.14 . . . . 0.0 110.75 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 139' ' ' ARG . 16.7 mm -51.41 -52.44 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.422 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.445 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -87.65 15.66 6.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.337 -178.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m170 62.15 -174.86 0.14 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.765 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.392 179.21 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.75 0.309 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -141.35 -178.57 5.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.954 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 60.89 55.74 3.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.396 0.617 . . . . 0.0 110.521 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -128.21 108.18 10.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.443 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -87.46 -178.95 6.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.45 -38.2 86.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.639 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -156.35 148.5 23.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -65.99 97.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.01 131.28 34.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -129.7 19.99 5.22 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.3 p -120.21 168.75 10.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.664 -0.768 . . . . 0.0 110.668 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.35 131.42 51.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.368 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.478 ' C ' ' HG1' ' A' ' 4' ' ' THR . 0.7 OUTLIER -112.59 -172.05 1.97 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.478 ' HG1' ' C ' ' A' ' 3' ' ' GLU . 31.4 p 56.56 176.15 0.04 OUTLIER 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 112.256 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t 70.82 -62.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.381 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.01 95.71 4.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.601 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.47 146.46 54.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.532 . . . . 0.0 110.58 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -71.53 -55.11 8.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.76 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.543 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 3.3 mmp_? 61.05 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 72.91 126.27 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 tp -136.65 144.22 43.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.199 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mt -138.55 147.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.955 0.407 . . . . 0.0 110.793 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 p -122.56 79.62 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.462 0.648 . . . . 0.0 110.566 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.78 168.18 9.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.387 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 56.7 Cg_exo -52.61 120.31 7.3 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.689 2.259 . . . . 0.0 111.649 174.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -58.45 130.13 45.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -97.88 -169.95 1.91 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.822 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.39 172.99 12.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.899 0.381 . . . . 0.0 110.339 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -68.9 178.18 2.29 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.506 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -146.97 140.89 25.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.065 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.46 175.29 13.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 2.6 m-85 -122.2 -5.85 8.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.076 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.52 175.5 43.91 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.425 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.33 154.71 10.73 Favored 'Trans proline' 0 C--O 1.224 -0.224 0 C-N-CA 124.0 3.133 . . . . 0.0 111.34 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.98 -11.82 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 124.483 3.455 . . . . 0.0 115.161 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -74.06 -61.89 1.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 32.2 m-80 58.84 -178.58 0.08 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.489 0.493 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -91.43 125.52 36.21 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.584 HD21 HD12 ' A' ' 57' ' ' LEU . 13.1 tp -138.14 129.09 27.06 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.88 -176.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -140.32 104.36 4.77 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.093 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.636 HG12 ' HB ' ' A' ' 53' ' ' VAL . 47.9 mt -114.69 141.49 31.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.182 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.8 117.57 14.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.996 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -98.62 132.42 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.103 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t 179.52 -162.56 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.2 m-80 63.58 77.44 0.32 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.98 142.17 30.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.392 2.061 . . . . 0.0 113.051 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -131.9 111.22 11.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.059 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.0 101.57 4.52 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.3 88.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.426 0.632 . . . . 0.0 110.235 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.44 -167.62 33.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.837 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.2 t -111.35 156.28 12.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.144 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.41 -49.04 6.98 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.465 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -99.08 85.1 3.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.084 0.469 . . . . 0.0 109.744 171.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.42 38.99 0.64 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.565 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.606 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 10.1 ttt180 -89.49 140.46 29.5 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.24 154.82 42.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.844 0.355 . . . . 0.0 110.759 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 m -110.57 122.97 49.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 p -92.55 155.91 17.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.859 0.361 . . . . 0.0 110.829 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 80.5 m-85 -119.12 141.42 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.728 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 31.3 tt0 -90.64 123.62 34.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.349 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.577 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -102.73 115.6 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.41 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 57.4 mtp180 -105.52 139.41 40.17 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.556 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.636 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -146.39 140.7 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -128.83 143.08 50.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.039 165.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.405 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 15.0 t -172.9 164.46 5.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.912 0.387 . . . . 0.0 111.964 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.52 31.12 6.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.628 0.728 . . . . 0.0 110.137 166.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.584 HD12 HD21 ' A' ' 29' ' ' LEU . 23.2 mt -67.86 145.2 97.83 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.273 174.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.53 -28.53 5.38 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.598 2.199 . . . . 0.0 111.777 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.4 OUTLIER -69.94 -41.36 79.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.878 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 145' ' ' LEU . 2.3 m-30 -69.96 -33.0 71.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.593 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.1 tmmm? 75.11 -58.13 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.582 0.551 . . . . 0.0 112.101 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.75 -14.83 60.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 122.284 -0.26 . . . . 0.0 111.039 -172.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp 73.66 -38.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.851 0.719 . . . . 0.0 110.857 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.62 140.25 30.04 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.411 0.624 . . . . 0.0 109.956 174.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -160.28 151.55 19.37 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.109 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.9 m -140.39 133.95 30.14 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.021 0.439 . . . . 0.0 109.935 173.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 21.0 m -129.96 179.52 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.624 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 36.3 ttm180 -145.96 101.83 3.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 mmp_? -122.95 172.61 8.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.137 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -88.83 161.83 16.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.539 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 38.5 t80 -55.26 -37.53 67.37 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.437 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 35.5 m -61.99 -26.17 68.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.648 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.8 -36.42 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.65 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 52.1 m-85 -66.46 -39.89 89.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.998 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 32.9 mt-10 -57.06 -56.94 15.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.585 0.707 . . . . 0.0 110.826 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.46 ' CD1' HG23 ' A' ' 150' ' ' ILE . 4.7 t-105 -63.33 -34.09 76.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.733 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.629 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -69.19 -43.97 73.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 31.8 ttt180 -57.54 -59.52 5.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.797 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -60.58 -32.95 72.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.301 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.7 mm-40 -63.14 -46.37 87.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.014 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 85' ' ' SER . 88.8 mt -71.06 -16.31 62.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.0 110.755 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 47.5 mt-10 -87.73 -50.08 6.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.107 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 1.5 ppt_? -62.2 -21.79 65.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -165.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 9.5 pt-20 -138.12 -34.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.282 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.92 158.85 33.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.203 0.525 . . . . 0.0 110.476 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -96.53 17.86 15.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.238 0.542 . . . . 0.0 109.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 135' ' ' ALA . 90.7 t -56.06 140.24 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.93 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' VAL . 9.8 p -75.53 37.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.611 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.519 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -51.69 118.72 12.01 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.411 -175.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 6.3 Cg_exo -72.43 160.56 46.53 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.495 2.797 . . . . 0.0 112.525 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 142.2 42.3 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.876 2.384 . . . . 0.0 111.983 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.1 mt -69.37 150.57 97.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -86.49 109.65 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.881 2.388 . . . . 0.0 111.957 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.63 -174.53 27.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.078 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.43 ' N ' HD23 ' A' ' 98' ' ' LEU . 51.8 tttp 71.09 -55.25 0.65 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.824 . . . . 0.0 112.035 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.61 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -73.36 -18.17 61.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.482 -170.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 97' ' ' PHE . 2.1 mm? -69.14 -44.34 72.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.772 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 26.48 4.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.536 0.684 . . . . 0.0 110.178 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -116.69 -41.51 3.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 62.6 mt -80.57 163.6 55.7 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.62 147.35 86.15 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.961 2.441 . . . . 0.0 111.499 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -104.76 94.82 5.49 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -125.76 -30.88 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.094 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.65 -167.31 43.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.439 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.9 -47.89 76.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.273 0.558 . . . . 0.0 110.936 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -136.41 -51.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.997 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.36 -10.38 1.3 Allowed Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.206 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.775 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.8 pt -65.53 -16.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 111.928 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -81.22 -16.12 53.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.357 0.599 . . . . 0.0 110.119 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.42 122.16 28.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.68 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.64 -27.0 64.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.581 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 14.3 m120 -55.09 -60.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.487 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.775 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -54.84 -47.71 73.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.51 0.506 . . . . 0.0 110.895 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 mt -51.47 -51.27 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.275 -173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.51 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -73.11 -22.33 60.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.48 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 66.2 mm-40 -74.87 -32.45 61.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.802 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 14.7 tpp180 -78.97 -35.49 42.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.58 -54.01 51.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.467 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.708 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -59.33 -40.41 86.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.998 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -34.84 32.91 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.133 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.65 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.5 OUTLIER -67.12 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.732 0.266 . . . . 0.0 111.298 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.597 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -73.43 -32.43 64.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.708 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.4 mm-40 -62.31 -58.17 8.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 7.1 t80 -48.89 -53.27 20.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.613 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.514 HG23 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.34 -41.05 90.36 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.776 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.97 -19.72 45.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 111.809 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.422 ' HE2' ' O ' ' A' ' 124' ' ' GLN . 31.8 mttm -90.72 -58.83 2.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.76 0.791 . . . . 0.0 110.66 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.628 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.32 -13.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.023 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 126' ' ' ILE . . . -111.18 10.93 21.85 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.981 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.89 8.64 1.3 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.796 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.786 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 59.2 t60 -98.42 144.97 29.06 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 117.217 0.509 . . . . 0.0 110.214 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.786 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.0 Cg_exo -41.9 -48.86 5.89 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.23 3.286 . . . . 0.0 113.775 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.633 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -71.09 -38.91 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.777 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.628 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -69.14 -41.49 77.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.359 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.468 ' O ' HD12 ' A' ' 59' ' ' ILE . 6.1 mm-40 -65.93 -4.13 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.194 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 0.3 OUTLIER -106.46 -7.95 17.34 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.875 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.2 mm-40 -106.51 135.14 48.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.01 -0.431 . . . . 0.0 110.998 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.628 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -57.02 -17.68 10.89 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.616 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.3 m -58.3 -30.0 66.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.317 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 135' ' ' ALA . 6.5 mp -74.78 -29.97 61.29 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.22 -0.3 . . . . 0.0 111.357 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -58.51 -43.57 89.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.308 0.575 . . . . 0.0 109.864 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.3 ptm -77.84 -31.22 51.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.188 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.629 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 5.0 t80 -77.45 -41.31 40.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.109 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.9 mt -98.29 -47.5 5.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 112.005 -169.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -81.03 -46.39 15.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.014 -171.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.65 154.96 20.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.182 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.463 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.7 pm0 -66.42 -29.51 69.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.739 0.781 . . . . 0.0 110.164 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.524 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -134.22 132.37 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.07 -167.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.483 HG21 ' HE3' ' A' ' 143' ' ' MET . 3.3 mp -70.66 105.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.282 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 153' ' ' SER . 14.2 t70 -83.51 99.41 10.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.048 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -71.86 11.61 0.5 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 112.309 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 151' ' ' ASP . 22.1 t -111.99 11.28 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.665 175.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.423 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 0.4 OUTLIER -62.8 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.281 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 50.4 m -94.3 114.32 63.02 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.784 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 21.9 Cg_exo -68.88 68.44 1.22 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.432 2.755 . . . . 0.0 112.067 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -140.24 -159.39 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.626 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.628 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 6.6 mmmm -88.25 158.91 18.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 59' ' ' ILE . 16.5 mm -50.35 -46.29 25.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.679 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 31.76 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.8 m170 63.66 -178.39 0.16 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.607 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.122 -178.642 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.201 0.524 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -85.1 76.76 10.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -154.22 -62.87 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.739 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -146.61 116.0 7.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.504 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -89.02 130.41 35.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.845 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -81.43 125.87 30.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -94.29 -3.95 49.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.966 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -134.18 81.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.916 0.389 . . . . 0.0 110.796 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.29 158.83 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.516 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -135.58 -143.87 4.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.775 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 p -71.75 109.3 5.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.55 131.49 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.132 0.895 . . . . 0.0 111.774 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.03 -59.02 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.865 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -103.97 145.92 29.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.53 162.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.182 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.04 77.53 2.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 0.0 110.042 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.35 149.47 25.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.392 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 10' ' ' ARG . 31.2 p -67.11 -53.31 31.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 71.53 -42.68 0.54 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.738 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' N ' ' HD3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -158.06 -171.08 3.37 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 tp -161.56 139.19 8.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.172 0.511 . . . . 0.0 111.014 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.9 mt -140.61 168.84 16.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.4 p 57.16 74.47 0.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.75 0.786 . . . . 0.0 111.311 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.8 158.19 83.0 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.776 -177.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -45.44 128.12 9.97 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.664 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.38 112.08 24.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.459 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -98.29 160.21 14.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.95 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.51 -179.04 6.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -72.89 168.8 18.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.487 0.66 . . . . 0.0 111.137 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.87 149.04 14.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.224 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.39 -61.01 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.508 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -125.1 -65.56 1.02 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.082 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.17 172.0 15.48 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.725 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.04 159.43 9.68 Favored 'Trans proline' 0 C--O 1.222 -0.31 0 C-N-CA 124.201 3.267 . . . . 0.0 111.591 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.99 -24.87 0.47 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.421 3.414 . . . . 0.0 115.452 -170.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -70.53 -62.29 1.44 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.26 0.224 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.8 m-80 61.81 -178.67 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.212 0.53 . . . . 0.0 111.632 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -97.3 140.49 31.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD22 HD12 ' A' ' 57' ' ' LEU . 13.4 tp -147.11 130.58 16.73 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.429 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.87 103.64 4.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.637 HG12 ' HB ' ' A' ' 53' ' ' VAL . 32.8 mt -115.43 143.29 25.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.01 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.84 115.68 10.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.769 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.2 m -99.25 132.52 44.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.8 t 179.31 -163.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.4 m-80 61.94 81.6 0.23 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 121.124 0.488 . . . . 0.0 110.47 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.67 152.92 59.57 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.724 2.283 . . . . 0.0 113.541 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.1 tp60 -144.84 107.78 4.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.007 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.1 m -76.52 104.3 6.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.4 p -130.86 88.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.706 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.5 -168.17 34.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.0 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.4 t -102.11 158.32 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.068 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.91 -49.78 6.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.972 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.82 87.03 4.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.118 0.485 . . . . 0.0 109.803 169.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.26 34.54 0.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.971 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.6 ttt180 -89.46 126.12 35.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -131.76 156.7 45.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.5 m -107.72 124.74 50.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.368 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 32.0 p -92.09 162.43 14.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.52 139.43 53.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.4 tt0 -91.11 118.35 30.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.571 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.8 mp -93.0 116.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 76.0 mtp180 -105.87 131.87 52.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.971 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.637 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.99 138.39 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.81 137.01 52.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.133 169.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 63' ' ' LYS . 13.3 t -170.31 163.74 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.272 0.558 . . . . 0.0 112.147 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.448 ' HA ' ' CD ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -118.91 22.54 11.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.203 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD12 HD22 ' A' ' 29' ' ' LEU . 21.4 mt -56.3 146.71 51.11 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.723 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -9.7 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.503 2.135 . . . . 0.0 111.918 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -88.49 -40.56 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.416 -177.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.541 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.9 m-30 -69.86 -17.36 63.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HB3' HD12 ' A' ' 62' ' ' LEU . 35.7 ttpt 75.21 -71.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -75.91 -1.45 25.5 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -169.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' HG21 ' A' ' 55' ' ' THR . 4.4 mmtm 68.31 -48.09 0.54 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.092 0.87 . . . . 0.0 111.6 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.7 pp20? -156.59 140.36 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.833 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -168.71 174.97 6.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.345 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.0 m -141.12 135.62 31.1 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.238 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 HG23 HH21 ' A' ' 69' ' ' ARG . 0.2 OUTLIER -145.4 130.62 13.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.926 -173.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 31.6 ttm180 -97.93 110.89 23.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.39 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.603 HH11 HD11 ' A' ' 150' ' ' ILE . 41.4 mtt-85 -125.64 177.01 6.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.158 -172.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -92.81 156.5 16.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.823 0.344 . . . . 0.0 111.779 -175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.581 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.5 t80 -59.63 -34.13 72.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t -58.26 -33.4 69.36 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.924 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 150' ' ' ILE . 25.5 m-20 -65.13 -45.24 85.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.412 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 60.6 m-85 -59.81 -40.55 88.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.514 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 32.1 mt-10 -57.04 -56.3 23.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.391 0.615 . . . . 0.0 111.096 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.464 ' CD1' HG23 ' A' ' 150' ' ' ILE . 0.6 OUTLIER -68.41 -28.98 67.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.525 -178.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -68.23 -42.77 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.484 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 55.8 ttt180 -57.89 -62.52 1.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.278 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -63.15 -27.42 69.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.545 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -68.96 -42.06 77.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 85' ' ' SER . 97.1 mt -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.632 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -90.18 -41.44 11.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.693 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.556 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 3.4 ppt_? -78.67 -35.21 45.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.556 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 6.0 mm-40 -101.73 -26.82 13.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.986 0.422 . . . . 0.0 111.779 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -112.38 167.8 10.15 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.451 -169.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -105.33 21.14 17.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.439 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG23 HD21 ' A' ' 81' ' ' LEU . 87.3 t -53.68 144.91 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.907 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 88' ' ' VAL . 5.4 p -72.64 31.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.081 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.484 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -52.42 119.51 15.32 Favored Pre-proline 0 N--CA 1.467 0.407 0 O-C-N 122.228 -0.295 . . . . 0.0 111.367 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.476 ' HG3' ' CD ' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -88.21 168.37 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.868 2.379 . . . . 0.0 111.884 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 148.65 84.02 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.503 2.136 . . . . 0.0 112.495 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 75' ' ' GLU . 67.6 mt -77.22 154.83 82.33 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.641 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.454 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 61.0 Cg_endo -83.06 142.12 10.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.73 -163.35 36.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.277 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 68.06 -60.53 0.41 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 112.234 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.29 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -62.09 -16.1 49.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.471 -168.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.406 HD21 ' H ' ' A' ' 98' ' ' LEU . 2.2 mm? -69.5 -37.47 77.22 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.597 -174.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 12.81 32.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.316 0.579 . . . . 0.0 109.931 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.558 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.4 tp-100 -97.58 -38.97 9.34 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.771 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.9 mt -83.07 166.87 32.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.859 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.2 142.0 90.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.804 2.336 . . . . 0.0 111.553 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.26 5.5 37.98 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.261 0.553 . . . . 0.0 110.876 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -70.33 -14.25 62.5 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.358 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.4 -178.49 38.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.571 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.08 -45.3 94.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -151.38 -27.98 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.884 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 -0.34 12.97 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.723 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.6 pt -74.81 -15.39 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -84.22 -7.3 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.382 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.25 135.84 36.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.312 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -30.81 71.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.31 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.63 -58.5 6.74 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.723 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -51.5 -48.25 62.97 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.412 0.445 . . . . 0.0 111.101 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.8 mt -50.57 -51.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.218 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.76 -20.62 56.27 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.642 -177.296 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.562 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 21.2 mm-40 -75.09 -33.27 61.62 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.229 0.538 . . . . 0.0 109.878 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 9.8 tpp180 -78.7 -38.22 39.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.518 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.03 -52.27 59.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 -178.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.771 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.62 -41.65 95.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.111 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -80.34 -32.25 35.37 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.5 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.5 tp -67.55 -40.45 84.96 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.799 -0.201 . . . . 0.0 111.156 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 12.6 pt-20 -72.09 -32.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.771 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.7 mm-40 -61.34 -57.75 11.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.449 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.3 t80 -50.12 -52.1 37.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.758 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.504 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -64.7 -42.04 93.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.928 -170.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -60.64 -17.78 49.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.476 ' CD ' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -88.2 -57.98 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.869 0.842 . . . . 0.0 110.395 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.515 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -65.36 -12.83 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.181 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.32 6.25 28.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.366 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.09 15.94 1.52 Allowed Glycine 0 C--N 1.332 0.352 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.883 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.731 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 50.1 t60 -100.26 144.38 28.31 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 117.328 0.564 . . . . 0.0 110.385 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.731 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 21.2 Cg_exo -38.95 -49.12 2.8 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.403 3.402 . . . . 0.0 113.827 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.677 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -70.94 -39.5 72.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.138 -175.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' ASN . . . -68.02 -41.01 82.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.716 -175.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -70.8 4.82 2.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.735 0.779 . . . . 0.0 109.846 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.7 t-20 -119.24 4.3 11.29 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.1 mm-40 -117.26 128.14 54.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.446 ' HA ' HD12 ' A' ' 159' ' ' ILE . 20.0 tpt180 -54.81 -16.56 2.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.817 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.672 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.9 m -55.5 -28.73 56.38 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.075 0.55 . . . . 0.0 111.461 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.593 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.0 mp -78.75 -29.42 45.19 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.341 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 52.6 t-80 -56.79 -39.55 74.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.7 ptm -79.59 -31.41 41.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.685 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -81.39 -36.12 29.93 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -94.02 -37.7 11.52 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.137 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.2 mt-30 -94.59 174.12 7.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.54 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.0 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -102.72 -30.71 10.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.55 0.691 . . . . 0.0 110.666 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -138.69 158.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.132 -167.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.603 HD11 HH11 ' A' ' 69' ' ' ARG . 2.2 mp -86.85 123.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.638 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.7 106.53 18.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.215 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.458 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 9.4 mptt -77.2 11.24 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.213 0.53 . . . . 0.0 112.158 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 t -126.33 18.01 7.63 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -170.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.277 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 85.5 m -82.26 112.65 37.8 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.458 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -72.87 61.34 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.358 2.705 . . . . 0.0 112.675 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.0 m -136.86 -157.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 122.309 -0.244 . . . . 0.0 110.841 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -87.08 158.82 19.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 119.907 -0.092 . . . . 0.0 110.83 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 59' ' ' ILE . 17.5 mm -52.2 -49.95 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.287 0.565 . . . . 0.0 110.539 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 20.52 4.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.875 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 7.6 m170 60.77 -178.26 0.11 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.353 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.029 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.732 178.304 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.846 0.355 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -119.1 5.46 11.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.395 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -70.27 -32.54 70.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -111.05 155.83 22.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -78.76 36.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.893 0.377 . . . . 0.0 111.932 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.04 0.448 . . . . 0.0 110.447 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -83.04 -9.33 59.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.967 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -96.0 81.64 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.244 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.15 128.83 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -119.5 62.88 0.46 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.779 -0.725 . . . . 0.0 111.931 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.4 p -72.13 121.17 18.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.065 0.459 . . . . 0.0 111.503 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.42 128.15 17.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.445 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.24 -62.56 0.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.105 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -101.76 160.94 14.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.846 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG23 ' H ' ' A' ' 6' ' ' ALA . 2.0 m 41.53 -100.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 124.633 1.208 . . . . 0.0 113.93 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.483 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -77.72 142.39 38.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.911 0.386 . . . . 0.0 111.664 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.63 168.94 10.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.9 p -76.54 -60.62 2.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 64.44 146.12 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.863 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.545 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -164.39 138.54 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.179 177.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.0 tp -145.3 146.65 31.73 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.869 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.51 141.03 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.943 0.401 . . . . 0.0 110.663 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 p -125.95 138.87 53.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.714 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 5.4 mptt -106.47 153.33 40.59 Favored Pre-proline 0 C--N 1.322 -0.594 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.693 -176.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -48.35 127.39 15.54 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.827 3.018 . . . . 0.0 112.772 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -77.51 154.23 32.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.894 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.84 -167.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.635 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.5 mm? -69.61 -175.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.546 178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.48 168.1 15.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.803 0.811 . . . . 0.0 111.607 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -148.59 144.05 26.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.647 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.99 -56.26 0.42 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.176 0.513 . . . . 0.0 110.543 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.419 ' CB ' ' HB2' ' A' ' 56' ' ' ASN . 38.6 m-85 -96.89 -30.2 13.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.755 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.52 172.36 45.39 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.88 157.47 10.34 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.859 3.039 . . . . 0.0 112.48 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.29 -18.36 0.73 Allowed 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.997 3.798 . . . . 0.0 115.439 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -69.91 -61.58 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.564 ' OD1' HD22 ' A' ' 57' ' ' LEU . 26.8 m120 61.44 164.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.311 0.644 . . . . 0.0 112.675 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -89.65 143.43 26.81 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.599 HD21 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -147.77 126.66 12.72 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.08 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.2 pt-20 -133.29 100.04 4.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.12 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.646 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.1 mt -113.08 137.55 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.235 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.82 112.9 11.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.345 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.562 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -92.68 130.97 40.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 t -179.9 -163.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.1 m-80 60.32 77.22 0.38 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.477 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.58 150.67 86.35 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' THR . 46.8 tp60 -135.75 110.66 8.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.955 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 m -74.56 98.21 3.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 109.41 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.12 91.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.51 -167.58 32.72 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.86 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -109.77 148.89 13.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 119.41 -0.328 . . . . 0.0 110.36 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.91 -49.93 4.2 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 121.599 -0.334 . . . . 0.0 112.841 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.59 85.34 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.991 0.425 . . . . 0.0 109.89 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.92 39.02 0.67 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.914 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.3 ttp180 -85.94 150.01 24.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 122.487 0.315 . . . . 0.0 110.252 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -149.83 171.27 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.826 0.346 . . . . 0.0 110.798 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 74.0 m -124.63 126.56 45.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.711 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 21.1 p -92.69 161.53 14.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.66 0.267 . . . . 0.0 110.35 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -123.26 140.98 52.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.297 0.57 . . . . 0.0 110.838 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.1 tt0 -92.4 121.06 33.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.073 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -97.52 119.07 45.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.612 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 93.6 mtt180 -109.18 142.05 40.53 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.36 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.646 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.71 142.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 25.2 ttmt -133.81 142.35 47.82 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.527 168.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.591 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 10.1 t -170.12 163.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.72 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.581 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -112.69 20.22 16.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.81 169.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.599 HD11 HD21 ' A' ' 29' ' ' LEU . 30.6 mt -58.71 147.85 69.67 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.4 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -84.6 -30.75 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.808 1.672 . . . . 0.0 112.075 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -61.26 -43.16 95.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 178.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.574 ' CE1' HD12 ' A' ' 57' ' ' LEU . 2.8 m-30 -65.7 -33.56 76.17 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 75.54 -53.72 0.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -81.1 -12.12 59.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 122.017 -0.427 . . . . 0.0 110.392 -176.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 55' ' ' THR . 10.6 mmmm 68.51 -44.55 0.51 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 124.094 0.871 . . . . 0.0 111.09 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -141.36 141.78 33.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 t -170.48 157.48 5.97 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.129 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.5 m -141.85 130.06 22.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 0.0 110.873 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.7 173.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.599 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -137.26 109.93 7.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 173.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.433 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 21.4 mmm180 -127.67 179.6 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.586 -175.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -100.22 165.72 11.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.787 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.545 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.1 t80 -53.72 -39.63 65.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.062 174.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.419 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 34.1 m -53.18 -36.65 61.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.622 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' CG ' ' HB3' ' A' ' 69' ' ' ARG . 4.2 m-20 -64.37 -41.64 96.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -64.44 -37.79 88.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.411 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 27.6 mt-10 -60.12 -55.65 31.24 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.38 0.61 . . . . 0.0 111.19 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.408 ' CD1' HG23 ' A' ' 150' ' ' ILE . 3.5 t-105 -67.74 -27.54 66.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.25 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.521 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -69.04 -47.47 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.6 ttt180 -55.68 -61.35 2.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.359 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 t -61.63 -27.71 68.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.382 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.6 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.8 tp10 -73.38 -47.23 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.339 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.96 -35.65 73.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 110.751 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 37.6 mt-10 -64.61 -37.58 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.439 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.5 ppt_? -91.36 -28.39 17.74 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.39 -30.87 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.515 ' HB3' HG22 ' A' ' 87' ' ' VAL . 24.3 t -144.32 -175.11 4.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 110.921 -171.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -100.36 26.81 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.204 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 85' ' ' SER . 74.7 t -52.46 139.68 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.308 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.401 ' O ' HG11 ' A' ' 88' ' ' VAL . 8.7 p -73.41 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.988 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -53.15 121.32 23.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 O-C-N 122.023 -0.423 . . . . 0.0 110.565 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.0 Cg_endo -85.77 162.94 10.61 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.605 2.203 . . . . 0.0 112.401 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 29.6 Cg_endo -63.57 146.24 92.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.765 2.31 . . . . 0.0 112.191 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 75' ' ' GLU . 97.6 mt -74.3 142.9 79.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.9 Cg_exo -73.94 117.56 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.885 2.39 . . . . 0.0 111.224 176.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.09 61.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.257 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.43 -45.35 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.01 -85.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -49.45 -32.03 11.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.579 1.152 . . . . 0.0 113.979 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.432 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -57.46 -47.3 82.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.07 27.83 8.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.618 0.723 . . . . 0.0 110.145 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -122.96 -32.73 3.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.871 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.53 168.12 12.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.31 156.26 66.96 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.865 2.376 . . . . 0.0 111.551 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -79.2 -90.42 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.498 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 64.97 -72.0 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.637 0.586 . . . . 0.0 111.344 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.02 65.16 4.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 66.57 -71.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.297 1.039 . . . . 0.0 111.326 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.83 -19.18 12.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.338 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.28 8.47 31.09 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 50.3 pt -75.56 -17.39 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.819 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -79.35 -15.43 57.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.031 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.8 132.41 41.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.155 0.503 . . . . 0.0 109.884 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.48 -27.3 69.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.717 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 50.2 m-80 -65.83 -52.43 50.63 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -53.95 -49.4 68.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.522 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.6 mt -52.57 -48.7 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.925 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.13 -21.85 59.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.605 -178.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 46.8 mm-40 -73.66 -33.86 64.67 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.621 0.724 . . . . 0.0 109.634 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.79 -35.82 43.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.433 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -57.24 -53.12 61.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.11 -178.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.661 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -61.17 -45.0 96.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.605 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.17 -43.41 95.52 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.804 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -32.14 70.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.629 0.715 . . . . 0.0 111.599 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.563 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 14.9 pt-20 -74.92 -33.3 61.98 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.661 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.0 mm-40 -59.88 -57.64 12.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.513 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.2 t80 -51.68 -53.31 40.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.499 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.532 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.9 tp -64.41 -39.95 87.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.018 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.58 -20.49 60.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 112.026 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.0 mttm -88.46 -56.26 3.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.667 0.746 . . . . 0.0 110.899 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.5 m -66.9 -11.73 14.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.025 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.07 -11.7 16.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.499 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.482 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -122.65 -6.17 8.04 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.936 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.734 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.6 t60 -84.09 143.55 42.85 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 117.328 0.564 . . . . 0.0 110.633 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.734 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 17.2 Cg_exo -39.33 -50.03 2.95 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.514 3.476 . . . . 0.0 113.813 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.42 -30.71 66.38 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.352 -174.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -77.0 -44.54 30.55 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.45 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.57 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.14 -0.76 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.421 176.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.575 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 2.5 t30 -104.11 -21.13 13.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.409 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 17.9 mm-40 -102.11 143.12 32.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.905 0.775 . . . . 0.0 112.627 -166.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -62.85 -21.25 65.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.513 -166.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.545 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 1.9 t -60.41 -26.15 66.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.23 0.538 . . . . 0.0 110.076 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 135' ' ' ALA . 4.6 mp -71.48 -28.51 63.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.342 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.82 -47.18 86.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.545 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.5 ptm -72.44 -30.64 64.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.521 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t80 -75.92 -48.37 21.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.651 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 1.6 mt -96.97 -43.68 7.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.558 . . . . 0.0 111.545 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 62' ' ' LEU . 54.4 mt-30 -91.43 -15.51 28.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.573 -166.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -111.43 174.64 5.77 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -79.15 -32.72 44.43 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.089 0.947 . . . . 0.0 110.013 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.465 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -139.9 143.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.132 -167.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.509 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.9 mp -71.58 106.67 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.036 173.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 104.02 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.897 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -69.16 -1.01 6.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.9 p -113.24 18.03 18.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.471 0.653 . . . . 0.0 110.596 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.441 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -64.3 -171.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.604 178.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.7 m -86.45 112.12 44.06 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.14 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 22.1 Cg_exo -69.38 82.43 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.403 2.735 . . . . 0.0 111.621 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 m -156.73 -153.58 0.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -105.02 177.65 4.79 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.697 177.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 59' ' ' ILE . 17.1 mm -66.78 -36.16 76.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.589 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -76.34 7.04 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.496 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.7 m170 68.02 -179.83 0.23 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.184 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.362 -178.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.079 0.466 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.28 112.92 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.205 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -134.95 46.83 2.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.175 0.512 . . . . 0.0 110.02 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 48.7 m80 59.26 49.06 9.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.545 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -118.21 83.76 2.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -64.25 116.82 6.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -97.73 67.11 1.98 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.679 0.752 . . . . 0.0 110.006 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -108.81 157.41 18.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.903 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.1 m -76.6 82.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.559 0.695 . . . . 0.0 111.364 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 108.96 -93.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.142 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.6 p 49.66 97.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.99 0.916 . . . . 0.0 112.831 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.44 142.7 28.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.678 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -82.09 -46.79 13.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.417 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 p -107.74 151.8 25.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.585 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.5 t -119.02 -46.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.763 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.39 123.87 30.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.32 148.61 46.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -54.62 -49.75 69.74 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 122.499 0.32 . . . . 0.0 110.936 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 6.0 mmp_? 64.44 154.76 0.06 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.785 0.678 . . . . 0.0 111.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -169.06 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.2 tp 72.22 137.42 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.553 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 143.25 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.917 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -136.13 130.11 32.82 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -83.8 157.72 63.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.324 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.55 127.11 13.26 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.275 2.65 . . . . 0.0 112.386 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.86 134.47 50.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.656 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -115.19 -166.78 1.15 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.76 -164.6 0.94 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' ND2' ' H ' ' A' ' 20' ' ' ASP . 1.3 p-10 -43.56 -67.65 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.075 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.529 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 5.5 p-10 -133.36 134.61 43.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.223 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -179.07 168.04 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.133 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -143.55 -53.75 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.185 0.517 . . . . 0.0 110.147 -171.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 -179.68 43.01 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.44 154.92 7.82 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.531 2.821 . . . . 0.0 111.499 173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.49 -7.71 2.27 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.798 2.998 . . . . 0.0 113.953 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 p -77.12 -53.58 7.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.589 ' OD1' HD23 ' A' ' 57' ' ' LEU . 28.7 m120 62.85 170.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.671 0.607 . . . . 0.0 111.494 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.65 134.9 33.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.543 HD22 HD11 ' A' ' 57' ' ' LEU . 14.9 tp -142.17 130.25 22.01 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.114 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -141.46 101.11 3.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.824 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.645 HG12 ' HB ' ' A' ' 53' ' ' VAL . 42.9 mt -115.07 140.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -132.59 106.92 8.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.938 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -84.6 130.64 35.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 170.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -179.1 -164.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 59.2 71.75 0.9 Allowed Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 110.284 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.39 133.37 37.15 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.088 2.525 . . . . 0.0 113.487 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 44.0 tp60 -117.65 106.96 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.686 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -78.22 90.1 4.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.554 0.692 . . . . 0.0 109.953 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -117.29 91.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.612 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.45 -166.28 31.53 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.399 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.1 t -101.2 146.94 8.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.346 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.34 -48.13 4.6 Favored Glycine 0 N--CA 1.465 0.584 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.245 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -102.22 88.21 3.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.39 0.614 . . . . 0.0 109.713 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.9 0.93 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.575 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 13.8 ttt180 -85.31 139.86 31.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 39.3 p90 -129.72 153.57 48.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 86.7 m -111.31 124.08 51.5 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.0 p -92.74 153.58 18.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.117 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.26 136.45 51.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.02 0.438 . . . . 0.0 110.765 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 29.3 tt0 -90.58 116.6 28.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 mp -94.27 113.75 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.865 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HG2' ' OG1' ' A' ' 66' ' ' THR . 66.4 mtt180 -105.53 121.98 45.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.843 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.645 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -128.9 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.0 111.882 -177.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -127.92 133.74 49.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 63' ' ' LYS . 7.1 t -168.27 165.44 12.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.595 0.712 . . . . 0.0 112.121 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.493 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.94 21.63 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.752 167.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.589 HD23 ' OD1' ' A' ' 27' ' ' ASN . 26.7 mt -56.14 131.96 74.81 Favored Pre-proline 0 CA--C 1.521 -0.163 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.801 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 11.7 Cg_exo -66.82 -37.94 18.97 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.413 2.076 . . . . 0.0 111.186 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 HG23 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -58.2 -42.43 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.448 176.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CE1' HD12 ' A' ' 57' ' ' LEU . 3.8 m-30 -68.87 -23.69 64.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.47 -64.57 0.34 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -73.44 -25.68 60.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -174.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 55' ' ' THR . 19.2 mmtp 82.02 -34.24 0.1 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.822 171.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.32 125.19 1.82 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.546 0.688 . . . . 0.0 110.08 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.7 t -170.71 176.13 4.34 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.751 -173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.549 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 27.9 m -141.73 133.19 26.72 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.3 178.35 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.301 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -143.24 106.08 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -127.41 167.59 16.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.449 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.584 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 58.0 ttp180 -94.82 165.13 12.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.002 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.507 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.2 t80 -52.52 -40.73 62.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.621 0.248 . . . . 0.0 110.809 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -54.17 -35.5 62.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.7 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.65 -41.51 96.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.97 -38.02 89.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 22.3 mt-10 -60.71 -52.12 66.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.376 0.607 . . . . 0.0 110.935 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.518 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 8.3 t-105 -67.26 -27.53 67.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.283 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -71.32 -46.58 60.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 53.5 ttt180 -58.17 -58.63 7.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.266 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 p -62.74 -32.28 73.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.453 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 1.1 tm-20 -59.4 -48.0 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.0 110.264 176.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.556 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 92.5 mt -65.4 -30.05 70.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.942 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 40.0 mt-10 -82.03 -35.53 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.988 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 2.6 ppt_? -69.59 -25.14 63.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.53 -55.06 2.14 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.056 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.495 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 75.7 m -87.21 171.09 10.91 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.754 0.787 . . . . 0.0 112.221 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -102.66 30.61 4.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.447 HG22 ' CB ' ' A' ' 134' ' ' LEU . 99.0 t -50.8 142.23 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.699 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 88' ' ' VAL . 6.5 p -72.01 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.726 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -58.74 119.66 39.06 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.435 . . . . 0.0 110.882 -176.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 91.9 Cg_endo -85.5 162.12 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.882 2.388 . . . . 0.0 112.288 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 135.03 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.988 2.458 . . . . 0.0 112.661 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 75' ' ' GLU . 93.5 mt -66.19 151.26 95.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.401 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.49 113.01 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.635 2.223 . . . . 0.0 111.248 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.48 166.57 37.08 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.635 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.59 25.7 10.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.536 0.684 . . . . 0.0 110.925 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -116.63 -74.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.016 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.495 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -69.96 -22.29 63.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.02 -176.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -66.83 -47.0 73.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.517 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -92.98 28.74 2.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.842 0.829 . . . . 0.0 110.051 176.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.495 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.6 tp-100 -124.7 -41.29 2.14 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.854 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.74 165.63 20.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.08 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 179.54 3.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.2 2.6 . . . . 0.0 111.966 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.94 -75.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.009 0.433 . . . . 0.0 110.2 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 68.06 -57.48 0.47 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.063 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.31 -159.26 25.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.717 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.09 -48.24 82.34 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.407 0.622 . . . . 0.0 110.719 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.88 -21.85 2.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.438 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.82 11.15 38.4 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.575 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 49.8 pt -90.96 -17.93 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.723 -173.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -82.9 10.44 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.357 0.599 . . . . 0.0 109.789 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.88 126.94 40.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.332 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.0 -21.16 65.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.628 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.4 m-80 -71.45 -55.14 8.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -50.82 -50.06 57.31 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.616 0.572 . . . . 0.0 111.129 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.96 -48.99 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.653 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -81.69 -14.84 56.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.913 -177.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 35.7 mm-40 -69.44 -35.13 75.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.3 0.571 . . . . 0.0 109.698 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.6 ttp180 -79.44 -34.32 41.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.212 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -57.41 -51.29 70.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.631 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -61.2 -37.63 83.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.311 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.6 -33.3 25.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.388 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.8 tp -66.6 -38.02 86.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.181 0.192 . . . . 0.0 110.945 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.564 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.8 pt-20 -71.28 -30.87 66.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.776 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 22.0 mm-40 -61.16 -59.64 5.01 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.44 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.5 t80 -48.47 -52.52 21.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.963 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.515 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -64.08 -40.28 88.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.79 -172.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.09 -18.02 44.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.1 -59.24 2.28 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.827 0.822 . . . . 0.0 110.396 175.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 81' ' ' LEU . 1.3 m -63.45 -12.46 10.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.64 -0.89 27.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.436 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.46 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.73 11.94 2.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.685 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.711 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 38.3 t60 -101.57 141.34 22.39 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.474 -0.427 . . . . 0.0 110.82 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.711 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 7.9 Cg_exo -41.27 -50.47 4.42 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.365 3.377 . . . . 0.0 113.79 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.447 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.64 -26.24 64.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.16 -174.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -84.47 -41.67 16.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.651 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.3 mm100 -66.29 -4.68 8.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.201 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.9 t-20 -106.26 0.77 25.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.438 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.495 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 5.1 mm-40 -112.26 127.46 55.98 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.999 -0.438 . . . . 0.0 110.986 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' HA ' HD13 ' A' ' 159' ' ' ILE . 13.7 tpp85 -57.98 -21.53 45.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.42 -172.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.797 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 4.3 t -61.88 -22.78 65.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 110.537 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.506 ' O ' HD21 ' A' ' 145' ' ' LEU . 7.3 mp -72.76 -32.46 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.096 -0.378 . . . . 0.0 111.441 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.625 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 18.8 t60 -58.0 -44.1 87.0 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.363 0.602 . . . . 0.0 109.643 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.797 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -77.83 -24.4 48.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.174 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.488 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.4 t80 -80.37 -57.18 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.83 -24.81 26.59 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.686 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.625 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.4 mt-30 -109.16 158.76 17.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.375 -168.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 62.51 -107.06 0.22 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.258 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -146.26 -39.78 0.22 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -139.85 151.78 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -161.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.517 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -77.59 109.11 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.314 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.59 102.3 15.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.931 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 31.6 mmtp -66.25 -5.42 10.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -106.9 18.19 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.311 0.577 . . . . 0.0 110.123 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.32 -170.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.951 -179.048 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.6 m -87.84 111.6 43.41 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.136 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.7 Cg_exo -70.72 81.68 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.247 2.631 . . . . 0.0 111.785 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.6 m -155.56 -159.24 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.264 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 18.1 mmmt -84.92 167.31 16.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.475 HG23 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.77 -45.17 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.661 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.19 125.72 28.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -75.19 174.07 9.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.71 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.684 -179.298 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . 62.39 84.65 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.238 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -129.13 132.29 47.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.086 0.469 . . . . 0.0 110.264 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -139.35 56.67 1.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.289 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 71.34 -77.89 0.05 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.468 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -152.97 156.01 38.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.771 0.32 . . . . 0.0 110.531 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -90.35 -32.37 16.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.935 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -80.05 93.63 5.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.821 0.343 . . . . 0.0 111.064 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.7 t 62.15 89.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.832 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -83.37 -85.75 0.84 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.629 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 m -79.49 148.34 31.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.96 124.0 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.103 0.478 . . . . 0.0 110.955 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.62 -50.05 4.87 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.979 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -79.61 138.74 37.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.74 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -154.81 -41.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.257 -173.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.01 127.49 29.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.449 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.12 -167.88 1.73 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.456 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.4 p -58.14 -67.73 0.32 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 56.86 -171.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.891 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -169.45 -177.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.1 tp -160.39 146.32 15.21 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mt -121.26 143.4 33.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.4 p -138.35 121.98 17.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.46 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.67 162.43 67.52 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.18 104.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.935 2.423 . . . . 0.0 112.118 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.48 167.11 11.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.919 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -123.3 153.69 39.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.763 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.81 151.47 29.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.521 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -86.09 -179.66 6.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 4.8 m-20 -86.9 143.83 27.24 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 20' ' ' ASP . . . 71.91 168.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 124.154 0.909 . . . . 0.0 110.849 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.3 m-85 -122.15 -13.62 8.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.636 -171.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.66 172.23 38.18 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.753 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.92 156.56 6.93 Favored 'Trans proline' 0 C--O 1.224 -0.207 0 C-N-CA 124.16 3.24 . . . . 0.0 112.223 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -42.64 -22.51 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 124.81 3.673 . . . . 0.0 115.728 -171.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -72.0 -61.51 1.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.1 m-80 60.95 -178.26 0.11 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.932 0.396 . . . . 0.0 111.523 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.42 130.52 35.76 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD23 HD13 ' A' ' 57' ' ' LEU . 18.6 tp -145.1 129.56 17.89 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.041 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -143.04 100.09 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.9 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.657 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.8 mt -111.07 146.05 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.442 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.2 114.99 11.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.719 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.1 m -97.14 132.36 41.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.53 -161.73 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.94 71.87 0.7 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.738 0.304 . . . . 0.0 110.524 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.403 ' HG3' HG22 ' A' ' 115' ' ' ILE . 51.3 Cg_endo -67.19 132.66 28.39 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.777 2.318 . . . . 0.0 113.183 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.1 tp60 -122.25 111.65 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.569 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.9 m -75.87 98.14 4.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 109.541 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -130.04 94.45 2.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.873 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -170.64 -167.77 31.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.515 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 4.0 t -110.23 151.48 12.44 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.171 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.27 -49.1 4.58 Favored Glycine 0 N--CA 1.46 0.272 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.465 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.23 78.68 3.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.351 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.61 41.12 0.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.945 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.532 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 6.2 ttp180 -82.28 145.85 29.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -146.95 159.67 43.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.069 0.462 . . . . 0.0 111.072 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.6 m -112.36 128.79 56.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.928 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 20.1 p -92.29 146.22 23.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.002 0.429 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 78.9 m-85 -108.18 132.56 53.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.996 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 32.0 tt0 -87.14 119.06 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.73 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.467 HD12 ' CZ ' ' A' ' 74' ' ' PHE . 3.1 mp -94.09 111.67 25.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.104 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 91.6 mtt180 -104.66 132.64 50.67 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.141 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.9 138.44 34.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -125.74 133.91 51.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.596 168.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.481 HG22 ' CD2' ' A' ' 60' ' ' PHE . 15.0 t -166.3 164.24 17.6 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.422 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.84 25.78 10.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.682 167.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 HD13 HD23 ' A' ' 29' ' ' LEU . 29.4 mt -61.42 133.58 93.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.496 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.8 Cg_exo -70.66 -32.01 15.56 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.462 2.108 . . . . 0.0 111.262 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -63.62 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.963 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.519 ' O ' HD21 ' A' ' 62' ' ' LEU . 3.8 m-30 -71.07 -19.16 62.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.5 tttp 71.19 -64.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 170.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.29 -5.52 56.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -174.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' O ' HG21 ' A' ' 55' ' ' THR . 4.9 mmpp? 71.22 -38.41 0.42 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.769 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -160.35 135.94 8.22 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.014 0.435 . . . . 0.0 110.038 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -170.08 175.45 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.585 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.8 m -140.83 141.67 34.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.776 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.86 -179.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 40.7 ptt180 -150.37 126.97 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.14 0.495 . . . . 0.0 111.106 171.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.492 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.0 mmp_? -139.36 167.24 22.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.802 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.41 156.6 20.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -51.72 -39.34 58.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.723 0.297 . . . . 0.0 110.744 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.9 m -54.17 -32.77 56.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.863 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.13 -35.85 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CZ ' HD12 ' A' ' 51' ' ' ILE . 51.5 m-85 -64.52 -39.59 94.06 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.482 ' HA ' HD13 ' A' ' 92' ' ' LEU . 15.7 mt-10 -60.09 -51.6 68.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.8 t-105 -65.44 -27.46 68.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.256 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.582 HD21 ' CD2' ' A' ' 144' ' ' PHE . 34.4 tp -72.08 -48.46 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 43.3 ttt180 -53.98 -59.38 4.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.839 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.626 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 p -60.06 -40.3 89.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.033 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.6 -52.57 59.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.594 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 87.6 mt -65.51 -34.8 79.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.383 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 35.0 mt-10 -70.06 -43.96 70.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 79' ' ' SER . 20.6 mmt180 -76.73 -48.07 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.177 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.81 -23.07 31.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.044 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.6 t -132.79 -177.52 4.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.408 0.623 . . . . 0.0 111.237 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -108.54 18.24 21.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.217 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' C ' ' H ' ' A' ' 89' ' ' VAL . 90.1 t -48.89 141.13 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.287 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.1 p -71.91 38.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.466 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.517 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -55.99 118.88 22.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.163 -0.335 . . . . 0.0 110.774 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.79 161.62 14.17 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.845 2.363 . . . . 0.0 111.976 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.62 139.22 62.77 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.716 2.277 . . . . 0.0 112.223 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 75' ' ' GLU . 90.9 mt -70.27 154.96 94.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.857 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.06 110.07 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 0.0 110.919 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.3 171.32 39.8 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.297 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 56.91 51.28 10.92 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.445 0.64 . . . . 0.0 110.125 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.29 -83.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.543 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.531 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -64.1 -17.96 63.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.814 -174.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 97' ' ' PHE . 2.0 mm? -65.85 -41.58 91.53 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.983 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 24.97 7.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.882 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -96.64 -48.92 5.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.446 -177.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -92.85 165.34 19.04 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.696 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.554 ' N ' HD23 ' A' ' 101' ' ' LEU . 24.0 Cg_exo -59.96 -78.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.489 2.793 . . . . 0.0 113.217 -175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -149.36 -88.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.457 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 67.3 -56.12 0.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.694 0.798 . . . . 0.0 112.632 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.68 170.01 20.02 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.546 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.71 -53.52 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.049 0.54 . . . . 0.0 111.051 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.61 -4.86 19.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.94 58.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.766 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.4 pt -73.57 -14.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.205 -0.498 . . . . 0.0 111.673 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -84.34 1.07 46.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.756 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -103.8 136.59 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.27 -25.57 65.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.638 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.453 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -61.85 -61.4 2.52 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.766 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.2 -50.43 38.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.354 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.403 HG22 ' HG3' ' A' ' 36' ' ' PRO . 55.5 mt -51.59 -53.89 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -174.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.18 -20.1 60.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.494 -177.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.525 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 65.2 mm-40 -74.26 -33.62 63.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.27 0.557 . . . . 0.0 109.639 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.1 tpp180 -76.64 -40.12 50.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -53.02 -51.44 61.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.859 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.747 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -61.46 -36.26 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.819 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.65 -33.1 10.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.699 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.1 tp -67.39 -36.35 81.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.978 -0.13 . . . . 0.0 111.083 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.624 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.7 pt-20 -72.37 -28.84 63.27 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.747 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 18.2 mm-40 -65.18 -61.34 2.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' O ' HG12 ' A' ' 129' ' ' VAL . 5.5 t80 -44.01 -52.98 6.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.89 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -62.81 -41.15 91.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.476 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -59.29 -17.42 28.77 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -90.47 -58.08 2.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.734 0.778 . . . . 0.0 110.452 175.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -64.47 -12.5 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.884 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.63 0.45 26.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.376 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.477 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.33 13.89 2.29 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.026 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.684 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 55.2 t60 -101.21 141.83 23.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 117.156 0.478 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.684 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.72 -49.49 5.36 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 124.014 3.143 . . . . 0.0 113.523 -173.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.31 -33.17 73.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.331 -175.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -74.08 -41.29 61.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.822 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.656 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -70.3 0.13 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.187 0.994 . . . . 0.0 109.36 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -117.28 14.86 14.85 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.242 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.58 130.52 47.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.798 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -49.51 -22.38 1.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.795 0.838 . . . . 0.0 113.002 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.692 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 2.8 m -55.4 -28.0 51.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.21 0.604 . . . . 0.0 112.13 -174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.502 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.2 mp -78.26 -34.39 49.06 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.784 -0.573 . . . . 0.0 111.735 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.8 t60 -63.12 -35.69 81.11 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.45 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.692 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.6 ptm -77.47 -28.94 52.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.452 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CD2' HD21 ' A' ' 77' ' ' LEU . 2.1 t80 -80.7 -58.57 3.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.199 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.502 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -83.12 -22.71 33.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.077 -172.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.507 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 42.6 mt-30 -120.98 179.19 4.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.711 -169.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.5 t70 65.73 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.831 0.707 . . . . 0.0 110.542 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.81 -56.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.68 0.752 . . . . 0.0 110.044 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.511 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.49 143.29 40.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.05 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.538 HG21 ' HE1' ' A' ' 143' ' ' MET . 2.9 mp -65.44 119.35 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.585 173.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.4 106.68 18.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -73.89 10.0 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -129.93 19.22 5.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.47 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -63.71 -172.31 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.015 -177.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 89.7 m -87.31 112.24 46.66 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -69.94 77.92 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.167 2.578 . . . . 0.0 111.105 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -153.73 -161.61 1.29 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.476 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 4.5 mmmm -86.83 158.72 19.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.414 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -57.16 -39.63 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.209 0.528 . . . . 0.0 110.524 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -67.92 113.06 5.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.681 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -82.87 174.16 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.508 0.671 . . . . 0.0 110.483 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.825 -179.286 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.452 0.168 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -146.11 36.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.368 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -134.69 54.52 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.258 0.551 . . . . 0.0 109.747 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -142.68 105.95 4.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.561 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -173.26 151.57 2.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.214 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -136.96 -56.45 0.72 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.364 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 63.65 86.8 0.12 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.241 0.543 . . . . 0.0 110.102 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -81.06 -36.58 30.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.979 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.0 m -126.62 162.21 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.231 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 78.99 -79.59 1.58 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.828 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 m -91.84 147.89 22.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.63 132.77 46.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.9 -55.99 1.48 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -94.45 144.14 25.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.451 0.643 . . . . 0.0 111.489 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.57 163.37 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.0 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.54 123.88 42.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.245 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -113.05 160.81 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.3 p -63.68 -57.09 11.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.769 0.319 . . . . 0.0 110.407 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 58.0 -89.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.313 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -139.95 127.5 21.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 109.957 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -107.64 -62.14 1.47 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 122.213 1.006 . . . . 0.0 108.703 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.426 HG13 ' C ' ' A' ' 11' ' ' LEU . 5.7 mt 70.52 146.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 112.258 -2.246 . . . . 0.0 112.294 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 p -106.11 107.72 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.521 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -98.42 168.73 9.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.827 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.48 111.5 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.375 2.05 . . . . 0.0 111.371 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.4 147.39 47.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.68 159.3 21.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.404 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -91.57 154.69 18.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.349 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 20' ' ' ASP . 3.5 p-10 -50.87 -60.76 2.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.558 0.694 . . . . 0.0 110.37 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.6 m-20 -123.33 149.72 44.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.769 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.08 175.96 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.927 0.767 . . . . 0.0 111.783 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 5.2 m-85 -124.97 -9.57 7.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.757 -173.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.14 174.25 46.61 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -54.33 154.27 19.57 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.988 3.126 . . . . 0.0 111.486 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.47 -19.25 0.63 Allowed 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.42 3.413 . . . . 0.0 115.379 -170.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -70.46 -57.44 4.79 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.453 ' HB2' HD21 ' A' ' 57' ' ' LEU . 36.9 m-80 59.07 -178.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.469 0.481 . . . . 0.0 111.765 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -95.46 136.4 35.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD21 HD12 ' A' ' 57' ' ' LEU . 13.9 tp -145.79 131.28 18.73 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.09 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.9 pt-20 -140.81 99.72 3.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.063 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.63 HG12 ' HB ' ' A' ' 53' ' ' VAL . 22.4 mt -112.06 138.81 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.24 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.09 107.72 6.23 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -83.89 136.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -179.9 -167.17 0.09 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.2 84.88 0.2 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.61 0.569 . . . . 0.0 111.479 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HG3' HG21 ' A' ' 115' ' ' ILE . 94.4 Cg_endo -76.35 119.9 5.44 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 113.738 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -102.55 106.26 16.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.386 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.459 HG22 ' HE ' ' A' ' 45' ' ' ARG . 28.5 m -78.75 89.28 4.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.685 0.755 . . . . 0.0 110.115 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 94.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.7 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.61 -167.48 32.67 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.558 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 10.1 t -104.32 152.59 6.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.177 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.1 -51.81 6.01 Favored Glycine 0 N--CA 1.461 0.347 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.188 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.56 83.15 4.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.884 0.373 . . . . 0.0 110.171 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 39.73 0.72 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.384 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.558 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 23.5 ttt180 -84.09 141.12 31.35 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 43.5 p90 -131.1 164.3 25.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.6 m -117.45 127.14 53.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.232 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.594 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 16.6 p -92.15 128.22 37.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 91.8 m-85 -90.63 131.87 36.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.458 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 29.6 tt0 -81.74 116.37 21.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.314 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.46 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 mp -92.83 109.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.707 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 27.5 mtp180 -100.29 136.09 40.72 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.765 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.63 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.49 135.67 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 112.337 -178.457 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -124.39 139.82 53.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.024 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.462 HG22 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -170.55 164.32 8.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.4 0.619 . . . . 0.0 112.317 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.55 27.35 8.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.949 167.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.586 HD12 HD21 ' A' ' 29' ' ' LEU . 23.0 mt -60.98 141.88 93.19 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.751 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.5 Cg_exo -76.04 -33.04 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.569 2.179 . . . . 0.0 111.524 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.6 OUTLIER -63.05 -41.91 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.807 177.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.464 ' CE2' HD23 ' A' ' 145' ' ' LEU . 3.5 m-30 -68.95 -26.52 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.9 tmmm? 73.81 -60.64 0.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -79.69 -7.83 58.84 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.126 -0.359 . . . . 0.0 110.684 -173.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' O ' HG21 ' A' ' 55' ' ' THR . 5.4 mmtp 70.25 -40.83 0.48 Allowed 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.063 0.852 . . . . 0.0 111.24 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.9 pp20? -161.16 136.48 7.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 167.79 13.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.454 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 19.0 m -141.81 137.17 31.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.191 0.52 . . . . 0.0 111.559 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -132.74 -176.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.088 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 8.3 ptp180 -150.33 116.21 5.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.929 173.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 24.4 mmm180 -135.01 160.44 38.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.874 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 32.9 ptt180 -89.8 172.63 8.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -169.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.474 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 26.7 t80 -54.46 -41.88 69.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.247 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 t -55.42 -33.98 64.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.314 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.66 -37.47 73.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.46 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 61.7 m-85 -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.0 mt-10 -60.08 -53.48 57.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.754 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.424 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 3.1 t-105 -67.57 -27.9 67.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.403 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.0 tm? -70.49 -41.71 72.34 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 57.2 ttt180 -59.06 -60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 7.5 p -61.45 -37.13 82.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.373 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.96 -49.99 72.01 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.132 0.27 . . . . 0.0 110.755 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.6 mt -61.44 -34.36 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.909 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 32.2 mt-10 -75.22 -18.54 60.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.805 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 79' ' ' SER . 31.7 mmt180 -80.28 -62.99 1.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.208 0.528 . . . . 0.0 111.81 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -88.73 -21.52 23.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.264 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.511 ' HB2' HG22 ' A' ' 87' ' ' VAL . 16.2 m -123.75 169.39 11.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.314 0.578 . . . . 0.0 111.263 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -100.45 32.36 3.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.219 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 85' ' ' SER . 80.8 t -53.08 142.04 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.145 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.7 p -71.21 36.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.737 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.54 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -59.51 116.37 16.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 O-C-N 122.055 -0.403 . . . . 0.0 110.953 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.3 Cg_endo -85.36 162.72 11.2 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.783 2.322 . . . . 0.0 112.606 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 131.86 33.94 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.898 2.399 . . . . 0.0 112.112 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 75' ' ' GLU . 62.5 mt -63.99 152.0 88.41 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.555 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.52 129.74 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.689 2.26 . . . . 0.0 111.202 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -179.23 48.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.3 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.6 mptt 66.58 -58.12 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.088 0.955 . . . . 0.0 112.185 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.501 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -71.75 -22.03 61.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.499 -170.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.7 mm? -65.71 -45.61 82.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.005 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 22.19 8.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.388 0.613 . . . . 0.0 110.38 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -115.97 -45.56 2.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.638 -177.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 46.5 mt -82.26 169.4 18.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.521 -174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.04 145.41 73.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.743 2.295 . . . . 0.0 111.054 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.5 -71.19 0.38 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.075 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 68.83 -56.37 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.887 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.27 -169.15 37.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -53.0 -50.33 64.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.34 0.59 . . . . 0.0 111.246 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.92 -26.44 5.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.62 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.26 -13.8 8.92 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.715 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 24.9 pt -68.75 -16.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.743 -0.729 . . . . 0.0 111.44 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.94 2.15 27.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -116.08 145.31 43.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.13 0.491 . . . . 0.0 110.421 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.84 -17.5 59.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.513 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 93.2 m-20 -66.73 -60.28 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.475 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.715 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -51.42 -48.29 62.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.405 HG21 ' HG3' ' A' ' 36' ' ' PRO . 39.0 mt -50.94 -53.32 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.355 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.24 -20.14 60.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.768 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.612 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 45.4 mm-40 -73.36 -32.96 64.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.057 0.456 . . . . 0.0 110.301 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.474 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 33.4 ttm180 -80.8 -36.45 31.71 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.48 -49.83 66.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.144 -178.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.732 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.4 pt20 -58.0 -36.75 73.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 -174.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.41 -32.67 9.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.441 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.7 tp -66.35 -35.45 80.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.547 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.1 pt-20 -72.46 -35.54 68.27 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 17.8 mm-40 -56.49 -53.84 52.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.565 ' O ' HG11 ' A' ' 129' ' ' VAL . 2.6 t80 -53.39 -52.71 58.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.296 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.0 tp -64.41 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.836 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -62.11 -23.56 66.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 111.668 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.488 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 42.9 mttm -81.35 -56.19 4.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.943 0.878 . . . . 0.0 110.367 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 125' ' ' PHE . 1.5 m -68.24 -11.84 14.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.332 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.21 -2.75 19.1 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.832 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.29 -1.12 5.75 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.166 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.708 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 42.6 t60 -89.64 142.03 29.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 122.65 -0.323 . . . . 0.0 110.736 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.708 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.7 Cg_exo -41.52 -48.86 5.38 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.436 3.424 . . . . 0.0 113.659 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.431 ' C ' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.92 -26.63 64.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.347 -174.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.559 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.67 -47.75 10.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.86 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.529 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.71 -6.16 1.11 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.236 172.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.613 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -83.54 -33.72 25.41 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.519 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 7.8 pt-20 -113.57 149.98 33.69 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 117.622 -1.631 . . . . 0.0 114.547 -164.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.1 tpt180 -58.14 -21.38 46.62 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 113.138 -1.846 . . . . 0.0 112.026 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 143' ' ' MET . 7.8 t -60.97 -27.68 68.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.545 0.688 . . . . 0.0 109.896 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 145' ' ' LEU . 1.2 tp -71.56 -31.64 67.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.251 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.484 ' HA ' ' CD ' ' A' ' 146' ' ' GLN . 57.3 t60 -69.52 -29.57 67.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.636 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.55 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.7 ptm -79.68 -29.08 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.661 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.447 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 12.8 t80 -80.15 -53.62 6.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.954 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 141' ' ' LEU . 1.2 mp -105.41 -27.74 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.174 0.512 . . . . 0.0 111.792 -172.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.484 ' CD ' ' HA ' ' A' ' 142' ' ' HIS . 31.2 mt-30 -106.43 9.7 31.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.357 -164.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.482 ' O ' HG12 ' A' ' 67' ' ' VAL . 3.2 t70 -137.86 -177.56 4.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -83.5 -33.74 25.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 119.475 1.034 . . . . 0.0 110.257 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.408 HD12 ' H ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -143.62 143.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.643 -167.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.55 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.4 mp -75.04 108.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.924 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.8 108.36 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.424 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 28.8 mmtp -73.53 10.68 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -130.92 19.71 5.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.032 0.444 . . . . 0.0 110.142 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.453 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 0.5 OUTLIER -65.15 -174.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.308 -176.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 96.4 m -79.46 112.47 29.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -71.56 43.94 0.57 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.762 2.975 . . . . 0.0 113.143 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 31.9 m -115.01 -158.96 0.69 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 23.3 mmmt -101.07 170.02 8.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.216 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.525 HG12 ' C ' ' A' ' 138' ' ' GLU . 20.1 mm -60.15 -42.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.35 75.0 7.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -85.37 160.75 19.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.251 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.164 175.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.398 0.142 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -77.78 77.73 4.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.132 0.491 . . . . 0.0 110.851 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -168.47 148.04 4.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -63.92 94.77 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.275 0.359 . . . . 0.0 110.482 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -103.33 -37.2 7.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.013 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -71.65 130.91 42.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . 0.415 ' O ' ' HB ' ' A' ' -1' ' ' VAL . 95.6 m-70 -61.74 108.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' -2' ' ' HIS . 84.4 t 72.11 125.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 O-C-N 123.98 0.8 . . . . 0.0 110.483 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 98.88 -164.81 20.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.953 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 43.2 p 51.36 98.16 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.74 0.816 . . . . 0.0 112.306 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.97 121.58 41.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -169.44 -59.47 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 p -92.7 151.46 20.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.185 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t 67.98 -66.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 124.06 0.85 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.93 117.07 28.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.256 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 9' ' ' ARG . 26.4 t70 -95.09 153.03 17.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.425 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.9 p -64.97 -70.28 0.24 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.239 0.337 . . . . 0.0 111.429 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HG2' ' OD2' ' A' ' 7' ' ' ASP . 37.5 mmt180 61.88 140.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.737 -172.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -166.2 -83.13 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.292 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.6 tp 71.2 142.14 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 124.027 0.829 . . . . 0.0 110.866 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.32 145.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p 68.72 126.22 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.354 1.034 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 11.1 mptt -71.56 164.92 53.83 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.688 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 85.6 Cg_exo -47.98 128.05 15.83 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.871 2.381 . . . . 0.0 111.927 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.88 140.86 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.06 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.98 150.01 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.812 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.06 172.55 7.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -69.9 -177.49 1.32 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.762 0.792 . . . . 0.0 111.349 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -143.96 148.66 35.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.25 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.1 -79.4 0.39 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.6 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 32.5 m-85 -72.92 -37.87 67.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.66 175.29 36.54 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.74 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 158.92 21.53 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.823 3.015 . . . . 0.0 110.792 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.45 -19.42 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 124.635 3.557 . . . . 0.0 115.49 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 p -71.97 -59.94 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.441 0.296 . . . . 0.0 110.446 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.506 ' HB2' HD22 ' A' ' 57' ' ' LEU . 45.7 m-80 61.7 -178.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.357 0.598 . . . . 0.0 112.153 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -98.35 145.37 26.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.579 HD21 HD12 ' A' ' 57' ' ' LEU . 16.6 tp -150.02 130.19 13.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.835 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.8 pt-20 -139.06 112.39 8.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.987 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.599 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.7 mt -122.27 135.81 61.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.793 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.31 117.37 18.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.334 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t 178.98 -162.11 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.5 m-80 63.87 83.5 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-O 120.969 0.414 . . . . 0.0 110.322 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -72.6 123.76 9.29 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.424 2.082 . . . . 0.0 113.329 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.567 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 27.2 tp60 -110.63 102.71 11.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 HG21 ' NE ' ' A' ' 45' ' ' ARG . 27.9 m -77.5 102.06 6.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.342 0.591 . . . . 0.0 109.748 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -132.36 89.83 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.735 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.01 -166.76 31.96 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.883 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.5 t -98.69 154.96 3.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.442 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.61 -54.3 4.93 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.508 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -95.01 85.38 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 32.04 1.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.588 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.557 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 15.5 ttt180 -77.42 136.91 38.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.71 167.09 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.724 0.297 . . . . 0.0 110.41 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 m -119.56 132.3 55.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 23.4 p -92.52 127.66 38.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -93.74 131.33 39.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.976 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 20.3 tt0 -91.2 120.77 32.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.719 -173.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 mp -93.38 118.21 38.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.672 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 37.7 mtp180 -107.24 130.04 54.79 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.168 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.599 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.96 138.14 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 112.439 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -118.69 140.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.693 167.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.457 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.36 164.29 7.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.243 0.544 . . . . 0.0 111.328 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.6 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -122.36 26.75 8.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.872 168.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.579 HD12 HD21 ' A' ' 29' ' ' LEU . 18.8 mt -62.63 139.22 96.89 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.973 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.76 -41.68 5.51 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.427 2.085 . . . . 0.0 111.408 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.587 HD11 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -57.26 -42.7 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.3 m-85 -69.33 -22.44 63.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.24 -60.14 0.54 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 171.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -83.62 -11.06 57.77 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.239 0.472 . . . . 0.0 111.448 -171.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp 71.46 -43.05 0.55 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.001 0.813 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -153.23 135.16 14.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.061 178.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -170.57 172.47 5.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.658 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.57 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 8.0 m -140.79 136.38 32.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.203 0.525 . . . . 0.0 111.079 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 26.4 m -135.12 175.15 11.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.692 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 22.1 ptt180 -148.84 133.05 17.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.544 0.688 . . . . 0.0 111.864 172.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' HB3' ' CB ' ' A' ' 73' ' ' ASP . 3.1 mmp_? -136.69 158.02 45.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.4 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 13.6 ptm180 -79.27 167.41 20.97 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.65 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.55 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 34.7 t80 -52.32 -42.65 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.538 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 15.0 m -58.24 -29.62 65.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.038 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.677 ' OD1' ' HG2' ' A' ' 70' ' ' ARG . 2.2 m-20 -68.46 -38.91 81.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.446 ' CZ ' HD13 ' A' ' 51' ' ' ILE . 52.6 m-85 -66.65 -36.97 83.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.55 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 26.8 mt-10 -61.83 -51.46 68.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.947 0.88 . . . . 0.0 110.071 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.56 -29.54 70.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.406 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.632 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -74.18 -44.71 52.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.581 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 45.8 ttt180 -55.59 -57.07 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.752 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.713 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 25.0 p -62.89 -40.66 98.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.142 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 5.9 mm-40 -57.41 -38.61 74.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.457 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.0 mt -72.63 -34.34 67.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.839 0.352 . . . . 0.0 110.586 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 36.2 mt-10 -73.49 -26.33 60.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.197 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.713 ' HG2' ' O ' ' A' ' 79' ' ' SER . 28.0 mmm180 -55.24 -62.52 1.62 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.73 -2.82 10.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 26.5 t -114.02 173.97 6.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.411 0.624 . . . . 0.0 111.162 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -107.55 20.36 18.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.222 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 93.6 t -51.77 141.59 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.476 -176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' O ' HG11 ' A' ' 88' ' ' VAL . 10.0 p -73.48 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.532 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -56.38 120.18 33.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.873 -0.517 . . . . 0.0 110.9 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.442 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 92.3 Cg_endo -85.62 163.03 10.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.354 2.703 . . . . 0.0 112.269 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.55 138.18 44.95 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.793 2.329 . . . . 0.0 112.339 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 75' ' ' GLU . 90.8 mt -67.33 156.42 88.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.558 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -90.26 109.37 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.146 2.564 . . . . 0.0 111.876 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.81 70.51 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.226 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -143.01 -8.59 0.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.78 0.324 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -115.21 -84.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -171.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.79 -32.85 9.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.518 1.127 . . . . 0.0 113.688 -171.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.64 -49.42 76.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.832 0.349 . . . . 0.0 111.568 -172.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -102.31 20.24 17.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.49 0.662 . . . . 0.0 110.483 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -113.61 -34.3 5.58 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.446 -177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' CD ' ' A' ' 102' ' ' PRO . 86.5 mt -83.95 176.74 3.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.471 ' CD ' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -66.27 -146.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.654 2.236 . . . . 0.0 112.238 172.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' O ' ' HB2' ' A' ' 104' ' ' ARG . 79.9 m-85 -121.0 -89.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.141 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 103' ' ' PHE . 63.1 mtt180 68.35 -48.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.799 0.687 . . . . 0.0 111.429 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.2 -150.01 8.64 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -90.08 -30.87 17.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.134 0.492 . . . . 0.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.445 ' HB2' HG21 ' A' ' 109' ' ' ILE . 12.4 m-20 -111.99 -27.76 8.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.733 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 105.37 25.34 6.71 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.398 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.582 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 26.3 pt -73.23 -14.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.482 . . . . 0.0 111.749 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -77.61 -8.15 57.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.771 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.32 119.9 32.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.392 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.32 -33.03 71.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.949 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 94.4 m-20 -55.38 -56.16 23.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.236 0.335 . . . . 0.0 110.354 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -46.75 -50.75 17.62 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.564 0.54 . . . . 0.0 111.057 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.66 -51.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.07 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.54 -18.81 47.31 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.78 -177.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 33.4 mt-10 -76.36 -30.94 57.78 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 109.713 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 16.3 tpp180 -74.81 -42.57 57.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 170.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -53.95 -52.06 61.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.328 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.755 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -59.11 -36.93 76.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 -175.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 124' ' ' GLN . . . -88.85 -32.92 10.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.051 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.439 ' HB3' HG23 ' A' ' 33' ' ' VAL . 7.4 tp -67.74 -34.9 77.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.864 -0.198 . . . . 0.0 110.945 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HA ' HG23 ' A' ' 126' ' ' ILE . 13.2 pt-20 -71.79 -31.93 67.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.755 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 21.1 mm-40 -59.07 -58.21 9.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.415 ' O ' HG12 ' A' ' 129' ' ' VAL . 1.8 t80 -51.08 -51.86 49.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.011 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -62.92 -39.68 86.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -62.5 -19.91 64.07 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 2.9 mptp? -83.36 -58.69 2.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.834 0.826 . . . . 0.0 110.063 173.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.643 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.1 m -64.84 -11.84 11.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.281 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.17 -12.12 15.45 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.435 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.433 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -128.85 3.92 6.47 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.964 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.725 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.9 t60 -91.89 142.42 26.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 117.133 0.466 . . . . 0.0 110.216 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.725 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.1 Cg_exo -41.23 -47.34 5.36 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.173 3.248 . . . . 0.0 113.364 -174.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -70.41 -34.25 72.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.098 -175.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -75.8 -45.9 33.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.348 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.587 ' O ' HD11 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.49 -6.53 1.1 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 173.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.77 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t30 -95.9 -20.01 19.11 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.869 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 29.7 mm-40 -103.49 136.79 42.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -165.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HA ' HD11 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -56.98 -20.18 22.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.854 -171.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.3 m -54.76 -33.99 62.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.891 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.573 ' O ' HD22 ' A' ' 145' ' ' LEU . 8.0 mp -73.43 -34.03 65.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.109 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 27.9 t-80 -57.45 -34.9 69.46 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.185 0.517 . . . . 0.0 110.345 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.562 ' HG3' HG12 ' A' ' 150' ' ' ILE . 4.2 ptm -83.24 -30.03 28.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.632 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.0 t80 -72.7 -49.49 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -94.02 -42.74 8.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.079 -175.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 21.1 mp0 -88.01 0.75 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.849 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.516 ' OD1' HD12 ' A' ' 149' ' ' ILE . 8.8 t70 -141.8 150.89 42.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.909 0.385 . . . . 0.0 110.138 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.9 pm0 -75.11 -31.85 61.25 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.108 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.577 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -136.73 120.78 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.645 -170.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.595 HD12 ' CD2' ' A' ' 144' ' ' PHE . 11.0 mt -63.82 122.47 14.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.356 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.31 99.57 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.697 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -68.27 -3.98 12.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.866 0.365 . . . . 0.0 111.516 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.4 m -116.58 20.62 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.482 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -64.42 -171.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.93 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.3 m -82.26 111.72 30.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.448 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 19.2 Cg_exo -71.62 73.85 2.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.579 2.853 . . . . 0.0 111.987 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -152.36 -148.62 0.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.77 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -99.73 -178.0 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.93 0.871 . . . . 0.0 112.091 -176.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.48 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -76.71 -35.23 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.616 175.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -75.19 -1.07 21.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.173 -171.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.8 m80 68.78 -175.77 0.2 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.162 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.247 -179.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.045 0.45 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.17 151.35 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.452 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.57 48.07 2.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -75.81 113.94 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.703 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -88.06 122.89 32.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -73.16 123.06 22.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.815 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.41 -3.11 21.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -99.58 -61.15 1.4 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.159 176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.22 156.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -87.43 53.51 4.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.601 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 34.7 p -101.71 104.11 14.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.119 0.485 . . . . 0.0 110.63 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.48 137.81 17.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.801 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' C ' ' HG1' ' A' ' 4' ' ' THR . 11.6 tp10 -148.57 -66.81 0.23 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.452 ' HG1' ' C ' ' A' ' 3' ' ' GLU . 2.1 p 52.71 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.324 1.059 . . . . 0.0 112.762 -171.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.03 157.35 41.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.427 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.59 143.88 32.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.86 159.96 33.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.7 p -51.86 -46.36 64.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.241 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 65.86 147.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.981 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.577 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 8.0 ppt_? -150.93 141.79 22.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.044 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.3 tp -146.83 146.22 30.15 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.77 140.97 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.107 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.3 p -104.29 117.96 35.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.607 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 9.1 mptt -76.9 159.18 79.27 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.019 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.71 144.92 84.92 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.463 2.775 . . . . 0.0 112.728 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -81.16 138.3 35.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.579 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -106.12 150.41 25.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.203 0.525 . . . . 0.0 111.403 -175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.86 175.04 11.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.683 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 38.55 -104.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.059 0.849 . . . . 0.0 112.667 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 22.5 m-20 -131.02 135.22 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.8 0.273 . . . . 0.0 110.549 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 20' ' ' ASP . . . 174.16 172.17 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 124.058 0.849 . . . . 0.0 110.631 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.533 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 7.6 m-85 -126.26 -9.49 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.48 -172.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.54 43.99 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.678 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.89 156.23 4.96 Favored 'Trans proline' 0 CA--C 1.526 0.103 0 C-N-CA 124.32 3.347 . . . . 0.0 112.33 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.29 -8.87 0.24 Allowed 'Trans proline' 0 N--CA 1.482 0.82 0 C-N-CA 124.504 3.469 . . . . 0.0 115.213 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -71.42 -63.92 1.02 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.606 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.1 m120 59.54 172.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.669 0.605 . . . . 0.0 111.979 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -95.63 140.93 29.75 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.608 HD21 HD12 ' A' ' 57' ' ' LEU . 13.5 tp -144.88 131.26 19.68 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.343 0.592 . . . . 0.0 110.956 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.23 102.4 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.024 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.633 HG12 ' HB ' ' A' ' 53' ' ' VAL . 54.8 mt -113.49 140.01 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -177.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -139.05 112.8 8.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.174 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.1 m -96.99 133.45 38.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.3 t 178.75 -161.64 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 66.96 78.87 0.24 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.187 0.518 . . . . 0.0 110.227 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.48 119.44 5.23 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.688 2.258 . . . . 0.0 113.355 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' THR . 43.7 tp60 -107.73 113.58 26.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.964 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 m -76.04 98.56 4.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.411 0.624 . . . . 0.0 109.478 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.34 91.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.976 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.41 -167.04 31.91 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.702 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.4 t -110.71 154.67 12.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 CA-C-O 119.28 -0.391 . . . . 0.0 109.996 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.6 3.24 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.625 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.86 88.53 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.283 0.563 . . . . 0.0 109.837 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.64 36.35 0.79 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.497 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 5.5 ttp180 -86.23 130.45 34.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.38 171.72 14.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.054 0.454 . . . . 0.0 111.361 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 98.3 m -121.79 129.64 52.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.576 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.411 ' HG1' ' HB3' ' A' ' 37' ' ' GLN . 29.2 p -92.57 130.0 38.34 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -93.43 131.5 38.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.564 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 9.8 tt0 -88.29 118.02 27.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.562 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 mp -93.18 108.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 66.7 mtp180 -92.96 135.88 33.76 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.069 173.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.633 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.56 135.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 111.868 177.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -123.88 134.87 53.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.452 HG22 ' CD2' ' A' ' 60' ' ' PHE . 13.3 t -169.48 164.45 10.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.499 0.666 . . . . 0.0 112.01 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.535 HD21 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -118.76 23.19 11.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.285 171.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.608 HD12 HD21 ' A' ' 29' ' ' LEU . 24.7 mt -57.91 141.11 81.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.955 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.56 -16.25 21.49 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.709 2.272 . . . . 0.0 111.463 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -86.12 -40.99 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.557 -178.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD2' HG22 ' A' ' 55' ' ' THR . 3.2 m-85 -70.05 -8.31 48.29 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -166.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.87 -69.79 0.17 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 167.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -84.25 -5.81 59.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.968 -0.457 . . . . 0.0 110.682 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.533 ' HD2' ' CE1' ' A' ' 22' ' ' TYR . 5.0 mmtp 70.68 -43.89 0.57 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.122 0.889 . . . . 0.0 111.418 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.1 pp20? -158.86 130.03 6.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.231 0.538 . . . . 0.0 110.063 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.7 t -170.24 173.74 5.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.486 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 28.6 m -141.86 123.05 14.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.416 0.627 . . . . 0.0 111.469 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.17 179.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.105 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 30.9 ptt180 -150.45 126.85 10.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.25 0.548 . . . . 0.0 111.204 171.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -138.53 177.25 8.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.247 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -83.65 167.34 17.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.258 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.543 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.6 t80 -60.29 -39.66 87.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.531 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 18.5 m -58.55 -27.08 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.679 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -77.31 -34.22 55.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 35.8 m-85 -63.95 -38.79 92.37 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 26.2 mt-10 -57.12 -56.25 24.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.158 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -65.15 -28.39 69.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.392 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 2.9 tm? -71.63 -38.99 70.71 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 49.6 ttt180 -62.16 -61.47 2.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.042 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.534 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 8.8 p -57.52 -38.03 73.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.278 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.615 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 1.0 OUTLIER -58.31 -47.62 83.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.33 -36.67 84.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.186 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 62.5 mt-10 -69.04 -30.74 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.497 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 79' ' ' SER . 27.8 mmt180 -80.26 -58.93 2.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.661 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.85 -25.48 63.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.511 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.493 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 0.5 OUTLIER -144.52 -178.72 6.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.725 0.774 . . . . 0.0 112.323 -177.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.86 23.38 8.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.526 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 89' ' ' VAL . 94.5 t -45.89 139.71 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.6 p -70.09 33.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.074 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.548 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -54.86 120.55 29.29 Favored Pre-proline 0 CA--C 1.531 0.241 0 O-C-N 122.134 -0.354 . . . . 0.0 111.0 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 90.1 Cg_endo -85.85 164.29 10.38 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.953 2.435 . . . . 0.0 112.584 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.6 132.1 29.86 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 75' ' ' GLU . 84.5 mt -66.97 143.81 98.18 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.452 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.11 108.63 2.52 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.416 2.077 . . . . 0.0 111.014 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . -172.68 30.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.814 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -131.89 7.64 4.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 110.503 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.16 -90.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.521 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -53.7 -29.64 40.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD21 ' HA2' ' A' ' 94' ' ' GLY . 1.0 OUTLIER -60.85 -49.13 78.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.041 0.448 . . . . 0.0 110.58 -174.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.58 26.18 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.496 0.665 . . . . 0.0 109.922 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.3 tt0 -123.02 -36.91 2.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -176.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.9 mt -92.49 165.39 19.52 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.28 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.58 164.31 35.98 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.328 2.685 . . . . 0.0 111.257 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.17 -76.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.697 0.284 . . . . 0.0 111.474 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 69.13 -63.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.205 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.07 -150.61 26.84 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.514 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.23 -41.79 96.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.941 0.401 . . . . 0.0 110.389 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -138.28 -17.45 1.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.692 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.9 10.92 23.72 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.324 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.642 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.2 pt -83.34 -18.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 0.0 111.872 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -85.8 -2.01 57.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.252 0.549 . . . . 0.0 110.439 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.47 127.45 34.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.851 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.34 -30.83 67.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.1 m-20 -56.1 -60.29 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -53.78 -47.82 70.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.092 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.52 -47.33 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.105 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -75.05 -21.89 58.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -178.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 73.5 mm-40 -71.53 -35.57 70.74 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.262 0.553 . . . . 0.0 109.761 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.521 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 10.9 tpp180 -76.89 -35.8 57.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.4 -53.8 54.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.458 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.707 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -58.75 -40.79 84.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.067 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.16 -37.34 28.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.963 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -65.6 -34.19 77.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.564 0.182 . . . . 0.0 111.272 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.51 ' HA ' HG23 ' A' ' 126' ' ' ILE . 7.4 pt-20 -78.09 -31.47 50.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.441 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.707 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 16.3 mm-40 -59.59 -58.58 7.98 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.517 ' O ' HG11 ' A' ' 129' ' ' VAL . 7.5 t80 -49.2 -53.32 21.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.906 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.51 HG23 ' HA ' ' A' ' 123' ' ' GLU . 11.0 tp -65.04 -40.75 90.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.19 -19.91 62.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 111.65 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.3 mttm -87.21 -56.61 3.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.661 0.743 . . . . 0.0 110.731 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.563 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.24 -11.65 14.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.974 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.93 -6.29 17.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.291 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.42 10.58 5.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.307 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.689 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.2 t60 -98.19 140.62 21.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.511 -0.405 . . . . 0.0 110.41 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.689 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.51 -48.86 5.36 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.306 3.337 . . . . 0.0 113.672 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.83 -33.16 73.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.323 -175.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.74 -44.41 41.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.912 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.473 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -63.82 -0.74 1.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.005 173.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.488 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -111.16 -2.87 15.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.493 ' CD ' ' HG ' ' A' ' 85' ' ' SER . 47.1 mm-40 -112.84 132.31 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.111 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.4 tpp85 -53.82 -25.81 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.418 -172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 m -51.26 -34.46 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.459 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -67.4 -33.1 74.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.413 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 146' ' ' GLN . 9.5 t60 -62.5 -40.12 95.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.098 0.475 . . . . 0.0 109.748 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.6 ptm -77.95 -26.18 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.975 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.462 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 21.4 t80 -79.75 -63.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.116 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -110.83 -4.29 15.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.426 ' HB2' ' HA ' ' A' ' 142' ' ' HIS . 12.0 mt-30 -117.92 23.59 11.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.853 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 148' ' ' GLU . 8.9 t70 -148.55 -142.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 147' ' ' ASP . 7.3 tp10 -121.08 -56.76 1.91 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.85 0.834 . . . . 0.0 109.511 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.479 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -129.65 139.77 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.107 -176.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.514 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -66.26 112.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 100.73 13.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.21 -7.96 10.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.1 m -108.91 17.88 21.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.415 ' CD1' ' HE3' ' A' ' 143' ' ' MET . 0.3 OUTLIER -66.49 -172.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.658 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.4 m -92.06 114.82 63.3 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.68 83.1 1.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.923 2.415 . . . . 0.0 111.251 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 89.3 p -145.85 -150.17 0.32 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.636 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.488 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 13.1 mmmt -95.4 164.07 12.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.541 HG22 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -63.89 -34.56 69.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.056 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.49 87.92 5.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.44 -172.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -109.96 165.5 11.67 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.961 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.556 178.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -129.28 30.42 4.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.206 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 66.98 172.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.107 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -134.19 94.22 3.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.726 0.298 . . . . 0.0 111.116 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -138.41 136.36 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.406 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -87.51 125.69 34.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -84.6 78.35 9.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -90.96 -37.67 13.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.6 m -90.77 157.23 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.316 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -133.83 174.61 20.72 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.585 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.3 p -70.58 115.99 10.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.29 119.09 10.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.518 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -165.18 -65.33 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.046 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -81.48 155.61 25.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.979 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t 67.18 163.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.865 0.728 . . . . 0.0 110.527 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.32 106.58 14.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.857 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.54 162.98 28.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.14 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 p -63.57 -69.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 33.5 mmt180 59.96 160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.178 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -141.77 140.26 33.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.51 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.7 tp -149.76 145.41 26.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.6 mt -132.89 155.41 41.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 p 69.26 109.78 0.05 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.22 1.008 . . . . 0.0 111.807 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 38.4 mmtm -76.29 168.0 31.83 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.53 111.26 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.321 2.014 . . . . 0.0 111.814 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 70.8 mt-30 -94.15 98.4 10.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.448 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.401 ' C ' HD21 ' A' ' 18' ' ' LEU . 71.8 m-20 67.64 154.18 0.1 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.08 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 17' ' ' ASN . 3.7 mm? -123.57 -170.06 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.538 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -89.52 -179.71 5.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.234 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -106.46 132.83 52.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.79 167.81 6.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.342 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 7.5 m-85 -133.26 -24.87 1.8 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.474 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.01 174.98 45.42 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.162 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.14 158.37 14.99 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 124.304 3.336 . . . . 0.0 111.696 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.82 -24.99 0.89 Allowed 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.704 3.602 . . . . 0.0 115.267 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -68.81 -58.51 4.08 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' ND2' HD21 ' A' ' 57' ' ' LEU . 33.7 m-80 57.96 -170.59 0.11 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.953 0.406 . . . . 0.0 111.663 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -103.34 139.41 38.79 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.579 HD22 HD12 ' A' ' 57' ' ' LEU . 16.9 tp -150.3 131.88 14.85 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.675 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.48 99.43 3.49 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.015 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.658 HG12 ' HB ' ' A' ' 53' ' ' VAL . 29.1 mt -111.81 140.74 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.605 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.92 129.15 29.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.653 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.6 m -112.96 134.13 56.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 t 179.32 -162.58 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.3 m-80 62.77 68.86 0.94 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-O 121.132 0.491 . . . . 0.0 109.837 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.25 138.04 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.794 2.329 . . . . 0.0 113.162 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.4 tp60 -121.93 108.34 13.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.8 m -75.25 95.27 3.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.52 0.676 . . . . 0.0 109.646 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -121.9 92.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.232 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.531 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -167.23 32.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.524 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -101.34 150.17 6.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.589 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.05 -48.38 5.35 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.673 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -97.96 83.36 3.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.126 0.489 . . . . 0.0 110.01 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.35 35.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.468 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.531 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 19.7 ttt180 -83.35 127.89 34.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.679 0.276 . . . . 0.0 110.367 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -117.38 169.74 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.266 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.3 m -125.88 129.11 48.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.742 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 34.2 p -92.92 146.44 23.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.267 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 83.7 m-85 -118.5 142.64 47.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.133 0.492 . . . . 0.0 110.403 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 38.5 tt0 -90.15 117.96 29.31 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.565 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.4 mp -93.06 120.47 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.864 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 51.7 mtp180 -109.53 131.73 54.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.936 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.658 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.82 136.71 43.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.848 0.356 . . . . 0.0 111.575 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -125.93 135.07 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' O ' ' A' ' 63' ' ' LYS . 14.9 t -169.62 165.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.701 0.762 . . . . 0.0 112.763 -176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.11 26.16 9.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.768 167.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.638 HD13 ' CE1' ' A' ' 60' ' ' PHE . 18.6 mt -61.06 135.89 93.52 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.379 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -68.79 -38.01 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.405 2.07 . . . . 0.0 111.351 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 136' ' ' GLN . 0.4 OUTLIER -61.49 -40.82 87.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.14 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.638 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.0 m-85 -68.77 -25.26 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 73.25 -64.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -76.77 -6.03 50.6 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.899 -0.501 . . . . 0.0 110.282 -175.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.415 ' O ' HG21 ' A' ' 55' ' ' THR . 4.0 mmpp? 70.91 -37.94 0.41 Allowed 'General case' 0 C--O 1.22 -0.487 0 O-C-N 123.936 0.772 . . . . 0.0 111.452 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.8 pp20? -162.04 142.93 10.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -170.24 169.2 7.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 13.6 m -141.4 135.57 30.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.706 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.537 HG21 HH21 ' A' ' 69' ' ' ARG . 0.5 OUTLIER -147.09 134.87 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.408 -171.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 41.0 ttp180 -99.1 111.25 23.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.936 0.398 . . . . 0.0 110.139 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.539 HH11 HD12 ' A' ' 150' ' ' ILE . 56.2 mtt-85 -124.99 178.1 5.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.476 -173.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -95.23 155.98 16.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.754 0.311 . . . . 0.0 111.306 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.41 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 32.5 t80 -59.59 -37.98 79.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 109.924 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.46 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 34.4 t -59.64 -30.06 68.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.854 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.87 -39.51 83.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.525 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 51.4 m-85 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.46 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 12.8 mt-10 -71.97 -49.11 40.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.503 0.668 . . . . 0.0 110.539 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.426 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 8.8 t-105 -65.82 -28.27 68.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.71 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.49 -42.0 59.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 64.2 ttt180 -57.72 -59.2 5.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 6.4 p -60.04 -41.47 92.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.573 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.09 -45.99 79.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.674 0.273 . . . . 0.0 111.253 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.4 mt -65.89 -40.72 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.06 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 73.5 mt-10 -65.53 -45.13 84.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.466 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.6 mmt180 -66.96 -60.78 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.92 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -77.73 -18.93 56.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.463 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 t -134.8 -175.82 4.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.472 0.653 . . . . 0.0 111.315 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -109.58 13.44 23.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.29 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 89' ' ' VAL . 99.0 t -42.09 140.16 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.518 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.8 p -71.17 36.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.857 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.513 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -57.48 119.71 34.72 Favored Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 122.046 -0.409 . . . . 0.0 111.014 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.523 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 96.1 Cg_endo -87.71 167.1 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.93 2.42 . . . . 0.0 112.488 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.5 Cg_endo -66.5 146.87 81.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.699 2.266 . . . . 0.0 112.756 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 HD12 ' HG2' ' A' ' 75' ' ' GLU . 50.0 mt -73.44 158.87 85.96 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.541 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 67.6 Cg_endo -87.5 108.86 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.754 2.303 . . . . 0.0 111.466 174.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.54 38.71 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.433 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -145.28 42.24 1.28 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.63 -83.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.158 0.504 . . . . 0.0 112.181 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -52.05 -24.78 7.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.339 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.3 mm? -61.14 -43.53 98.74 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.16 24.64 8.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.809 0.814 . . . . 0.0 109.686 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -120.42 -40.08 2.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.045 -177.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.65 166.24 26.03 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.356 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.402 ' HG2' ' NH1' ' A' ' 104' ' ' ARG . 15.0 Cg_exo -70.4 -163.62 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.411 2.741 . . . . 0.0 112.726 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.89 -91.09 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.538 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.402 ' NH1' ' HG2' ' A' ' 102' ' ' PRO . 73.1 mtm-85 65.31 -70.86 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.503 0.721 . . . . 0.0 111.855 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.53 77.15 0.32 Allowed Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.603 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.4 t0 67.84 -69.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 110.857 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -125.17 -7.21 7.1 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.17 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.22 8.53 35.76 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.704 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 48.5 pt -82.62 -18.25 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.78 -175.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.18 -8.72 59.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.538 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.84 139.27 30.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.83 -22.59 64.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.69 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.579 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 12.5 m120 -63.25 -59.02 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.704 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -54.28 -48.37 71.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.728 0.299 . . . . 0.0 110.753 177.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.3 mt -52.77 -45.54 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.786 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.507 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -73.53 -23.32 59.98 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.327 -178.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 39.4 mm-40 -70.78 -32.62 69.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.447 0.641 . . . . 0.0 109.78 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.3 ttm180 -79.89 -39.65 30.02 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.507 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -54.22 -49.91 68.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.825 -178.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.703 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -59.92 -40.36 88.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.439 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -84.08 -31.82 24.93 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.065 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.541 ' N ' ' HG3' ' A' ' 93' ' ' PRO . 6.7 tp -65.61 -35.69 81.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.297 0.239 . . . . 0.0 111.063 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.549 ' HA ' HG21 ' A' ' 126' ' ' ILE . 12.9 pt-20 -76.73 -35.39 57.83 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.5 mm-40 -56.71 -55.46 33.86 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' O ' HG11 ' A' ' 129' ' ' VAL . 7.4 t80 -51.23 -54.05 29.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.732 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.3 tp -64.35 -38.22 81.99 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.161 -170.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -64.03 -21.67 66.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.523 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 39.7 mttm -85.15 -55.03 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.757 0.789 . . . . 0.0 110.763 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.38 -12.4 15.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.816 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.33 8.81 21.51 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.332 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.6 9.24 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 47.7 t60 -100.87 140.91 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.637 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.671 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.3 Cg_endo -46.17 -48.03 13.73 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.709 2.939 . . . . 0.0 112.936 -172.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.554 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.66 -30.01 69.44 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.039 -176.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -79.08 -43.79 23.45 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.655 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.9 mm100 -66.85 -7.69 23.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.245 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.59 ' ND2' ' HE2' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -92.23 -15.37 27.61 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.632 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 45.7 mm-40 -105.73 130.84 53.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.608 -170.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.482 ' HA ' HD13 ' A' ' 159' ' ' ILE . 19.2 tpt180 -56.7 -25.87 55.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.592 -172.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 143' ' ' MET . 1.2 p -60.32 -21.24 61.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.7 mp -70.01 -35.6 74.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.878 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.593 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 36.1 t60 -56.65 -35.35 68.26 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.122 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.575 ' HG3' HG13 ' A' ' 150' ' ' ILE . 3.8 ptm -82.66 -34.0 27.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.639 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.464 ' N ' ' HG2' ' A' ' 143' ' ' MET . 11.2 t80 -82.11 -26.71 33.33 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.476 HD11 ' CE1' ' A' ' 60' ' ' PHE . 2.3 mt -99.48 -46.89 5.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.37 0.605 . . . . 0.0 109.837 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.593 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 34.4 mt-30 -91.75 175.89 6.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.852 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 59.59 -168.92 0.15 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -98.31 -34.11 10.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.556 0.693 . . . . 0.0 110.768 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.72 166.1 15.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.35 -166.22 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.575 HG13 ' HG3' ' A' ' 143' ' ' MET . 1.9 mp -85.18 119.91 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.124 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -90.52 99.48 12.5 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.426 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 31.8 mmtp -67.31 -3.21 7.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.73 0.3 . . . . 0.0 111.684 -172.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.7 m -113.79 18.59 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.5 OUTLIER -66.53 -171.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.798 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.2 m -90.64 113.06 56.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.207 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.75 83.82 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.153 2.569 . . . . 0.0 111.69 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.4 m -153.36 -145.26 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.327 -0.233 . . . . 0.0 110.801 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.59 ' HE2' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -100.67 155.6 17.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 139' ' ' ARG . 19.5 mm -57.7 -41.07 78.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.516 . . . . 0.0 109.909 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.39 94.95 10.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.523 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -103.9 169.48 8.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.673 178.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -129.97 47.54 2.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.782 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -75.94 88.21 2.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -101.44 -4.36 26.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 -177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -83.87 66.76 9.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.89 0.376 . . . . 0.0 110.411 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -99.77 -29.3 12.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.72 148.07 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.415 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -143.52 140.71 30.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.118 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.48 131.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.233 0.54 . . . . 0.0 111.04 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 118.75 -113.53 2.6 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.685 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.21 127.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.328 0.651 . . . . 0.0 111.716 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.38 124.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.013 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -108.75 -44.77 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.349 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 p -74.25 156.96 36.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t 72.42 -54.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 123.889 0.743 . . . . 0.0 111.19 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.38 83.82 7.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.951 0.405 . . . . 0.0 110.418 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 11.5 t70 -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.354 0.597 . . . . 0.0 111.144 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -88.87 -39.26 13.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.314 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -46.48 -56.43 5.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.51 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -147.47 -84.48 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 24.7 tp 73.52 136.41 0.05 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.215 1.007 . . . . 0.0 111.566 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 mt -138.93 147.64 24.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.187 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -120.52 107.31 12.71 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.818 0.342 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -105.55 160.56 25.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.54 130.67 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.971 2.447 . . . . 0.0 111.859 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -89.24 109.13 20.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.837 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.18 150.15 33.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.185 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.24 144.64 35.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.451 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -124.23 -171.42 2.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.622 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -111.4 137.89 48.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.217 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.98 -65.13 0.06 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.972 0.415 . . . . 0.0 110.878 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.08 -43.26 54.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.88 174.56 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.745 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.87 159.14 9.75 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.763 2.975 . . . . 0.0 111.533 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.65 -9.21 1.02 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.17 3.247 . . . . 0.0 114.569 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -73.49 -55.75 5.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.619 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.7 m120 61.48 169.94 0.11 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.7 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.49 130.9 34.71 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 57' ' ' LEU . 21.9 tp -141.69 129.31 21.5 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.501 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -137.81 99.36 3.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.024 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.655 HG12 ' HB ' ' A' ' 53' ' ' VAL . 44.4 mt -110.57 134.62 52.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.718 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -134.36 113.98 12.47 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -95.52 134.34 33.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t 178.43 -161.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 28.0 m-80 68.09 76.78 0.26 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HB3' HG23 ' A' ' 115' ' ' ILE . 57.6 Cg_endo -71.76 119.27 6.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.069 1.846 . . . . 0.0 112.981 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' HB3' ' HG1' ' A' ' 48' ' ' THR . 49.4 tp60 -111.89 104.71 13.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.6 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.2 m -76.03 106.51 7.67 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -133.51 89.61 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.025 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.93 -167.5 32.94 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.513 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.5 t -101.08 146.89 8.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 119.324 -0.369 . . . . 0.0 110.409 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.72 -51.42 3.96 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.13 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -98.77 89.96 4.52 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.405 0.621 . . . . 0.0 109.554 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.14 29.81 1.43 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.791 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 16.2 ttt180 -82.46 143.12 31.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.527 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 35.0 p90 -137.66 156.62 47.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.695 0.283 . . . . 0.0 110.81 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.2 m -113.78 125.15 53.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.462 . . . . 0.0 110.879 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.459 ' HG1' ' HB3' ' A' ' 37' ' ' GLN . 37.2 p -92.79 143.85 25.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.397 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -103.89 141.58 35.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.377 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 20.1 tt0 -96.19 115.42 27.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.816 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -94.27 111.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 38.0 mtp180 -96.7 141.61 29.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -147.84 136.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.179 0.514 . . . . 0.0 112.174 177.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.97 142.22 51.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.734 167.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.479 HG23 ' CD2' ' A' ' 60' ' ' PHE . 14.0 t -171.49 164.68 6.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 111.261 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.508 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.57 21.47 13.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.766 167.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.619 HD23 ' OD1' ' A' ' 27' ' ' ASN . 28.6 mt -55.76 133.3 72.5 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.685 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 7.6 Cg_exo -68.83 -34.65 17.62 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.475 2.117 . . . . 0.0 111.39 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.488 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.53 -42.53 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.479 ' CD2' HG23 ' A' ' 55' ' ' THR . 3.7 m-30 -68.29 -23.66 64.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 71.1 -61.91 0.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.8 -14.3 59.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.876 0.307 . . . . 0.0 111.021 -173.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp 71.46 -35.09 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.778 0.674 . . . . 0.0 111.302 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -144.32 145.9 32.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.0 t -169.58 153.41 5.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 7.5 m -141.11 130.56 23.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.138 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -127.1 172.9 13.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 32.5 ttp180 -138.24 109.8 7.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.963 0.411 . . . . 0.0 110.229 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' CZ ' HG21 ' A' ' 149' ' ' ILE . 7.4 tpp180 -135.7 171.82 13.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -171.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 56.6 ttp180 -96.45 158.18 15.55 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.472 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.5 t80 -51.35 -41.16 60.42 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.539 0.336 . . . . 0.0 111.0 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.49 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 33.3 p -56.57 -29.62 62.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.8 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 28.3 m-20 -77.55 -30.39 52.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.22 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 46.1 m-85 -64.04 -38.74 92.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 109.679 173.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 92' ' ' LEU . 10.9 mt-10 -65.94 -47.97 72.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.633 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.472 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 6.1 t-105 -62.34 -35.29 78.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.703 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -65.64 -44.33 86.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.2 ttt180 -58.53 -61.33 2.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.24 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -60.12 -35.12 74.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.856 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 5.5 tp10 -66.54 -44.88 81.22 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.297 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.61 -42.36 96.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.858 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 30.8 mt-10 -64.53 -33.12 75.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.953 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.6 ppt_? -90.18 -23.34 21.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -172.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.32 -41.61 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.033 0.444 . . . . 0.0 111.648 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -130.67 174.87 9.5 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.532 0.682 . . . . 0.0 111.227 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -97.12 32.5 2.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.702 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 89' ' ' VAL . 94.6 t -51.54 142.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.958 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.5 p -71.28 35.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -56.5 119.31 27.65 Favored Pre-proline 0 N--CA 1.467 0.406 0 O-C-N 121.873 -0.517 . . . . 0.0 111.167 -176.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 163.31 10.7 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.146 2.564 . . . . 0.0 112.411 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.22 135.15 39.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.886 2.391 . . . . 0.0 112.304 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 75' ' ' GLU . 81.8 mt -64.58 152.02 90.56 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.91 124.31 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.46 2.107 . . . . 0.0 110.811 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.0 175.9 47.74 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 68.91 -54.41 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.659 0.784 . . . . 0.0 112.162 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -47.57 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -172.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.475 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -65.31 -24.08 67.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.669 -170.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.3 mm? -67.4 -46.62 72.69 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.972 0.415 . . . . 0.0 110.602 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.1 ppt_? -95.89 27.26 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.469 0.652 . . . . 0.0 110.395 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -123.27 -42.39 2.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.12 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.79 168.51 11.1 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.471 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.8 140.45 46.47 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.252 2.635 . . . . 0.0 111.151 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -82.48 -75.47 0.3 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 69.78 -56.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.98 -175.91 48.9 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.516 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.44 -51.4 27.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.388 0.613 . . . . 0.0 110.656 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 109' ' ' ILE . 6.8 t70 -117.33 -32.97 4.79 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.53 176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.11 -6.55 7.72 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.289 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.707 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 33.5 pt -66.53 -15.15 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.176 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -78.04 -13.03 60.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.666 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 -17.45 63.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.934 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 47.6 m-80 -73.89 -57.87 3.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.707 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -48.51 -50.56 31.33 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.343 0.402 . . . . 0.0 110.911 178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 HG23 ' HB3' ' A' ' 36' ' ' PRO . 49.4 mt -49.65 -54.81 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.331 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.69 -17.89 58.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.791 -175.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.54 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 67.9 mm-40 -73.27 -35.15 66.14 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.935 0.398 . . . . 0.0 110.481 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 32.7 ttp180 -81.2 -32.48 33.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.99 -50.67 71.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.711 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -60.43 -32.65 71.56 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.544 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 -33.58 10.01 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.734 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.3 tp -66.35 -33.36 75.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.206 0.203 . . . . 0.0 111.223 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.506 ' HA ' HG22 ' A' ' 126' ' ' ILE . 11.9 pt-20 -75.29 -31.85 60.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.711 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.4 mm-40 -59.97 -59.66 5.07 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.487 ' O ' HG11 ' A' ' 129' ' ' VAL . 2.6 t80 -45.84 -51.63 12.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.033 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.5 tp -65.36 -39.53 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.984 -172.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.85 -16.14 60.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -87.68 -57.8 2.81 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.914 0.864 . . . . 0.0 110.01 174.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 m -64.49 -13.12 13.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.043 -177.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.75 4.68 23.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.32 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.459 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.07 10.91 2.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.71 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.692 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 51.4 t60 -101.19 141.39 22.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 117.176 0.488 . . . . 0.0 110.665 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.692 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.4 Cg_exo -40.87 -49.01 4.51 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.131 3.221 . . . . 0.0 113.822 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.84 -25.73 63.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.441 -174.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -84.11 -40.78 17.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.926 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -68.78 -0.13 5.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.103 176.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.9 t-20 -112.14 10.9 20.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.07 131.79 50.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.002 -0.437 . . . . 0.0 111.013 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -55.67 -17.49 5.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -175.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.72 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.2 m -55.33 -31.14 61.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.699 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.57 ' O ' HD21 ' A' ' 145' ' ' LEU . 5.7 mp -73.63 -35.32 65.3 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.667 -0.646 . . . . 0.0 111.484 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 9.9 t60 -58.53 -39.22 79.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.72 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -76.02 -27.71 57.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.795 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t80 -81.03 -57.87 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -84.47 -26.21 28.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.149 -172.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 9.2 mt-30 -113.83 167.24 10.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.531 -166.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.07 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.885 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -175.04 -60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.577 0.703 . . . . 0.0 111.316 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.541 HG21 ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -121.9 144.49 30.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.868 -171.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.484 HG22 ' HE3' ' A' ' 143' ' ' MET . 3.0 mp -65.85 100.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.28 102.23 5.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.416 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.472 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 32.2 mmtp -69.88 6.55 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.707 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.4 m -120.81 18.19 11.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.357 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.408 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.74 -171.32 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.267 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.3 m -87.51 114.16 57.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.901 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -71.06 78.52 1.44 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.751 2.301 . . . . 0.0 110.951 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -155.56 -168.74 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.886 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.477 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 4.6 mmmm -80.85 157.98 25.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.92 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.488 HG13 HD12 ' A' ' 59' ' ' ILE . 15.2 mm -50.57 -42.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.155 0.502 . . . . 0.0 110.069 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 100.92 4.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -73.67 175.47 7.13 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.483 0.658 . . . . 0.0 111.616 -171.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.559 -175.404 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -128.27 34.99 4.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -83.51 72.18 10.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -75.73 113.47 13.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.161 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -133.85 101.74 5.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.802 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -87.87 97.53 10.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 -175.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -130.9 167.94 18.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.573 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.68 98.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.664 0.603 . . . . 0.0 110.7 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.74 162.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.445 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 116.92 58.15 0.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.397 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 149.07 26.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.672 0.272 . . . . 0.0 110.753 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.66 132.31 44.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.2 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -159.44 -62.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.197 0.522 . . . . 0.0 109.614 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -94.27 154.05 17.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t 65.37 -74.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 124.058 0.849 . . . . 0.0 111.019 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.15 68.8 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.298 0.57 . . . . 0.0 109.786 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.49 154.62 40.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.837 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 p -59.46 -43.73 93.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.247 0.546 . . . . 0.0 110.726 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 52.5 mmt-85 66.2 -172.9 0.19 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.496 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 17.0 mmt180 75.24 130.89 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.826 0.822 . . . . 0.0 111.51 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 12' ' ' ILE . 12.5 tp -120.8 -169.99 1.92 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.057 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.573 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 8.2 mt 67.57 152.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.739 0.78 . . . . 0.0 113.048 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.5 p -114.75 88.57 2.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -58.77 156.78 22.65 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.913 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.46 121.18 5.95 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.397 2.732 . . . . 0.0 112.188 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.1 18.16 11.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.151 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.17 150.75 43.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.766 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.49 169.65 8.72 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 12.5 p-10 -50.93 -69.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.034 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 4.4 p-10 -155.4 143.43 20.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 64.28 163.91 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.484 0.659 . . . . 0.0 111.919 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -144.94 -38.11 0.28 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.258 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.83 177.17 46.24 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.607 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.76 153.92 13.67 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 124.098 3.198 . . . . 0.0 112.307 175.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.92 -14.75 2.61 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.495 3.463 . . . . 0.0 115.431 -172.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -51.07 13.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.596 ' OD1' HD21 ' A' ' 57' ' ' LEU . 27.9 m120 61.27 176.83 0.11 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.021 175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -90.63 137.64 32.2 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD21 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -145.15 130.54 18.7 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.978 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.41 100.45 4.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.651 HG12 ' HB ' ' A' ' 53' ' ' VAL . 48.0 mt -111.76 142.27 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.487 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -132.86 119.39 20.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -101.21 130.44 50.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t 178.96 -162.35 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.9 m-80 64.93 76.22 0.33 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.25 147.26 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.86 2.373 . . . . 0.0 113.465 -171.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -130.99 118.85 21.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.572 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -77.56 95.9 4.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.63 0.729 . . . . 0.0 109.341 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.02 91.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.159 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.29 -167.38 33.03 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.355 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.0 t -104.3 145.14 13.39 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -37.97 -53.63 2.01 Favored Glycine 0 N--CA 1.463 0.472 0 O-C-N 123.182 0.301 . . . . 0.0 113.445 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -100.62 89.94 4.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.498 0.666 . . . . 0.0 109.435 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.48 35.26 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.573 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.77 147.31 25.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 122.957 0.503 . . . . 0.0 110.67 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -140.01 167.71 21.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.5 m -123.47 131.9 53.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 p -94.67 148.84 21.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.878 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.13 146.67 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.384 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 32.8 tt0 -103.48 121.56 43.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.366 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.0 mp -94.39 118.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.227 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 27.1 mtt180 -108.97 126.08 52.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.093 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.651 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -130.66 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.035 0.445 . . . . 0.0 112.123 -177.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.67 137.23 53.85 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.442 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.65 165.18 6.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.364 0.602 . . . . 0.0 112.227 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.61 26.07 9.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.971 168.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 60' ' ' PHE . 19.9 mt -60.88 140.33 93.58 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.38 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.4 -23.21 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.824 2.349 . . . . 0.0 111.688 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.06 -41.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.375 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.663 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 3.0 m-85 -67.26 -27.26 67.06 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -60.2 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.15 -11.12 59.77 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.282 -0.261 . . . . 0.0 111.301 -174.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp 70.9 -33.5 0.27 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.798 0.686 . . . . 0.0 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.22 139.11 25.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.103 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 48.5 t -155.59 154.09 31.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.665 -176.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 5.8 m -140.77 129.28 22.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.147 0.498 . . . . 0.0 110.427 171.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HB ' ' NH1' ' A' ' 69' ' ' ARG . 2.7 m -139.98 145.46 26.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.04 -175.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -115.35 116.27 28.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.582 ' NH1' ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -140.13 169.02 18.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.533 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.98 170.1 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.587 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 36.9 t80 -51.76 -40.59 60.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.575 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.557 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 21.7 m -54.34 -31.87 55.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.048 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 69' ' ' ARG . 44.9 m-20 -74.38 -35.63 63.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.464 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 58.5 m-85 -66.36 -36.55 83.16 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 31.4 mt-10 -60.09 -56.05 26.45 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -64.7 -28.06 69.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.372 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.52 -46.03 56.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 46.3 ttt180 -57.29 -58.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.361 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.674 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 14.4 p -60.82 -37.47 82.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.472 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -63.3 -39.01 93.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.951 0.405 . . . . 0.0 110.731 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.573 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.3 mt -62.99 -34.07 76.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.63 -22.79 53.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 79' ' ' SER . 38.9 mmt180 -68.82 -62.23 1.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.01 0.433 . . . . 0.0 111.948 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -98.63 -18.05 18.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.236 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -126.61 166.37 17.45 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.49 0.662 . . . . 0.0 111.117 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -98.51 32.78 2.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.526 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.9 t -51.81 141.33 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.864 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.3 p -71.11 35.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.929 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.517 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -59.81 120.69 52.04 Favored Pre-proline 0 C--O 1.236 0.346 0 O-C-N 121.816 -0.553 . . . . 0.0 111.144 -176.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 72.9 Cg_endo -85.65 165.32 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.843 2.362 . . . . 0.0 112.249 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.86 141.51 65.44 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.6 2.2 . . . . 0.0 111.883 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 75' ' ' GLU . 86.8 mt -69.05 145.48 96.52 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.18 109.33 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.744 2.296 . . . . 0.0 111.479 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.32 46.94 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.003 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 59.08 18.62 6.54 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.913 0.485 . . . . 0.0 111.642 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.526 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -118.62 -81.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 0.0 111.627 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.685 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.72 -23.47 67.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.165 -176.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.486 ' H ' ' CD2' ' A' ' 98' ' ' LEU . 1.1 mm? -62.93 -48.1 80.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.942 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.526 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -94.05 20.03 8.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.138 177.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -115.22 -41.9 3.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.322 -177.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 4.5 pp -107.53 169.1 7.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.463 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.2 Cg_exo -69.47 132.07 23.01 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.482 2.788 . . . . 0.0 112.66 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 13.6 m-85 -55.92 -63.47 1.17 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.78 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 73.85 -56.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.566 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.426 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -110.98 -165.95 18.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.196 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -50.85 -47.53 60.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.22 0.533 . . . . 0.0 111.611 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 109' ' ' ILE . 4.7 t70 -120.62 -29.78 4.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.68 -13.95 6.81 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.638 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 38.2 pt -64.54 -16.31 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.571 -0.814 . . . . 0.0 112.105 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 91.5 m-85 -80.06 -9.36 59.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.677 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.33 137.29 40.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.45 -17.4 61.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.224 -173.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -69.34 -52.43 27.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.227 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.638 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -50.1 -50.63 47.76 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.478 0.486 . . . . 0.0 111.083 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.19 -52.2 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.27 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.552 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -73.48 -20.58 60.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.359 -176.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 63.3 mm-40 -72.07 -35.47 69.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 110.036 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 36.7 ttm180 -80.92 -34.98 33.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.552 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -54.44 -50.98 66.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.24 -178.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -62.19 -37.46 85.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.481 -174.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.33 -34.94 12.86 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.594 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.4 tp -67.78 -32.39 72.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 122.14 0.176 . . . . 0.0 111.228 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.553 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -75.81 -29.79 58.82 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.694 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.2 mm-40 -64.41 -54.17 36.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 129' ' ' VAL . 6.1 t80 -48.85 -53.7 18.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.399 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.522 HG21 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -65.57 -40.23 87.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.878 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -61.46 -16.99 52.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.109 0.48 . . . . 0.0 111.891 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.488 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 67.2 mttt -90.45 -58.75 2.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.018 0.914 . . . . 0.0 110.69 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.595 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.3 m -66.22 -11.73 13.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.337 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.59 -0.07 20.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.51 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -132.67 6.13 5.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.407 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.704 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 30.3 t60 -100.71 143.42 26.54 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 117.028 0.414 . . . . 0.0 110.921 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.704 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 4.5 Cg_exo -43.17 -50.17 6.67 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.105 3.203 . . . . 0.0 113.266 -174.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.409 ' C ' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -67.91 -28.08 67.19 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.249 -174.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -81.28 -42.7 20.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.857 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 7.6 mm-40 -62.29 -6.25 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.932 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.8 t-20 -108.75 10.1 26.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.824 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.489 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 51.0 mm-40 -115.71 126.08 53.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.951 0.405 . . . . 0.0 111.206 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.454 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -56.14 -26.18 49.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.847 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.751 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.3 p -62.2 -24.72 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.488 ' HG ' HD11 ' A' ' 145' ' ' LEU . 2.7 mp -66.52 -33.81 76.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.653 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.519 ' HA ' ' OE1' ' A' ' 146' ' ' GLN . 33.4 t-80 -62.77 -34.85 78.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.384 -175.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.751 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -85.04 -28.16 25.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.376 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.459 ' N ' ' HG2' ' A' ' 143' ' ' MET . 31.9 t80 -81.17 -44.81 17.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.532 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.663 HD12 ' CZ ' ' A' ' 60' ' ' PHE . 4.0 mt -93.05 -45.41 7.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.625 0.726 . . . . 0.0 110.574 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.519 ' OE1' ' HA ' ' A' ' 142' ' ' HIS . 30.6 mt-30 -97.87 -172.71 2.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.652 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.13 -132.62 1.76 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.537 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -130.01 -37.56 1.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.414 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -148.33 161.35 6.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.53 0.681 . . . . 0.0 112.515 -168.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.494 ' CG2' ' HE3' ' A' ' 152' ' ' LYS . 3.8 mp -87.14 105.59 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.626 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 153' ' ' SER . 25.7 t70 -90.46 109.03 20.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.802 175.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 10.7 mptt -76.45 10.8 1.87 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.724 0.774 . . . . 0.0 111.325 -173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 151' ' ' ASP . 12.5 m -115.19 14.61 16.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.82 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -65.74 -171.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.493 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.3 m -89.38 114.0 58.68 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 23.0 Cg_exo -67.02 95.62 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.984 2.456 . . . . 0.0 110.835 174.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 9.4 t -165.95 -155.73 0.24 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.384 0.611 . . . . 0.0 110.501 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.491 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.4 mmmt -97.92 161.94 13.49 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.506 HG22 HG13 ' A' ' 59' ' ' ILE . 22.2 mm -53.74 -47.57 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.402 ' N ' ' HD2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -89.0 95.11 10.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.343 173.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.95 174.38 6.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.202 -169.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.813 177.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.981 0.419 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -109.8 102.11 10.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -78.31 123.63 27.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.466 . . . . 0.0 110.059 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.94 143.36 27.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.815 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.16 -37.14 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.268 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -152.22 148.93 28.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.468 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -150.35 157.23 42.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.597 0.237 . . . . 0.0 111.038 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -131.54 74.22 1.58 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.987 0.899 . . . . 0.0 109.924 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.89 168.17 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.846 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 100.25 29.92 6.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.092 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.8 p 46.63 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.783 0.833 . . . . 0.0 112.933 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.12 129.05 36.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.469 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -162.77 -60.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.071 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -71.57 140.33 49.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 111.482 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.11 164.38 34.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.217 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.27 140.53 51.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.774 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.19 137.62 38.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.514 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 22.4 p -88.42 -44.5 10.69 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.037 -172.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 8' ' ' THR . 11.6 mmt180 72.03 -56.79 0.64 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.238 0.961 . . . . 0.0 110.238 -175.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HD2' ' C ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -149.87 139.97 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.01 145.16 49.21 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.407 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.46 153.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p 67.54 130.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.015 0.926 . . . . 0.0 111.426 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.9 mptp? -78.58 157.74 76.86 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.971 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -45.2 116.54 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.46 2.773 . . . . 0.0 112.332 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.94 151.62 24.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.606 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -87.0 155.84 20.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.66 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.12 122.58 37.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.831 0.348 . . . . 0.0 110.319 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.477 HD21 ' C ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -79.87 176.61 9.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.235 -178.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.547 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.6 m-20 -80.2 141.67 35.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . 71.8 165.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.129 0.893 . . . . 0.0 109.498 -171.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.443 ' CD2' ' HB2' ' A' ' 56' ' ' ASN . 1.9 m-85 -133.39 -60.4 0.84 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.261 -169.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.66 178.37 47.95 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.42 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.92 157.36 8.09 Favored 'Trans proline' 0 C--N 1.335 -0.17 0 C-N-CA 124.288 3.326 . . . . 0.0 112.392 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.96 -19.66 0.88 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.947 3.765 . . . . 0.0 115.441 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -75.22 -53.41 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.593 ' OD1' HD21 ' A' ' 57' ' ' LEU . 26.8 m120 61.11 178.4 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.588 0.355 . . . . 0.0 111.928 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -92.96 139.27 30.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.552 HD21 HD12 ' A' ' 57' ' ' LEU . 18.3 tp -145.56 131.51 19.2 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.159 -176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 7.8 pt-20 -140.31 102.57 4.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.254 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.614 HG12 ' HB ' ' A' ' 53' ' ' VAL . 51.6 mt -114.05 140.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.345 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -137.12 108.91 7.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.6 m -85.85 129.52 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t 179.95 -164.3 0.06 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.4 m-80 53.34 67.81 3.42 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.51 164.51 14.42 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.96 2.44 . . . . 0.0 113.41 -168.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -142.82 116.26 9.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.797 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.429 HG21 ' NE ' ' A' ' 45' ' ' ARG . 45.6 m -80.17 89.22 5.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.561 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.1 98.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.145 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.9 -167.07 31.53 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.964 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.8 t -102.29 148.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.123 -176.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.73 -49.81 5.97 Favored Glycine 0 N--CA 1.461 0.351 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.51 85.27 3.58 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.51 36.27 0.86 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.699 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.564 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 18.0 ttt180 -81.31 150.07 28.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.82 168.64 19.31 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 m -124.61 126.57 45.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 111.143 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 p -93.62 153.84 18.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.233 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -124.02 142.01 51.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.877 0.37 . . . . 0.0 110.5 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.4 tt0 -94.26 121.45 35.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.133 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.7 mp -97.61 108.96 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 110.623 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 34.0 mtp180 -97.97 136.53 38.11 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.703 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.614 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.24 136.99 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -125.46 138.31 54.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.812 168.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.539 HG23 ' CD2' ' A' ' 60' ' ' PHE . 15.3 t -168.5 165.53 12.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 111.834 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.487 HD21 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -119.1 24.34 10.84 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.812 169.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.593 HD21 ' OD1' ' A' ' 27' ' ' ASN . 28.4 mt -60.82 135.02 92.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.89 174.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.85 -30.88 21.18 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.375 2.05 . . . . 0.0 111.404 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -65.22 -42.27 93.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.393 175.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' CD2' HG23 ' A' ' 55' ' ' THR . 3.4 m-30 -68.5 -12.47 61.29 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -168.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 72.01 -66.78 0.29 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 169.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.442 HD12 ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -83.1 -7.56 59.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 122.368 -0.208 . . . . 0.0 110.869 -173.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' O ' HG22 ' A' ' 55' ' ' THR . 4.8 mmpp? 70.93 -39.41 0.45 Allowed 'General case' 0 C--O 1.218 -0.592 0 O-C-N 123.873 0.733 . . . . 0.0 111.205 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.0 pp20? -157.77 141.5 15.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.094 0.473 . . . . 0.0 109.989 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.9 t -170.2 172.13 6.47 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.23 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 22.3 m -141.59 127.96 19.95 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.192 0.52 . . . . 0.0 110.492 174.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.61 173.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.462 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 68' ' ' ARG . 18.5 ttm180 -137.69 115.24 11.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.117 0.484 . . . . 0.0 110.511 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.445 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 3.4 mmp_? -140.92 167.44 22.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.846 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.515 ' HG2' ' N ' ' A' ' 71' ' ' TYR . 46.9 ttt180 -98.52 165.48 11.81 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.068 -173.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.515 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 40.4 t80 -50.58 -39.86 50.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.6 0.238 . . . . 0.0 111.433 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.8 p -57.03 -31.35 65.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.72 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -71.43 -38.59 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 51.2 m-85 -61.73 -42.39 98.89 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 0.0 109.949 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' HA ' HD13 ' A' ' 92' ' ' LEU . 29.1 mt-10 -55.9 -55.05 37.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.321 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -61.93 -33.23 73.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.312 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.516 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 2.8 tm? -71.68 -42.89 66.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.579 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.5 ttt180 -56.06 -63.95 1.02 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.139 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.584 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -59.86 -34.49 73.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.049 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.62 -43.95 96.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.098 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.51 -37.66 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.737 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 56.5 mt-10 -67.37 -33.73 75.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.277 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 79' ' ' SER . 24.4 mmt180 -76.34 -61.15 2.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.255 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -66.99 -31.51 72.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.277 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.419 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 1.5 m -139.16 179.68 6.37 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.67 0.748 . . . . 0.0 112.069 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -97.86 22.42 9.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.696 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 89' ' ' VAL . 84.8 t -44.54 140.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.103 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.42 33.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.98 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -54.88 119.8 24.42 Favored Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 122.161 -0.337 . . . . 0.0 110.697 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.478 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 93.6 Cg_endo -85.5 163.53 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.697 2.265 . . . . 0.0 112.398 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 136.05 52.55 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.841 2.36 . . . . 0.0 112.097 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 75' ' ' GLU . 89.3 mt -69.23 149.08 97.56 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.723 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.9 Cg_exo -72.7 109.28 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.446 2.097 . . . . 0.0 110.966 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.616 ' O ' HD21 ' A' ' 98' ' ' LEU . . . -166.45 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.559 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.58 45.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.1 -0.647 . . . . 0.0 110.35 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.8 -103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.552 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -53.54 -30.25 40.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.616 HD21 ' O ' ' A' ' 94' ' ' GLY . 1.8 mm? -66.74 -44.97 80.1 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.179 -0.326 . . . . 0.0 111.299 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 8.42 42.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.771 0.796 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.6 tp-100 -97.11 -38.75 9.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.328 176.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 42.5 mt -94.32 163.69 22.39 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.58 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.11 175.94 9.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.388 2.726 . . . . 0.0 111.432 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -76.07 -79.28 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 60.62 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.585 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.87 75.53 1.08 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.874 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 69.16 -63.22 0.38 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.885 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.42 -29.84 1.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.375 0.607 . . . . 0.0 110.356 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.75 15.76 3.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.966 -173.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.699 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.1 pt -83.53 -18.95 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.387 . . . . 0.0 112.037 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.24 -9.42 59.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 109.794 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.03 118.7 23.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.653 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.06 -17.01 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.835 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.656 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 85.9 m-20 -63.35 -61.58 2.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.699 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -47.78 -51.47 22.3 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.635 0.584 . . . . 0.0 111.441 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.1 mt -50.13 -50.31 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.314 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.495 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -83.74 -14.31 51.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.817 -177.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 30.2 mt-10 -80.16 -28.12 38.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -75.71 -37.6 59.32 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.98 -52.04 67.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.055 -178.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.689 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -59.13 -43.3 91.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 -36.26 38.68 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.062 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -64.01 -38.6 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.811 0.306 . . . . 0.0 111.62 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.555 ' HA ' HG23 ' A' ' 126' ' ' ILE . 12.3 pt-20 -73.0 -31.13 64.3 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.689 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.9 mm-40 -61.58 -59.36 5.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.543 ' O ' HG12 ' A' ' 129' ' ' VAL . 8.5 t80 -48.82 -54.09 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.756 -1.565 . . . . 0.0 111.383 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -64.04 -41.03 91.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.031 -170.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.32 0.509 . . . . 0.0 111.836 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.478 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -90.49 -58.59 2.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.849 0.833 . . . . 0.0 110.248 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.3 m -64.75 -12.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.256 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -109.74 3.0 20.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.08 -8.01 2.44 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.327 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.661 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 58.9 t60 -82.49 139.81 44.58 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.661 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.8 Cg_endo -44.15 -47.31 10.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.096 3.197 . . . . 0.0 113.292 -172.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.415 ' CB ' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -68.61 -33.16 73.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.125 -176.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -76.74 -43.84 35.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.745 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.492 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.67 -6.41 3.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.229 172.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.531 HD21 ' HE3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -99.79 -6.35 27.1 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.164 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' C ' HG12 ' A' ' 159' ' ' ILE . 30.1 mm-40 -107.43 129.93 54.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.693 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.466 ' HA ' HD12 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -56.04 -20.34 16.43 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.584 -174.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.52 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.0 m -59.25 -30.31 68.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.359 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 135' ' ' ALA . 1.1 mp -69.79 -35.33 74.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.172 -0.33 . . . . 0.0 111.208 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.681 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 11.9 t-80 -54.25 -41.36 68.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.626 0.727 . . . . 0.0 109.691 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.52 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 3.3 ptm -81.0 -27.93 35.68 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.446 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.516 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 20.3 t80 -79.87 -59.17 2.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.154 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 144' ' ' PHE . 0.0 OUTLIER -106.38 7.09 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -175.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.681 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.5 mt-30 -121.33 -176.1 3.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.65 -111.64 0.58 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.408 0.443 . . . . 0.0 110.889 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -145.42 -39.13 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 112.027 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.06 148.69 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.161 -166.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.51 ' CG2' ' HE3' ' A' ' 152' ' ' LYS . 3.4 mp -72.25 102.84 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.812 172.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -89.74 102.94 15.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.25 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 5.4 mptt -74.74 11.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.296 0.57 . . . . 0.0 111.913 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -111.79 12.53 20.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.166 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -171.84 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.679 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.2 m -92.52 113.71 60.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.54 89.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.018 2.479 . . . . 0.0 110.941 174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 t -159.7 -154.63 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.395 0.617 . . . . 0.0 110.868 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.531 ' HE3' HD21 ' A' ' 137' ' ' ASN . 14.8 mmmt -96.8 157.78 15.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.474 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.49 HG21 HG13 ' A' ' 59' ' ' ILE . 19.6 mm -57.77 -41.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.0 109.922 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -66.15 -25.26 66.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.01 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.528 ' CG ' ' H ' ' A' ' 162' ' ' ALA . 19.2 t-80 64.03 -176.12 0.16 Allowed 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.753 172.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.528 ' H ' ' CG ' ' A' ' 161' ' ' HIS . . . . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.994 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 2.8 ppp? . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.744 0.307 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -108.3 4.89 25.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.733 0.301 . . . . 0.0 111.228 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -109.13 110.59 21.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.847 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -72.88 129.5 38.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -110.75 -6.98 14.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.122 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -114.84 130.59 56.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.555 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -98.99 -22.72 15.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -66.97 128.39 36.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.4 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.82 129.63 51.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.474 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.66 -33.61 18.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.582 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 32.1 p -129.59 109.11 10.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.289 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.33 129.51 9.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.898 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -172.51 -44.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.803 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p -70.8 152.52 43.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.664 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.12 -49.91 4.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.989 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.71 70.82 0.73 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -67.61 145.41 54.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.842 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 26.6 p -100.24 -54.14 2.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.667 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 64.59 -60.78 0.21 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.62 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -133.45 -37.48 0.95 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.713 0.768 . . . . 0.0 110.679 -172.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.723 HD21 ' N ' ' A' ' 12' ' ' ILE . 5.4 tt -72.57 135.02 45.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.37 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.723 ' N ' HD21 ' A' ' 11' ' ' LEU . 1.7 mt -144.43 172.31 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.278 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.425 ' H ' HG21 ' A' ' 12' ' ' ILE . 40.0 p 58.46 80.94 0.17 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.861 0.839 . . . . 0.0 110.291 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mptt -78.22 165.59 49.24 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.642 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 84.5 Cg_exo -49.07 136.22 29.79 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.697 2.265 . . . . 0.0 111.358 173.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.0 173.42 7.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.266 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -62.59 146.25 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.325 0.583 . . . . 0.0 111.137 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.69 -166.48 1.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.644 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 4.6 p30 -53.43 -71.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.062 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 9.9 m-20 -129.66 129.46 44.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 170.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 178.82 158.61 0.55 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.911 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -133.97 -45.51 0.79 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.909 0.385 . . . . 0.0 110.746 -168.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.7 40.15 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.041 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.38 153.45 13.4 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 124.088 3.192 . . . . 0.0 111.608 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -41.13 -30.26 0.65 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 124.6 3.533 . . . . 0.0 115.504 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -70.75 -52.21 22.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 30.9 m-80 61.53 -179.42 0.12 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 112.135 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.39 132.41 36.22 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 57' ' ' LEU . 13.2 tp -143.0 127.21 17.56 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.58 0.705 . . . . 0.0 111.188 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.15 100.79 3.79 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.688 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.644 HG12 ' HB ' ' A' ' 53' ' ' VAL . 46.7 mt -111.82 138.71 39.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.116 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -131.77 103.24 6.23 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -79.35 131.51 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -178.03 -165.13 0.09 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 63.06 81.73 0.22 Allowed Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 121.375 0.607 . . . . 0.0 110.432 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.13 119.59 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.123 2.549 . . . . 0.0 112.527 -175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.487 ' HB3' ' HG1' ' A' ' 48' ' ' THR . 50.0 tp60 -108.81 106.47 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.541 174.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.8 m -77.84 103.15 7.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -134.07 89.9 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.05 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.42 -167.86 33.02 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.218 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 t -104.37 149.91 7.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.337 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.86 3.19 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 121.549 -0.357 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -96.67 86.9 4.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.647 . . . . 0.0 109.858 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.94 34.85 0.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.975 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 20.9 ttt180 -82.71 146.84 28.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -143.47 165.76 26.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.901 0.381 . . . . 0.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 36.5 m -121.78 129.02 52.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.481 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.487 ' HG1' ' HB3' ' A' ' 37' ' ' GLN . 44.0 p -92.73 140.86 29.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.439 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 98.6 m-85 -100.22 126.75 46.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.07 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.626 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 15.5 tt0 -86.17 120.34 27.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.289 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -93.34 106.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.691 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -95.44 112.03 23.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.424 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.644 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -122.66 140.68 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -126.86 136.87 52.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.244 168.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.562 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.1 t -170.65 164.54 8.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.31 0.576 . . . . 0.0 112.152 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.04 26.02 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.824 168.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 29' ' ' LEU . 26.5 mt -60.4 136.42 91.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.543 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -68.34 -32.87 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.227 1.952 . . . . 0.0 111.162 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 159' ' ' ILE . 1.1 tt -66.69 -37.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.411 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.691 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 4.0 m-30 -75.07 -5.37 43.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -169.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 tttt 67.16 -74.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.438 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.18 -4.38 55.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 120.518 0.199 . . . . 0.0 110.502 -171.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 5.5 mmtp 70.31 -42.38 0.52 Allowed 'General case' 0 C--O 1.221 -0.417 0 O-C-N 124.122 0.889 . . . . 0.0 111.496 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LEU . 2.1 pp20? -158.19 127.27 5.67 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.408 0.623 . . . . 0.0 110.121 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 t -166.97 176.22 7.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.547 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.626 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 21.5 m -140.68 122.74 15.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 111.947 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.49 -178.1 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.866 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 38.6 ptt180 -150.53 133.1 15.72 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.109 170.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 4.0 mmp_? -136.11 177.99 7.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.624 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' O ' ' HD1' ' A' ' 74' ' ' PHE . 61.6 mtp180 -93.13 173.2 7.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.282 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.545 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.9 t80 -60.48 -40.52 91.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 p -60.49 -26.78 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' HB3' HD13 ' A' ' 150' ' ' ILE . 9.3 m-20 -73.23 -37.02 66.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.913 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.607 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 34.9 m-85 -65.98 -41.36 91.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.8 mt-10 -55.91 -53.53 55.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.021 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.443 ' CD1' HG23 ' A' ' 150' ' ' ILE . 8.5 t-105 -64.07 -30.27 71.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.331 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -73.44 -43.96 59.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 35.5 ttt180 -56.59 -61.82 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.176 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.412 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 32.7 t -59.62 -38.54 81.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.586 -173.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -48.48 75.93 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.2 mt -63.79 -40.37 96.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.201 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.9 mt-10 -66.94 -41.84 86.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.824 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.3 mmm180 -74.96 -53.6 8.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.791 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -82.86 -25.83 32.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.101 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 m -130.46 175.3 9.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.717 0.77 . . . . 0.0 111.569 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -99.13 29.96 3.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.581 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 134' ' ' LEU . 60.3 t -54.61 142.31 8.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.0 p -73.15 34.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.037 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -57.05 122.9 56.65 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 121.886 -0.509 . . . . 0.0 111.206 -175.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.62 167.82 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.926 2.418 . . . . 0.0 111.868 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 150.31 64.66 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.478 2.119 . . . . 0.0 112.244 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD11 ' HA ' ' A' ' 75' ' ' GLU . 92.6 mt -78.41 151.99 78.21 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.255 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.32 110.8 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.778 2.319 . . . . 0.0 111.154 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.415 ' HA2' HD22 ' A' ' 98' ' ' LEU . . . -176.3 43.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.724 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -153.18 58.74 0.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.489 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -165.43 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.626 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -59.47 -29.0 67.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.945 -173.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD22 ' HA2' ' A' ' 94' ' ' GLY . 1.1 mm? -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.444 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.3 ppt_? -99.81 29.33 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 0.0 110.196 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -124.83 -41.43 2.12 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.405 -177.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 54.1 mt -85.23 166.76 29.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.18 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 33.5 Cg_exo -60.06 143.07 99.58 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.986 2.457 . . . . 0.0 112.254 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.604 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 6.9 m-85 -73.65 -62.95 1.31 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 69.77 -60.49 0.47 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.886 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.31 -145.83 7.29 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.954 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.96 -42.47 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 111.432 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -127.87 -53.26 1.32 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -173.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 141.43 -12.57 2.74 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.599 -171.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.636 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 39.3 pt -56.12 -19.84 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -76.22 -7.29 54.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.434 . . . . 0.0 110.834 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.01 125.7 34.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -69.45 -17.94 63.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.122 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.9 m-80 -72.58 -47.41 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.636 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -49.03 -49.57 40.52 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.5 0.5 . . . . 0.0 110.71 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.95 -50.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.618 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -79.18 -16.31 56.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.849 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 65.4 mm-40 -73.31 -35.32 66.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.439 ' HD2' ' OH ' ' A' ' 49' ' ' TYR . 33.0 ttm180 -79.04 -31.89 44.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.91 -50.96 72.06 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.652 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.683 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -61.45 -37.56 84.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 -40.49 16.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.136 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.607 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -62.11 -35.43 78.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.9 0.35 . . . . 0.0 111.281 178.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 15.9 pt-20 -75.52 -33.18 60.7 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.6 mm-40 -61.67 -56.1 23.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.481 ' O ' HG11 ' A' ' 129' ' ' VAL . 6.1 t80 -51.15 -52.77 40.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.433 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.44 -41.06 90.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.055 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -60.41 -17.99 47.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 0.0 111.981 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -88.25 -59.39 2.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.111 0.957 . . . . 0.0 110.593 177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 125' ' ' PHE . 1.4 m -65.35 -13.13 14.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.398 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.41 -5.64 23.89 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.443 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.36 14.3 4.82 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.004 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.669 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 45.1 t60 -100.19 139.45 20.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.796 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.1 Cg_exo -41.32 -49.53 4.84 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.516 3.477 . . . . 0.0 113.706 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.432 ' CB ' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.68 -26.63 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.386 -174.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 137' ' ' ASN . . . -86.76 -42.16 13.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.423 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.39 -2.66 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.182 170.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t-20 -111.3 7.83 21.19 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.937 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -116.03 126.98 54.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.0 0.429 . . . . 0.0 111.199 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -52.46 -29.31 24.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.041 -173.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.657 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 15.5 t -63.75 -22.47 66.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.83 0.347 . . . . 0.0 111.434 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -68.45 -30.85 69.81 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.793 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 7.3 t60 -67.09 -38.09 85.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 6.3 ptm -79.61 -25.28 41.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.826 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.5 ' CD2' HD11 ' A' ' 150' ' ' ILE . 24.7 t80 -80.17 -52.54 7.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.192 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.691 ' HG ' ' CZ ' ' A' ' 60' ' ' PHE . 3.2 mm? -78.36 -25.83 46.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.921 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.677 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 28.1 mt-30 -129.48 176.7 7.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.068 -164.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.49 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HG3' HG13 ' A' ' 149' ' ' ILE . 9.3 tp10 177.18 -58.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.656 0.741 . . . . 0.0 110.862 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -116.24 135.85 55.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.824 -171.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.528 ' CG2' ' HE1' ' A' ' 143' ' ' MET . 46.6 mt -72.98 111.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.621 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 153' ' ' SER . 10.3 t70 -91.82 99.86 12.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.49 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.0 mptt -70.85 11.64 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 151' ' ' ASP . 25.4 m -116.06 14.03 15.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.2 174.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.447 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -61.2 -170.93 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.611 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 93.7 m -91.66 112.21 53.29 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -70.57 88.7 0.62 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.325 2.683 . . . . 0.0 111.724 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 50.1 m -156.95 -159.56 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.175 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.538 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.5 mmmt -91.23 160.02 15.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.479 HG22 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.29 -44.27 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.716 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.45 96.11 9.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 160.64 22.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.066 0.46 . . . . 0.0 110.47 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.129 179.497 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -157.21 148.63 22.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -142.42 100.78 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.826 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.02 71.0 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.423 0.63 . . . . 0.0 110.536 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -108.76 106.43 16.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -105.02 -10.13 17.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.133 0.492 . . . . 0.0 110.199 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.95 74.43 8.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -75.12 90.75 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.385 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.55 153.31 38.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -110.92 80.2 0.27 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.852 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 m -94.28 143.65 26.21 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.83 125.02 50.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.848 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -120.88 -59.63 1.72 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.442 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -113.38 143.48 44.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.0 111.092 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.4 -46.89 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.926 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.44 14.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.243 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -113.8 156.77 23.27 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.0 p -80.08 -66.67 0.85 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.583 0.23 . . . . 0.0 110.558 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 54.4 -172.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.796 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' N ' ' HD3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -170.15 -177.02 2.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.9 tp -156.36 144.25 19.52 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.5 mt -131.52 144.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.143 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -133.59 122.36 23.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.736 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -79.76 163.58 57.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -46.98 113.02 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.647 2.231 . . . . 0.0 111.442 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -70.53 93.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.305 0.574 . . . . 0.0 111.202 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.46 170.19 8.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.209 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.57 119.07 38.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -68.71 -46.43 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.054 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -145.6 160.07 42.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.396 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 74.79 170.87 0.28 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.864 0.728 . . . . 0.0 111.033 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.63 -49.03 0.89 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.555 -169.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.87 45.42 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.807 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 155.24 14.42 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 C-N-CA 123.889 3.06 . . . . 0.0 112.334 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -49.35 -18.67 2.35 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.853 3.702 . . . . 0.0 114.698 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.2 m -70.84 -54.19 12.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.535 HD21 ' ND2' ' A' ' 56' ' ' ASN . 27.4 m120 61.29 163.24 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.588 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -87.07 139.06 30.96 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD21 HD13 ' A' ' 57' ' ' LEU . 18.6 tp -143.79 129.75 19.51 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.545 -177.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -142.03 101.43 3.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.72 0.771 . . . . 0.0 110.237 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.654 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.6 mt -111.04 133.68 55.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.223 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.36 100.79 6.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.279 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -78.01 128.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 106.716 -1.586 . . . . 0.0 106.716 171.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 p -176.8 -163.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 27.3 m-80 58.26 70.76 1.15 Allowed Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.398 . . . . 0.0 110.271 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' A' ' 115' ' ' ILE . 97.4 Cg_endo -77.15 132.34 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.796 2.331 . . . . 0.0 113.414 -172.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.3 tp60 -119.92 107.78 13.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.546 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.481 HG23 ' NE ' ' A' ' 45' ' ' ARG . 54.6 m -78.02 96.12 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.569 0.7 . . . . 0.0 109.896 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.2 p -123.82 94.39 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.379 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.65 -165.82 30.26 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.078 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.9 t -97.22 146.43 7.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.166 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.16 -48.18 6.59 Favored Glycine 0 N--CA 1.46 0.263 0 C-N-CA 121.521 -0.371 . . . . 0.0 113.144 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.91 89.85 3.43 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.57 0.7 . . . . 0.0 109.222 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.74 33.09 0.95 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.474 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 27.8 ttt180 -85.66 146.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.057 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.43 149.47 51.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.54 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.5 m -105.19 128.29 53.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.347 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 35.9 p -93.16 144.3 25.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.87 138.75 49.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 110.767 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 34.8 tt0 -96.79 120.79 37.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.204 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.611 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.9 mp -98.64 109.82 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -96.1 145.02 25.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.699 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.654 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.68 138.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.497 . . . . 0.0 112.175 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -127.54 143.61 51.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.009 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -171.75 164.58 6.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.022 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.535 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.62 23.94 11.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.596 167.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.551 HD13 HD21 ' A' ' 29' ' ' LEU . 28.2 mt -58.57 138.58 85.87 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.713 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 2.4 Cg_endo -77.0 -24.99 9.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.5 2.134 . . . . 0.0 111.424 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.552 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.41 -42.27 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.545 ' CE1' HD11 ' A' ' 57' ' ' LEU . 3.5 m-30 -68.46 -25.59 65.07 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -170.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.63 -60.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -80.77 -9.02 59.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.831 0.287 . . . . 0.0 111.293 -172.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 70.0 -41.7 0.49 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.839 0.712 . . . . 0.0 110.994 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.53 144.93 36.22 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -163.81 158.12 19.7 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.5 m -142.31 136.61 29.89 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.534 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.85 176.04 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.655 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 35.2 ttp180 -137.89 113.8 9.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.03 0.443 . . . . 0.0 110.438 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 12.1 mmm180 -131.44 177.4 7.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -100.23 172.08 7.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.29 . . . . 0.0 111.11 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.622 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.6 t80 -61.81 -38.18 87.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.494 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 17.0 p -57.77 -28.62 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.248 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' HB3' HD11 ' A' ' 150' ' ' ILE . 5.0 m-20 -70.88 -40.13 72.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.128 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.27 -40.27 95.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 109.892 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 19.9 mt-10 -61.76 -44.98 95.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.826 0.822 . . . . 0.0 110.138 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CE2' ' HG3' ' A' ' 152' ' ' LYS . 7.3 t-105 -64.03 -36.31 83.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.521 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.672 HD22 ' CD2' ' A' ' 144' ' ' PHE . 32.3 tp -70.77 -48.03 56.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.144 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.609 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 56.8 ttt180 -50.61 -60.11 3.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.72 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.2 p -61.86 -42.21 98.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.959 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.43 -49.28 64.87 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.332 0.395 . . . . 0.0 111.149 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.21 -38.4 90.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.609 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.6 mt-10 -70.89 -20.19 62.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.752 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.72 ' HG2' ' O ' ' A' ' 79' ' ' SER . 26.5 mmt180 -80.21 -61.77 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.499 . . . . 0.0 112.113 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' OE2' ' A' ' 138' ' ' GLU . 43.7 mm-40 -84.74 -22.98 29.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.054 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.468 ' HG ' ' CD ' ' A' ' 138' ' ' GLU . 46.7 m -131.98 171.88 13.04 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.687 0.756 . . . . 0.0 112.005 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -97.99 33.46 2.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.402 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 89' ' ' VAL . 66.6 t -54.3 140.0 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.535 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 88' ' ' VAL . 6.1 p -72.41 32.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.99 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.501 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -53.56 122.36 31.88 Favored Pre-proline 0 N--CA 1.466 0.334 0 O-C-N 122.126 -0.359 . . . . 0.0 111.258 -175.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.488 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 87.2 Cg_endo -85.75 165.17 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.175 2.583 . . . . 0.0 112.514 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.8 Cg_endo -65.76 142.95 72.12 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.852 2.368 . . . . 0.0 112.285 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.7 mt -69.8 154.17 94.93 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.775 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.52 109.11 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.506 2.137 . . . . 0.0 110.953 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.88 -177.12 37.2 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.073 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.423 ' N ' HD21 ' A' ' 98' ' ' LEU . 12.5 mptt 68.15 -63.18 0.34 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.605 0.762 . . . . 0.0 112.202 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.71 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.55 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -76.16 -22.37 55.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.542 -169.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 97' ' ' PHE . 1.7 mm? -64.82 -42.82 94.67 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 30.11 3.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.621 0.724 . . . . 0.0 110.064 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.7 tt0 -130.06 -38.78 1.41 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.293 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.481 HD12 ' HG3' ' A' ' 117' ' ' GLU . 54.0 mt -90.03 169.21 12.82 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.104 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.34 140.43 70.21 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.636 2.224 . . . . 0.0 111.527 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 45.2 m-85 -83.15 -83.13 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.208 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 66.87 -69.4 0.13 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.862 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 110' ' ' PHE . . . -88.85 71.13 2.45 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.636 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.15 -71.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.29 1.036 . . . . 0.0 111.366 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.01 -36.4 9.03 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.827 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.73 -5.01 7.51 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.521 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.682 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.6 pt -68.92 -17.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 58.1 m-85 -81.25 -4.62 56.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.836 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -100.01 131.47 45.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.268 0.556 . . . . 0.0 109.904 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.51 -25.65 64.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.4 m-20 -64.21 -59.98 3.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.682 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.66 -47.23 58.71 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.419 0.449 . . . . 0.0 111.044 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.424 HG23 ' HG3' ' A' ' 36' ' ' PRO . 65.4 mt -52.72 -52.98 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.617 -174.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.93 -19.52 61.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.291 -177.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 40.6 mm-40 -75.63 -31.23 59.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.437 0.637 . . . . 0.0 109.64 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.03 -39.89 32.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.7 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.64 -51.34 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.795 -178.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.659 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.8 pt20 -61.25 -41.18 96.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.18 -38.67 59.02 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.563 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.12 -35.64 80.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.205 0.502 . . . . 0.0 111.236 178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.513 ' HA ' HG22 ' A' ' 126' ' ' ILE . 8.2 pt-20 -76.12 -29.04 57.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.3 mm-40 -62.52 -58.86 6.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.419 ' O ' HG11 ' A' ' 129' ' ' VAL . 6.2 t80 -51.3 -52.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.074 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG22 ' HA ' ' A' ' 123' ' ' GLU . 9.7 tp -63.35 -43.8 98.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -170.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -59.78 -20.12 54.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.488 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 38.3 mttm -84.0 -58.25 2.85 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.987 0.898 . . . . 0.0 110.14 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.3 m -65.3 -11.96 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.338 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.16 -15.41 20.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.626 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.425 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -123.68 1.89 9.38 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.281 -0.961 . . . . 0.0 114.044 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.7 t60 -89.67 141.94 28.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 117.321 0.561 . . . . 0.0 110.758 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.3 Cg_exo -40.55 -50.57 3.76 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.356 3.37 . . . . 0.0 113.774 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.34 -23.85 62.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.422 -174.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -88.36 -42.22 12.34 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.439 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.457 ' O ' HD13 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.57 -4.26 1.88 Allowed 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.523 0.678 . . . . 0.0 110.256 172.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -105.6 2.1 27.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.269 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 138' ' ' GLU . 4.9 mm-40 -114.29 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.879 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -55.48 -20.88 14.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.421 -175.111 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' MET . 6.0 t -65.51 -24.23 67.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.579 ' O ' HD21 ' A' ' 145' ' ' LEU . 5.3 mp -71.6 -31.11 66.57 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.7 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.532 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 6.3 t60 -61.73 -34.18 75.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.1 ptm -84.43 -26.16 28.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.672 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.5 t80 -78.98 -54.13 6.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.552 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.579 HD21 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.29 -33.84 22.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 0.0 110.713 -174.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 8.5 mt-30 -107.54 -175.44 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.329 -170.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 54.75 -145.05 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -117.92 -32.83 4.66 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 111.543 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -145.42 156.76 13.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.874 0.845 . . . . 0.0 113.132 -166.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.585 HD12 ' CD2' ' A' ' 144' ' ' PHE . 81.3 mt -89.12 111.99 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.02 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 153' ' ' SER . 25.2 t70 -99.78 106.24 18.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.781 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.48 ' HG3' ' CE2' ' A' ' 76' ' ' TRP . 9.5 mptt -71.39 5.55 2.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 111.773 -171.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 151' ' ' ASP . 15.4 m -109.31 13.74 24.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.834 176.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.455 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 1.2 p90 -63.48 -172.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.499 177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 99.0 m -95.45 112.83 60.19 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -69.82 50.21 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.916 3.078 . . . . 0.0 113.262 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 71.2 m -108.69 -160.59 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.82 0.343 . . . . 0.0 110.536 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 18.5 mmmt -86.78 160.31 18.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.552 HG21 HG13 ' A' ' 59' ' ' ILE . 17.5 mm -52.78 -45.87 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.62 1.96 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.306 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.437 ' CG ' ' H ' ' A' ' 162' ' ' ALA . 21.6 t-80 -74.46 178.2 5.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.347 1.07 . . . . 0.0 111.611 -171.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.437 ' H ' ' CG ' ' A' ' 161' ' ' HIS . . . . . . . . 0 C--N 1.3 -1.562 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.918 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 63.1 mtm . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -83.09 86.03 7.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 110.983 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -62.02 -37.95 86.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -111.4 16.29 20.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.778 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 54.29 41.64 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.744 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -122.78 36.9 4.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.3 m80 66.79 -95.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.868 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -172.24 23.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.3 150.05 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.118 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -114.19 -157.03 11.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.532 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 p -63.76 144.61 56.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.961 0.41 . . . . 0.0 111.332 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.33 137.93 32.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.435 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' C ' ' HG1' ' A' ' 4' ' ' THR . 7.7 tt0 -151.02 -169.06 3.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.427 ' HG1' ' C ' ' A' ' 3' ' ' GLU . 61.6 p 60.21 175.6 0.09 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.011 0.924 . . . . 0.0 113.296 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t 67.99 -82.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.075 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.85 140.47 36.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.861 0.362 . . . . 0.0 111.332 -175.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.41 164.61 19.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -58.05 -63.02 1.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 59.55 -179.6 0.09 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.564 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -168.57 170.22 9.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.6 tp -145.27 143.85 30.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.864 0.364 . . . . 0.0 110.357 -176.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.92 153.06 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p 67.06 137.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.003 0.921 . . . . 0.0 112.577 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 9.6 mptt -79.65 168.68 24.48 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.455 175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 69.1 Cg_exo -45.59 147.55 2.81 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.746 2.298 . . . . 0.0 112.313 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -55.18 127.4 29.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.373 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -68.98 155.27 40.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 18' ' ' LEU . 2.6 mm? -97.04 -171.49 2.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.39 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.37 -171.61 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.404 0.621 . . . . 0.0 111.06 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.29 126.93 54.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.992 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.14 36.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.838 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.4 m-85 -130.1 -9.76 4.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.309 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.2 178.78 41.2 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.28 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.02 154.43 13.37 Favored 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 124.314 3.343 . . . . 0.0 111.866 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.39 -27.01 4.5 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 124.078 3.185 . . . . 0.0 115.354 -169.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.413 ' O ' HD21 ' A' ' 57' ' ' LEU . 9.0 t -87.72 -33.55 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.794 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.52 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 22.0 m-80 57.41 -173.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.96 128.99 34.87 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD22 HD12 ' A' ' 57' ' ' LEU . 16.7 tp -141.36 130.47 23.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.129 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -139.19 109.0 6.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.245 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.656 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.9 mt -120.84 137.8 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 115.75 14.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.2 m -98.08 133.79 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 31.2 t 179.16 -161.54 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 62.22 68.66 1.04 Allowed Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 0.0 110.271 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.84 134.57 23.97 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.797 2.331 . . . . 0.0 113.832 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.627 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.6 tp60 -117.36 106.52 13.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.006 170.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.542 HG21 ' HE ' ' A' ' 45' ' ' ARG . 32.4 m -78.95 97.12 5.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.0 110.037 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -125.81 90.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.973 -170.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -165.41 29.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.9 t -97.02 149.13 5.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.649 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.09 -48.1 6.48 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 121.508 -0.377 . . . . 0.0 113.299 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -101.9 87.99 3.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 34.2 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.5 ttt180 -84.36 140.27 31.7 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -125.24 157.31 36.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.938 0.399 . . . . 0.0 110.408 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 m -110.35 127.72 55.2 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.079 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.627 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.2 p -92.82 128.55 38.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 87.6 m-85 -101.9 134.84 44.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 37.2 tt0 -86.91 121.76 29.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.897 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.6 mp -95.55 116.26 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.48 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 35.0 mtt180 -109.82 119.33 39.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.55 175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.656 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -123.57 142.5 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 111.953 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -127.49 138.16 52.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -171.12 165.24 7.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.5 0.667 . . . . 0.0 111.899 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' A' ' 22' ' ' TYR . 0.1 OUTLIER -121.79 28.46 7.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.397 169.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.679 HD13 ' CE1' ' A' ' 60' ' ' PHE . 17.8 mt -62.82 145.24 96.17 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.575 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.8 -15.68 13.29 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.726 2.284 . . . . 0.0 112.345 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 HG22 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -85.06 -41.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.75 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.679 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.3 m-30 -68.51 -29.69 68.34 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 74.25 -57.52 0.61 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.421 0.451 . . . . 0.0 112.023 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.11 -12.44 59.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.648 0.204 . . . . 0.0 111.099 -173.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp 71.93 -38.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.809 0.693 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.44 146.36 26.61 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.176 0.512 . . . . 0.0 109.911 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -170.09 159.14 7.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.196 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.4 m -140.84 136.55 32.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.416 0.627 . . . . 0.0 111.462 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 4.6 m -143.71 179.92 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.765 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 7.1 ptp180 -140.31 126.01 19.26 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.446 173.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.552 HH11 HG13 ' A' ' 150' ' ' ILE . 22.2 mmt85 -125.58 161.39 27.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.487 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -82.09 159.84 23.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.553 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 24.7 t80 -55.26 -38.31 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -59.26 -28.05 66.36 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.461 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB3' HD13 ' A' ' 150' ' ' ILE . 52.2 m-20 -74.72 -37.24 62.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.187 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -65.02 -36.16 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.937 175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.1 mt-10 -63.45 -51.77 64.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 5.0 t-105 -61.64 -34.93 76.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.945 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.645 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -67.79 -44.24 77.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 66.4 ttt180 -57.14 -59.61 4.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.973 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.674 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 t -62.33 -36.01 80.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.973 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -53.93 -56.45 17.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 109.758 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.16 -35.28 76.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.296 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 20.3 mt-10 -69.37 -38.84 78.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.674 ' HG2' ' O ' ' A' ' 79' ' ' SER . 33.3 mmt180 -69.29 -60.36 2.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 0.0 111.443 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.66 -22.29 29.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.929 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -126.64 175.21 8.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.208 0.528 . . . . 0.0 112.112 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -103.0 21.03 16.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.874 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' CG1' HG21 ' A' ' 89' ' ' VAL . 89.9 t -48.01 142.0 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.125 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 88' ' ' VAL . 9.8 p -72.89 36.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.787 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.514 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -55.61 119.6 26.05 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -175.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 86.0 Cg_endo -85.9 168.37 9.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.13 2.553 . . . . 0.0 112.325 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 147.3 70.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.697 2.265 . . . . 0.0 112.554 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 75' ' ' GLU . 78.2 mt -73.97 157.67 86.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.418 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.4 109.03 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.577 2.185 . . . . 0.0 111.439 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.5 -171.46 38.07 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.602 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 68.03 -2.75 1.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.785 0.434 . . . . 0.0 111.733 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.57 -89.98 0.46 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.571 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -52.6 -23.57 6.7 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 113.296 -174.41 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.8 mm? -60.86 -41.55 96.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.994 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 18.24 21.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.692 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.0 tp-100 -113.71 -40.24 3.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.96 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.448 ' CD1' ' HB2' ' A' ' 114' ' ' PHE . 35.8 mt -89.7 165.87 23.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.515 -175.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.02 164.15 28.57 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.081 2.521 . . . . 0.0 111.962 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -83.23 -100.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 65.78 -65.87 0.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 111.577 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.96 52.18 4.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.146 -0.55 . . . . 0.0 111.952 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 63.9 -71.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.69 1.196 . . . . 0.0 110.391 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.01 -20.06 17.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.933 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.7 14.03 20.59 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.631 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.9 pt -83.21 -16.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.989 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 70.0 m-85 -79.69 1.24 27.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.453 175.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 113' ' ' ASN . 24.9 t70 -86.45 129.92 34.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.64 -19.76 63.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.88 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.553 ' HB2' ' OD2' ' A' ' 111' ' ' ASP . 46.4 m-80 -74.14 -54.37 7.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.631 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -49.87 -50.05 47.11 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.748 0.655 . . . . 0.0 111.158 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.7 mt -52.26 -45.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.278 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.0 -15.24 57.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.742 -178.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 42.4 mm-40 -70.78 -34.69 72.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.302 0.573 . . . . 0.0 109.767 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.48 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 36.5 ttm180 -78.52 -36.37 45.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -55.13 -49.32 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.827 -178.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.713 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -61.46 -33.72 74.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.496 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.02 -33.66 9.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.992 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 7.4 tp -66.32 -33.61 76.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.138 0.175 . . . . 0.0 111.018 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 10.5 pt-20 -75.22 -32.47 61.16 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.713 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.9 mm-40 -59.96 -59.85 4.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 4.7 t80 -45.63 -51.72 11.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.022 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.12 -39.05 84.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.83 -172.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.17 -12.53 28.65 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HD3' ' HG3' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -90.78 -59.46 2.17 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.734 0.778 . . . . 0.0 110.177 172.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.543 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 1.1 m -65.03 -12.19 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.056 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.02 1.5 22.49 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.354 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.417 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.87 12.95 2.4 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.509 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 54.8 t60 -100.26 140.32 21.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.987 0.394 . . . . 0.0 110.19 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 3.8 Cg_exo -43.94 -43.91 12.15 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.936 3.091 . . . . 0.0 113.54 -171.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.0 -28.72 61.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.454 -175.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 129' ' ' VAL . . . -80.35 -41.21 25.16 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.551 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.683 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.2 mm100 -67.55 -0.67 4.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.528 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -100.71 -7.01 24.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.386 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -117.52 132.7 56.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -49.44 -31.86 10.67 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.556 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.447 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.6 p -58.83 -25.2 62.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 111.6 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -70.52 -33.88 71.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -55.51 -41.17 72.72 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.303 0.573 . . . . 0.0 109.7 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.605 ' HE2' ' O ' ' A' ' 151' ' ' ASP . 1.8 mpp? -66.81 -56.66 9.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.61 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.645 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.053 -1.43 . . . . 0.0 112.856 -173.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 60' ' ' PHE . 1.5 mt -99.2 -40.73 7.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.054 0.454 . . . . 0.0 112.117 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.4 -49.44 5.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -168.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' HG12 ' A' ' 67' ' ' VAL . 74.8 m-20 -73.66 -178.67 3.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -83.74 -30.95 26.26 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.459 0.647 . . . . 0.0 110.246 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.495 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -149.5 158.86 5.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.237 -169.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.58 HG22 ' HE3' ' A' ' 143' ' ' MET . 70.9 mt -86.4 111.81 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.103 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.605 ' O ' ' HE2' ' A' ' 143' ' ' MET . 52.2 t0 -82.48 113.86 20.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.018 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.4 mptt -77.13 -3.13 37.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.91 0.862 . . . . 0.0 110.234 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.5 t -108.7 19.6 19.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.342 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 6.2 p90 -61.16 -174.18 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.959 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.589 HG23 ' OG ' ' A' ' 157' ' ' SER . 73.6 m -93.02 108.26 31.14 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.404 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 35.6 Cg_exo -65.87 92.54 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.321 2.68 . . . . 0.0 111.734 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.589 ' OG ' HG23 ' A' ' 155' ' ' THR . 4.9 p -164.68 -169.62 1.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -174.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.6 mmmm -81.61 152.2 27.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.004 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.475 HG22 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -52.56 -42.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.373 0.606 . . . . 0.0 110.328 173.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 10.82 9.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.795 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.63 -176.82 0.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.644 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.685 176.322 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -133.6 123.34 24.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.244 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 37.3 m80 67.34 122.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.992 0.807 . . . . 0.0 111.877 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.55 91.33 6.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.347 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -79.84 167.65 20.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.677 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -103.78 56.73 0.73 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.024 0.44 . . . . 0.0 111.806 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -111.41 19.29 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.646 173.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -90.49 67.44 6.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.802 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.03 132.22 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.011 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -93.95 147.72 18.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.7 p -65.38 119.01 10.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.688 0.244 . . . . 0.0 110.767 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.32 119.26 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.787 0.803 . . . . 0.0 111.506 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.72 -58.09 2.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -99.92 147.07 25.95 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.46 -47.4 4.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.303 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.19 66.38 2.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.404 0.621 . . . . 0.0 109.778 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 165.38 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.8 p -62.24 -68.81 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.614 0.245 . . . . 0.0 110.36 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 56.99 -173.01 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.495 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -167.56 176.26 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.4 tp -152.17 147.34 26.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.6 mt -134.78 150.63 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 110.438 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 p -119.86 93.99 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 111.01 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -76.4 171.66 11.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 54.8 Cg_exo -54.52 150.97 32.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.475 2.117 . . . . 0.0 112.063 173.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -68.8 137.33 53.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.54 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.19 165.21 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.39 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.88 -171.91 1.78 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.721 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 19.5 p-10 -45.42 -57.51 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.79 175.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.9 p-10 -162.47 134.38 5.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.638 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . 171.65 172.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.338 -175.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 -57.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.913 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.03 178.27 48.21 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.049 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.17 156.2 8.02 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 124.145 3.23 . . . . 0.0 112.323 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -50.53 -17.32 2.79 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 124.496 3.464 . . . . 0.0 114.831 -173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.9 m -76.29 -51.21 12.45 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.615 ' OD1' HD21 ' A' ' 57' ' ' LEU . 26.7 m120 60.95 176.08 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.555 0.535 . . . . 0.0 111.382 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -88.95 135.43 33.55 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.532 HD23 HD12 ' A' ' 57' ' ' LEU . 15.3 tp -142.85 132.89 24.33 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.097 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.5 99.41 3.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.147 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.618 HG12 ' HB ' ' A' ' 53' ' ' VAL . 34.5 mt -110.67 141.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.058 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -140.43 118.26 11.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -99.5 136.6 29.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.24 -163.19 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 60.39 77.22 0.38 Allowed Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 110.574 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.29 148.18 38.36 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.633 2.222 . . . . 0.0 112.996 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.53 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.2 tp60 -134.51 108.91 8.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.688 175.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -76.7 94.1 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.407 0.623 . . . . 0.0 109.75 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -122.97 92.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.269 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.07 -165.35 29.89 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.878 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.0 t -101.99 145.42 11.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.246 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.0 -48.2 5.29 Favored Glycine 0 N--CA 1.463 0.498 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.008 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.4 86.29 2.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.69 36.11 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.492 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.54 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 11.3 ttt180 -87.34 140.95 29.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -129.19 142.25 50.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.91 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -100.48 124.32 45.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.275 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 40.4 p -93.09 152.33 19.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.545 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.07 143.89 46.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.446 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 33.6 tt0 -96.35 120.57 36.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.461 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.5 mp -93.95 117.96 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 13.3 mtp180 -105.52 136.95 44.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.25 139.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -126.69 138.93 53.47 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.564 168.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 60' ' ' PHE . 14.1 t -170.91 164.02 7.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.219 0.533 . . . . 0.0 111.48 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.51 ' ND2' HD21 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.93 23.42 11.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.255 168.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.615 HD21 ' OD1' ' A' ' 27' ' ' ASN . 27.0 mt -57.44 139.93 80.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.705 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 -25.84 13.52 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.469 HD13 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -75.84 -40.97 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.07 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.592 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.39 -18.43 64.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HD3' ' NE2' ' A' ' 146' ' ' GLN . 57.4 tttt 72.22 -66.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 171.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.7 -11.8 58.9 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 122.24 -0.288 . . . . 0.0 110.314 -172.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 72.21 -42.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.053 0.845 . . . . 0.0 110.762 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -149.57 138.26 20.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.581 0.705 . . . . 0.0 110.755 176.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -171.33 162.63 6.83 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.823 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.5 m -137.95 129.95 28.69 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.116 0.484 . . . . 0.0 111.015 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -127.1 169.22 18.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.153 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -134.18 121.35 21.27 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.782 ' NH1' ' HA ' ' A' ' 144' ' ' PHE . 16.7 ptp180 -151.26 163.47 38.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 111.316 -173.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.591 ' HG3' ' H ' ' A' ' 72' ' ' SER . 30.1 tpt180 -86.6 148.0 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.127 -170.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 38.6 t80 -48.03 -37.33 14.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.004 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.591 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 5.5 m -54.13 -34.24 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 111.244 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -74.22 -33.94 63.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 33.6 m-85 -60.21 -36.24 77.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.044 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.489 ' OE2' ' HA ' ' A' ' 72' ' ' SER . 18.6 mt-10 -64.9 -53.3 48.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.743 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -28.92 66.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.786 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.4 tm? -71.73 -43.84 65.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 60.0 ttt180 -59.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.631 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.541 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.1 p -62.85 -33.49 75.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.76 -47.97 82.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.56 -42.15 91.78 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.846 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 33.0 mt-10 -66.03 -32.83 74.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.616 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.1 mmt180 -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.083 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -75.67 -33.09 60.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.961 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 m -124.62 177.46 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.314 0.578 . . . . 0.0 111.037 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -101.98 29.3 5.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.491 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 89' ' ' VAL . 57.3 t -51.13 140.18 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.038 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' O ' HG11 ' A' ' 88' ' ' VAL . 5.6 p -71.22 31.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.279 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -51.72 123.05 23.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 111.354 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.4 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 92.6 Cg_endo -86.12 166.51 9.62 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.171 2.581 . . . . 0.0 112.192 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 43.5 Cg_endo -67.8 142.6 58.23 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.764 2.309 . . . . 0.0 112.477 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 75' ' ' GLU . 91.4 mt -69.69 150.72 96.65 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.293 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.79 116.95 2.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.551 2.168 . . . . 0.0 110.571 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.38 48.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.554 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -149.95 42.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.436 0.636 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.531 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -151.48 -81.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.016 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.54 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -56.53 -26.22 54.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.087 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' H ' ' CD2' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.63 -47.67 84.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -174.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 3.4 ppt_? -97.12 24.52 6.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.401 0.62 . . . . 0.0 110.689 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.52 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -112.84 -47.18 3.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.879 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.75 HD11 ' C ' ' A' ' 101' ' ' LEU . 3.2 pp -91.04 173.03 5.9 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.671 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.56 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.4 Cg_exo -71.93 -143.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 124.115 3.21 . . . . 0.0 113.292 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -116.95 -83.81 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 65.27 -74.42 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.834 0.708 . . . . 0.0 111.61 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -107.09 75.82 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.366 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.29 -72.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.026 0.93 . . . . 0.0 111.852 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -104.21 -34.15 8.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.113 -175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.62 3.02 10.41 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.606 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.548 ' HA ' ' CD1' ' A' ' 114' ' ' PHE . 47.8 pt -70.18 -17.86 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.441 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 49.4 m-85 -76.76 -7.72 55.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.24 129.37 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.101 0.477 . . . . 0.0 110.009 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.74 -26.03 68.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.05 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.647 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 43.3 m-80 -69.56 -56.87 6.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -46.75 -47.94 20.6 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 123.673 0.608 . . . . 0.0 111.091 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 mt -53.37 -46.65 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.368 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -78.53 -19.17 53.53 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.116 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 32.1 mm-40 -72.98 -34.65 66.59 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.64 -42.35 61.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.659 174.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.85 -50.89 71.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.612 -176.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -60.28 -35.19 74.98 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.984 -173.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.62 -31.96 9.78 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.13 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.3 tp -64.86 -35.36 80.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.807 -0.231 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.493 ' HA ' HG22 ' A' ' 126' ' ' ILE . 10.5 pt-20 -69.88 -31.35 69.12 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.738 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 65.4 mm-40 -65.83 -58.78 4.82 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' O ' HG11 ' A' ' 129' ' ' VAL . 5.2 t80 -45.45 -53.38 8.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.641 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.7 tp -64.23 -38.67 83.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.644 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -60.48 -19.34 56.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -89.6 -56.98 3.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.882 0.849 . . . . 0.0 110.449 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 135' ' ' ALA . 1.2 m -63.85 -12.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.898 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.8 3.83 24.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.479 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.28 12.02 2.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.551 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.685 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 39.4 t60 -101.43 140.47 21.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 122.483 -0.422 . . . . 0.0 110.875 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.685 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 14.5 Cg_exo -40.59 -47.14 4.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.242 3.294 . . . . 0.0 114.058 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.19 -26.54 61.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.333 -174.185 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 129' ' ' VAL . . . -83.16 -40.13 20.13 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.989 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.0 mm100 -67.61 -3.01 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.225 176.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.5 t-20 -112.56 12.35 19.87 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.231 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -122.67 126.53 47.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.673 0.273 . . . . 0.0 110.929 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 159' ' ' ILE . 15.7 tpt180 -57.36 -15.7 7.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.486 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.714 ' O ' ' HG2' ' A' ' 143' ' ' MET . 3.2 m -56.07 -29.39 60.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.095 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.534 ' O ' HD21 ' A' ' 145' ' ' LEU . 6.5 mp -74.5 -28.97 61.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.199 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 60.9 t-80 -57.28 -43.29 82.99 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.913 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.737 ' SD ' HG22 ' A' ' 150' ' ' ILE . 3.9 ptp -70.89 -35.24 72.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.782 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -77.61 -46.01 23.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.592 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -88.79 -36.47 16.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.388 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.468 ' NE2' ' HD3' ' A' ' 61' ' ' LYS . 7.1 mt-30 -100.82 -174.01 2.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.394 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 57.41 -165.21 0.16 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.363 0.414 . . . . 0.0 110.274 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.465 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -100.17 -32.38 10.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.428 0.632 . . . . 0.0 110.773 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.465 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -155.44 173.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.163 -169.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.737 HG22 ' SD ' ' A' ' 143' ' ' MET . 2.1 mp -78.35 120.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.556 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 154' ' ' TYR . 9.6 t0 -96.24 99.88 11.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.414 ' HG2' ' CG2' ' A' ' 150' ' ' ILE . 81.6 mttt -74.63 -2.59 26.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.624 0.726 . . . . 0.0 111.966 -170.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.8 m -108.37 18.88 20.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.318 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -62.71 -170.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.141 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 56.1 m -84.1 110.84 28.88 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.948 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.2 Cg_exo -71.06 77.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.611 2.874 . . . . 0.0 112.227 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -151.44 -162.92 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.449 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.9 mmmt -81.37 163.25 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.925 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 139' ' ' ARG . 17.0 mm -56.25 -39.39 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.2 0.524 . . . . 0.0 109.612 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -79.61 11.76 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.842 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.412 ' H ' ' C ' ' A' ' 159' ' ' ILE . 6.8 m170 65.08 179.84 0.18 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.533 -177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.437 -179.367 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.621 0.248 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -74.39 150.81 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.762 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 50.3 m80 72.69 116.68 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 124.083 0.865 . . . . 0.0 111.116 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -74.97 126.41 30.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.074 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -98.42 102.99 14.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.817 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -78.78 83.81 4.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -111.77 -45.08 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.956 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -87.56 132.42 34.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.68 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 29.8 m -105.01 141.72 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.057 0.456 . . . . 0.0 110.823 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -150.3 90.12 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.709 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p -62.54 101.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.246 0.546 . . . . 0.0 111.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.96 125.18 5.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.348 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.65 -62.46 1.24 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.189 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -107.9 152.39 24.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.164 0.507 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 m -119.84 -162.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.116 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.63 117.08 3.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.559 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.6 169.17 10.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.474 ' HB ' HG12 ' A' ' 12' ' ' ILE . 41.1 p -63.78 -46.83 83.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.416 0.627 . . . . 0.0 109.789 176.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.67 -103.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.52 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -125.15 -46.1 1.82 Allowed 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.038 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' C ' HG13 ' A' ' 12' ' ' ILE . 12.7 tp -43.36 -76.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.128 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.474 HG12 ' HB ' ' A' ' 8' ' ' THR . 3.9 mt 62.27 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.981 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.419 ' H ' HG21 ' A' ' 12' ' ' ILE . 6.7 p 70.88 109.14 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.779 0.8 . . . . 0.0 112.019 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 11.1 mptt -70.64 164.94 50.67 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.64 175.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 94.0 Cg_exo -42.96 108.27 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.216 2.611 . . . . 0.0 113.076 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -85.6 149.5 25.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.449 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.8 160.45 0.13 Allowed 'General case' 0 C--O 1.232 0.141 0 O-C-N 123.814 0.696 . . . . 0.0 110.558 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.56 134.05 51.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.6 -167.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.83 134.2 46.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.575 0.702 . . . . 0.0 110.425 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.51 159.59 16.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.152 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.13 -42.2 0.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.382 -167.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.36 169.2 38.18 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.329 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.99 160.24 13.0 Favored 'Trans proline' 0 C--O 1.224 -0.214 0 C-N-CA 123.911 3.074 . . . . 0.0 111.282 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.14 -21.6 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 124.839 3.693 . . . . 0.0 115.571 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -70.67 -63.59 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.522 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.4 m-80 60.24 177.41 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.108 0.48 . . . . 0.0 111.709 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -91.21 134.82 34.24 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD23 HD13 ' A' ' 57' ' ' LEU . 14.2 tp -146.46 131.82 18.58 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.368 -175.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -144.11 100.42 3.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.079 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.649 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.5 mt -109.99 140.1 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -139.29 108.21 5.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.106 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.83 133.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t 179.74 -163.15 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 56.31 64.46 4.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.315 0.578 . . . . 0.0 109.685 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.82 154.19 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.026 2.484 . . . . 0.0 113.408 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.512 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.5 tp60 -135.09 112.2 10.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.557 173.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 HG23 ' HE ' ' A' ' 45' ' ' ARG . 45.5 m -76.38 92.4 3.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.738 . . . . 0.0 109.9 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -119.93 94.74 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.549 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.59 -166.3 30.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.356 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.3 t -95.9 147.55 5.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.26 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.53 -48.96 5.87 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.333 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -102.25 88.63 3.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.487 0.661 . . . . 0.0 109.484 170.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.75 34.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.783 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.8 ttt180 -85.16 132.67 34.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.862 0.363 . . . . 0.0 110.449 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -117.17 174.51 6.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.993 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.4 m -129.0 133.38 47.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.282 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.512 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.6 p -92.83 129.92 38.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -105.92 133.01 51.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.978 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 35.7 tt0 -86.36 118.15 25.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.327 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.491 HD13 ' CZ ' ' A' ' 74' ' ' PHE . 3.8 mp -94.39 109.45 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 42.6 mtp180 -96.02 132.41 41.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.236 173.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.649 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.4 137.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 0.0 111.262 177.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -125.32 137.0 54.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.549 HG21 ' O ' ' A' ' 63' ' ' LYS . 11.8 t -170.51 165.22 8.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.363 0.601 . . . . 0.0 112.394 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HA ' ' CD ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -115.89 24.4 11.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.276 166.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD11 ' CE1' ' A' ' 60' ' ' PHE . 23.1 mt -61.09 134.48 93.0 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 173.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -67.11 -39.97 12.48 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.645 2.23 . . . . 0.0 111.797 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -60.07 -41.61 87.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.285 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CE1' HD11 ' A' ' 57' ' ' LEU . 3.3 m-30 -66.32 -16.28 63.92 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 tttt 71.77 -65.69 0.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -86.04 -5.68 59.17 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.415 -0.178 . . . . 0.0 110.717 -174.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.549 ' O ' HG21 ' A' ' 55' ' ' THR . 14.7 mmtp 71.64 -41.61 0.51 Allowed 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.849 0.718 . . . . 0.0 111.715 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -160.05 122.41 3.34 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.429 0.633 . . . . 0.0 109.896 -177.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -160.89 176.89 10.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.525 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.534 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 20.1 m -141.84 132.5 25.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.125 0.488 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.06 179.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.436 176.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 35.0 ttt180 -145.29 111.23 5.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.619 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -138.16 152.68 48.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.806 0.813 . . . . 0.0 112.716 -173.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' A' ' 72' ' ' SER . 28.9 ttp180 -74.02 144.31 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.705 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.41 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 40.3 t80 -50.98 -36.47 39.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.484 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.575 ' H ' ' HG2' ' A' ' 70' ' ' ARG . 11.0 m -61.87 -21.81 65.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.767 0.318 . . . . 0.0 111.777 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -89.03 -24.49 22.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 51' ' ' ILE . 23.6 m-85 -61.78 -34.15 75.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.512 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.8 mt-10 -64.4 -50.92 65.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.485 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 6.6 t-105 -62.02 -30.45 70.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.586 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.513 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -70.2 -45.65 66.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.549 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 47.4 ttt180 -56.83 -61.68 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.717 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 11.1 p -59.3 -34.85 72.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.043 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.598 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 3.2 mm-40 -62.36 -37.11 84.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 85' ' ' SER . 97.7 mt -75.7 -17.99 59.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.102 0.477 . . . . 0.0 110.45 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 41.2 mt-10 -88.02 -26.36 22.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.284 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 79' ' ' SER . 41.5 mmt180 -58.43 -64.2 1.0 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -118.86 5.78 11.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 33.5 t -119.54 167.5 11.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.612 0.72 . . . . 0.0 111.169 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -101.2 19.45 17.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.535 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 89' ' ' VAL . 89.2 t -51.24 139.07 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.421 0.629 . . . . 0.0 111.762 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.25 35.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.815 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.549 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -55.45 120.26 30.06 Favored Pre-proline 0 N--CA 1.465 0.286 0 O-C-N 122.042 -0.411 . . . . 0.0 111.159 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.519 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.3 Cg_endo -87.52 165.22 7.9 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.978 2.452 . . . . 0.0 112.249 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 38.1 Cg_endo -66.23 144.75 76.01 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.76 2.307 . . . . 0.0 112.65 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 75' ' ' GLU . 74.0 mt -70.92 150.39 95.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.111 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -84.93 114.55 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.8 2.333 . . . . 0.0 111.192 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.29 32.78 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.8 18.21 2.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.218 0.509 . . . . 0.0 110.935 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -110.49 -83.31 0.57 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.078 0.466 . . . . 0.0 111.891 -176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.549 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -58.01 -27.18 63.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.323 -173.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 97' ' ' PHE . 1.5 mm? -60.93 -46.94 88.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.023 0.439 . . . . 0.0 111.128 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.26 29.95 4.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.49 0.662 . . . . 0.0 109.948 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.9 tt0 -128.46 -36.83 1.85 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.432 -173.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 74.7 mt -85.08 172.17 9.4 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.947 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 Cg_exo -66.42 -157.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.929 2.419 . . . . 0.0 112.671 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -87.76 -74.65 0.44 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.43 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 64.31 -81.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.743 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.58 108.78 0.44 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.822 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.3 t70 69.43 -65.27 0.31 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 111.836 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -139.22 -5.82 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.085 0.469 . . . . 0.0 110.45 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.86 9.63 22.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.779 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 42.7 pt -76.05 -18.0 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.131 0.491 . . . . 0.0 111.182 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.468 ' CE2' ' HD3' ' A' ' 45' ' ' ARG . 84.0 m-85 -87.47 18.19 4.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.625 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.66 134.97 54.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.692 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.04 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.734 -174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.501 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -64.67 -60.06 3.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.268 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.779 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -52.88 -46.89 68.15 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.041 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.69 -46.41 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.157 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.65 -18.54 47.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.549 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 56.5 mm-40 -67.55 -38.83 84.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.542 0.687 . . . . 0.0 109.177 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -67.78 -43.35 79.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.835 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -55.77 -52.54 63.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.174 -175.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.693 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -62.52 -35.24 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.581 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.71 -34.02 17.15 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.413 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.7 tp -66.76 -36.59 82.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 122.043 0.137 . . . . 0.0 111.181 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 119' ' ' LYS . 5.1 pt-20 -72.23 -31.7 66.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.693 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.3 mm-40 -60.32 -59.75 4.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 129' ' ' VAL . 3.5 t80 -47.22 -52.73 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.944 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.32 -40.15 87.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.918 -171.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.51 -21.06 59.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.1 0.476 . . . . 0.0 111.87 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.536 ' HE2' ' O ' ' A' ' 124' ' ' GLN . 36.7 mttm -87.86 -55.22 3.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.719 0.771 . . . . 0.0 110.453 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.587 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -69.08 -12.58 16.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.605 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 126' ' ' ILE . . . -114.35 12.15 17.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -136.23 -9.51 1.42 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.534 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.745 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.8 t60 -87.15 146.38 40.15 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.446 -0.311 . . . . 0.0 111.282 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.745 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.3 Cg_exo -43.08 -51.24 5.74 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.915 3.077 . . . . 0.0 113.337 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.528 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -66.5 -32.59 74.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.151 -174.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.16 -44.91 35.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.152 -177.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.569 ' O ' HD12 ' A' ' 59' ' ' ILE . 43.2 mm-40 -61.52 -6.49 2.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.016 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -98.87 -21.44 16.31 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.066 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 13.0 mm-40 -99.91 137.38 38.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.634 0.652 . . . . 0.0 112.352 -168.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 3.5 mmt180 -50.46 -24.45 3.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.023 0.929 . . . . 0.0 112.716 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.647 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.1 m -56.86 -29.94 63.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.464 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.527 HD21 ' O ' ' A' ' 135' ' ' ALA . 5.9 mp -75.36 -35.26 61.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 110.662 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -64.33 -35.32 80.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.4 ptm -81.74 -31.79 31.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.513 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 22.3 t80 -80.29 -43.36 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.332 -175.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.429 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 11.0 mt -92.02 -26.46 18.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.361 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -117.16 178.3 4.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.364 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.88 -82.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.053 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 176.92 -55.01 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.797 0.808 . . . . 0.0 109.576 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.485 HD11 ' H ' ' A' ' 149' ' ' ILE . 0.1 OUTLIER -130.66 154.16 40.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.894 -175.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.51 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -71.15 113.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.855 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.78 97.71 4.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.756 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -66.46 -6.91 16.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.881 0.372 . . . . 0.0 111.322 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.2 m -112.96 19.68 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.366 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -64.21 -170.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.997 -178.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.5 m -86.31 113.2 51.09 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.7 Cg_exo -69.83 71.94 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.42 2.747 . . . . 0.0 111.589 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -161.56 1.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -92.85 168.27 11.29 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.799 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.444 HG13 HD12 ' A' ' 59' ' ' ILE . 8.6 mm -54.71 -48.72 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 122.781 0.432 . . . . 0.0 111.076 -174.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 120.45 20.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.488 -177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -80.97 171.22 15.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.053 0.454 . . . . 0.0 110.039 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.228 -179.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.64 27.26 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 69.93 -73.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.632 0.773 . . . . 0.0 111.452 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -150.31 20.06 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 109.843 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -95.86 153.18 17.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -160.34 161.69 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.596 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 17.2 t60 56.45 71.5 0.56 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.355 0.598 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -114.4 105.48 13.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.661 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.42 151.97 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 91.39 174.4 43.35 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.769 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 56.3 p 50.56 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.62 0.768 . . . . 0.0 112.091 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.43 130.85 22.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.584 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.75 -48.04 7.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.42 0.629 . . . . 0.0 109.336 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 p -120.49 152.47 37.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.243 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.04 -45.18 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.721 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.78 48.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.544 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -54.34 134.42 45.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.46 0.648 . . . . 0.0 110.964 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -70.41 -46.79 63.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.131 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -54.67 144.38 22.11 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.749 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -125.65 130.27 51.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 tp -140.67 140.5 34.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.867 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.6 mt -140.02 167.93 18.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.4 p 64.04 99.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.844 0.831 . . . . 0.0 111.224 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -94.51 166.41 15.35 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.526 -174.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 65.5 Cg_exo -42.82 134.54 5.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.056 2.504 . . . . 0.0 112.804 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -53.02 138.19 31.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -117.28 -161.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.682 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.13 -173.33 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 6.4 p-10 -60.45 -73.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 15.4 m-20 -139.21 141.54 37.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.49 165.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.941 0.776 . . . . 0.0 111.32 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 8.4 m-85 -132.35 -23.98 2.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.308 -170.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.93 173.98 46.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.368 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.2 155.53 9.05 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 C-N-CA 124.124 3.216 . . . . 0.0 111.882 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.28 -21.08 0.36 Allowed 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.769 3.646 . . . . 0.0 115.737 -170.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.5 m -75.16 -59.44 2.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.458 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.0 m-80 62.29 -178.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 111.812 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.4 132.11 37.03 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.57 HD21 HD12 ' A' ' 57' ' ' LEU . 19.2 tp -147.02 128.82 15.29 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.791 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 4.3 pt-20 -138.01 99.78 3.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.89 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.649 HG12 ' HB ' ' A' ' 53' ' ' VAL . 30.9 mt -113.34 142.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.801 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -142.21 111.74 6.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.646 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.558 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.48 136.37 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 171.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 22.9 t 179.79 -163.08 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 38.6 m-80 62.44 79.7 0.26 Allowed Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.191 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -64.83 143.69 80.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.187 2.591 . . . . 0.0 112.574 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.52 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -134.15 108.31 8.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.905 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 m -76.11 93.11 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 109.535 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.2 89.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.04 -166.98 32.31 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.955 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 9.9 t -117.41 152.17 19.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.638 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.54 -46.63 4.66 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 121.771 -0.252 . . . . 0.0 113.019 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.18 83.06 2.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.82 40.8 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.316 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.6 ttt180 -89.17 142.05 27.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.76 162.4 36.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.916 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 22.4 m -114.56 126.08 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.9 p -92.22 154.82 18.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.78 136.24 53.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.243 0.544 . . . . 0.0 110.836 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.582 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 28.6 tt0 -93.13 119.4 32.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.769 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.5 mp -93.75 115.37 32.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.96 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 29.6 mtp180 -102.37 128.19 49.06 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.649 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -137.49 140.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.568 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 11.4 ttmt -128.97 136.28 50.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' LYS . 10.4 t -170.21 164.63 9.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.401 0.619 . . . . 0.0 112.493 -175.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.45 ' HA ' ' CD ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.29 25.21 10.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.08 164.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.57 HD12 HD21 ' A' ' 29' ' ' LEU . 30.3 mt -58.55 134.38 85.79 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.493 171.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 8.5 Cg_exo -67.79 -36.26 19.06 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.727 2.284 . . . . 0.0 111.475 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.457 HD12 HG13 ' A' ' 159' ' ' ILE . 1.3 tt -61.03 -40.54 85.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.202 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.644 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 4.9 m-30 -71.1 -18.33 62.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.46 -67.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' C ' ' H ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -77.28 -1.72 31.13 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.432 -0.167 . . . . 0.0 111.389 -171.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.557 ' O ' HG23 ' A' ' 55' ' ' THR . 4.5 mmtm 68.06 -45.54 0.51 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.07 0.856 . . . . 0.0 112.045 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.1 pp20? -159.79 138.96 10.99 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.659 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -170.52 177.54 3.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.582 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 23.9 m -142.26 127.27 18.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.63 172.09 7.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.775 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -140.83 129.1 22.32 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.646 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.1 177.06 9.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.361 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 85.5 mtt180 -85.54 168.5 14.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.441 -172.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 46.5 t80 -60.77 -40.56 92.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.529 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 55.0 m -61.32 -23.3 65.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' HB3' HD12 ' A' ' 150' ' ' ILE . 6.3 m-20 -72.94 -36.7 67.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.449 ' CZ ' HD12 ' A' ' 51' ' ' ILE . 70.9 m-85 -64.54 -40.15 95.08 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 28.9 mt-10 -59.17 -53.43 58.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.608 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -60.65 -31.32 70.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -73.23 -44.67 59.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 39.3 ttt180 -55.82 -61.04 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.017 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -59.42 -35.11 73.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.629 -174.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 6.4 tp10 -64.3 -44.77 90.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.811 0.338 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.455 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.1 mt -62.64 -40.59 97.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.581 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.39 -34.66 78.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.209 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 3.2 ppt_? -90.24 -28.76 18.62 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -172.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' HG2' ' HD2' ' A' ' 83' ' ' ARG . 4.8 mm-40 -95.35 -17.29 21.72 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.956 -0.465 . . . . 0.0 112.189 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.408 ' HB3' HG22 ' A' ' 87' ' ' VAL . 22.7 t -144.95 178.71 7.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.745 0.783 . . . . 0.0 111.685 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -103.64 19.78 19.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.423 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 85' ' ' SER . 79.3 t -45.41 140.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.563 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' O ' HG11 ' A' ' 88' ' ' VAL . 9.8 p -72.73 37.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.883 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.502 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -54.95 121.16 33.73 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.128 -0.358 . . . . 0.0 111.075 -176.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 71.9 Cg_endo -83.47 165.9 14.09 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.324 2.682 . . . . 0.0 113.188 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.19 143.92 79.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.192 2.595 . . . . 0.0 112.686 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.473 HD13 ' HG2' ' A' ' 75' ' ' GLU . 95.8 mt -81.55 141.43 48.72 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.769 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.0 Cg_exo -73.79 114.22 3.98 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.173 2.582 . . . . 0.0 111.998 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.83 38.26 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.72 -34.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 111.428 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.21 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.521 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -53.99 -26.78 27.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.094 0.958 . . . . 0.0 113.542 -170.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 HD21 ' CD1' ' A' ' 97' ' ' PHE . 1.2 mm? -62.7 -48.03 81.06 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.82 13.64 23.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -102.15 -29.2 11.87 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.001 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 mt -99.99 165.69 14.11 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.073 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 -153.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.542 2.828 . . . . 0.0 112.231 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -103.05 -78.79 0.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.144 172.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 68.05 -65.81 0.24 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.135 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.8 -155.51 30.92 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.053 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -62.54 -30.83 71.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 111.143 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.65 -47.08 0.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.32 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.93 -9.57 1.8 Allowed Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.406 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.423 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 30.8 pt -65.46 -17.58 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.175 -0.512 . . . . 0.0 112.169 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -86.92 39.49 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.375 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.99 136.12 54.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.76 -21.52 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -170.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 38.2 m-80 -71.05 -60.42 2.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.423 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -45.77 -49.98 14.43 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.646 0.591 . . . . 0.0 111.263 178.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.05 -46.84 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.456 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -83.42 -17.85 40.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.519 -178.329 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 28.5 mt-10 -80.51 -30.35 37.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 109.89 -176.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -80.02 -29.37 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.69 -52.5 63.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.108 178.082 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.667 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -59.92 -38.5 82.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.312 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.44 -42.2 65.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.882 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -69.54 -30.77 68.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 117.794 0.797 . . . . 0.0 111.313 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 10.8 pt-20 -74.05 -33.74 63.81 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 9.4 mm-40 -59.84 -60.56 3.64 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' O ' HG11 ' A' ' 129' ' ' VAL . 9.7 t80 -48.34 -52.76 20.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.577 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.519 HG23 ' HA ' ' A' ' 123' ' ' GLU . 11.2 tp -66.11 -34.76 72.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.625 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.553 ' ND2' ' HB ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -61.37 -21.23 63.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -88.02 -59.42 2.25 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.689 0.757 . . . . 0.0 110.33 175.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.602 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.75 -11.94 11.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.477 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.01 8.08 20.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.64 15.66 1.61 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.977 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.684 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 69.8 t60 -101.09 142.07 23.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.684 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.1 Cg_endo -47.93 -44.03 28.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.375 2.717 . . . . 0.0 113.193 -170.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -73.56 -25.67 60.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.161 -175.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.602 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -82.44 -42.81 18.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.632 -176.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.4 mm100 -65.21 -7.08 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.468 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -91.11 -18.87 23.81 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.969 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 36.5 mm-40 -105.01 129.81 53.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.724 -168.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.499 ' HA ' HD11 ' A' ' 159' ' ' ILE . 21.1 tpt180 -54.59 -28.54 46.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.653 -172.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 143' ' ' MET . 2.3 p -60.71 -18.6 55.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.512 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -72.13 -32.58 67.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.935 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 58.8 t-80 -66.33 -34.05 77.12 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.484 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.622 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -81.35 -27.31 34.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.344 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.535 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 32.5 t80 -73.91 -52.31 13.33 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.552 HD23 ' CE2' ' A' ' 60' ' ' PHE . 4.3 mp -96.41 -24.43 16.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.438 -173.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.644 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 29.1 mt-30 -118.92 -169.79 1.79 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.015 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 61.66 -88.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.604 0.565 . . . . 0.0 110.493 -174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.426 ' HG3' HG13 ' A' ' 149' ' ' ILE . 5.8 tp10 -179.41 -58.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.687 0.756 . . . . 0.0 109.509 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.496 ' H ' HD13 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.11 154.27 35.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.562 -175.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.518 HG12 ' HG3' ' A' ' 143' ' ' MET . 90.7 mt -85.75 115.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -98.05 105.3 17.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.829 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -73.07 3.03 5.96 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.601 0.715 . . . . 0.0 111.43 -171.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.6 m -110.45 15.62 22.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.126 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.7 OUTLIER -67.65 -171.61 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.824 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 52.4 m -83.13 111.68 32.52 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.347 177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -72.83 77.01 2.36 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 123.329 2.686 . . . . 0.0 111.801 175.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -147.69 -154.34 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.694 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 15.7 mmmt -95.6 161.72 13.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.594 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' A' ' 139' ' ' ARG . 19.5 mm -56.41 -48.75 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.825 0.345 . . . . 0.0 110.167 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.17 103.27 15.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -69.53 170.91 9.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -171.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.142 -176.677 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.897 0.38 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.36 -179.97 45.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.375 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 15.4 Cg_endo -55.69 157.61 15.38 Favored 'Trans proline' 0 C--O 1.225 -0.134 0 C-N-CA 124.142 3.228 . . . . 0.0 111.963 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 48.0 Cg_exo -56.49 -9.03 3.23 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.916 3.078 . . . . 0.0 114.462 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.5 t -73.32 -54.28 8.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.632 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.6 m120 58.14 -178.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.434 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -97.36 138.52 34.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.694 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -148.17 132.95 17.95 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.552 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -146.92 106.87 3.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.681 HG12 ' HB ' ' A' ' 53' ' ' VAL . 36.0 mt -115.36 147.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.209 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.62 111.61 7.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -88.97 131.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -179.33 -165.7 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 37.6 m-80 58.21 67.36 2.24 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-O 121.123 0.487 . . . . 0.0 110.388 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 115' ' ' ILE . 72.4 Cg_endo -72.74 152.77 53.42 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.933 2.422 . . . . 0.0 113.532 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.8 tp60 -138.93 111.57 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.322 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.411 HG22 ' NE ' ' A' ' 45' ' ' ARG . 68.0 m -78.92 90.22 4.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.856 0.836 . . . . 0.0 110.25 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.0 OUTLIER -116.9 96.82 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.353 -174.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.64 -167.53 31.97 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.525 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.6 t -98.7 152.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-O 119.419 -0.324 . . . . 0.0 110.52 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.16 -46.57 8.15 Favored Glycine 0 N--CA 1.46 0.248 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.321 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -100.2 84.84 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.23 0.538 . . . . 0.0 109.852 172.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.58 37.29 0.79 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.274 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.578 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 21.1 ttt180 -83.38 130.32 35.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.8 0.333 . . . . 0.0 110.379 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -122.52 159.17 28.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.1 m -111.95 127.32 55.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.483 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 43.4 p -92.5 152.36 19.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.293 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -119.62 140.5 50.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 32.9 tt0 -90.89 119.48 31.12 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.67 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.0 mp -94.39 111.98 26.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.069 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 58.9 mtp85 -104.79 134.86 47.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -144.64 141.57 23.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.1 ttmt -127.39 135.95 51.19 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.072 169.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 63' ' ' LYS . 15.0 t -171.23 163.86 7.17 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.514 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -116.98 27.25 9.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.836 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.38 139.06 94.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.029 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.13 -12.27 19.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.151 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -89.67 -41.22 13.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.432 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.528 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.3 m-85 -65.37 -13.53 58.81 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 71.35 -66.5 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.505 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.77 -2.85 58.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 122.174 -0.329 . . . . 0.0 110.462 -172.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmpp? 70.45 -46.18 0.61 Allowed 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.129 0.893 . . . . 0.0 111.545 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -158.41 118.98 3.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.893 0.854 . . . . 0.0 110.905 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 t -155.58 179.33 9.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.517 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.477 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 14.2 m -141.36 137.02 32.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 m -125.96 175.62 7.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.452 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -145.72 118.59 8.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.729 0.3 . . . . 0.0 110.855 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.657 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -151.9 173.53 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' OD2' ' A' ' 73' ' ' ASP . 20.6 ptt180 -99.32 170.54 8.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -164.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.489 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 33.7 t80 -53.88 -38.71 65.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.488 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.606 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 29.9 m -59.38 -25.24 64.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.776 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 20.7 m-20 -80.5 -35.18 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 57.0 m-85 -59.48 -38.86 81.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.445 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 20.1 mt-10 -61.68 -53.24 58.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.56 0.695 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.523 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -68.25 -23.46 64.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.206 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.749 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -71.95 -42.95 65.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -55.31 -60.58 3.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.815 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.728 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.5 p -64.2 -35.37 80.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.371 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 4.6 mm-40 -59.37 -37.25 77.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.408 HD13 HG11 ' A' ' 87' ' ' VAL . 95.2 mt -73.36 -27.8 61.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.058 0.456 . . . . 0.0 110.656 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.38 -18.33 36.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.355 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.0 mmm180 -58.84 -61.7 2.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -119.64 0.05 10.88 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -125.43 166.99 15.6 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.778 0.799 . . . . 0.0 111.911 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.51 30.41 3.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.47 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 97.2 t -52.49 141.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.873 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 88' ' ' VAL . 4.0 p -66.42 27.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.882 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.5 OUTLIER -57.88 120.33 41.31 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 121.809 -0.557 . . . . 0.0 111.777 -174.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 97.4 Cg_endo -88.58 168.25 5.99 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.005 2.47 . . . . 0.0 112.147 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 146.06 75.81 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 112.184 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 75' ' ' GLU . 80.1 mt -69.26 152.02 96.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.15 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.53 109.98 2.97 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.965 2.443 . . . . 0.0 111.932 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.61 176.82 44.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.081 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.2 31.49 16.56 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.567 0.699 . . . . 0.0 110.346 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.7 -85.23 0.59 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.912 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -61.76 -18.19 58.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.327 -177.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.9 mm? -69.6 -44.14 71.34 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 -174.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -90.45 17.88 6.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 109.844 176.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.2 tt0 -118.5 -39.88 2.97 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.689 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 mt -92.83 171.76 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.998 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.14 -172.86 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.737 2.291 . . . . 0.0 111.732 171.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 61.5 m-85 -105.65 -86.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.655 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 65.19 -75.57 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.677 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.78 64.82 3.62 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.376 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.2 t70 65.93 -69.96 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.324 1.05 . . . . 0.0 110.331 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.53 -23.97 12.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.128 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 113.78 7.28 20.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.124 -174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.764 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.8 pt -71.95 -19.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.886 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.92 -12.04 60.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.791 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.37 135.19 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.471 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.69 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 48.3 m-80 -73.52 -58.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.764 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -50.65 -48.18 58.31 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.526 0.516 . . . . 0.0 111.192 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 36' ' ' PRO . 37.5 mt -51.76 -48.38 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.433 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.14 -20.51 59.36 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.262 -177.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 29.9 mm-40 -71.88 -32.79 67.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.209 0.528 . . . . 0.0 109.762 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 43.5 ttp180 -81.93 -34.34 29.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.237 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.02 -50.05 71.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.524 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.748 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -59.47 -39.97 85.42 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.166 -175.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.5 -36.54 23.08 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.443 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.656 ' HB3' HG21 ' A' ' 33' ' ' VAL . 4.6 tp -64.24 -36.61 84.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.435 0.16 . . . . 0.0 111.037 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 33' ' ' VAL . 13.1 pt-20 -75.65 -29.99 59.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.5 mm100 -64.01 -53.61 47.32 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.6 t80 -49.9 -54.55 18.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.287 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.1 tp -64.67 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.865 -172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -62.21 -16.96 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.16 -0.338 . . . . 0.0 111.825 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.463 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.1 mttm -89.92 -58.65 2.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.038 0.923 . . . . 0.0 110.568 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 89' ' ' VAL . 1.3 m -66.05 -13.51 15.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.027 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.92 10.28 20.62 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.405 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -136.16 2.25 3.54 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.436 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.68 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 35.1 t60 -99.91 144.36 28.22 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 117.185 0.492 . . . . 0.0 111.74 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.68 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.8 Cg_exo -39.64 -50.52 3.1 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.578 3.519 . . . . 0.0 113.879 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.37 -30.14 68.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.522 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -78.03 -39.99 40.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.25 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 53.8 mm-40 -65.56 -6.38 10.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.584 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 53.6 t30 -108.7 6.07 25.39 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.974 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 138' ' ' GLU . 5.1 mm-40 -118.48 129.18 55.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.824 0.345 . . . . 0.0 111.128 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -54.21 -20.41 6.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.518 -176.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.5 m -53.45 -35.81 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.432 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.5 mp -69.95 -33.53 72.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.238 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.0 t60 -56.88 -39.72 74.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.132 0.491 . . . . 0.0 110.249 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.571 ' HG3' HG13 ' A' ' 150' ' ' ILE . 2.5 ptm -79.96 -28.57 39.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.081 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.749 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.26 -47.81 14.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -93.98 -19.91 20.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.113 -174.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 7.6 mt-30 -119.95 -172.61 2.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.151 -168.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 53.06 -116.75 1.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.257 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -134.89 -35.15 0.87 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.701 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.98 162.65 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.75 0.786 . . . . 0.0 112.868 -167.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.571 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -74.82 115.65 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.895 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.32 112.89 24.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.844 0.354 . . . . 0.0 110.186 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 27.1 mmtp -75.69 11.04 1.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -172.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.0 m -129.08 19.21 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.212 0.53 . . . . 0.0 110.297 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -174.2 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.16 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.0 m -90.89 112.49 53.79 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.161 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.72 76.68 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 123.453 2.768 . . . . 0.0 112.111 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -146.82 -161.78 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 19.1 mmmt -85.93 165.07 17.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -60.54 -40.92 85.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.217 0.532 . . . . 0.0 110.261 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 79.6 m-85 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.44 174.75 46.95 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.602 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.69 158.62 19.51 Favored 'Trans proline' 0 C--O 1.222 -0.276 0 C-N-CA 124.336 3.358 . . . . 0.0 111.174 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.63 -14.67 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.418 3.412 . . . . 0.0 115.206 -171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 p -68.63 -62.45 1.38 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.6 m120 58.13 -177.37 0.07 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.262 0.553 . . . . 0.0 111.902 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -99.47 138.17 36.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 57' ' ' LEU . 15.9 tp -145.58 132.33 20.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.057 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.73 106.05 3.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.174 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.2 mt -114.55 142.87 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.058 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -136.55 118.47 15.24 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -100.23 135.04 37.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 36.2 t 178.85 -161.97 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 31.7 m-80 62.5 73.42 0.54 Allowed Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 110.46 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HG3' HG21 ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.01 131.85 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.802 2.335 . . . . 0.0 112.865 -173.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 47.6 tp60 -117.02 112.34 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.14 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.9 m -73.17 104.04 4.1 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.42 90.66 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.268 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.22 -167.57 33.24 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.814 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.4 t -100.71 147.98 7.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 119.278 -0.392 . . . . 0.0 110.134 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.34 5.55 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 121.59 -0.338 . . . . 0.0 113.152 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -103.96 88.62 3.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.462 0.649 . . . . 0.0 109.416 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.37 32.35 0.98 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.725 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.592 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 8.9 ttp180 -84.34 152.21 24.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.403 0.281 . . . . 0.0 110.304 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.14 162.3 35.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.747 0.308 . . . . 0.0 110.359 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -113.92 131.35 56.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.608 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 15.9 p -99.64 153.39 19.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.54 144.97 43.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.237 0.541 . . . . 0.0 110.627 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 35.9 tt0 -95.79 123.2 39.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.347 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.55 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -96.72 117.84 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.276 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 94.6 mtt180 -110.5 109.81 20.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.407 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -119.46 137.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.013 0.435 . . . . 0.0 111.993 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -125.89 134.97 51.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.307 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.4 t -170.31 165.95 8.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.288 0.566 . . . . 0.0 111.626 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 19.1 p30 -120.45 26.26 9.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.119 168.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.667 HD11 HD22 ' A' ' 29' ' ' LEU . 20.9 mt -60.62 143.36 90.54 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.192 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.84 -29.64 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.431 2.088 . . . . 0.0 111.711 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.545 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.29 -40.19 79.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.95 178.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.616 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.4 m-30 -69.1 -19.98 64.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.49 -64.33 0.39 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.11 -7.66 59.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 122.182 -0.324 . . . . 0.0 110.833 -172.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 5.6 mmtp 70.68 -43.43 0.55 Allowed 'General case' 0 C--O 1.218 -0.578 0 O-C-N 124.014 0.822 . . . . 0.0 111.163 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.58 130.82 5.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 109.998 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.2 t -160.43 165.85 30.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.609 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 37.7 m -140.5 130.4 24.58 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.292 0.568 . . . . 0.0 110.853 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 147' ' ' ASP . 5.8 m -133.47 174.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -144.06 122.88 12.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.197 0.522 . . . . 0.0 111.567 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -145.05 -177.66 5.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -100.66 167.57 10.25 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -169.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.7 t80 -55.09 -34.38 63.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.42 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 16.9 m -55.03 -33.58 62.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.738 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -75.06 -38.14 61.45 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 59.9 m-85 -60.12 -37.47 80.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.644 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 25.7 mt-10 -62.52 -55.07 30.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.752 0.787 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -64.9 -28.64 69.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.436 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -69.35 -40.73 77.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 63.9 ttt180 -57.95 -64.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.446 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.722 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -61.28 -37.17 82.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.014 -172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.19 -44.73 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.373 0.42 . . . . 0.0 111.431 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.37 -37.06 85.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.73 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -73.82 -24.95 59.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.138 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 79' ' ' SER . 25.1 mmt180 -67.98 -62.53 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.063 0.459 . . . . 0.0 111.816 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -85.46 -30.05 23.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.323 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 m -120.66 175.03 6.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.654 0.74 . . . . 0.0 112.004 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -105.0 23.6 13.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.738 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 89' ' ' VAL . 97.6 t -42.6 140.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.846 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -69.19 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.371 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.2 t -56.07 121.65 42.65 Favored Pre-proline 0 N--CA 1.464 0.268 0 O-C-N 121.945 -0.472 . . . . 0.0 110.836 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 89.0 Cg_endo -88.28 166.4 6.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.904 2.403 . . . . 0.0 112.302 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.66 150.82 87.55 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.867 2.378 . . . . 0.0 112.459 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 49.6 mt -80.51 153.39 73.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.436 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -88.44 109.27 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.912 2.408 . . . . 0.0 112.289 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.12 59.15 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.443 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -144.55 -25.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.778 0.323 . . . . 0.0 111.4 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.85 -82.32 0.29 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.573 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -49.94 -24.5 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.951 1.3 . . . . 0.0 114.14 -171.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.6 mm? -59.34 -45.16 92.15 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.915 0.388 . . . . 0.0 111.221 -173.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -99.53 20.65 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.716 0.769 . . . . 0.0 109.432 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.3 tt0 -118.1 -28.31 5.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.866 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 mt -101.67 169.16 8.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.25 -161.38 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.898 2.399 . . . . 0.0 112.484 173.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 37.9 m-85 -106.97 -80.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.608 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 68.38 -64.99 0.28 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.538 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -113.86 79.07 0.27 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.431 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.64 -71.41 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.056 0.943 . . . . 0.0 111.911 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.9 -32.11 7.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.842 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 123.3 4.42 8.35 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.936 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 45.8 pt -73.09 -15.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 54.5 m-85 -79.88 -15.1 58.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.97 134.48 36.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.992 0.425 . . . . 0.0 110.245 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.97 -24.7 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.67 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.604 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 42.7 m-80 -65.64 -57.71 7.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -51.34 -51.03 58.08 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.661 0.601 . . . . 0.0 110.879 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HG3' ' A' ' 36' ' ' PRO . 23.7 mt -50.59 -50.35 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.995 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.55 -20.59 58.55 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.883 -177.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 37.3 mm-40 -74.25 -33.64 63.38 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.166 0.508 . . . . 0.0 109.95 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 37.5 ttm180 -80.63 -33.68 35.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -55.89 -50.88 69.45 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.551 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.73 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.6 -41.91 95.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.844 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.0 -34.5 33.47 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.439 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 4.2 tp -67.52 -36.59 81.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.025 -0.103 . . . . 0.0 111.243 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.588 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.8 pt-20 -72.77 -33.33 66.24 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.73 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.9 mm100 -60.45 -58.44 8.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' O ' HG13 ' A' ' 129' ' ' VAL . 15.0 t80 -47.57 -55.43 9.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.443 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -63.93 -39.49 85.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.83 -172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -61.62 -20.27 63.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.017 0.437 . . . . 0.0 111.986 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 35.1 mttm -90.18 -56.36 3.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.939 0.876 . . . . 0.0 110.641 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 125' ' ' PHE . 1.2 m -65.84 -13.15 15.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.002 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -110.11 7.61 23.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.088 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -141.14 12.36 2.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.463 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 57.7 t60 -100.32 139.8 20.96 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 122.397 -0.472 . . . . 0.0 110.499 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.622 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 6.8 Cg_exo -41.38 -47.1 5.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.21 3.273 . . . . 0.0 113.888 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -70.81 -32.55 69.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.102 -176.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.62 -42.47 51.61 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.716 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -66.0 -6.57 13.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.141 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.441 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 5.4 t-20 -99.61 -10.04 22.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 5.5 mm-40 -106.61 131.87 53.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 111.967 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 159' ' ' ILE . 16.3 tpt180 -58.24 -19.08 31.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.852 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.629 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 0.7 OUTLIER -63.97 -24.17 67.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.0 110.965 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.1 mp -75.55 -31.23 59.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.553 -0.717 . . . . 0.0 110.999 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 65.0 t-80 -57.61 -38.3 74.7 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.629 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 4.0 ptm -80.47 -26.76 38.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.559 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.652 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.14 -53.74 6.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -78.78 -36.31 43.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.357 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.6 mt-30 -95.3 166.67 11.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' HG11 ' A' ' 67' ' ' VAL . 46.1 m-20 61.96 -179.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.638 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.17 -35.25 14.65 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.048 0.928 . . . . 0.0 110.392 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -134.8 152.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.182 -165.592 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.624 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.2 mp -81.72 116.05 25.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.64 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.19 101.58 6.24 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.054 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -71.77 11.34 0.52 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.0 m -130.28 19.17 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 110.657 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.18 -171.43 0.05 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.534 0.683 . . . . 0.0 112.122 -179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 87.4 m -88.48 113.01 53.64 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.161 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.65 65.64 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.442 2.761 . . . . 0.0 112.303 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -140.59 -154.04 0.5 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.626 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.441 ' HE3' ' OD1' ' A' ' 137' ' ' ASN . 20.9 mmmt -86.24 158.98 19.59 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.475 -0.14 . . . . 0.0 110.75 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.545 HG13 HD12 ' A' ' 59' ' ' ILE . 16.7 mm -51.41 -52.44 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.422 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.337 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 2.6 m-85 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.52 175.5 43.91 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.425 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.33 154.71 10.73 Favored 'Trans proline' 0 C--O 1.224 -0.224 0 C-N-CA 124.0 3.133 . . . . 0.0 111.34 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.98 -11.82 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 124.483 3.455 . . . . 0.0 115.161 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -74.06 -61.89 1.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.4 m120 58.84 -178.58 0.08 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.489 0.493 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -91.43 125.52 36.21 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 57' ' ' LEU . 13.1 tp -138.14 129.09 27.06 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.88 -176.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -140.32 104.36 4.77 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.093 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.664 HG12 ' HB ' ' A' ' 53' ' ' VAL . 47.9 mt -114.69 141.49 31.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.182 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.8 117.57 14.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.996 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -98.62 132.42 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t 179.52 -162.56 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.2 m-80 63.58 77.44 0.32 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 115' ' ' ILE . 69.5 Cg_endo -73.98 142.17 30.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.392 2.061 . . . . 0.0 113.051 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -131.9 111.22 11.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.059 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.0 101.57 4.52 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.3 88.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.426 0.632 . . . . 0.0 110.235 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.44 -167.62 33.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.837 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.2 t -111.35 156.28 12.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.144 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.41 -49.04 6.98 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.465 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -99.08 85.1 3.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.084 0.469 . . . . 0.0 109.744 171.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.42 38.99 0.64 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.565 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 10.1 ttt180 -89.49 140.46 29.5 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.24 154.82 42.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.844 0.355 . . . . 0.0 110.759 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 m -110.57 122.97 49.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 p -92.55 155.91 17.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.859 0.361 . . . . 0.0 110.829 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 80.5 m-85 -119.12 141.42 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.728 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 31.3 tt0 -90.64 123.62 34.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.349 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -102.73 115.6 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.41 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 57.4 mtp180 -105.52 139.41 40.17 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.556 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -146.39 140.7 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -128.83 143.08 50.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.039 165.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.407 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 15.0 t -172.9 164.46 5.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.912 0.387 . . . . 0.0 111.964 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -117.52 31.12 6.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.628 0.728 . . . . 0.0 110.137 166.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.81 HD11 HD22 ' A' ' 29' ' ' LEU . 23.2 mt -67.86 145.2 97.83 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.273 174.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.53 -28.53 5.38 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.598 2.199 . . . . 0.0 111.777 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.94 -41.36 79.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.878 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.3 m-30 -69.96 -33.0 71.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.593 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' C ' ' HD2' ' A' ' 61' ' ' LYS . 1.1 tmmm? 75.11 -58.13 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.582 0.551 . . . . 0.0 112.101 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.75 -14.83 60.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 122.284 -0.26 . . . . 0.0 111.039 -172.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp 73.66 -38.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.851 0.719 . . . . 0.0 110.857 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.62 140.25 30.04 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.411 0.624 . . . . 0.0 109.956 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -160.28 151.55 19.37 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.109 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.9 m -140.39 133.95 30.14 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.021 0.439 . . . . 0.0 109.935 173.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 21.0 m -129.96 179.52 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.624 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 36.3 ttm180 -145.96 101.83 3.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.585 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.2 mmp_? -122.95 172.61 8.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.137 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -88.83 161.83 16.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.539 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 38.5 t80 -55.26 -37.53 67.37 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.428 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 35.5 m -61.99 -26.17 68.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.648 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.8 -36.42 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 52.1 m-85 -66.46 -39.89 89.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.998 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.9 mt-10 -57.06 -56.94 15.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.585 0.707 . . . . 0.0 110.826 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.45 ' CD1' HG21 ' A' ' 150' ' ' ILE . 4.7 t-105 -63.33 -34.09 76.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.733 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -69.19 -43.97 73.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 31.8 ttt180 -57.54 -59.52 5.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.797 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -60.58 -32.95 72.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.301 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.7 mm-40 -63.14 -46.37 87.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.014 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 85' ' ' SER . 88.8 mt -71.06 -16.31 62.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.0 110.755 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 47.5 mt-10 -87.73 -50.08 6.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.107 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 1.5 ppt_? -62.2 -21.79 65.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -165.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 9.5 pt-20 -138.12 -34.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.282 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.92 158.85 33.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.203 0.525 . . . . 0.0 110.476 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -96.53 17.86 15.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.238 0.542 . . . . 0.0 109.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 135' ' ' ALA . 90.7 t -56.06 140.24 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.93 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -75.53 37.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.611 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -51.69 118.72 12.01 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.411 -175.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 128' ' ' LYS . 6.3 Cg_exo -72.43 160.56 46.53 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.495 2.797 . . . . 0.0 112.525 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 142.2 42.3 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.876 2.384 . . . . 0.0 111.983 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.1 mt -69.37 150.57 97.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 27.5 Cg_endo -86.49 109.65 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.881 2.388 . . . . 0.0 111.957 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.63 -174.53 27.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.078 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' N ' HD23 ' A' ' 98' ' ' LEU . 51.8 tttp 71.09 -55.25 0.65 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.824 . . . . 0.0 112.035 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -47.61 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -73.36 -18.17 61.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.482 -170.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.1 mm? -69.14 -44.34 72.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.772 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -95.96 26.48 4.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.536 0.684 . . . . 0.0 110.178 176.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.5 tp60 -116.69 -41.51 3.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.696 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 62.6 mt -80.57 163.6 55.7 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.62 147.35 86.15 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.961 2.441 . . . . 0.0 111.499 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -104.76 94.82 5.49 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -125.76 -30.88 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.094 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.65 -167.31 43.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.439 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.9 -47.89 76.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.273 0.558 . . . . 0.0 110.936 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -136.41 -51.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.997 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.36 -10.38 1.3 Allowed Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.206 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.783 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.8 pt -65.53 -16.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 111.928 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -81.22 -16.12 53.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.357 0.599 . . . . 0.0 110.119 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.42 122.16 28.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.68 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.64 -27.0 64.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.581 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 14.3 m120 -55.09 -60.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.487 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.783 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -54.84 -47.71 73.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.51 0.506 . . . . 0.0 110.895 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 36' ' ' PRO . 47.9 mt -51.47 -51.27 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.275 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -73.11 -22.33 60.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.48 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 66.2 mm-40 -74.87 -32.45 61.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.802 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 14.7 tpp180 -78.97 -35.49 42.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.58 -54.01 51.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.467 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.712 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -59.33 -40.41 86.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.998 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -34.84 32.91 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.133 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.12 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.732 0.266 . . . . 0.0 111.298 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.612 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -73.43 -32.43 64.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.8 mm100 -62.31 -58.17 8.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 7.1 t80 -48.89 -53.27 20.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.613 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.34 -41.05 90.36 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.776 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.97 -19.72 45.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 111.809 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.448 ' HD2' ' HG2' ' A' ' 90' ' ' PRO . 31.8 mttm -90.72 -58.83 2.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.76 0.791 . . . . 0.0 110.66 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.32 -13.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.023 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.18 10.93 21.85 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.981 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.89 8.64 1.3 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.796 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.772 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 59.2 t60 -98.42 144.97 29.06 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 117.217 0.509 . . . . 0.0 110.214 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.772 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.0 Cg_exo -41.9 -48.86 5.89 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.23 3.286 . . . . 0.0 113.775 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -71.09 -38.91 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.777 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -69.14 -41.49 77.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.359 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.45 ' O ' HD12 ' A' ' 59' ' ' ILE . 6.1 mm-40 -65.93 -4.13 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.194 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 20.2 t-20 -106.46 -7.95 17.34 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.875 -177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.2 mm-40 -106.51 135.14 48.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.01 -0.431 . . . . 0.0 110.998 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -57.02 -17.68 10.89 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.621 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.3 m -58.3 -30.0 66.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.317 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 135' ' ' ALA . 6.5 mp -74.78 -29.97 61.29 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.22 -0.3 . . . . 0.0 111.357 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -58.51 -43.57 89.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.308 0.575 . . . . 0.0 109.864 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.627 ' HE2' HG23 ' A' ' 150' ' ' ILE . 5.3 ptm -77.84 -31.22 51.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.188 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 5.0 t80 -77.45 -41.31 40.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.109 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.445 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.9 mt -98.29 -47.5 5.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 112.005 -169.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -81.03 -46.39 15.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.014 -171.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.65 154.96 20.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.182 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.7 pm0 -66.42 -29.51 69.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.739 0.781 . . . . 0.0 110.164 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.567 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -134.22 132.37 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.07 -167.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.627 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.3 mp -70.66 105.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.282 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.51 99.41 10.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.048 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' A' ' 150' ' ' ILE . 2.0 mptt -71.86 11.61 0.5 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 112.309 -173.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.1 t -111.99 11.28 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.665 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.281 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 50.4 m -94.3 114.32 63.02 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.784 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 21.9 Cg_exo -68.88 68.44 1.22 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.432 2.755 . . . . 0.0 112.067 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -140.24 -159.39 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.626 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 6.6 mmmm -88.25 158.91 18.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 59' ' ' ILE . 16.5 mm -50.35 -46.29 25.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.679 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 110.28 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.17 172.0 15.48 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.725 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.04 159.43 9.68 Favored 'Trans proline' 0 C--O 1.222 -0.31 0 C-N-CA 124.201 3.267 . . . . 0.0 111.591 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.99 -24.87 0.47 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.421 3.414 . . . . 0.0 115.452 -170.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -70.53 -62.29 1.44 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.26 0.224 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 12.7 m120 61.81 -178.67 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.212 0.53 . . . . 0.0 111.632 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -97.3 140.49 31.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 13.4 tp -147.11 130.58 16.73 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.429 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.87 103.64 4.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.663 HG12 ' HB ' ' A' ' 53' ' ' VAL . 32.8 mt -115.43 143.29 25.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.01 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.84 115.68 10.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.769 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -99.25 132.52 44.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.8 t 179.31 -163.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.4 m-80 61.94 81.6 0.23 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 121.124 0.488 . . . . 0.0 110.47 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.67 152.92 59.57 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.724 2.283 . . . . 0.0 113.541 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.1 tp60 -144.84 107.78 4.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.007 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.1 m -76.52 104.3 6.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.4 p -130.86 88.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.706 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.5 -168.17 34.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.0 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.4 t -102.11 158.32 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.068 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.91 -49.78 6.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.972 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.82 87.03 4.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.118 0.485 . . . . 0.0 109.803 169.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.26 34.54 0.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.971 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.6 ttt180 -89.46 126.12 35.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -131.76 156.7 45.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.5 m -107.72 124.74 50.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.368 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 70' ' ' ARG . 32.0 p -92.09 162.43 14.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.52 139.43 53.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.4 tt0 -91.11 118.35 30.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.571 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.8 mp -93.0 116.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 76.0 mtp180 -105.87 131.87 52.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.971 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.663 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.99 138.39 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 16.4 ttmt -127.81 137.01 52.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.133 169.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 63' ' ' LYS . 13.3 t -170.31 163.74 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.272 0.558 . . . . 0.0 112.147 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 17.3 p30 -118.91 22.54 11.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.203 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.701 HD11 HD22 ' A' ' 29' ' ' LEU . 21.4 mt -56.3 146.71 51.11 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.723 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -9.7 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.503 2.135 . . . . 0.0 111.918 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.575 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -88.49 -40.56 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.416 -177.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.542 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.9 m-30 -69.86 -17.36 63.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' HD13 ' A' ' 62' ' ' LEU . 35.7 ttpt 75.21 -71.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.546 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -75.91 -1.45 25.5 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -169.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mmtm 68.31 -48.09 0.54 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.092 0.87 . . . . 0.0 111.6 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 2.7 pp20? -156.59 140.36 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.833 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -168.71 174.97 6.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.345 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.0 m -141.12 135.62 31.1 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.238 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -145.4 130.62 13.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.926 -173.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 31.6 ttm180 -97.93 110.89 23.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.39 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.701 HH11 HD12 ' A' ' 150' ' ' ILE . 41.4 mtt-85 -125.64 177.01 6.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.158 -172.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' A' ' 48' ' ' THR . 67.0 mtp180 -92.81 156.5 16.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.823 0.344 . . . . 0.0 111.779 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.5 t80 -59.63 -34.13 72.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t -58.26 -33.4 69.36 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.924 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HB ' ' A' ' 150' ' ' ILE . 25.5 m-20 -65.13 -45.24 85.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 60.6 m-85 -59.81 -40.55 88.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.514 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.1 mt-10 -57.04 -56.3 23.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.391 0.615 . . . . 0.0 111.096 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.449 ' CD1' HG21 ' A' ' 150' ' ' ILE . 0.6 OUTLIER -68.41 -28.98 67.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.525 -178.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.702 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -68.23 -42.77 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 55.8 ttt180 -57.89 -62.52 1.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.278 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -63.15 -27.42 69.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.545 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 12.0 tp10 -68.96 -42.06 77.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 85' ' ' SER . 97.1 mt -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.632 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 25.5 mt-10 -90.18 -41.44 11.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.693 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 3.4 ppt_? -78.67 -35.21 45.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.549 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 6.0 mm-40 -101.73 -26.82 13.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.986 0.422 . . . . 0.0 111.779 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -112.38 167.8 10.15 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.451 -169.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -105.33 21.14 17.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.439 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 81' ' ' LEU . 87.3 t -53.68 144.91 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.907 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.4 p -72.64 31.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.081 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 129' ' ' VAL . 1.4 t -52.42 119.51 15.32 Favored Pre-proline 0 N--CA 1.467 0.407 0 O-C-N 122.228 -0.295 . . . . 0.0 111.367 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -88.21 168.37 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.868 2.379 . . . . 0.0 111.884 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 148.65 84.02 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.503 2.136 . . . . 0.0 112.495 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 75' ' ' GLU . 67.6 mt -77.22 154.83 82.33 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.641 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 61.0 Cg_endo -83.06 142.12 10.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.73 -163.35 36.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.277 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 68.06 -60.53 0.41 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 112.234 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.29 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -62.09 -16.1 49.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.471 -168.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.52 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.2 mm? -69.5 -37.47 77.22 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.597 -174.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 12.81 32.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.316 0.579 . . . . 0.0 109.931 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 31.1 tp60 -97.58 -38.97 9.34 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.771 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 76.9 mt -83.07 166.87 32.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.859 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 27.2 Cg_exo -62.2 142.0 90.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.804 2.336 . . . . 0.0 111.553 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.26 5.5 37.98 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.261 0.553 . . . . 0.0 110.876 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -70.33 -14.25 62.5 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.358 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.4 -178.49 38.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.571 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.08 -45.3 94.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -151.38 -27.98 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.884 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 -0.34 12.97 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.6 pt -74.81 -15.39 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -84.22 -7.3 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.382 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.25 135.84 36.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.312 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -30.81 71.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.31 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.63 -58.5 6.74 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -51.5 -48.25 62.97 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.412 0.445 . . . . 0.0 111.101 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.8 mt -50.57 -51.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.218 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.76 -20.62 56.27 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.642 -177.296 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.566 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 21.2 mm-40 -75.09 -33.27 61.62 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.229 0.538 . . . . 0.0 109.878 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 9.8 tpp180 -78.7 -38.22 39.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.03 -52.27 59.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 -178.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.62 -41.65 95.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.111 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -80.34 -32.25 35.37 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.5 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.5 tp -67.55 -40.45 84.96 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.799 -0.201 . . . . 0.0 111.156 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.6 pt-20 -72.09 -32.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.776 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.9 mm100 -61.34 -57.75 11.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.3 t80 -50.12 -52.1 37.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.758 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -64.7 -42.04 93.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.928 -170.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -60.64 -17.78 49.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.54 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -88.2 -57.98 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.869 0.842 . . . . 0.0 110.395 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -65.36 -12.83 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.181 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.32 6.25 28.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.366 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.09 15.94 1.52 Allowed Glycine 0 C--N 1.332 0.352 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.883 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 50.1 t60 -100.26 144.38 28.31 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 117.328 0.564 . . . . 0.0 110.385 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 21.2 Cg_exo -38.95 -49.12 2.8 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.403 3.402 . . . . 0.0 113.827 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.69 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -70.94 -39.5 72.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.138 -175.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -68.02 -41.01 82.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.716 -175.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -70.8 4.82 2.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.735 0.779 . . . . 0.0 109.846 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' ALA . 52.2 t30 -119.24 4.3 11.29 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.1 mm-40 -117.26 128.14 54.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.0 tpt180 -54.81 -16.56 2.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.817 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.694 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.9 m -55.5 -28.73 56.38 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.075 0.55 . . . . 0.0 111.461 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.613 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.0 mp -78.75 -29.42 45.19 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.341 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 52.6 t-80 -56.79 -39.55 74.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.7 ptm -79.59 -31.41 41.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.702 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -81.39 -36.12 29.93 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -94.02 -37.7 11.52 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.137 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.2 mt-30 -94.59 174.12 7.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.54 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.0 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.4 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -102.72 -30.71 10.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.55 0.691 . . . . 0.0 110.666 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -138.69 158.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.132 -167.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.701 HD12 HH11 ' A' ' 69' ' ' ARG . 2.2 mp -86.85 123.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.638 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.7 106.53 18.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.215 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 9.4 mptt -77.2 11.24 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.213 0.53 . . . . 0.0 112.158 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 t -126.33 18.01 7.63 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -170.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.277 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 85.5 m -82.26 112.65 37.8 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.458 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 16.9 Cg_exo -72.87 61.34 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.358 2.705 . . . . 0.0 112.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.0 m -136.86 -157.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 122.309 -0.244 . . . . 0.0 110.841 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 5.5 mmmm -87.08 158.82 19.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 119.907 -0.092 . . . . 0.0 110.83 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.575 HG13 HD12 ' A' ' 59' ' ' ILE . 17.5 mm -52.2 -49.95 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.287 0.565 . . . . 0.0 110.539 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.875 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ASN . 38.6 m-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.52 172.36 45.39 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.88 157.47 10.34 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.859 3.039 . . . . 0.0 112.48 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.29 -18.36 0.73 Allowed 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.997 3.798 . . . . 0.0 115.439 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -69.91 -61.58 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.554 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.8 m120 61.44 164.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.311 0.644 . . . . 0.0 112.675 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -89.65 143.43 26.81 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -147.77 126.66 12.72 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.08 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.2 pt-20 -133.29 100.04 4.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.12 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.68 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.1 mt -113.08 137.55 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.235 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.82 112.9 11.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.345 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -92.68 130.97 40.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 t -179.9 -163.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.1 m-80 60.32 77.22 0.38 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.477 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.58 150.67 86.35 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' THR . 46.8 tp60 -135.75 110.66 8.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.955 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 m -74.56 98.21 3.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 109.41 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -130.12 91.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.51 -167.58 32.72 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.86 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -109.77 148.89 13.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 119.41 -0.328 . . . . 0.0 110.36 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.91 -49.93 4.2 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 121.599 -0.334 . . . . 0.0 112.841 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.59 85.34 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.991 0.425 . . . . 0.0 109.89 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.92 39.02 0.67 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.914 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.3 ttp180 -85.94 150.01 24.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 122.487 0.315 . . . . 0.0 110.252 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -149.83 171.27 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.826 0.346 . . . . 0.0 110.798 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 74.0 m -124.63 126.56 45.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.711 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 21.1 p -92.69 161.53 14.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.66 0.267 . . . . 0.0 110.35 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -123.26 140.98 52.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.297 0.57 . . . . 0.0 110.838 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.1 tt0 -92.4 121.06 33.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.073 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -97.52 119.07 45.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.612 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 93.6 mtt180 -109.18 142.05 40.53 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.36 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.71 142.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -133.81 142.35 47.82 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.527 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.625 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 10.1 t -170.12 163.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.72 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 34.5 p30 -112.69 20.22 16.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.81 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.744 HD11 HD22 ' A' ' 29' ' ' LEU . 30.6 mt -58.71 147.85 69.67 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.4 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -84.6 -30.75 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.808 1.672 . . . . 0.0 112.075 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.26 -43.16 95.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 178.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.8 m-30 -65.7 -33.56 76.17 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 75.54 -53.72 0.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -81.1 -12.12 59.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 122.017 -0.427 . . . . 0.0 110.392 -176.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.625 ' HE2' ' O ' ' A' ' 55' ' ' THR . 10.6 mmmm 68.51 -44.55 0.51 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 124.094 0.871 . . . . 0.0 111.09 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -141.36 141.78 33.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 t -170.48 157.48 5.97 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.129 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.5 m -141.85 130.06 22.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 0.0 110.873 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.7 173.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.599 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 51.8 ttp180 -137.26 109.93 7.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 21.4 mmm180 -127.67 179.6 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.586 -175.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -100.22 165.72 11.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.787 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.1 t80 -53.72 -39.63 65.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.062 174.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.418 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 34.1 m -53.18 -36.65 61.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.622 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 69' ' ' ARG . 4.2 m-20 -64.37 -41.64 96.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -64.44 -37.79 88.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.411 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.654 ' HA ' HD11 ' A' ' 92' ' ' LEU . 27.6 mt-10 -60.12 -55.65 31.24 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.38 0.61 . . . . 0.0 111.19 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 150' ' ' ILE . 3.5 t-105 -67.74 -27.54 66.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.25 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -69.04 -47.47 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.561 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.6 ttt180 -55.68 -61.35 2.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.359 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 t -61.63 -27.71 68.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.382 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.618 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.8 tp10 -73.38 -47.23 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.339 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.96 -35.65 73.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 110.751 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 37.6 mt-10 -64.61 -37.58 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.439 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HD2' ' C ' ' A' ' 83' ' ' ARG . 4.5 ppt_? -91.36 -28.39 17.74 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.39 -30.87 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 87' ' ' VAL . 24.3 t -144.32 -175.11 4.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 110.921 -171.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -100.36 26.81 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.204 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 85' ' ' SER . 74.7 t -52.46 139.68 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.308 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.454 HG12 ' CG ' ' A' ' 132' ' ' HIS . 8.7 p -73.41 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.988 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -53.15 121.32 23.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 O-C-N 122.023 -0.423 . . . . 0.0 110.565 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.0 Cg_endo -85.77 162.94 10.61 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.605 2.203 . . . . 0.0 112.401 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 29.6 Cg_endo -63.57 146.24 92.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.765 2.31 . . . . 0.0 112.191 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 75' ' ' GLU . 97.6 mt -74.3 142.9 79.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.9 Cg_exo -73.94 117.56 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.885 2.39 . . . . 0.0 111.224 176.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.09 61.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.257 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.43 -45.35 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.01 -85.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -49.45 -32.03 11.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.579 1.152 . . . . 0.0 113.979 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -57.46 -47.3 82.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.07 27.83 8.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.618 0.723 . . . . 0.0 110.145 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -122.96 -32.73 3.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.871 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.53 168.12 12.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.31 156.26 66.96 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.865 2.376 . . . . 0.0 111.551 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -79.2 -90.42 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.498 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 64.97 -72.0 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.637 0.586 . . . . 0.0 111.344 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.02 65.16 4.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 66.57 -71.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.297 1.039 . . . . 0.0 111.326 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.83 -19.18 12.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.338 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.28 8.47 31.09 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 50.3 pt -75.56 -17.39 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.819 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -79.35 -15.43 57.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.031 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.8 132.41 41.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.155 0.503 . . . . 0.0 109.884 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.48 -27.3 69.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.717 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 50.2 m-80 -65.83 -52.43 50.63 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -53.95 -49.4 68.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.522 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.6 mt -52.57 -48.7 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.925 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.13 -21.85 59.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.605 -178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 46.8 mm-40 -73.66 -33.86 64.67 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.621 0.724 . . . . 0.0 109.634 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.79 -35.82 43.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.433 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -57.24 -53.12 61.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.11 -178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.8 pt20 -61.17 -45.0 96.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.605 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.17 -43.41 95.52 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.804 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -69.51 -32.14 70.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.629 0.715 . . . . 0.0 111.599 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.615 ' HA ' HG22 ' A' ' 126' ' ' ILE . 14.9 pt-20 -74.92 -33.3 61.98 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.9 mm100 -59.88 -57.64 12.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.513 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.2 t80 -51.68 -53.31 40.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.499 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.9 tp -64.41 -39.95 87.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.018 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.58 -20.49 60.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 112.026 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.0 mttm -88.46 -56.26 3.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.667 0.746 . . . . 0.0 110.899 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.651 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -66.9 -11.73 14.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.025 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.07 -11.7 16.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.499 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.479 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -122.65 -6.17 8.04 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.936 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.6 t60 -84.09 143.55 42.85 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 117.328 0.564 . . . . 0.0 110.633 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 17.2 Cg_exo -39.33 -50.03 2.95 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.514 3.476 . . . . 0.0 113.813 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.42 -30.71 66.38 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.352 -174.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.651 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -77.0 -44.54 30.55 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.45 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.14 -0.76 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.421 176.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 2.5 t30 -104.11 -21.13 13.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.409 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 17.9 mm-40 -102.11 143.12 32.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.905 0.775 . . . . 0.0 112.627 -166.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 139' ' ' ARG . 6.7 tpp85 -62.85 -21.25 65.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.513 -166.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.566 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 1.9 t -60.41 -26.15 66.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.23 0.538 . . . . 0.0 110.076 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 135' ' ' ALA . 4.6 mp -71.48 -28.51 63.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.342 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -61.82 -47.18 86.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.5 ptm -72.44 -30.64 64.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t80 -75.92 -48.37 21.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.651 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 1.6 mt -96.97 -43.68 7.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.558 . . . . 0.0 111.545 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.668 ' HA ' HD11 ' A' ' 62' ' ' LEU . 54.4 mt-30 -91.43 -15.51 28.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.573 -166.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -111.43 174.64 5.77 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -79.15 -32.72 44.43 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.089 0.947 . . . . 0.0 110.013 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -139.9 143.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.132 -167.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.9 mp -71.58 106.67 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.036 173.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 104.02 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.897 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -69.16 -1.01 6.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.9 p -113.24 18.03 18.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.471 0.653 . . . . 0.0 110.596 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.434 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.3 -171.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.604 178.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.7 m -86.45 112.12 44.06 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.14 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 22.1 Cg_exo -69.38 82.43 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.403 2.735 . . . . 0.0 111.621 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 m -156.73 -153.58 0.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -105.02 177.65 4.79 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.697 177.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 59' ' ' ILE . 17.1 mm -66.78 -36.16 76.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.589 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.496 -174.982 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.185 0.517 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 -179.68 43.01 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 9.4 Cg_endo -51.44 154.92 7.82 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.531 2.821 . . . . 0.0 111.499 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 51.7 Cg_exo -56.49 -7.71 2.27 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.798 2.998 . . . . 0.0 113.953 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 p -77.12 -53.58 7.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 28.7 m120 62.85 170.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.671 0.607 . . . . 0.0 111.494 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.65 134.9 33.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 57' ' ' LEU . 14.9 tp -142.17 130.25 22.01 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.114 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -141.46 101.11 3.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.824 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.679 HG12 ' HB ' ' A' ' 53' ' ' VAL . 42.9 mt -115.07 140.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -132.59 106.92 8.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.938 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -84.6 130.64 35.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 170.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -179.1 -164.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.4 m-80 59.2 71.75 0.9 Allowed Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 110.284 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.39 133.37 37.15 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.088 2.525 . . . . 0.0 113.487 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 47' ' ' THR . 5.7 tp-100 -117.65 106.96 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.686 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -78.22 90.1 4.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.554 0.692 . . . . 0.0 109.953 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -117.29 91.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.612 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.45 -166.28 31.53 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.399 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.1 t -101.2 146.94 8.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.346 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.34 -48.13 4.6 Favored Glycine 0 N--CA 1.465 0.584 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.245 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -102.22 88.21 3.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.39 0.614 . . . . 0.0 109.713 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.9 0.93 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.62 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 13.8 ttt180 -85.31 139.86 31.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 39.3 p90 -129.72 153.57 48.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 86.7 m -111.31 124.08 51.5 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.0 p -92.74 153.58 18.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.117 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.26 136.45 51.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.02 0.438 . . . . 0.0 110.765 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 29.3 tt0 -90.58 116.6 28.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 mp -94.27 113.75 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.865 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HG2' ' OG1' ' A' ' 66' ' ' THR . 66.4 mtt180 -105.53 121.98 45.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.843 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -128.9 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.0 111.882 -177.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -127.92 133.74 49.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 7.1 t -168.27 165.44 12.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.595 0.712 . . . . 0.0 112.121 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -117.94 21.63 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.752 167.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 29' ' ' LEU . 26.7 mt -56.14 131.96 74.81 Favored Pre-proline 0 CA--C 1.521 -0.163 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.801 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 11.7 Cg_exo -66.82 -37.94 18.97 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.413 2.076 . . . . 0.0 111.186 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -58.2 -42.43 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.448 176.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.87 -23.69 64.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.47 -64.57 0.34 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -73.44 -25.68 60.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -174.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' O ' HG22 ' A' ' 55' ' ' THR . 19.2 mmtp 82.02 -34.24 0.1 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.822 171.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.32 125.19 1.82 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.546 0.688 . . . . 0.0 110.08 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 62' ' ' LEU . 16.7 t -170.71 176.13 4.34 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.751 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.57 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 27.9 m -141.73 133.19 26.72 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.5 m -121.3 178.35 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.301 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -143.24 106.08 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -127.41 167.59 16.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.449 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.602 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 58.0 ttp180 -94.82 165.13 12.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.002 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.2 t80 -52.52 -40.73 62.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.621 0.248 . . . . 0.0 110.809 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -54.17 -35.5 62.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.7 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.65 -41.51 96.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 69.1 m-85 -64.97 -38.02 89.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.3 mt-10 -60.71 -52.12 66.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.376 0.607 . . . . 0.0 110.935 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.519 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 8.3 t-105 -67.26 -27.53 67.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.283 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -71.32 -46.58 60.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 53.5 ttt180 -58.17 -58.63 7.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.266 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 p -62.74 -32.28 73.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.453 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 1.1 tm-20 -59.4 -48.0 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.0 110.264 176.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 92.5 mt -65.4 -30.05 70.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.942 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 40.0 mt-10 -82.03 -35.53 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.988 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 2.6 ppt_? -69.59 -25.14 63.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG3' ' HD2' ' A' ' 83' ' ' ARG . 4.0 mt-10 -119.53 -55.06 2.14 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.056 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.7 m -87.21 171.09 10.91 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.754 0.787 . . . . 0.0 112.221 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -102.66 30.61 4.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -50.8 142.23 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.699 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.5 p -72.01 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.726 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -58.74 119.66 39.06 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.435 . . . . 0.0 110.882 -176.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 91.9 Cg_endo -85.5 162.12 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.882 2.388 . . . . 0.0 112.288 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 135.03 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.988 2.458 . . . . 0.0 112.661 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 93.5 mt -66.19 151.26 95.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.401 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.49 113.01 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.635 2.223 . . . . 0.0 111.248 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.48 166.57 37.08 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.635 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.59 25.7 10.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.536 0.684 . . . . 0.0 110.925 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -116.63 -74.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.016 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -69.96 -22.29 63.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.02 -176.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -66.83 -47.0 73.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.517 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -92.98 28.74 2.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.842 0.829 . . . . 0.0 110.051 176.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 32.6 tp60 -124.7 -41.29 2.14 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.854 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.74 165.63 20.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.08 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 179.54 3.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.2 2.6 . . . . 0.0 111.966 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.94 -75.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.009 0.433 . . . . 0.0 110.2 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 104' ' ' ARG . 29.2 mtm180 68.06 -57.48 0.47 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.063 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.31 -159.26 25.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.717 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.09 -48.24 82.34 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.407 0.622 . . . . 0.0 110.719 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.88 -21.85 2.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.438 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.82 11.15 38.4 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 49.8 pt -90.96 -17.93 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.723 -173.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -82.9 10.44 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.357 0.599 . . . . 0.0 109.789 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.88 126.94 40.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.332 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.0 -21.16 65.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.628 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.582 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.4 m-80 -71.45 -55.14 8.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -50.82 -50.06 57.31 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.616 0.572 . . . . 0.0 111.129 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.96 -48.99 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.653 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -81.69 -14.84 56.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.913 -177.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 35.7 mm-40 -69.44 -35.13 75.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.3 0.571 . . . . 0.0 109.698 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.573 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.6 ttp180 -79.44 -34.32 41.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.212 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -57.41 -51.29 70.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.631 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.779 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.7 pt20 -61.2 -37.63 83.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.311 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.6 -33.3 25.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.388 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.8 tp -66.6 -38.02 86.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.181 0.192 . . . . 0.0 110.945 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.59 ' HA ' HG22 ' A' ' 126' ' ' ILE . 9.8 pt-20 -71.28 -30.87 66.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.779 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 10.3 mm100 -61.16 -59.64 5.01 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 2.5 t80 -48.47 -52.52 21.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.963 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -64.08 -40.28 88.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.79 -172.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.09 -18.02 44.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.1 -59.24 2.28 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.827 0.822 . . . . 0.0 110.396 175.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 81' ' ' LEU . 1.3 m -63.45 -12.46 10.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.64 -0.89 27.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.436 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.73 11.94 2.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.685 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.695 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 38.3 t60 -101.57 141.34 22.39 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.474 -0.427 . . . . 0.0 110.82 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.695 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 7.9 Cg_exo -41.27 -50.47 4.42 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.365 3.377 . . . . 0.0 113.79 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.64 -26.24 64.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.16 -174.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.47 -41.67 16.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.3 mm100 -66.29 -4.68 8.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.201 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 135' ' ' ALA . 55.7 t30 -106.26 0.77 25.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.438 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' A' ' 138' ' ' GLU . 5.1 mm-40 -112.26 127.46 55.98 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.999 -0.438 . . . . 0.0 110.986 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 159' ' ' ILE . 13.7 tpp85 -57.98 -21.53 45.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.42 -172.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.814 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 4.3 t -61.88 -22.78 65.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 110.537 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.539 ' O ' HD22 ' A' ' 145' ' ' LEU . 7.3 mp -72.76 -32.46 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.096 -0.378 . . . . 0.0 111.441 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 18.8 t60 -58.0 -44.1 87.0 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.363 0.602 . . . . 0.0 109.643 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.814 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -77.83 -24.4 48.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.174 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.4 t80 -80.37 -57.18 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.83 -24.81 26.59 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.686 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.4 mt-30 -109.16 158.76 17.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.375 -168.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 62.51 -107.06 0.22 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.258 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.6 pm0 -146.26 -39.78 0.22 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.597 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -139.85 151.78 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -161.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -77.59 109.11 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.314 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.59 102.3 15.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.931 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 31.6 mmtp -66.25 -5.42 10.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -174.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -106.9 18.19 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.311 0.577 . . . . 0.0 110.123 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.447 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.32 -170.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.951 -179.048 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.6 m -87.84 111.6 43.41 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.136 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.7 Cg_exo -70.72 81.68 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.247 2.631 . . . . 0.0 111.785 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.6 m -155.56 -159.24 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.264 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -84.92 167.31 16.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.77 -45.17 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.661 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 4.3 m-85 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.66 172.23 38.18 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.753 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.92 156.56 6.93 Favored 'Trans proline' 0 C--O 1.224 -0.207 0 C-N-CA 124.16 3.24 . . . . 0.0 112.223 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -42.64 -22.51 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 124.81 3.673 . . . . 0.0 115.728 -171.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -72.0 -61.51 1.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.507 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.7 m120 60.95 -178.26 0.11 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.932 0.396 . . . . 0.0 111.523 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.53 ' HD2' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.42 130.52 35.76 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.735 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -145.1 129.56 17.89 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.041 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -143.04 100.09 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.9 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.689 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.8 mt -111.07 146.05 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.442 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.2 114.99 11.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.719 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -97.14 132.36 41.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.53 -161.73 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.94 71.87 0.7 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.738 0.304 . . . . 0.0 110.524 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.19 132.66 28.39 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.777 2.318 . . . . 0.0 113.183 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.1 tp60 -122.25 111.65 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.569 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.9 m -75.87 98.14 4.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 109.541 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -130.04 94.45 2.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.873 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -170.64 -167.77 31.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.515 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 4.0 t -110.23 151.48 12.44 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.171 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.27 -49.1 4.58 Favored Glycine 0 N--CA 1.46 0.272 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.465 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.23 78.68 3.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.351 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.61 41.12 0.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.945 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 6.2 ttp180 -82.28 145.85 29.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -146.95 159.67 43.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.069 0.462 . . . . 0.0 111.072 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.6 m -112.36 128.79 56.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.928 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 20.1 p -92.29 146.22 23.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.002 0.429 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 78.9 m-85 -108.18 132.56 53.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.996 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 32.0 tt0 -87.14 119.06 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.73 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.541 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.1 mp -94.09 111.67 25.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.104 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 91.6 mtt180 -104.66 132.64 50.67 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.141 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.689 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.9 138.44 34.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 7.1 ttmt -125.74 133.91 51.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.596 168.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.0 t -166.3 164.24 17.6 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.422 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' ND2' ' HD2' ' A' ' 28' ' ' PHE . 24.3 p30 -115.84 25.78 10.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.682 167.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.735 HD11 HD22 ' A' ' 29' ' ' LEU . 29.4 mt -61.42 133.58 93.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.496 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.8 Cg_exo -70.66 -32.01 15.56 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.462 2.108 . . . . 0.0 111.262 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -63.62 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.963 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.523 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 3.8 m-30 -71.07 -19.16 62.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 62' ' ' LEU . 54.5 tttp 71.19 -64.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.29 -5.52 56.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -174.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 55' ' ' THR . 4.9 mmpp? 71.22 -38.41 0.42 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.769 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -160.35 135.94 8.22 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.014 0.435 . . . . 0.0 110.038 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -170.08 175.45 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.585 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.8 m -140.83 141.67 34.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.776 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.6 m -138.86 -179.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 40.7 ptt180 -150.37 126.97 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.14 0.495 . . . . 0.0 111.106 171.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.0 mmp_? -139.36 167.24 22.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.802 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.41 156.6 20.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.3 t80 -51.72 -39.34 58.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.723 0.297 . . . . 0.0 110.744 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.9 m -54.17 -32.77 56.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.863 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.13 -35.85 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 51.5 m-85 -64.52 -39.59 94.06 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 92' ' ' LEU . 15.7 mt-10 -60.09 -51.6 68.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' HG21 ' A' ' 150' ' ' ILE . 6.8 t-105 -65.44 -27.46 68.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.256 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.594 HD22 ' CD2' ' A' ' 144' ' ' PHE . 34.4 tp -72.08 -48.46 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 43.3 ttt180 -53.98 -59.38 4.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.839 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.632 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 p -60.06 -40.3 89.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.033 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.6 -52.57 59.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.594 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 87.6 mt -65.51 -34.8 79.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.383 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 35.0 mt-10 -70.06 -43.96 70.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 79' ' ' SER . 20.6 mmt180 -76.73 -48.07 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.177 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.81 -23.07 31.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.044 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.6 t -132.79 -177.52 4.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.408 0.623 . . . . 0.0 111.237 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -108.54 18.24 21.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.217 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.433 ' CG1' HG22 ' A' ' 89' ' ' VAL . 90.1 t -48.89 141.13 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.287 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.1 p -71.91 38.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.466 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -55.99 118.88 22.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.163 -0.335 . . . . 0.0 110.774 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 91.6 Cg_endo -83.79 161.62 14.17 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.845 2.363 . . . . 0.0 111.976 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.62 139.22 62.77 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.716 2.277 . . . . 0.0 112.223 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.9 mt -70.27 154.96 94.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.857 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 3.2 Cg_exo -79.06 110.07 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 0.0 110.919 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.3 171.32 39.8 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.297 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 56.91 51.28 10.92 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.445 0.64 . . . . 0.0 110.125 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.29 -83.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.543 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.599 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -64.1 -17.96 63.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.814 -174.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.698 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.0 mm? -65.85 -41.58 91.53 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.983 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 24.97 7.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.882 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -96.64 -48.92 5.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.446 -177.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.595 HD22 ' C ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -92.85 165.34 19.04 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.696 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -59.96 -78.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.489 2.793 . . . . 0.0 113.217 -175.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -149.36 -88.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.457 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 104' ' ' ARG . 17.6 tpt180 67.3 -56.12 0.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.694 0.798 . . . . 0.0 112.632 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.68 170.01 20.02 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.546 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.71 -53.52 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.049 0.54 . . . . 0.0 111.051 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.61 -4.86 19.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.94 58.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.782 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.4 pt -73.57 -14.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.205 -0.498 . . . . 0.0 111.673 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -84.34 1.07 46.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.756 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -103.8 136.59 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.27 -25.57 65.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.638 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -61.85 -61.4 2.52 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.782 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.2 -50.43 38.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.354 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.5 mt -51.59 -53.89 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.18 -20.1 60.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.494 -177.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 65.2 mm-40 -74.26 -33.62 63.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.27 0.557 . . . . 0.0 109.639 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.1 tpp180 -76.64 -40.12 50.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -53.02 -51.44 61.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.859 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.756 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -61.46 -36.26 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.819 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.65 -33.1 10.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.699 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 33' ' ' VAL . 8.1 tp -67.39 -36.35 81.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.978 -0.13 . . . . 0.0 111.083 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.644 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.7 pt-20 -72.37 -28.84 63.27 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.756 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 9.6 mm100 -65.18 -61.34 2.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.462 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.5 t80 -44.01 -52.98 6.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.89 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -62.81 -41.15 91.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.476 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -59.29 -17.42 28.77 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -90.47 -58.08 2.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.734 0.778 . . . . 0.0 110.452 175.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -64.47 -12.5 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.884 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.63 0.45 26.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.376 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.476 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.33 13.89 2.29 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.026 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.67 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 55.2 t60 -101.21 141.83 23.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 117.156 0.478 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.72 -49.49 5.36 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 124.014 3.143 . . . . 0.0 113.523 -173.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -33.17 73.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.331 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -74.08 -41.29 61.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.822 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -70.3 0.13 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.187 0.994 . . . . 0.0 109.36 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 135' ' ' ALA . 56.8 t30 -117.28 14.86 14.85 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.242 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.58 130.52 47.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.798 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 139' ' ' ARG . 4.3 mmt180 -49.51 -22.38 1.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.795 0.838 . . . . 0.0 113.002 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.712 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 2.8 m -55.4 -28.0 51.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.21 0.604 . . . . 0.0 112.13 -174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.51 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.2 mp -78.26 -34.39 49.06 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.784 -0.573 . . . . 0.0 111.735 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.8 t60 -63.12 -35.69 81.11 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.45 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.712 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.6 ptm -77.47 -28.94 52.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.452 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.594 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.1 t80 -80.7 -58.57 3.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.199 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -83.12 -22.71 33.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.077 -172.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 42.6 mt-30 -120.98 179.19 4.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.711 -169.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.5 t70 65.73 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.831 0.707 . . . . 0.0 110.542 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.81 -56.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.68 0.752 . . . . 0.0 110.044 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.49 143.29 40.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.05 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.668 HG23 ' HE2' ' A' ' 143' ' ' MET . 2.9 mp -65.44 119.35 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.585 173.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.4 106.68 18.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -73.89 10.0 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -129.93 19.22 5.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -63.71 -172.31 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.015 -177.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 89.7 m -87.31 112.24 46.66 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -69.94 77.92 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.167 2.578 . . . . 0.0 111.105 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -153.73 -161.61 1.29 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.5 mmmm -86.83 158.72 19.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.414 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.572 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -57.16 -39.63 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.209 0.528 . . . . 0.0 110.524 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.681 -173.175 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 5.2 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.198 0.523 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.14 174.25 46.61 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -54.33 154.27 19.57 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.988 3.126 . . . . 0.0 111.486 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.47 -19.25 0.63 Allowed 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.42 3.413 . . . . 0.0 115.379 -170.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -70.46 -57.44 4.79 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 12.2 m120 59.07 -178.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.469 0.481 . . . . 0.0 111.765 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -95.46 136.4 35.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 57' ' ' LEU . 13.9 tp -145.79 131.28 18.73 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.09 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.9 pt-20 -140.81 99.72 3.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.063 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.665 HG12 ' HB ' ' A' ' 53' ' ' VAL . 22.4 mt -112.06 138.81 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.24 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.09 107.72 6.23 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -83.89 136.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -179.9 -167.17 0.09 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.2 84.88 0.2 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.61 0.569 . . . . 0.0 111.479 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HB3' HG21 ' A' ' 115' ' ' ILE . 94.4 Cg_endo -76.35 119.9 5.44 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 113.738 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -102.55 106.26 16.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.386 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' HE ' ' A' ' 45' ' ' ARG . 28.5 m -78.75 89.28 4.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.685 0.755 . . . . 0.0 110.115 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 94.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.7 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.61 -167.48 32.67 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.558 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 10.1 t -104.32 152.59 6.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.177 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.1 -51.81 6.01 Favored Glycine 0 N--CA 1.461 0.347 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.188 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.56 83.15 4.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.884 0.373 . . . . 0.0 110.171 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 39.73 0.72 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.384 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.593 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 23.5 ttt180 -84.09 141.12 31.35 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 43.5 p90 -131.1 164.3 25.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.6 m -117.45 127.14 53.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.232 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.594 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 16.6 p -92.15 128.22 37.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 91.8 m-85 -90.63 131.87 36.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.458 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 29.6 tt0 -81.74 116.37 21.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.314 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.504 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 mp -92.83 109.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.707 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 27.5 mtp180 -100.29 136.09 40.72 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.765 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.49 135.67 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 112.337 -178.457 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 15.5 ttmt -124.39 139.82 53.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.024 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -170.55 164.32 8.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.4 0.619 . . . . 0.0 112.317 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -118.55 27.35 8.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.949 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 29' ' ' LEU . 23.0 mt -60.98 141.88 93.19 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.751 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.5 Cg_exo -76.04 -33.04 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.569 2.179 . . . . 0.0 111.524 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -63.05 -41.91 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.807 177.108 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 145' ' ' LEU . 3.5 m-30 -68.95 -26.52 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' C ' ' HD2' ' A' ' 61' ' ' LYS . 1.9 tmmm? 73.81 -60.64 0.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.69 -7.83 58.84 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.126 -0.359 . . . . 0.0 110.684 -173.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 5.4 mmtp 70.25 -40.83 0.48 Allowed 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.063 0.852 . . . . 0.0 111.24 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.9 pp20? -161.16 136.48 7.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 167.79 13.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 19.0 m -141.81 137.17 31.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.191 0.52 . . . . 0.0 111.559 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -132.74 -176.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.088 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 8.3 ptp180 -150.33 116.21 5.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.929 173.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 24.4 mmm180 -135.01 160.44 38.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.874 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 32.9 ptt180 -89.8 172.63 8.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -169.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 26.7 t80 -54.46 -41.88 69.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.247 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 t -55.42 -33.98 64.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.314 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.66 -37.47 73.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.504 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 61.7 m-85 -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.0 mt-10 -60.08 -53.48 57.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.754 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.444 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 3.1 t-105 -67.57 -27.9 67.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.403 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.0 tm? -70.49 -41.71 72.34 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 57.2 ttt180 -59.06 -60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.733 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 7.5 p -61.45 -37.13 82.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.373 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.96 -49.99 72.01 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.132 0.27 . . . . 0.0 110.755 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.6 mt -61.44 -34.36 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.909 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 32.2 mt-10 -75.22 -18.54 60.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.805 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HG2' ' O ' ' A' ' 79' ' ' SER . 31.7 mmt180 -80.28 -62.99 1.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.208 0.528 . . . . 0.0 111.81 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -88.73 -21.52 23.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.264 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 87' ' ' VAL . 16.2 m -123.75 169.39 11.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.314 0.578 . . . . 0.0 111.263 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -100.45 32.36 3.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.219 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 85' ' ' SER . 80.8 t -53.08 142.04 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.145 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.7 p -71.21 36.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.737 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.55 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -59.51 116.37 16.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 O-C-N 122.055 -0.403 . . . . 0.0 110.953 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.3 Cg_endo -85.36 162.72 11.2 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.783 2.322 . . . . 0.0 112.606 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 131.86 33.94 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.898 2.399 . . . . 0.0 112.112 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD11 ' HA ' ' A' ' 75' ' ' GLU . 62.5 mt -63.99 152.0 88.41 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.555 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 2.8 Cg_exo -75.52 129.74 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.689 2.26 . . . . 0.0 111.202 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -179.23 48.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.3 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' N ' HD23 ' A' ' 98' ' ' LEU . 10.6 mptt 66.58 -58.12 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.088 0.955 . . . . 0.0 112.185 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -71.75 -22.03 61.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.499 -170.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.696 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -65.71 -45.61 82.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.005 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 22.19 8.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.388 0.613 . . . . 0.0 110.38 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.3 tp60 -115.97 -45.56 2.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.638 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 46.5 mt -82.26 169.4 18.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.521 -174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.04 145.41 73.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.743 2.295 . . . . 0.0 111.054 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.5 -71.19 0.38 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.075 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 68.83 -56.37 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.887 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.27 -169.15 37.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -53.0 -50.33 64.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.34 0.59 . . . . 0.0 111.246 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.92 -26.44 5.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.62 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.26 -13.8 8.92 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 24.9 pt -68.75 -16.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.743 -0.729 . . . . 0.0 111.44 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.94 2.15 27.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -116.08 145.31 43.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.13 0.491 . . . . 0.0 110.421 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.84 -17.5 59.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.513 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 93.2 m-20 -66.73 -60.28 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.475 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -51.42 -48.29 62.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 36' ' ' PRO . 39.0 mt -50.94 -53.32 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.355 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.24 -20.14 60.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.768 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 45.4 mm-40 -73.36 -32.96 64.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.057 0.456 . . . . 0.0 110.301 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 33.4 ttm180 -80.8 -36.45 31.71 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.48 -49.83 66.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.144 -178.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.4 pt20 -58.0 -36.75 73.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 -174.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.41 -32.67 9.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.7 tp -66.35 -35.45 80.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.1 pt-20 -72.46 -35.54 68.27 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.739 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.8 mm100 -56.49 -53.84 52.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -53.39 -52.71 58.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.296 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.0 tp -64.41 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.836 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.8 m-80 -62.11 -23.56 66.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 111.668 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.565 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 42.9 mttm -81.35 -56.19 4.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.943 0.878 . . . . 0.0 110.367 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.564 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -68.24 -11.84 14.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.332 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.21 -2.75 19.1 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.832 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.29 -1.12 5.75 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.166 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.69 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 42.6 t60 -89.64 142.03 29.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 122.65 -0.323 . . . . 0.0 110.736 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.7 Cg_exo -41.52 -48.86 5.38 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.436 3.424 . . . . 0.0 113.659 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.92 -26.63 64.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.347 -174.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.67 -47.75 10.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.86 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.71 -6.16 1.11 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.236 172.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 32.9 t-20 -83.54 -33.72 25.41 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.519 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 7.8 pt-20 -113.57 149.98 33.69 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 117.622 -1.631 . . . . 0.0 114.547 -164.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.1 tpt180 -58.14 -21.38 46.62 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 113.138 -1.846 . . . . 0.0 112.026 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 143' ' ' MET . 7.8 t -60.97 -27.68 68.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.545 0.688 . . . . 0.0 109.896 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' C ' ' A' ' 135' ' ' ALA . 1.2 tp -71.56 -31.64 67.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.251 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.492 ' HA ' ' CD ' ' A' ' 146' ' ' GLN . 57.3 t60 -69.52 -29.57 67.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.636 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.6 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.7 ptm -79.68 -29.08 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.661 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 12.8 t80 -80.15 -53.62 6.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.954 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 60' ' ' PHE . 1.2 mp -105.41 -27.74 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.174 0.512 . . . . 0.0 111.792 -172.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.492 ' CD ' ' HA ' ' A' ' 142' ' ' HIS . 31.2 mt-30 -106.43 9.7 31.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.357 -164.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.487 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.2 t70 -137.86 -177.56 4.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -83.5 -33.74 25.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 119.475 1.034 . . . . 0.0 110.257 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -143.62 143.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.643 -167.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.6 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.4 mp -75.04 108.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.924 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.8 108.36 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 28.8 mmtp -73.53 10.68 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -130.92 19.71 5.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.032 0.444 . . . . 0.0 110.142 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -174.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.308 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 96.4 m -79.46 112.47 29.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 22.7 Cg_exo -71.56 43.94 0.57 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.762 2.975 . . . . 0.0 113.143 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 31.9 m -115.01 -158.96 0.69 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 23.3 mmmt -101.07 170.02 8.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.216 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 59' ' ' ILE . 20.1 mm -60.15 -42.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.613 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 32.5 m-85 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.66 175.29 36.54 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.74 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 158.92 21.53 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.823 3.015 . . . . 0.0 110.792 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.45 -19.42 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 124.635 3.557 . . . . 0.0 115.49 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 p -71.97 -59.94 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.441 0.296 . . . . 0.0 110.446 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.477 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 16.1 m120 61.7 -178.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.357 0.598 . . . . 0.0 112.153 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -98.35 145.37 26.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.657 HD22 HD11 ' A' ' 57' ' ' LEU . 16.6 tp -150.02 130.19 13.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.835 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.8 pt-20 -139.06 112.39 8.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.987 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.634 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.7 mt -122.27 135.81 61.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.793 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.31 117.37 18.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.334 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t 178.98 -162.11 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.5 m-80 63.87 83.5 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-O 120.969 0.414 . . . . 0.0 110.322 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.6 123.76 9.29 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.424 2.082 . . . . 0.0 113.329 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.566 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 27.2 tp60 -110.63 102.71 11.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.453 HG22 ' NE ' ' A' ' 45' ' ' ARG . 27.9 m -77.5 102.06 6.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.342 0.591 . . . . 0.0 109.748 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -132.36 89.83 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.735 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.01 -166.76 31.96 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.883 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.5 t -98.69 154.96 3.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.442 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.61 -54.3 4.93 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.508 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -95.01 85.38 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 32.04 1.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.588 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 15.5 ttt180 -77.42 136.91 38.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.71 167.09 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.724 0.297 . . . . 0.0 110.41 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 m -119.56 132.3 55.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 23.4 p -92.52 127.66 38.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -93.74 131.33 39.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.976 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 20.3 tt0 -91.2 120.77 32.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.719 -173.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.38 118.21 38.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.672 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 37.7 mtp180 -107.24 130.04 54.79 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.168 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.96 138.14 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 112.439 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -118.69 140.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.693 167.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.422 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.36 164.29 7.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.243 0.544 . . . . 0.0 111.328 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.613 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 17.9 p30 -122.36 26.75 8.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.872 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 29' ' ' LEU . 18.8 mt -62.63 139.22 96.89 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.973 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.76 -41.68 5.51 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.427 2.085 . . . . 0.0 111.408 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.587 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -57.26 -42.7 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.3 m-85 -69.33 -22.44 63.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.24 -60.14 0.54 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 171.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.62 -11.06 57.77 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.239 0.472 . . . . 0.0 111.448 -171.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp 71.46 -43.05 0.55 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.001 0.813 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -153.23 135.16 14.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.061 178.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -170.57 172.47 5.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.658 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.592 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 8.0 m -140.79 136.38 32.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.203 0.525 . . . . 0.0 111.079 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 26.4 m -135.12 175.15 11.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.692 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 22.1 ptt180 -148.84 133.05 17.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.544 0.688 . . . . 0.0 111.864 172.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 73' ' ' ASP . 3.1 mmp_? -136.69 158.02 45.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.4 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 13.6 ptm180 -79.27 167.41 20.97 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.65 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 34.7 t80 -52.32 -42.65 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.534 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 15.0 m -58.24 -29.62 65.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.038 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 70' ' ' ARG . 2.2 m-20 -68.46 -38.91 81.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.518 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 52.6 m-85 -66.65 -36.97 83.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.8 mt-10 -61.83 -51.46 68.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.947 0.88 . . . . 0.0 110.071 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.56 -29.54 70.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.406 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -74.18 -44.71 52.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 45.8 ttt180 -55.59 -57.07 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.752 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.717 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 25.0 p -62.89 -40.66 98.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.142 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.659 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 5.9 mm-40 -57.41 -38.61 74.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.0 mt -72.63 -34.34 67.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.839 0.352 . . . . 0.0 110.586 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 36.2 mt-10 -73.49 -26.33 60.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.197 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 79' ' ' SER . 28.0 mmm180 -55.24 -62.52 1.62 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.73 -2.82 10.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 26.5 t -114.02 173.97 6.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.411 0.624 . . . . 0.0 111.162 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -107.55 20.36 18.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.222 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 89' ' ' VAL . 93.6 t -51.77 141.59 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.476 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 88' ' ' VAL . 10.0 p -73.48 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.532 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.594 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -56.38 120.18 33.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.873 -0.517 . . . . 0.0 110.9 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 92.3 Cg_endo -85.62 163.03 10.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.354 2.703 . . . . 0.0 112.269 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.55 138.18 44.95 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.793 2.329 . . . . 0.0 112.339 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.8 mt -67.33 156.42 88.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.558 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -90.26 109.37 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.146 2.564 . . . . 0.0 111.876 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . 177.81 70.51 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.226 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -143.01 -8.59 0.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.78 0.324 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -115.21 -84.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -171.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.438 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -48.79 -32.85 9.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.518 1.127 . . . . 0.0 113.688 -171.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.806 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -57.64 -49.42 76.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.832 0.349 . . . . 0.0 111.568 -172.665 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -102.31 20.24 17.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.49 0.662 . . . . 0.0 110.483 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.7 tp60 -113.61 -34.3 5.58 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.446 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 86.5 mt -83.95 176.74 3.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -66.27 -146.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.654 2.236 . . . . 0.0 112.238 172.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 79.9 m-85 -121.0 -89.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.141 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HD2' ' OD1' ' A' ' 111' ' ' ASP . 63.1 mtt180 68.35 -48.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.799 0.687 . . . . 0.0 111.429 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.2 -150.01 8.64 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -90.08 -30.87 17.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.134 0.492 . . . . 0.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB2' HG23 ' A' ' 109' ' ' ILE . 12.4 m-20 -111.99 -27.76 8.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.733 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 105.37 25.34 6.71 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.398 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.585 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 26.3 pt -73.23 -14.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.482 . . . . 0.0 111.749 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -77.61 -8.15 57.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.771 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 104' ' ' ARG . 0.7 OUTLIER -93.32 119.9 32.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.392 172.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.32 -33.03 71.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.949 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.595 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 94.4 m-20 -55.38 -56.16 23.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.236 0.335 . . . . 0.0 110.354 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -46.75 -50.75 17.62 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.564 0.54 . . . . 0.0 111.057 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 38.3 mt -50.66 -51.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.07 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.54 -18.81 47.31 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.78 -177.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 33.4 mt-10 -76.36 -30.94 57.78 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 109.713 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 16.3 tpp180 -74.81 -42.57 57.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 170.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -53.95 -52.06 61.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.328 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.762 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.7 pt20 -59.11 -36.93 76.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 -175.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLN . . . -88.85 -32.92 10.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.051 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.4 tp -67.74 -34.9 77.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.864 -0.198 . . . . 0.0 110.945 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.2 pt-20 -71.79 -31.93 67.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.762 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 10.3 mm100 -59.07 -58.21 9.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.432 ' CE1' HG11 ' A' ' 129' ' ' VAL . 1.8 t80 -51.08 -51.86 49.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.011 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -62.92 -39.68 86.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -62.5 -19.91 64.07 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.9 mptp? -83.36 -58.69 2.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.834 0.826 . . . . 0.0 110.063 173.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.652 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -64.84 -11.84 11.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.281 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -107.17 -12.12 15.45 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.435 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -128.85 3.92 6.47 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.964 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.716 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.9 t60 -91.89 142.42 26.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 117.133 0.466 . . . . 0.0 110.216 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.716 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.1 Cg_exo -41.23 -47.34 5.36 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.173 3.248 . . . . 0.0 113.364 -174.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -70.41 -34.25 72.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.098 -175.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.8 -45.9 33.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.348 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.49 -6.53 1.1 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 173.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t30 -95.9 -20.01 19.11 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.869 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 29.7 mm-40 -103.49 136.79 42.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -165.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -56.98 -20.18 22.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.854 -171.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.3 m -54.76 -33.99 62.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.891 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.583 ' O ' HD22 ' A' ' 145' ' ' LEU . 8.0 mp -73.43 -34.03 65.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.109 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 27.9 t-80 -57.45 -34.9 69.46 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.185 0.517 . . . . 0.0 110.345 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.686 ' HE2' HG23 ' A' ' 150' ' ' ILE . 4.2 ptm -83.24 -30.03 28.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.0 t80 -72.7 -49.49 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -94.02 -42.74 8.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.079 -175.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 21.1 mp0 -88.01 0.75 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.849 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.53 ' OD1' HD12 ' A' ' 149' ' ' ILE . 8.8 t70 -141.8 150.89 42.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.909 0.385 . . . . 0.0 110.138 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.611 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.9 pm0 -75.11 -31.85 61.25 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.108 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.611 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -136.73 120.78 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.645 -170.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.686 HG23 ' HE2' ' A' ' 143' ' ' MET . 11.0 mt -63.82 122.47 14.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.356 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.31 99.57 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.697 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HD3' HG22 ' A' ' 150' ' ' ILE . 33.4 mmtp -68.27 -3.98 12.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.866 0.365 . . . . 0.0 111.516 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.4 m -116.58 20.62 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.471 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -64.42 -171.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.93 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.3 m -82.26 111.72 30.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.448 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 19.2 Cg_exo -71.62 73.85 2.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.579 2.853 . . . . 0.0 111.987 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -152.36 -148.62 0.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.776 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -99.73 -178.0 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.93 0.871 . . . . 0.0 112.091 -176.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.582 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -76.71 -35.23 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.616 175.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.173 -171.187 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.536 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 7.6 m-85 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 121.158 0.504 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.54 43.99 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.678 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.3 Cg_endo -50.89 156.23 4.96 Favored 'Trans proline' 0 CA--C 1.526 0.103 0 C-N-CA 124.32 3.347 . . . . 0.0 112.33 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 73.1 Cg_exo -51.29 -8.87 0.24 Allowed 'Trans proline' 0 N--CA 1.482 0.82 0 C-N-CA 124.504 3.469 . . . . 0.0 115.213 -174.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -71.42 -63.92 1.02 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.601 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.1 m120 59.54 172.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.669 0.605 . . . . 0.0 111.979 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -95.63 140.93 29.75 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 57' ' ' LEU . 13.5 tp -144.88 131.26 19.68 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.343 0.592 . . . . 0.0 110.956 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.23 102.4 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.024 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' VAL . 54.8 mt -113.49 140.01 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -139.05 112.8 8.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.174 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.1 m -96.99 133.45 38.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 16.3 t 178.75 -161.64 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 66.96 78.87 0.24 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.187 0.518 . . . . 0.0 110.227 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.48 119.44 5.23 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.688 2.258 . . . . 0.0 113.355 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' THR . 43.7 tp60 -107.73 113.58 26.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.964 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 m -76.04 98.56 4.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.411 0.624 . . . . 0.0 109.478 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.34 91.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.976 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.41 -167.04 31.91 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.702 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.4 t -110.71 154.67 12.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 CA-C-O 119.28 -0.391 . . . . 0.0 109.996 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.6 3.24 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.625 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.86 88.53 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.283 0.563 . . . . 0.0 109.837 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.64 36.35 0.79 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.497 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 5.5 ttp180 -86.23 130.45 34.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.38 171.72 14.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.054 0.454 . . . . 0.0 111.361 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 98.3 m -121.79 129.64 52.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.576 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.2 p -92.57 130.0 38.34 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -93.43 131.5 38.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 9.8 tt0 -88.29 118.02 27.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.562 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.18 108.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 66.7 mtp180 -92.96 135.88 33.76 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.069 173.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.56 135.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 111.868 177.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -123.88 134.87 53.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.3 t -169.48 164.45 10.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.499 0.666 . . . . 0.0 112.01 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.501 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 31.2 p30 -118.76 23.19 11.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.285 171.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 29' ' ' LEU . 24.7 mt -57.91 141.11 81.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.955 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.56 -16.25 21.49 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.709 2.272 . . . . 0.0 111.463 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.821 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -86.12 -40.99 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.557 -178.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.2 m-85 -70.05 -8.31 48.29 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -166.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER 70.87 -69.79 0.17 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -84.25 -5.81 59.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.968 -0.457 . . . . 0.0 110.682 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HD2' ' CE1' ' A' ' 22' ' ' TYR . 5.0 mmtp 70.68 -43.89 0.57 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.122 0.889 . . . . 0.0 111.418 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -158.86 130.03 6.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.231 0.538 . . . . 0.0 110.063 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.7 t -170.24 173.74 5.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.486 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.588 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 28.6 m -141.86 123.05 14.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.416 0.627 . . . . 0.0 111.469 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 23.6 m -114.17 179.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.105 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 30.9 ptt180 -150.45 126.85 10.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.25 0.548 . . . . 0.0 111.204 171.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -138.53 177.25 8.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.247 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -83.65 167.34 17.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.258 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.562 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.6 t80 -60.29 -39.66 87.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.527 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 18.5 m -58.55 -27.08 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.679 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -77.31 -34.22 55.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.621 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 35.8 m-85 -63.95 -38.79 92.37 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.2 mt-10 -57.12 -56.25 24.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.158 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -65.15 -28.39 69.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.392 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 2.9 tm? -71.63 -38.99 70.71 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.559 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 49.6 ttt180 -62.16 -61.47 2.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.042 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.544 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 8.8 p -57.52 -38.03 73.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.278 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.622 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 1.0 OUTLIER -58.31 -47.62 83.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.33 -36.67 84.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.186 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 62.5 mt-10 -69.04 -30.74 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.497 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' SER . 27.8 mmt180 -80.26 -58.93 2.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.661 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.85 -25.48 63.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.511 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.52 -178.72 6.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.725 0.774 . . . . 0.0 112.323 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.86 23.38 8.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.526 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.5 t -45.89 139.71 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.6 p -70.09 33.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.074 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.559 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -54.86 120.55 29.29 Favored Pre-proline 0 CA--C 1.531 0.241 0 O-C-N 122.134 -0.354 . . . . 0.0 111.0 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.61 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 90.1 Cg_endo -85.85 164.29 10.38 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.953 2.435 . . . . 0.0 112.584 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.6 132.1 29.86 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 84.5 mt -66.97 143.81 98.18 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.452 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 10.5 Cg_exo -72.11 108.63 2.52 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.416 2.077 . . . . 0.0 111.014 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . -172.68 30.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.814 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -131.89 7.64 4.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 110.503 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.16 -90.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -53.7 -29.64 40.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -60.85 -49.13 78.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.041 0.448 . . . . 0.0 110.58 -174.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.58 26.18 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.496 0.665 . . . . 0.0 109.922 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.3 tt0 -123.02 -36.91 2.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -176.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.9 mt -92.49 165.39 19.52 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.28 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.58 164.31 35.98 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.328 2.685 . . . . 0.0 111.257 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.17 -76.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.697 0.284 . . . . 0.0 111.474 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 69.13 -63.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.205 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.07 -150.61 26.84 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.514 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.23 -41.79 96.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.941 0.401 . . . . 0.0 110.389 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -138.28 -17.45 1.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.692 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.9 10.92 23.72 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.324 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.2 pt -83.34 -18.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 0.0 111.872 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -85.8 -2.01 57.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.252 0.549 . . . . 0.0 110.439 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.47 127.45 34.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.851 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.34 -30.83 67.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.1 m-20 -56.1 -60.29 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -53.78 -47.82 70.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.092 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.52 -47.33 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.105 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -75.05 -21.89 58.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -178.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 73.5 mm-40 -71.53 -35.57 70.74 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.262 0.553 . . . . 0.0 109.761 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 10.9 tpp180 -76.89 -35.8 57.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.4 -53.8 54.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.458 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 11.1 pt20 -58.75 -40.79 84.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.067 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.16 -37.34 28.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.963 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -65.6 -34.19 77.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.564 0.182 . . . . 0.0 111.272 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.698 ' HB3' HG22 ' A' ' 33' ' ' VAL . 7.4 pt-20 -78.09 -31.47 50.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.441 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.3 mm100 -59.59 -58.58 7.98 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.5 t80 -49.2 -53.32 21.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.906 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.0 tp -65.04 -40.75 90.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.19 -19.91 62.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 111.65 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.61 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.3 mttm -87.21 -56.61 3.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.661 0.743 . . . . 0.0 110.731 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.578 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.24 -11.65 14.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.974 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.93 -6.29 17.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.291 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.42 10.58 5.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.307 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.2 t60 -98.19 140.62 21.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.511 -0.405 . . . . 0.0 110.41 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.51 -48.86 5.36 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.306 3.337 . . . . 0.0 113.672 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.83 -33.16 73.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.323 -175.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.74 -44.41 41.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.912 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -63.82 -0.74 1.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.005 173.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 16.9 t-20 -111.16 -2.87 15.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 47.1 mm-40 -112.84 132.31 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.111 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HA ' HD13 ' A' ' 159' ' ' ILE . 6.4 tpp85 -53.82 -25.81 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.418 -172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 m -51.26 -34.46 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.459 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -67.4 -33.1 74.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.413 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 146' ' ' GLN . 9.5 t60 -62.5 -40.12 95.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.098 0.475 . . . . 0.0 109.748 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.568 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.6 ptm -77.95 -26.18 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.975 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 21.4 t80 -79.75 -63.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.116 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -110.83 -4.29 15.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.566 ' HG3' HD12 ' A' ' 145' ' ' LEU . 12.0 mt-30 -117.92 23.59 11.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.853 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.55 -142.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.457 ' HG3' HG13 ' A' ' 149' ' ' ILE . 7.3 tp10 -121.08 -56.76 1.91 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.85 0.834 . . . . 0.0 109.511 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -129.65 139.77 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.107 -176.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -66.26 112.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 100.73 13.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.21 -7.96 10.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.1 m -108.91 17.88 21.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.405 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.3 OUTLIER -66.49 -172.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.658 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.4 m -92.06 114.82 63.3 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.68 83.1 1.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.923 2.415 . . . . 0.0 111.251 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 89.3 p -145.85 -150.17 0.32 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.636 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 13.1 mmmt -95.4 164.07 12.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.821 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -63.89 -34.56 69.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.056 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.44 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 7.5 m-85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.01 174.98 45.42 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.162 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.14 158.37 14.99 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 124.304 3.336 . . . . 0.0 111.696 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.82 -24.99 0.89 Allowed 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.704 3.602 . . . . 0.0 115.267 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -68.81 -58.51 4.08 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.8 m120 57.96 -170.59 0.11 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.953 0.406 . . . . 0.0 111.663 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -103.34 139.41 38.79 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 57' ' ' LEU . 16.9 tp -150.3 131.88 14.85 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.675 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.48 99.43 3.49 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.015 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.687 HG12 ' HB ' ' A' ' 53' ' ' VAL . 29.1 mt -111.81 140.74 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.605 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.92 129.15 29.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.653 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.6 m -112.96 134.13 56.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 t 179.32 -162.58 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.3 m-80 62.77 68.86 0.94 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-O 121.132 0.491 . . . . 0.0 109.837 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.25 138.04 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.794 2.329 . . . . 0.0 113.162 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.534 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.4 tp60 -121.93 108.34 13.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.8 m -75.25 95.27 3.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.52 0.676 . . . . 0.0 109.646 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -121.9 92.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.232 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -167.23 32.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.524 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -101.34 150.17 6.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.589 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.05 -48.38 5.35 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.673 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -97.96 83.36 3.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.126 0.489 . . . . 0.0 110.01 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.35 35.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.468 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 19.7 ttt180 -83.35 127.89 34.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.679 0.276 . . . . 0.0 110.367 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -117.38 169.74 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.266 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.3 m -125.88 129.11 48.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.742 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 34.2 p -92.92 146.44 23.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.267 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.427 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 83.7 m-85 -118.5 142.64 47.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.133 0.492 . . . . 0.0 110.403 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 38.5 tt0 -90.15 117.96 29.31 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.565 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.4 mp -93.06 120.47 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.864 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 51.7 mtp180 -109.53 131.73 54.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.936 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.687 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.82 136.71 43.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.848 0.356 . . . . 0.0 111.575 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 10.9 ttmt -125.93 135.07 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 t -169.62 165.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.701 0.762 . . . . 0.0 112.763 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -117.11 26.16 9.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.768 167.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.712 HD11 HD22 ' A' ' 29' ' ' LEU . 18.6 mt -61.06 135.89 93.52 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.379 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -68.79 -38.01 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.405 2.07 . . . . 0.0 111.351 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.49 -40.82 87.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.14 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.0 m-85 -68.77 -25.26 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 73.25 -64.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 ' HG2' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -76.77 -6.03 50.6 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.899 -0.501 . . . . 0.0 110.282 -175.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.0 mmpp? 70.91 -37.94 0.41 Allowed 'General case' 0 C--O 1.22 -0.487 0 O-C-N 123.936 0.772 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.8 pp20? -162.04 142.93 10.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -170.24 169.2 7.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 13.6 m -141.4 135.57 30.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.706 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.569 HG21 HH21 ' A' ' 69' ' ' ARG . 0.5 OUTLIER -147.09 134.87 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.408 -171.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 41.0 ttp180 -99.1 111.25 23.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.936 0.398 . . . . 0.0 110.139 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.659 HH11 HD12 ' A' ' 150' ' ' ILE . 56.2 mtt-85 -124.99 178.1 5.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.476 -173.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -95.23 155.98 16.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.754 0.311 . . . . 0.0 111.306 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 32.5 t80 -59.59 -37.98 79.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 109.924 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 34.4 t -59.64 -30.06 68.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.854 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.87 -39.51 83.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.53 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 51.4 m-85 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HG2' HD13 ' A' ' 92' ' ' LEU . 12.8 mt-10 -71.97 -49.11 40.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.503 0.668 . . . . 0.0 110.539 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.487 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.8 t-105 -65.82 -28.27 68.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.71 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.49 -42.0 59.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 64.2 ttt180 -57.72 -59.2 5.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 6.4 p -60.04 -41.47 92.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.573 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.09 -45.99 79.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.674 0.273 . . . . 0.0 111.253 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 135' ' ' ALA . 96.4 mt -65.89 -40.72 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.06 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 73.5 mt-10 -65.53 -45.13 84.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.466 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.6 mmt180 -66.96 -60.78 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.92 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -77.73 -18.93 56.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.463 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 t -134.8 -175.82 4.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.472 0.653 . . . . 0.0 111.315 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -109.58 13.44 23.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.29 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -42.09 140.16 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.518 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.8 p -71.17 36.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.857 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -57.48 119.71 34.72 Favored Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 122.046 -0.409 . . . . 0.0 111.014 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.591 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 96.1 Cg_endo -87.71 167.1 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.93 2.42 . . . . 0.0 112.488 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.5 Cg_endo -66.5 146.87 81.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.699 2.266 . . . . 0.0 112.756 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' A' ' 75' ' ' GLU . 50.0 mt -73.44 158.87 85.96 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.56 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 67.6 Cg_endo -87.5 108.86 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.754 2.303 . . . . 0.0 111.466 174.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.54 38.71 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.433 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -145.28 42.24 1.28 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.63 -83.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.158 0.504 . . . . 0.0 112.181 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -52.05 -24.78 7.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.339 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -61.14 -43.53 98.74 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.16 24.64 8.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.809 0.814 . . . . 0.0 109.686 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -120.42 -40.08 2.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.045 -177.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.65 166.24 26.03 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.356 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.405 ' HG2' ' NH1' ' A' ' 104' ' ' ARG . 15.0 Cg_exo -70.4 -163.62 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.411 2.741 . . . . 0.0 112.726 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.89 -91.09 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.538 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' PRO . 73.1 mtm-85 65.31 -70.86 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.503 0.721 . . . . 0.0 111.855 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.53 77.15 0.32 Allowed Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.603 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.4 t0 67.84 -69.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 110.857 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -125.17 -7.21 7.1 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.17 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.22 8.53 35.76 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 48.5 pt -82.62 -18.25 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.78 -175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.18 -8.72 59.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.538 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.84 139.27 30.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.83 -22.59 64.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.69 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 91.4 m-20 -63.25 -59.02 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -54.28 -48.37 71.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.728 0.299 . . . . 0.0 110.753 177.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.3 mt -52.77 -45.54 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.786 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -73.53 -23.32 59.98 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.327 -178.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 39.4 mm-40 -70.78 -32.62 69.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.447 0.641 . . . . 0.0 109.78 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.3 ttm180 -79.89 -39.65 30.02 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -54.22 -49.91 68.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.825 -178.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -59.92 -40.36 88.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -84.08 -31.82 24.93 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.065 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.7 tp -65.61 -35.69 81.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.297 0.239 . . . . 0.0 111.063 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.737 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.9 pt-20 -76.73 -35.39 57.83 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.7 mm100 -56.71 -55.46 33.86 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.525 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.4 t80 -51.23 -54.05 29.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.732 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.3 tp -64.35 -38.22 81.99 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.161 -170.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -64.03 -21.67 66.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 39.7 mttm -85.15 -55.03 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.757 0.789 . . . . 0.0 110.763 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.57 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.38 -12.4 15.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.816 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.33 8.81 21.51 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.332 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.6 9.24 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.658 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 47.7 t60 -100.87 140.91 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.637 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.658 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.3 Cg_endo -46.17 -48.03 13.73 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.709 2.939 . . . . 0.0 112.936 -172.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.66 -30.01 69.44 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.039 -176.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -79.08 -43.79 23.45 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.655 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.9 mm100 -66.85 -7.69 23.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.245 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.449 ' OD1' ' HE2' ' A' ' 158' ' ' LYS . 6.3 t-20 -92.23 -15.37 27.61 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.632 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 45.7 mm-40 -105.73 130.84 53.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.608 -170.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HA ' HD13 ' A' ' 159' ' ' ILE . 19.2 tpt180 -56.7 -25.87 55.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.592 -172.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 143' ' ' MET . 1.2 p -60.32 -21.24 61.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.7 mp -70.01 -35.6 74.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.878 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 36.1 t60 -56.65 -35.35 68.26 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.122 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.622 ' HG3' HG13 ' A' ' 150' ' ' ILE . 3.8 ptm -82.66 -34.0 27.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.639 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.476 ' N ' ' HG2' ' A' ' 143' ' ' MET . 11.2 t80 -82.11 -26.71 33.33 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.492 HD13 ' CE1' ' A' ' 60' ' ' PHE . 2.3 mt -99.48 -46.89 5.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.37 0.605 . . . . 0.0 109.837 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 34.4 mt-30 -91.75 175.89 6.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.852 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 59.59 -168.92 0.15 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -98.31 -34.11 10.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.556 0.693 . . . . 0.0 110.768 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.72 166.1 15.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.35 -166.22 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.659 HD12 HH11 ' A' ' 69' ' ' ARG . 1.9 mp -85.18 119.91 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.124 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -90.52 99.48 12.5 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 31.8 mmtp -67.31 -3.21 7.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.73 0.3 . . . . 0.0 111.684 -172.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.7 m -113.79 18.59 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.417 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.5 OUTLIER -66.53 -171.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.798 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.2 m -90.64 113.06 56.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.207 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.75 83.82 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.153 2.569 . . . . 0.0 111.69 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.4 m -153.36 -145.26 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.327 -0.233 . . . . 0.0 110.801 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 137' ' ' ASN . 5.5 mmmm -100.67 155.6 17.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 59' ' ' ILE . 19.5 mm -57.7 -41.07 78.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.516 . . . . 0.0 109.909 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.523 175.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.265 0.555 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.88 174.56 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.745 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.87 159.14 9.75 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.763 2.975 . . . . 0.0 111.533 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.65 -9.21 1.02 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.17 3.247 . . . . 0.0 114.569 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -73.49 -55.75 5.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.7 m120 61.48 169.94 0.11 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.7 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.405 ' HD2' ' ND2' ' A' ' 56' ' ' ASN . 1.1 p90 -84.49 130.9 34.71 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 57' ' ' LEU . 21.9 tp -141.69 129.31 21.5 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.501 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -137.81 99.36 3.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.024 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.696 HG12 ' HB ' ' A' ' 53' ' ' VAL . 44.4 mt -110.57 134.62 52.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.718 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -134.36 113.98 12.47 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -95.52 134.34 33.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t 178.43 -161.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 28.0 m-80 68.09 76.78 0.26 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HB3' HG21 ' A' ' 115' ' ' ILE . 57.6 Cg_endo -71.76 119.27 6.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.069 1.846 . . . . 0.0 112.981 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.4 tp60 -111.89 104.71 13.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.6 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.2 m -76.03 106.51 7.67 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -133.51 89.61 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.025 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.93 -167.5 32.94 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.513 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.5 t -101.08 146.89 8.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 119.324 -0.369 . . . . 0.0 110.409 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.72 -51.42 3.96 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.13 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -98.77 89.96 4.52 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.405 0.621 . . . . 0.0 109.554 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.14 29.81 1.43 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.791 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.2 ttt180 -82.46 143.12 31.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 35.0 p90 -137.66 156.62 47.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.695 0.283 . . . . 0.0 110.81 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.2 m -113.78 125.15 53.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.462 . . . . 0.0 110.879 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -92.79 143.85 25.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.397 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -103.89 141.58 35.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.377 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 20.1 tt0 -96.19 115.42 27.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.816 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -94.27 111.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 38.0 mtp180 -96.7 141.61 29.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -147.84 136.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.179 0.514 . . . . 0.0 112.174 177.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.97 142.22 51.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.734 167.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.447 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.0 t -171.49 164.68 6.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 111.261 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' ND2' ' HD2' ' A' ' 28' ' ' PHE . 32.0 p30 -116.57 21.47 13.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.766 167.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.695 HD11 HD22 ' A' ' 29' ' ' LEU . 28.6 mt -55.76 133.3 72.5 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.685 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 7.6 Cg_exo -68.83 -34.65 17.62 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.475 2.117 . . . . 0.0 111.39 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.641 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.53 -42.53 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.247 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.7 m-30 -68.29 -23.66 64.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 71.1 -61.91 0.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.545 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.8 -14.3 59.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.876 0.307 . . . . 0.0 111.021 -173.181 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp 71.46 -35.09 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.778 0.674 . . . . 0.0 111.302 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -144.32 145.9 32.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.075 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.0 t -169.58 153.41 5.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 7.5 m -141.11 130.56 23.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.138 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -127.1 172.9 13.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 32.5 ttp180 -138.24 109.8 7.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.963 0.411 . . . . 0.0 110.229 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 7.4 tpp180 -135.7 171.82 13.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -171.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 56.6 ttp180 -96.45 158.18 15.55 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.5 t80 -51.35 -41.16 60.42 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.539 0.336 . . . . 0.0 111.0 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.496 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 33.3 p -56.57 -29.62 62.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.8 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 28.3 m-20 -77.55 -30.39 52.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.22 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 46.1 m-85 -64.04 -38.74 92.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 109.679 173.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HA ' HD11 ' A' ' 92' ' ' LEU . 10.9 mt-10 -65.94 -47.97 72.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.633 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.469 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 6.1 t-105 -62.34 -35.29 78.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.703 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.658 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -65.64 -44.33 86.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.2 ttt180 -58.53 -61.33 2.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.24 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -60.12 -35.12 74.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.856 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 5.5 tp10 -66.54 -44.88 81.22 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.297 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.61 -42.36 96.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.858 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 30.8 mt-10 -64.53 -33.12 75.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.953 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 83' ' ' ARG . 4.6 ppt_? -90.18 -23.34 21.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -172.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.32 -41.61 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.033 0.444 . . . . 0.0 111.648 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -130.67 174.87 9.5 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.532 0.682 . . . . 0.0 111.227 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -97.12 32.5 2.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.702 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 94.6 t -51.54 142.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.958 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.5 p -71.28 35.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -56.5 119.31 27.65 Favored Pre-proline 0 N--CA 1.467 0.406 0 O-C-N 121.873 -0.517 . . . . 0.0 111.167 -176.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 163.31 10.7 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.146 2.564 . . . . 0.0 112.411 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.22 135.15 39.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.886 2.391 . . . . 0.0 112.304 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 75' ' ' GLU . 81.8 mt -64.58 152.02 90.56 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.91 124.31 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.46 2.107 . . . . 0.0 110.811 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.0 175.9 47.74 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 68.91 -54.41 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.659 0.784 . . . . 0.0 112.162 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -47.57 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -172.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -65.31 -24.08 67.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.669 -170.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.747 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -67.4 -46.62 72.69 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.972 0.415 . . . . 0.0 110.602 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.1 ppt_? -95.89 27.26 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.469 0.652 . . . . 0.0 110.395 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -123.27 -42.39 2.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.12 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.79 168.51 11.1 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.471 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.8 140.45 46.47 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.252 2.635 . . . . 0.0 111.151 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -82.48 -75.47 0.3 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 69.78 -56.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.98 -175.91 48.9 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.516 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.44 -51.4 27.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.388 0.613 . . . . 0.0 110.656 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 109' ' ' ILE . 6.8 t70 -117.33 -32.97 4.79 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.53 176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.11 -6.55 7.72 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.289 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.713 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 33.5 pt -66.53 -15.15 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.176 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -78.04 -13.03 60.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.666 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 -17.45 63.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.934 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 47.6 m-80 -73.89 -57.87 3.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.713 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -48.51 -50.56 31.33 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.343 0.402 . . . . 0.0 110.911 178.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.544 HG21 ' HB3' ' A' ' 36' ' ' PRO . 49.4 mt -49.65 -54.81 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.331 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.69 -17.89 58.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.791 -175.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 67.9 mm-40 -73.27 -35.15 66.14 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.935 0.398 . . . . 0.0 110.481 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 32.7 ttp180 -81.2 -32.48 33.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.99 -50.67 71.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -60.43 -32.65 71.56 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.544 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 -33.58 10.01 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.734 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.3 tp -66.35 -33.36 75.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.206 0.203 . . . . 0.0 111.223 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 33' ' ' VAL . 11.9 pt-20 -75.29 -31.85 60.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.9 mm100 -59.97 -59.66 5.07 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.474 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -45.84 -51.63 12.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.033 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.557 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.5 tp -65.36 -39.53 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.984 -172.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.85 -16.14 60.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -87.68 -57.8 2.81 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.914 0.864 . . . . 0.0 110.01 174.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.534 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.49 -13.12 13.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.043 -177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.75 4.68 23.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.32 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.07 10.91 2.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.71 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.678 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 51.4 t60 -101.19 141.39 22.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 117.176 0.488 . . . . 0.0 110.665 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.4 Cg_exo -40.87 -49.01 4.51 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.131 3.221 . . . . 0.0 113.822 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.84 -25.73 63.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.441 -174.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.11 -40.78 17.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.926 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -68.78 -0.13 5.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.103 176.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 58.1 t30 -112.14 10.9 20.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.07 131.79 50.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.002 -0.437 . . . . 0.0 111.013 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -55.67 -17.49 5.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -175.398 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.725 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.2 m -55.33 -31.14 61.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.699 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.7 mp -73.63 -35.32 65.3 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.667 -0.646 . . . . 0.0 111.484 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 9.9 t60 -58.53 -39.22 79.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.725 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -76.02 -27.71 57.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.795 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t80 -81.03 -57.87 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -84.47 -26.21 28.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.149 -172.064 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 9.2 mt-30 -113.83 167.24 10.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.531 -166.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.07 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.885 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -175.04 -60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.577 0.703 . . . . 0.0 111.316 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG23 ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -121.9 144.49 30.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.868 -171.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.606 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -65.85 100.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.28 102.23 5.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.416 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 32.2 mmtp -69.88 6.55 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.707 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.4 m -120.81 18.19 11.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.357 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -66.74 -171.32 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.267 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.3 m -87.51 114.16 57.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.901 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -71.06 78.52 1.44 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.751 2.301 . . . . 0.0 110.951 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -155.56 -168.74 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.886 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 4.6 mmmm -80.85 157.98 25.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.92 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.641 HG21 HG13 ' A' ' 59' ' ' ILE . 15.2 mm -50.57 -42.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.155 0.502 . . . . 0.0 110.069 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.83 177.17 46.24 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.607 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.9 Cg_endo -52.76 153.92 13.67 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 124.098 3.198 . . . . 0.0 112.307 175.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 77.1 Cg_exo -51.92 -14.75 2.61 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.495 3.463 . . . . 0.0 115.431 -172.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -51.07 13.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 27.9 m120 61.27 176.83 0.11 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.021 175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -90.63 137.64 32.2 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -145.15 130.54 18.7 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.978 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.41 100.45 4.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.686 HG12 ' HB ' ' A' ' 53' ' ' VAL . 48.0 mt -111.76 142.27 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.487 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -132.86 119.39 20.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -101.21 130.44 50.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t 178.96 -162.35 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.9 m-80 64.93 76.22 0.33 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.25 147.26 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.86 2.373 . . . . 0.0 113.465 -171.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 43.5 tp60 -130.99 118.85 21.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.572 172.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -77.56 95.9 4.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.63 0.729 . . . . 0.0 109.341 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.02 91.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.159 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.29 -167.38 33.03 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.355 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.0 t -104.3 145.14 13.39 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -37.97 -53.63 2.01 Favored Glycine 0 N--CA 1.463 0.472 0 O-C-N 123.182 0.301 . . . . 0.0 113.445 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -100.62 89.94 4.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.498 0.666 . . . . 0.0 109.435 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.48 35.26 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.573 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -87.77 147.31 25.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 122.957 0.503 . . . . 0.0 110.67 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -140.01 167.71 21.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.5 m -123.47 131.9 53.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 22.3 p -94.67 148.84 21.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.878 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.13 146.67 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.384 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 32.8 tt0 -103.48 121.56 43.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.366 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.806 HD13 ' HD3' ' A' ' 69' ' ' ARG . 2.0 mp -94.39 118.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.227 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HG3' HG23 ' A' ' 66' ' ' THR . 27.1 mtt180 -108.97 126.08 52.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.093 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -130.66 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.035 0.445 . . . . 0.0 112.123 -177.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.67 137.23 53.85 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.65 165.18 6.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.364 0.602 . . . . 0.0 112.227 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -117.61 26.07 9.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.971 168.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 29' ' ' LEU . 19.9 mt -60.88 140.33 93.58 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.38 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.4 -23.21 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.824 2.349 . . . . 0.0 111.688 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.06 -41.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.375 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 145' ' ' LEU . 3.0 m-85 -67.26 -27.26 67.06 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -60.2 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.15 -11.12 59.77 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.282 -0.261 . . . . 0.0 111.301 -174.158 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp 70.9 -33.5 0.27 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.798 0.686 . . . . 0.0 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.22 139.11 25.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.103 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 48.5 t -155.59 154.09 31.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.665 -176.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 52' ' ' ARG . 5.8 m -140.77 129.28 22.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.147 0.498 . . . . 0.0 110.427 171.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HB ' ' NH1' ' A' ' 69' ' ' ARG . 2.7 m -139.98 145.46 26.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.04 -175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' NH1' ' HB2' ' A' ' 37' ' ' GLN . 22.1 ttm180 -115.35 116.27 28.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.806 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.13 169.02 18.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.533 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.98 170.1 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.601 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 36.9 t80 -51.76 -40.59 60.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.575 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.559 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 21.7 m -54.34 -31.87 55.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.048 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 69' ' ' ARG . 44.9 m-20 -74.38 -35.63 63.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 58.5 m-85 -66.36 -36.55 83.16 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.689 ' HA ' HD11 ' A' ' 92' ' ' LEU . 31.4 mt-10 -60.09 -56.05 26.45 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 150' ' ' ILE . 7.2 t-105 -64.7 -28.06 69.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.372 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.52 -46.03 56.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 46.3 ttt180 -57.29 -58.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.361 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.676 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 14.4 p -60.82 -37.47 82.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.472 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -63.3 -39.01 93.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.951 0.405 . . . . 0.0 110.731 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.3 mt -62.99 -34.07 76.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.63 -22.79 53.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 79' ' ' SER . 38.9 mmt180 -68.82 -62.23 1.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.01 0.433 . . . . 0.0 111.948 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -98.63 -18.05 18.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.236 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -126.61 166.37 17.45 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.49 0.662 . . . . 0.0 111.117 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -98.51 32.78 2.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.526 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.9 t -51.81 141.33 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.864 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.3 p -71.11 35.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.929 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -59.81 120.69 52.04 Favored Pre-proline 0 C--O 1.236 0.346 0 O-C-N 121.816 -0.553 . . . . 0.0 111.144 -176.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 72.9 Cg_endo -85.65 165.32 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.843 2.362 . . . . 0.0 112.249 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.86 141.51 65.44 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.6 2.2 . . . . 0.0 111.883 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 75' ' ' GLU . 86.8 mt -69.05 145.48 96.52 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 7.8 Cg_exo -71.18 109.33 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.744 2.296 . . . . 0.0 111.479 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.32 46.94 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.003 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 59.08 18.62 6.54 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.913 0.485 . . . . 0.0 111.642 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -118.62 -81.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 0.0 111.627 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.71 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.72 -23.47 67.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.165 -176.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.863 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -62.93 -48.1 80.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.942 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -94.05 20.03 8.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.138 177.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -115.22 -41.9 3.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.322 -177.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 4.5 pp -107.53 169.1 7.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.2 Cg_exo -69.47 132.07 23.01 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.482 2.788 . . . . 0.0 112.66 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 13.6 m-85 -55.92 -63.47 1.17 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.78 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 73.85 -56.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.566 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -110.98 -165.95 18.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.196 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -50.85 -47.53 60.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.22 0.533 . . . . 0.0 111.611 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 109' ' ' ILE . 4.7 t70 -120.62 -29.78 4.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.68 -13.95 6.81 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.644 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 38.2 pt -64.54 -16.31 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.571 -0.814 . . . . 0.0 112.105 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 91.5 m-85 -80.06 -9.36 59.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.677 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.33 137.29 40.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.45 -17.4 61.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.224 -173.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 53.3 m-80 -69.34 -52.43 27.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.227 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.644 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -50.1 -50.63 47.76 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.478 0.486 . . . . 0.0 111.083 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.19 -52.2 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.27 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -73.48 -20.58 60.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.359 -176.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 63.3 mm-40 -72.07 -35.47 69.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 110.036 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 36.7 ttm180 -80.92 -34.98 33.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -54.44 -50.98 66.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.24 -178.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.7 pt20 -62.19 -37.46 85.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.481 -174.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.33 -34.94 12.86 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.594 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.4 tp -67.78 -32.39 72.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 122.14 0.176 . . . . 0.0 111.228 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.7 pt-20 -75.81 -29.79 58.82 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.6 mm100 -64.41 -54.17 36.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -48.85 -53.7 18.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.399 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -65.57 -40.23 87.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.878 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -61.46 -16.99 52.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.109 0.48 . . . . 0.0 111.891 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.559 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 67.2 mttt -90.45 -58.75 2.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.018 0.914 . . . . 0.0 110.69 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -66.22 -11.73 13.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.337 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.59 -0.07 20.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.506 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -132.67 6.13 5.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.407 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.693 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 30.3 t60 -100.71 143.42 26.54 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 117.028 0.414 . . . . 0.0 110.921 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.693 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 4.5 Cg_exo -43.17 -50.17 6.67 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.105 3.203 . . . . 0.0 113.266 -174.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -67.91 -28.08 67.19 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.249 -174.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -81.28 -42.7 20.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.857 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 7.6 mm-40 -62.29 -6.25 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.932 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 135' ' ' ALA . 57.8 t30 -108.75 10.1 26.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.824 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.508 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 51.0 mm-40 -115.71 126.08 53.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.951 0.405 . . . . 0.0 111.206 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -56.14 -26.18 49.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.847 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.764 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.3 p -62.2 -24.72 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 145' ' ' LEU . 2.7 mp -66.52 -33.81 76.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.653 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.529 ' HA ' ' OE1' ' A' ' 146' ' ' GLN . 33.4 t-80 -62.77 -34.85 78.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.384 -175.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.764 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -85.04 -28.16 25.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.376 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' N ' ' HG2' ' A' ' 143' ' ' MET . 31.9 t80 -81.17 -44.81 17.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.532 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.0 mt -93.05 -45.41 7.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.625 0.726 . . . . 0.0 110.574 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 142' ' ' HIS . 30.6 mt-30 -97.87 -172.71 2.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.652 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.13 -132.62 1.76 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.537 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.469 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -130.01 -37.56 1.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -148.33 161.35 6.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.53 0.681 . . . . 0.0 112.515 -168.2 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.518 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.8 mp -87.14 105.59 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.626 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.46 109.03 20.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.802 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 10.7 mptt -76.45 10.8 1.87 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.724 0.774 . . . . 0.0 111.325 -173.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -115.19 14.61 16.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.82 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -65.74 -171.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.493 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.3 m -89.38 114.0 58.68 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 23.0 Cg_exo -67.02 95.62 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.984 2.456 . . . . 0.0 110.835 174.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 9.4 t -165.95 -155.73 0.24 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.384 0.611 . . . . 0.0 110.501 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -97.92 161.94 13.49 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.847 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.654 HG21 HG13 ' A' ' 59' ' ' ILE . 22.2 mm -53.74 -47.57 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.833 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.343 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.459 ' CD2' ' HB2' ' A' ' 56' ' ' ASN . 1.9 m-85 . . . . . 0 CA--C 1.518 -0.27 0 CA-C-O 120.447 0.165 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.66 178.37 47.95 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.42 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.92 157.36 8.09 Favored 'Trans proline' 0 C--N 1.335 -0.17 0 C-N-CA 124.288 3.326 . . . . 0.0 112.392 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.96 -19.66 0.88 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.947 3.765 . . . . 0.0 115.441 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -75.22 -53.41 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.59 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.8 m120 61.11 178.4 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.588 0.355 . . . . 0.0 111.928 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -92.96 139.27 30.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 57' ' ' LEU . 18.3 tp -145.56 131.51 19.2 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.159 -176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 7.8 pt-20 -140.31 102.57 4.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.254 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.642 HG12 ' HB ' ' A' ' 53' ' ' VAL . 51.6 mt -114.05 140.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.345 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -137.12 108.91 7.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.656 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.6 m -85.85 129.52 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t 179.95 -164.3 0.06 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.4 m-80 53.34 67.81 3.42 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.51 164.51 14.42 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.96 2.44 . . . . 0.0 113.41 -168.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -142.82 116.26 9.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.797 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.494 HG22 ' NE ' ' A' ' 45' ' ' ARG . 45.6 m -80.17 89.22 5.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.561 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.1 98.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.145 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.9 -167.07 31.53 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.964 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.8 t -102.29 148.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.123 -176.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.73 -49.81 5.97 Favored Glycine 0 N--CA 1.461 0.351 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.51 85.27 3.58 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.51 36.27 0.86 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.699 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 18.0 ttt180 -81.31 150.07 28.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.82 168.64 19.31 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 m -124.61 126.57 45.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 111.143 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 p -93.62 153.84 18.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.233 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -124.02 142.01 51.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.877 0.37 . . . . 0.0 110.5 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.4 tt0 -94.26 121.45 35.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.133 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.7 mp -97.61 108.96 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 110.623 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 34.0 mtp180 -97.97 136.53 38.11 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.703 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.642 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.24 136.99 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 13.0 ttmt -125.46 138.31 54.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.812 168.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.524 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.3 t -168.5 165.53 12.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 111.834 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.459 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 33.1 p30 -119.1 24.34 10.84 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.812 169.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.67 HD11 HD22 ' A' ' 29' ' ' LEU . 28.4 mt -60.82 135.02 92.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.89 174.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.2 Cg_exo -69.85 -30.88 21.18 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.375 2.05 . . . . 0.0 111.404 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.63 HG13 HG21 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -65.22 -42.27 93.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.393 175.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.4 m-30 -68.5 -12.47 61.29 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -168.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 72.01 -66.78 0.29 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 169.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.1 -7.56 59.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 122.368 -0.208 . . . . 0.0 110.869 -173.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmpp? 70.93 -39.41 0.45 Allowed 'General case' 0 C--O 1.218 -0.592 0 O-C-N 123.873 0.733 . . . . 0.0 111.205 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.0 pp20? -157.77 141.5 15.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.094 0.473 . . . . 0.0 109.989 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.9 t -170.2 172.13 6.47 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.23 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 22.3 m -141.59 127.96 19.95 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.192 0.52 . . . . 0.0 110.492 174.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.0 m -118.61 173.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 68' ' ' ARG . 18.5 ttm180 -137.69 115.24 11.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.117 0.484 . . . . 0.0 110.511 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 3.4 mmp_? -140.92 167.44 22.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.846 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 71' ' ' TYR . 46.9 ttt180 -98.52 165.48 11.81 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.068 -173.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.524 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 40.4 t80 -50.58 -39.86 50.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.6 0.238 . . . . 0.0 111.433 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.8 p -57.03 -31.35 65.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.72 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -71.43 -38.59 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 51.2 m-85 -61.73 -42.39 98.89 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 0.0 109.949 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HA ' HD11 ' A' ' 92' ' ' LEU . 29.1 mt-10 -55.9 -55.05 37.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.321 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.447 ' CD1' HG21 ' A' ' 150' ' ' ILE . 5.8 t-105 -61.93 -33.23 73.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.312 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 2.8 tm? -71.68 -42.89 66.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.5 ttt180 -56.06 -63.95 1.02 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.139 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.596 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -59.86 -34.49 73.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.049 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.62 -43.95 96.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.098 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.51 -37.66 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.737 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 56.5 mt-10 -67.37 -33.73 75.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.277 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 79' ' ' SER . 24.4 mmt180 -76.34 -61.15 2.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.255 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -66.99 -31.51 72.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.277 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -139.16 179.68 6.37 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.67 0.748 . . . . 0.0 112.069 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -97.86 22.42 9.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.696 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 89' ' ' VAL . 84.8 t -44.54 140.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.103 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.2 p -71.42 33.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.98 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -54.88 119.8 24.42 Favored Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 122.161 -0.337 . . . . 0.0 110.697 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 93.6 Cg_endo -85.5 163.53 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.697 2.265 . . . . 0.0 112.398 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 136.05 52.55 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.841 2.36 . . . . 0.0 112.097 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 89.3 mt -69.23 149.08 97.56 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.723 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.9 Cg_exo -72.7 109.28 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.446 2.097 . . . . 0.0 110.966 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -166.45 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.559 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.58 45.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.1 -0.647 . . . . 0.0 110.35 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.8 -103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -53.54 -30.25 40.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 94' ' ' GLY . 1.8 mm? -66.74 -44.97 80.1 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.179 -0.326 . . . . 0.0 111.299 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 8.42 42.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.771 0.796 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 7.0 tp60 -97.11 -38.75 9.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.328 176.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 42.5 mt -94.32 163.69 22.39 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.58 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.11 175.94 9.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.388 2.726 . . . . 0.0 111.432 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -76.07 -79.28 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 60.62 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.585 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.87 75.53 1.08 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.874 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 69.16 -63.22 0.38 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.885 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.42 -29.84 1.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.375 0.607 . . . . 0.0 110.356 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.75 15.76 3.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.966 -173.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.703 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.1 pt -83.53 -18.95 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.387 . . . . 0.0 112.037 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.24 -9.42 59.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 109.794 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.03 118.7 23.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.653 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.06 -17.01 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.835 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 85.9 m-20 -63.35 -61.58 2.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.703 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -47.78 -51.47 22.3 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.635 0.584 . . . . 0.0 111.441 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.1 mt -50.13 -50.31 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.314 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -83.74 -14.31 51.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.817 -177.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.665 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 30.2 mt-10 -80.16 -28.12 38.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -75.71 -37.6 59.32 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.98 -52.04 67.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.055 -178.277 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.69 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -59.13 -43.3 91.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 -36.26 38.68 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.062 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -64.01 -38.6 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.811 0.306 . . . . 0.0 111.62 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.3 pt-20 -73.0 -31.13 64.3 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.7 mm100 -61.58 -59.36 5.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.5 t80 -48.82 -54.09 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.756 -1.565 . . . . 0.0 111.383 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -64.04 -41.03 91.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.031 -170.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.32 0.509 . . . . 0.0 111.836 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -90.49 -58.59 2.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.849 0.833 . . . . 0.0 110.248 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.75 -12.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.256 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.51 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -109.74 3.0 20.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.08 -8.01 2.44 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.327 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.641 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 58.9 t60 -82.49 139.81 44.58 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.8 Cg_endo -44.15 -47.31 10.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.096 3.197 . . . . 0.0 113.292 -172.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.436 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -68.61 -33.16 73.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.125 -176.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.74 -43.84 35.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.745 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.493 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.67 -6.41 3.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.229 172.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.497 ' ND2' ' HE ' ' A' ' 160' ' ' ARG . 1.7 t-20 -99.79 -6.35 27.1 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.164 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.442 ' C ' HG12 ' A' ' 159' ' ' ILE . 30.1 mm-40 -107.43 129.93 54.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.693 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.427 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -56.04 -20.34 16.43 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.584 -174.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.538 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.0 m -59.25 -30.31 68.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.359 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 145' ' ' LEU . 1.1 mp -69.79 -35.33 74.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.172 -0.33 . . . . 0.0 111.208 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.679 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 11.9 t-80 -54.25 -41.36 68.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.626 0.727 . . . . 0.0 109.691 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 3.3 ptm -81.0 -27.93 35.68 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.446 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.3 t80 -79.87 -59.17 2.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.154 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.619 HD11 ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -106.38 7.09 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -175.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 46.1 mt-30 -121.33 -176.1 3.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.65 -111.64 0.58 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.408 0.443 . . . . 0.0 110.889 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.7 pm0 -145.42 -39.13 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 112.027 175.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.06 148.69 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.161 -166.184 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.551 HG22 ' HE3' ' A' ' 152' ' ' LYS . 3.4 mp -72.25 102.84 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.812 172.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -89.74 102.94 15.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.25 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.551 ' HE3' HG22 ' A' ' 150' ' ' ILE . 5.4 mptt -74.74 11.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.296 0.57 . . . . 0.0 111.913 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -111.79 12.53 20.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.166 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -171.84 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.679 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.2 m -92.52 113.71 60.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.54 89.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.018 2.479 . . . . 0.0 110.941 174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 t -159.7 -154.63 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.395 0.617 . . . . 0.0 110.868 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -96.8 157.78 15.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.474 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.63 HG21 HG13 ' A' ' 59' ' ' ILE . 19.6 mm -57.77 -41.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.0 109.922 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HE ' ' ND2' ' A' ' 137' ' ' ASN . 4.5 mmt180 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.01 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.7 40.15 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.041 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.38 153.45 13.4 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 124.088 3.192 . . . . 0.0 111.608 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -41.13 -30.26 0.65 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 124.6 3.533 . . . . 0.0 115.504 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -70.75 -52.21 22.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 9.8 m120 61.53 -179.42 0.12 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 112.135 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.39 132.41 36.22 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 57' ' ' LEU . 13.2 tp -143.0 127.21 17.56 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.58 0.705 . . . . 0.0 111.188 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.15 100.79 3.79 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.688 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.682 HG12 ' HB ' ' A' ' 53' ' ' VAL . 46.7 mt -111.82 138.71 39.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.116 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -131.77 103.24 6.23 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -79.35 131.51 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -178.03 -165.13 0.09 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 63.06 81.73 0.22 Allowed Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 121.375 0.607 . . . . 0.0 110.432 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.13 119.59 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.123 2.549 . . . . 0.0 112.527 -175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 50.0 tp60 -108.81 106.47 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.541 174.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.8 m -77.84 103.15 7.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -134.07 89.9 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.05 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.42 -167.86 33.02 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.218 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 t -104.37 149.91 7.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.337 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.86 3.19 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 121.549 -0.357 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -96.67 86.9 4.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.647 . . . . 0.0 109.858 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.94 34.85 0.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.975 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 20.9 ttt180 -82.71 146.84 28.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -143.47 165.76 26.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.901 0.381 . . . . 0.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 36.5 m -121.78 129.02 52.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.481 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 44.0 p -92.73 140.86 29.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 98.6 m-85 -100.22 126.75 46.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.07 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.648 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 15.5 tt0 -86.17 120.34 27.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.289 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -93.34 106.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.691 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -95.44 112.03 23.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.424 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.682 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -122.66 140.68 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -126.86 136.87 52.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.244 168.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.532 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.1 t -170.65 164.54 8.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.31 0.576 . . . . 0.0 112.152 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -117.04 26.02 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.824 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 29' ' ' LEU . 26.5 mt -60.4 136.42 91.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.543 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -68.34 -32.87 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.227 1.952 . . . . 0.0 111.162 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 159' ' ' ILE . 1.1 tt -66.69 -37.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.411 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 4.0 m-30 -75.07 -5.37 43.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -169.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 tttt 67.16 -74.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.554 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.18 -4.38 55.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 120.518 0.199 . . . . 0.0 110.502 -171.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 5.5 mmtp 70.31 -42.38 0.52 Allowed 'General case' 0 C--O 1.221 -0.417 0 O-C-N 124.122 0.889 . . . . 0.0 111.496 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.19 127.27 5.67 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.408 0.623 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 t -166.97 176.22 7.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.547 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.648 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 21.5 m -140.68 122.74 15.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 111.947 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.49 -178.1 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.866 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 38.6 ptt180 -150.53 133.1 15.72 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.109 170.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 4.0 mmp_? -136.11 177.99 7.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.624 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' HD1' ' A' ' 74' ' ' PHE . 61.6 mtp180 -93.13 173.2 7.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.282 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.9 t80 -60.48 -40.52 91.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 p -60.49 -26.78 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB3' HD12 ' A' ' 150' ' ' ILE . 9.3 m-20 -73.23 -37.02 66.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.913 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 34.9 m-85 -65.98 -41.36 91.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 92' ' ' LEU . 21.8 mt-10 -55.91 -53.53 55.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.021 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.444 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.5 t-105 -64.07 -30.27 71.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.331 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -73.44 -43.96 59.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 35.5 ttt180 -56.59 -61.82 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.176 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 32.7 t -59.62 -38.54 81.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.586 -173.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -48.48 75.93 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.2 mt -63.79 -40.37 96.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.201 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.9 mt-10 -66.94 -41.84 86.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.824 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.3 mmm180 -74.96 -53.6 8.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.791 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -82.86 -25.83 32.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.101 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 m -130.46 175.3 9.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.717 0.77 . . . . 0.0 111.569 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -99.13 29.96 3.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.581 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' A' ' 89' ' ' VAL . 60.3 t -54.61 142.31 8.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.0 p -73.15 34.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.037 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.516 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -57.05 122.9 56.65 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 121.886 -0.509 . . . . 0.0 111.206 -175.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 88.7 Cg_endo -85.62 167.82 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.926 2.418 . . . . 0.0 111.868 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 150.31 64.66 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.478 2.119 . . . . 0.0 112.244 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 75' ' ' GLU . 92.6 mt -78.41 151.99 78.21 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.255 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.32 110.8 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.778 2.319 . . . . 0.0 111.154 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.3 43.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.724 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -153.18 58.74 0.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.492 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -165.43 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.626 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -59.47 -29.0 67.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.945 -173.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.444 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.3 ppt_? -99.81 29.33 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 0.0 110.196 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.2 tp60 -124.83 -41.43 2.12 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.405 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 54.1 mt -85.23 166.76 29.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.18 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 33.5 Cg_exo -60.06 143.07 99.58 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.986 2.457 . . . . 0.0 112.254 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 6.9 m-85 -73.65 -62.95 1.31 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 69.77 -60.49 0.47 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.886 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.31 -145.83 7.29 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.954 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.96 -42.47 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 111.432 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -127.87 -53.26 1.32 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -173.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 141.43 -12.57 2.74 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.599 -171.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 39.3 pt -56.12 -19.84 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -76.22 -7.29 54.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.434 . . . . 0.0 110.834 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.01 125.7 34.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -69.45 -17.94 63.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.122 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.9 m-80 -72.58 -47.41 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -49.03 -49.57 40.52 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.5 0.5 . . . . 0.0 110.71 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.95 -50.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.618 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -79.18 -16.31 56.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.849 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 65.4 mm-40 -73.31 -35.32 66.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.445 ' HD2' ' OH ' ' A' ' 49' ' ' TYR . 33.0 ttm180 -79.04 -31.89 44.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -58.91 -50.96 72.06 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.652 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.688 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -61.45 -37.56 84.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 -40.49 16.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.136 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -62.11 -35.43 78.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.9 0.35 . . . . 0.0 111.281 178.126 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 126' ' ' ILE . 15.9 pt-20 -75.52 -33.18 60.7 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.0 mm100 -61.67 -56.1 23.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -51.15 -52.77 40.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.433 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.44 -41.06 90.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.055 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -60.41 -17.99 47.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 0.0 111.981 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.9 mttm -88.25 -59.39 2.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.111 0.957 . . . . 0.0 110.593 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 126' ' ' ILE . 1.4 m -65.35 -13.13 14.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.398 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.41 -5.64 23.89 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.443 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.36 14.3 4.82 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.004 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 45.1 t60 -100.19 139.45 20.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.796 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.1 Cg_exo -41.32 -49.53 4.84 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.516 3.477 . . . . 0.0 113.706 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.68 -26.63 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.386 -174.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.492 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -86.76 -42.16 13.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.423 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.39 -2.66 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.182 170.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 135' ' ' ALA . 56.9 t30 -111.3 7.83 21.19 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.937 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -116.03 126.98 54.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.0 0.429 . . . . 0.0 111.199 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -52.46 -29.31 24.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.041 -173.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.666 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 15.5 t -63.75 -22.47 66.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.83 0.347 . . . . 0.0 111.434 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -68.45 -30.85 69.81 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.793 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 7.3 t60 -67.09 -38.09 85.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.666 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 6.3 ptm -79.61 -25.28 41.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.826 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 150' ' ' ILE . 24.7 t80 -80.17 -52.54 7.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.192 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.699 ' HG ' ' CZ ' ' A' ' 60' ' ' PHE . 3.2 mm? -78.36 -25.83 46.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.921 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 60' ' ' PHE . 8.5 mt-30 -129.48 176.7 7.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.068 -164.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.49 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 149' ' ' ILE . 9.3 tp10 177.18 -58.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.656 0.741 . . . . 0.0 110.862 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -116.24 135.85 55.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.824 -171.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 144' ' ' PHE . 46.6 mt -72.98 111.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.621 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 153' ' ' SER . 10.3 t70 -91.82 99.86 12.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.0 mptt -70.85 11.64 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 151' ' ' ASP . 25.4 m -116.06 14.03 15.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.2 174.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -61.2 -170.93 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.611 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 93.7 m -91.66 112.21 53.29 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -70.57 88.7 0.62 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.325 2.683 . . . . 0.0 111.724 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 50.1 m -156.95 -159.56 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.175 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 19.5 mmmt -91.23 160.02 15.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.619 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.29 -44.27 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.716 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.088 0.47 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.87 45.42 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.807 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 155.24 14.42 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 C-N-CA 123.889 3.06 . . . . 0.0 112.334 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -49.35 -18.67 2.35 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.853 3.702 . . . . 0.0 114.698 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.2 m -70.84 -54.19 12.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.508 ' OD1' HD23 ' A' ' 57' ' ' LEU . 27.4 m120 61.29 163.24 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.588 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -87.07 139.06 30.96 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -143.79 129.75 19.51 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.545 -177.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -142.03 101.43 3.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.72 0.771 . . . . 0.0 110.237 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.6 mt -111.04 133.68 55.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.223 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.36 100.79 6.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.279 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -78.01 128.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 106.716 -1.586 . . . . 0.0 106.716 171.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 p -176.8 -163.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 27.3 m-80 58.26 70.76 1.15 Allowed Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.398 . . . . 0.0 110.271 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 115' ' ' ILE . 97.4 Cg_endo -77.15 132.34 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.796 2.331 . . . . 0.0 113.414 -172.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.3 tp60 -119.92 107.78 13.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.546 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.532 HG22 ' NE ' ' A' ' 45' ' ' ARG . 54.6 m -78.02 96.12 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.569 0.7 . . . . 0.0 109.896 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.2 p -123.82 94.39 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.379 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.65 -165.82 30.26 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.078 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.9 t -97.22 146.43 7.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.166 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.16 -48.18 6.59 Favored Glycine 0 N--CA 1.46 0.263 0 C-N-CA 121.521 -0.371 . . . . 0.0 113.144 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.91 89.85 3.43 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.57 0.7 . . . . 0.0 109.222 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.74 33.09 0.95 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.474 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.585 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 27.8 ttt180 -85.66 146.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.057 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.43 149.47 51.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.54 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.5 m -105.19 128.29 53.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.347 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 35.9 p -93.16 144.3 25.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.87 138.75 49.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 110.767 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 34.8 tt0 -96.79 120.79 37.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.204 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.9 mp -98.64 109.82 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -96.1 145.02 25.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.699 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.68 138.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.497 . . . . 0.0 112.175 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -127.54 143.61 51.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.009 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -171.75 164.58 6.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.022 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -117.62 23.94 11.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.596 167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 29' ' ' LEU . 28.2 mt -58.57 138.58 85.87 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.713 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 2.4 Cg_endo -77.0 -24.99 9.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.5 2.134 . . . . 0.0 111.424 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.41 -42.27 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.532 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.5 m-30 -68.46 -25.59 65.07 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -170.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.63 -60.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.77 -9.02 59.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.831 0.287 . . . . 0.0 111.293 -172.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 70.0 -41.7 0.49 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.839 0.712 . . . . 0.0 110.994 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.53 144.93 36.22 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -163.81 158.12 19.7 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.5 m -142.31 136.61 29.89 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.534 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.85 176.04 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.655 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 35.2 ttp180 -137.89 113.8 9.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.03 0.443 . . . . 0.0 110.438 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 12.1 mmm180 -131.44 177.4 7.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 70' ' ' ARG . 53.7 mtm180 -100.23 172.08 7.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.29 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.6 t80 -61.81 -38.18 87.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.492 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 17.0 p -57.77 -28.62 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.248 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 150' ' ' ILE . 5.0 m-20 -70.88 -40.13 72.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.128 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.27 -40.27 95.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 109.892 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 19.9 mt-10 -61.76 -44.98 95.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.826 0.822 . . . . 0.0 110.138 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE2' ' HG3' ' A' ' 152' ' ' LYS . 7.3 t-105 -64.03 -36.31 83.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.521 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 144' ' ' PHE . 32.3 tp -70.77 -48.03 56.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.144 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 56.8 ttt180 -50.61 -60.11 3.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.2 p -61.86 -42.21 98.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.959 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.43 -49.28 64.87 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.332 0.395 . . . . 0.0 111.149 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.21 -38.4 90.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.6 mt-10 -70.89 -20.19 62.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.752 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 79' ' ' SER . 26.5 mmt180 -80.21 -61.77 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.499 . . . . 0.0 112.113 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB2' ' OE2' ' A' ' 138' ' ' GLU . 43.7 mm-40 -84.74 -22.98 29.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.054 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 m -131.98 171.88 13.04 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.687 0.756 . . . . 0.0 112.005 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -97.99 33.46 2.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.402 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 66.6 t -54.3 140.0 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.535 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.1 p -72.41 32.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.99 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 78' ' ' ARG . 1.4 t -53.56 122.36 31.88 Favored Pre-proline 0 N--CA 1.466 0.334 0 O-C-N 122.126 -0.359 . . . . 0.0 111.258 -175.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 87.2 Cg_endo -85.75 165.17 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.175 2.583 . . . . 0.0 112.514 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.8 Cg_endo -65.76 142.95 72.12 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.852 2.368 . . . . 0.0 112.285 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.7 mt -69.8 154.17 94.93 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.775 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 60.1 Cg_endo -77.52 109.11 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.506 2.137 . . . . 0.0 110.953 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.88 -177.12 37.2 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.073 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.583 ' N ' HD23 ' A' ' 98' ' ' LEU . 12.5 mptt 68.15 -63.18 0.34 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.605 0.762 . . . . 0.0 112.202 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.71 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -76.16 -22.37 55.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.542 -169.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.73 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -64.82 -42.82 94.67 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 30.11 3.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.621 0.724 . . . . 0.0 110.064 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.601 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.7 tt0 -130.06 -38.78 1.41 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.293 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG3' ' A' ' 117' ' ' GLU . 54.0 mt -90.03 169.21 12.82 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.104 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -64.34 140.43 70.21 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.636 2.224 . . . . 0.0 111.527 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 45.2 m-85 -83.15 -83.13 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.208 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 66.87 -69.4 0.13 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.862 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 110' ' ' PHE . . . -88.85 71.13 2.45 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.636 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.15 -71.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.29 1.036 . . . . 0.0 111.366 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.01 -36.4 9.03 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.827 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.73 -5.01 7.51 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.521 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.689 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.6 pt -68.92 -17.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.472 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 58.1 m-85 -81.25 -4.62 56.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.836 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -100.01 131.47 45.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.268 0.556 . . . . 0.0 109.904 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.51 -25.65 64.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.572 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.4 m-20 -64.21 -59.98 3.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.689 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.66 -47.23 58.71 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.419 0.449 . . . . 0.0 111.044 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' A' ' 36' ' ' PRO . 65.4 mt -52.72 -52.98 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.617 -174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.93 -19.52 61.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.291 -177.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 40.6 mm-40 -75.63 -31.23 59.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.437 0.637 . . . . 0.0 109.64 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.03 -39.89 32.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.7 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.64 -51.34 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.795 -178.038 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 12.4 pt20 -61.25 -41.18 96.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 93' ' ' PRO . . . -72.18 -38.67 59.02 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.563 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -67.12 -35.64 80.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.205 0.502 . . . . 0.0 111.236 178.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 126' ' ' ILE . 8.2 pt-20 -76.12 -29.04 57.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.3 mm100 -62.52 -58.86 6.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.2 t80 -51.3 -52.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.074 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' A' ' 123' ' ' GLU . 9.7 tp -63.35 -43.8 98.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -170.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -59.78 -20.12 54.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 38.3 mttm -84.0 -58.25 2.85 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.987 0.898 . . . . 0.0 110.14 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.541 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -65.3 -11.96 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.338 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -97.16 -15.41 20.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.626 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.426 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -123.68 1.89 9.38 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.281 -0.961 . . . . 0.0 114.044 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.676 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.7 t60 -89.67 141.94 28.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 117.321 0.561 . . . . 0.0 110.758 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.676 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.3 Cg_exo -40.55 -50.57 3.76 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.356 3.37 . . . . 0.0 113.774 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.34 -23.85 62.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.422 -174.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -88.36 -42.22 12.34 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.439 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.463 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.57 -4.26 1.88 Allowed 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.523 0.678 . . . . 0.0 110.256 172.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 11.9 t-20 -105.6 2.1 27.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.269 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 84' ' ' GLU . 4.9 mm-40 -114.29 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.879 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -55.48 -20.88 14.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.421 -175.111 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 143' ' ' MET . 6.0 t -65.51 -24.23 67.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.3 mp -71.6 -31.11 66.57 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.7 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 31.0 t-80 -61.73 -34.18 75.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.1 ptm -84.43 -26.16 28.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.5 t80 -78.98 -54.13 6.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.552 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.29 -33.84 22.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 0.0 110.713 -174.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 33.8 mt-30 -107.54 -175.44 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.329 -170.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 54.75 -145.05 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -117.92 -32.83 4.66 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 111.543 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -145.42 156.76 13.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.874 0.845 . . . . 0.0 113.132 -166.488 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.592 HG12 ' HG3' ' A' ' 143' ' ' MET . 81.3 mt -89.12 111.99 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.02 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -99.78 106.24 18.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.781 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' CE2' ' A' ' 76' ' ' TRP . 9.5 mptt -71.39 5.55 2.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 111.773 -171.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 m -109.31 13.74 24.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.834 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.48 -172.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.499 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 99.0 m -95.45 112.83 60.19 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -69.82 50.21 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.916 3.078 . . . . 0.0 113.262 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 71.2 m -108.69 -160.59 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.82 0.343 . . . . 0.0 110.536 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 18.5 mmmt -86.78 160.31 18.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 59' ' ' ILE . 17.5 mm -52.78 -45.87 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.547 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.306 174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.596 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.4 m-85 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.2 178.78 41.2 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.28 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.02 154.43 13.37 Favored 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 124.314 3.343 . . . . 0.0 111.866 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.39 -27.01 4.5 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 124.078 3.185 . . . . 0.0 115.354 -169.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' HD21 ' A' ' 57' ' ' LEU . 9.0 t -87.72 -33.55 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.794 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 6.7 m120 57.41 -173.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.96 128.99 34.87 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 57' ' ' LEU . 16.7 tp -141.36 130.47 23.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.129 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 7.7 pt-20 -139.19 109.0 6.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.245 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.69 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.9 mt -120.84 137.8 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 115.75 14.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -98.08 133.79 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.2 t 179.16 -161.54 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.1 m-80 62.22 68.66 1.04 Allowed Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 0.0 110.271 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.84 134.57 23.97 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.797 2.331 . . . . 0.0 113.832 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.6 tp60 -117.36 106.52 13.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.006 170.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.569 HG22 ' HE ' ' A' ' 45' ' ' ARG . 32.4 m -78.95 97.12 5.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.0 110.037 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -125.81 90.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.973 -170.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -165.41 29.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.9 t -97.02 149.13 5.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.649 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.09 -48.1 6.48 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 121.508 -0.377 . . . . 0.0 113.299 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -101.9 87.99 3.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 34.2 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.5 ttt180 -84.36 140.27 31.7 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -125.24 157.31 36.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.938 0.399 . . . . 0.0 110.408 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 m -110.35 127.72 55.2 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.079 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.629 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.2 p -92.82 128.55 38.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 87.6 m-85 -101.9 134.84 44.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 tt0 -86.91 121.76 29.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.897 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.6 mp -95.55 116.26 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 35.0 mtt180 -109.82 119.33 39.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.55 175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -123.57 142.5 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 111.953 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 15.9 ttmt -127.49 138.16 52.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 165.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -171.12 165.24 7.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.5 0.667 . . . . 0.0 111.899 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.596 ' ND2' ' HB2' ' A' ' 22' ' ' TYR . 30.8 p-10 -121.79 28.46 7.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.397 169.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 29' ' ' LEU . 17.8 mt -62.82 145.24 96.17 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.575 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.8 -15.68 13.29 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.726 2.284 . . . . 0.0 112.345 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -85.06 -41.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.75 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' HD13 ' A' ' 145' ' ' LEU . 2.3 m-30 -68.51 -29.69 68.34 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 74.25 -57.52 0.61 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.421 0.451 . . . . 0.0 112.023 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.11 -12.44 59.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.648 0.204 . . . . 0.0 111.099 -173.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp 71.93 -38.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.809 0.693 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.44 146.36 26.61 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.176 0.512 . . . . 0.0 109.911 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -170.09 159.14 7.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.196 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.4 m -140.84 136.55 32.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.416 0.627 . . . . 0.0 111.462 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 4.6 m -143.71 179.92 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.765 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 7.1 ptp180 -140.31 126.01 19.26 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.446 173.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.581 HH11 HG13 ' A' ' 150' ' ' ILE . 22.2 mmt85 -125.58 161.39 27.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.487 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -82.09 159.84 23.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 24.7 t80 -55.26 -38.31 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -59.26 -28.05 66.36 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.461 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 150' ' ' ILE . 52.2 m-20 -74.72 -37.24 62.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.187 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 57.2 m-85 -65.02 -36.16 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.937 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.1 mt-10 -63.45 -51.77 64.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 5.0 t-105 -61.64 -34.93 76.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.945 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -67.79 -44.24 77.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 66.4 ttt180 -57.14 -59.61 4.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.973 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.677 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 t -62.33 -36.01 80.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.973 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -53.93 -56.45 17.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 109.758 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.16 -35.28 76.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.296 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 20.3 mt-10 -69.37 -38.84 78.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 79' ' ' SER . 33.3 mmt180 -69.29 -60.36 2.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 0.0 111.443 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.66 -22.29 29.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.929 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -126.64 175.21 8.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.208 0.528 . . . . 0.0 112.112 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -103.0 21.03 16.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.874 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.9 t -48.01 142.0 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.125 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.89 36.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.787 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -55.61 119.6 26.05 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -175.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 86.0 Cg_endo -85.9 168.37 9.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.13 2.553 . . . . 0.0 112.325 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 147.3 70.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.697 2.265 . . . . 0.0 112.554 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 75' ' ' GLU . 78.2 mt -73.97 157.67 86.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.418 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.4 109.03 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.577 2.185 . . . . 0.0 111.439 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.5 -171.46 38.07 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.602 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 68.03 -2.75 1.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.785 0.434 . . . . 0.0 111.733 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.57 -89.98 0.46 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -52.6 -23.57 6.7 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 113.296 -174.41 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.8 mm? -60.86 -41.55 96.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.994 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 18.24 21.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.692 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 28.7 tp60 -113.71 -40.24 3.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.96 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 114' ' ' PHE . 35.8 mt -89.7 165.87 23.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.515 -175.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.02 164.15 28.57 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.081 2.521 . . . . 0.0 111.962 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -83.23 -100.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 65.78 -65.87 0.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 111.577 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.96 52.18 4.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.146 -0.55 . . . . 0.0 111.952 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 63.9 -71.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.69 1.196 . . . . 0.0 110.391 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.01 -20.06 17.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.933 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.7 14.03 20.59 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.642 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.9 pt -83.21 -16.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.989 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 70.0 m-85 -79.69 1.24 27.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.453 175.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 113' ' ' ASN . 24.9 t70 -86.45 129.92 34.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.64 -19.76 63.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.88 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB2' ' OD2' ' A' ' 111' ' ' ASP . 46.4 m-80 -74.14 -54.37 7.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -49.87 -50.05 47.11 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.748 0.655 . . . . 0.0 111.158 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.7 mt -52.26 -45.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.278 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.0 -15.24 57.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.742 -178.203 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 42.4 mm-40 -70.78 -34.69 72.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.302 0.573 . . . . 0.0 109.767 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.483 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 36.5 ttm180 -78.52 -36.37 45.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -55.13 -49.32 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.827 -178.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 9.0 pt20 -61.46 -33.72 74.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.496 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.02 -33.66 9.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.992 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 122' ' ' LEU . 7.4 tp -66.32 -33.61 76.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.138 0.175 . . . . 0.0 111.018 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.645 ' HB3' HG22 ' A' ' 33' ' ' VAL . 10.5 pt-20 -75.22 -32.47 61.16 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.6 mm100 -59.96 -59.85 4.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 4.7 t80 -45.63 -51.72 11.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.022 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.12 -39.05 84.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.83 -172.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.17 -12.53 28.65 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HD3' ' HG3' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -90.78 -59.46 2.17 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.734 0.778 . . . . 0.0 110.177 172.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.563 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -65.03 -12.19 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.056 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.02 1.5 22.49 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.354 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.87 12.95 2.4 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.509 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.69 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 54.8 t60 -100.26 140.32 21.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.987 0.394 . . . . 0.0 110.19 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.668 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 3.8 Cg_exo -43.94 -43.91 12.15 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.936 3.091 . . . . 0.0 113.54 -171.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.418 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.0 -28.72 61.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.454 -175.148 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -80.35 -41.21 25.16 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.551 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.2 mm100 -67.55 -0.67 4.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.528 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 5.0 t-20 -100.71 -7.01 24.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.386 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -117.52 132.7 56.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -49.44 -31.86 10.67 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.556 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.6 p -58.83 -25.2 62.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 111.6 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -70.52 -33.88 71.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -55.51 -41.17 72.72 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.303 0.573 . . . . 0.0 109.7 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.577 ' HB3' ' HA ' ' A' ' 150' ' ' ILE . 1.8 mpp? -66.81 -56.66 9.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.61 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' HD11 ' A' ' 150' ' ' ILE . 2.4 t80 -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.053 -1.43 . . . . 0.0 112.856 -173.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.688 HD13 ' CE1' ' A' ' 60' ' ' PHE . 1.5 mt -99.2 -40.73 7.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.054 0.454 . . . . 0.0 112.117 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.4 -49.44 5.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -168.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.411 ' O ' HG11 ' A' ' 67' ' ' VAL . 74.8 m-20 -73.66 -178.67 3.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -83.74 -30.95 26.26 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.459 0.647 . . . . 0.0 110.246 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -149.5 158.86 5.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.237 -169.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 144' ' ' PHE . 70.9 mt -86.4 111.81 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.103 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' A' ' 143' ' ' MET . 52.2 t0 -82.48 113.86 20.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.018 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.4 mptt -77.13 -3.13 37.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.91 0.862 . . . . 0.0 110.234 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.5 t -108.7 19.6 19.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.342 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.546 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 6.2 p90 -61.16 -174.18 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.959 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.472 HG22 ' OG ' ' A' ' 157' ' ' SER . 73.6 m -93.02 108.26 31.14 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.404 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 35.6 Cg_exo -65.87 92.54 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.321 2.68 . . . . 0.0 111.734 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 155' ' ' THR . 4.9 p -164.68 -169.62 1.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -174.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.6 mmmm -81.61 152.2 27.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.004 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.556 HG13 HD12 ' A' ' 59' ' ' ILE . 12.1 mm -52.56 -42.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.373 0.606 . . . . 0.0 110.328 173.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.408 ' H ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.795 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 120.614 0.245 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.03 178.27 48.21 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.049 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.8 Cg_endo -52.17 156.2 8.02 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 124.145 3.23 . . . . 0.0 112.323 175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 88.3 Cg_exo -50.53 -17.32 2.79 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 124.496 3.464 . . . . 0.0 114.831 -173.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.9 m -76.29 -51.21 12.45 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.7 m120 60.95 176.08 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.555 0.535 . . . . 0.0 111.382 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -88.95 135.43 33.55 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.706 HD22 HD11 ' A' ' 57' ' ' LEU . 15.3 tp -142.85 132.89 24.33 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.097 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.5 99.41 3.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.147 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 53' ' ' VAL . 34.5 mt -110.67 141.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.058 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -140.43 118.26 11.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -99.5 136.6 29.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.24 -163.19 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 60.39 77.22 0.38 Allowed Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 110.574 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.29 148.18 38.36 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.633 2.222 . . . . 0.0 112.996 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.2 tp60 -134.51 108.91 8.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.688 175.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -76.7 94.1 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.407 0.623 . . . . 0.0 109.75 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -122.97 92.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.269 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.07 -165.35 29.89 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.878 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.0 t -101.99 145.42 11.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.246 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.0 -48.2 5.29 Favored Glycine 0 N--CA 1.463 0.498 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.008 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.4 86.29 2.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.69 36.11 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.492 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 11.3 ttt180 -87.34 140.95 29.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -129.19 142.25 50.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.91 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -100.48 124.32 45.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.275 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 40.4 p -93.09 152.33 19.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.545 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.07 143.89 46.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 33.6 tt0 -96.35 120.57 36.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.461 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.95 117.96 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 13.3 mtp180 -105.52 136.95 44.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.25 139.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 64' ' ' GLU . 12.5 ttmt -126.69 138.93 53.47 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.564 168.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.489 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.1 t -170.91 164.02 7.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.219 0.533 . . . . 0.0 111.48 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -116.93 23.42 11.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.255 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.706 HD11 HD22 ' A' ' 29' ' ' LEU . 27.0 mt -57.44 139.93 80.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.705 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 -25.84 13.52 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.586 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -75.84 -40.97 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.07 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.39 -18.43 64.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 57.4 tttt 72.22 -66.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 171.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.7 -11.8 58.9 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 122.24 -0.288 . . . . 0.0 110.314 -172.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 72.21 -42.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.053 0.845 . . . . 0.0 110.762 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -149.57 138.26 20.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.581 0.705 . . . . 0.0 110.755 176.25 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -171.33 162.63 6.83 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.823 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.5 m -137.95 129.95 28.69 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.116 0.484 . . . . 0.0 111.015 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -127.1 169.22 18.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.153 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -134.18 121.35 21.27 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.807 ' NH1' ' HA ' ' A' ' 144' ' ' PHE . 16.7 ptp180 -151.26 163.47 38.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 111.316 -173.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.667 ' HG3' ' H ' ' A' ' 72' ' ' SER . 30.1 tpt180 -86.6 148.0 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.127 -170.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 38.6 t80 -48.03 -37.33 14.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.004 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.667 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 5.5 m -54.13 -34.24 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 111.244 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 150' ' ' ILE . 15.7 m-20 -74.22 -33.94 63.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.123 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 33.6 m-85 -60.21 -36.24 77.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.044 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.511 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.6 mt-10 -64.9 -53.3 48.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.743 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -28.92 66.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.786 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.4 tm? -71.73 -43.84 65.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 60.0 ttt180 -59.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.631 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.551 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.1 p -62.85 -33.49 75.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.76 -47.97 82.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.56 -42.15 91.78 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.846 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 33.0 mt-10 -66.03 -32.83 74.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.616 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.1 mmt180 -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.083 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -75.67 -33.09 60.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.961 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 m -124.62 177.46 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.314 0.578 . . . . 0.0 111.037 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -101.98 29.3 5.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.491 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 57.3 t -51.13 140.18 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.038 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -71.22 31.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.279 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.555 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -51.72 123.05 23.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 111.354 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 92.6 Cg_endo -86.12 166.51 9.62 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.171 2.581 . . . . 0.0 112.192 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 43.5 Cg_endo -67.8 142.6 58.23 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.764 2.309 . . . . 0.0 112.477 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.511 HD11 ' HA ' ' A' ' 75' ' ' GLU . 91.4 mt -69.69 150.72 96.65 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.293 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -81.79 116.95 2.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.551 2.168 . . . . 0.0 110.571 173.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.38 48.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.554 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -149.95 42.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.436 0.636 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -151.48 -81.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.016 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -56.53 -26.22 54.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.087 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.883 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.63 -47.67 84.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -174.531 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 3.4 ppt_? -97.12 24.52 6.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.401 0.62 . . . . 0.0 110.689 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -112.84 -47.18 3.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.879 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.2 pp -91.04 173.03 5.9 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.671 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.559 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.4 Cg_exo -71.93 -143.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 124.115 3.21 . . . . 0.0 113.292 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -116.95 -83.81 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 65.27 -74.42 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.834 0.708 . . . . 0.0 111.61 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -107.09 75.82 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.366 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.29 -72.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.026 0.93 . . . . 0.0 111.852 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 109' ' ' ILE . 2.8 t70 -104.21 -34.15 8.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.113 -175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.62 3.02 10.41 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.606 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.55 ' HA ' ' CD1' ' A' ' 114' ' ' PHE . 47.8 pt -70.18 -17.86 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 49.4 m-85 -76.76 -7.72 55.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.24 129.37 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.101 0.477 . . . . 0.0 110.009 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.74 -26.03 68.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.05 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.661 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 43.3 m-80 -69.56 -56.87 6.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -46.75 -47.94 20.6 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 123.673 0.608 . . . . 0.0 111.091 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 mt -53.37 -46.65 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.368 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -78.53 -19.17 53.53 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.116 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 32.1 mm-40 -72.98 -34.65 66.59 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.64 -42.35 61.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.659 174.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.85 -50.89 71.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.612 -176.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.751 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 11.6 pt20 -60.28 -35.19 74.98 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.984 -173.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.62 -31.96 9.78 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.13 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.3 tp -64.86 -35.36 80.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.807 -0.231 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.528 ' HA ' HG22 ' A' ' 126' ' ' ILE . 10.5 pt-20 -69.88 -31.35 69.12 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.751 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 65.4 mm-40 -65.83 -58.78 4.82 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.511 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.2 t80 -45.45 -53.38 8.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.641 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.7 tp -64.23 -38.67 83.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.644 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -60.48 -19.34 56.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -89.6 -56.98 3.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.882 0.849 . . . . 0.0 110.449 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -63.85 -12.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.898 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.8 3.83 24.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.479 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.28 12.02 2.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.551 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.669 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 39.4 t60 -101.43 140.47 21.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 122.483 -0.422 . . . . 0.0 110.875 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 14.5 Cg_exo -40.59 -47.14 4.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.242 3.294 . . . . 0.0 114.058 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.19 -26.54 61.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.333 -174.185 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.16 -40.13 20.13 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.989 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.0 mm100 -67.61 -3.01 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.225 176.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 135' ' ' ALA . 55.3 t30 -112.56 12.35 19.87 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.231 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -122.67 126.53 47.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.673 0.273 . . . . 0.0 110.929 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 159' ' ' ILE . 15.7 tpt180 -57.36 -15.7 7.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.486 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 143' ' ' MET . 3.2 m -56.07 -29.39 60.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.095 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.5 mp -74.5 -28.97 61.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.199 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 60.9 t-80 -57.28 -43.29 82.99 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.913 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.75 ' SD ' HG23 ' A' ' 150' ' ' ILE . 3.9 ptp -70.89 -35.24 72.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.807 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -77.61 -46.01 23.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.601 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -88.79 -36.47 16.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.388 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 28.8 mt-30 -100.82 -174.01 2.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.394 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 57.41 -165.21 0.16 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.363 0.414 . . . . 0.0 110.274 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -100.17 -32.38 10.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.428 0.632 . . . . 0.0 110.773 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -155.44 173.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.163 -169.28 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.75 HG23 ' SD ' ' A' ' 143' ' ' MET . 2.1 mp -78.35 120.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.556 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 154' ' ' TYR . 9.6 t0 -96.24 99.88 11.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HG2' ' CG2' ' A' ' 150' ' ' ILE . 81.6 mttt -74.63 -2.59 26.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.624 0.726 . . . . 0.0 111.966 -170.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.8 m -108.37 18.88 20.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.318 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -62.71 -170.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.141 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 56.1 m -84.1 110.84 28.88 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.948 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.2 Cg_exo -71.06 77.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.611 2.874 . . . . 0.0 112.227 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -151.44 -162.92 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -81.37 163.25 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.925 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.586 HG21 HG13 ' A' ' 59' ' ' ILE . 17.0 mm -56.25 -39.39 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.2 0.524 . . . . 0.0 109.612 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.842 -179.698 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.36 169.2 38.18 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.329 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.99 160.24 13.0 Favored 'Trans proline' 0 C--O 1.224 -0.214 0 C-N-CA 123.911 3.074 . . . . 0.0 111.282 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.14 -21.6 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 124.839 3.693 . . . . 0.0 115.571 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -70.67 -63.59 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.536 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 13.1 m120 60.24 177.41 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.108 0.48 . . . . 0.0 111.709 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -91.21 134.82 34.24 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -146.46 131.82 18.58 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.368 -175.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -144.11 100.42 3.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.079 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.5 mt -109.99 140.1 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -139.29 108.21 5.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.106 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.83 133.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.108 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t 179.74 -163.15 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 56.31 64.46 4.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.315 0.578 . . . . 0.0 109.685 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.82 154.19 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.026 2.484 . . . . 0.0 113.408 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.5 tp60 -135.09 112.2 10.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.557 173.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.538 HG22 ' HE ' ' A' ' 45' ' ' ARG . 45.5 m -76.38 92.4 3.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.738 . . . . 0.0 109.9 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -119.93 94.74 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.549 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.59 -166.3 30.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.356 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.3 t -95.9 147.55 5.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.26 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.53 -48.96 5.87 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.333 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -102.25 88.63 3.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.487 0.661 . . . . 0.0 109.484 170.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.75 34.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.783 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.563 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.8 ttt180 -85.16 132.67 34.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.862 0.363 . . . . 0.0 110.449 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -117.17 174.51 6.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.993 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.4 m -129.0 133.38 47.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.282 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.6 p -92.83 129.92 38.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -105.92 133.01 51.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.978 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 35.7 tt0 -86.36 118.15 25.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.327 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.8 mp -94.39 109.45 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 42.6 mtp180 -96.02 132.41 41.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.236 173.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.4 137.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 0.0 111.262 177.268 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -125.32 137.0 54.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 63' ' ' LYS . 11.8 t -170.51 165.22 8.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.363 0.601 . . . . 0.0 112.394 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -115.89 24.4 11.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.276 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.761 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.09 134.48 93.0 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 173.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 12.2 Cg_exo -67.11 -39.97 12.48 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.645 2.23 . . . . 0.0 111.797 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -60.07 -41.61 87.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.285 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.3 m-30 -66.32 -16.28 63.92 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 tttt 71.77 -65.69 0.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.04 -5.68 59.17 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.415 -0.178 . . . . 0.0 110.717 -174.074 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 55' ' ' THR . 14.7 mmtp 71.64 -41.61 0.51 Allowed 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.849 0.718 . . . . 0.0 111.715 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -160.05 122.41 3.34 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.429 0.633 . . . . 0.0 109.896 -177.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -160.89 176.89 10.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.525 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 20.1 m -141.84 132.5 25.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.125 0.488 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.06 179.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.436 176.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 35.0 ttt180 -145.29 111.23 5.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -138.16 152.68 48.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.806 0.813 . . . . 0.0 112.716 -173.529 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.645 ' HG2' ' H ' ' A' ' 72' ' ' SER . 28.9 ttp180 -74.02 144.31 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.705 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 40.3 t80 -50.98 -36.47 39.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.484 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.645 ' H ' ' HG2' ' A' ' 70' ' ' ARG . 11.0 m -61.87 -21.81 65.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.767 0.318 . . . . 0.0 111.777 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -89.03 -24.49 22.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 23.6 m-85 -61.78 -34.15 75.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.535 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.8 mt-10 -64.4 -50.92 65.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.466 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 6.6 t-105 -62.02 -30.45 70.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.586 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -70.2 -45.65 66.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 47.4 ttt180 -56.83 -61.68 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.716 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 11.1 p -59.3 -34.85 72.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.043 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 3.2 mm-40 -62.36 -37.11 84.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 85' ' ' SER . 97.7 mt -75.7 -17.99 59.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.102 0.477 . . . . 0.0 110.45 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 41.2 mt-10 -88.02 -26.36 22.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.284 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 79' ' ' SER . 41.5 mmt180 -58.43 -64.2 1.0 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -118.86 5.78 11.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 33.5 t -119.54 167.5 11.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.612 0.72 . . . . 0.0 111.169 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -101.2 19.45 17.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.535 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.437 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.2 t -51.24 139.07 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.421 0.629 . . . . 0.0 111.762 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.6 p -72.25 35.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.815 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.56 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -55.45 120.26 30.06 Favored Pre-proline 0 N--CA 1.465 0.286 0 O-C-N 122.042 -0.411 . . . . 0.0 111.159 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.594 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.3 Cg_endo -87.52 165.22 7.9 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.978 2.452 . . . . 0.0 112.249 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 38.1 Cg_endo -66.23 144.75 76.01 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.76 2.307 . . . . 0.0 112.65 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 75' ' ' GLU . 74.0 mt -70.92 150.39 95.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.111 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 6.0 Cg_endo -84.93 114.55 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.8 2.333 . . . . 0.0 111.192 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.29 32.78 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.8 18.21 2.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.218 0.509 . . . . 0.0 110.935 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -110.49 -83.31 0.57 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.078 0.466 . . . . 0.0 111.891 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -58.01 -27.18 63.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.323 -173.17 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? -60.93 -46.94 88.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.023 0.439 . . . . 0.0 111.128 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -101.26 29.95 4.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.49 0.662 . . . . 0.0 109.948 178.033 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.9 tt0 -128.46 -36.83 1.85 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.432 -173.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 74.7 mt -85.08 172.17 9.4 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.947 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 Cg_exo -66.42 -157.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.929 2.419 . . . . 0.0 112.671 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -87.76 -74.65 0.44 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.43 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 64.31 -81.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.743 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.58 108.78 0.44 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.822 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.3 t70 69.43 -65.27 0.31 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 111.836 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -139.22 -5.82 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.085 0.469 . . . . 0.0 110.45 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.86 9.63 22.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.787 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 42.7 pt -76.05 -18.0 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.131 0.491 . . . . 0.0 111.182 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.48 ' CE2' ' HD3' ' A' ' 45' ' ' ARG . 84.0 m-85 -87.47 18.19 4.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.625 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.66 134.97 54.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.692 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.04 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.734 -174.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -64.67 -60.06 3.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.268 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.787 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -52.88 -46.89 68.15 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.041 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.69 -46.41 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.157 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -80.65 -18.54 47.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 56.5 mm-40 -67.55 -38.83 84.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.542 0.687 . . . . 0.0 109.177 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -67.78 -43.35 79.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.835 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -55.77 -52.54 63.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.174 -175.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 11.4 pt20 -62.52 -35.24 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.581 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.71 -34.02 17.15 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.413 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.7 tp -66.76 -36.59 82.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 122.043 0.137 . . . . 0.0 111.181 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' HG22 ' A' ' 126' ' ' ILE . 5.1 pt-20 -72.23 -31.7 66.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.4 mm100 -60.32 -59.75 4.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.5 t80 -47.22 -52.73 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.944 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.32 -40.15 87.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.918 -171.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.51 -21.06 59.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.1 0.476 . . . . 0.0 111.87 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.594 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 36.7 mttm -87.86 -55.22 3.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.719 0.771 . . . . 0.0 110.453 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -69.08 -12.58 16.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.605 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -114.35 12.15 17.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -136.23 -9.51 1.42 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.534 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.729 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.8 t60 -87.15 146.38 40.15 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.446 -0.311 . . . . 0.0 111.282 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.729 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.3 Cg_exo -43.08 -51.24 5.74 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.915 3.077 . . . . 0.0 113.337 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -66.5 -32.59 74.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.151 -174.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.16 -44.91 35.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.152 -177.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 43.2 mm-40 -61.52 -6.49 2.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.016 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 9.7 t-20 -98.87 -21.44 16.31 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.066 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 13.0 mm-40 -99.91 137.38 38.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.634 0.652 . . . . 0.0 112.352 -168.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 3.5 mmt180 -50.46 -24.45 3.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.023 0.929 . . . . 0.0 112.716 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.1 m -56.86 -29.94 63.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.464 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.9 mp -75.36 -35.26 61.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 110.662 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -64.33 -35.32 80.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 150' ' ' ILE . 8.4 ptm -81.74 -31.79 31.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.529 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 22.3 t80 -80.29 -43.36 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.332 -175.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 11.0 mt -92.02 -26.46 18.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.361 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -117.16 178.3 4.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.364 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.88 -82.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.053 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 176.92 -55.01 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.797 0.808 . . . . 0.0 109.576 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -130.66 154.16 40.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.894 -175.259 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.811 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -71.15 113.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.855 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.78 97.71 4.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.756 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -66.46 -6.91 16.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.881 0.372 . . . . 0.0 111.322 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.2 m -112.96 19.68 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.366 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.457 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.2 OUTLIER -64.21 -170.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.997 -178.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.5 m -86.31 113.2 51.09 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.7 Cg_exo -69.83 71.94 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.42 2.747 . . . . 0.0 111.589 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -161.56 1.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -92.85 168.27 11.29 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.799 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.544 HG21 HG13 ' A' ' 59' ' ' ILE . 8.6 mm -54.71 -48.72 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 122.781 0.432 . . . . 0.0 111.076 -174.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.488 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 8.4 m-85 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 121.144 0.497 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.93 173.98 46.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.368 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.2 155.53 9.05 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 C-N-CA 124.124 3.216 . . . . 0.0 111.882 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.28 -21.08 0.36 Allowed 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.769 3.646 . . . . 0.0 115.737 -170.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.5 m -75.16 -59.44 2.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.8 m120 62.29 -178.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 111.812 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.4 132.11 37.03 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 57' ' ' LEU . 19.2 tp -147.02 128.82 15.29 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.791 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 4.3 pt-20 -138.01 99.78 3.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.89 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 30.9 mt -113.34 142.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.801 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -142.21 111.74 6.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.646 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.9 OUTLIER -85.48 136.37 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 171.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 22.9 t 179.79 -163.08 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 38.6 m-80 62.44 79.7 0.26 Allowed Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.191 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -64.83 143.69 80.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.187 2.591 . . . . 0.0 112.574 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -134.15 108.31 8.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.905 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 m -76.11 93.11 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 109.535 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.2 89.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.04 -166.98 32.31 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.955 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 9.9 t -117.41 152.17 19.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.638 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.54 -46.63 4.66 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 121.771 -0.252 . . . . 0.0 113.019 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.18 83.06 2.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.82 40.8 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.316 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.6 ttt180 -89.17 142.05 27.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.76 162.4 36.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.916 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 22.4 m -114.56 126.08 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.9 p -92.22 154.82 18.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.78 136.24 53.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.243 0.544 . . . . 0.0 110.836 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.602 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 28.6 tt0 -93.13 119.4 32.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.769 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.75 115.37 32.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.96 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 29.6 mtp180 -102.37 128.19 49.06 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -137.49 140.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 11.4 ttmt -128.97 136.28 50.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 63' ' ' LYS . 10.4 t -170.21 164.63 9.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.401 0.619 . . . . 0.0 112.493 -175.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 19.8 p30 -116.29 25.21 10.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.08 164.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.796 HD11 HD22 ' A' ' 29' ' ' LEU . 30.3 mt -58.55 134.38 85.79 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.493 171.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 8.5 Cg_exo -67.79 -36.26 19.06 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.727 2.284 . . . . 0.0 111.475 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 159' ' ' ILE . 1.3 tt -61.03 -40.54 85.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.202 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.66 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 4.9 m-30 -71.1 -18.33 62.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.46 -67.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.28 -1.72 31.13 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.432 -0.167 . . . . 0.0 111.389 -171.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.538 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmtm 68.06 -45.54 0.51 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.07 0.856 . . . . 0.0 112.045 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 1.1 pp20? -159.79 138.96 10.99 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.659 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -170.52 177.54 3.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.602 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 23.9 m -142.26 127.27 18.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.63 172.09 7.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.775 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -140.83 129.1 22.32 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.646 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.1 177.06 9.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.361 179.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 85.5 mtt180 -85.54 168.5 14.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.441 -172.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 46.5 t80 -60.77 -40.56 92.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 55.0 m -61.32 -23.3 65.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 150' ' ' ILE . 6.3 m-20 -72.94 -36.7 67.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 70.9 m-85 -64.54 -40.15 95.08 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 28.9 mt-10 -59.17 -53.43 58.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.608 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -60.65 -31.32 70.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -73.23 -44.67 59.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 39.3 ttt180 -55.82 -61.04 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.017 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -59.42 -35.11 73.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.629 -174.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 6.4 tp10 -64.3 -44.77 90.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.811 0.338 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.1 mt -62.64 -40.59 97.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.581 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.39 -34.66 78.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.209 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 3.2 ppt_? -90.24 -28.76 18.62 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -172.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' HD2' ' A' ' 83' ' ' ARG . 4.8 mm-40 -95.35 -17.29 21.72 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.956 -0.465 . . . . 0.0 112.189 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 87' ' ' VAL . 22.7 t -144.95 178.71 7.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.745 0.783 . . . . 0.0 111.685 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -103.64 19.78 19.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.423 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' A' ' 89' ' ' VAL . 79.3 t -45.41 140.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.563 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.73 37.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.883 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -54.95 121.16 33.73 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.128 -0.358 . . . . 0.0 111.075 -176.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 71.9 Cg_endo -83.47 165.9 14.09 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.324 2.682 . . . . 0.0 113.188 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.19 143.92 79.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.192 2.595 . . . . 0.0 112.686 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 95.8 mt -81.55 141.43 48.72 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.769 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.0 Cg_exo -73.79 114.22 3.98 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.173 2.582 . . . . 0.0 111.998 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.83 38.26 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.72 -34.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 111.428 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.21 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -53.99 -26.78 27.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.094 0.958 . . . . 0.0 113.542 -170.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -62.7 -48.03 81.06 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.82 13.64 23.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -102.15 -29.2 11.87 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.001 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 mt -99.99 165.69 14.11 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.073 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 -153.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.542 2.828 . . . . 0.0 112.231 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -103.05 -78.79 0.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.144 172.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 68.05 -65.81 0.24 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.135 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.8 -155.51 30.92 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.053 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -62.54 -30.83 71.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 111.143 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.65 -47.08 0.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.32 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.93 -9.57 1.8 Allowed Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.406 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 30.8 pt -65.46 -17.58 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.175 -0.512 . . . . 0.0 112.169 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -86.92 39.49 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.375 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.99 136.12 54.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.76 -21.52 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -170.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 38.2 m-80 -71.05 -60.42 2.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -45.77 -49.98 14.43 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.646 0.591 . . . . 0.0 111.263 178.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.05 -46.84 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.465 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -83.42 -17.85 40.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.519 -178.329 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 28.5 mt-10 -80.51 -30.35 37.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 109.89 -176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -80.02 -29.37 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.69 -52.5 63.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.108 178.082 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.662 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.3 pt20 -59.92 -38.5 82.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.312 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.44 -42.2 65.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.882 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -69.54 -30.77 68.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 117.794 0.797 . . . . 0.0 111.313 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HA ' HG13 ' A' ' 33' ' ' VAL . 10.8 pt-20 -74.05 -33.74 63.81 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.2 mm100 -59.84 -60.56 3.64 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.47 ' O ' HG13 ' A' ' 129' ' ' VAL . 9.7 t80 -48.34 -52.76 20.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.577 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.2 tp -66.11 -34.76 72.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.625 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' HB ' ' A' ' 31' ' ' ILE . 5.6 m-20 -61.37 -21.23 63.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -88.02 -59.42 2.25 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.689 0.757 . . . . 0.0 110.33 175.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.623 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.75 -11.94 11.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.477 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.01 8.08 20.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.64 15.66 1.61 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.977 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 69.8 t60 -101.09 142.07 23.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.1 Cg_endo -47.93 -44.03 28.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.375 2.717 . . . . 0.0 113.193 -170.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -73.56 -25.67 60.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.161 -175.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -82.44 -42.81 18.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.632 -176.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.4 mm100 -65.21 -7.08 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.468 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 8.9 t-20 -91.11 -18.87 23.81 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.969 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 36.5 mm-40 -105.01 129.81 53.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.724 -168.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.523 ' HA ' HD13 ' A' ' 159' ' ' ILE . 21.1 tpt180 -54.59 -28.54 46.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.653 -172.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' MET . 2.3 p -60.71 -18.6 55.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.512 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -72.13 -32.58 67.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.935 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 58.8 t-80 -66.33 -34.05 77.12 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.484 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -81.35 -27.31 34.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.344 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.555 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 32.5 t80 -73.91 -52.31 13.33 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 60' ' ' PHE . 4.3 mp -96.41 -24.43 16.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.438 -173.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 29.1 mt-30 -118.92 -169.79 1.79 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.015 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 61.66 -88.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.604 0.565 . . . . 0.0 110.493 -174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.464 ' HG3' HG13 ' A' ' 149' ' ' ILE . 5.8 tp10 -179.41 -58.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.687 0.756 . . . . 0.0 109.509 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.11 154.27 35.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.562 -175.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 143' ' ' MET . 90.7 mt -85.75 115.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -98.05 105.3 17.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.829 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -73.07 3.03 5.96 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.601 0.715 . . . . 0.0 111.43 -171.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.6 m -110.45 15.62 22.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.126 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.7 OUTLIER -67.65 -171.61 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.824 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 52.4 m -83.13 111.68 32.52 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.347 177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -72.83 77.01 2.36 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 123.329 2.686 . . . . 0.0 111.801 175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -147.69 -154.34 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.694 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 15.7 mmmt -95.6 161.72 13.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.594 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.563 HG21 HG13 ' A' ' 59' ' ' ILE . 19.5 mm -56.41 -48.75 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.825 0.345 . . . . 0.0 110.167 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.24 11.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 110.127 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -89.53 118.99 29.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.33 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -149.92 138.1 20.43 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.01 0.433 . . . . 0.0 110.505 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -110.3 2.59 19.25 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.475 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.38 138.31 38.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.514 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -157.53 133.78 9.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.072 0.463 . . . . 0.0 111.067 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -129.05 42.46 3.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.491 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.33 141.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.83 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 63.82 -147.63 50.71 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.776 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.3 p -81.31 107.45 14.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.12 127.77 32.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.934 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.46 -52.79 0.82 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.014 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -85.77 147.25 26.41 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.249 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.35 165.8 3.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.823 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.38 77.32 3.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.288 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -102.53 -164.93 1.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -113.42 -52.5 2.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.139 0.495 . . . . 0.0 109.801 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 62.23 -87.94 0.02 OUTLIER 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.274 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -157.32 -94.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp 64.19 -82.18 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.828 0.705 . . . . 0.0 112.623 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mt 71.5 146.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.0 111.761 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 p -121.97 84.31 2.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.802 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.509 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -111.89 152.45 44.23 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.989 -177.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.58 103.17 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.551 2.834 . . . . 0.0 111.869 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -98.04 29.17 3.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.066 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 62.14 -168.65 0.19 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.473 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.52 149.13 50.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 110.817 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -108.03 -173.22 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.532 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -118.67 140.98 49.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.999 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.83 -58.96 0.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -114.43 -50.74 2.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.541 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.36 -179.97 45.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.375 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 15.4 Cg_endo -55.69 157.61 15.38 Favored 'Trans proline' 0 C--O 1.225 -0.134 0 C-N-CA 124.142 3.228 . . . . 0.0 111.963 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 48.0 Cg_exo -56.49 -9.03 3.23 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.916 3.078 . . . . 0.0 114.462 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.5 t -73.32 -54.28 8.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.632 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.6 m120 58.14 -178.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.434 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -97.36 138.52 34.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.694 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -148.17 132.95 17.95 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.552 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -146.92 106.87 3.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.681 HG12 ' HB ' ' A' ' 53' ' ' VAL . 36.0 mt -115.36 147.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.209 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.62 111.61 7.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -88.97 131.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -179.33 -165.7 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 37.6 m-80 58.21 67.36 2.24 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-O 121.123 0.487 . . . . 0.0 110.388 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 115' ' ' ILE . 72.4 Cg_endo -72.74 152.77 53.42 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.933 2.422 . . . . 0.0 113.532 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.8 tp60 -138.93 111.57 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.322 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.411 HG22 ' NE ' ' A' ' 45' ' ' ARG . 68.0 m -78.92 90.22 4.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.856 0.836 . . . . 0.0 110.25 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.0 OUTLIER -116.9 96.82 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.353 -174.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.64 -167.53 31.97 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.525 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.6 t -98.7 152.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-O 119.419 -0.324 . . . . 0.0 110.52 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.16 -46.57 8.15 Favored Glycine 0 N--CA 1.46 0.248 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.321 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -100.2 84.84 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.23 0.538 . . . . 0.0 109.852 172.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.58 37.29 0.79 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.274 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.578 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 21.1 ttt180 -83.38 130.32 35.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.8 0.333 . . . . 0.0 110.379 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -122.52 159.17 28.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.1 m -111.95 127.32 55.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.483 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 43.4 p -92.5 152.36 19.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.293 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -119.62 140.5 50.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 32.9 tt0 -90.89 119.48 31.12 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.67 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.0 mp -94.39 111.98 26.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.069 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 58.9 mtp85 -104.79 134.86 47.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -144.64 141.57 23.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.1 ttmt -127.39 135.95 51.19 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.072 169.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 63' ' ' LYS . 15.0 t -171.23 163.86 7.17 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.514 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -116.98 27.25 9.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.836 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.38 139.06 94.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.029 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.13 -12.27 19.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.151 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -89.67 -41.22 13.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.432 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.528 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.3 m-85 -65.37 -13.53 58.81 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 71.35 -66.5 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.77 -2.85 58.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 122.174 -0.329 . . . . 0.0 110.462 -172.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmpp? 70.45 -46.18 0.61 Allowed 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.129 0.893 . . . . 0.0 111.545 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -158.41 118.98 3.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.893 0.854 . . . . 0.0 110.905 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 t -155.58 179.33 9.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.517 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.477 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 14.2 m -141.36 137.02 32.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 m -125.96 175.62 7.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.452 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -145.72 118.59 8.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.729 0.3 . . . . 0.0 110.855 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.657 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -151.9 173.53 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' OD2' ' A' ' 73' ' ' ASP . 20.6 ptt180 -99.32 170.54 8.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -164.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 33.7 t80 -53.88 -38.71 65.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.488 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.606 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 29.9 m -59.38 -25.24 64.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.776 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 20.7 m-20 -80.5 -35.18 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 57.0 m-85 -59.48 -38.86 81.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.445 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 20.1 mt-10 -61.68 -53.24 58.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.56 0.695 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.523 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -68.25 -23.46 64.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.206 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.749 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -71.95 -42.95 65.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -55.31 -60.58 3.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.815 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.728 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.5 p -64.2 -35.37 80.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.371 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 4.6 mm-40 -59.37 -37.25 77.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.408 HD13 HG11 ' A' ' 87' ' ' VAL . 95.2 mt -73.36 -27.8 61.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.058 0.456 . . . . 0.0 110.656 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.38 -18.33 36.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.355 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.0 mmm180 -58.84 -61.7 2.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -119.64 0.05 10.88 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -125.43 166.99 15.6 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.778 0.799 . . . . 0.0 111.911 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.51 30.41 3.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.47 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 97.2 t -52.49 141.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.873 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 88' ' ' VAL . 4.0 p -66.42 27.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.882 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.5 OUTLIER -57.88 120.33 41.31 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 121.809 -0.557 . . . . 0.0 111.777 -174.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 97.4 Cg_endo -88.58 168.25 5.99 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.005 2.47 . . . . 0.0 112.147 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 146.06 75.81 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 112.184 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 75' ' ' GLU . 80.1 mt -69.26 152.02 96.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.15 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.53 109.98 2.97 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.965 2.443 . . . . 0.0 111.932 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.61 176.82 44.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.081 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.2 31.49 16.56 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.567 0.699 . . . . 0.0 110.346 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.7 -85.23 0.59 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.912 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -61.76 -18.19 58.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.327 -177.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.9 mm? -69.6 -44.14 71.34 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 -174.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -90.45 17.88 6.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 109.844 176.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.2 tt0 -118.5 -39.88 2.97 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.689 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 mt -92.83 171.76 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.998 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.14 -172.86 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.737 2.291 . . . . 0.0 111.732 171.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 61.5 m-85 -105.65 -86.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.655 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 65.19 -75.57 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.677 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.78 64.82 3.62 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.376 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.2 t70 65.93 -69.96 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.324 1.05 . . . . 0.0 110.331 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.53 -23.97 12.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.128 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 113.78 7.28 20.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.124 -174.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.764 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.8 pt -71.95 -19.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.886 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.92 -12.04 60.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.791 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.37 135.19 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.471 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.69 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 48.3 m-80 -73.52 -58.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.764 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -50.65 -48.18 58.31 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.526 0.516 . . . . 0.0 111.192 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 36' ' ' PRO . 37.5 mt -51.76 -48.38 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.433 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.14 -20.51 59.36 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.262 -177.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 29.9 mm-40 -71.88 -32.79 67.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.209 0.528 . . . . 0.0 109.762 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 43.5 ttp180 -81.93 -34.34 29.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.237 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.02 -50.05 71.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.524 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.748 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -59.47 -39.97 85.42 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.166 -175.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.5 -36.54 23.08 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.443 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.656 ' HB3' HG21 ' A' ' 33' ' ' VAL . 4.6 tp -64.24 -36.61 84.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.435 0.16 . . . . 0.0 111.037 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 33' ' ' VAL . 13.1 pt-20 -75.65 -29.99 59.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.5 mm100 -64.01 -53.61 47.32 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.6 t80 -49.9 -54.55 18.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.287 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.1 tp -64.67 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.865 -172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -62.21 -16.96 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.16 -0.338 . . . . 0.0 111.825 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.463 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.1 mttm -89.92 -58.65 2.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.038 0.923 . . . . 0.0 110.568 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 89' ' ' VAL . 1.3 m -66.05 -13.51 15.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.027 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.405 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.92 10.28 20.62 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.405 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -136.16 2.25 3.54 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.436 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.68 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 35.1 t60 -99.91 144.36 28.22 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 117.185 0.492 . . . . 0.0 111.74 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.68 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.8 Cg_exo -39.64 -50.52 3.1 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.578 3.519 . . . . 0.0 113.879 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.37 -30.14 68.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.522 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -78.03 -39.99 40.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.25 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 53.8 mm-40 -65.56 -6.38 10.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.584 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 53.6 t30 -108.7 6.07 25.39 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.974 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 138' ' ' GLU . 5.1 mm-40 -118.48 129.18 55.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.824 0.345 . . . . 0.0 111.128 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -54.21 -20.41 6.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.518 -176.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.5 m -53.45 -35.81 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.432 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.5 mp -69.95 -33.53 72.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.238 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.0 t60 -56.88 -39.72 74.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.132 0.491 . . . . 0.0 110.249 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.571 ' HG3' HG13 ' A' ' 150' ' ' ILE . 2.5 ptm -79.96 -28.57 39.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.081 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.749 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.26 -47.81 14.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -93.98 -19.91 20.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.113 -174.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 7.6 mt-30 -119.95 -172.61 2.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.151 -168.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 53.06 -116.75 1.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.257 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -134.89 -35.15 0.87 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.701 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.98 162.65 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.75 0.786 . . . . 0.0 112.868 -167.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.571 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -74.82 115.65 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.895 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.32 112.89 24.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.844 0.354 . . . . 0.0 110.186 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 27.1 mmtp -75.69 11.04 1.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -172.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.0 m -129.08 19.21 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.212 0.53 . . . . 0.0 110.297 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -174.2 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.16 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.0 m -90.89 112.49 53.79 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.161 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.72 76.68 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 123.453 2.768 . . . . 0.0 112.111 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -146.82 -161.78 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 19.1 mmmt -85.93 165.07 17.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -60.54 -40.92 85.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.217 0.532 . . . . 0.0 110.261 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 120.45 25.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.52 20.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 111.014 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.758 177.458 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 20.8 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.214 0.53 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . 55.65 40.91 30.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.642 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -122.89 80.9 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.175 0.512 . . . . 0.0 109.797 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -129.36 165.48 21.42 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.134 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -88.64 -30.77 18.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.767 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 63.82 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.359 0.664 . . . . 0.0 110.725 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -145.9 33.19 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.76 0.79 . . . . 0.0 108.912 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -123.02 112.27 17.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.706 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.0 124.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 109.835 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -79.47 -170.13 39.21 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.805 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 m -86.24 10.99 13.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.291 1.043 . . . . 0.0 110.182 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.37 128.42 4.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.065 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -159.29 -58.8 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.12 144.9 30.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.623 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.4 -157.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 124.302 1.001 . . . . 0.0 111.56 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.56 67.05 0.75 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.238 0.542 . . . . 0.0 112.2 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.4 155.92 33.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.896 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.1 p -56.13 -54.19 48.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.806 0.336 . . . . 0.0 110.433 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 70.82 143.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.504 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.714 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 5.7 ppt_? -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.704 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.639 ' C ' HG13 ' A' ' 12' ' ' ILE . 16.4 tp -153.68 -71.41 0.14 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.066 0.46 . . . . 0.0 110.732 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.639 HG13 ' C ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER 63.4 -159.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.712 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.49 ' H ' HG22 ' A' ' 12' ' ' ILE . 13.1 p 72.81 112.59 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.0 111.682 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.5 mptt -76.79 170.99 13.56 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.344 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 82.9 Cg_exo -48.32 118.53 3.31 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.192 1.928 . . . . 0.0 112.448 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -100.23 144.04 29.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.94 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.8 127.88 44.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HG ' ' CZ ' ' A' ' 160' ' ' ARG . 3.5 mm? -105.78 -173.32 2.27 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.148 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -77.51 176.15 9.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.97 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -159.12 162.97 36.52 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.855 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.0 -46.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.162 0.505 . . . . 0.0 111.061 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 79.6 m-85 -121.45 -20.05 6.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.592 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.44 174.75 46.95 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.602 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.69 158.62 19.51 Favored 'Trans proline' 0 C--O 1.222 -0.276 0 C-N-CA 124.336 3.358 . . . . 0.0 111.174 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.63 -14.67 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.418 3.412 . . . . 0.0 115.206 -171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 p -68.63 -62.45 1.38 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.6 m120 58.13 -177.37 0.07 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.262 0.553 . . . . 0.0 111.902 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -99.47 138.17 36.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 57' ' ' LEU . 15.9 tp -145.58 132.33 20.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.057 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.73 106.05 3.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.174 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.2 mt -114.55 142.87 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.058 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -136.55 118.47 15.24 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -100.23 135.04 37.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 36.2 t 178.85 -161.97 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 31.7 m-80 62.5 73.42 0.54 Allowed Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 110.46 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HG3' HG21 ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.01 131.85 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.802 2.335 . . . . 0.0 112.865 -173.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 47.6 tp60 -117.02 112.34 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.14 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.9 m -73.17 104.04 4.1 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.42 90.66 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.268 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.22 -167.57 33.24 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.814 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.4 t -100.71 147.98 7.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 119.278 -0.392 . . . . 0.0 110.134 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.34 5.55 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 121.59 -0.338 . . . . 0.0 113.152 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -103.96 88.62 3.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.462 0.649 . . . . 0.0 109.416 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.37 32.35 0.98 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.725 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.592 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 8.9 ttp180 -84.34 152.21 24.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.403 0.281 . . . . 0.0 110.304 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.14 162.3 35.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.747 0.308 . . . . 0.0 110.359 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -113.92 131.35 56.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.608 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 15.9 p -99.64 153.39 19.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.54 144.97 43.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.237 0.541 . . . . 0.0 110.627 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 35.9 tt0 -95.79 123.2 39.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.347 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.55 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -96.72 117.84 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.276 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 94.6 mtt180 -110.5 109.81 20.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.407 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -119.46 137.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.013 0.435 . . . . 0.0 111.993 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -125.89 134.97 51.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.307 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.4 t -170.31 165.95 8.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.288 0.566 . . . . 0.0 111.626 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 19.1 p30 -120.45 26.26 9.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.119 168.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.667 HD11 HD22 ' A' ' 29' ' ' LEU . 20.9 mt -60.62 143.36 90.54 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.192 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.84 -29.64 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.431 2.088 . . . . 0.0 111.711 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.545 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.29 -40.19 79.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.95 178.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.616 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.4 m-30 -69.1 -19.98 64.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.49 -64.33 0.39 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.11 -7.66 59.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 122.182 -0.324 . . . . 0.0 110.833 -172.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 5.6 mmtp 70.68 -43.43 0.55 Allowed 'General case' 0 C--O 1.218 -0.578 0 O-C-N 124.014 0.822 . . . . 0.0 111.163 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.58 130.82 5.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 109.998 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.2 t -160.43 165.85 30.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.609 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 37.7 m -140.5 130.4 24.58 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.292 0.568 . . . . 0.0 110.853 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 147' ' ' ASP . 5.8 m -133.47 174.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -144.06 122.88 12.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.197 0.522 . . . . 0.0 111.567 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -145.05 -177.66 5.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -100.66 167.57 10.25 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -169.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.7 t80 -55.09 -34.38 63.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.42 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 16.9 m -55.03 -33.58 62.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.738 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -75.06 -38.14 61.45 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 59.9 m-85 -60.12 -37.47 80.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.644 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 25.7 mt-10 -62.52 -55.07 30.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.752 0.787 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -64.9 -28.64 69.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.436 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -69.35 -40.73 77.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 63.9 ttt180 -57.95 -64.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.446 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.722 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -61.28 -37.17 82.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.014 -172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.19 -44.73 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.373 0.42 . . . . 0.0 111.431 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.37 -37.06 85.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.73 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -73.82 -24.95 59.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.138 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 79' ' ' SER . 25.1 mmt180 -67.98 -62.53 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.063 0.459 . . . . 0.0 111.816 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -85.46 -30.05 23.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.323 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 m -120.66 175.03 6.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.654 0.74 . . . . 0.0 112.004 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -105.0 23.6 13.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.738 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 89' ' ' VAL . 97.6 t -42.6 140.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.846 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -69.19 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.371 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.2 t -56.07 121.65 42.65 Favored Pre-proline 0 N--CA 1.464 0.268 0 O-C-N 121.945 -0.472 . . . . 0.0 110.836 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 89.0 Cg_endo -88.28 166.4 6.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.904 2.403 . . . . 0.0 112.302 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.66 150.82 87.55 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.867 2.378 . . . . 0.0 112.459 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 49.6 mt -80.51 153.39 73.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.436 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -88.44 109.27 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.912 2.408 . . . . 0.0 112.289 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.12 59.15 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.443 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -144.55 -25.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.778 0.323 . . . . 0.0 111.4 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.85 -82.32 0.29 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.573 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -49.94 -24.5 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.951 1.3 . . . . 0.0 114.14 -171.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.6 mm? -59.34 -45.16 92.15 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.915 0.388 . . . . 0.0 111.221 -173.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -99.53 20.65 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.716 0.769 . . . . 0.0 109.432 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.3 tt0 -118.1 -28.31 5.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.866 -176.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 mt -101.67 169.16 8.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.25 -161.38 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.898 2.399 . . . . 0.0 112.484 173.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 37.9 m-85 -106.97 -80.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.608 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 68.38 -64.99 0.28 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.538 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -113.86 79.07 0.27 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.431 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.64 -71.41 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.056 0.943 . . . . 0.0 111.911 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.9 -32.11 7.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.842 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 123.3 4.42 8.35 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.936 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 45.8 pt -73.09 -15.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 54.5 m-85 -79.88 -15.1 58.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.97 134.48 36.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.992 0.425 . . . . 0.0 110.245 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.97 -24.7 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.67 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.604 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 42.7 m-80 -65.64 -57.71 7.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -51.34 -51.03 58.08 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.661 0.601 . . . . 0.0 110.879 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HG3' ' A' ' 36' ' ' PRO . 23.7 mt -50.59 -50.35 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.995 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.55 -20.59 58.55 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.883 -177.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 37.3 mm-40 -74.25 -33.64 63.38 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.166 0.508 . . . . 0.0 109.95 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 37.5 ttm180 -80.63 -33.68 35.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -55.89 -50.88 69.45 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.551 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.73 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.6 -41.91 95.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.844 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.0 -34.5 33.47 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.439 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 4.2 tp -67.52 -36.59 81.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.025 -0.103 . . . . 0.0 111.243 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.588 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.8 pt-20 -72.77 -33.33 66.24 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.73 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.9 mm100 -60.45 -58.44 8.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' O ' HG13 ' A' ' 129' ' ' VAL . 15.0 t80 -47.57 -55.43 9.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.443 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -63.93 -39.49 85.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.83 -172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -61.62 -20.27 63.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.017 0.437 . . . . 0.0 111.986 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 35.1 mttm -90.18 -56.36 3.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.939 0.876 . . . . 0.0 110.641 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 125' ' ' PHE . 1.2 m -65.84 -13.15 15.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.002 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -110.11 7.61 23.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.088 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -141.14 12.36 2.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.463 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 57.7 t60 -100.32 139.8 20.96 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 122.397 -0.472 . . . . 0.0 110.499 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.622 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 6.8 Cg_exo -41.38 -47.1 5.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.21 3.273 . . . . 0.0 113.888 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -70.81 -32.55 69.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.102 -176.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.62 -42.47 51.61 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.716 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -66.0 -6.57 13.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.141 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.441 ' OD1' ' HE3' ' A' ' 158' ' ' LYS . 5.4 t-20 -99.61 -10.04 22.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 5.5 mm-40 -106.61 131.87 53.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 111.967 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 159' ' ' ILE . 16.3 tpt180 -58.24 -19.08 31.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.852 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.629 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 0.7 OUTLIER -63.97 -24.17 67.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.0 110.965 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.1 mp -75.55 -31.23 59.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.553 -0.717 . . . . 0.0 110.999 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 65.0 t-80 -57.61 -38.3 74.7 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.629 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 4.0 ptm -80.47 -26.76 38.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.559 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.652 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.14 -53.74 6.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -78.78 -36.31 43.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.357 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.6 mt-30 -95.3 166.67 11.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' HG11 ' A' ' 67' ' ' VAL . 46.1 m-20 61.96 -179.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.638 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.17 -35.25 14.65 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.048 0.928 . . . . 0.0 110.392 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -134.8 152.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.182 -165.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.624 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.2 mp -81.72 116.05 25.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.64 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.19 101.58 6.24 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.054 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -71.77 11.34 0.52 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.0 m -130.28 19.17 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 110.657 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.18 -171.43 0.05 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.534 0.683 . . . . 0.0 112.122 -179.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 87.4 m -88.48 113.01 53.64 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.161 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.65 65.64 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.442 2.761 . . . . 0.0 112.303 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -140.59 -154.04 0.5 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.626 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.441 ' HE3' ' OD1' ' A' ' 137' ' ' ASN . 20.9 mmmt -86.24 158.98 19.59 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.475 -0.14 . . . . 0.0 110.75 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.545 HG13 HD12 ' A' ' 59' ' ' ILE . 16.7 mm -51.41 -52.44 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.422 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -87.65 15.66 6.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.337 -178.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m170 62.15 -174.86 0.14 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.765 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.392 179.21 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.75 0.309 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -141.35 -178.57 5.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.954 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 60.89 55.74 3.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.396 0.617 . . . . 0.0 110.521 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -128.21 108.18 10.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.443 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -87.46 -178.95 6.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.45 -38.2 86.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.639 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -156.35 148.5 23.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -65.99 97.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.01 131.28 34.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -129.7 19.99 5.22 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.3 p -120.21 168.75 10.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.664 -0.768 . . . . 0.0 110.668 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.35 131.42 51.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.368 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.59 -172.05 1.97 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p 56.56 176.15 0.04 OUTLIER 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 112.256 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t 70.82 -62.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.381 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.01 95.71 4.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.601 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.47 146.46 54.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.532 . . . . 0.0 110.58 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -71.53 -55.11 8.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.76 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 9' ' ' ARG . 3.3 mmp_? 61.05 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 72.91 126.27 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 tp -136.65 144.22 43.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.199 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mt -138.55 147.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.955 0.407 . . . . 0.0 110.793 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 p -122.56 79.62 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.462 0.648 . . . . 0.0 110.566 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.78 168.18 9.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.387 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 56.7 Cg_exo -52.61 120.31 7.3 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.689 2.259 . . . . 0.0 111.649 174.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -58.45 130.13 45.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -97.88 -169.95 1.91 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.822 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.39 172.99 12.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.899 0.381 . . . . 0.0 110.339 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -68.9 178.18 2.29 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.506 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -146.97 140.89 25.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.065 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.46 175.29 13.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 2.6 m-85 -122.2 -5.85 8.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.076 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.52 175.5 43.91 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.425 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.33 154.71 10.73 Favored 'Trans proline' 0 C--O 1.224 -0.224 0 C-N-CA 124.0 3.133 . . . . 0.0 111.34 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.98 -11.82 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 124.483 3.455 . . . . 0.0 115.161 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -74.06 -61.89 1.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.4 m120 58.84 -178.58 0.08 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.489 0.493 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -91.43 125.52 36.21 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 57' ' ' LEU . 13.1 tp -138.14 129.09 27.06 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.88 -176.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -140.32 104.36 4.77 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.093 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.664 HG12 ' HB ' ' A' ' 53' ' ' VAL . 47.9 mt -114.69 141.49 31.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.182 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.8 117.57 14.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.996 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -98.62 132.42 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t 179.52 -162.56 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.2 m-80 63.58 77.44 0.32 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 115' ' ' ILE . 69.5 Cg_endo -73.98 142.17 30.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.392 2.061 . . . . 0.0 113.051 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -131.9 111.22 11.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.059 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.0 101.57 4.52 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.3 88.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.426 0.632 . . . . 0.0 110.235 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.44 -167.62 33.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.837 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.2 t -111.35 156.28 12.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.144 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.41 -49.04 6.98 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.465 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -99.08 85.1 3.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.084 0.469 . . . . 0.0 109.744 171.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.42 38.99 0.64 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.565 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 10.1 ttt180 -89.49 140.46 29.5 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.24 154.82 42.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.844 0.355 . . . . 0.0 110.759 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 m -110.57 122.97 49.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 p -92.55 155.91 17.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.859 0.361 . . . . 0.0 110.829 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 80.5 m-85 -119.12 141.42 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.728 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 31.3 tt0 -90.64 123.62 34.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.349 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -102.73 115.6 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.41 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 57.4 mtp180 -105.52 139.41 40.17 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.556 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -146.39 140.7 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -128.83 143.08 50.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.039 165.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.407 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 15.0 t -172.9 164.46 5.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.912 0.387 . . . . 0.0 111.964 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -117.52 31.12 6.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.628 0.728 . . . . 0.0 110.137 166.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.81 HD11 HD22 ' A' ' 29' ' ' LEU . 23.2 mt -67.86 145.2 97.83 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.273 174.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.53 -28.53 5.38 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.598 2.199 . . . . 0.0 111.777 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.94 -41.36 79.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.878 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.3 m-30 -69.96 -33.0 71.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.593 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' C ' ' HD2' ' A' ' 61' ' ' LYS . 1.1 tmmm? 75.11 -58.13 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.582 0.551 . . . . 0.0 112.101 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.75 -14.83 60.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 122.284 -0.26 . . . . 0.0 111.039 -172.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp 73.66 -38.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.851 0.719 . . . . 0.0 110.857 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.62 140.25 30.04 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.411 0.624 . . . . 0.0 109.956 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -160.28 151.55 19.37 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.109 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.9 m -140.39 133.95 30.14 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.021 0.439 . . . . 0.0 109.935 173.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 21.0 m -129.96 179.52 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.624 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 36.3 ttm180 -145.96 101.83 3.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.585 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.2 mmp_? -122.95 172.61 8.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.137 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -88.83 161.83 16.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.539 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 38.5 t80 -55.26 -37.53 67.37 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.428 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 35.5 m -61.99 -26.17 68.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.648 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.8 -36.42 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 52.1 m-85 -66.46 -39.89 89.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.998 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.9 mt-10 -57.06 -56.94 15.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.585 0.707 . . . . 0.0 110.826 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.45 ' CD1' HG21 ' A' ' 150' ' ' ILE . 4.7 t-105 -63.33 -34.09 76.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.733 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -69.19 -43.97 73.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 31.8 ttt180 -57.54 -59.52 5.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.797 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -60.58 -32.95 72.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.301 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.7 mm-40 -63.14 -46.37 87.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.014 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 85' ' ' SER . 88.8 mt -71.06 -16.31 62.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.0 110.755 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 47.5 mt-10 -87.73 -50.08 6.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.107 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 1.5 ppt_? -62.2 -21.79 65.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -165.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 9.5 pt-20 -138.12 -34.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.282 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.92 158.85 33.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.203 0.525 . . . . 0.0 110.476 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -96.53 17.86 15.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.238 0.542 . . . . 0.0 109.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 135' ' ' ALA . 90.7 t -56.06 140.24 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.93 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -75.53 37.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.611 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -51.69 118.72 12.01 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.411 -175.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 128' ' ' LYS . 6.3 Cg_exo -72.43 160.56 46.53 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.495 2.797 . . . . 0.0 112.525 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 142.2 42.3 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.876 2.384 . . . . 0.0 111.983 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.1 mt -69.37 150.57 97.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 27.5 Cg_endo -86.49 109.65 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.881 2.388 . . . . 0.0 111.957 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.63 -174.53 27.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.078 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' N ' HD23 ' A' ' 98' ' ' LEU . 51.8 tttp 71.09 -55.25 0.65 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.824 . . . . 0.0 112.035 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -47.61 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -73.36 -18.17 61.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.482 -170.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.1 mm? -69.14 -44.34 72.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.772 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -95.96 26.48 4.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.536 0.684 . . . . 0.0 110.178 176.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.5 tp60 -116.69 -41.51 3.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.696 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 62.6 mt -80.57 163.6 55.7 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.62 147.35 86.15 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.961 2.441 . . . . 0.0 111.499 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -104.76 94.82 5.49 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -125.76 -30.88 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.094 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.65 -167.31 43.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.439 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.9 -47.89 76.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.273 0.558 . . . . 0.0 110.936 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -136.41 -51.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.997 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.36 -10.38 1.3 Allowed Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.206 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.783 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.8 pt -65.53 -16.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 111.928 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -81.22 -16.12 53.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.357 0.599 . . . . 0.0 110.119 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.42 122.16 28.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.68 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.64 -27.0 64.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.581 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 14.3 m120 -55.09 -60.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.487 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.783 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -54.84 -47.71 73.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.51 0.506 . . . . 0.0 110.895 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 36' ' ' PRO . 47.9 mt -51.47 -51.27 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.275 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -73.11 -22.33 60.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.48 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 66.2 mm-40 -74.87 -32.45 61.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.802 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 14.7 tpp180 -78.97 -35.49 42.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.58 -54.01 51.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.467 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.712 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -59.33 -40.41 86.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.998 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -34.84 32.91 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.133 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.12 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.732 0.266 . . . . 0.0 111.298 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.612 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -73.43 -32.43 64.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.8 mm100 -62.31 -58.17 8.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 7.1 t80 -48.89 -53.27 20.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.613 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.34 -41.05 90.36 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.776 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.97 -19.72 45.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 111.809 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.448 ' HD2' ' HG2' ' A' ' 90' ' ' PRO . 31.8 mttm -90.72 -58.83 2.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.76 0.791 . . . . 0.0 110.66 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.32 -13.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.023 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.18 10.93 21.85 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.981 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.89 8.64 1.3 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.796 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.772 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 59.2 t60 -98.42 144.97 29.06 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 117.217 0.509 . . . . 0.0 110.214 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.772 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.0 Cg_exo -41.9 -48.86 5.89 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.23 3.286 . . . . 0.0 113.775 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -71.09 -38.91 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.777 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -69.14 -41.49 77.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.359 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.45 ' O ' HD12 ' A' ' 59' ' ' ILE . 6.1 mm-40 -65.93 -4.13 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.194 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 20.2 t-20 -106.46 -7.95 17.34 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.875 -177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.2 mm-40 -106.51 135.14 48.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.01 -0.431 . . . . 0.0 110.998 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -57.02 -17.68 10.89 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.621 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.3 m -58.3 -30.0 66.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.317 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 135' ' ' ALA . 6.5 mp -74.78 -29.97 61.29 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.22 -0.3 . . . . 0.0 111.357 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -58.51 -43.57 89.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.308 0.575 . . . . 0.0 109.864 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.627 ' HE2' HG23 ' A' ' 150' ' ' ILE . 5.3 ptm -77.84 -31.22 51.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.188 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 5.0 t80 -77.45 -41.31 40.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.109 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.445 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.9 mt -98.29 -47.5 5.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 112.005 -169.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -81.03 -46.39 15.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.014 -171.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.65 154.96 20.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.182 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.7 pm0 -66.42 -29.51 69.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.739 0.781 . . . . 0.0 110.164 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.567 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -134.22 132.37 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.07 -167.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.627 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.3 mp -70.66 105.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.282 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.51 99.41 10.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.048 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' A' ' 150' ' ' ILE . 2.0 mptt -71.86 11.61 0.5 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 112.309 -173.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.1 t -111.99 11.28 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.665 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.281 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 50.4 m -94.3 114.32 63.02 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.784 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 21.9 Cg_exo -68.88 68.44 1.22 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.432 2.755 . . . . 0.0 112.067 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -140.24 -159.39 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.626 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 6.6 mmmm -88.25 158.91 18.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 59' ' ' ILE . 16.5 mm -50.35 -46.29 25.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.679 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 31.76 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.8 m170 63.66 -178.39 0.16 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.607 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.122 -178.642 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.201 0.524 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -85.1 76.76 10.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -154.22 -62.87 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.739 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -146.61 116.0 7.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.504 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -89.02 130.41 35.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.845 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -81.43 125.87 30.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -94.29 -3.95 49.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.966 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -134.18 81.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.916 0.389 . . . . 0.0 110.796 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.29 158.83 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.516 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -135.58 -143.87 4.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.775 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 p -71.75 109.3 5.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.55 131.49 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.132 0.895 . . . . 0.0 111.774 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.03 -59.02 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.865 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -103.97 145.92 29.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.53 162.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.182 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.04 77.53 2.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 0.0 110.042 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.35 149.47 25.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.392 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.2 p -67.11 -53.31 31.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 71.53 -42.68 0.54 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.738 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -158.06 -171.08 3.37 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 tp -161.56 139.19 8.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.172 0.511 . . . . 0.0 111.014 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.9 mt -140.61 168.84 16.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.4 p 57.16 74.47 0.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.75 0.786 . . . . 0.0 111.311 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.642 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.8 158.19 83.0 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.776 -177.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 87.6 Cg_exo -45.44 128.12 9.97 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.664 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -98.38 112.08 24.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.459 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -98.29 160.21 14.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.95 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.51 -179.04 6.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -72.89 168.8 18.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.487 0.66 . . . . 0.0 111.137 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.87 149.04 14.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.224 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.39 -61.01 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.508 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -125.1 -65.56 1.02 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.082 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.17 172.0 15.48 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.725 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.04 159.43 9.68 Favored 'Trans proline' 0 C--O 1.222 -0.31 0 C-N-CA 124.201 3.267 . . . . 0.0 111.591 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.99 -24.87 0.47 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.421 3.414 . . . . 0.0 115.452 -170.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -70.53 -62.29 1.44 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.26 0.224 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 12.7 m120 61.81 -178.67 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.212 0.53 . . . . 0.0 111.632 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -97.3 140.49 31.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 13.4 tp -147.11 130.58 16.73 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.429 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.87 103.64 4.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.663 HG12 ' HB ' ' A' ' 53' ' ' VAL . 32.8 mt -115.43 143.29 25.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.01 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.84 115.68 10.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.769 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -99.25 132.52 44.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.8 t 179.31 -163.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.4 m-80 61.94 81.6 0.23 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 121.124 0.488 . . . . 0.0 110.47 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.67 152.92 59.57 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.724 2.283 . . . . 0.0 113.541 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.1 tp60 -144.84 107.78 4.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.007 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.1 m -76.52 104.3 6.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.4 p -130.86 88.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.706 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.5 -168.17 34.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.0 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.4 t -102.11 158.32 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.068 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.91 -49.78 6.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.972 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.82 87.03 4.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.118 0.485 . . . . 0.0 109.803 169.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.26 34.54 0.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.971 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.6 ttt180 -89.46 126.12 35.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -131.76 156.7 45.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.5 m -107.72 124.74 50.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.368 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 70' ' ' ARG . 32.0 p -92.09 162.43 14.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.52 139.43 53.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.4 tt0 -91.11 118.35 30.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.571 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.8 mp -93.0 116.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 76.0 mtp180 -105.87 131.87 52.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.971 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.663 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.99 138.39 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 16.4 ttmt -127.81 137.01 52.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.133 169.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 63' ' ' LYS . 13.3 t -170.31 163.74 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.272 0.558 . . . . 0.0 112.147 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 17.3 p30 -118.91 22.54 11.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.203 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.701 HD11 HD22 ' A' ' 29' ' ' LEU . 21.4 mt -56.3 146.71 51.11 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.723 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -9.7 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.503 2.135 . . . . 0.0 111.918 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.575 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -88.49 -40.56 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.416 -177.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.542 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.9 m-30 -69.86 -17.36 63.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' HD13 ' A' ' 62' ' ' LEU . 35.7 ttpt 75.21 -71.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.546 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -75.91 -1.45 25.5 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -169.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mmtm 68.31 -48.09 0.54 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.092 0.87 . . . . 0.0 111.6 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 2.7 pp20? -156.59 140.36 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.833 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -168.71 174.97 6.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.345 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.0 m -141.12 135.62 31.1 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.238 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -145.4 130.62 13.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.926 -173.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 31.6 ttm180 -97.93 110.89 23.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.39 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.701 HH11 HD12 ' A' ' 150' ' ' ILE . 41.4 mtt-85 -125.64 177.01 6.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.158 -172.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' A' ' 48' ' ' THR . 67.0 mtp180 -92.81 156.5 16.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.823 0.344 . . . . 0.0 111.779 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.5 t80 -59.63 -34.13 72.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t -58.26 -33.4 69.36 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.924 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HB ' ' A' ' 150' ' ' ILE . 25.5 m-20 -65.13 -45.24 85.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 60.6 m-85 -59.81 -40.55 88.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.514 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.1 mt-10 -57.04 -56.3 23.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.391 0.615 . . . . 0.0 111.096 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.449 ' CD1' HG21 ' A' ' 150' ' ' ILE . 0.6 OUTLIER -68.41 -28.98 67.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.525 -178.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.702 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -68.23 -42.77 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 55.8 ttt180 -57.89 -62.52 1.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.278 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -63.15 -27.42 69.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.545 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 12.0 tp10 -68.96 -42.06 77.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 85' ' ' SER . 97.1 mt -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.632 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 25.5 mt-10 -90.18 -41.44 11.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.693 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 3.4 ppt_? -78.67 -35.21 45.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.549 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 6.0 mm-40 -101.73 -26.82 13.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.986 0.422 . . . . 0.0 111.779 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -112.38 167.8 10.15 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.451 -169.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -105.33 21.14 17.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.439 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 81' ' ' LEU . 87.3 t -53.68 144.91 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.907 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.4 p -72.64 31.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.081 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 129' ' ' VAL . 1.4 t -52.42 119.51 15.32 Favored Pre-proline 0 N--CA 1.467 0.407 0 O-C-N 122.228 -0.295 . . . . 0.0 111.367 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -88.21 168.37 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.868 2.379 . . . . 0.0 111.884 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 148.65 84.02 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.503 2.136 . . . . 0.0 112.495 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 75' ' ' GLU . 67.6 mt -77.22 154.83 82.33 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.641 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 61.0 Cg_endo -83.06 142.12 10.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.73 -163.35 36.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.277 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 68.06 -60.53 0.41 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 112.234 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.29 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -62.09 -16.1 49.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.471 -168.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.52 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.2 mm? -69.5 -37.47 77.22 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.597 -174.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 12.81 32.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.316 0.579 . . . . 0.0 109.931 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 31.1 tp60 -97.58 -38.97 9.34 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.771 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 76.9 mt -83.07 166.87 32.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.859 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 27.2 Cg_exo -62.2 142.0 90.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.804 2.336 . . . . 0.0 111.553 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.26 5.5 37.98 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.261 0.553 . . . . 0.0 110.876 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -70.33 -14.25 62.5 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.358 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.4 -178.49 38.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.571 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.08 -45.3 94.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -151.38 -27.98 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.884 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 -0.34 12.97 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.6 pt -74.81 -15.39 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -84.22 -7.3 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.382 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.25 135.84 36.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.312 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -30.81 71.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.31 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.63 -58.5 6.74 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -51.5 -48.25 62.97 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.412 0.445 . . . . 0.0 111.101 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.8 mt -50.57 -51.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.218 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.76 -20.62 56.27 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.642 -177.296 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.566 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 21.2 mm-40 -75.09 -33.27 61.62 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.229 0.538 . . . . 0.0 109.878 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 9.8 tpp180 -78.7 -38.22 39.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.03 -52.27 59.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 -178.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.62 -41.65 95.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.111 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -80.34 -32.25 35.37 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.5 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.5 tp -67.55 -40.45 84.96 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.799 -0.201 . . . . 0.0 111.156 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.6 pt-20 -72.09 -32.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.776 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.9 mm100 -61.34 -57.75 11.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.3 t80 -50.12 -52.1 37.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.758 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -64.7 -42.04 93.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.928 -170.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -60.64 -17.78 49.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.54 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -88.2 -57.98 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.869 0.842 . . . . 0.0 110.395 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -65.36 -12.83 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.181 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.32 6.25 28.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.366 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.09 15.94 1.52 Allowed Glycine 0 C--N 1.332 0.352 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.883 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 50.1 t60 -100.26 144.38 28.31 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 117.328 0.564 . . . . 0.0 110.385 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 21.2 Cg_exo -38.95 -49.12 2.8 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.403 3.402 . . . . 0.0 113.827 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.69 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -70.94 -39.5 72.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.138 -175.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -68.02 -41.01 82.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.716 -175.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -70.8 4.82 2.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.735 0.779 . . . . 0.0 109.846 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' ALA . 52.2 t30 -119.24 4.3 11.29 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.1 mm-40 -117.26 128.14 54.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.0 tpt180 -54.81 -16.56 2.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.817 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.694 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.9 m -55.5 -28.73 56.38 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.075 0.55 . . . . 0.0 111.461 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.613 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.0 mp -78.75 -29.42 45.19 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.341 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 52.6 t-80 -56.79 -39.55 74.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.7 ptm -79.59 -31.41 41.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.702 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -81.39 -36.12 29.93 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -94.02 -37.7 11.52 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.137 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.2 mt-30 -94.59 174.12 7.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.54 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.0 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -102.72 -30.71 10.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.55 0.691 . . . . 0.0 110.666 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -138.69 158.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.132 -167.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.701 HD12 HH11 ' A' ' 69' ' ' ARG . 2.2 mp -86.85 123.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.638 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.7 106.53 18.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.215 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 9.4 mptt -77.2 11.24 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.213 0.53 . . . . 0.0 112.158 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 t -126.33 18.01 7.63 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -170.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.277 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 85.5 m -82.26 112.65 37.8 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.458 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 16.9 Cg_exo -72.87 61.34 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.358 2.705 . . . . 0.0 112.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.0 m -136.86 -157.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 122.309 -0.244 . . . . 0.0 110.841 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 5.5 mmmm -87.08 158.82 19.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 119.907 -0.092 . . . . 0.0 110.83 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.575 HG13 HD12 ' A' ' 59' ' ' ILE . 17.5 mm -52.2 -49.95 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.287 0.565 . . . . 0.0 110.539 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 20.52 4.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.875 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 7.6 m170 60.77 -178.26 0.11 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.353 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.029 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.732 178.304 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.846 0.355 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -119.1 5.46 11.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.395 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -70.27 -32.54 70.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -111.05 155.83 22.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -78.76 36.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.893 0.377 . . . . 0.0 111.932 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.04 0.448 . . . . 0.0 110.447 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -83.04 -9.33 59.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.967 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -96.0 81.64 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.244 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.15 128.83 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -119.5 62.88 0.46 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.779 -0.725 . . . . 0.0 111.931 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.4 p -72.13 121.17 18.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.065 0.459 . . . . 0.0 111.503 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.42 128.15 17.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.445 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.24 -62.56 0.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.105 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -101.76 160.94 14.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.846 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 6' ' ' ALA . 2.0 m 41.53 -100.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 124.633 1.208 . . . . 0.0 113.93 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.497 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -77.72 142.39 38.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.911 0.386 . . . . 0.0 111.664 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.63 168.94 10.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.9 p -76.54 -60.62 2.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 64.44 146.12 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.863 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -164.39 138.54 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.179 177.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.0 tp -145.3 146.65 31.73 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.869 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.51 141.03 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.943 0.401 . . . . 0.0 110.663 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 p -125.95 138.87 53.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.714 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -106.47 153.33 40.59 Favored Pre-proline 0 C--N 1.322 -0.594 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.693 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -48.35 127.39 15.54 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.827 3.018 . . . . 0.0 112.772 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -77.51 154.23 32.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.894 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.84 -167.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.635 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.61 -175.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.546 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.48 168.1 15.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.803 0.811 . . . . 0.0 111.607 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -148.59 144.05 26.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.647 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.99 -56.26 0.42 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.176 0.513 . . . . 0.0 110.543 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ASN . 38.6 m-85 -96.89 -30.2 13.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.755 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.52 172.36 45.39 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.88 157.47 10.34 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.859 3.039 . . . . 0.0 112.48 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.29 -18.36 0.73 Allowed 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.997 3.798 . . . . 0.0 115.439 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -69.91 -61.58 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.554 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.8 m120 61.44 164.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.311 0.644 . . . . 0.0 112.675 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -89.65 143.43 26.81 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -147.77 126.66 12.72 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.08 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.2 pt-20 -133.29 100.04 4.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.12 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.68 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.1 mt -113.08 137.55 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.235 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.82 112.9 11.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.345 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -92.68 130.97 40.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 t -179.9 -163.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.1 m-80 60.32 77.22 0.38 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.477 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.58 150.67 86.35 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' THR . 46.8 tp60 -135.75 110.66 8.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.955 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 m -74.56 98.21 3.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 109.41 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -130.12 91.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.51 -167.58 32.72 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.86 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -109.77 148.89 13.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 119.41 -0.328 . . . . 0.0 110.36 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.91 -49.93 4.2 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 121.599 -0.334 . . . . 0.0 112.841 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.59 85.34 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.991 0.425 . . . . 0.0 109.89 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.92 39.02 0.67 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.914 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.3 ttp180 -85.94 150.01 24.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 122.487 0.315 . . . . 0.0 110.252 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -149.83 171.27 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.826 0.346 . . . . 0.0 110.798 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 74.0 m -124.63 126.56 45.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.711 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 21.1 p -92.69 161.53 14.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.66 0.267 . . . . 0.0 110.35 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -123.26 140.98 52.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.297 0.57 . . . . 0.0 110.838 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.1 tt0 -92.4 121.06 33.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.073 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -97.52 119.07 45.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.612 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 93.6 mtt180 -109.18 142.05 40.53 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.36 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.71 142.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -133.81 142.35 47.82 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.527 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.625 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 10.1 t -170.12 163.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.72 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 34.5 p30 -112.69 20.22 16.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.81 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.744 HD11 HD22 ' A' ' 29' ' ' LEU . 30.6 mt -58.71 147.85 69.67 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.4 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -84.6 -30.75 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.808 1.672 . . . . 0.0 112.075 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.26 -43.16 95.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 178.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.8 m-30 -65.7 -33.56 76.17 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 75.54 -53.72 0.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -81.1 -12.12 59.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 122.017 -0.427 . . . . 0.0 110.392 -176.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.625 ' HE2' ' O ' ' A' ' 55' ' ' THR . 10.6 mmmm 68.51 -44.55 0.51 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 124.094 0.871 . . . . 0.0 111.09 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -141.36 141.78 33.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 t -170.48 157.48 5.97 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.129 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.5 m -141.85 130.06 22.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 0.0 110.873 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.7 173.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.599 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 51.8 ttp180 -137.26 109.93 7.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 21.4 mmm180 -127.67 179.6 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.586 -175.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -100.22 165.72 11.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.787 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.1 t80 -53.72 -39.63 65.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.062 174.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.418 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 34.1 m -53.18 -36.65 61.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.622 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 69' ' ' ARG . 4.2 m-20 -64.37 -41.64 96.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -64.44 -37.79 88.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.411 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.654 ' HA ' HD11 ' A' ' 92' ' ' LEU . 27.6 mt-10 -60.12 -55.65 31.24 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.38 0.61 . . . . 0.0 111.19 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 150' ' ' ILE . 3.5 t-105 -67.74 -27.54 66.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.25 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -69.04 -47.47 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.561 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.6 ttt180 -55.68 -61.35 2.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.359 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 t -61.63 -27.71 68.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.382 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.618 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.8 tp10 -73.38 -47.23 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.339 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.96 -35.65 73.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 110.751 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 37.6 mt-10 -64.61 -37.58 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.439 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' HD2' ' C ' ' A' ' 83' ' ' ARG . 4.5 ppt_? -91.36 -28.39 17.74 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.39 -30.87 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 87' ' ' VAL . 24.3 t -144.32 -175.11 4.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 110.921 -171.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -100.36 26.81 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.204 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 85' ' ' SER . 74.7 t -52.46 139.68 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.308 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.454 HG12 ' CG ' ' A' ' 132' ' ' HIS . 8.7 p -73.41 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.988 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -53.15 121.32 23.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 O-C-N 122.023 -0.423 . . . . 0.0 110.565 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.0 Cg_endo -85.77 162.94 10.61 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.605 2.203 . . . . 0.0 112.401 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 29.6 Cg_endo -63.57 146.24 92.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.765 2.31 . . . . 0.0 112.191 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 75' ' ' GLU . 97.6 mt -74.3 142.9 79.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.9 Cg_exo -73.94 117.56 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.885 2.39 . . . . 0.0 111.224 176.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.09 61.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.257 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.43 -45.35 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.01 -85.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -49.45 -32.03 11.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.579 1.152 . . . . 0.0 113.979 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -57.46 -47.3 82.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.07 27.83 8.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.618 0.723 . . . . 0.0 110.145 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -122.96 -32.73 3.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.871 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.53 168.12 12.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.31 156.26 66.96 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.865 2.376 . . . . 0.0 111.551 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -79.2 -90.42 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.498 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 64.97 -72.0 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.637 0.586 . . . . 0.0 111.344 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.02 65.16 4.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 66.57 -71.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.297 1.039 . . . . 0.0 111.326 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.83 -19.18 12.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.338 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.28 8.47 31.09 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 50.3 pt -75.56 -17.39 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.819 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -79.35 -15.43 57.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.031 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.8 132.41 41.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.155 0.503 . . . . 0.0 109.884 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.48 -27.3 69.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.717 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 50.2 m-80 -65.83 -52.43 50.63 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -53.95 -49.4 68.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.522 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.6 mt -52.57 -48.7 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.925 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.13 -21.85 59.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.605 -178.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 46.8 mm-40 -73.66 -33.86 64.67 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.621 0.724 . . . . 0.0 109.634 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.79 -35.82 43.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.433 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -57.24 -53.12 61.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.11 -178.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.8 pt20 -61.17 -45.0 96.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.605 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.17 -43.41 95.52 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.804 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -69.51 -32.14 70.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.629 0.715 . . . . 0.0 111.599 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.615 ' HA ' HG22 ' A' ' 126' ' ' ILE . 14.9 pt-20 -74.92 -33.3 61.98 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.9 mm100 -59.88 -57.64 12.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.513 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.2 t80 -51.68 -53.31 40.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.499 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.9 tp -64.41 -39.95 87.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.018 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.58 -20.49 60.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 112.026 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.0 mttm -88.46 -56.26 3.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.667 0.746 . . . . 0.0 110.899 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.651 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -66.9 -11.73 14.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.025 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.07 -11.7 16.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.499 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -122.65 -6.17 8.04 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.936 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.6 t60 -84.09 143.55 42.85 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 117.328 0.564 . . . . 0.0 110.633 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 17.2 Cg_exo -39.33 -50.03 2.95 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.514 3.476 . . . . 0.0 113.813 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.42 -30.71 66.38 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.352 -174.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.651 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -77.0 -44.54 30.55 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.45 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.14 -0.76 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.421 176.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 2.5 t30 -104.11 -21.13 13.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.409 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 17.9 mm-40 -102.11 143.12 32.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.905 0.775 . . . . 0.0 112.627 -166.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 139' ' ' ARG . 6.7 tpp85 -62.85 -21.25 65.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.513 -166.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.566 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 1.9 t -60.41 -26.15 66.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.23 0.538 . . . . 0.0 110.076 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 135' ' ' ALA . 4.6 mp -71.48 -28.51 63.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.342 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -61.82 -47.18 86.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.5 ptm -72.44 -30.64 64.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t80 -75.92 -48.37 21.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.651 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 1.6 mt -96.97 -43.68 7.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.558 . . . . 0.0 111.545 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.668 ' HA ' HD11 ' A' ' 62' ' ' LEU . 54.4 mt-30 -91.43 -15.51 28.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.573 -166.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -111.43 174.64 5.77 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -79.15 -32.72 44.43 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.089 0.947 . . . . 0.0 110.013 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -139.9 143.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.132 -167.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.9 mp -71.58 106.67 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.036 173.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 104.02 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.897 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -69.16 -1.01 6.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.9 p -113.24 18.03 18.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.471 0.653 . . . . 0.0 110.596 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.434 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.3 -171.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.604 178.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.7 m -86.45 112.12 44.06 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.14 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 22.1 Cg_exo -69.38 82.43 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.403 2.735 . . . . 0.0 111.621 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 m -156.73 -153.58 0.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -105.02 177.65 4.79 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.697 177.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 59' ' ' ILE . 17.1 mm -66.78 -36.16 76.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.589 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -76.34 7.04 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.496 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.7 m170 68.02 -179.83 0.23 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.184 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.362 -178.406 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.079 0.466 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.28 112.92 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.205 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -134.95 46.83 2.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.175 0.512 . . . . 0.0 110.02 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 48.7 m80 59.26 49.06 9.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.545 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -118.21 83.76 2.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -64.25 116.82 6.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -97.73 67.11 1.98 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.679 0.752 . . . . 0.0 110.006 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -108.81 157.41 18.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.903 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.1 m -76.6 82.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.559 0.695 . . . . 0.0 111.364 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 108.96 -93.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.142 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.6 p 49.66 97.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.99 0.916 . . . . 0.0 112.831 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.44 142.7 28.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.678 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -82.09 -46.79 13.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.417 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 p -107.74 151.8 25.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.585 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.5 t -119.02 -46.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.763 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.39 123.87 30.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.32 148.61 46.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -54.62 -49.75 69.74 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 122.499 0.32 . . . . 0.0 110.936 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 9' ' ' ARG . 6.0 mmp_? 64.44 154.76 0.06 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.785 0.678 . . . . 0.0 111.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -169.06 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.2 tp 72.22 137.42 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.553 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 143.25 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.917 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -136.13 130.11 32.82 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -83.8 157.72 63.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.324 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.55 127.11 13.26 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.275 2.65 . . . . 0.0 112.386 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -67.86 134.47 50.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.656 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -115.19 -166.78 1.15 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.76 -164.6 0.94 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 20' ' ' ASP . 1.3 p-10 -43.56 -67.65 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.075 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 5.5 p-10 -133.36 134.61 43.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.223 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -179.07 168.04 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.133 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -143.55 -53.75 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.185 0.517 . . . . 0.0 110.147 -171.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 -179.68 43.01 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 9.4 Cg_endo -51.44 154.92 7.82 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.531 2.821 . . . . 0.0 111.499 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 51.7 Cg_exo -56.49 -7.71 2.27 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.798 2.998 . . . . 0.0 113.953 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 p -77.12 -53.58 7.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 28.7 m120 62.85 170.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.671 0.607 . . . . 0.0 111.494 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.65 134.9 33.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 57' ' ' LEU . 14.9 tp -142.17 130.25 22.01 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.114 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -141.46 101.11 3.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.824 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.679 HG12 ' HB ' ' A' ' 53' ' ' VAL . 42.9 mt -115.07 140.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -132.59 106.92 8.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.938 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -84.6 130.64 35.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 170.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -179.1 -164.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.4 m-80 59.2 71.75 0.9 Allowed Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 110.284 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.39 133.37 37.15 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.088 2.525 . . . . 0.0 113.487 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 47' ' ' THR . 5.7 tp-100 -117.65 106.96 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.686 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -78.22 90.1 4.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.554 0.692 . . . . 0.0 109.953 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 p -117.29 91.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.612 -174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.45 -166.28 31.53 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.399 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.1 t -101.2 146.94 8.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.346 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.34 -48.13 4.6 Favored Glycine 0 N--CA 1.465 0.584 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.245 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -102.22 88.21 3.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.39 0.614 . . . . 0.0 109.713 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.9 0.93 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.62 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 13.8 ttt180 -85.31 139.86 31.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 39.3 p90 -129.72 153.57 48.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 86.7 m -111.31 124.08 51.5 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.0 p -92.74 153.58 18.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.117 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.26 136.45 51.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.02 0.438 . . . . 0.0 110.765 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 29.3 tt0 -90.58 116.6 28.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 mp -94.27 113.75 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.865 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HG2' ' OG1' ' A' ' 66' ' ' THR . 66.4 mtt180 -105.53 121.98 45.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.843 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -128.9 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.0 111.882 -177.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -127.92 133.74 49.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 7.1 t -168.27 165.44 12.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.595 0.712 . . . . 0.0 112.121 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -117.94 21.63 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.752 167.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 29' ' ' LEU . 26.7 mt -56.14 131.96 74.81 Favored Pre-proline 0 CA--C 1.521 -0.163 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.801 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 11.7 Cg_exo -66.82 -37.94 18.97 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.413 2.076 . . . . 0.0 111.186 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -58.2 -42.43 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.448 176.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.87 -23.69 64.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.47 -64.57 0.34 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -73.44 -25.68 60.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -174.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' O ' HG22 ' A' ' 55' ' ' THR . 19.2 mmtp 82.02 -34.24 0.1 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.822 171.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.32 125.19 1.82 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.546 0.688 . . . . 0.0 110.08 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 62' ' ' LEU . 16.7 t -170.71 176.13 4.34 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.751 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.57 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 27.9 m -141.73 133.19 26.72 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.5 m -121.3 178.35 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.301 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -143.24 106.08 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -127.41 167.59 16.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.449 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.602 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 58.0 ttp180 -94.82 165.13 12.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.002 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.2 t80 -52.52 -40.73 62.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.621 0.248 . . . . 0.0 110.809 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -54.17 -35.5 62.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.7 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.65 -41.51 96.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 69.1 m-85 -64.97 -38.02 89.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.3 mt-10 -60.71 -52.12 66.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.376 0.607 . . . . 0.0 110.935 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.519 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 8.3 t-105 -67.26 -27.53 67.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.283 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -71.32 -46.58 60.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 53.5 ttt180 -58.17 -58.63 7.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.266 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 p -62.74 -32.28 73.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.453 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 1.1 tm-20 -59.4 -48.0 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.0 110.264 176.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 92.5 mt -65.4 -30.05 70.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.942 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 40.0 mt-10 -82.03 -35.53 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.988 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 2.6 ppt_? -69.59 -25.14 63.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG3' ' HD2' ' A' ' 83' ' ' ARG . 4.0 mt-10 -119.53 -55.06 2.14 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.056 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.7 m -87.21 171.09 10.91 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.754 0.787 . . . . 0.0 112.221 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -102.66 30.61 4.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -50.8 142.23 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.699 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.5 p -72.01 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.726 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -58.74 119.66 39.06 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.435 . . . . 0.0 110.882 -176.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 91.9 Cg_endo -85.5 162.12 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.882 2.388 . . . . 0.0 112.288 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 135.03 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.988 2.458 . . . . 0.0 112.661 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 93.5 mt -66.19 151.26 95.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.401 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.49 113.01 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.635 2.223 . . . . 0.0 111.248 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.48 166.57 37.08 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.635 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.59 25.7 10.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.536 0.684 . . . . 0.0 110.925 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -116.63 -74.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.016 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -69.96 -22.29 63.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.02 -176.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -66.83 -47.0 73.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.517 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -92.98 28.74 2.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.842 0.829 . . . . 0.0 110.051 176.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 32.6 tp60 -124.7 -41.29 2.14 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.854 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.74 165.63 20.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.08 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 179.54 3.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.2 2.6 . . . . 0.0 111.966 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.94 -75.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.009 0.433 . . . . 0.0 110.2 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 104' ' ' ARG . 29.2 mtm180 68.06 -57.48 0.47 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.063 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.31 -159.26 25.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.717 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.09 -48.24 82.34 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.407 0.622 . . . . 0.0 110.719 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.88 -21.85 2.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.438 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.82 11.15 38.4 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 49.8 pt -90.96 -17.93 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.723 -173.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -82.9 10.44 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.357 0.599 . . . . 0.0 109.789 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.88 126.94 40.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.332 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.0 -21.16 65.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.628 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.582 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.4 m-80 -71.45 -55.14 8.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -50.82 -50.06 57.31 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.616 0.572 . . . . 0.0 111.129 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.96 -48.99 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.653 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -81.69 -14.84 56.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.913 -177.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 35.7 mm-40 -69.44 -35.13 75.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.3 0.571 . . . . 0.0 109.698 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.573 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.6 ttp180 -79.44 -34.32 41.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.212 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -57.41 -51.29 70.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.631 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.779 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.7 pt20 -61.2 -37.63 83.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.311 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.6 -33.3 25.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.388 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.8 tp -66.6 -38.02 86.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.181 0.192 . . . . 0.0 110.945 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.59 ' HA ' HG22 ' A' ' 126' ' ' ILE . 9.8 pt-20 -71.28 -30.87 66.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.779 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 10.3 mm100 -61.16 -59.64 5.01 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 2.5 t80 -48.47 -52.52 21.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.963 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -64.08 -40.28 88.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.79 -172.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.09 -18.02 44.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.1 -59.24 2.28 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.827 0.822 . . . . 0.0 110.396 175.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 81' ' ' LEU . 1.3 m -63.45 -12.46 10.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.64 -0.89 27.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.436 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.73 11.94 2.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.685 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.695 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 38.3 t60 -101.57 141.34 22.39 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.474 -0.427 . . . . 0.0 110.82 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.695 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 7.9 Cg_exo -41.27 -50.47 4.42 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.365 3.377 . . . . 0.0 113.79 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.64 -26.24 64.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.16 -174.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.47 -41.67 16.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.3 mm100 -66.29 -4.68 8.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.201 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 135' ' ' ALA . 55.7 t30 -106.26 0.77 25.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.438 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' A' ' 138' ' ' GLU . 5.1 mm-40 -112.26 127.46 55.98 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.999 -0.438 . . . . 0.0 110.986 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 159' ' ' ILE . 13.7 tpp85 -57.98 -21.53 45.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.42 -172.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.814 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 4.3 t -61.88 -22.78 65.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 110.537 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.539 ' O ' HD22 ' A' ' 145' ' ' LEU . 7.3 mp -72.76 -32.46 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.096 -0.378 . . . . 0.0 111.441 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 18.8 t60 -58.0 -44.1 87.0 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.363 0.602 . . . . 0.0 109.643 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.814 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -77.83 -24.4 48.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.174 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.4 t80 -80.37 -57.18 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.83 -24.81 26.59 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.686 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.4 mt-30 -109.16 158.76 17.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.375 -168.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 62.51 -107.06 0.22 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.258 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.6 pm0 -146.26 -39.78 0.22 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.597 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -139.85 151.78 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -161.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -77.59 109.11 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.314 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.59 102.3 15.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.931 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 31.6 mmtp -66.25 -5.42 10.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -174.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -106.9 18.19 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.311 0.577 . . . . 0.0 110.123 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.447 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.32 -170.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.951 -179.048 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.6 m -87.84 111.6 43.41 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.136 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.7 Cg_exo -70.72 81.68 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.247 2.631 . . . . 0.0 111.785 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.6 m -155.56 -159.24 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.264 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -84.92 167.31 16.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.77 -45.17 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.661 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.19 125.72 28.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -75.19 174.07 9.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.71 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.684 -179.298 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . 62.39 84.65 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.238 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -129.13 132.29 47.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.086 0.469 . . . . 0.0 110.264 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -139.35 56.67 1.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.289 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 71.34 -77.89 0.05 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.468 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -152.97 156.01 38.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.771 0.32 . . . . 0.0 110.531 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -90.35 -32.37 16.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.935 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -80.05 93.63 5.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.821 0.343 . . . . 0.0 111.064 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.7 t 62.15 89.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.832 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -83.37 -85.75 0.84 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.629 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 m -79.49 148.34 31.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.96 124.0 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.103 0.478 . . . . 0.0 110.955 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.62 -50.05 4.87 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.979 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -79.61 138.74 37.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.74 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -154.81 -41.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.257 -173.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.01 127.49 29.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.449 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.12 -167.88 1.73 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.456 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.4 p -58.14 -67.73 0.32 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 56.86 -171.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.891 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -169.45 -177.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.1 tp -160.39 146.32 15.21 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mt -121.26 143.4 33.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.4 p -138.35 121.98 17.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.46 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.67 162.43 67.52 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.18 104.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.935 2.423 . . . . 0.0 112.118 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.48 167.11 11.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.919 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -123.3 153.69 39.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.763 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.81 151.47 29.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.521 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -86.09 -179.66 6.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.8 m-20 -86.9 143.83 27.24 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . 71.91 168.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 124.154 0.909 . . . . 0.0 110.849 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 4.3 m-85 -122.15 -13.62 8.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.636 -171.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.66 172.23 38.18 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.753 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.92 156.56 6.93 Favored 'Trans proline' 0 C--O 1.224 -0.207 0 C-N-CA 124.16 3.24 . . . . 0.0 112.223 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -42.64 -22.51 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 124.81 3.673 . . . . 0.0 115.728 -171.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -72.0 -61.51 1.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.507 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.7 m120 60.95 -178.26 0.11 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.932 0.396 . . . . 0.0 111.523 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' HD2' ' ND2' ' A' ' 56' ' ' ASN . 0.3 OUTLIER -89.42 130.52 35.76 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.735 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -145.1 129.56 17.89 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.041 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -143.04 100.09 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.9 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.689 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.8 mt -111.07 146.05 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.442 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.2 114.99 11.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.719 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -97.14 132.36 41.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.53 -161.73 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.94 71.87 0.7 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.738 0.304 . . . . 0.0 110.524 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.19 132.66 28.39 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.777 2.318 . . . . 0.0 113.183 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.1 tp60 -122.25 111.65 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.569 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.9 m -75.87 98.14 4.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 109.541 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -130.04 94.45 2.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.873 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -170.64 -167.77 31.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.515 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 4.0 t -110.23 151.48 12.44 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.171 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.27 -49.1 4.58 Favored Glycine 0 N--CA 1.46 0.272 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.465 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.23 78.68 3.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.351 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.61 41.12 0.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.945 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 6.2 ttp180 -82.28 145.85 29.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -146.95 159.67 43.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.069 0.462 . . . . 0.0 111.072 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.6 m -112.36 128.79 56.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.928 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 20.1 p -92.29 146.22 23.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.002 0.429 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 78.9 m-85 -108.18 132.56 53.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.996 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 32.0 tt0 -87.14 119.06 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.73 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.541 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.1 mp -94.09 111.67 25.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.104 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 91.6 mtt180 -104.66 132.64 50.67 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.141 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.689 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.9 138.44 34.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 7.1 ttmt -125.74 133.91 51.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.596 168.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.0 t -166.3 164.24 17.6 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.422 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' ND2' ' HD2' ' A' ' 28' ' ' PHE . 24.3 p30 -115.84 25.78 10.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.682 167.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.735 HD11 HD22 ' A' ' 29' ' ' LEU . 29.4 mt -61.42 133.58 93.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.496 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.8 Cg_exo -70.66 -32.01 15.56 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.462 2.108 . . . . 0.0 111.262 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -63.62 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.963 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.523 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 3.8 m-30 -71.07 -19.16 62.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 62' ' ' LEU . 54.5 tttp 71.19 -64.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.29 -5.52 56.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -174.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 55' ' ' THR . 4.9 mmpp? 71.22 -38.41 0.42 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.769 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -160.35 135.94 8.22 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.014 0.435 . . . . 0.0 110.038 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -170.08 175.45 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.585 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.8 m -140.83 141.67 34.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.776 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.6 m -138.86 -179.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 40.7 ptt180 -150.37 126.97 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.14 0.495 . . . . 0.0 111.106 171.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.0 mmp_? -139.36 167.24 22.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.802 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.41 156.6 20.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.3 t80 -51.72 -39.34 58.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.723 0.297 . . . . 0.0 110.744 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.9 m -54.17 -32.77 56.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.863 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.13 -35.85 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 51.5 m-85 -64.52 -39.59 94.06 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 92' ' ' LEU . 15.7 mt-10 -60.09 -51.6 68.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' HG21 ' A' ' 150' ' ' ILE . 6.8 t-105 -65.44 -27.46 68.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.256 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.594 HD22 ' CD2' ' A' ' 144' ' ' PHE . 34.4 tp -72.08 -48.46 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 43.3 ttt180 -53.98 -59.38 4.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.839 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.632 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 p -60.06 -40.3 89.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.033 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.6 -52.57 59.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.594 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 87.6 mt -65.51 -34.8 79.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.383 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 35.0 mt-10 -70.06 -43.96 70.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 79' ' ' SER . 20.6 mmt180 -76.73 -48.07 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.177 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.81 -23.07 31.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.044 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.6 t -132.79 -177.52 4.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.408 0.623 . . . . 0.0 111.237 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -108.54 18.24 21.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.217 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.433 ' CG1' HG22 ' A' ' 89' ' ' VAL . 90.1 t -48.89 141.13 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.287 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.1 p -71.91 38.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.466 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -55.99 118.88 22.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.163 -0.335 . . . . 0.0 110.774 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 91.6 Cg_endo -83.79 161.62 14.17 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.845 2.363 . . . . 0.0 111.976 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.62 139.22 62.77 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.716 2.277 . . . . 0.0 112.223 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.9 mt -70.27 154.96 94.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.857 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 3.2 Cg_exo -79.06 110.07 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 0.0 110.919 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.3 171.32 39.8 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.297 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 56.91 51.28 10.92 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.445 0.64 . . . . 0.0 110.125 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.29 -83.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.543 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.599 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -64.1 -17.96 63.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.814 -174.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.698 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.0 mm? -65.85 -41.58 91.53 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.983 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 24.97 7.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.882 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.1 OUTLIER -96.64 -48.92 5.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.446 -177.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.595 HD22 ' C ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -92.85 165.34 19.04 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.696 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -59.96 -78.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.489 2.793 . . . . 0.0 113.217 -175.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -149.36 -88.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.457 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 104' ' ' ARG . 17.6 tpt180 67.3 -56.12 0.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.694 0.798 . . . . 0.0 112.632 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.68 170.01 20.02 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.546 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.71 -53.52 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.049 0.54 . . . . 0.0 111.051 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.61 -4.86 19.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.94 58.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.782 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.4 pt -73.57 -14.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.205 -0.498 . . . . 0.0 111.673 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -84.34 1.07 46.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.756 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -103.8 136.59 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.27 -25.57 65.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.638 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -61.85 -61.4 2.52 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.782 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.2 -50.43 38.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.354 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.5 mt -51.59 -53.89 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.18 -20.1 60.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.494 -177.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 65.2 mm-40 -74.26 -33.62 63.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.27 0.557 . . . . 0.0 109.639 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.1 tpp180 -76.64 -40.12 50.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -53.02 -51.44 61.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.859 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.756 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -61.46 -36.26 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.819 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.65 -33.1 10.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.699 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 33' ' ' VAL . 8.1 tp -67.39 -36.35 81.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.978 -0.13 . . . . 0.0 111.083 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.644 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.7 pt-20 -72.37 -28.84 63.27 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.756 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 9.6 mm100 -65.18 -61.34 2.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.462 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.5 t80 -44.01 -52.98 6.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.89 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -62.81 -41.15 91.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.476 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -59.29 -17.42 28.77 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -90.47 -58.08 2.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.734 0.778 . . . . 0.0 110.452 175.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -64.47 -12.5 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.884 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.63 0.45 26.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.376 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.476 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.33 13.89 2.29 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.026 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.67 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 55.2 t60 -101.21 141.83 23.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 117.156 0.478 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.72 -49.49 5.36 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 124.014 3.143 . . . . 0.0 113.523 -173.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -33.17 73.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.331 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -74.08 -41.29 61.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.822 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -70.3 0.13 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.187 0.994 . . . . 0.0 109.36 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 135' ' ' ALA . 56.8 t30 -117.28 14.86 14.85 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.242 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.58 130.52 47.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.798 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 139' ' ' ARG . 4.3 mmt180 -49.51 -22.38 1.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.795 0.838 . . . . 0.0 113.002 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.712 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 2.8 m -55.4 -28.0 51.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.21 0.604 . . . . 0.0 112.13 -174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.51 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.2 mp -78.26 -34.39 49.06 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.784 -0.573 . . . . 0.0 111.735 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.8 t60 -63.12 -35.69 81.11 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.45 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.712 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.6 ptm -77.47 -28.94 52.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.452 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.594 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.1 t80 -80.7 -58.57 3.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.199 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -83.12 -22.71 33.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.077 -172.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 42.6 mt-30 -120.98 179.19 4.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.711 -169.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.5 t70 65.73 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.831 0.707 . . . . 0.0 110.542 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.81 -56.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.68 0.752 . . . . 0.0 110.044 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.49 143.29 40.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.05 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.668 HG23 ' HE2' ' A' ' 143' ' ' MET . 2.9 mp -65.44 119.35 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.585 173.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.4 106.68 18.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -73.89 10.0 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -129.93 19.22 5.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -63.71 -172.31 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.015 -177.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 89.7 m -87.31 112.24 46.66 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -69.94 77.92 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.167 2.578 . . . . 0.0 111.105 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -153.73 -161.61 1.29 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.5 mmmm -86.83 158.72 19.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.414 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.572 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -57.16 -39.63 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.209 0.528 . . . . 0.0 110.524 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -67.92 113.06 5.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.681 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -82.87 174.16 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.508 0.671 . . . . 0.0 110.483 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.825 -179.286 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.452 0.168 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -146.11 36.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.368 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -134.69 54.52 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.258 0.551 . . . . 0.0 109.747 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -142.68 105.95 4.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.561 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -173.26 151.57 2.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.214 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -136.96 -56.45 0.72 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.364 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 63.65 86.8 0.12 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.241 0.543 . . . . 0.0 110.102 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -81.06 -36.58 30.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.979 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.0 m -126.62 162.21 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.231 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 78.99 -79.59 1.58 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.828 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 m -91.84 147.89 22.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.63 132.77 46.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.9 -55.99 1.48 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -94.45 144.14 25.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.451 0.643 . . . . 0.0 111.489 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.57 163.37 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.0 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.54 123.88 42.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.245 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -113.05 160.81 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.3 p -63.68 -57.09 11.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.769 0.319 . . . . 0.0 110.407 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 58.0 -89.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.313 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -139.95 127.5 21.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 109.957 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.428 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -107.64 -62.14 1.47 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 122.213 1.006 . . . . 0.0 108.703 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 11' ' ' LEU . 5.7 mt 70.52 146.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 112.258 -2.246 . . . . 0.0 112.294 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 p -106.11 107.72 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.521 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 7.1 mptt -98.42 168.73 9.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.827 -177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 47.3 Cg_exo -57.48 111.5 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.375 2.05 . . . . 0.0 111.371 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -71.4 147.39 47.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.68 159.3 21.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.404 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -91.57 154.69 18.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.349 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 20' ' ' ASP . 3.5 p-10 -50.87 -60.76 2.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.558 0.694 . . . . 0.0 110.37 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.6 m-20 -123.33 149.72 44.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.769 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.08 175.96 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.927 0.767 . . . . 0.0 111.783 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 5.2 m-85 -124.97 -9.57 7.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.757 -173.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.14 174.25 46.61 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -54.33 154.27 19.57 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.988 3.126 . . . . 0.0 111.486 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.47 -19.25 0.63 Allowed 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.42 3.413 . . . . 0.0 115.379 -170.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -70.46 -57.44 4.79 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 12.2 m120 59.07 -178.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.469 0.481 . . . . 0.0 111.765 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -95.46 136.4 35.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 57' ' ' LEU . 13.9 tp -145.79 131.28 18.73 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.09 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.9 pt-20 -140.81 99.72 3.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.063 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.665 HG12 ' HB ' ' A' ' 53' ' ' VAL . 22.4 mt -112.06 138.81 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.24 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.09 107.72 6.23 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -83.89 136.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -179.9 -167.17 0.09 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.2 84.88 0.2 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.61 0.569 . . . . 0.0 111.479 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HB3' HG21 ' A' ' 115' ' ' ILE . 94.4 Cg_endo -76.35 119.9 5.44 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 113.738 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -102.55 106.26 16.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.386 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' HE ' ' A' ' 45' ' ' ARG . 28.5 m -78.75 89.28 4.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.685 0.755 . . . . 0.0 110.115 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 94.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.7 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.61 -167.48 32.67 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.558 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 10.1 t -104.32 152.59 6.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.177 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.1 -51.81 6.01 Favored Glycine 0 N--CA 1.461 0.347 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.188 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.56 83.15 4.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.884 0.373 . . . . 0.0 110.171 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 39.73 0.72 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.384 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.593 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 23.5 ttt180 -84.09 141.12 31.35 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 43.5 p90 -131.1 164.3 25.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.6 m -117.45 127.14 53.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.232 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.594 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 16.6 p -92.15 128.22 37.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 91.8 m-85 -90.63 131.87 36.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.458 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 29.6 tt0 -81.74 116.37 21.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.314 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.504 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 mp -92.83 109.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.707 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 27.5 mtp180 -100.29 136.09 40.72 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.765 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.49 135.67 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 112.337 -178.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 15.5 ttmt -124.39 139.82 53.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.024 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -170.55 164.32 8.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.4 0.619 . . . . 0.0 112.317 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -118.55 27.35 8.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.949 167.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 29' ' ' LEU . 23.0 mt -60.98 141.88 93.19 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.751 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.5 Cg_exo -76.04 -33.04 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.569 2.179 . . . . 0.0 111.524 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -63.05 -41.91 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.807 177.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 145' ' ' LEU . 3.5 m-30 -68.95 -26.52 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' C ' ' HD2' ' A' ' 61' ' ' LYS . 1.9 tmmm? 73.81 -60.64 0.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.69 -7.83 58.84 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.126 -0.359 . . . . 0.0 110.684 -173.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 5.4 mmtp 70.25 -40.83 0.48 Allowed 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.063 0.852 . . . . 0.0 111.24 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.9 pp20? -161.16 136.48 7.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 167.79 13.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 19.0 m -141.81 137.17 31.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.191 0.52 . . . . 0.0 111.559 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -132.74 -176.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.088 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 8.3 ptp180 -150.33 116.21 5.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.929 173.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 24.4 mmm180 -135.01 160.44 38.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.874 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 32.9 ptt180 -89.8 172.63 8.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -169.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 26.7 t80 -54.46 -41.88 69.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.247 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 t -55.42 -33.98 64.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.314 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.66 -37.47 73.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.504 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 61.7 m-85 -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.0 mt-10 -60.08 -53.48 57.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.754 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.444 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 3.1 t-105 -67.57 -27.9 67.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.403 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.0 tm? -70.49 -41.71 72.34 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 57.2 ttt180 -59.06 -60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.733 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 7.5 p -61.45 -37.13 82.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.373 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.96 -49.99 72.01 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.132 0.27 . . . . 0.0 110.755 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.6 mt -61.44 -34.36 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.909 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 32.2 mt-10 -75.22 -18.54 60.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.805 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HG2' ' O ' ' A' ' 79' ' ' SER . 31.7 mmt180 -80.28 -62.99 1.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.208 0.528 . . . . 0.0 111.81 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -88.73 -21.52 23.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.264 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 87' ' ' VAL . 16.2 m -123.75 169.39 11.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.314 0.578 . . . . 0.0 111.263 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -100.45 32.36 3.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.219 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 85' ' ' SER . 80.8 t -53.08 142.04 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.145 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.7 p -71.21 36.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.737 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.55 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -59.51 116.37 16.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 O-C-N 122.055 -0.403 . . . . 0.0 110.953 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.3 Cg_endo -85.36 162.72 11.2 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.783 2.322 . . . . 0.0 112.606 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 131.86 33.94 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.898 2.399 . . . . 0.0 112.112 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD11 ' HA ' ' A' ' 75' ' ' GLU . 62.5 mt -63.99 152.0 88.41 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.555 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 2.8 Cg_exo -75.52 129.74 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.689 2.26 . . . . 0.0 111.202 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -179.23 48.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.3 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' N ' HD23 ' A' ' 98' ' ' LEU . 10.6 mptt 66.58 -58.12 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.088 0.955 . . . . 0.0 112.185 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -71.75 -22.03 61.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.499 -170.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.696 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -65.71 -45.61 82.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.005 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 22.19 8.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.388 0.613 . . . . 0.0 110.38 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.3 tp60 -115.97 -45.56 2.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.638 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 46.5 mt -82.26 169.4 18.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.521 -174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.04 145.41 73.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.743 2.295 . . . . 0.0 111.054 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.5 -71.19 0.38 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.075 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 68.83 -56.37 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.887 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.27 -169.15 37.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -53.0 -50.33 64.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.34 0.59 . . . . 0.0 111.246 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.92 -26.44 5.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.62 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.26 -13.8 8.92 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 24.9 pt -68.75 -16.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.743 -0.729 . . . . 0.0 111.44 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.94 2.15 27.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -116.08 145.31 43.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.13 0.491 . . . . 0.0 110.421 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.84 -17.5 59.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.513 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 93.2 m-20 -66.73 -60.28 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.475 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -51.42 -48.29 62.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 36' ' ' PRO . 39.0 mt -50.94 -53.32 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.355 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.24 -20.14 60.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.768 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 45.4 mm-40 -73.36 -32.96 64.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.057 0.456 . . . . 0.0 110.301 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 33.4 ttm180 -80.8 -36.45 31.71 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.48 -49.83 66.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.144 -178.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.4 pt20 -58.0 -36.75 73.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 -174.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.41 -32.67 9.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.7 tp -66.35 -35.45 80.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.1 pt-20 -72.46 -35.54 68.27 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.739 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.8 mm100 -56.49 -53.84 52.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -53.39 -52.71 58.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.296 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.0 tp -64.41 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.836 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.8 m-80 -62.11 -23.56 66.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 111.668 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.565 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 42.9 mttm -81.35 -56.19 4.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.943 0.878 . . . . 0.0 110.367 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.564 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -68.24 -11.84 14.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.332 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.21 -2.75 19.1 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.832 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.29 -1.12 5.75 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.166 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.69 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 42.6 t60 -89.64 142.03 29.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 122.65 -0.323 . . . . 0.0 110.736 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.7 Cg_exo -41.52 -48.86 5.38 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.436 3.424 . . . . 0.0 113.659 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.92 -26.63 64.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.347 -174.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.67 -47.75 10.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.86 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.71 -6.16 1.11 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.236 172.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 32.9 t-20 -83.54 -33.72 25.41 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.519 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 7.8 pt-20 -113.57 149.98 33.69 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 117.622 -1.631 . . . . 0.0 114.547 -164.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.1 tpt180 -58.14 -21.38 46.62 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 113.138 -1.846 . . . . 0.0 112.026 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 143' ' ' MET . 7.8 t -60.97 -27.68 68.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.545 0.688 . . . . 0.0 109.896 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' C ' ' A' ' 135' ' ' ALA . 1.2 tp -71.56 -31.64 67.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.251 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.492 ' HA ' ' CD ' ' A' ' 146' ' ' GLN . 57.3 t60 -69.52 -29.57 67.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.636 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.6 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.7 ptm -79.68 -29.08 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.661 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 12.8 t80 -80.15 -53.62 6.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.954 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 60' ' ' PHE . 1.2 mp -105.41 -27.74 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.174 0.512 . . . . 0.0 111.792 -172.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.492 ' CD ' ' HA ' ' A' ' 142' ' ' HIS . 31.2 mt-30 -106.43 9.7 31.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.357 -164.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.487 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.2 t70 -137.86 -177.56 4.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -83.5 -33.74 25.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 119.475 1.034 . . . . 0.0 110.257 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -143.62 143.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.643 -167.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.6 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.4 mp -75.04 108.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.924 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.8 108.36 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 28.8 mmtp -73.53 10.68 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -130.92 19.71 5.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.032 0.444 . . . . 0.0 110.142 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -174.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.308 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 96.4 m -79.46 112.47 29.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 22.7 Cg_exo -71.56 43.94 0.57 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.762 2.975 . . . . 0.0 113.143 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 31.9 m -115.01 -158.96 0.69 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 23.3 mmmt -101.07 170.02 8.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.216 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 59' ' ' ILE . 20.1 mm -60.15 -42.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.35 75.0 7.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -85.37 160.75 19.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.251 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.164 175.91 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.398 0.142 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -77.78 77.73 4.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.132 0.491 . . . . 0.0 110.851 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -168.47 148.04 4.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -63.92 94.77 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.275 0.359 . . . . 0.0 110.482 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -103.33 -37.2 7.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.013 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -71.65 130.91 42.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' HIS . . . . . 0.42 ' O ' ' HB ' ' A' ' -1' ' ' VAL . 95.6 m-70 -61.74 108.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -1' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' -2' ' ' HIS . 84.4 t 72.11 125.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 O-C-N 123.98 0.8 . . . . 0.0 110.483 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 98.88 -164.81 20.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.953 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 43.2 p 51.36 98.16 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.74 0.816 . . . . 0.0 112.306 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.97 121.58 41.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -169.44 -59.47 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 p -92.7 151.46 20.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.185 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t 67.98 -66.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 124.06 0.85 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.93 117.07 28.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.256 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 9' ' ' ARG . 26.4 t70 -95.09 153.03 17.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.425 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.9 p -64.97 -70.28 0.24 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.239 0.337 . . . . 0.0 111.429 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HG2' ' OD2' ' A' ' 7' ' ' ASP . 37.5 mmt180 61.88 140.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.737 -172.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -166.2 -83.13 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.292 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.6 tp 71.2 142.14 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 124.027 0.829 . . . . 0.0 110.866 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.32 145.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p 68.72 126.22 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.354 1.034 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 11.1 mptt -71.56 164.92 53.83 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.688 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 85.6 Cg_exo -47.98 128.05 15.83 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.871 2.381 . . . . 0.0 111.927 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.88 140.86 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.06 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.98 150.01 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.812 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.06 172.55 7.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -69.9 -177.49 1.32 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.762 0.792 . . . . 0.0 111.349 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -143.96 148.66 35.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.25 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.1 -79.4 0.39 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.613 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 32.5 m-85 -72.92 -37.87 67.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.66 175.29 36.54 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.74 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 158.92 21.53 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.823 3.015 . . . . 0.0 110.792 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.45 -19.42 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 124.635 3.557 . . . . 0.0 115.49 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 p -71.97 -59.94 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.441 0.296 . . . . 0.0 110.446 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.477 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 16.1 m120 61.7 -178.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.357 0.598 . . . . 0.0 112.153 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -98.35 145.37 26.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.657 HD22 HD11 ' A' ' 57' ' ' LEU . 16.6 tp -150.02 130.19 13.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.835 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.8 pt-20 -139.06 112.39 8.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.987 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.634 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.7 mt -122.27 135.81 61.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.793 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.31 117.37 18.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.334 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t 178.98 -162.11 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.5 m-80 63.87 83.5 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-O 120.969 0.414 . . . . 0.0 110.322 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.6 123.76 9.29 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.424 2.082 . . . . 0.0 113.329 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.566 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 27.2 tp60 -110.63 102.71 11.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.453 HG22 ' NE ' ' A' ' 45' ' ' ARG . 27.9 m -77.5 102.06 6.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.342 0.591 . . . . 0.0 109.748 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -132.36 89.83 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.735 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.01 -166.76 31.96 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.883 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.5 t -98.69 154.96 3.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.442 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.61 -54.3 4.93 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.508 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -95.01 85.38 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 32.04 1.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.588 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 15.5 ttt180 -77.42 136.91 38.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.71 167.09 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.724 0.297 . . . . 0.0 110.41 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 m -119.56 132.3 55.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 23.4 p -92.52 127.66 38.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -93.74 131.33 39.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.976 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 20.3 tt0 -91.2 120.77 32.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.719 -173.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.38 118.21 38.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.672 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 37.7 mtp180 -107.24 130.04 54.79 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.168 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.96 138.14 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 112.439 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -118.69 140.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.693 167.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.422 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.36 164.29 7.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.243 0.544 . . . . 0.0 111.328 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.613 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 17.9 p30 -122.36 26.75 8.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.872 168.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 29' ' ' LEU . 18.8 mt -62.63 139.22 96.89 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.973 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.76 -41.68 5.51 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.427 2.085 . . . . 0.0 111.408 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.587 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -57.26 -42.7 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.3 m-85 -69.33 -22.44 63.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.24 -60.14 0.54 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 171.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.62 -11.06 57.77 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.239 0.472 . . . . 0.0 111.448 -171.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp 71.46 -43.05 0.55 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.001 0.813 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -153.23 135.16 14.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.061 178.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -170.57 172.47 5.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.658 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.592 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 8.0 m -140.79 136.38 32.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.203 0.525 . . . . 0.0 111.079 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 26.4 m -135.12 175.15 11.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.692 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 22.1 ptt180 -148.84 133.05 17.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.544 0.688 . . . . 0.0 111.864 172.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 73' ' ' ASP . 3.1 mmp_? -136.69 158.02 45.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.4 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 13.6 ptm180 -79.27 167.41 20.97 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.65 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 34.7 t80 -52.32 -42.65 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.534 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 15.0 m -58.24 -29.62 65.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.038 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 70' ' ' ARG . 2.2 m-20 -68.46 -38.91 81.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.518 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 52.6 m-85 -66.65 -36.97 83.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.8 mt-10 -61.83 -51.46 68.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.947 0.88 . . . . 0.0 110.071 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.56 -29.54 70.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.406 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -74.18 -44.71 52.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 45.8 ttt180 -55.59 -57.07 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.752 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.717 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 25.0 p -62.89 -40.66 98.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.142 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.659 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 5.9 mm-40 -57.41 -38.61 74.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.0 mt -72.63 -34.34 67.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.839 0.352 . . . . 0.0 110.586 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 36.2 mt-10 -73.49 -26.33 60.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.197 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 79' ' ' SER . 28.0 mmm180 -55.24 -62.52 1.62 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.73 -2.82 10.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 26.5 t -114.02 173.97 6.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.411 0.624 . . . . 0.0 111.162 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -107.55 20.36 18.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.222 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 89' ' ' VAL . 93.6 t -51.77 141.59 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.476 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 88' ' ' VAL . 10.0 p -73.48 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.532 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.594 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -56.38 120.18 33.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.873 -0.517 . . . . 0.0 110.9 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 92.3 Cg_endo -85.62 163.03 10.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.354 2.703 . . . . 0.0 112.269 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.55 138.18 44.95 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.793 2.329 . . . . 0.0 112.339 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.8 mt -67.33 156.42 88.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.558 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -90.26 109.37 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.146 2.564 . . . . 0.0 111.876 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . 177.81 70.51 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.226 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -143.01 -8.59 0.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.78 0.324 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -115.21 -84.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -171.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.438 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -48.79 -32.85 9.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.518 1.127 . . . . 0.0 113.688 -171.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.806 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -57.64 -49.42 76.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.832 0.349 . . . . 0.0 111.568 -172.665 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -102.31 20.24 17.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.49 0.662 . . . . 0.0 110.483 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.7 tp60 -113.61 -34.3 5.58 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.446 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 86.5 mt -83.95 176.74 3.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -66.27 -146.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.654 2.236 . . . . 0.0 112.238 172.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 79.9 m-85 -121.0 -89.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.141 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HD2' ' OD1' ' A' ' 111' ' ' ASP . 63.1 mtt180 68.35 -48.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.799 0.687 . . . . 0.0 111.429 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.2 -150.01 8.64 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -90.08 -30.87 17.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.134 0.492 . . . . 0.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB2' HG23 ' A' ' 109' ' ' ILE . 12.4 m-20 -111.99 -27.76 8.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.733 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 105.37 25.34 6.71 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.398 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.585 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 26.3 pt -73.23 -14.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.482 . . . . 0.0 111.749 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -77.61 -8.15 57.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.771 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 104' ' ' ARG . 0.7 OUTLIER -93.32 119.9 32.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.392 172.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.32 -33.03 71.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.949 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.595 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 94.4 m-20 -55.38 -56.16 23.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.236 0.335 . . . . 0.0 110.354 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -46.75 -50.75 17.62 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.564 0.54 . . . . 0.0 111.057 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 38.3 mt -50.66 -51.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.07 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.54 -18.81 47.31 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.78 -177.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 33.4 mt-10 -76.36 -30.94 57.78 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 109.713 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 16.3 tpp180 -74.81 -42.57 57.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 170.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -53.95 -52.06 61.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.328 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.762 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.7 pt20 -59.11 -36.93 76.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 -175.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLN . . . -88.85 -32.92 10.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.051 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.4 tp -67.74 -34.9 77.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.864 -0.198 . . . . 0.0 110.945 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.2 pt-20 -71.79 -31.93 67.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.762 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 10.3 mm100 -59.07 -58.21 9.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.432 ' CE1' HG11 ' A' ' 129' ' ' VAL . 1.8 t80 -51.08 -51.86 49.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.011 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -62.92 -39.68 86.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -62.5 -19.91 64.07 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 128' ' ' LYS . 2.9 mptp? -83.36 -58.69 2.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.834 0.826 . . . . 0.0 110.063 173.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.652 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -64.84 -11.84 11.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.281 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -107.17 -12.12 15.45 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.435 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -128.85 3.92 6.47 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.964 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.716 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.9 t60 -91.89 142.42 26.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 117.133 0.466 . . . . 0.0 110.216 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.716 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.1 Cg_exo -41.23 -47.34 5.36 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.173 3.248 . . . . 0.0 113.364 -174.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -70.41 -34.25 72.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.098 -175.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.8 -45.9 33.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.348 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.49 -6.53 1.1 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 173.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t30 -95.9 -20.01 19.11 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.869 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 29.7 mm-40 -103.49 136.79 42.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -165.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -56.98 -20.18 22.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.854 -171.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.3 m -54.76 -33.99 62.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.891 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.583 ' O ' HD22 ' A' ' 145' ' ' LEU . 8.0 mp -73.43 -34.03 65.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.109 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 27.9 t-80 -57.45 -34.9 69.46 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.185 0.517 . . . . 0.0 110.345 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.686 ' HE2' HG23 ' A' ' 150' ' ' ILE . 4.2 ptm -83.24 -30.03 28.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.0 t80 -72.7 -49.49 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -94.02 -42.74 8.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.079 -175.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 21.1 mp0 -88.01 0.75 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.849 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.53 ' OD1' HD12 ' A' ' 149' ' ' ILE . 8.8 t70 -141.8 150.89 42.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.909 0.385 . . . . 0.0 110.138 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.611 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.9 pm0 -75.11 -31.85 61.25 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.108 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.611 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -136.73 120.78 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.645 -170.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.686 HG23 ' HE2' ' A' ' 143' ' ' MET . 11.0 mt -63.82 122.47 14.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.356 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.31 99.57 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.697 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HD3' HG22 ' A' ' 150' ' ' ILE . 33.4 mmtp -68.27 -3.98 12.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.866 0.365 . . . . 0.0 111.516 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.4 m -116.58 20.62 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.471 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -64.42 -171.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.93 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.3 m -82.26 111.72 30.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.448 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 19.2 Cg_exo -71.62 73.85 2.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.579 2.853 . . . . 0.0 111.987 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -152.36 -148.62 0.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.776 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -99.73 -178.0 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.93 0.871 . . . . 0.0 112.091 -176.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.582 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -76.71 -35.23 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.616 175.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -75.19 -1.07 21.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.173 -171.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.8 m80 68.78 -175.77 0.2 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.162 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.247 -179.813 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.045 0.45 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.17 151.35 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.452 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.57 48.07 2.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -75.81 113.94 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.703 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -88.06 122.89 32.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -73.16 123.06 22.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.815 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.41 -3.11 21.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -99.58 -61.15 1.4 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.159 176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.22 156.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -87.43 53.51 4.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.601 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 34.7 p -101.71 104.11 14.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.119 0.485 . . . . 0.0 110.63 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.48 137.81 17.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.801 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -148.57 -66.81 0.23 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 p 52.71 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.324 1.059 . . . . 0.0 112.762 -171.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.03 157.35 41.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.427 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.59 143.88 32.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.86 159.96 33.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.7 p -51.86 -46.36 64.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.241 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 65.86 147.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.981 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 10' ' ' ARG . 8.0 ppt_? -150.93 141.79 22.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.044 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.3 tp -146.83 146.22 30.15 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.77 140.97 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.107 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.3 p -104.29 117.96 35.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.607 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 9.1 mptt -76.9 159.18 79.27 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.019 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.71 144.92 84.92 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.463 2.775 . . . . 0.0 112.728 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -81.16 138.3 35.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.579 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -106.12 150.41 25.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.203 0.525 . . . . 0.0 111.403 -175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.86 175.04 11.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.683 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 38.55 -104.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.059 0.849 . . . . 0.0 112.667 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -131.02 135.22 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.8 0.273 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 58' ' ' PRO . . . 174.16 172.17 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 124.058 0.849 . . . . 0.0 110.631 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.536 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 7.6 m-85 -126.26 -9.49 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.48 -172.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.54 43.99 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.678 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.3 Cg_endo -50.89 156.23 4.96 Favored 'Trans proline' 0 CA--C 1.526 0.103 0 C-N-CA 124.32 3.347 . . . . 0.0 112.33 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 73.1 Cg_exo -51.29 -8.87 0.24 Allowed 'Trans proline' 0 N--CA 1.482 0.82 0 C-N-CA 124.504 3.469 . . . . 0.0 115.213 -174.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -71.42 -63.92 1.02 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.601 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.1 m120 59.54 172.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.669 0.605 . . . . 0.0 111.979 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -95.63 140.93 29.75 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 57' ' ' LEU . 13.5 tp -144.88 131.26 19.68 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.343 0.592 . . . . 0.0 110.956 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.23 102.4 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.024 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' VAL . 54.8 mt -113.49 140.01 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -177.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -139.05 112.8 8.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.174 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.1 m -96.99 133.45 38.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 16.3 t 178.75 -161.64 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 66.96 78.87 0.24 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.187 0.518 . . . . 0.0 110.227 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.48 119.44 5.23 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.688 2.258 . . . . 0.0 113.355 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' THR . 43.7 tp60 -107.73 113.58 26.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.964 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 m -76.04 98.56 4.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.411 0.624 . . . . 0.0 109.478 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.34 91.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.976 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.41 -167.04 31.91 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.702 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.4 t -110.71 154.67 12.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 CA-C-O 119.28 -0.391 . . . . 0.0 109.996 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.6 3.24 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.625 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.86 88.53 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.283 0.563 . . . . 0.0 109.837 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.64 36.35 0.79 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.497 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 5.5 ttp180 -86.23 130.45 34.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.38 171.72 14.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.054 0.454 . . . . 0.0 111.361 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 98.3 m -121.79 129.64 52.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.576 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.2 p -92.57 130.0 38.34 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -93.43 131.5 38.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 9.8 tt0 -88.29 118.02 27.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.562 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.18 108.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 66.7 mtp180 -92.96 135.88 33.76 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.069 173.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.56 135.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 111.868 177.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -123.88 134.87 53.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.3 t -169.48 164.45 10.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.499 0.666 . . . . 0.0 112.01 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.501 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 31.2 p30 -118.76 23.19 11.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.285 171.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 29' ' ' LEU . 24.7 mt -57.91 141.11 81.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.955 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 21' ' ' ALA . 51.5 Cg_endo -74.56 -16.25 21.49 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.709 2.272 . . . . 0.0 111.463 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.821 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -86.12 -40.99 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.557 -178.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.2 m-85 -70.05 -8.31 48.29 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -166.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER 70.87 -69.79 0.17 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -84.25 -5.81 59.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.968 -0.457 . . . . 0.0 110.682 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HD2' ' CE1' ' A' ' 22' ' ' TYR . 5.0 mmtp 70.68 -43.89 0.57 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.122 0.889 . . . . 0.0 111.418 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -158.86 130.03 6.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.231 0.538 . . . . 0.0 110.063 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.7 t -170.24 173.74 5.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.486 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.588 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 28.6 m -141.86 123.05 14.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.416 0.627 . . . . 0.0 111.469 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 23.6 m -114.17 179.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.105 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 30.9 ptt180 -150.45 126.85 10.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.25 0.548 . . . . 0.0 111.204 171.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -138.53 177.25 8.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.247 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -83.65 167.34 17.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.258 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.562 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.6 t80 -60.29 -39.66 87.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.527 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 18.5 m -58.55 -27.08 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.679 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -77.31 -34.22 55.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.621 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 35.8 m-85 -63.95 -38.79 92.37 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.2 mt-10 -57.12 -56.25 24.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.158 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -65.15 -28.39 69.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.392 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 2.9 tm? -71.63 -38.99 70.71 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.559 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 49.6 ttt180 -62.16 -61.47 2.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.042 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.544 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 8.8 p -57.52 -38.03 73.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.278 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.622 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 1.0 OUTLIER -58.31 -47.62 83.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.33 -36.67 84.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.186 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 62.5 mt-10 -69.04 -30.74 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.497 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' SER . 27.8 mmt180 -80.26 -58.93 2.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.661 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.85 -25.48 63.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.511 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.52 -178.72 6.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.725 0.774 . . . . 0.0 112.323 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.86 23.38 8.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.526 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.5 t -45.89 139.71 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.6 p -70.09 33.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.074 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.559 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -54.86 120.55 29.29 Favored Pre-proline 0 CA--C 1.531 0.241 0 O-C-N 122.134 -0.354 . . . . 0.0 111.0 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.61 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 90.1 Cg_endo -85.85 164.29 10.38 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.953 2.435 . . . . 0.0 112.584 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.6 132.1 29.86 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 84.5 mt -66.97 143.81 98.18 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.452 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 10.5 Cg_exo -72.11 108.63 2.52 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.416 2.077 . . . . 0.0 111.014 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . -172.68 30.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.814 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -131.89 7.64 4.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 110.503 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.16 -90.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -53.7 -29.64 40.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -60.85 -49.13 78.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.041 0.448 . . . . 0.0 110.58 -174.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.58 26.18 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.496 0.665 . . . . 0.0 109.922 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.3 tt0 -123.02 -36.91 2.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -176.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.9 mt -92.49 165.39 19.52 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.28 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.58 164.31 35.98 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.328 2.685 . . . . 0.0 111.257 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.17 -76.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.697 0.284 . . . . 0.0 111.474 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 69.13 -63.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.205 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.07 -150.61 26.84 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.514 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.23 -41.79 96.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.941 0.401 . . . . 0.0 110.389 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -138.28 -17.45 1.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.692 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.9 10.92 23.72 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.324 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.2 pt -83.34 -18.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 0.0 111.872 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -85.8 -2.01 57.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.252 0.549 . . . . 0.0 110.439 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.47 127.45 34.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.851 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.34 -30.83 67.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.1 m-20 -56.1 -60.29 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -53.78 -47.82 70.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.092 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.52 -47.33 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.105 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -75.05 -21.89 58.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -178.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 73.5 mm-40 -71.53 -35.57 70.74 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.262 0.553 . . . . 0.0 109.761 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 10.9 tpp180 -76.89 -35.8 57.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.4 -53.8 54.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.458 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 11.1 pt20 -58.75 -40.79 84.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.067 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.16 -37.34 28.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.963 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -65.6 -34.19 77.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.564 0.182 . . . . 0.0 111.272 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.698 ' HB3' HG22 ' A' ' 33' ' ' VAL . 7.4 pt-20 -78.09 -31.47 50.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.441 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.3 mm100 -59.59 -58.58 7.98 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.5 t80 -49.2 -53.32 21.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.906 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.0 tp -65.04 -40.75 90.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.19 -19.91 62.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 111.65 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.61 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.3 mttm -87.21 -56.61 3.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.661 0.743 . . . . 0.0 110.731 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.578 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.24 -11.65 14.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.974 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.93 -6.29 17.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.291 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.42 10.58 5.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.307 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.2 t60 -98.19 140.62 21.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.511 -0.405 . . . . 0.0 110.41 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.51 -48.86 5.36 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.306 3.337 . . . . 0.0 113.672 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.83 -33.16 73.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.323 -175.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.74 -44.41 41.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.912 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -63.82 -0.74 1.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.005 173.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 16.9 t-20 -111.16 -2.87 15.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 47.1 mm-40 -112.84 132.31 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.111 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HA ' HD13 ' A' ' 159' ' ' ILE . 6.4 tpp85 -53.82 -25.81 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.418 -172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 m -51.26 -34.46 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.459 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -67.4 -33.1 74.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.413 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 146' ' ' GLN . 9.5 t60 -62.5 -40.12 95.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.098 0.475 . . . . 0.0 109.748 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.568 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.6 ptm -77.95 -26.18 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.975 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 21.4 t80 -79.75 -63.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.116 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -110.83 -4.29 15.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.566 ' HG3' HD12 ' A' ' 145' ' ' LEU . 12.0 mt-30 -117.92 23.59 11.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.853 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.55 -142.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.457 ' HG3' HG13 ' A' ' 149' ' ' ILE . 7.3 tp10 -121.08 -56.76 1.91 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.85 0.834 . . . . 0.0 109.511 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -129.65 139.77 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.107 -176.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -66.26 112.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 100.73 13.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.21 -7.96 10.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.1 m -108.91 17.88 21.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.405 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.3 OUTLIER -66.49 -172.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.658 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.4 m -92.06 114.82 63.3 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.68 83.1 1.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.923 2.415 . . . . 0.0 111.251 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 89.3 p -145.85 -150.17 0.32 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.636 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 13.1 mmmt -95.4 164.07 12.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.821 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -63.89 -34.56 69.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.056 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.49 87.92 5.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.44 -172.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -109.96 165.5 11.67 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.961 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.556 178.869 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -129.28 30.42 4.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.206 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 66.98 172.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.107 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -134.19 94.22 3.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.726 0.298 . . . . 0.0 111.116 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -138.41 136.36 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.406 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -87.51 125.69 34.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -84.6 78.35 9.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -90.96 -37.67 13.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.6 m -90.77 157.23 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.316 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -133.83 174.61 20.72 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.585 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.3 p -70.58 115.99 10.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.29 119.09 10.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.518 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -165.18 -65.33 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.046 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -81.48 155.61 25.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.979 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 6' ' ' ALA . 15.6 t 67.18 163.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.865 0.728 . . . . 0.0 110.527 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' N ' HG12 ' A' ' 5' ' ' VAL . . . -115.32 106.58 14.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.857 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.54 162.98 28.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.14 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 p -63.57 -69.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 33.5 mmt180 59.96 160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.178 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -141.77 140.26 33.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.51 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.7 tp -149.76 145.41 26.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.6 mt -132.89 155.41 41.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 p 69.26 109.78 0.05 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.22 1.008 . . . . 0.0 111.807 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 38.4 mmtm -76.29 168.0 31.83 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 41.8 Cg_exo -56.53 111.26 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.321 2.014 . . . . 0.0 111.814 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 70.8 mt-30 -94.15 98.4 10.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.448 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' C ' HD22 ' A' ' 18' ' ' LEU . 71.8 m-20 67.64 154.18 0.1 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.08 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.408 HD22 ' C ' ' A' ' 17' ' ' ASN . 3.7 mm? -123.57 -170.06 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.538 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -89.52 -179.71 5.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.234 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -106.46 132.83 52.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.79 167.81 6.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.342 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 7.5 m-85 -133.26 -24.87 1.8 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.474 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.01 174.98 45.42 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.162 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.14 158.37 14.99 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 124.304 3.336 . . . . 0.0 111.696 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.82 -24.99 0.89 Allowed 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.704 3.602 . . . . 0.0 115.267 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -68.81 -58.51 4.08 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.8 m120 57.96 -170.59 0.11 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.953 0.406 . . . . 0.0 111.663 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -103.34 139.41 38.79 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 57' ' ' LEU . 16.9 tp -150.3 131.88 14.85 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.675 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.48 99.43 3.49 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.015 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.687 HG12 ' HB ' ' A' ' 53' ' ' VAL . 29.1 mt -111.81 140.74 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.605 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.92 129.15 29.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.653 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.6 m -112.96 134.13 56.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 t 179.32 -162.58 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.3 m-80 62.77 68.86 0.94 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-O 121.132 0.491 . . . . 0.0 109.837 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.25 138.04 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.794 2.329 . . . . 0.0 113.162 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.534 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.4 tp60 -121.93 108.34 13.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.8 m -75.25 95.27 3.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.52 0.676 . . . . 0.0 109.646 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -121.9 92.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.232 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -167.23 32.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.524 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -101.34 150.17 6.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.589 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.05 -48.38 5.35 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.673 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -97.96 83.36 3.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.126 0.489 . . . . 0.0 110.01 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.35 35.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.468 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 19.7 ttt180 -83.35 127.89 34.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.679 0.276 . . . . 0.0 110.367 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -117.38 169.74 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.266 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.3 m -125.88 129.11 48.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.742 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 34.2 p -92.92 146.44 23.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.267 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.427 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 83.7 m-85 -118.5 142.64 47.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.133 0.492 . . . . 0.0 110.403 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 38.5 tt0 -90.15 117.96 29.31 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.565 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.4 mp -93.06 120.47 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.864 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 51.7 mtp180 -109.53 131.73 54.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.936 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.687 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.82 136.71 43.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.848 0.356 . . . . 0.0 111.575 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 10.9 ttmt -125.93 135.07 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 t -169.62 165.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.701 0.762 . . . . 0.0 112.763 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -117.11 26.16 9.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.768 167.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.712 HD11 HD22 ' A' ' 29' ' ' LEU . 18.6 mt -61.06 135.89 93.52 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.379 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -68.79 -38.01 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.405 2.07 . . . . 0.0 111.351 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.49 -40.82 87.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.14 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.0 m-85 -68.77 -25.26 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 73.25 -64.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 ' HG2' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -76.77 -6.03 50.6 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.899 -0.501 . . . . 0.0 110.282 -175.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.0 mmpp? 70.91 -37.94 0.41 Allowed 'General case' 0 C--O 1.22 -0.487 0 O-C-N 123.936 0.772 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.8 pp20? -162.04 142.93 10.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -170.24 169.2 7.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 13.6 m -141.4 135.57 30.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.706 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.569 HG21 HH21 ' A' ' 69' ' ' ARG . 0.5 OUTLIER -147.09 134.87 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.408 -171.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 41.0 ttp180 -99.1 111.25 23.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.936 0.398 . . . . 0.0 110.139 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.659 HH11 HD12 ' A' ' 150' ' ' ILE . 56.2 mtt-85 -124.99 178.1 5.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.476 -173.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -95.23 155.98 16.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.754 0.311 . . . . 0.0 111.306 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 32.5 t80 -59.59 -37.98 79.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 109.924 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 34.4 t -59.64 -30.06 68.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.854 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.87 -39.51 83.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.53 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 51.4 m-85 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HG2' HD13 ' A' ' 92' ' ' LEU . 12.8 mt-10 -71.97 -49.11 40.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.503 0.668 . . . . 0.0 110.539 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.487 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.8 t-105 -65.82 -28.27 68.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.71 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.49 -42.0 59.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 64.2 ttt180 -57.72 -59.2 5.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 6.4 p -60.04 -41.47 92.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.573 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.09 -45.99 79.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.674 0.273 . . . . 0.0 111.253 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 135' ' ' ALA . 96.4 mt -65.89 -40.72 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.06 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 73.5 mt-10 -65.53 -45.13 84.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.466 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.6 mmt180 -66.96 -60.78 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.92 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -77.73 -18.93 56.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.463 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 t -134.8 -175.82 4.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.472 0.653 . . . . 0.0 111.315 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -109.58 13.44 23.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.29 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -42.09 140.16 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.518 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.8 p -71.17 36.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.857 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -57.48 119.71 34.72 Favored Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 122.046 -0.409 . . . . 0.0 111.014 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.591 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 96.1 Cg_endo -87.71 167.1 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.93 2.42 . . . . 0.0 112.488 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.5 Cg_endo -66.5 146.87 81.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.699 2.266 . . . . 0.0 112.756 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' A' ' 75' ' ' GLU . 50.0 mt -73.44 158.87 85.96 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.56 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 67.6 Cg_endo -87.5 108.86 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.754 2.303 . . . . 0.0 111.466 174.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.54 38.71 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.433 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -145.28 42.24 1.28 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.63 -83.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.158 0.504 . . . . 0.0 112.181 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -52.05 -24.78 7.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.339 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -61.14 -43.53 98.74 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.16 24.64 8.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.809 0.814 . . . . 0.0 109.686 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -120.42 -40.08 2.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.045 -177.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.65 166.24 26.03 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.356 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.405 ' HG2' ' NH1' ' A' ' 104' ' ' ARG . 15.0 Cg_exo -70.4 -163.62 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.411 2.741 . . . . 0.0 112.726 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.89 -91.09 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.538 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' PRO . 73.1 mtm-85 65.31 -70.86 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.503 0.721 . . . . 0.0 111.855 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.53 77.15 0.32 Allowed Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.603 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.4 t0 67.84 -69.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 110.857 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -125.17 -7.21 7.1 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.17 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.22 8.53 35.76 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 48.5 pt -82.62 -18.25 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.78 -175.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.18 -8.72 59.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.538 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.84 139.27 30.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.83 -22.59 64.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.69 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 91.4 m-20 -63.25 -59.02 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -54.28 -48.37 71.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.728 0.299 . . . . 0.0 110.753 177.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.3 mt -52.77 -45.54 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.786 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -73.53 -23.32 59.98 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.327 -178.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 39.4 mm-40 -70.78 -32.62 69.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.447 0.641 . . . . 0.0 109.78 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.3 ttm180 -79.89 -39.65 30.02 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -54.22 -49.91 68.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.825 -178.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -59.92 -40.36 88.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -84.08 -31.82 24.93 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.065 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.7 tp -65.61 -35.69 81.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.297 0.239 . . . . 0.0 111.063 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.737 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.9 pt-20 -76.73 -35.39 57.83 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.7 mm100 -56.71 -55.46 33.86 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.525 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.4 t80 -51.23 -54.05 29.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.732 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.3 tp -64.35 -38.22 81.99 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.161 -170.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -64.03 -21.67 66.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 39.7 mttm -85.15 -55.03 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.757 0.789 . . . . 0.0 110.763 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.57 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.38 -12.4 15.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.816 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.33 8.81 21.51 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.332 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.6 9.24 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.658 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 47.7 t60 -100.87 140.91 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.637 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.658 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.3 Cg_endo -46.17 -48.03 13.73 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.709 2.939 . . . . 0.0 112.936 -172.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.66 -30.01 69.44 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.039 -176.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -79.08 -43.79 23.45 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.655 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.9 mm100 -66.85 -7.69 23.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.245 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.449 ' OD1' ' HE2' ' A' ' 158' ' ' LYS . 6.3 t-20 -92.23 -15.37 27.61 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.632 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 45.7 mm-40 -105.73 130.84 53.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.608 -170.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HA ' HD13 ' A' ' 159' ' ' ILE . 19.2 tpt180 -56.7 -25.87 55.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.592 -172.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 143' ' ' MET . 1.2 p -60.32 -21.24 61.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.7 mp -70.01 -35.6 74.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.878 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 36.1 t60 -56.65 -35.35 68.26 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.122 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.622 ' HG3' HG13 ' A' ' 150' ' ' ILE . 3.8 ptm -82.66 -34.0 27.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.639 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.476 ' N ' ' HG2' ' A' ' 143' ' ' MET . 11.2 t80 -82.11 -26.71 33.33 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.492 HD13 ' CE1' ' A' ' 60' ' ' PHE . 2.3 mt -99.48 -46.89 5.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.37 0.605 . . . . 0.0 109.837 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 34.4 mt-30 -91.75 175.89 6.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.852 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 59.59 -168.92 0.15 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -98.31 -34.11 10.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.556 0.693 . . . . 0.0 110.768 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.72 166.1 15.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.35 -166.22 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.659 HD12 HH11 ' A' ' 69' ' ' ARG . 1.9 mp -85.18 119.91 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.124 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -90.52 99.48 12.5 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 31.8 mmtp -67.31 -3.21 7.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.73 0.3 . . . . 0.0 111.684 -172.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.7 m -113.79 18.59 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.417 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.5 OUTLIER -66.53 -171.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.798 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.2 m -90.64 113.06 56.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.207 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.75 83.82 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.153 2.569 . . . . 0.0 111.69 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.4 m -153.36 -145.26 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.327 -0.233 . . . . 0.0 110.801 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 137' ' ' ASN . 5.5 mmmm -100.67 155.6 17.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 59' ' ' ILE . 19.5 mm -57.7 -41.07 78.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.516 . . . . 0.0 109.909 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.39 94.95 10.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.523 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -103.9 169.48 8.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.673 178.766 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -129.97 47.54 2.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.782 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -75.94 88.21 2.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -101.44 -4.36 26.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 -177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -83.87 66.76 9.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.89 0.376 . . . . 0.0 110.411 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -99.77 -29.3 12.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.72 148.07 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.415 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -143.52 140.71 30.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.118 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.48 131.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.233 0.54 . . . . 0.0 111.04 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 118.75 -113.53 2.6 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.685 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.21 127.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.328 0.651 . . . . 0.0 111.716 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.38 124.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.013 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -108.75 -44.77 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.349 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 p -74.25 156.96 36.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t 72.42 -54.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 123.889 0.743 . . . . 0.0 111.19 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.38 83.82 7.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.951 0.405 . . . . 0.0 110.418 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 11.5 t70 -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.354 0.597 . . . . 0.0 111.144 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -88.87 -39.26 13.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.314 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -46.48 -56.43 5.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.51 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -147.47 -84.48 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 24.7 tp 73.52 136.41 0.05 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.215 1.007 . . . . 0.0 111.566 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 mt -138.93 147.64 24.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.187 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -120.52 107.31 12.71 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.818 0.342 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -105.55 160.56 25.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.54 130.67 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.971 2.447 . . . . 0.0 111.859 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -89.24 109.13 20.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.837 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.18 150.15 33.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.185 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.24 144.64 35.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.451 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -124.23 -171.42 2.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.622 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -111.4 137.89 48.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.217 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.98 -65.13 0.06 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.972 0.415 . . . . 0.0 110.878 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.08 -43.26 54.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.88 174.56 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.745 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.87 159.14 9.75 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.763 2.975 . . . . 0.0 111.533 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.65 -9.21 1.02 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.17 3.247 . . . . 0.0 114.569 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -73.49 -55.75 5.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.7 m120 61.48 169.94 0.11 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.7 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.405 ' HD2' ' ND2' ' A' ' 56' ' ' ASN . 1.1 p90 -84.49 130.9 34.71 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 57' ' ' LEU . 21.9 tp -141.69 129.31 21.5 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.501 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -137.81 99.36 3.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.024 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.696 HG12 ' HB ' ' A' ' 53' ' ' VAL . 44.4 mt -110.57 134.62 52.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.718 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -134.36 113.98 12.47 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -95.52 134.34 33.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t 178.43 -161.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 28.0 m-80 68.09 76.78 0.26 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HB3' HG21 ' A' ' 115' ' ' ILE . 57.6 Cg_endo -71.76 119.27 6.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.069 1.846 . . . . 0.0 112.981 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.4 tp60 -111.89 104.71 13.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.6 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.2 m -76.03 106.51 7.67 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -133.51 89.61 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.025 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.93 -167.5 32.94 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.513 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.5 t -101.08 146.89 8.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 119.324 -0.369 . . . . 0.0 110.409 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.72 -51.42 3.96 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.13 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -98.77 89.96 4.52 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.405 0.621 . . . . 0.0 109.554 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.14 29.81 1.43 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.791 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.2 ttt180 -82.46 143.12 31.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 35.0 p90 -137.66 156.62 47.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.695 0.283 . . . . 0.0 110.81 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.2 m -113.78 125.15 53.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.462 . . . . 0.0 110.879 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -92.79 143.85 25.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.397 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -103.89 141.58 35.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.377 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 20.1 tt0 -96.19 115.42 27.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.816 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -94.27 111.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 38.0 mtp180 -96.7 141.61 29.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -147.84 136.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.179 0.514 . . . . 0.0 112.174 177.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.97 142.22 51.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.734 167.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.447 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.0 t -171.49 164.68 6.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 111.261 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.405 ' ND2' ' HD2' ' A' ' 28' ' ' PHE . 32.0 p30 -116.57 21.47 13.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.766 167.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.695 HD11 HD22 ' A' ' 29' ' ' LEU . 28.6 mt -55.76 133.3 72.5 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.685 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 7.6 Cg_exo -68.83 -34.65 17.62 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.475 2.117 . . . . 0.0 111.39 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.641 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.53 -42.53 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.247 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.7 m-30 -68.29 -23.66 64.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 71.1 -61.91 0.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.545 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.8 -14.3 59.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.876 0.307 . . . . 0.0 111.021 -173.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp 71.46 -35.09 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.778 0.674 . . . . 0.0 111.302 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -144.32 145.9 32.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.075 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.0 t -169.58 153.41 5.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 7.5 m -141.11 130.56 23.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.138 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -127.1 172.9 13.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 32.5 ttp180 -138.24 109.8 7.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.963 0.411 . . . . 0.0 110.229 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 7.4 tpp180 -135.7 171.82 13.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -171.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 56.6 ttp180 -96.45 158.18 15.55 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.5 t80 -51.35 -41.16 60.42 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.539 0.336 . . . . 0.0 111.0 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.496 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 33.3 p -56.57 -29.62 62.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.8 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 28.3 m-20 -77.55 -30.39 52.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.22 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 46.1 m-85 -64.04 -38.74 92.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 109.679 173.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HA ' HD11 ' A' ' 92' ' ' LEU . 10.9 mt-10 -65.94 -47.97 72.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.633 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.469 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 6.1 t-105 -62.34 -35.29 78.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.703 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.658 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -65.64 -44.33 86.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.2 ttt180 -58.53 -61.33 2.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.24 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -60.12 -35.12 74.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.856 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 5.5 tp10 -66.54 -44.88 81.22 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.297 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.61 -42.36 96.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.858 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 30.8 mt-10 -64.53 -33.12 75.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.953 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 83' ' ' ARG . 4.6 ppt_? -90.18 -23.34 21.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -172.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.32 -41.61 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.033 0.444 . . . . 0.0 111.648 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -130.67 174.87 9.5 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.532 0.682 . . . . 0.0 111.227 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -97.12 32.5 2.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.702 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 94.6 t -51.54 142.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.958 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.5 p -71.28 35.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -56.5 119.31 27.65 Favored Pre-proline 0 N--CA 1.467 0.406 0 O-C-N 121.873 -0.517 . . . . 0.0 111.167 -176.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 163.31 10.7 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.146 2.564 . . . . 0.0 112.411 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.22 135.15 39.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.886 2.391 . . . . 0.0 112.304 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 75' ' ' GLU . 81.8 mt -64.58 152.02 90.56 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.91 124.31 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.46 2.107 . . . . 0.0 110.811 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.0 175.9 47.74 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 68.91 -54.41 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.659 0.784 . . . . 0.0 112.162 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -47.57 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -172.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -65.31 -24.08 67.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.669 -170.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.747 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -67.4 -46.62 72.69 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.972 0.415 . . . . 0.0 110.602 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.1 ppt_? -95.89 27.26 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.469 0.652 . . . . 0.0 110.395 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -123.27 -42.39 2.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.12 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.79 168.51 11.1 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.471 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.8 140.45 46.47 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.252 2.635 . . . . 0.0 111.151 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -82.48 -75.47 0.3 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 69.78 -56.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.98 -175.91 48.9 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.516 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.44 -51.4 27.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.388 0.613 . . . . 0.0 110.656 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 109' ' ' ILE . 6.8 t70 -117.33 -32.97 4.79 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.53 176.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.11 -6.55 7.72 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.289 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.713 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 33.5 pt -66.53 -15.15 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.176 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -78.04 -13.03 60.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.666 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 -17.45 63.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.934 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 47.6 m-80 -73.89 -57.87 3.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.713 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -48.51 -50.56 31.33 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.343 0.402 . . . . 0.0 110.911 178.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.544 HG21 ' HB3' ' A' ' 36' ' ' PRO . 49.4 mt -49.65 -54.81 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.331 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.69 -17.89 58.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.791 -175.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 67.9 mm-40 -73.27 -35.15 66.14 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.935 0.398 . . . . 0.0 110.481 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 32.7 ttp180 -81.2 -32.48 33.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.99 -50.67 71.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -60.43 -32.65 71.56 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.544 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 -33.58 10.01 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.734 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.3 tp -66.35 -33.36 75.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.206 0.203 . . . . 0.0 111.223 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 33' ' ' VAL . 11.9 pt-20 -75.29 -31.85 60.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.9 mm100 -59.97 -59.66 5.07 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.474 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -45.84 -51.63 12.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.033 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.557 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.5 tp -65.36 -39.53 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.984 -172.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.85 -16.14 60.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -87.68 -57.8 2.81 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.914 0.864 . . . . 0.0 110.01 174.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.534 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.49 -13.12 13.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.043 -177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.75 4.68 23.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.32 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.07 10.91 2.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.71 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.678 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 51.4 t60 -101.19 141.39 22.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 117.176 0.488 . . . . 0.0 110.665 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.4 Cg_exo -40.87 -49.01 4.51 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.131 3.221 . . . . 0.0 113.822 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.84 -25.73 63.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.441 -174.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.11 -40.78 17.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.926 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -68.78 -0.13 5.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.103 176.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 58.1 t30 -112.14 10.9 20.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.07 131.79 50.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.002 -0.437 . . . . 0.0 111.013 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -55.67 -17.49 5.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -175.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.725 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.2 m -55.33 -31.14 61.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.699 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.7 mp -73.63 -35.32 65.3 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.667 -0.646 . . . . 0.0 111.484 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 9.9 t60 -58.53 -39.22 79.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.725 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -76.02 -27.71 57.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.795 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t80 -81.03 -57.87 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -84.47 -26.21 28.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.149 -172.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 9.2 mt-30 -113.83 167.24 10.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.531 -166.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.07 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.885 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -175.04 -60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.577 0.703 . . . . 0.0 111.316 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG23 ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -121.9 144.49 30.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.868 -171.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.606 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -65.85 100.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.28 102.23 5.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.416 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 32.2 mmtp -69.88 6.55 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.707 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.4 m -120.81 18.19 11.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.357 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -66.74 -171.32 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.267 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.3 m -87.51 114.16 57.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.901 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -71.06 78.52 1.44 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.751 2.301 . . . . 0.0 110.951 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -155.56 -168.74 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.886 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 4.6 mmmm -80.85 157.98 25.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.92 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.641 HG21 HG13 ' A' ' 59' ' ' ILE . 15.2 mm -50.57 -42.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.155 0.502 . . . . 0.0 110.069 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 100.92 4.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -73.67 175.47 7.13 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.483 0.658 . . . . 0.0 111.616 -171.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.559 -175.404 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -128.27 34.99 4.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -83.51 72.18 10.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -75.73 113.47 13.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.161 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -133.85 101.74 5.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.802 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -87.87 97.53 10.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 -175.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -130.9 167.94 18.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.573 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.68 98.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.664 0.603 . . . . 0.0 110.7 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.74 162.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.445 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 116.92 58.15 0.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.397 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 149.07 26.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.672 0.272 . . . . 0.0 110.753 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.66 132.31 44.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.2 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -159.44 -62.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.197 0.522 . . . . 0.0 109.614 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -94.27 154.05 17.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t 65.37 -74.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 124.058 0.849 . . . . 0.0 111.019 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.15 68.8 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.298 0.57 . . . . 0.0 109.786 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.49 154.62 40.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.837 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 p -59.46 -43.73 93.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.247 0.546 . . . . 0.0 110.726 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 52.5 mmt-85 66.2 -172.9 0.19 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.496 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 17.0 mmt180 75.24 130.89 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.826 0.822 . . . . 0.0 111.51 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' HG ' ' H ' ' A' ' 12' ' ' ILE . 12.5 tp -120.8 -169.99 1.92 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.057 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 8.2 mt 67.57 152.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.739 0.78 . . . . 0.0 113.048 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.5 p -114.75 88.57 2.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -58.77 156.78 22.65 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.913 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.46 121.18 5.95 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.397 2.732 . . . . 0.0 112.188 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.1 18.16 11.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.151 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.17 150.75 43.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.766 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.49 169.65 8.72 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 12.5 p-10 -50.93 -69.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.034 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 4.4 p-10 -155.4 143.43 20.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 64.28 163.91 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.484 0.659 . . . . 0.0 111.919 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -144.94 -38.11 0.28 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.258 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.83 177.17 46.24 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.607 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.9 Cg_endo -52.76 153.92 13.67 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 124.098 3.198 . . . . 0.0 112.307 175.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 77.1 Cg_exo -51.92 -14.75 2.61 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.495 3.463 . . . . 0.0 115.431 -172.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -51.07 13.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 27.9 m120 61.27 176.83 0.11 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.021 175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -90.63 137.64 32.2 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -145.15 130.54 18.7 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.978 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.41 100.45 4.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.686 HG12 ' HB ' ' A' ' 53' ' ' VAL . 48.0 mt -111.76 142.27 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.487 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -132.86 119.39 20.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -101.21 130.44 50.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t 178.96 -162.35 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.9 m-80 64.93 76.22 0.33 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.25 147.26 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.86 2.373 . . . . 0.0 113.465 -171.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 43.5 tp60 -130.99 118.85 21.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.572 172.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -77.56 95.9 4.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.63 0.729 . . . . 0.0 109.341 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.02 91.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.159 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.29 -167.38 33.03 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.355 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.0 t -104.3 145.14 13.39 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -37.97 -53.63 2.01 Favored Glycine 0 N--CA 1.463 0.472 0 O-C-N 123.182 0.301 . . . . 0.0 113.445 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -100.62 89.94 4.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.498 0.666 . . . . 0.0 109.435 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.48 35.26 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.573 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -87.77 147.31 25.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 122.957 0.503 . . . . 0.0 110.67 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -140.01 167.71 21.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.5 m -123.47 131.9 53.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 22.3 p -94.67 148.84 21.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.878 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.13 146.67 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.384 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 32.8 tt0 -103.48 121.56 43.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.366 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.806 HD13 ' HD3' ' A' ' 69' ' ' ARG . 2.0 mp -94.39 118.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.227 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HG3' HG23 ' A' ' 66' ' ' THR . 27.1 mtt180 -108.97 126.08 52.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.093 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -130.66 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.035 0.445 . . . . 0.0 112.123 -177.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.67 137.23 53.85 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.65 165.18 6.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.364 0.602 . . . . 0.0 112.227 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -117.61 26.07 9.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.971 168.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 29' ' ' LEU . 19.9 mt -60.88 140.33 93.58 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.38 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.4 -23.21 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.824 2.349 . . . . 0.0 111.688 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.06 -41.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.375 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 145' ' ' LEU . 3.0 m-85 -67.26 -27.26 67.06 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -60.2 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.15 -11.12 59.77 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.282 -0.261 . . . . 0.0 111.301 -174.158 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp 70.9 -33.5 0.27 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.798 0.686 . . . . 0.0 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.22 139.11 25.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.103 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 48.5 t -155.59 154.09 31.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.665 -176.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 52' ' ' ARG . 5.8 m -140.77 129.28 22.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.147 0.498 . . . . 0.0 110.427 171.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HB ' ' NH1' ' A' ' 69' ' ' ARG . 2.7 m -139.98 145.46 26.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.04 -175.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' NH1' ' HB2' ' A' ' 37' ' ' GLN . 22.1 ttm180 -115.35 116.27 28.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.806 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.13 169.02 18.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.533 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.98 170.1 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.601 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 36.9 t80 -51.76 -40.59 60.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.575 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.559 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 21.7 m -54.34 -31.87 55.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.048 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 69' ' ' ARG . 44.9 m-20 -74.38 -35.63 63.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 58.5 m-85 -66.36 -36.55 83.16 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.689 ' HA ' HD11 ' A' ' 92' ' ' LEU . 31.4 mt-10 -60.09 -56.05 26.45 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 150' ' ' ILE . 7.2 t-105 -64.7 -28.06 69.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.372 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.52 -46.03 56.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 46.3 ttt180 -57.29 -58.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.361 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.676 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 14.4 p -60.82 -37.47 82.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.472 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -63.3 -39.01 93.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.951 0.405 . . . . 0.0 110.731 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.3 mt -62.99 -34.07 76.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.63 -22.79 53.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 79' ' ' SER . 38.9 mmt180 -68.82 -62.23 1.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.01 0.433 . . . . 0.0 111.948 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -98.63 -18.05 18.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.236 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -126.61 166.37 17.45 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.49 0.662 . . . . 0.0 111.117 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -98.51 32.78 2.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.526 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.9 t -51.81 141.33 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.864 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.3 p -71.11 35.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.929 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -59.81 120.69 52.04 Favored Pre-proline 0 C--O 1.236 0.346 0 O-C-N 121.816 -0.553 . . . . 0.0 111.144 -176.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 72.9 Cg_endo -85.65 165.32 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.843 2.362 . . . . 0.0 112.249 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.86 141.51 65.44 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.6 2.2 . . . . 0.0 111.883 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 75' ' ' GLU . 86.8 mt -69.05 145.48 96.52 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 7.8 Cg_exo -71.18 109.33 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.744 2.296 . . . . 0.0 111.479 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.32 46.94 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.003 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 59.08 18.62 6.54 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.913 0.485 . . . . 0.0 111.642 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -118.62 -81.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 0.0 111.627 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.71 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.72 -23.47 67.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.165 -176.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.863 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -62.93 -48.1 80.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.942 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -94.05 20.03 8.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.138 177.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.0 OUTLIER -115.22 -41.9 3.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.322 -177.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 4.5 pp -107.53 169.1 7.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.2 Cg_exo -69.47 132.07 23.01 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.482 2.788 . . . . 0.0 112.66 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 13.6 m-85 -55.92 -63.47 1.17 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.78 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 73.85 -56.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.566 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -110.98 -165.95 18.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.196 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -50.85 -47.53 60.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.22 0.533 . . . . 0.0 111.611 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 109' ' ' ILE . 4.7 t70 -120.62 -29.78 4.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.68 -13.95 6.81 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.644 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 38.2 pt -64.54 -16.31 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.571 -0.814 . . . . 0.0 112.105 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 91.5 m-85 -80.06 -9.36 59.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.677 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.33 137.29 40.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.45 -17.4 61.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.224 -173.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 53.3 m-80 -69.34 -52.43 27.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.227 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.644 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -50.1 -50.63 47.76 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.478 0.486 . . . . 0.0 111.083 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.19 -52.2 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.27 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -73.48 -20.58 60.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.359 -176.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 63.3 mm-40 -72.07 -35.47 69.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 110.036 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 36.7 ttm180 -80.92 -34.98 33.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -54.44 -50.98 66.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.24 -178.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.7 pt20 -62.19 -37.46 85.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.481 -174.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.33 -34.94 12.86 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.594 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.4 tp -67.78 -32.39 72.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 122.14 0.176 . . . . 0.0 111.228 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.7 pt-20 -75.81 -29.79 58.82 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.6 mm100 -64.41 -54.17 36.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -48.85 -53.7 18.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.399 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -65.57 -40.23 87.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.878 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -61.46 -16.99 52.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.109 0.48 . . . . 0.0 111.891 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.559 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 67.2 mttt -90.45 -58.75 2.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.018 0.914 . . . . 0.0 110.69 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -66.22 -11.73 13.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.337 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.59 -0.07 20.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.506 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -132.67 6.13 5.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.407 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.693 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 30.3 t60 -100.71 143.42 26.54 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 117.028 0.414 . . . . 0.0 110.921 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.693 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 4.5 Cg_exo -43.17 -50.17 6.67 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.105 3.203 . . . . 0.0 113.266 -174.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -67.91 -28.08 67.19 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.249 -174.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -81.28 -42.7 20.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.857 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 7.6 mm-40 -62.29 -6.25 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.932 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.434 ' H ' ' C ' ' A' ' 135' ' ' ALA . 57.8 t30 -108.75 10.1 26.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.824 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.508 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 51.0 mm-40 -115.71 126.08 53.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.951 0.405 . . . . 0.0 111.206 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -56.14 -26.18 49.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.847 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.764 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.3 p -62.2 -24.72 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 145' ' ' LEU . 2.7 mp -66.52 -33.81 76.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.653 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.529 ' HA ' ' OE1' ' A' ' 146' ' ' GLN . 33.4 t-80 -62.77 -34.85 78.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.384 -175.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.764 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -85.04 -28.16 25.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.376 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' N ' ' HG2' ' A' ' 143' ' ' MET . 31.9 t80 -81.17 -44.81 17.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.532 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.0 mt -93.05 -45.41 7.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.625 0.726 . . . . 0.0 110.574 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 142' ' ' HIS . 30.6 mt-30 -97.87 -172.71 2.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.652 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.13 -132.62 1.76 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.537 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.469 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -130.01 -37.56 1.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -148.33 161.35 6.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.53 0.681 . . . . 0.0 112.515 -168.2 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.518 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.8 mp -87.14 105.59 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.626 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.46 109.03 20.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.802 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 10.7 mptt -76.45 10.8 1.87 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.724 0.774 . . . . 0.0 111.325 -173.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -115.19 14.61 16.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.82 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -65.74 -171.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.493 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.3 m -89.38 114.0 58.68 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 23.0 Cg_exo -67.02 95.62 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.984 2.456 . . . . 0.0 110.835 174.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 9.4 t -165.95 -155.73 0.24 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.384 0.611 . . . . 0.0 110.501 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -97.92 161.94 13.49 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.847 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.654 HG21 HG13 ' A' ' 59' ' ' ILE . 22.2 mm -53.74 -47.57 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 95.11 10.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.343 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.95 174.38 6.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.202 -169.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.813 177.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.981 0.419 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -109.8 102.11 10.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -78.31 123.63 27.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.466 . . . . 0.0 110.059 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.94 143.36 27.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.815 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.16 -37.14 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.268 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -152.22 148.93 28.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.468 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -150.35 157.23 42.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.597 0.237 . . . . 0.0 111.038 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -131.54 74.22 1.58 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.987 0.899 . . . . 0.0 109.924 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.89 168.17 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.846 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 100.25 29.92 6.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.092 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.8 p 46.63 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.783 0.833 . . . . 0.0 112.933 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.12 129.05 36.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.469 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -162.77 -60.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.071 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -71.57 140.33 49.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 111.482 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.11 164.38 34.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.217 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.27 140.53 51.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.774 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.19 137.62 38.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.514 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 22.4 p -88.42 -44.5 10.69 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.037 -172.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 9' ' ' ARG . 11.6 mmt180 72.03 -56.79 0.64 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.238 0.961 . . . . 0.0 110.238 -175.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' C ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -149.87 139.97 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.01 145.16 49.21 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.407 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.46 153.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p 67.54 130.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.015 0.926 . . . . 0.0 111.426 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 2.9 mptp? -78.58 157.74 76.86 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.971 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 87.4 Cg_exo -45.2 116.54 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.46 2.773 . . . . 0.0 112.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.94 151.62 24.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.606 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -87.0 155.84 20.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.66 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.12 122.58 37.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.831 0.348 . . . . 0.0 110.319 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.87 176.61 9.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.235 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.6 m-20 -80.2 141.67 35.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . 71.8 165.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.129 0.893 . . . . 0.0 109.498 -171.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' CD2' ' HB2' ' A' ' 56' ' ' ASN . 1.9 m-85 -133.39 -60.4 0.84 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.261 -169.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.66 178.37 47.95 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.42 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.92 157.36 8.09 Favored 'Trans proline' 0 C--N 1.335 -0.17 0 C-N-CA 124.288 3.326 . . . . 0.0 112.392 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.96 -19.66 0.88 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.947 3.765 . . . . 0.0 115.441 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -75.22 -53.41 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.59 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.8 m120 61.11 178.4 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.588 0.355 . . . . 0.0 111.928 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -92.96 139.27 30.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 57' ' ' LEU . 18.3 tp -145.56 131.51 19.2 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.159 -176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 7.8 pt-20 -140.31 102.57 4.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.254 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.642 HG12 ' HB ' ' A' ' 53' ' ' VAL . 51.6 mt -114.05 140.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.345 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -137.12 108.91 7.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.656 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.6 m -85.85 129.52 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t 179.95 -164.3 0.06 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.4 m-80 53.34 67.81 3.42 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.51 164.51 14.42 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.96 2.44 . . . . 0.0 113.41 -168.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -142.82 116.26 9.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.797 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.494 HG22 ' NE ' ' A' ' 45' ' ' ARG . 45.6 m -80.17 89.22 5.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.561 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.1 98.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.145 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.9 -167.07 31.53 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.964 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.8 t -102.29 148.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.123 -176.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.73 -49.81 5.97 Favored Glycine 0 N--CA 1.461 0.351 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.51 85.27 3.58 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.51 36.27 0.86 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.699 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 18.0 ttt180 -81.31 150.07 28.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.82 168.64 19.31 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 m -124.61 126.57 45.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 111.143 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 p -93.62 153.84 18.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.233 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -124.02 142.01 51.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.877 0.37 . . . . 0.0 110.5 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.4 tt0 -94.26 121.45 35.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.133 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.7 mp -97.61 108.96 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 110.623 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 34.0 mtp180 -97.97 136.53 38.11 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.703 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.642 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.24 136.99 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 13.0 ttmt -125.46 138.31 54.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.812 168.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.524 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.3 t -168.5 165.53 12.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 111.834 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.459 ' HB2' ' CD2' ' A' ' 22' ' ' TYR . 33.1 p30 -119.1 24.34 10.84 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.812 169.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.67 HD11 HD22 ' A' ' 29' ' ' LEU . 28.4 mt -60.82 135.02 92.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.89 174.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.2 Cg_exo -69.85 -30.88 21.18 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.375 2.05 . . . . 0.0 111.404 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG13 HG21 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -65.22 -42.27 93.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.393 175.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.4 m-30 -68.5 -12.47 61.29 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -168.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 72.01 -66.78 0.29 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 169.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.1 -7.56 59.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 122.368 -0.208 . . . . 0.0 110.869 -173.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmpp? 70.93 -39.41 0.45 Allowed 'General case' 0 C--O 1.218 -0.592 0 O-C-N 123.873 0.733 . . . . 0.0 111.205 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.0 pp20? -157.77 141.5 15.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.094 0.473 . . . . 0.0 109.989 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.9 t -170.2 172.13 6.47 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.23 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 22.3 m -141.59 127.96 19.95 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.192 0.52 . . . . 0.0 110.492 174.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.0 m -118.61 173.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 68' ' ' ARG . 18.5 ttm180 -137.69 115.24 11.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.117 0.484 . . . . 0.0 110.511 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 3.4 mmp_? -140.92 167.44 22.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.846 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 71' ' ' TYR . 46.9 ttt180 -98.52 165.48 11.81 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.068 -173.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 40.4 t80 -50.58 -39.86 50.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.6 0.238 . . . . 0.0 111.433 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.8 p -57.03 -31.35 65.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.72 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -71.43 -38.59 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 51.2 m-85 -61.73 -42.39 98.89 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 0.0 109.949 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HA ' HD11 ' A' ' 92' ' ' LEU . 29.1 mt-10 -55.9 -55.05 37.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.321 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.447 ' CD1' HG21 ' A' ' 150' ' ' ILE . 5.8 t-105 -61.93 -33.23 73.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.312 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 2.8 tm? -71.68 -42.89 66.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.5 ttt180 -56.06 -63.95 1.02 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.139 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.596 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -59.86 -34.49 73.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.049 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.62 -43.95 96.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.098 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.51 -37.66 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.737 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 56.5 mt-10 -67.37 -33.73 75.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.277 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 79' ' ' SER . 24.4 mmt180 -76.34 -61.15 2.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.255 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -66.99 -31.51 72.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.277 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -139.16 179.68 6.37 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.67 0.748 . . . . 0.0 112.069 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -97.86 22.42 9.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.696 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 89' ' ' VAL . 84.8 t -44.54 140.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.103 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.2 p -71.42 33.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.98 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -54.88 119.8 24.42 Favored Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 122.161 -0.337 . . . . 0.0 110.697 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 93.6 Cg_endo -85.5 163.53 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.697 2.265 . . . . 0.0 112.398 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 136.05 52.55 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.841 2.36 . . . . 0.0 112.097 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 89.3 mt -69.23 149.08 97.56 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.723 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.9 Cg_exo -72.7 109.28 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.446 2.097 . . . . 0.0 110.966 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -166.45 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.559 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.58 45.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.1 -0.647 . . . . 0.0 110.35 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.8 -103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -53.54 -30.25 40.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 94' ' ' GLY . 1.8 mm? -66.74 -44.97 80.1 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.179 -0.326 . . . . 0.0 111.299 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 8.42 42.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.771 0.796 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 7.0 tp60 -97.11 -38.75 9.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.328 176.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 42.5 mt -94.32 163.69 22.39 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.58 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.11 175.94 9.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.388 2.726 . . . . 0.0 111.432 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -76.07 -79.28 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 60.62 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.585 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.87 75.53 1.08 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.874 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 69.16 -63.22 0.38 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.885 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.42 -29.84 1.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.375 0.607 . . . . 0.0 110.356 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.75 15.76 3.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.966 -173.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.703 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.1 pt -83.53 -18.95 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.387 . . . . 0.0 112.037 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.24 -9.42 59.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 109.794 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.03 118.7 23.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.653 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.06 -17.01 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.835 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 85.9 m-20 -63.35 -61.58 2.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.703 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -47.78 -51.47 22.3 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.635 0.584 . . . . 0.0 111.441 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.1 mt -50.13 -50.31 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.314 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -83.74 -14.31 51.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.817 -177.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.665 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 30.2 mt-10 -80.16 -28.12 38.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -75.71 -37.6 59.32 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.98 -52.04 67.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.055 -178.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.69 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -59.13 -43.3 91.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 -36.26 38.68 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.062 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -64.01 -38.6 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.811 0.306 . . . . 0.0 111.62 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.3 pt-20 -73.0 -31.13 64.3 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.7 mm100 -61.58 -59.36 5.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.5 t80 -48.82 -54.09 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.756 -1.565 . . . . 0.0 111.383 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -64.04 -41.03 91.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.031 -170.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.32 0.509 . . . . 0.0 111.836 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -90.49 -58.59 2.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.849 0.833 . . . . 0.0 110.248 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.75 -12.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.256 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.51 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -109.74 3.0 20.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.08 -8.01 2.44 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.327 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.641 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 58.9 t60 -82.49 139.81 44.58 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.8 Cg_endo -44.15 -47.31 10.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.096 3.197 . . . . 0.0 113.292 -172.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.436 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -68.61 -33.16 73.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.125 -176.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.74 -43.84 35.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.745 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.67 -6.41 3.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.229 172.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.497 ' ND2' ' HE ' ' A' ' 160' ' ' ARG . 1.7 t-20 -99.79 -6.35 27.1 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.164 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.442 ' C ' HG12 ' A' ' 159' ' ' ILE . 30.1 mm-40 -107.43 129.93 54.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.693 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.427 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -56.04 -20.34 16.43 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.584 -174.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.538 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.0 m -59.25 -30.31 68.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.359 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 145' ' ' LEU . 1.1 mp -69.79 -35.33 74.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.172 -0.33 . . . . 0.0 111.208 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.679 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 11.9 t-80 -54.25 -41.36 68.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.626 0.727 . . . . 0.0 109.691 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 3.3 ptm -81.0 -27.93 35.68 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.446 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.3 t80 -79.87 -59.17 2.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.154 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.619 HD11 ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -106.38 7.09 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -175.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 46.1 mt-30 -121.33 -176.1 3.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.65 -111.64 0.58 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.408 0.443 . . . . 0.0 110.889 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.7 pm0 -145.42 -39.13 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 112.027 175.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.06 148.69 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.161 -166.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.551 HG22 ' HE3' ' A' ' 152' ' ' LYS . 3.4 mp -72.25 102.84 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.812 172.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -89.74 102.94 15.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.25 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.551 ' HE3' HG22 ' A' ' 150' ' ' ILE . 5.4 mptt -74.74 11.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.296 0.57 . . . . 0.0 111.913 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -111.79 12.53 20.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.166 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -171.84 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.679 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.2 m -92.52 113.71 60.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.54 89.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.018 2.479 . . . . 0.0 110.941 174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 t -159.7 -154.63 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.395 0.617 . . . . 0.0 110.868 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -96.8 157.78 15.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.474 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.63 HG21 HG13 ' A' ' 59' ' ' ILE . 19.6 mm -57.77 -41.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.0 109.922 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.497 ' HE ' ' ND2' ' A' ' 137' ' ' ASN . 4.5 mmt180 -66.15 -25.26 66.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.01 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' A' ' 162' ' ' ALA . 19.2 t-80 64.03 -176.12 0.16 Allowed 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.753 172.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' H ' ' CG ' ' A' ' 161' ' ' HIS . . . . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.994 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 2.8 ppp? . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.744 0.307 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -108.3 4.89 25.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.733 0.301 . . . . 0.0 111.228 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -109.13 110.59 21.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.847 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -72.88 129.5 38.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -110.75 -6.98 14.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.122 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -114.84 130.59 56.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.555 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -98.99 -22.72 15.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -66.97 128.39 36.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.4 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.82 129.63 51.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.474 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.66 -33.61 18.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.582 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 32.1 p -129.59 109.11 10.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.289 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.33 129.51 9.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.898 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -172.51 -44.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.803 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p -70.8 152.52 43.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.664 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.12 -49.91 4.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.989 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.71 70.82 0.73 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -67.61 145.41 54.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.842 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 26.6 p -100.24 -54.14 2.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.667 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 64.59 -60.78 0.21 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.62 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -133.45 -37.48 0.95 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.713 0.768 . . . . 0.0 110.679 -172.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 12' ' ' ILE . 5.4 tt -72.57 135.02 45.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.37 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.713 ' N ' HD23 ' A' ' 11' ' ' LEU . 1.7 mt -144.43 172.31 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.278 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.526 ' H ' HG22 ' A' ' 12' ' ' ILE . 40.0 p 58.46 80.94 0.17 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.861 0.839 . . . . 0.0 110.291 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 8.8 mptt -78.22 165.59 49.24 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.642 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 84.5 Cg_exo -49.07 136.22 29.79 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.697 2.265 . . . . 0.0 111.358 173.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.0 173.42 7.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.266 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -62.59 146.25 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.325 0.583 . . . . 0.0 111.137 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.69 -166.48 1.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.644 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.43 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 4.6 p30 -53.43 -71.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.062 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 9.9 m-20 -129.66 129.46 44.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 170.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 178.82 158.61 0.55 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.911 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -133.97 -45.51 0.79 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.909 0.385 . . . . 0.0 110.746 -168.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.7 40.15 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.041 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.38 153.45 13.4 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 124.088 3.192 . . . . 0.0 111.608 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -41.13 -30.26 0.65 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 124.6 3.533 . . . . 0.0 115.504 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -70.75 -52.21 22.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 9.8 m120 61.53 -179.42 0.12 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 112.135 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.39 132.41 36.22 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 57' ' ' LEU . 13.2 tp -143.0 127.21 17.56 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.58 0.705 . . . . 0.0 111.188 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.15 100.79 3.79 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.688 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.682 HG12 ' HB ' ' A' ' 53' ' ' VAL . 46.7 mt -111.82 138.71 39.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.116 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -131.77 103.24 6.23 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -79.35 131.51 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -178.03 -165.13 0.09 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 63.06 81.73 0.22 Allowed Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 121.375 0.607 . . . . 0.0 110.432 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.13 119.59 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.123 2.549 . . . . 0.0 112.527 -175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 50.0 tp60 -108.81 106.47 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.541 174.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.8 m -77.84 103.15 7.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -134.07 89.9 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.05 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.42 -167.86 33.02 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.218 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 t -104.37 149.91 7.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.337 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.86 3.19 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 121.549 -0.357 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -96.67 86.9 4.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.647 . . . . 0.0 109.858 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.94 34.85 0.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.975 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 20.9 ttt180 -82.71 146.84 28.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -143.47 165.76 26.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.901 0.381 . . . . 0.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 36.5 m -121.78 129.02 52.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.481 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 44.0 p -92.73 140.86 29.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 98.6 m-85 -100.22 126.75 46.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.07 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.648 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 15.5 tt0 -86.17 120.34 27.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.289 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -93.34 106.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.691 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -95.44 112.03 23.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.424 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.682 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -122.66 140.68 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -126.86 136.87 52.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.244 168.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.532 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.1 t -170.65 164.54 8.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.31 0.576 . . . . 0.0 112.152 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -117.04 26.02 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.824 168.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 29' ' ' LEU . 26.5 mt -60.4 136.42 91.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.543 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -68.34 -32.87 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.227 1.952 . . . . 0.0 111.162 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 159' ' ' ILE . 1.1 tt -66.69 -37.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.411 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 4.0 m-30 -75.07 -5.37 43.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -169.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 tttt 67.16 -74.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.18 -4.38 55.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 120.518 0.199 . . . . 0.0 110.502 -171.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 5.5 mmtp 70.31 -42.38 0.52 Allowed 'General case' 0 C--O 1.221 -0.417 0 O-C-N 124.122 0.889 . . . . 0.0 111.496 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.19 127.27 5.67 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.408 0.623 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 t -166.97 176.22 7.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.547 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.648 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 21.5 m -140.68 122.74 15.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 111.947 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.49 -178.1 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.866 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 38.6 ptt180 -150.53 133.1 15.72 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.109 170.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 4.0 mmp_? -136.11 177.99 7.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.624 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' HD1' ' A' ' 74' ' ' PHE . 61.6 mtp180 -93.13 173.2 7.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.282 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.9 t80 -60.48 -40.52 91.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 p -60.49 -26.78 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB3' HD12 ' A' ' 150' ' ' ILE . 9.3 m-20 -73.23 -37.02 66.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.913 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 34.9 m-85 -65.98 -41.36 91.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 92' ' ' LEU . 21.8 mt-10 -55.91 -53.53 55.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.021 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.444 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.5 t-105 -64.07 -30.27 71.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.331 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -73.44 -43.96 59.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 35.5 ttt180 -56.59 -61.82 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.176 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 32.7 t -59.62 -38.54 81.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.586 -173.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -48.48 75.93 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.2 mt -63.79 -40.37 96.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.201 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.9 mt-10 -66.94 -41.84 86.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.824 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.3 mmm180 -74.96 -53.6 8.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.791 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -82.86 -25.83 32.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.101 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 m -130.46 175.3 9.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.717 0.77 . . . . 0.0 111.569 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -99.13 29.96 3.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.581 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' A' ' 89' ' ' VAL . 60.3 t -54.61 142.31 8.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.0 p -73.15 34.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.037 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.516 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -57.05 122.9 56.65 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 121.886 -0.509 . . . . 0.0 111.206 -175.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 88.7 Cg_endo -85.62 167.82 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.926 2.418 . . . . 0.0 111.868 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 150.31 64.66 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.478 2.119 . . . . 0.0 112.244 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 75' ' ' GLU . 92.6 mt -78.41 151.99 78.21 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.255 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.32 110.8 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.778 2.319 . . . . 0.0 111.154 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.3 43.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.724 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -153.18 58.74 0.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.492 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -165.43 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.626 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -59.47 -29.0 67.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.945 -173.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.444 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.3 ppt_? -99.81 29.33 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 0.0 110.196 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.2 tp60 -124.83 -41.43 2.12 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.405 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 54.1 mt -85.23 166.76 29.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.18 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 33.5 Cg_exo -60.06 143.07 99.58 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.986 2.457 . . . . 0.0 112.254 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 6.9 m-85 -73.65 -62.95 1.31 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 69.77 -60.49 0.47 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.886 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.31 -145.83 7.29 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.954 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.96 -42.47 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 111.432 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -127.87 -53.26 1.32 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -173.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 141.43 -12.57 2.74 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.599 -171.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 39.3 pt -56.12 -19.84 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -76.22 -7.29 54.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.434 . . . . 0.0 110.834 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.01 125.7 34.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -69.45 -17.94 63.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.122 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.9 m-80 -72.58 -47.41 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -49.03 -49.57 40.52 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.5 0.5 . . . . 0.0 110.71 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.95 -50.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.618 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -79.18 -16.31 56.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.849 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 65.4 mm-40 -73.31 -35.32 66.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.445 ' HD2' ' OH ' ' A' ' 49' ' ' TYR . 33.0 ttm180 -79.04 -31.89 44.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -58.91 -50.96 72.06 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.652 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.688 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -61.45 -37.56 84.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 -40.49 16.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.136 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -62.11 -35.43 78.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.9 0.35 . . . . 0.0 111.281 178.126 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 126' ' ' ILE . 15.9 pt-20 -75.52 -33.18 60.7 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.0 mm100 -61.67 -56.1 23.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -51.15 -52.77 40.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.433 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.44 -41.06 90.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.055 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -60.41 -17.99 47.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 0.0 111.981 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.9 mttm -88.25 -59.39 2.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.111 0.957 . . . . 0.0 110.593 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 126' ' ' ILE . 1.4 m -65.35 -13.13 14.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.398 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.41 -5.64 23.89 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.443 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.36 14.3 4.82 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.004 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 45.1 t60 -100.19 139.45 20.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.796 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.1 Cg_exo -41.32 -49.53 4.84 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.516 3.477 . . . . 0.0 113.706 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.68 -26.63 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.386 -174.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.492 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -86.76 -42.16 13.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.423 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.39 -2.66 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.182 170.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 135' ' ' ALA . 56.9 t30 -111.3 7.83 21.19 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.937 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -116.03 126.98 54.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.0 0.429 . . . . 0.0 111.199 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -52.46 -29.31 24.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.041 -173.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.666 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 15.5 t -63.75 -22.47 66.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.83 0.347 . . . . 0.0 111.434 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -68.45 -30.85 69.81 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.793 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 7.3 t60 -67.09 -38.09 85.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.666 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 6.3 ptm -79.61 -25.28 41.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.826 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 150' ' ' ILE . 24.7 t80 -80.17 -52.54 7.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.192 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.699 ' HG ' ' CZ ' ' A' ' 60' ' ' PHE . 3.2 mm? -78.36 -25.83 46.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.921 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.547 ' OE1' ' HA ' ' A' ' 60' ' ' PHE . 8.5 mt-30 -129.48 176.7 7.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.068 -164.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.49 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 149' ' ' ILE . 9.3 tp10 177.18 -58.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.656 0.741 . . . . 0.0 110.862 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -116.24 135.85 55.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.824 -171.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 144' ' ' PHE . 46.6 mt -72.98 111.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.621 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 153' ' ' SER . 10.3 t70 -91.82 99.86 12.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.0 mptt -70.85 11.64 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 151' ' ' ASP . 25.4 m -116.06 14.03 15.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.2 174.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -61.2 -170.93 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.611 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 93.7 m -91.66 112.21 53.29 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -70.57 88.7 0.62 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.325 2.683 . . . . 0.0 111.724 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 50.1 m -156.95 -159.56 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.175 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 19.5 mmmt -91.23 160.02 15.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.619 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.29 -44.27 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.716 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.45 96.11 9.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 160.64 22.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.066 0.46 . . . . 0.0 110.47 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.129 179.497 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -157.21 148.63 22.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -142.42 100.78 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.826 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.02 71.0 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.423 0.63 . . . . 0.0 110.536 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -108.76 106.43 16.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -105.02 -10.13 17.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.133 0.492 . . . . 0.0 110.199 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.95 74.43 8.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -75.12 90.75 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.385 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.55 153.31 38.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -110.92 80.2 0.27 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.852 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 m -94.28 143.65 26.21 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.83 125.02 50.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.848 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -120.88 -59.63 1.72 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.442 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -113.38 143.48 44.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.0 111.092 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.4 -46.89 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.926 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.44 14.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.243 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -113.8 156.77 23.27 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.0 p -80.08 -66.67 0.85 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.583 0.23 . . . . 0.0 110.558 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 54.4 -172.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.796 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -170.15 -177.02 2.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.9 tp -156.36 144.25 19.52 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.5 mt -131.52 144.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.143 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -133.59 122.36 23.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.736 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 27.5 mmtp -79.76 163.58 57.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 87.1 Cg_exo -46.98 113.02 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.647 2.231 . . . . 0.0 111.442 174.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -70.53 93.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.305 0.574 . . . . 0.0 111.202 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -102.46 170.19 8.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.209 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.57 119.07 38.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -68.71 -46.43 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.054 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -145.6 160.07 42.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.396 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 74.79 170.87 0.28 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.864 0.728 . . . . 0.0 111.033 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.63 -49.03 0.89 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.555 -169.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.87 45.42 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.807 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 155.24 14.42 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 C-N-CA 123.889 3.06 . . . . 0.0 112.334 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -49.35 -18.67 2.35 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.853 3.702 . . . . 0.0 114.698 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.2 m -70.84 -54.19 12.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.508 ' OD1' HD23 ' A' ' 57' ' ' LEU . 27.4 m120 61.29 163.24 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.588 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -87.07 139.06 30.96 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -143.79 129.75 19.51 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.545 -177.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -142.03 101.43 3.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.72 0.771 . . . . 0.0 110.237 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.6 mt -111.04 133.68 55.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.223 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.36 100.79 6.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.279 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -78.01 128.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 106.716 -1.586 . . . . 0.0 106.716 171.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 p -176.8 -163.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 27.3 m-80 58.26 70.76 1.15 Allowed Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.398 . . . . 0.0 110.271 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 115' ' ' ILE . 97.4 Cg_endo -77.15 132.34 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.796 2.331 . . . . 0.0 113.414 -172.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.3 tp60 -119.92 107.78 13.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.546 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.532 HG22 ' NE ' ' A' ' 45' ' ' ARG . 54.6 m -78.02 96.12 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.569 0.7 . . . . 0.0 109.896 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.2 p -123.82 94.39 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.379 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.65 -165.82 30.26 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.078 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.9 t -97.22 146.43 7.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.166 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.16 -48.18 6.59 Favored Glycine 0 N--CA 1.46 0.263 0 C-N-CA 121.521 -0.371 . . . . 0.0 113.144 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.91 89.85 3.43 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.57 0.7 . . . . 0.0 109.222 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.74 33.09 0.95 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.474 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.585 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 27.8 ttt180 -85.66 146.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.057 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.43 149.47 51.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.54 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.5 m -105.19 128.29 53.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.347 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 35.9 p -93.16 144.3 25.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.87 138.75 49.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 110.767 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 34.8 tt0 -96.79 120.79 37.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.204 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.9 mp -98.64 109.82 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -96.1 145.02 25.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.699 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.68 138.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.497 . . . . 0.0 112.175 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -127.54 143.61 51.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.009 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -171.75 164.58 6.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.022 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.8 p30 -117.62 23.94 11.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.596 167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 29' ' ' LEU . 28.2 mt -58.57 138.58 85.87 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.713 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 2.4 Cg_endo -77.0 -24.99 9.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.5 2.134 . . . . 0.0 111.424 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.41 -42.27 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.532 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.5 m-30 -68.46 -25.59 65.07 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -170.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.63 -60.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.77 -9.02 59.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.831 0.287 . . . . 0.0 111.293 -172.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 70.0 -41.7 0.49 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.839 0.712 . . . . 0.0 110.994 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.53 144.93 36.22 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -163.81 158.12 19.7 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.5 m -142.31 136.61 29.89 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.534 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.85 176.04 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.655 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 35.2 ttp180 -137.89 113.8 9.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.03 0.443 . . . . 0.0 110.438 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 12.1 mmm180 -131.44 177.4 7.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 70' ' ' ARG . 53.7 mtm180 -100.23 172.08 7.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.29 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.6 t80 -61.81 -38.18 87.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.492 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 17.0 p -57.77 -28.62 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.248 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 150' ' ' ILE . 5.0 m-20 -70.88 -40.13 72.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.128 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.27 -40.27 95.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 109.892 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 19.9 mt-10 -61.76 -44.98 95.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.826 0.822 . . . . 0.0 110.138 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE2' ' HG3' ' A' ' 152' ' ' LYS . 7.3 t-105 -64.03 -36.31 83.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.521 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 144' ' ' PHE . 32.3 tp -70.77 -48.03 56.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.144 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 56.8 ttt180 -50.61 -60.11 3.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.2 p -61.86 -42.21 98.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.959 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.43 -49.28 64.87 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.332 0.395 . . . . 0.0 111.149 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.21 -38.4 90.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.6 mt-10 -70.89 -20.19 62.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.752 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 79' ' ' SER . 26.5 mmt180 -80.21 -61.77 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.499 . . . . 0.0 112.113 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB2' ' OE2' ' A' ' 138' ' ' GLU . 43.7 mm-40 -84.74 -22.98 29.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.054 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 m -131.98 171.88 13.04 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.687 0.756 . . . . 0.0 112.005 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -97.99 33.46 2.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.402 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 66.6 t -54.3 140.0 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.535 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.1 p -72.41 32.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.99 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 78' ' ' ARG . 1.4 t -53.56 122.36 31.88 Favored Pre-proline 0 N--CA 1.466 0.334 0 O-C-N 122.126 -0.359 . . . . 0.0 111.258 -175.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 87.2 Cg_endo -85.75 165.17 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.175 2.583 . . . . 0.0 112.514 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.8 Cg_endo -65.76 142.95 72.12 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.852 2.368 . . . . 0.0 112.285 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.7 mt -69.8 154.17 94.93 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.775 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 60.1 Cg_endo -77.52 109.11 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.506 2.137 . . . . 0.0 110.953 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.88 -177.12 37.2 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.073 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.583 ' N ' HD23 ' A' ' 98' ' ' LEU . 12.5 mptt 68.15 -63.18 0.34 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.605 0.762 . . . . 0.0 112.202 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.71 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -76.16 -22.37 55.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.542 -169.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.73 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -64.82 -42.82 94.67 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 30.11 3.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.621 0.724 . . . . 0.0 110.064 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.601 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.7 tt0 -130.06 -38.78 1.41 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.293 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG3' ' A' ' 117' ' ' GLU . 54.0 mt -90.03 169.21 12.82 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.104 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -64.34 140.43 70.21 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.636 2.224 . . . . 0.0 111.527 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 45.2 m-85 -83.15 -83.13 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.208 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 66.87 -69.4 0.13 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.862 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 110' ' ' PHE . . . -88.85 71.13 2.45 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.636 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.15 -71.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.29 1.036 . . . . 0.0 111.366 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.01 -36.4 9.03 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.827 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.73 -5.01 7.51 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.521 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.689 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.6 pt -68.92 -17.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.472 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 58.1 m-85 -81.25 -4.62 56.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.836 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -100.01 131.47 45.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.268 0.556 . . . . 0.0 109.904 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.51 -25.65 64.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.572 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.4 m-20 -64.21 -59.98 3.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.689 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.66 -47.23 58.71 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.419 0.449 . . . . 0.0 111.044 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' A' ' 36' ' ' PRO . 65.4 mt -52.72 -52.98 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.617 -174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.93 -19.52 61.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.291 -177.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 40.6 mm-40 -75.63 -31.23 59.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.437 0.637 . . . . 0.0 109.64 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.03 -39.89 32.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.7 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.64 -51.34 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.795 -178.038 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 12.4 pt20 -61.25 -41.18 96.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 93' ' ' PRO . . . -72.18 -38.67 59.02 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.563 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -67.12 -35.64 80.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.205 0.502 . . . . 0.0 111.236 178.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 126' ' ' ILE . 8.2 pt-20 -76.12 -29.04 57.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.3 mm100 -62.52 -58.86 6.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.2 t80 -51.3 -52.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.074 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' A' ' 123' ' ' GLU . 9.7 tp -63.35 -43.8 98.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -170.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -59.78 -20.12 54.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 38.3 mttm -84.0 -58.25 2.85 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.987 0.898 . . . . 0.0 110.14 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.541 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -65.3 -11.96 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.338 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -97.16 -15.41 20.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.626 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.426 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -123.68 1.89 9.38 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.281 -0.961 . . . . 0.0 114.044 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.676 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.7 t60 -89.67 141.94 28.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 117.321 0.561 . . . . 0.0 110.758 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.676 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.3 Cg_exo -40.55 -50.57 3.76 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.356 3.37 . . . . 0.0 113.774 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.34 -23.85 62.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.422 -174.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -88.36 -42.22 12.34 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.439 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.463 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.57 -4.26 1.88 Allowed 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.523 0.678 . . . . 0.0 110.256 172.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 11.9 t-20 -105.6 2.1 27.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.269 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 84' ' ' GLU . 4.9 mm-40 -114.29 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.879 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -55.48 -20.88 14.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.421 -175.111 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 143' ' ' MET . 6.0 t -65.51 -24.23 67.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.3 mp -71.6 -31.11 66.57 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.7 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 31.0 t-80 -61.73 -34.18 75.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.1 ptm -84.43 -26.16 28.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.5 t80 -78.98 -54.13 6.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.552 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.29 -33.84 22.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 0.0 110.713 -174.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 33.8 mt-30 -107.54 -175.44 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.329 -170.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 54.75 -145.05 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -117.92 -32.83 4.66 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 111.543 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -145.42 156.76 13.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.874 0.845 . . . . 0.0 113.132 -166.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.592 HG12 ' HG3' ' A' ' 143' ' ' MET . 81.3 mt -89.12 111.99 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.02 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -99.78 106.24 18.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.781 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' CE2' ' A' ' 76' ' ' TRP . 9.5 mptt -71.39 5.55 2.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 111.773 -171.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 m -109.31 13.74 24.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.834 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.48 -172.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.499 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 99.0 m -95.45 112.83 60.19 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -69.82 50.21 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.916 3.078 . . . . 0.0 113.262 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 71.2 m -108.69 -160.59 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.82 0.343 . . . . 0.0 110.536 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 18.5 mmmt -86.78 160.31 18.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 59' ' ' ILE . 17.5 mm -52.78 -45.87 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.62 1.96 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.306 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -74.46 178.2 5.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.347 1.07 . . . . 0.0 111.611 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.562 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.918 174.531 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 63.1 mtm . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -8' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' -5' ' ' HIS . . . -83.09 86.03 7.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 110.983 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -62.02 -37.95 86.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -111.4 16.29 20.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.778 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -5' ' ' HIS . . . . . 0.474 ' HA ' ' HB1' ' A' ' -8' ' ' ALA . 16.4 t-80 54.29 41.64 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.744 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 32.6 t-80 -122.78 36.9 4.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.3 m80 66.79 -95.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.868 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -172.24 23.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.3 150.05 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.118 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -114.19 -157.03 11.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.532 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 p -63.76 144.61 56.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.961 0.41 . . . . 0.0 111.332 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.33 137.93 32.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.435 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 4' ' ' THR . 7.7 tt0 -151.02 -169.06 3.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 61.6 p 60.21 175.6 0.09 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.011 0.924 . . . . 0.0 113.296 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t 67.99 -82.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.075 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.85 140.47 36.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.861 0.362 . . . . 0.0 111.332 -175.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.41 164.61 19.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -58.05 -63.02 1.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 59.55 -179.6 0.09 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.564 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -168.57 170.22 9.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.6 tp -145.27 143.85 30.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.864 0.364 . . . . 0.0 110.357 -176.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.92 153.06 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p 67.06 137.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.003 0.921 . . . . 0.0 112.577 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 9.6 mptt -79.65 168.68 24.48 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.455 175.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 69.1 Cg_exo -45.59 147.55 2.81 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.746 2.298 . . . . 0.0 112.313 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -55.18 127.4 29.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.373 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -68.98 155.27 40.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.6 mm? -97.04 -171.49 2.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.39 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.37 -171.61 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.404 0.621 . . . . 0.0 111.06 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.29 126.93 54.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.992 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.14 36.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.838 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.596 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.4 m-85 -130.1 -9.76 4.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.309 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.2 178.78 41.2 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.28 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.02 154.43 13.37 Favored 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 124.314 3.343 . . . . 0.0 111.866 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.39 -27.01 4.5 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 124.078 3.185 . . . . 0.0 115.354 -169.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' HD21 ' A' ' 57' ' ' LEU . 9.0 t -87.72 -33.55 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.794 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 6.7 m120 57.41 -173.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.96 128.99 34.87 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 57' ' ' LEU . 16.7 tp -141.36 130.47 23.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.129 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 7.7 pt-20 -139.19 109.0 6.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.245 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.69 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.9 mt -120.84 137.8 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 115.75 14.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -98.08 133.79 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.2 t 179.16 -161.54 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.1 m-80 62.22 68.66 1.04 Allowed Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 0.0 110.271 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.84 134.57 23.97 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.797 2.331 . . . . 0.0 113.832 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.6 tp60 -117.36 106.52 13.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.006 170.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.569 HG22 ' HE ' ' A' ' 45' ' ' ARG . 32.4 m -78.95 97.12 5.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.0 110.037 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -125.81 90.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.973 -170.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -165.41 29.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.9 t -97.02 149.13 5.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.649 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.09 -48.1 6.48 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 121.508 -0.377 . . . . 0.0 113.299 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -101.9 87.99 3.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 34.2 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.5 ttt180 -84.36 140.27 31.7 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -125.24 157.31 36.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.938 0.399 . . . . 0.0 110.408 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 m -110.35 127.72 55.2 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.079 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.629 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.2 p -92.82 128.55 38.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 87.6 m-85 -101.9 134.84 44.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 tt0 -86.91 121.76 29.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.897 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.6 mp -95.55 116.26 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 35.0 mtt180 -109.82 119.33 39.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.55 175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -123.57 142.5 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 111.953 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 15.9 ttmt -127.49 138.16 52.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 165.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -171.12 165.24 7.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.5 0.667 . . . . 0.0 111.899 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.596 ' ND2' ' HB2' ' A' ' 22' ' ' TYR . 30.8 p-10 -121.79 28.46 7.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.397 169.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 29' ' ' LEU . 17.8 mt -62.82 145.24 96.17 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.575 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.8 -15.68 13.29 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.726 2.284 . . . . 0.0 112.345 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -85.06 -41.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.75 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' HD13 ' A' ' 145' ' ' LEU . 2.3 m-30 -68.51 -29.69 68.34 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 74.25 -57.52 0.61 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.421 0.451 . . . . 0.0 112.023 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.11 -12.44 59.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.648 0.204 . . . . 0.0 111.099 -173.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp 71.93 -38.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.809 0.693 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.44 146.36 26.61 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.176 0.512 . . . . 0.0 109.911 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -170.09 159.14 7.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.196 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.4 m -140.84 136.55 32.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.416 0.627 . . . . 0.0 111.462 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 4.6 m -143.71 179.92 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.765 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 7.1 ptp180 -140.31 126.01 19.26 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.446 173.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.581 HH11 HG13 ' A' ' 150' ' ' ILE . 22.2 mmt85 -125.58 161.39 27.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.487 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -82.09 159.84 23.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 24.7 t80 -55.26 -38.31 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -59.26 -28.05 66.36 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.461 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 150' ' ' ILE . 52.2 m-20 -74.72 -37.24 62.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.187 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 57.2 m-85 -65.02 -36.16 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.937 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.1 mt-10 -63.45 -51.77 64.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 5.0 t-105 -61.64 -34.93 76.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.945 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -67.79 -44.24 77.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 66.4 ttt180 -57.14 -59.61 4.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.973 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.677 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 t -62.33 -36.01 80.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.973 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -53.93 -56.45 17.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 109.758 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.16 -35.28 76.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.296 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 20.3 mt-10 -69.37 -38.84 78.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 79' ' ' SER . 33.3 mmt180 -69.29 -60.36 2.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 0.0 111.443 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.66 -22.29 29.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.929 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -126.64 175.21 8.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.208 0.528 . . . . 0.0 112.112 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -103.0 21.03 16.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.874 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.9 t -48.01 142.0 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.125 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.89 36.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.787 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -55.61 119.6 26.05 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -175.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 86.0 Cg_endo -85.9 168.37 9.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.13 2.553 . . . . 0.0 112.325 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 147.3 70.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.697 2.265 . . . . 0.0 112.554 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 75' ' ' GLU . 78.2 mt -73.97 157.67 86.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.418 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.4 109.03 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.577 2.185 . . . . 0.0 111.439 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.5 -171.46 38.07 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.602 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 68.03 -2.75 1.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.785 0.434 . . . . 0.0 111.733 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.57 -89.98 0.46 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -52.6 -23.57 6.7 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 113.296 -174.41 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.8 mm? -60.86 -41.55 96.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.994 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 18.24 21.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.692 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 28.7 tp60 -113.71 -40.24 3.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.96 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 114' ' ' PHE . 35.8 mt -89.7 165.87 23.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.515 -175.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.02 164.15 28.57 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.081 2.521 . . . . 0.0 111.962 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -83.23 -100.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 65.78 -65.87 0.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 111.577 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.96 52.18 4.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.146 -0.55 . . . . 0.0 111.952 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 63.9 -71.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.69 1.196 . . . . 0.0 110.391 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.01 -20.06 17.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.933 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.7 14.03 20.59 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.642 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.9 pt -83.21 -16.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.989 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 70.0 m-85 -79.69 1.24 27.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.453 175.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 113' ' ' ASN . 24.9 t70 -86.45 129.92 34.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.64 -19.76 63.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.88 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB2' ' OD2' ' A' ' 111' ' ' ASP . 46.4 m-80 -74.14 -54.37 7.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -49.87 -50.05 47.11 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.748 0.655 . . . . 0.0 111.158 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.7 mt -52.26 -45.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.278 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.0 -15.24 57.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.742 -178.203 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 42.4 mm-40 -70.78 -34.69 72.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.302 0.573 . . . . 0.0 109.767 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.483 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 36.5 ttm180 -78.52 -36.37 45.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -55.13 -49.32 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.827 -178.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 9.0 pt20 -61.46 -33.72 74.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.496 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.02 -33.66 9.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.992 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 122' ' ' LEU . 7.4 tp -66.32 -33.61 76.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.138 0.175 . . . . 0.0 111.018 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.645 ' HB3' HG22 ' A' ' 33' ' ' VAL . 10.5 pt-20 -75.22 -32.47 61.16 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.6 mm100 -59.96 -59.85 4.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 4.7 t80 -45.63 -51.72 11.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.022 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.12 -39.05 84.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.83 -172.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.17 -12.53 28.65 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HD3' ' HG3' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -90.78 -59.46 2.17 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.734 0.778 . . . . 0.0 110.177 172.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.563 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -65.03 -12.19 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.056 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.02 1.5 22.49 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.354 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.87 12.95 2.4 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.509 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.69 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 54.8 t60 -100.26 140.32 21.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.987 0.394 . . . . 0.0 110.19 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.668 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 3.8 Cg_exo -43.94 -43.91 12.15 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.936 3.091 . . . . 0.0 113.54 -171.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.418 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.0 -28.72 61.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.454 -175.148 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -80.35 -41.21 25.16 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.551 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.2 mm100 -67.55 -0.67 4.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.528 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 5.0 t-20 -100.71 -7.01 24.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.386 -178.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -117.52 132.7 56.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -49.44 -31.86 10.67 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.556 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.6 p -58.83 -25.2 62.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 111.6 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -70.52 -33.88 71.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -55.51 -41.17 72.72 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.303 0.573 . . . . 0.0 109.7 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.577 ' HB3' ' HA ' ' A' ' 150' ' ' ILE . 1.8 mpp? -66.81 -56.66 9.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.61 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' HD11 ' A' ' 150' ' ' ILE . 2.4 t80 -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.053 -1.43 . . . . 0.0 112.856 -173.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.688 HD13 ' CE1' ' A' ' 60' ' ' PHE . 1.5 mt -99.2 -40.73 7.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.054 0.454 . . . . 0.0 112.117 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.4 -49.44 5.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -168.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.411 ' O ' HG11 ' A' ' 67' ' ' VAL . 74.8 m-20 -73.66 -178.67 3.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -83.74 -30.95 26.26 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.459 0.647 . . . . 0.0 110.246 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -149.5 158.86 5.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.237 -169.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 144' ' ' PHE . 70.9 mt -86.4 111.81 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.103 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' A' ' 143' ' ' MET . 52.2 t0 -82.48 113.86 20.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.018 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.4 mptt -77.13 -3.13 37.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.91 0.862 . . . . 0.0 110.234 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.5 t -108.7 19.6 19.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.342 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.546 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 6.2 p90 -61.16 -174.18 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.959 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.472 HG22 ' OG ' ' A' ' 157' ' ' SER . 73.6 m -93.02 108.26 31.14 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.404 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 35.6 Cg_exo -65.87 92.54 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.321 2.68 . . . . 0.0 111.734 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 155' ' ' THR . 4.9 p -164.68 -169.62 1.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -174.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.6 mmmm -81.61 152.2 27.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.004 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.556 HG13 HD12 ' A' ' 59' ' ' ILE . 12.1 mm -52.56 -42.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.373 0.606 . . . . 0.0 110.328 173.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.408 ' H ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -84.01 10.82 9.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.795 -173.378 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.63 -176.82 0.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.644 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.685 176.322 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -133.6 123.34 24.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.244 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 37.3 m80 67.34 122.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.992 0.807 . . . . 0.0 111.877 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.55 91.33 6.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.347 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -79.84 167.65 20.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.677 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -103.78 56.73 0.73 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.024 0.44 . . . . 0.0 111.806 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -111.41 19.29 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.646 173.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -90.49 67.44 6.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.802 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.03 132.22 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.011 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -93.95 147.72 18.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.7 p -65.38 119.01 10.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.688 0.244 . . . . 0.0 110.767 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.32 119.26 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.787 0.803 . . . . 0.0 111.506 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.72 -58.09 2.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -99.92 147.07 25.95 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.46 -47.4 4.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.303 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.19 66.38 2.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.404 0.621 . . . . 0.0 109.778 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 165.38 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.8 p -62.24 -68.81 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.614 0.245 . . . . 0.0 110.36 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 56.99 -173.01 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -167.56 176.26 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.4 tp -152.17 147.34 26.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.6 mt -134.78 150.63 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 110.438 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 p -119.86 93.99 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 111.01 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -76.4 171.66 11.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 54.8 Cg_exo -54.52 150.97 32.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.475 2.117 . . . . 0.0 112.063 173.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -68.8 137.33 53.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.54 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.19 165.21 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.39 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.88 -171.91 1.78 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.721 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -45.42 -57.51 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.79 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -162.47 134.38 5.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.638 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 171.65 172.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.338 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 -57.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.913 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.03 178.27 48.21 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.049 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.8 Cg_endo -52.17 156.2 8.02 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 124.145 3.23 . . . . 0.0 112.323 175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 88.3 Cg_exo -50.53 -17.32 2.79 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 124.496 3.464 . . . . 0.0 114.831 -173.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.9 m -76.29 -51.21 12.45 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.7 m120 60.95 176.08 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.555 0.535 . . . . 0.0 111.382 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -88.95 135.43 33.55 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.706 HD22 HD11 ' A' ' 57' ' ' LEU . 15.3 tp -142.85 132.89 24.33 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.097 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.5 99.41 3.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.147 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 53' ' ' VAL . 34.5 mt -110.67 141.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.058 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -140.43 118.26 11.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -99.5 136.6 29.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.24 -163.19 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 60.39 77.22 0.38 Allowed Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 110.574 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.29 148.18 38.36 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.633 2.222 . . . . 0.0 112.996 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.2 tp60 -134.51 108.91 8.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.688 175.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -76.7 94.1 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.407 0.623 . . . . 0.0 109.75 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -122.97 92.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.269 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.07 -165.35 29.89 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.878 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.0 t -101.99 145.42 11.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.246 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.0 -48.2 5.29 Favored Glycine 0 N--CA 1.463 0.498 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.008 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.4 86.29 2.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.69 36.11 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.492 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 11.3 ttt180 -87.34 140.95 29.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -129.19 142.25 50.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.91 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -100.48 124.32 45.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.275 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 40.4 p -93.09 152.33 19.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.545 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.07 143.89 46.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 33.6 tt0 -96.35 120.57 36.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.461 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.95 117.96 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 13.3 mtp180 -105.52 136.95 44.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.25 139.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 64' ' ' GLU . 12.5 ttmt -126.69 138.93 53.47 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.564 168.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.489 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.1 t -170.91 164.02 7.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.219 0.533 . . . . 0.0 111.48 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -116.93 23.42 11.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.255 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.706 HD11 HD22 ' A' ' 29' ' ' LEU . 27.0 mt -57.44 139.93 80.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.705 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 -25.84 13.52 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.586 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -75.84 -40.97 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.07 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.39 -18.43 64.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 57.4 tttt 72.22 -66.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 171.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.7 -11.8 58.9 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 122.24 -0.288 . . . . 0.0 110.314 -172.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 72.21 -42.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.053 0.845 . . . . 0.0 110.762 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -149.57 138.26 20.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.581 0.705 . . . . 0.0 110.755 176.25 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -171.33 162.63 6.83 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.823 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.5 m -137.95 129.95 28.69 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.116 0.484 . . . . 0.0 111.015 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -127.1 169.22 18.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.153 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -134.18 121.35 21.27 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.807 ' NH1' ' HA ' ' A' ' 144' ' ' PHE . 16.7 ptp180 -151.26 163.47 38.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 111.316 -173.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.667 ' HG3' ' H ' ' A' ' 72' ' ' SER . 30.1 tpt180 -86.6 148.0 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.127 -170.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 38.6 t80 -48.03 -37.33 14.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.004 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.667 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 5.5 m -54.13 -34.24 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 111.244 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 150' ' ' ILE . 15.7 m-20 -74.22 -33.94 63.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.123 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 33.6 m-85 -60.21 -36.24 77.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.044 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.511 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.6 mt-10 -64.9 -53.3 48.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.743 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -28.92 66.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.786 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.4 tm? -71.73 -43.84 65.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 60.0 ttt180 -59.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.631 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.551 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.1 p -62.85 -33.49 75.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.76 -47.97 82.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.56 -42.15 91.78 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.846 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 33.0 mt-10 -66.03 -32.83 74.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.616 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.1 mmt180 -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.083 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -75.67 -33.09 60.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.961 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 m -124.62 177.46 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.314 0.578 . . . . 0.0 111.037 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -101.98 29.3 5.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.491 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 57.3 t -51.13 140.18 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.038 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -71.22 31.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.279 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.555 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -51.72 123.05 23.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 111.354 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 92.6 Cg_endo -86.12 166.51 9.62 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.171 2.581 . . . . 0.0 112.192 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 43.5 Cg_endo -67.8 142.6 58.23 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.764 2.309 . . . . 0.0 112.477 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.511 HD11 ' HA ' ' A' ' 75' ' ' GLU . 91.4 mt -69.69 150.72 96.65 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.293 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -81.79 116.95 2.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.551 2.168 . . . . 0.0 110.571 173.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.38 48.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.554 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -149.95 42.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.436 0.636 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -151.48 -81.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.016 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -56.53 -26.22 54.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.087 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.883 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.63 -47.67 84.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -174.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 3.4 ppt_? -97.12 24.52 6.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.401 0.62 . . . . 0.0 110.689 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -112.84 -47.18 3.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.879 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 101' ' ' LEU . 3.2 pp -91.04 173.03 5.9 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.671 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.559 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.4 Cg_exo -71.93 -143.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 124.115 3.21 . . . . 0.0 113.292 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -116.95 -83.81 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 65.27 -74.42 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.834 0.708 . . . . 0.0 111.61 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -107.09 75.82 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.366 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.29 -72.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.026 0.93 . . . . 0.0 111.852 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 109' ' ' ILE . 2.8 t70 -104.21 -34.15 8.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.113 -175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.62 3.02 10.41 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.606 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.55 ' HA ' ' CD1' ' A' ' 114' ' ' PHE . 47.8 pt -70.18 -17.86 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 49.4 m-85 -76.76 -7.72 55.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.24 129.37 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.101 0.477 . . . . 0.0 110.009 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.74 -26.03 68.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.05 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.661 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 43.3 m-80 -69.56 -56.87 6.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -46.75 -47.94 20.6 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 123.673 0.608 . . . . 0.0 111.091 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 mt -53.37 -46.65 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.368 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -78.53 -19.17 53.53 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.116 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 32.1 mm-40 -72.98 -34.65 66.59 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.64 -42.35 61.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.659 174.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.85 -50.89 71.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.612 -176.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.751 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 11.6 pt20 -60.28 -35.19 74.98 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.984 -173.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.62 -31.96 9.78 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.13 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.3 tp -64.86 -35.36 80.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.807 -0.231 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' HA ' HG22 ' A' ' 126' ' ' ILE . 10.5 pt-20 -69.88 -31.35 69.12 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.751 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 65.4 mm-40 -65.83 -58.78 4.82 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.2 t80 -45.45 -53.38 8.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.641 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.7 tp -64.23 -38.67 83.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.644 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -60.48 -19.34 56.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -89.6 -56.98 3.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.882 0.849 . . . . 0.0 110.449 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -63.85 -12.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.898 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.8 3.83 24.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.479 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.28 12.02 2.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.551 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.669 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 39.4 t60 -101.43 140.47 21.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 122.483 -0.422 . . . . 0.0 110.875 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 14.5 Cg_exo -40.59 -47.14 4.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.242 3.294 . . . . 0.0 114.058 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.19 -26.54 61.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.333 -174.185 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.16 -40.13 20.13 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.989 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.0 mm100 -67.61 -3.01 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.225 176.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 135' ' ' ALA . 55.3 t30 -112.56 12.35 19.87 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.231 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -122.67 126.53 47.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.673 0.273 . . . . 0.0 110.929 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 159' ' ' ILE . 15.7 tpt180 -57.36 -15.7 7.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.486 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 143' ' ' MET . 3.2 m -56.07 -29.39 60.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.095 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.5 mp -74.5 -28.97 61.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.199 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 60.9 t-80 -57.28 -43.29 82.99 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.913 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.75 ' SD ' HG23 ' A' ' 150' ' ' ILE . 3.9 ptp -70.89 -35.24 72.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.807 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -77.61 -46.01 23.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.601 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -88.79 -36.47 16.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.388 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 28.8 mt-30 -100.82 -174.01 2.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.394 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 57.41 -165.21 0.16 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.363 0.414 . . . . 0.0 110.274 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -100.17 -32.38 10.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.428 0.632 . . . . 0.0 110.773 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -155.44 173.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.163 -169.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.75 HG23 ' SD ' ' A' ' 143' ' ' MET . 2.1 mp -78.35 120.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.556 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 154' ' ' TYR . 9.6 t0 -96.24 99.88 11.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HG2' ' CG2' ' A' ' 150' ' ' ILE . 81.6 mttt -74.63 -2.59 26.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.624 0.726 . . . . 0.0 111.966 -170.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.8 m -108.37 18.88 20.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.318 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -62.71 -170.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.141 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 56.1 m -84.1 110.84 28.88 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.948 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.2 Cg_exo -71.06 77.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.611 2.874 . . . . 0.0 112.227 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -151.44 -162.92 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -81.37 163.25 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.925 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.586 HG21 HG13 ' A' ' 59' ' ' ILE . 17.0 mm -56.25 -39.39 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.2 0.524 . . . . 0.0 109.612 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -79.61 11.76 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.842 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.8 m170 65.08 179.84 0.18 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.533 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.437 -179.367 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.621 0.248 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -74.39 150.81 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.762 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 50.3 m80 72.69 116.68 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 124.083 0.865 . . . . 0.0 111.116 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -74.97 126.41 30.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.074 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -98.42 102.99 14.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.817 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -78.78 83.81 4.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -111.77 -45.08 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.956 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -87.56 132.42 34.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.68 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 29.8 m -105.01 141.72 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.057 0.456 . . . . 0.0 110.823 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -150.3 90.12 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.709 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p -62.54 101.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.246 0.546 . . . . 0.0 111.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.96 125.18 5.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.348 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.65 -62.46 1.24 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.189 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -107.9 152.39 24.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.164 0.507 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 m -119.84 -162.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.116 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.63 117.08 3.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.559 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.6 169.17 10.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.507 ' HB ' HG12 ' A' ' 12' ' ' ILE . 41.1 p -63.78 -46.83 83.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.416 0.627 . . . . 0.0 109.789 176.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.67 -103.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.52 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 10' ' ' ARG . 21.7 mmt180 -125.15 -46.1 1.82 Allowed 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.038 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' C ' HG13 ' A' ' 12' ' ' ILE . 12.7 tp -43.36 -76.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.128 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 13' ' ' THR . 3.9 mt 62.27 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.981 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.588 ' H ' HG22 ' A' ' 12' ' ' ILE . 6.7 p 70.88 109.14 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.779 0.8 . . . . 0.0 112.019 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 11.1 mptt -70.64 164.94 50.67 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.64 175.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 94.0 Cg_exo -42.96 108.27 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.216 2.611 . . . . 0.0 113.076 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -85.6 149.5 25.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.449 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 65.8 160.45 0.13 Allowed 'General case' 0 C--O 1.232 0.141 0 O-C-N 123.814 0.696 . . . . 0.0 110.558 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.56 134.05 51.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.6 -167.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.83 134.2 46.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.575 0.702 . . . . 0.0 110.425 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.51 159.59 16.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.152 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.13 -42.2 0.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.382 -167.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.36 169.2 38.18 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.329 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.99 160.24 13.0 Favored 'Trans proline' 0 C--O 1.224 -0.214 0 C-N-CA 123.911 3.074 . . . . 0.0 111.282 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.14 -21.6 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 124.839 3.693 . . . . 0.0 115.571 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -70.67 -63.59 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.536 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 13.1 m120 60.24 177.41 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.108 0.48 . . . . 0.0 111.709 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -91.21 134.82 34.24 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -146.46 131.82 18.58 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.368 -175.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -144.11 100.42 3.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.079 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.5 mt -109.99 140.1 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -139.29 108.21 5.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.106 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.83 133.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t 179.74 -163.15 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 56.31 64.46 4.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.315 0.578 . . . . 0.0 109.685 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.82 154.19 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.026 2.484 . . . . 0.0 113.408 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.5 tp60 -135.09 112.2 10.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.557 173.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.538 HG22 ' HE ' ' A' ' 45' ' ' ARG . 45.5 m -76.38 92.4 3.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.738 . . . . 0.0 109.9 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -119.93 94.74 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.549 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.59 -166.3 30.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.356 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.3 t -95.9 147.55 5.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.26 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.53 -48.96 5.87 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.333 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -102.25 88.63 3.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.487 0.661 . . . . 0.0 109.484 170.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.75 34.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.783 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.563 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.8 ttt180 -85.16 132.67 34.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.862 0.363 . . . . 0.0 110.449 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -117.17 174.51 6.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.993 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.4 m -129.0 133.38 47.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.282 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.6 p -92.83 129.92 38.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -105.92 133.01 51.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.978 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 35.7 tt0 -86.36 118.15 25.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.327 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.8 mp -94.39 109.45 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 42.6 mtp180 -96.02 132.41 41.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.236 173.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.4 137.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 0.0 111.262 177.268 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -125.32 137.0 54.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 63' ' ' LYS . 11.8 t -170.51 165.22 8.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.363 0.601 . . . . 0.0 112.394 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -115.89 24.4 11.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.276 166.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.761 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.09 134.48 93.0 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 173.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 12.2 Cg_exo -67.11 -39.97 12.48 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.645 2.23 . . . . 0.0 111.797 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -60.07 -41.61 87.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.285 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.3 m-30 -66.32 -16.28 63.92 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 tttt 71.77 -65.69 0.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.04 -5.68 59.17 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.415 -0.178 . . . . 0.0 110.717 -174.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 55' ' ' THR . 14.7 mmtp 71.64 -41.61 0.51 Allowed 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.849 0.718 . . . . 0.0 111.715 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -160.05 122.41 3.34 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.429 0.633 . . . . 0.0 109.896 -177.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -160.89 176.89 10.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.525 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 20.1 m -141.84 132.5 25.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.125 0.488 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.06 179.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.436 176.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 35.0 ttt180 -145.29 111.23 5.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -138.16 152.68 48.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.806 0.813 . . . . 0.0 112.716 -173.529 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.645 ' HG2' ' H ' ' A' ' 72' ' ' SER . 28.9 ttp180 -74.02 144.31 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.705 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 40.3 t80 -50.98 -36.47 39.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.484 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.645 ' H ' ' HG2' ' A' ' 70' ' ' ARG . 11.0 m -61.87 -21.81 65.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.767 0.318 . . . . 0.0 111.777 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -89.03 -24.49 22.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 23.6 m-85 -61.78 -34.15 75.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.535 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.8 mt-10 -64.4 -50.92 65.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.466 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 6.6 t-105 -62.02 -30.45 70.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.586 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -70.2 -45.65 66.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 47.4 ttt180 -56.83 -61.68 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.716 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 11.1 p -59.3 -34.85 72.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.043 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 3.2 mm-40 -62.36 -37.11 84.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 85' ' ' SER . 97.7 mt -75.7 -17.99 59.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.102 0.477 . . . . 0.0 110.45 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 41.2 mt-10 -88.02 -26.36 22.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.284 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 79' ' ' SER . 41.5 mmt180 -58.43 -64.2 1.0 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -118.86 5.78 11.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 33.5 t -119.54 167.5 11.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.612 0.72 . . . . 0.0 111.169 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -101.2 19.45 17.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.535 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.437 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.2 t -51.24 139.07 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.421 0.629 . . . . 0.0 111.762 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.6 p -72.25 35.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.815 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.56 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -55.45 120.26 30.06 Favored Pre-proline 0 N--CA 1.465 0.286 0 O-C-N 122.042 -0.411 . . . . 0.0 111.159 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.594 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.3 Cg_endo -87.52 165.22 7.9 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.978 2.452 . . . . 0.0 112.249 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 38.1 Cg_endo -66.23 144.75 76.01 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.76 2.307 . . . . 0.0 112.65 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 75' ' ' GLU . 74.0 mt -70.92 150.39 95.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.111 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 6.0 Cg_endo -84.93 114.55 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.8 2.333 . . . . 0.0 111.192 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.29 32.78 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.8 18.21 2.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.218 0.509 . . . . 0.0 110.935 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -110.49 -83.31 0.57 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.078 0.466 . . . . 0.0 111.891 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -58.01 -27.18 63.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.323 -173.17 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? -60.93 -46.94 88.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.023 0.439 . . . . 0.0 111.128 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -101.26 29.95 4.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.49 0.662 . . . . 0.0 109.948 178.033 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.9 tt0 -128.46 -36.83 1.85 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.432 -173.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 74.7 mt -85.08 172.17 9.4 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.947 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 Cg_exo -66.42 -157.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.929 2.419 . . . . 0.0 112.671 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -87.76 -74.65 0.44 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.43 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 64.31 -81.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.743 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.58 108.78 0.44 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.822 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.3 t70 69.43 -65.27 0.31 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 111.836 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -139.22 -5.82 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.085 0.469 . . . . 0.0 110.45 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.86 9.63 22.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.787 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 42.7 pt -76.05 -18.0 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.131 0.491 . . . . 0.0 111.182 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' CE2' ' HD3' ' A' ' 45' ' ' ARG . 84.0 m-85 -87.47 18.19 4.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.625 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.66 134.97 54.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.692 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.04 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.734 -174.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -64.67 -60.06 3.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.268 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.787 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -52.88 -46.89 68.15 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.041 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.69 -46.41 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.157 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -80.65 -18.54 47.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 56.5 mm-40 -67.55 -38.83 84.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.542 0.687 . . . . 0.0 109.177 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -67.78 -43.35 79.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.835 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -55.77 -52.54 63.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.174 -175.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 11.4 pt20 -62.52 -35.24 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.581 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.71 -34.02 17.15 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.413 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.7 tp -66.76 -36.59 82.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 122.043 0.137 . . . . 0.0 111.181 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' HG22 ' A' ' 126' ' ' ILE . 5.1 pt-20 -72.23 -31.7 66.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 7.4 mm100 -60.32 -59.75 4.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.5 t80 -47.22 -52.73 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.944 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.32 -40.15 87.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.918 -171.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.51 -21.06 59.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.1 0.476 . . . . 0.0 111.87 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.594 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 36.7 mttm -87.86 -55.22 3.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.719 0.771 . . . . 0.0 110.453 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -69.08 -12.58 16.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.605 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -114.35 12.15 17.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -136.23 -9.51 1.42 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.534 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.729 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.8 t60 -87.15 146.38 40.15 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.446 -0.311 . . . . 0.0 111.282 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.729 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.3 Cg_exo -43.08 -51.24 5.74 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.915 3.077 . . . . 0.0 113.337 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -66.5 -32.59 74.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.151 -174.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.16 -44.91 35.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.152 -177.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 43.2 mm-40 -61.52 -6.49 2.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.016 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 9.7 t-20 -98.87 -21.44 16.31 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.066 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 13.0 mm-40 -99.91 137.38 38.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.634 0.652 . . . . 0.0 112.352 -168.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 3.5 mmt180 -50.46 -24.45 3.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.023 0.929 . . . . 0.0 112.716 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.1 m -56.86 -29.94 63.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.464 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.9 mp -75.36 -35.26 61.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 110.662 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -64.33 -35.32 80.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 150' ' ' ILE . 8.4 ptm -81.74 -31.79 31.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.529 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 22.3 t80 -80.29 -43.36 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.332 -175.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 11.0 mt -92.02 -26.46 18.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.361 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -117.16 178.3 4.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.364 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.88 -82.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.053 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 176.92 -55.01 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.797 0.808 . . . . 0.0 109.576 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -130.66 154.16 40.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.894 -175.259 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.811 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -71.15 113.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.855 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.78 97.71 4.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.756 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -66.46 -6.91 16.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.881 0.372 . . . . 0.0 111.322 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.2 m -112.96 19.68 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.366 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.457 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.2 OUTLIER -64.21 -170.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.997 -178.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.5 m -86.31 113.2 51.09 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.7 Cg_exo -69.83 71.94 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.42 2.747 . . . . 0.0 111.589 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -161.56 1.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -92.85 168.27 11.29 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.799 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.544 HG21 HG13 ' A' ' 59' ' ' ILE . 8.6 mm -54.71 -48.72 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 122.781 0.432 . . . . 0.0 111.076 -174.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 120.45 20.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.488 -177.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -80.97 171.22 15.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.053 0.454 . . . . 0.0 110.039 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.228 -179.808 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.64 27.26 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 69.93 -73.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.632 0.773 . . . . 0.0 111.452 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -150.31 20.06 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 109.843 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -95.86 153.18 17.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -160.34 161.69 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.596 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 17.2 t60 56.45 71.5 0.56 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.355 0.598 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -114.4 105.48 13.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.661 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.42 151.97 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 91.39 174.4 43.35 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.769 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 56.3 p 50.56 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.62 0.768 . . . . 0.0 112.091 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.43 130.85 22.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.584 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.75 -48.04 7.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.42 0.629 . . . . 0.0 109.336 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 p -120.49 152.47 37.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.243 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.04 -45.18 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.721 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.78 48.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.544 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -54.34 134.42 45.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.46 0.648 . . . . 0.0 110.964 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -70.41 -46.79 63.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.131 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -54.67 144.38 22.11 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.749 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -125.65 130.27 51.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 tp -140.67 140.5 34.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.867 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 13' ' ' THR . 15.6 mt -140.02 167.93 18.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 12' ' ' ILE . 30.4 p 64.04 99.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.844 0.831 . . . . 0.0 111.224 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -94.51 166.41 15.35 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.526 -174.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 65.5 Cg_exo -42.82 134.54 5.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.056 2.504 . . . . 0.0 112.804 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -53.02 138.19 31.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -117.28 -161.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.682 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.13 -173.33 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.469 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 6.4 p-10 -60.45 -73.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 15.4 m-20 -139.21 141.54 37.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.49 165.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.941 0.776 . . . . 0.0 111.32 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 22' ' ' TYR . 8.4 m-85 -132.35 -23.98 2.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.308 -170.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.93 173.98 46.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.368 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.2 155.53 9.05 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 C-N-CA 124.124 3.216 . . . . 0.0 111.882 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.28 -21.08 0.36 Allowed 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.769 3.646 . . . . 0.0 115.737 -170.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.5 m -75.16 -59.44 2.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 10.8 m120 62.29 -178.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 111.812 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.4 132.11 37.03 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 57' ' ' LEU . 19.2 tp -147.02 128.82 15.29 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.791 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 4.3 pt-20 -138.01 99.78 3.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.89 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 30.9 mt -113.34 142.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.801 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -142.21 111.74 6.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.646 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.9 OUTLIER -85.48 136.37 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 171.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 22.9 t 179.79 -163.08 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 38.6 m-80 62.44 79.7 0.26 Allowed Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.191 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -64.83 143.69 80.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.187 2.591 . . . . 0.0 112.574 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -134.15 108.31 8.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.905 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 m -76.11 93.11 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 109.535 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.2 89.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.04 -166.98 32.31 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.955 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 9.9 t -117.41 152.17 19.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.638 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.54 -46.63 4.66 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 121.771 -0.252 . . . . 0.0 113.019 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.18 83.06 2.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.82 40.8 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.316 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.6 ttt180 -89.17 142.05 27.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.76 162.4 36.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.916 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 22.4 m -114.56 126.08 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.9 p -92.22 154.82 18.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.78 136.24 53.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.243 0.544 . . . . 0.0 110.836 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.602 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 28.6 tt0 -93.13 119.4 32.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.769 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.75 115.37 32.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.96 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 29.6 mtp180 -102.37 128.19 49.06 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -137.49 140.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.568 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 11.4 ttmt -128.97 136.28 50.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 63' ' ' LYS . 10.4 t -170.21 164.63 9.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.401 0.619 . . . . 0.0 112.493 -175.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 19.8 p30 -116.29 25.21 10.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.08 164.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.796 HD11 HD22 ' A' ' 29' ' ' LEU . 30.3 mt -58.55 134.38 85.79 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.493 171.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 8.5 Cg_exo -67.79 -36.26 19.06 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.727 2.284 . . . . 0.0 111.475 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 159' ' ' ILE . 1.3 tt -61.03 -40.54 85.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.202 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.66 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 4.9 m-30 -71.1 -18.33 62.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.46 -67.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.28 -1.72 31.13 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.432 -0.167 . . . . 0.0 111.389 -171.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.538 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmtm 68.06 -45.54 0.51 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.07 0.856 . . . . 0.0 112.045 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 1.1 pp20? -159.79 138.96 10.99 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.659 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -170.52 177.54 3.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.602 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 23.9 m -142.26 127.27 18.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.63 172.09 7.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.775 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -140.83 129.1 22.32 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.646 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.1 177.06 9.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.361 179.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 85.5 mtt180 -85.54 168.5 14.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.441 -172.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 46.5 t80 -60.77 -40.56 92.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 55.0 m -61.32 -23.3 65.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 150' ' ' ILE . 6.3 m-20 -72.94 -36.7 67.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 70.9 m-85 -64.54 -40.15 95.08 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 28.9 mt-10 -59.17 -53.43 58.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.608 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -60.65 -31.32 70.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -73.23 -44.67 59.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 39.3 ttt180 -55.82 -61.04 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.017 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -59.42 -35.11 73.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.629 -174.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 6.4 tp10 -64.3 -44.77 90.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.811 0.338 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.1 mt -62.64 -40.59 97.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.581 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.39 -34.66 78.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.209 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 3.2 ppt_? -90.24 -28.76 18.62 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -172.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' HD2' ' A' ' 83' ' ' ARG . 4.8 mm-40 -95.35 -17.29 21.72 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.956 -0.465 . . . . 0.0 112.189 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 87' ' ' VAL . 22.7 t -144.95 178.71 7.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.745 0.783 . . . . 0.0 111.685 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -103.64 19.78 19.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.423 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' A' ' 89' ' ' VAL . 79.3 t -45.41 140.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.563 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.73 37.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.883 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -54.95 121.16 33.73 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.128 -0.358 . . . . 0.0 111.075 -176.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 71.9 Cg_endo -83.47 165.9 14.09 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.324 2.682 . . . . 0.0 113.188 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.19 143.92 79.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.192 2.595 . . . . 0.0 112.686 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 95.8 mt -81.55 141.43 48.72 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.769 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.0 Cg_exo -73.79 114.22 3.98 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.173 2.582 . . . . 0.0 111.998 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.83 38.26 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.72 -34.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 111.428 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.21 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -53.99 -26.78 27.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.094 0.958 . . . . 0.0 113.542 -170.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -62.7 -48.03 81.06 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.82 13.64 23.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -102.15 -29.2 11.87 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.001 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 mt -99.99 165.69 14.11 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.073 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 -153.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.542 2.828 . . . . 0.0 112.231 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -103.05 -78.79 0.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.144 172.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 68.05 -65.81 0.24 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.135 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.8 -155.51 30.92 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.053 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -62.54 -30.83 71.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 111.143 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.65 -47.08 0.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.32 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.93 -9.57 1.8 Allowed Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.406 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 30.8 pt -65.46 -17.58 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.175 -0.512 . . . . 0.0 112.169 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -86.92 39.49 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.375 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.99 136.12 54.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.76 -21.52 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -170.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 38.2 m-80 -71.05 -60.42 2.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -45.77 -49.98 14.43 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.646 0.591 . . . . 0.0 111.263 178.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.05 -46.84 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -83.42 -17.85 40.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.519 -178.329 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 28.5 mt-10 -80.51 -30.35 37.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 109.89 -176.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -80.02 -29.37 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.69 -52.5 63.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.108 178.082 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.662 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 10.3 pt20 -59.92 -38.5 82.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.312 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.44 -42.2 65.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.882 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -69.54 -30.77 68.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 117.794 0.797 . . . . 0.0 111.313 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HA ' HG13 ' A' ' 33' ' ' VAL . 10.8 pt-20 -74.05 -33.74 63.81 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 6.2 mm100 -59.84 -60.56 3.64 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.47 ' O ' HG13 ' A' ' 129' ' ' VAL . 9.7 t80 -48.34 -52.76 20.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.577 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.2 tp -66.11 -34.76 72.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.625 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' HB ' ' A' ' 31' ' ' ILE . 5.6 m-20 -61.37 -21.23 63.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -88.02 -59.42 2.25 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.689 0.757 . . . . 0.0 110.33 175.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.623 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.75 -11.94 11.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.477 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.01 8.08 20.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.64 15.66 1.61 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.977 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 69.8 t60 -101.09 142.07 23.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.1 Cg_endo -47.93 -44.03 28.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.375 2.717 . . . . 0.0 113.193 -170.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -73.56 -25.67 60.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.161 -175.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -82.44 -42.81 18.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.632 -176.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.4 mm100 -65.21 -7.08 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.468 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 8.9 t-20 -91.11 -18.87 23.81 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.969 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 36.5 mm-40 -105.01 129.81 53.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.724 -168.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.523 ' HA ' HD13 ' A' ' 159' ' ' ILE . 21.1 tpt180 -54.59 -28.54 46.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.653 -172.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' MET . 2.3 p -60.71 -18.6 55.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.512 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -72.13 -32.58 67.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.935 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 58.8 t-80 -66.33 -34.05 77.12 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.484 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -81.35 -27.31 34.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.344 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.555 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 32.5 t80 -73.91 -52.31 13.33 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 60' ' ' PHE . 4.3 mp -96.41 -24.43 16.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.438 -173.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 29.1 mt-30 -118.92 -169.79 1.79 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.015 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 61.66 -88.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.604 0.565 . . . . 0.0 110.493 -174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.464 ' HG3' HG13 ' A' ' 149' ' ' ILE . 5.8 tp10 -179.41 -58.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.687 0.756 . . . . 0.0 109.509 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.11 154.27 35.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.562 -175.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 143' ' ' MET . 90.7 mt -85.75 115.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -98.05 105.3 17.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.829 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -73.07 3.03 5.96 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.601 0.715 . . . . 0.0 111.43 -171.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.6 m -110.45 15.62 22.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.126 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.7 OUTLIER -67.65 -171.61 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.824 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 52.4 m -83.13 111.68 32.52 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.347 177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -72.83 77.01 2.36 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 123.329 2.686 . . . . 0.0 111.801 175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -147.69 -154.34 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.694 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 15.7 mmmt -95.6 161.72 13.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.594 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.563 HG21 HG13 ' A' ' 59' ' ' ILE . 19.5 mm -56.41 -48.75 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.825 0.345 . . . . 0.0 110.167 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -88.17 103.27 15.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -69.53 170.91 9.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -171.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.142 -176.677 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.897 0.38 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.36 -179.97 45.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.375 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 15.4 Cg_endo -55.69 157.61 15.38 Favored 'Trans proline' 0 C--O 1.225 -0.134 0 C-N-CA 124.142 3.228 . . . . 0.0 111.963 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 48.0 Cg_exo -56.49 -9.03 3.23 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.916 3.078 . . . . 0.0 114.462 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.5 t -73.32 -54.28 8.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.632 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.6 m120 58.14 -178.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.434 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -97.36 138.52 34.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.694 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -148.17 132.95 17.95 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.552 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -146.92 106.87 3.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.681 HG12 ' HB ' ' A' ' 53' ' ' VAL . 36.0 mt -115.36 147.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.209 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.62 111.61 7.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -88.97 131.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -179.33 -165.7 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 37.6 m-80 58.21 67.36 2.24 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-O 121.123 0.487 . . . . 0.0 110.388 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 115' ' ' ILE . 72.4 Cg_endo -72.74 152.77 53.42 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.933 2.422 . . . . 0.0 113.532 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.8 tp60 -138.93 111.57 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.322 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.411 HG22 ' NE ' ' A' ' 45' ' ' ARG . 68.0 m -78.92 90.22 4.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.856 0.836 . . . . 0.0 110.25 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.0 OUTLIER -116.9 96.82 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.353 -174.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.64 -167.53 31.97 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.525 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.6 t -98.7 152.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-O 119.419 -0.324 . . . . 0.0 110.52 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.16 -46.57 8.15 Favored Glycine 0 N--CA 1.46 0.248 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.321 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -100.2 84.84 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.23 0.538 . . . . 0.0 109.852 172.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.58 37.29 0.79 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.274 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.578 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 21.1 ttt180 -83.38 130.32 35.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.8 0.333 . . . . 0.0 110.379 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -122.52 159.17 28.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.1 m -111.95 127.32 55.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.483 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 43.4 p -92.5 152.36 19.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.293 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -119.62 140.5 50.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 32.9 tt0 -90.89 119.48 31.12 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.67 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.0 mp -94.39 111.98 26.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.069 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 58.9 mtp85 -104.79 134.86 47.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -144.64 141.57 23.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.1 ttmt -127.39 135.95 51.19 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.072 169.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 63' ' ' LYS . 15.0 t -171.23 163.86 7.17 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.514 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.557 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.98 27.25 9.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.836 169.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.38 139.06 94.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.029 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.13 -12.27 19.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.151 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -89.67 -41.22 13.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.432 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.528 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.3 m-85 -65.37 -13.53 58.81 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 71.35 -66.5 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.77 -2.85 58.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 122.174 -0.329 . . . . 0.0 110.462 -172.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmpp? 70.45 -46.18 0.61 Allowed 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.129 0.893 . . . . 0.0 111.545 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -158.41 118.98 3.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.893 0.854 . . . . 0.0 110.905 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 t -155.58 179.33 9.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.517 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.477 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 14.2 m -141.36 137.02 32.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 m -125.96 175.62 7.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.452 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -145.72 118.59 8.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.729 0.3 . . . . 0.0 110.855 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.657 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -151.9 173.53 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' OD2' ' A' ' 73' ' ' ASP . 20.6 ptt180 -99.32 170.54 8.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -164.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.489 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 33.7 t80 -53.88 -38.71 65.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.488 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.606 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 29.9 m -59.38 -25.24 64.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.776 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 20.7 m-20 -80.5 -35.18 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 57.0 m-85 -59.48 -38.86 81.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.445 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 20.1 mt-10 -61.68 -53.24 58.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.56 0.695 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.523 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -68.25 -23.46 64.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.206 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.749 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -71.95 -42.95 65.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -55.31 -60.58 3.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.815 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.728 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.5 p -64.2 -35.37 80.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.371 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 4.6 mm-40 -59.37 -37.25 77.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.408 HD13 HG11 ' A' ' 87' ' ' VAL . 95.2 mt -73.36 -27.8 61.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.058 0.456 . . . . 0.0 110.656 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.38 -18.33 36.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.355 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.0 mmm180 -58.84 -61.7 2.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -119.64 0.05 10.88 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -125.43 166.99 15.6 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.778 0.799 . . . . 0.0 111.911 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.51 30.41 3.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.47 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 97.2 t -52.49 141.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.873 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 88' ' ' VAL . 4.0 p -66.42 27.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.882 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.5 OUTLIER -57.88 120.33 41.31 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 121.809 -0.557 . . . . 0.0 111.777 -174.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 97.4 Cg_endo -88.58 168.25 5.99 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.005 2.47 . . . . 0.0 112.147 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 146.06 75.81 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 112.184 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 75' ' ' GLU . 80.1 mt -69.26 152.02 96.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.15 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.53 109.98 2.97 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.965 2.443 . . . . 0.0 111.932 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.61 176.82 44.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.081 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.2 31.49 16.56 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.567 0.699 . . . . 0.0 110.346 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.7 -85.23 0.59 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.912 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -61.76 -18.19 58.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.327 -177.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.9 mm? -69.6 -44.14 71.34 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 -174.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -90.45 17.88 6.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 109.844 176.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.2 tt0 -118.5 -39.88 2.97 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.689 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 mt -92.83 171.76 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.998 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.14 -172.86 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.737 2.291 . . . . 0.0 111.732 171.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 61.5 m-85 -105.65 -86.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.655 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 65.19 -75.57 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.677 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.78 64.82 3.62 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.376 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.2 t70 65.93 -69.96 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.324 1.05 . . . . 0.0 110.331 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.53 -23.97 12.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.128 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 113.78 7.28 20.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.124 -174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.764 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.8 pt -71.95 -19.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.886 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.92 -12.04 60.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.791 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.37 135.19 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.471 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.69 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 48.3 m-80 -73.52 -58.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.764 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -50.65 -48.18 58.31 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.526 0.516 . . . . 0.0 111.192 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 36' ' ' PRO . 37.5 mt -51.76 -48.38 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.433 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.14 -20.51 59.36 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.262 -177.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 29.9 mm-40 -71.88 -32.79 67.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.209 0.528 . . . . 0.0 109.762 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 43.5 ttp180 -81.93 -34.34 29.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.237 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.02 -50.05 71.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.524 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.748 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -59.47 -39.97 85.42 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.166 -175.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.5 -36.54 23.08 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.443 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.656 ' HB3' HG21 ' A' ' 33' ' ' VAL . 4.6 tp -64.24 -36.61 84.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.435 0.16 . . . . 0.0 111.037 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 33' ' ' VAL . 13.1 pt-20 -75.65 -29.99 59.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.7 mm-40 -64.01 -53.61 47.32 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.6 t80 -49.9 -54.55 18.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.287 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.1 tp -64.67 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.865 -172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -62.21 -16.96 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.16 -0.338 . . . . 0.0 111.825 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.463 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.1 mttm -89.92 -58.65 2.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.038 0.923 . . . . 0.0 110.568 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 89' ' ' VAL . 1.3 m -66.05 -13.51 15.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.027 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.92 10.28 20.62 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.405 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -136.16 2.25 3.54 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.436 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.68 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 35.1 t60 -99.91 144.36 28.22 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 117.185 0.492 . . . . 0.0 111.74 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.68 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.8 Cg_exo -39.64 -50.52 3.1 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.578 3.519 . . . . 0.0 113.879 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.37 -30.14 68.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.522 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -78.03 -39.99 40.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.25 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 53.8 mm-40 -65.56 -6.38 10.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.584 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -108.7 6.07 25.39 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.974 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 138' ' ' GLU . 5.1 mm-40 -118.48 129.18 55.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.824 0.345 . . . . 0.0 111.128 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -54.21 -20.41 6.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.518 -176.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.5 m -53.45 -35.81 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.432 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.5 mp -69.95 -33.53 72.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.238 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 37.1 t-80 -56.88 -39.72 74.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.132 0.491 . . . . 0.0 110.249 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.571 ' HG3' HG13 ' A' ' 150' ' ' ILE . 2.5 ptm -79.96 -28.57 39.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.081 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.749 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.26 -47.81 14.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -93.98 -19.91 20.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.113 -174.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 7.6 mt-30 -119.95 -172.61 2.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.151 -168.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 53.06 -116.75 1.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.257 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -134.89 -35.15 0.87 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.701 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.98 162.65 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.75 0.786 . . . . 0.0 112.868 -167.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.571 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -74.82 115.65 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.895 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.32 112.89 24.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.844 0.354 . . . . 0.0 110.186 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 27.1 mmtp -75.69 11.04 1.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -172.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.0 m -129.08 19.21 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.212 0.53 . . . . 0.0 110.297 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -174.2 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.16 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.0 m -90.89 112.49 53.79 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.161 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.72 76.68 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 123.453 2.768 . . . . 0.0 112.111 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -146.82 -161.78 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.448 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.1 mmmt -85.93 165.07 17.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -60.54 -40.92 85.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.217 0.532 . . . . 0.0 110.261 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 79.6 m-85 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.44 174.75 46.95 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.602 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.69 158.62 19.51 Favored 'Trans proline' 0 C--O 1.222 -0.276 0 C-N-CA 124.336 3.358 . . . . 0.0 111.174 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.63 -14.67 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.418 3.412 . . . . 0.0 115.206 -171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 p -68.63 -62.45 1.38 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 58.13 -177.37 0.07 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.262 0.553 . . . . 0.0 111.902 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -99.47 138.17 36.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 57' ' ' LEU . 15.9 tp -145.58 132.33 20.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.057 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.73 106.05 3.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.174 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.2 mt -114.55 142.87 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.058 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -136.55 118.47 15.24 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -100.23 135.04 37.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 36.2 t 178.85 -161.97 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 31.7 m-80 62.5 73.42 0.54 Allowed Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 110.46 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HG3' HG21 ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.01 131.85 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.802 2.335 . . . . 0.0 112.865 -173.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 47.6 tp60 -117.02 112.34 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.14 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.9 m -73.17 104.04 4.1 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.42 90.66 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.268 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.22 -167.57 33.24 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.814 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.4 t -100.71 147.98 7.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 119.278 -0.392 . . . . 0.0 110.134 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.34 5.55 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 121.59 -0.338 . . . . 0.0 113.152 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -103.96 88.62 3.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.462 0.649 . . . . 0.0 109.416 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.37 32.35 0.98 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.725 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.592 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 8.9 ttp180 -84.34 152.21 24.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.403 0.281 . . . . 0.0 110.304 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.14 162.3 35.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.747 0.308 . . . . 0.0 110.359 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -113.92 131.35 56.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.608 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 15.9 p -99.64 153.39 19.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.54 144.97 43.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.237 0.541 . . . . 0.0 110.627 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 35.9 tt0 -95.79 123.2 39.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.347 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.55 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -96.72 117.84 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.276 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 94.6 mtt180 -110.5 109.81 20.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.407 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -119.46 137.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.013 0.435 . . . . 0.0 111.993 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -125.89 134.97 51.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.307 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.4 t -170.31 165.95 8.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.288 0.566 . . . . 0.0 111.626 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -120.45 26.26 9.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.119 168.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.667 HD11 HD22 ' A' ' 29' ' ' LEU . 20.9 mt -60.62 143.36 90.54 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.192 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.84 -29.64 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.431 2.088 . . . . 0.0 111.711 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.545 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.29 -40.19 79.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.95 178.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.616 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.4 m-30 -69.1 -19.98 64.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.49 -64.33 0.39 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.11 -7.66 59.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 122.182 -0.324 . . . . 0.0 110.833 -172.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 5.6 mmtp 70.68 -43.43 0.55 Allowed 'General case' 0 C--O 1.218 -0.578 0 O-C-N 124.014 0.822 . . . . 0.0 111.163 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.58 130.82 5.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 109.998 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.2 t -160.43 165.85 30.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.609 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 37.7 m -140.5 130.4 24.58 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.292 0.568 . . . . 0.0 110.853 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 147' ' ' ASP . 5.8 m -133.47 174.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -144.06 122.88 12.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.197 0.522 . . . . 0.0 111.567 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -145.05 -177.66 5.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -100.66 167.57 10.25 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -169.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.7 t80 -55.09 -34.38 63.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.42 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 16.9 m -55.03 -33.58 62.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.738 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -75.06 -38.14 61.45 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 59.9 m-85 -60.12 -37.47 80.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.644 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 25.7 mt-10 -62.52 -55.07 30.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.752 0.787 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -64.9 -28.64 69.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.436 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -69.35 -40.73 77.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 63.9 ttt180 -57.95 -64.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.446 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.722 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -61.28 -37.17 82.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.014 -172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.19 -44.73 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.373 0.42 . . . . 0.0 111.431 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.37 -37.06 85.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.73 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -73.82 -24.95 59.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.138 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 79' ' ' SER . 25.1 mmt180 -67.98 -62.53 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.063 0.459 . . . . 0.0 111.816 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -85.46 -30.05 23.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.323 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 m -120.66 175.03 6.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.654 0.74 . . . . 0.0 112.004 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -105.0 23.6 13.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.738 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 89' ' ' VAL . 97.6 t -42.6 140.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.846 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -69.19 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.371 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.2 t -56.07 121.65 42.65 Favored Pre-proline 0 N--CA 1.464 0.268 0 O-C-N 121.945 -0.472 . . . . 0.0 110.836 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 89.0 Cg_endo -88.28 166.4 6.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.904 2.403 . . . . 0.0 112.302 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.66 150.82 87.55 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.867 2.378 . . . . 0.0 112.459 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 49.6 mt -80.51 153.39 73.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.436 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -88.44 109.27 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.912 2.408 . . . . 0.0 112.289 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.12 59.15 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.443 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -144.55 -25.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.778 0.323 . . . . 0.0 111.4 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.85 -82.32 0.29 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.573 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -49.94 -24.5 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.951 1.3 . . . . 0.0 114.14 -171.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.6 mm? -59.34 -45.16 92.15 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.915 0.388 . . . . 0.0 111.221 -173.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -99.53 20.65 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.716 0.769 . . . . 0.0 109.432 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -118.1 -28.31 5.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.866 -176.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 mt -101.67 169.16 8.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.25 -161.38 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.898 2.399 . . . . 0.0 112.484 173.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.443 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 37.9 m-85 -106.97 -80.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.608 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 68.38 -64.99 0.28 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.538 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -113.86 79.07 0.27 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.431 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.64 -71.41 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.056 0.943 . . . . 0.0 111.911 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.9 -32.11 7.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.842 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 123.3 4.42 8.35 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.936 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 45.8 pt -73.09 -15.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 54.5 m-85 -79.88 -15.1 58.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.97 134.48 36.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.992 0.425 . . . . 0.0 110.245 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.97 -24.7 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.67 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.604 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 42.7 m-80 -65.64 -57.71 7.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -51.34 -51.03 58.08 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.661 0.601 . . . . 0.0 110.879 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HG3' ' A' ' 36' ' ' PRO . 23.7 mt -50.59 -50.35 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.995 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.55 -20.59 58.55 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.883 -177.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 37.3 mm-40 -74.25 -33.64 63.38 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.166 0.508 . . . . 0.0 109.95 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 37.5 ttm180 -80.63 -33.68 35.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -55.89 -50.88 69.45 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.551 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.73 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.6 -41.91 95.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.844 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.0 -34.5 33.47 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.439 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 4.2 tp -67.52 -36.59 81.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.025 -0.103 . . . . 0.0 111.243 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.588 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.8 pt-20 -72.77 -33.33 66.24 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.73 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 15.6 mm-40 -60.45 -58.44 8.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.573 ' O ' HG13 ' A' ' 129' ' ' VAL . 15.0 t80 -47.57 -55.43 9.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.443 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -63.93 -39.49 85.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.83 -172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -61.62 -20.27 63.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.017 0.437 . . . . 0.0 111.986 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 35.1 mttm -90.18 -56.36 3.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.939 0.876 . . . . 0.0 110.641 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 125' ' ' PHE . 1.2 m -65.84 -13.15 15.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.002 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -110.11 7.61 23.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.088 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -141.14 12.36 2.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.463 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 57.7 t60 -100.32 139.8 20.96 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 122.397 -0.472 . . . . 0.0 110.499 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.622 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 6.8 Cg_exo -41.38 -47.1 5.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.21 3.273 . . . . 0.0 113.888 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -70.81 -32.55 69.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.102 -176.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.62 -42.47 51.61 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.716 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -66.0 -6.57 13.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.141 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.587 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -99.61 -10.04 22.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.464 179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 5.5 mm-40 -106.61 131.87 53.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 111.967 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 159' ' ' ILE . 16.3 tpt180 -58.24 -19.08 31.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.852 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.629 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 0.7 OUTLIER -63.97 -24.17 67.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.0 110.965 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.1 mp -75.55 -31.23 59.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.553 -0.717 . . . . 0.0 110.999 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 65.0 t-80 -57.61 -38.3 74.7 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.629 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 4.0 ptm -80.47 -26.76 38.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.559 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.652 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.14 -53.74 6.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -78.78 -36.31 43.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.357 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 11.6 mt-30 -95.3 166.67 11.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' HG11 ' A' ' 67' ' ' VAL . 46.1 m-20 61.96 -179.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.638 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.17 -35.25 14.65 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.048 0.928 . . . . 0.0 110.392 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -134.8 152.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.182 -165.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.624 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.2 mp -81.72 116.05 25.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.64 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.19 101.58 6.24 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.054 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -71.77 11.34 0.52 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.0 m -130.28 19.17 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 110.657 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.18 -171.43 0.05 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.534 0.683 . . . . 0.0 112.122 -179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 87.4 m -88.48 113.01 53.64 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.161 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.65 65.64 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.442 2.761 . . . . 0.0 112.303 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -140.59 -154.04 0.5 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.626 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.587 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 20.9 mmmt -86.24 158.98 19.59 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.475 -0.14 . . . . 0.0 110.75 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.545 HG13 HD12 ' A' ' 59' ' ' ILE . 16.7 mm -51.41 -52.44 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.422 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.337 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 2.6 m-85 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.219 0.533 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.52 175.5 43.91 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.425 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.33 154.71 10.73 Favored 'Trans proline' 0 C--O 1.224 -0.224 0 C-N-CA 124.0 3.133 . . . . 0.0 111.34 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.98 -11.82 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 124.483 3.455 . . . . 0.0 115.161 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -74.06 -61.89 1.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 32.2 m-80 58.84 -178.58 0.08 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.489 0.493 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -91.43 125.52 36.21 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 57' ' ' LEU . 13.1 tp -138.14 129.09 27.06 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.88 -176.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -140.32 104.36 4.77 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.093 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.664 HG12 ' HB ' ' A' ' 53' ' ' VAL . 47.9 mt -114.69 141.49 31.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.182 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.8 117.57 14.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.996 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -98.62 132.42 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t 179.52 -162.56 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.2 m-80 63.58 77.44 0.32 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 115' ' ' ILE . 69.5 Cg_endo -73.98 142.17 30.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.392 2.061 . . . . 0.0 113.051 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -131.9 111.22 11.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.059 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.0 101.57 4.52 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.3 88.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.426 0.632 . . . . 0.0 110.235 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.44 -167.62 33.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.837 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.2 t -111.35 156.28 12.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.144 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.41 -49.04 6.98 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.465 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -99.08 85.1 3.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.084 0.469 . . . . 0.0 109.744 171.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.42 38.99 0.64 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.565 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 10.1 ttt180 -89.49 140.46 29.5 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.24 154.82 42.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.844 0.355 . . . . 0.0 110.759 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 m -110.57 122.97 49.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 p -92.55 155.91 17.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.859 0.361 . . . . 0.0 110.829 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 80.5 m-85 -119.12 141.42 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.728 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 31.3 tt0 -90.64 123.62 34.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.349 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -102.73 115.6 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.41 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 57.4 mtp180 -105.52 139.41 40.17 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.556 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -146.39 140.7 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -128.83 143.08 50.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.039 165.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.407 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 15.0 t -172.9 164.46 5.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.912 0.387 . . . . 0.0 111.964 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.52 31.12 6.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.628 0.728 . . . . 0.0 110.137 166.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.81 HD11 HD22 ' A' ' 29' ' ' LEU . 23.2 mt -67.86 145.2 97.83 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.273 174.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.53 -28.53 5.38 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.598 2.199 . . . . 0.0 111.777 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.94 -41.36 79.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.878 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.3 m-30 -69.96 -33.0 71.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.593 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.1 tmmm? 75.11 -58.13 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.582 0.551 . . . . 0.0 112.101 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.75 -14.83 60.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 122.284 -0.26 . . . . 0.0 111.039 -172.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp 73.66 -38.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.851 0.719 . . . . 0.0 110.857 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.62 140.25 30.04 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.411 0.624 . . . . 0.0 109.956 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -160.28 151.55 19.37 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.109 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.9 m -140.39 133.95 30.14 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.021 0.439 . . . . 0.0 109.935 173.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 21.0 m -129.96 179.52 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.624 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 36.3 ttm180 -145.96 101.83 3.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.585 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 mmp_? -122.95 172.61 8.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.137 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -88.83 161.83 16.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.539 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 38.5 t80 -55.26 -37.53 67.37 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.428 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 35.5 m -61.99 -26.17 68.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.648 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.8 -36.42 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 52.1 m-85 -66.46 -39.89 89.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.998 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.9 mt-10 -57.06 -56.94 15.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.585 0.707 . . . . 0.0 110.826 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.45 ' CD1' HG21 ' A' ' 150' ' ' ILE . 4.7 t-105 -63.33 -34.09 76.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.733 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -69.19 -43.97 73.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 31.8 ttt180 -57.54 -59.52 5.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.797 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -60.58 -32.95 72.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.301 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.7 mm-40 -63.14 -46.37 87.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.014 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 85' ' ' SER . 88.8 mt -71.06 -16.31 62.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.0 110.755 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 47.5 mt-10 -87.73 -50.08 6.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.107 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 1.5 ppt_? -62.2 -21.79 65.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -165.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 9.5 pt-20 -138.12 -34.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.282 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.92 158.85 33.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.203 0.525 . . . . 0.0 110.476 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -96.53 17.86 15.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.238 0.542 . . . . 0.0 109.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 135' ' ' ALA . 90.7 t -56.06 140.24 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.93 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -75.53 37.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.611 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.528 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -51.69 118.72 12.01 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.411 -175.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 128' ' ' LYS . 6.3 Cg_exo -72.43 160.56 46.53 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.495 2.797 . . . . 0.0 112.525 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 142.2 42.3 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.876 2.384 . . . . 0.0 111.983 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.1 mt -69.37 150.57 97.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 27.5 Cg_endo -86.49 109.65 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.881 2.388 . . . . 0.0 111.957 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.63 -174.53 27.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.078 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' N ' HD23 ' A' ' 98' ' ' LEU . 51.8 tttp 71.09 -55.25 0.65 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.824 . . . . 0.0 112.035 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -47.61 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -73.36 -18.17 61.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.482 -170.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.1 mm? -69.14 -44.34 72.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.772 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -95.96 26.48 4.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.536 0.684 . . . . 0.0 110.178 176.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -116.69 -41.51 3.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 62.6 mt -80.57 163.6 55.7 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.62 147.35 86.15 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.961 2.441 . . . . 0.0 111.499 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -104.76 94.82 5.49 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -125.76 -30.88 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.094 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.65 -167.31 43.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.439 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.9 -47.89 76.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.273 0.558 . . . . 0.0 110.936 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -136.41 -51.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.997 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.36 -10.38 1.3 Allowed Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.206 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.783 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.8 pt -65.53 -16.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 111.928 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -81.22 -16.12 53.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.357 0.599 . . . . 0.0 110.119 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.42 122.16 28.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.68 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.64 -27.0 64.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.581 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 14.3 m120 -55.09 -60.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.487 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.783 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -54.84 -47.71 73.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.51 0.506 . . . . 0.0 110.895 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 36' ' ' PRO . 47.9 mt -51.47 -51.27 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.275 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -73.11 -22.33 60.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.48 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 66.2 mm-40 -74.87 -32.45 61.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.802 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 14.7 tpp180 -78.97 -35.49 42.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.58 -54.01 51.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.467 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.712 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -59.33 -40.41 86.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.998 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -34.84 32.91 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.133 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.12 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.732 0.266 . . . . 0.0 111.298 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.612 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -73.43 -32.43 64.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.4 mm-40 -62.31 -58.17 8.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 7.1 t80 -48.89 -53.27 20.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.613 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.34 -41.05 90.36 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.776 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.97 -19.72 45.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 111.809 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.448 ' HD2' ' HG2' ' A' ' 90' ' ' PRO . 31.8 mttm -90.72 -58.83 2.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.76 0.791 . . . . 0.0 110.66 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.32 -13.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.023 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.18 10.93 21.85 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.981 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.89 8.64 1.3 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.796 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.772 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 59.2 t60 -98.42 144.97 29.06 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 117.217 0.509 . . . . 0.0 110.214 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.772 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.0 Cg_exo -41.9 -48.86 5.89 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.23 3.286 . . . . 0.0 113.775 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -71.09 -38.91 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.777 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -69.14 -41.49 77.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.359 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.45 ' O ' HD12 ' A' ' 59' ' ' ILE . 6.1 mm-40 -65.93 -4.13 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.194 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 0.3 OUTLIER -106.46 -7.95 17.34 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.875 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.2 mm-40 -106.51 135.14 48.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.01 -0.431 . . . . 0.0 110.998 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -57.02 -17.68 10.89 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.621 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.3 m -58.3 -30.0 66.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.317 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 135' ' ' ALA . 6.5 mp -74.78 -29.97 61.29 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.22 -0.3 . . . . 0.0 111.357 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -58.51 -43.57 89.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.308 0.575 . . . . 0.0 109.864 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.627 ' HE2' HG23 ' A' ' 150' ' ' ILE . 5.3 ptm -77.84 -31.22 51.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.188 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 5.0 t80 -77.45 -41.31 40.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.109 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.445 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.9 mt -98.29 -47.5 5.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 112.005 -169.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -81.03 -46.39 15.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.014 -171.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.65 154.96 20.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.182 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.7 pm0 -66.42 -29.51 69.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.739 0.781 . . . . 0.0 110.164 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.567 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -134.22 132.37 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.07 -167.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.627 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.3 mp -70.66 105.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.282 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.51 99.41 10.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.048 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' A' ' 150' ' ' ILE . 2.0 mptt -71.86 11.61 0.5 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 112.309 -173.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.1 t -111.99 11.28 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.665 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.281 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 50.4 m -94.3 114.32 63.02 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.784 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 21.9 Cg_exo -68.88 68.44 1.22 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.432 2.755 . . . . 0.0 112.067 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -140.24 -159.39 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.626 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 6.6 mmmm -88.25 158.91 18.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 59' ' ' ILE . 16.5 mm -50.35 -46.29 25.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.679 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 110.28 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.17 172.0 15.48 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.725 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.04 159.43 9.68 Favored 'Trans proline' 0 C--O 1.222 -0.31 0 C-N-CA 124.201 3.267 . . . . 0.0 111.591 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.99 -24.87 0.47 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.421 3.414 . . . . 0.0 115.452 -170.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -70.53 -62.29 1.44 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.26 0.224 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.8 m-80 61.81 -178.67 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.212 0.53 . . . . 0.0 111.632 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -97.3 140.49 31.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 13.4 tp -147.11 130.58 16.73 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.429 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.87 103.64 4.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.663 HG12 ' HB ' ' A' ' 53' ' ' VAL . 32.8 mt -115.43 143.29 25.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.01 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.84 115.68 10.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.769 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -99.25 132.52 44.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.8 t 179.31 -163.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.4 m-80 61.94 81.6 0.23 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 121.124 0.488 . . . . 0.0 110.47 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.67 152.92 59.57 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.724 2.283 . . . . 0.0 113.541 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.1 tp60 -144.84 107.78 4.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.007 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.1 m -76.52 104.3 6.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.4 p -130.86 88.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.706 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.5 -168.17 34.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.0 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.4 t -102.11 158.32 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.068 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.91 -49.78 6.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.972 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.82 87.03 4.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.118 0.485 . . . . 0.0 109.803 169.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.26 34.54 0.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.971 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.6 ttt180 -89.46 126.12 35.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -131.76 156.7 45.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.5 m -107.72 124.74 50.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.368 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 70' ' ' ARG . 32.0 p -92.09 162.43 14.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.52 139.43 53.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.4 tt0 -91.11 118.35 30.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.571 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.8 mp -93.0 116.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 76.0 mtp180 -105.87 131.87 52.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.971 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.663 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.99 138.39 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 16.4 ttmt -127.81 137.01 52.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.133 169.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 63' ' ' LYS . 13.3 t -170.31 163.74 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.272 0.558 . . . . 0.0 112.147 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -118.91 22.54 11.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.203 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.701 HD11 HD22 ' A' ' 29' ' ' LEU . 21.4 mt -56.3 146.71 51.11 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.723 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -9.7 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.503 2.135 . . . . 0.0 111.918 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.575 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -88.49 -40.56 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.416 -177.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.542 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.9 m-30 -69.86 -17.36 63.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' HD13 ' A' ' 62' ' ' LEU . 35.7 ttpt 75.21 -71.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -75.91 -1.45 25.5 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -169.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mmtm 68.31 -48.09 0.54 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.092 0.87 . . . . 0.0 111.6 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 2.7 pp20? -156.59 140.36 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.833 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -168.71 174.97 6.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.345 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.0 m -141.12 135.62 31.1 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.238 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -145.4 130.62 13.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.926 -173.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 31.6 ttm180 -97.93 110.89 23.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.39 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.701 HH11 HD12 ' A' ' 150' ' ' ILE . 41.4 mtt-85 -125.64 177.01 6.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.158 -172.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' A' ' 48' ' ' THR . 67.0 mtp180 -92.81 156.5 16.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.823 0.344 . . . . 0.0 111.779 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.5 t80 -59.63 -34.13 72.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t -58.26 -33.4 69.36 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.924 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HB ' ' A' ' 150' ' ' ILE . 25.5 m-20 -65.13 -45.24 85.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 60.6 m-85 -59.81 -40.55 88.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.514 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.1 mt-10 -57.04 -56.3 23.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.391 0.615 . . . . 0.0 111.096 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.449 ' CD1' HG21 ' A' ' 150' ' ' ILE . 0.6 OUTLIER -68.41 -28.98 67.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.525 -178.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.702 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -68.23 -42.77 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 55.8 ttt180 -57.89 -62.52 1.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.278 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -63.15 -27.42 69.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.545 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 12.0 tp10 -68.96 -42.06 77.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 85' ' ' SER . 97.1 mt -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.632 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 25.5 mt-10 -90.18 -41.44 11.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.693 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 3.4 ppt_? -78.67 -35.21 45.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.549 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 6.0 mm-40 -101.73 -26.82 13.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.986 0.422 . . . . 0.0 111.779 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -112.38 167.8 10.15 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.451 -169.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -105.33 21.14 17.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.439 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 81' ' ' LEU . 87.3 t -53.68 144.91 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.907 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.4 p -72.64 31.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.081 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 129' ' ' VAL . 1.4 t -52.42 119.51 15.32 Favored Pre-proline 0 N--CA 1.467 0.407 0 O-C-N 122.228 -0.295 . . . . 0.0 111.367 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -88.21 168.37 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.868 2.379 . . . . 0.0 111.884 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 148.65 84.02 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.503 2.136 . . . . 0.0 112.495 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 75' ' ' GLU . 67.6 mt -77.22 154.83 82.33 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.641 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 61.0 Cg_endo -83.06 142.12 10.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.73 -163.35 36.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.277 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 68.06 -60.53 0.41 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 112.234 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.29 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -62.09 -16.1 49.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.471 -168.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.52 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.2 mm? -69.5 -37.47 77.22 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.597 -174.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 12.81 32.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.316 0.579 . . . . 0.0 109.931 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.4 tp-100 -97.58 -38.97 9.34 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.771 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 76.9 mt -83.07 166.87 32.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.859 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 27.2 Cg_exo -62.2 142.0 90.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.804 2.336 . . . . 0.0 111.553 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.26 5.5 37.98 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.261 0.553 . . . . 0.0 110.876 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -70.33 -14.25 62.5 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.358 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.4 -178.49 38.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.571 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.08 -45.3 94.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -151.38 -27.98 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.884 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 -0.34 12.97 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.6 pt -74.81 -15.39 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -84.22 -7.3 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.382 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.25 135.84 36.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.312 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -30.81 71.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.31 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.63 -58.5 6.74 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -51.5 -48.25 62.97 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.412 0.445 . . . . 0.0 111.101 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.8 mt -50.57 -51.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.218 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.76 -20.62 56.27 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.642 -177.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.566 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 21.2 mm-40 -75.09 -33.27 61.62 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.229 0.538 . . . . 0.0 109.878 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 9.8 tpp180 -78.7 -38.22 39.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.03 -52.27 59.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 -178.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.62 -41.65 95.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.111 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -80.34 -32.25 35.37 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.5 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.5 tp -67.55 -40.45 84.96 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.799 -0.201 . . . . 0.0 111.156 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.6 pt-20 -72.09 -32.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.776 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.7 mm-40 -61.34 -57.75 11.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.3 t80 -50.12 -52.1 37.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.758 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -64.7 -42.04 93.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.928 -170.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -60.64 -17.78 49.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.54 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -88.2 -57.98 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.869 0.842 . . . . 0.0 110.395 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -65.36 -12.83 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.181 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.32 6.25 28.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.366 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.09 15.94 1.52 Allowed Glycine 0 C--N 1.332 0.352 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.883 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 50.1 t60 -100.26 144.38 28.31 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 117.328 0.564 . . . . 0.0 110.385 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 21.2 Cg_exo -38.95 -49.12 2.8 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.403 3.402 . . . . 0.0 113.827 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.69 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -70.94 -39.5 72.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.138 -175.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -68.02 -41.01 82.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.716 -175.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -70.8 4.82 2.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.735 0.779 . . . . 0.0 109.846 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.7 t-20 -119.24 4.3 11.29 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.1 mm-40 -117.26 128.14 54.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.0 tpt180 -54.81 -16.56 2.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.817 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.694 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.9 m -55.5 -28.73 56.38 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.075 0.55 . . . . 0.0 111.461 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.613 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.0 mp -78.75 -29.42 45.19 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.341 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 52.6 t-80 -56.79 -39.55 74.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.7 ptm -79.59 -31.41 41.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.702 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -81.39 -36.12 29.93 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -94.02 -37.7 11.52 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.137 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.2 mt-30 -94.59 174.12 7.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.54 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.0 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.4 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -102.72 -30.71 10.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.55 0.691 . . . . 0.0 110.666 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -138.69 158.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.132 -167.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.701 HD12 HH11 ' A' ' 69' ' ' ARG . 2.2 mp -86.85 123.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.638 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.7 106.53 18.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.215 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 9.4 mptt -77.2 11.24 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.213 0.53 . . . . 0.0 112.158 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 t -126.33 18.01 7.63 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -170.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.277 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 85.5 m -82.26 112.65 37.8 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.458 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 16.9 Cg_exo -72.87 61.34 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.358 2.705 . . . . 0.0 112.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.0 m -136.86 -157.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 122.309 -0.244 . . . . 0.0 110.841 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -87.08 158.82 19.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 119.907 -0.092 . . . . 0.0 110.83 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.575 HG13 HD12 ' A' ' 59' ' ' ILE . 17.5 mm -52.2 -49.95 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.287 0.565 . . . . 0.0 110.539 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.875 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ASN . 38.6 m-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.52 172.36 45.39 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.88 157.47 10.34 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.859 3.039 . . . . 0.0 112.48 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.29 -18.36 0.73 Allowed 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.997 3.798 . . . . 0.0 115.439 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -69.91 -61.58 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.563 HD22 ' ND2' ' A' ' 56' ' ' ASN . 26.8 m120 61.44 164.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.311 0.644 . . . . 0.0 112.675 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -89.65 143.43 26.81 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -147.77 126.66 12.72 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.08 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.2 pt-20 -133.29 100.04 4.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.12 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.68 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.1 mt -113.08 137.55 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.235 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.82 112.9 11.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.345 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -92.68 130.97 40.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 t -179.9 -163.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.1 m-80 60.32 77.22 0.38 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.477 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.58 150.67 86.35 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' THR . 46.8 tp60 -135.75 110.66 8.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.955 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 m -74.56 98.21 3.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 109.41 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -130.12 91.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.51 -167.58 32.72 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.86 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -109.77 148.89 13.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 119.41 -0.328 . . . . 0.0 110.36 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.91 -49.93 4.2 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 121.599 -0.334 . . . . 0.0 112.841 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.59 85.34 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.991 0.425 . . . . 0.0 109.89 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.92 39.02 0.67 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.914 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.3 ttp180 -85.94 150.01 24.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 122.487 0.315 . . . . 0.0 110.252 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -149.83 171.27 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.826 0.346 . . . . 0.0 110.798 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 74.0 m -124.63 126.56 45.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.711 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 21.1 p -92.69 161.53 14.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.66 0.267 . . . . 0.0 110.35 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -123.26 140.98 52.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.297 0.57 . . . . 0.0 110.838 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.1 tt0 -92.4 121.06 33.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.073 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -97.52 119.07 45.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.612 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 93.6 mtt180 -109.18 142.05 40.53 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.36 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.71 142.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -133.81 142.35 47.82 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.527 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.625 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 10.1 t -170.12 163.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.72 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -112.69 20.22 16.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.81 169.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.744 HD11 HD22 ' A' ' 29' ' ' LEU . 30.6 mt -58.71 147.85 69.67 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.4 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -84.6 -30.75 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.808 1.672 . . . . 0.0 112.075 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.26 -43.16 95.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 178.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.8 m-30 -65.7 -33.56 76.17 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 75.54 -53.72 0.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -81.1 -12.12 59.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 122.017 -0.427 . . . . 0.0 110.392 -176.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.625 ' HE2' ' O ' ' A' ' 55' ' ' THR . 10.6 mmmm 68.51 -44.55 0.51 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 124.094 0.871 . . . . 0.0 111.09 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -141.36 141.78 33.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 t -170.48 157.48 5.97 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.129 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.5 m -141.85 130.06 22.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 0.0 110.873 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.7 173.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.599 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 51.8 ttp180 -137.26 109.93 7.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 21.4 mmm180 -127.67 179.6 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.586 -175.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -100.22 165.72 11.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.787 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.1 t80 -53.72 -39.63 65.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.062 174.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.418 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 34.1 m -53.18 -36.65 61.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.622 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 69' ' ' ARG . 4.2 m-20 -64.37 -41.64 96.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -64.44 -37.79 88.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.411 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.654 ' HA ' HD11 ' A' ' 92' ' ' LEU . 27.6 mt-10 -60.12 -55.65 31.24 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.38 0.61 . . . . 0.0 111.19 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 150' ' ' ILE . 3.5 t-105 -67.74 -27.54 66.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.25 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -69.04 -47.47 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.561 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.6 ttt180 -55.68 -61.35 2.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.359 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 t -61.63 -27.71 68.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.382 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.618 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.8 tp10 -73.38 -47.23 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.339 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.96 -35.65 73.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 110.751 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 37.6 mt-10 -64.61 -37.58 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.439 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.451 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.5 ppt_? -91.36 -28.39 17.74 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.39 -30.87 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 87' ' ' VAL . 24.3 t -144.32 -175.11 4.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 110.921 -171.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -100.36 26.81 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.204 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 85' ' ' SER . 74.7 t -52.46 139.68 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.308 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.454 HG12 ' CG ' ' A' ' 132' ' ' HIS . 8.7 p -73.41 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.988 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -53.15 121.32 23.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 O-C-N 122.023 -0.423 . . . . 0.0 110.565 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.0 Cg_endo -85.77 162.94 10.61 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.605 2.203 . . . . 0.0 112.401 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 29.6 Cg_endo -63.57 146.24 92.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.765 2.31 . . . . 0.0 112.191 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 75' ' ' GLU . 97.6 mt -74.3 142.9 79.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.9 Cg_exo -73.94 117.56 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.885 2.39 . . . . 0.0 111.224 176.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.09 61.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.257 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.43 -45.35 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.01 -85.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -49.45 -32.03 11.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.579 1.152 . . . . 0.0 113.979 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -57.46 -47.3 82.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.07 27.83 8.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.618 0.723 . . . . 0.0 110.145 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -122.96 -32.73 3.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.871 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.53 168.12 12.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.31 156.26 66.96 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.865 2.376 . . . . 0.0 111.551 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -79.2 -90.42 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.498 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 64.97 -72.0 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.637 0.586 . . . . 0.0 111.344 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.02 65.16 4.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 66.57 -71.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.297 1.039 . . . . 0.0 111.326 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.83 -19.18 12.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.338 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.28 8.47 31.09 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 50.3 pt -75.56 -17.39 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.819 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -79.35 -15.43 57.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.031 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.8 132.41 41.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.155 0.503 . . . . 0.0 109.884 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.48 -27.3 69.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.717 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 50.2 m-80 -65.83 -52.43 50.63 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -53.95 -49.4 68.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.522 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.6 mt -52.57 -48.7 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.925 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.13 -21.85 59.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.605 -178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 46.8 mm-40 -73.66 -33.86 64.67 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.621 0.724 . . . . 0.0 109.634 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.79 -35.82 43.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.433 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -57.24 -53.12 61.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.11 -178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -61.17 -45.0 96.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.605 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.17 -43.41 95.52 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.804 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -69.51 -32.14 70.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.629 0.715 . . . . 0.0 111.599 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.615 ' HA ' HG22 ' A' ' 126' ' ' ILE . 14.9 pt-20 -74.92 -33.3 61.98 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.0 mm-40 -59.88 -57.64 12.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.513 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.2 t80 -51.68 -53.31 40.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.499 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.9 tp -64.41 -39.95 87.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.018 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.58 -20.49 60.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 112.026 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.0 mttm -88.46 -56.26 3.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.667 0.746 . . . . 0.0 110.899 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.651 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -66.9 -11.73 14.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.025 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.07 -11.7 16.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.499 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.479 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -122.65 -6.17 8.04 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.936 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.6 t60 -84.09 143.55 42.85 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 117.328 0.564 . . . . 0.0 110.633 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 17.2 Cg_exo -39.33 -50.03 2.95 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.514 3.476 . . . . 0.0 113.813 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.42 -30.71 66.38 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.352 -174.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.651 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -77.0 -44.54 30.55 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.45 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.14 -0.76 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.421 176.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 2.5 t30 -104.11 -21.13 13.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.409 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 17.9 mm-40 -102.11 143.12 32.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.905 0.775 . . . . 0.0 112.627 -166.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 139' ' ' ARG . 6.7 tpp85 -62.85 -21.25 65.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.513 -166.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.566 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 1.9 t -60.41 -26.15 66.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.23 0.538 . . . . 0.0 110.076 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 135' ' ' ALA . 4.6 mp -71.48 -28.51 63.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.342 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.82 -47.18 86.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.5 ptm -72.44 -30.64 64.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t80 -75.92 -48.37 21.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.651 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 1.6 mt -96.97 -43.68 7.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.558 . . . . 0.0 111.545 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.668 ' HA ' HD11 ' A' ' 62' ' ' LEU . 54.4 mt-30 -91.43 -15.51 28.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.573 -166.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -111.43 174.64 5.77 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -79.15 -32.72 44.43 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.089 0.947 . . . . 0.0 110.013 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -139.9 143.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.132 -167.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.9 mp -71.58 106.67 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.036 173.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 104.02 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.897 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -69.16 -1.01 6.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.9 p -113.24 18.03 18.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.471 0.653 . . . . 0.0 110.596 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.434 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.3 -171.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.604 178.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.7 m -86.45 112.12 44.06 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.14 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 22.1 Cg_exo -69.38 82.43 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.403 2.735 . . . . 0.0 111.621 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 m -156.73 -153.58 0.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -105.02 177.65 4.79 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.697 177.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 59' ' ' ILE . 17.1 mm -66.78 -36.16 76.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.589 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.496 -174.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.185 0.517 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 -179.68 43.01 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 9.4 Cg_endo -51.44 154.92 7.82 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.531 2.821 . . . . 0.0 111.499 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 51.7 Cg_exo -56.49 -7.71 2.27 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.798 2.998 . . . . 0.0 113.953 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 p -77.12 -53.58 7.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 28.7 m120 62.85 170.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.671 0.607 . . . . 0.0 111.494 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.65 134.9 33.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 57' ' ' LEU . 14.9 tp -142.17 130.25 22.01 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.114 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -141.46 101.11 3.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.824 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.679 HG12 ' HB ' ' A' ' 53' ' ' VAL . 42.9 mt -115.07 140.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -132.59 106.92 8.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.938 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -84.6 130.64 35.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 170.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -179.1 -164.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.4 m-80 59.2 71.75 0.9 Allowed Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 110.284 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.39 133.37 37.15 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.088 2.525 . . . . 0.0 113.487 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 44.0 tp60 -117.65 106.96 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.686 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -78.22 90.1 4.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.554 0.692 . . . . 0.0 109.953 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HE21 ' A' ' 37' ' ' GLN . 1.8 p -117.29 91.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.612 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.45 -166.28 31.53 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.399 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.1 t -101.2 146.94 8.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.346 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.34 -48.13 4.6 Favored Glycine 0 N--CA 1.465 0.584 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.245 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -102.22 88.21 3.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.39 0.614 . . . . 0.0 109.713 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.9 0.93 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.62 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 13.8 ttt180 -85.31 139.86 31.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 39.3 p90 -129.72 153.57 48.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 86.7 m -111.31 124.08 51.5 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.0 p -92.74 153.58 18.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.117 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.26 136.45 51.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.02 0.438 . . . . 0.0 110.765 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 29.3 tt0 -90.58 116.6 28.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 mp -94.27 113.75 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.865 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HG2' ' OG1' ' A' ' 66' ' ' THR . 66.4 mtt180 -105.53 121.98 45.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.843 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -128.9 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.0 111.882 -177.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -127.92 133.74 49.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 7.1 t -168.27 165.44 12.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.595 0.712 . . . . 0.0 112.121 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.94 21.63 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.752 167.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 29' ' ' LEU . 26.7 mt -56.14 131.96 74.81 Favored Pre-proline 0 CA--C 1.521 -0.163 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.801 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 11.7 Cg_exo -66.82 -37.94 18.97 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.413 2.076 . . . . 0.0 111.186 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -58.2 -42.43 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.448 176.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.87 -23.69 64.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.47 -64.57 0.34 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -73.44 -25.68 60.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -174.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' O ' HG22 ' A' ' 55' ' ' THR . 19.2 mmtp 82.02 -34.24 0.1 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.822 171.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.32 125.19 1.82 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.546 0.688 . . . . 0.0 110.08 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 62' ' ' LEU . 16.7 t -170.71 176.13 4.34 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.751 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.57 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 27.9 m -141.73 133.19 26.72 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.5 m -121.3 178.35 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.301 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -143.24 106.08 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -127.41 167.59 16.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.449 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.602 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 58.0 ttp180 -94.82 165.13 12.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.002 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.2 t80 -52.52 -40.73 62.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.621 0.248 . . . . 0.0 110.809 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -54.17 -35.5 62.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.7 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.65 -41.51 96.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 69.1 m-85 -64.97 -38.02 89.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.3 mt-10 -60.71 -52.12 66.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.376 0.607 . . . . 0.0 110.935 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.519 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 8.3 t-105 -67.26 -27.53 67.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.283 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -71.32 -46.58 60.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 53.5 ttt180 -58.17 -58.63 7.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.266 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 p -62.74 -32.28 73.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.453 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 1.1 tm-20 -59.4 -48.0 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.0 110.264 176.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 92.5 mt -65.4 -30.05 70.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.942 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 40.0 mt-10 -82.03 -35.53 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.988 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 2.6 ppt_? -69.59 -25.14 63.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG3' ' HD2' ' A' ' 83' ' ' ARG . 4.0 mt-10 -119.53 -55.06 2.14 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.056 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.7 m -87.21 171.09 10.91 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.754 0.787 . . . . 0.0 112.221 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -102.66 30.61 4.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -50.8 142.23 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.699 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.5 p -72.01 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.726 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -58.74 119.66 39.06 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.435 . . . . 0.0 110.882 -176.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 91.9 Cg_endo -85.5 162.12 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.882 2.388 . . . . 0.0 112.288 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 135.03 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.988 2.458 . . . . 0.0 112.661 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 93.5 mt -66.19 151.26 95.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.401 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.49 113.01 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.635 2.223 . . . . 0.0 111.248 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.48 166.57 37.08 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.635 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.59 25.7 10.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.536 0.684 . . . . 0.0 110.925 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -116.63 -74.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.016 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -69.96 -22.29 63.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.02 -176.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -66.83 -47.0 73.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.517 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -92.98 28.74 2.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.842 0.829 . . . . 0.0 110.051 176.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.6 tp-100 -124.7 -41.29 2.14 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.854 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.74 165.63 20.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.08 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 179.54 3.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.2 2.6 . . . . 0.0 111.966 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.94 -75.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.009 0.433 . . . . 0.0 110.2 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 104' ' ' ARG . 29.2 mtm180 68.06 -57.48 0.47 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.063 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.31 -159.26 25.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.717 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.09 -48.24 82.34 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.407 0.622 . . . . 0.0 110.719 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.88 -21.85 2.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.438 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.82 11.15 38.4 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 49.8 pt -90.96 -17.93 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.723 -173.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -82.9 10.44 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.357 0.599 . . . . 0.0 109.789 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.88 126.94 40.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.332 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.0 -21.16 65.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.628 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.582 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.4 m-80 -71.45 -55.14 8.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -50.82 -50.06 57.31 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.616 0.572 . . . . 0.0 111.129 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.96 -48.99 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.653 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -81.69 -14.84 56.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.913 -177.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 35.7 mm-40 -69.44 -35.13 75.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.3 0.571 . . . . 0.0 109.698 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.573 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.6 ttp180 -79.44 -34.32 41.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.212 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -57.41 -51.29 70.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.631 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.779 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -61.2 -37.63 83.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.311 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.6 -33.3 25.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.388 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.8 tp -66.6 -38.02 86.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.181 0.192 . . . . 0.0 110.945 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.59 ' HA ' HG22 ' A' ' 126' ' ' ILE . 9.8 pt-20 -71.28 -30.87 66.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.779 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 22.0 mm-40 -61.16 -59.64 5.01 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 2.5 t80 -48.47 -52.52 21.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.963 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -64.08 -40.28 88.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.79 -172.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.09 -18.02 44.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.1 -59.24 2.28 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.827 0.822 . . . . 0.0 110.396 175.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 81' ' ' LEU . 1.3 m -63.45 -12.46 10.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.64 -0.89 27.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.436 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.73 11.94 2.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.685 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.695 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 38.3 t60 -101.57 141.34 22.39 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.474 -0.427 . . . . 0.0 110.82 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.695 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 7.9 Cg_exo -41.27 -50.47 4.42 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.365 3.377 . . . . 0.0 113.79 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.64 -26.24 64.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.16 -174.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.47 -41.67 16.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.3 mm100 -66.29 -4.68 8.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.201 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.481 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.9 t-20 -106.26 0.77 25.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.438 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 138' ' ' GLU . 5.1 mm-40 -112.26 127.46 55.98 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.999 -0.438 . . . . 0.0 110.986 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 159' ' ' ILE . 13.7 tpp85 -57.98 -21.53 45.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.42 -172.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.814 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 4.3 t -61.88 -22.78 65.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 110.537 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.539 ' O ' HD22 ' A' ' 145' ' ' LEU . 7.3 mp -72.76 -32.46 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.096 -0.378 . . . . 0.0 111.441 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 18.8 t60 -58.0 -44.1 87.0 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.363 0.602 . . . . 0.0 109.643 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.814 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -77.83 -24.4 48.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.174 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.4 t80 -80.37 -57.18 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.83 -24.81 26.59 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.686 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.4 mt-30 -109.16 158.76 17.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.375 -168.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 62.51 -107.06 0.22 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.258 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.6 pm0 -146.26 -39.78 0.22 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.597 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -139.85 151.78 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -161.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -77.59 109.11 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.314 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.59 102.3 15.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.931 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 31.6 mmtp -66.25 -5.42 10.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -174.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -106.9 18.19 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.311 0.577 . . . . 0.0 110.123 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.447 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.32 -170.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.951 -179.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.6 m -87.84 111.6 43.41 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.136 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.7 Cg_exo -70.72 81.68 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.247 2.631 . . . . 0.0 111.785 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.6 m -155.56 -159.24 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.264 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 18.1 mmmt -84.92 167.31 16.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.77 -45.17 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.661 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.3 m-85 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.835 0.35 . . . . 0.0 110.636 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.66 172.23 38.18 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.753 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.92 156.56 6.93 Favored 'Trans proline' 0 C--O 1.224 -0.207 0 C-N-CA 124.16 3.24 . . . . 0.0 112.223 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -42.64 -22.51 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 124.81 3.673 . . . . 0.0 115.728 -171.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -72.0 -61.51 1.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.507 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.1 m-80 60.95 -178.26 0.11 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.932 0.396 . . . . 0.0 111.523 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.42 130.52 35.76 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.735 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -145.1 129.56 17.89 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.041 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -143.04 100.09 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.9 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.689 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.8 mt -111.07 146.05 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.442 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.2 114.99 11.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.719 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -97.14 132.36 41.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.53 -161.73 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.94 71.87 0.7 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.738 0.304 . . . . 0.0 110.524 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.19 132.66 28.39 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.777 2.318 . . . . 0.0 113.183 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.1 tp60 -122.25 111.65 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.569 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.9 m -75.87 98.14 4.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 109.541 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -130.04 94.45 2.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.873 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -170.64 -167.77 31.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.515 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 4.0 t -110.23 151.48 12.44 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.171 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.27 -49.1 4.58 Favored Glycine 0 N--CA 1.46 0.272 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.465 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.23 78.68 3.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.351 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.61 41.12 0.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.945 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 6.2 ttp180 -82.28 145.85 29.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -146.95 159.67 43.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.069 0.462 . . . . 0.0 111.072 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.6 m -112.36 128.79 56.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.928 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 20.1 p -92.29 146.22 23.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.002 0.429 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 78.9 m-85 -108.18 132.56 53.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.996 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 32.0 tt0 -87.14 119.06 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.73 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.541 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.1 mp -94.09 111.67 25.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.104 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 91.6 mtt180 -104.66 132.64 50.67 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.141 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.689 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.9 138.44 34.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 7.1 ttmt -125.74 133.91 51.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.596 168.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.0 t -166.3 164.24 17.6 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.422 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.84 25.78 10.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.682 167.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.735 HD11 HD22 ' A' ' 29' ' ' LEU . 29.4 mt -61.42 133.58 93.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.496 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.8 Cg_exo -70.66 -32.01 15.56 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.462 2.108 . . . . 0.0 111.262 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -63.62 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.963 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.523 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 3.8 m-30 -71.07 -19.16 62.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 62' ' ' LEU . 54.5 tttp 71.19 -64.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.29 -5.52 56.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -174.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 55' ' ' THR . 4.9 mmpp? 71.22 -38.41 0.42 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.769 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -160.35 135.94 8.22 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.014 0.435 . . . . 0.0 110.038 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -170.08 175.45 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.585 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.8 m -140.83 141.67 34.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.776 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.6 m -138.86 -179.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 40.7 ptt180 -150.37 126.97 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.14 0.495 . . . . 0.0 111.106 171.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.0 mmp_? -139.36 167.24 22.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.802 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.41 156.6 20.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.3 t80 -51.72 -39.34 58.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.723 0.297 . . . . 0.0 110.744 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.9 m -54.17 -32.77 56.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.863 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.13 -35.85 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 51.5 m-85 -64.52 -39.59 94.06 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 92' ' ' LEU . 15.7 mt-10 -60.09 -51.6 68.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' HG21 ' A' ' 150' ' ' ILE . 6.8 t-105 -65.44 -27.46 68.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.256 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.594 HD22 ' CD2' ' A' ' 144' ' ' PHE . 34.4 tp -72.08 -48.46 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 43.3 ttt180 -53.98 -59.38 4.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.839 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.632 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 p -60.06 -40.3 89.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.033 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.6 -52.57 59.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.594 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 87.6 mt -65.51 -34.8 79.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.383 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 35.0 mt-10 -70.06 -43.96 70.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 79' ' ' SER . 20.6 mmt180 -76.73 -48.07 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.177 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.81 -23.07 31.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.044 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.6 t -132.79 -177.52 4.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.408 0.623 . . . . 0.0 111.237 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -108.54 18.24 21.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.217 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.433 ' CG1' HG22 ' A' ' 89' ' ' VAL . 90.1 t -48.89 141.13 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.287 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.1 p -71.91 38.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.466 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -55.99 118.88 22.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.163 -0.335 . . . . 0.0 110.774 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 91.6 Cg_endo -83.79 161.62 14.17 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.845 2.363 . . . . 0.0 111.976 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.62 139.22 62.77 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.716 2.277 . . . . 0.0 112.223 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.9 mt -70.27 154.96 94.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.857 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 3.2 Cg_exo -79.06 110.07 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 0.0 110.919 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.3 171.32 39.8 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.297 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 56.91 51.28 10.92 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.445 0.64 . . . . 0.0 110.125 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.29 -83.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.543 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.599 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -64.1 -17.96 63.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.814 -174.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.698 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.0 mm? -65.85 -41.58 91.53 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.983 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 24.97 7.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.882 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -96.64 -48.92 5.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.446 -177.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.595 ' C ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -92.85 165.34 19.04 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.696 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -59.96 -78.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.489 2.793 . . . . 0.0 113.217 -175.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -149.36 -88.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.457 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 104' ' ' ARG . 17.6 tpt180 67.3 -56.12 0.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.694 0.798 . . . . 0.0 112.632 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.68 170.01 20.02 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.546 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.71 -53.52 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.049 0.54 . . . . 0.0 111.051 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.61 -4.86 19.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.94 58.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.782 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.4 pt -73.57 -14.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.205 -0.498 . . . . 0.0 111.673 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -84.34 1.07 46.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.756 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -103.8 136.59 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.27 -25.57 65.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.638 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -61.85 -61.4 2.52 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.782 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.2 -50.43 38.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.354 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.5 mt -51.59 -53.89 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.18 -20.1 60.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.494 -177.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 65.2 mm-40 -74.26 -33.62 63.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.27 0.557 . . . . 0.0 109.639 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.1 tpp180 -76.64 -40.12 50.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -53.02 -51.44 61.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.859 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.756 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -61.46 -36.26 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.819 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.65 -33.1 10.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.699 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 33' ' ' VAL . 8.1 tp -67.39 -36.35 81.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.978 -0.13 . . . . 0.0 111.083 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.644 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.7 pt-20 -72.37 -28.84 63.27 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.756 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 18.2 mm-40 -65.18 -61.34 2.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.462 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.5 t80 -44.01 -52.98 6.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.89 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -62.81 -41.15 91.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.476 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -59.29 -17.42 28.77 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -90.47 -58.08 2.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.734 0.778 . . . . 0.0 110.452 175.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -64.47 -12.5 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.884 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.63 0.45 26.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.376 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.476 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.33 13.89 2.29 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.026 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.67 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 55.2 t60 -101.21 141.83 23.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 117.156 0.478 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.72 -49.49 5.36 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 124.014 3.143 . . . . 0.0 113.523 -173.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -33.17 73.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.331 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -74.08 -41.29 61.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.822 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -70.3 0.13 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.187 0.994 . . . . 0.0 109.36 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.482 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -117.28 14.86 14.85 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.242 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.58 130.52 47.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.798 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 139' ' ' ARG . 4.3 mmt180 -49.51 -22.38 1.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.795 0.838 . . . . 0.0 113.002 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.712 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 2.8 m -55.4 -28.0 51.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.21 0.604 . . . . 0.0 112.13 -174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.51 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.2 mp -78.26 -34.39 49.06 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.784 -0.573 . . . . 0.0 111.735 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.8 t60 -63.12 -35.69 81.11 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.45 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.712 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.6 ptm -77.47 -28.94 52.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.452 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.594 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.1 t80 -80.7 -58.57 3.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.199 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -83.12 -22.71 33.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.077 -172.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 42.6 mt-30 -120.98 179.19 4.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.711 -169.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.5 t70 65.73 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.831 0.707 . . . . 0.0 110.542 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.81 -56.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.68 0.752 . . . . 0.0 110.044 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.49 143.29 40.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.05 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.668 HG23 ' HE2' ' A' ' 143' ' ' MET . 2.9 mp -65.44 119.35 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.585 173.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.4 106.68 18.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -73.89 10.0 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -129.93 19.22 5.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -63.71 -172.31 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.015 -177.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 89.7 m -87.31 112.24 46.66 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -69.94 77.92 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.167 2.578 . . . . 0.0 111.105 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -153.73 -161.61 1.29 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 4.5 mmmm -86.83 158.72 19.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.414 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.572 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -57.16 -39.63 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.209 0.528 . . . . 0.0 110.524 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.681 -173.175 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 5.2 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.198 0.523 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.14 174.25 46.61 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -54.33 154.27 19.57 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.988 3.126 . . . . 0.0 111.486 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.47 -19.25 0.63 Allowed 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.42 3.413 . . . . 0.0 115.379 -170.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -70.46 -57.44 4.79 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 36.9 m-80 59.07 -178.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.469 0.481 . . . . 0.0 111.765 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -95.46 136.4 35.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 57' ' ' LEU . 13.9 tp -145.79 131.28 18.73 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.09 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.9 pt-20 -140.81 99.72 3.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.063 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.665 HG12 ' HB ' ' A' ' 53' ' ' VAL . 22.4 mt -112.06 138.81 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.24 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.09 107.72 6.23 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -83.89 136.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -179.9 -167.17 0.09 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.2 84.88 0.2 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.61 0.569 . . . . 0.0 111.479 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HB3' HG21 ' A' ' 115' ' ' ILE . 94.4 Cg_endo -76.35 119.9 5.44 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 113.738 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -102.55 106.26 16.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.386 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' HE ' ' A' ' 45' ' ' ARG . 28.5 m -78.75 89.28 4.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.685 0.755 . . . . 0.0 110.115 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 94.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.7 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.61 -167.48 32.67 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.558 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 10.1 t -104.32 152.59 6.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.177 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.1 -51.81 6.01 Favored Glycine 0 N--CA 1.461 0.347 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.188 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.56 83.15 4.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.884 0.373 . . . . 0.0 110.171 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 39.73 0.72 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.384 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.593 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 23.5 ttt180 -84.09 141.12 31.35 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 43.5 p90 -131.1 164.3 25.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.6 m -117.45 127.14 53.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.232 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.594 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 16.6 p -92.15 128.22 37.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 91.8 m-85 -90.63 131.87 36.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.458 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 29.6 tt0 -81.74 116.37 21.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.314 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.504 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 mp -92.83 109.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.707 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 27.5 mtp180 -100.29 136.09 40.72 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.765 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.49 135.67 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 112.337 -178.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 15.5 ttmt -124.39 139.82 53.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.024 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -170.55 164.32 8.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.4 0.619 . . . . 0.0 112.317 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.55 27.35 8.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.949 167.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 29' ' ' LEU . 23.0 mt -60.98 141.88 93.19 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.751 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.5 Cg_exo -76.04 -33.04 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.569 2.179 . . . . 0.0 111.524 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -63.05 -41.91 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.807 177.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 145' ' ' LEU . 3.5 m-30 -68.95 -26.52 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.9 tmmm? 73.81 -60.64 0.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.69 -7.83 58.84 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.126 -0.359 . . . . 0.0 110.684 -173.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 5.4 mmtp 70.25 -40.83 0.48 Allowed 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.063 0.852 . . . . 0.0 111.24 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.9 pp20? -161.16 136.48 7.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 167.79 13.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 19.0 m -141.81 137.17 31.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.191 0.52 . . . . 0.0 111.559 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -132.74 -176.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.088 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 8.3 ptp180 -150.33 116.21 5.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.929 173.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 24.4 mmm180 -135.01 160.44 38.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.874 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 32.9 ptt180 -89.8 172.63 8.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -169.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 26.7 t80 -54.46 -41.88 69.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.247 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 t -55.42 -33.98 64.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.314 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.66 -37.47 73.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.504 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 61.7 m-85 -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.0 mt-10 -60.08 -53.48 57.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.754 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.444 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 3.1 t-105 -67.57 -27.9 67.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.403 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.0 tm? -70.49 -41.71 72.34 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 57.2 ttt180 -59.06 -60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.733 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 7.5 p -61.45 -37.13 82.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.373 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.96 -49.99 72.01 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.132 0.27 . . . . 0.0 110.755 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.6 mt -61.44 -34.36 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.909 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 32.2 mt-10 -75.22 -18.54 60.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.805 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HG2' ' O ' ' A' ' 79' ' ' SER . 31.7 mmt180 -80.28 -62.99 1.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.208 0.528 . . . . 0.0 111.81 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -88.73 -21.52 23.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.264 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 87' ' ' VAL . 16.2 m -123.75 169.39 11.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.314 0.578 . . . . 0.0 111.263 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -100.45 32.36 3.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.219 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 85' ' ' SER . 80.8 t -53.08 142.04 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.145 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.7 p -71.21 36.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.737 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.55 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -59.51 116.37 16.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 O-C-N 122.055 -0.403 . . . . 0.0 110.953 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.3 Cg_endo -85.36 162.72 11.2 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.783 2.322 . . . . 0.0 112.606 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 131.86 33.94 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.898 2.399 . . . . 0.0 112.112 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD11 ' HA ' ' A' ' 75' ' ' GLU . 62.5 mt -63.99 152.0 88.41 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.555 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 2.8 Cg_exo -75.52 129.74 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.689 2.26 . . . . 0.0 111.202 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -179.23 48.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.3 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' N ' HD23 ' A' ' 98' ' ' LEU . 10.6 mptt 66.58 -58.12 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.088 0.955 . . . . 0.0 112.185 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -71.75 -22.03 61.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.499 -170.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.696 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -65.71 -45.61 82.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.005 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 22.19 8.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.388 0.613 . . . . 0.0 110.38 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -115.97 -45.56 2.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.638 -177.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 46.5 mt -82.26 169.4 18.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.521 -174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.04 145.41 73.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.743 2.295 . . . . 0.0 111.054 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.5 -71.19 0.38 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.075 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 68.83 -56.37 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.887 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.27 -169.15 37.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -53.0 -50.33 64.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.34 0.59 . . . . 0.0 111.246 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.92 -26.44 5.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.62 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.26 -13.8 8.92 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 24.9 pt -68.75 -16.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.743 -0.729 . . . . 0.0 111.44 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.94 2.15 27.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -116.08 145.31 43.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.13 0.491 . . . . 0.0 110.421 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.84 -17.5 59.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.513 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 93.2 m-20 -66.73 -60.28 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.475 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -51.42 -48.29 62.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 36' ' ' PRO . 39.0 mt -50.94 -53.32 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.355 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.24 -20.14 60.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.768 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 45.4 mm-40 -73.36 -32.96 64.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.057 0.456 . . . . 0.0 110.301 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 33.4 ttm180 -80.8 -36.45 31.71 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.48 -49.83 66.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.144 -178.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.4 pt20 -58.0 -36.75 73.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 -174.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.41 -32.67 9.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.7 tp -66.35 -35.45 80.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.1 pt-20 -72.46 -35.54 68.27 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.739 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 17.8 mm-40 -56.49 -53.84 52.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -53.39 -52.71 58.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.296 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.0 tp -64.41 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.836 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.8 m-80 -62.11 -23.56 66.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 111.668 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.565 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 42.9 mttm -81.35 -56.19 4.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.943 0.878 . . . . 0.0 110.367 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.564 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -68.24 -11.84 14.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.332 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.21 -2.75 19.1 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.832 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.29 -1.12 5.75 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.166 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.69 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 42.6 t60 -89.64 142.03 29.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 122.65 -0.323 . . . . 0.0 110.736 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.7 Cg_exo -41.52 -48.86 5.38 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.436 3.424 . . . . 0.0 113.659 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.92 -26.63 64.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.347 -174.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.67 -47.75 10.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.86 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.71 -6.16 1.11 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.236 172.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -83.54 -33.72 25.41 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.519 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 7.8 pt-20 -113.57 149.98 33.69 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 117.622 -1.631 . . . . 0.0 114.547 -164.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.1 tpt180 -58.14 -21.38 46.62 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 113.138 -1.846 . . . . 0.0 112.026 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 143' ' ' MET . 7.8 t -60.97 -27.68 68.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.545 0.688 . . . . 0.0 109.896 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' C ' ' A' ' 135' ' ' ALA . 1.2 tp -71.56 -31.64 67.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.251 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.492 ' HA ' ' CD ' ' A' ' 146' ' ' GLN . 57.3 t60 -69.52 -29.57 67.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.636 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.6 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.7 ptm -79.68 -29.08 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.661 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 12.8 t80 -80.15 -53.62 6.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.954 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 60' ' ' PHE . 1.2 mp -105.41 -27.74 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.174 0.512 . . . . 0.0 111.792 -172.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.492 ' CD ' ' HA ' ' A' ' 142' ' ' HIS . 31.2 mt-30 -106.43 9.7 31.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.357 -164.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.487 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.2 t70 -137.86 -177.56 4.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -83.5 -33.74 25.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 119.475 1.034 . . . . 0.0 110.257 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -143.62 143.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.643 -167.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.6 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.4 mp -75.04 108.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.924 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.8 108.36 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 28.8 mmtp -73.53 10.68 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -130.92 19.71 5.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.032 0.444 . . . . 0.0 110.142 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -174.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.308 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 96.4 m -79.46 112.47 29.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 22.7 Cg_exo -71.56 43.94 0.57 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.762 2.975 . . . . 0.0 113.143 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 31.9 m -115.01 -158.96 0.69 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 23.3 mmmt -101.07 170.02 8.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.216 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 59' ' ' ILE . 20.1 mm -60.15 -42.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.613 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 32.5 m-85 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.66 175.29 36.54 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.74 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 158.92 21.53 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.823 3.015 . . . . 0.0 110.792 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.45 -19.42 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 124.635 3.557 . . . . 0.0 115.49 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 p -71.97 -59.94 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.441 0.296 . . . . 0.0 110.446 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.477 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 45.7 m-80 61.7 -178.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.357 0.598 . . . . 0.0 112.153 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -98.35 145.37 26.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.657 HD22 HD11 ' A' ' 57' ' ' LEU . 16.6 tp -150.02 130.19 13.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.835 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.8 pt-20 -139.06 112.39 8.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.987 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.634 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.7 mt -122.27 135.81 61.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.793 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.31 117.37 18.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.334 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t 178.98 -162.11 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.5 m-80 63.87 83.5 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-O 120.969 0.414 . . . . 0.0 110.322 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.6 123.76 9.29 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.424 2.082 . . . . 0.0 113.329 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.566 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 27.2 tp60 -110.63 102.71 11.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.453 HG22 ' NE ' ' A' ' 45' ' ' ARG . 27.9 m -77.5 102.06 6.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.342 0.591 . . . . 0.0 109.748 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -132.36 89.83 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.735 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.01 -166.76 31.96 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.883 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.5 t -98.69 154.96 3.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.442 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.61 -54.3 4.93 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.508 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -95.01 85.38 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 32.04 1.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.588 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 15.5 ttt180 -77.42 136.91 38.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.71 167.09 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.724 0.297 . . . . 0.0 110.41 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 m -119.56 132.3 55.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 23.4 p -92.52 127.66 38.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -93.74 131.33 39.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.976 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 20.3 tt0 -91.2 120.77 32.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.719 -173.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.38 118.21 38.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.672 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 37.7 mtp180 -107.24 130.04 54.79 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.168 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.96 138.14 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 112.439 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -118.69 140.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.693 167.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.422 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.36 164.29 7.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.243 0.544 . . . . 0.0 111.328 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.613 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -122.36 26.75 8.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.872 168.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 29' ' ' LEU . 18.8 mt -62.63 139.22 96.89 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.973 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD3' ' ND2' ' A' ' 27' ' ' ASN . 11.5 Cg_exo -68.76 -41.68 5.51 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.427 2.085 . . . . 0.0 111.408 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.587 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -57.26 -42.7 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.3 m-85 -69.33 -22.44 63.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.24 -60.14 0.54 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 171.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.62 -11.06 57.77 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.239 0.472 . . . . 0.0 111.448 -171.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp 71.46 -43.05 0.55 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.001 0.813 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -153.23 135.16 14.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.061 178.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -170.57 172.47 5.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.658 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.592 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 8.0 m -140.79 136.38 32.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.203 0.525 . . . . 0.0 111.079 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 26.4 m -135.12 175.15 11.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.692 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 22.1 ptt180 -148.84 133.05 17.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.544 0.688 . . . . 0.0 111.864 172.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 73' ' ' ASP . 3.1 mmp_? -136.69 158.02 45.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.4 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 13.6 ptm180 -79.27 167.41 20.97 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.65 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 34.7 t80 -52.32 -42.65 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.534 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 15.0 m -58.24 -29.62 65.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.038 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 70' ' ' ARG . 2.2 m-20 -68.46 -38.91 81.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.518 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 52.6 m-85 -66.65 -36.97 83.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.8 mt-10 -61.83 -51.46 68.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.947 0.88 . . . . 0.0 110.071 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.56 -29.54 70.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.406 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -74.18 -44.71 52.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 45.8 ttt180 -55.59 -57.07 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.752 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.717 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 25.0 p -62.89 -40.66 98.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.142 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.659 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 5.9 mm-40 -57.41 -38.61 74.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.0 mt -72.63 -34.34 67.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.839 0.352 . . . . 0.0 110.586 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 36.2 mt-10 -73.49 -26.33 60.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.197 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 79' ' ' SER . 28.0 mmm180 -55.24 -62.52 1.62 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.73 -2.82 10.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 26.5 t -114.02 173.97 6.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.411 0.624 . . . . 0.0 111.162 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -107.55 20.36 18.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.222 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 89' ' ' VAL . 93.6 t -51.77 141.59 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.476 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 88' ' ' VAL . 10.0 p -73.48 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.532 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.594 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -56.38 120.18 33.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.873 -0.517 . . . . 0.0 110.9 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 92.3 Cg_endo -85.62 163.03 10.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.354 2.703 . . . . 0.0 112.269 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.55 138.18 44.95 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.793 2.329 . . . . 0.0 112.339 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.8 mt -67.33 156.42 88.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.558 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -90.26 109.37 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.146 2.564 . . . . 0.0 111.876 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . 177.81 70.51 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.226 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -143.01 -8.59 0.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.78 0.324 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -115.21 -84.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -171.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.438 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -48.79 -32.85 9.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.518 1.127 . . . . 0.0 113.688 -171.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.806 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -57.64 -49.42 76.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.832 0.349 . . . . 0.0 111.568 -172.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -102.31 20.24 17.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.49 0.662 . . . . 0.0 110.483 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.7 tp60 -113.61 -34.3 5.58 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.446 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 86.5 mt -83.95 176.74 3.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -66.27 -146.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.654 2.236 . . . . 0.0 112.238 172.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 79.9 m-85 -121.0 -89.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.141 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HD2' ' OD1' ' A' ' 111' ' ' ASP . 63.1 mtt180 68.35 -48.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.799 0.687 . . . . 0.0 111.429 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.2 -150.01 8.64 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -90.08 -30.87 17.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.134 0.492 . . . . 0.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB2' HG23 ' A' ' 109' ' ' ILE . 12.4 m-20 -111.99 -27.76 8.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.733 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 105.37 25.34 6.71 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.398 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.585 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 26.3 pt -73.23 -14.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.482 . . . . 0.0 111.749 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -77.61 -8.15 57.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.771 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 104' ' ' ARG . 0.7 OUTLIER -93.32 119.9 32.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.392 172.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.32 -33.03 71.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.949 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.595 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 94.4 m-20 -55.38 -56.16 23.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.236 0.335 . . . . 0.0 110.354 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -46.75 -50.75 17.62 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.564 0.54 . . . . 0.0 111.057 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 38.3 mt -50.66 -51.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.07 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.54 -18.81 47.31 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.78 -177.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 33.4 mt-10 -76.36 -30.94 57.78 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 109.713 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 16.3 tpp180 -74.81 -42.57 57.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 170.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -53.95 -52.06 61.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.328 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.762 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -59.11 -36.93 76.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 -175.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLN . . . -88.85 -32.92 10.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.051 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.4 tp -67.74 -34.9 77.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.864 -0.198 . . . . 0.0 110.945 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.2 pt-20 -71.79 -31.93 67.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.762 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 21.1 mm-40 -59.07 -58.21 9.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.432 ' CE1' HG11 ' A' ' 129' ' ' VAL . 1.8 t80 -51.08 -51.86 49.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.011 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -62.92 -39.68 86.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -62.5 -19.91 64.07 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 2.9 mptp? -83.36 -58.69 2.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.834 0.826 . . . . 0.0 110.063 173.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.652 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -64.84 -11.84 11.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.281 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -107.17 -12.12 15.45 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.435 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -128.85 3.92 6.47 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.964 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.716 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.9 t60 -91.89 142.42 26.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 117.133 0.466 . . . . 0.0 110.216 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.716 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.1 Cg_exo -41.23 -47.34 5.36 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.173 3.248 . . . . 0.0 113.364 -174.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -70.41 -34.25 72.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.098 -175.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.8 -45.9 33.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.348 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.49 -6.53 1.1 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 173.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t30 -95.9 -20.01 19.11 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.869 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 29.7 mm-40 -103.49 136.79 42.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -165.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -56.98 -20.18 22.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.854 -171.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.3 m -54.76 -33.99 62.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.891 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.583 ' O ' HD22 ' A' ' 145' ' ' LEU . 8.0 mp -73.43 -34.03 65.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.109 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 27.9 t-80 -57.45 -34.9 69.46 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.185 0.517 . . . . 0.0 110.345 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.686 ' HE2' HG23 ' A' ' 150' ' ' ILE . 4.2 ptm -83.24 -30.03 28.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.0 t80 -72.7 -49.49 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -94.02 -42.74 8.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.079 -175.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 21.1 mp0 -88.01 0.75 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.849 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.53 ' OD1' HD12 ' A' ' 149' ' ' ILE . 8.8 t70 -141.8 150.89 42.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.909 0.385 . . . . 0.0 110.138 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.611 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.9 pm0 -75.11 -31.85 61.25 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.108 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.611 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -136.73 120.78 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.645 -170.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.686 HG23 ' HE2' ' A' ' 143' ' ' MET . 11.0 mt -63.82 122.47 14.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.356 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.31 99.57 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.697 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HD3' HG22 ' A' ' 150' ' ' ILE . 33.4 mmtp -68.27 -3.98 12.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.866 0.365 . . . . 0.0 111.516 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.4 m -116.58 20.62 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.471 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -64.42 -171.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.93 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.3 m -82.26 111.72 30.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.448 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 19.2 Cg_exo -71.62 73.85 2.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.579 2.853 . . . . 0.0 111.987 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -152.36 -148.62 0.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.776 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -99.73 -178.0 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.93 0.871 . . . . 0.0 112.091 -176.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.582 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -76.71 -35.23 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.616 175.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.173 -171.187 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.536 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 7.6 m-85 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 121.158 0.504 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.54 43.99 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.678 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.3 Cg_endo -50.89 156.23 4.96 Favored 'Trans proline' 0 CA--C 1.526 0.103 0 C-N-CA 124.32 3.347 . . . . 0.0 112.33 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 73.1 Cg_exo -51.29 -8.87 0.24 Allowed 'Trans proline' 0 N--CA 1.482 0.82 0 C-N-CA 124.504 3.469 . . . . 0.0 115.213 -174.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -71.42 -63.92 1.02 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.601 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.1 m120 59.54 172.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.669 0.605 . . . . 0.0 111.979 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -95.63 140.93 29.75 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 57' ' ' LEU . 13.5 tp -144.88 131.26 19.68 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.343 0.592 . . . . 0.0 110.956 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.23 102.4 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.024 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' VAL . 54.8 mt -113.49 140.01 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -139.05 112.8 8.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.174 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.1 m -96.99 133.45 38.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 16.3 t 178.75 -161.64 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 66.96 78.87 0.24 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.187 0.518 . . . . 0.0 110.227 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.48 119.44 5.23 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.688 2.258 . . . . 0.0 113.355 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' THR . 43.7 tp60 -107.73 113.58 26.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.964 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 m -76.04 98.56 4.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.411 0.624 . . . . 0.0 109.478 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.34 91.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.976 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.41 -167.04 31.91 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.702 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.4 t -110.71 154.67 12.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 CA-C-O 119.28 -0.391 . . . . 0.0 109.996 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.6 3.24 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.625 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.86 88.53 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.283 0.563 . . . . 0.0 109.837 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.64 36.35 0.79 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.497 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 5.5 ttp180 -86.23 130.45 34.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.38 171.72 14.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.054 0.454 . . . . 0.0 111.361 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 98.3 m -121.79 129.64 52.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.576 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.2 p -92.57 130.0 38.34 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -93.43 131.5 38.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 9.8 tt0 -88.29 118.02 27.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.562 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.18 108.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 66.7 mtp180 -92.96 135.88 33.76 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.069 173.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.56 135.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 111.868 177.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -123.88 134.87 53.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.3 t -169.48 164.45 10.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.499 0.666 . . . . 0.0 112.01 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.54 HD22 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -118.76 23.19 11.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.285 171.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 29' ' ' LEU . 24.7 mt -57.91 141.11 81.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.955 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -74.56 -16.25 21.49 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.709 2.272 . . . . 0.0 111.463 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.821 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -86.12 -40.99 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.557 -178.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.2 m-85 -70.05 -8.31 48.29 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -166.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER 70.87 -69.79 0.17 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -84.25 -5.81 59.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.968 -0.457 . . . . 0.0 110.682 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HD2' ' CE1' ' A' ' 22' ' ' TYR . 5.0 mmtp 70.68 -43.89 0.57 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.122 0.889 . . . . 0.0 111.418 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -158.86 130.03 6.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.231 0.538 . . . . 0.0 110.063 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.7 t -170.24 173.74 5.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.486 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.588 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 28.6 m -141.86 123.05 14.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.416 0.627 . . . . 0.0 111.469 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 23.6 m -114.17 179.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.105 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 30.9 ptt180 -150.45 126.85 10.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.25 0.548 . . . . 0.0 111.204 171.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -138.53 177.25 8.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.247 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -83.65 167.34 17.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.258 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.562 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.6 t80 -60.29 -39.66 87.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.527 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 18.5 m -58.55 -27.08 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.679 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -77.31 -34.22 55.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.621 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 35.8 m-85 -63.95 -38.79 92.37 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.2 mt-10 -57.12 -56.25 24.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.158 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -65.15 -28.39 69.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.392 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 2.9 tm? -71.63 -38.99 70.71 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.559 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 49.6 ttt180 -62.16 -61.47 2.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.042 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.544 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 8.8 p -57.52 -38.03 73.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.278 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.622 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 1.0 OUTLIER -58.31 -47.62 83.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.33 -36.67 84.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.186 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 62.5 mt-10 -69.04 -30.74 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.497 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' SER . 27.8 mmt180 -80.26 -58.93 2.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.661 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.85 -25.48 63.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.511 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.52 -178.72 6.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.725 0.774 . . . . 0.0 112.323 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.86 23.38 8.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.526 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.5 t -45.89 139.71 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.6 p -70.09 33.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.074 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.559 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -54.86 120.55 29.29 Favored Pre-proline 0 CA--C 1.531 0.241 0 O-C-N 122.134 -0.354 . . . . 0.0 111.0 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.61 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 90.1 Cg_endo -85.85 164.29 10.38 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.953 2.435 . . . . 0.0 112.584 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.6 132.1 29.86 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 84.5 mt -66.97 143.81 98.18 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.452 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 10.5 Cg_exo -72.11 108.63 2.52 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.416 2.077 . . . . 0.0 111.014 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . -172.68 30.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.814 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -131.89 7.64 4.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 110.503 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.16 -90.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -53.7 -29.64 40.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -60.85 -49.13 78.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.041 0.448 . . . . 0.0 110.58 -174.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.58 26.18 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.496 0.665 . . . . 0.0 109.922 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.3 tt0 -123.02 -36.91 2.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -176.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.9 mt -92.49 165.39 19.52 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.28 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.58 164.31 35.98 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.328 2.685 . . . . 0.0 111.257 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.17 -76.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.697 0.284 . . . . 0.0 111.474 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 69.13 -63.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.205 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.07 -150.61 26.84 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.514 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.23 -41.79 96.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.941 0.401 . . . . 0.0 110.389 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -138.28 -17.45 1.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.692 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.9 10.92 23.72 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.324 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.2 pt -83.34 -18.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 0.0 111.872 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -85.8 -2.01 57.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.252 0.549 . . . . 0.0 110.439 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.47 127.45 34.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.851 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.34 -30.83 67.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.1 m-20 -56.1 -60.29 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -53.78 -47.82 70.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.092 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.52 -47.33 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.105 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -75.05 -21.89 58.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -178.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 73.5 mm-40 -71.53 -35.57 70.74 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.262 0.553 . . . . 0.0 109.761 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 10.9 tpp180 -76.89 -35.8 57.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.4 -53.8 54.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.458 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -58.75 -40.79 84.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.067 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.16 -37.34 28.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.963 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -65.6 -34.19 77.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.564 0.182 . . . . 0.0 111.272 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.698 ' HB3' HG22 ' A' ' 33' ' ' VAL . 7.4 pt-20 -78.09 -31.47 50.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.441 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 16.3 mm-40 -59.59 -58.58 7.98 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.5 t80 -49.2 -53.32 21.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.906 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.0 tp -65.04 -40.75 90.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.19 -19.91 62.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 111.65 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.61 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.3 mttm -87.21 -56.61 3.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.661 0.743 . . . . 0.0 110.731 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.578 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.24 -11.65 14.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.974 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.93 -6.29 17.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.291 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.42 10.58 5.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.307 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.2 t60 -98.19 140.62 21.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.511 -0.405 . . . . 0.0 110.41 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.51 -48.86 5.36 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.306 3.337 . . . . 0.0 113.672 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.83 -33.16 73.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.323 -175.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.74 -44.41 41.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.912 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -63.82 -0.74 1.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.005 173.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.506 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -111.16 -2.87 15.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 47.1 mm-40 -112.84 132.31 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.111 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HA ' HD13 ' A' ' 159' ' ' ILE . 6.4 tpp85 -53.82 -25.81 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.418 -172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 m -51.26 -34.46 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.459 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -67.4 -33.1 74.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.413 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 146' ' ' GLN . 9.5 t60 -62.5 -40.12 95.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.098 0.475 . . . . 0.0 109.748 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.568 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.6 ptm -77.95 -26.18 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.975 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 21.4 t80 -79.75 -63.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.116 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -110.83 -4.29 15.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.566 ' HG3' HD12 ' A' ' 145' ' ' LEU . 12.0 mt-30 -117.92 23.59 11.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.853 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.55 -142.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.457 ' HG3' HG13 ' A' ' 149' ' ' ILE . 7.3 tp10 -121.08 -56.76 1.91 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.85 0.834 . . . . 0.0 109.511 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -129.65 139.77 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.107 -176.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -66.26 112.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 100.73 13.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.21 -7.96 10.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.1 m -108.91 17.88 21.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.405 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.3 OUTLIER -66.49 -172.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.658 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.4 m -92.06 114.82 63.3 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.68 83.1 1.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.923 2.415 . . . . 0.0 111.251 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 89.3 p -145.85 -150.17 0.32 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.636 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.506 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 13.1 mmmt -95.4 164.07 12.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.821 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -63.89 -34.56 69.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.056 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.839 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.44 -172.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 7.5 m-85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.01 174.98 45.42 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.162 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.14 158.37 14.99 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 124.304 3.336 . . . . 0.0 111.696 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.82 -24.99 0.89 Allowed 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.704 3.602 . . . . 0.0 115.267 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -68.81 -58.51 4.08 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.7 m-80 57.96 -170.59 0.11 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.953 0.406 . . . . 0.0 111.663 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -103.34 139.41 38.79 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 57' ' ' LEU . 16.9 tp -150.3 131.88 14.85 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.675 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.48 99.43 3.49 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.015 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.687 HG12 ' HB ' ' A' ' 53' ' ' VAL . 29.1 mt -111.81 140.74 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.605 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.92 129.15 29.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.653 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.6 m -112.96 134.13 56.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 t 179.32 -162.58 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.3 m-80 62.77 68.86 0.94 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-O 121.132 0.491 . . . . 0.0 109.837 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.25 138.04 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.794 2.329 . . . . 0.0 113.162 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.534 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.4 tp60 -121.93 108.34 13.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.8 m -75.25 95.27 3.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.52 0.676 . . . . 0.0 109.646 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -121.9 92.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.232 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -167.23 32.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.524 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -101.34 150.17 6.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.589 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.05 -48.38 5.35 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.673 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -97.96 83.36 3.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.126 0.489 . . . . 0.0 110.01 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.35 35.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.468 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 19.7 ttt180 -83.35 127.89 34.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.679 0.276 . . . . 0.0 110.367 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -117.38 169.74 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.266 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.3 m -125.88 129.11 48.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.742 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 34.2 p -92.92 146.44 23.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.267 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.427 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 83.7 m-85 -118.5 142.64 47.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.133 0.492 . . . . 0.0 110.403 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 38.5 tt0 -90.15 117.96 29.31 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.565 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.4 mp -93.06 120.47 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.864 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 51.7 mtp180 -109.53 131.73 54.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.936 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.687 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.82 136.71 43.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.848 0.356 . . . . 0.0 111.575 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 10.9 ttmt -125.93 135.07 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 t -169.62 165.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.701 0.762 . . . . 0.0 112.763 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.11 26.16 9.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.768 167.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.712 HD11 HD22 ' A' ' 29' ' ' LEU . 18.6 mt -61.06 135.89 93.52 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.379 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -68.79 -38.01 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.405 2.07 . . . . 0.0 111.351 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.49 -40.82 87.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.14 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.0 m-85 -68.77 -25.26 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 73.25 -64.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 ' HG2' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -76.77 -6.03 50.6 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.899 -0.501 . . . . 0.0 110.282 -175.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.0 mmpp? 70.91 -37.94 0.41 Allowed 'General case' 0 C--O 1.22 -0.487 0 O-C-N 123.936 0.772 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.8 pp20? -162.04 142.93 10.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -170.24 169.2 7.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 13.6 m -141.4 135.57 30.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.706 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.569 HG21 HH21 ' A' ' 69' ' ' ARG . 0.5 OUTLIER -147.09 134.87 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.408 -171.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 41.0 ttp180 -99.1 111.25 23.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.936 0.398 . . . . 0.0 110.139 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.659 HH11 HD12 ' A' ' 150' ' ' ILE . 56.2 mtt-85 -124.99 178.1 5.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.476 -173.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -95.23 155.98 16.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.754 0.311 . . . . 0.0 111.306 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 32.5 t80 -59.59 -37.98 79.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 109.924 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 34.4 t -59.64 -30.06 68.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.854 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.87 -39.51 83.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.53 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 51.4 m-85 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HG2' HD13 ' A' ' 92' ' ' LEU . 12.8 mt-10 -71.97 -49.11 40.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.503 0.668 . . . . 0.0 110.539 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.487 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.8 t-105 -65.82 -28.27 68.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.71 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.49 -42.0 59.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 64.2 ttt180 -57.72 -59.2 5.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 6.4 p -60.04 -41.47 92.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.573 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.09 -45.99 79.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.674 0.273 . . . . 0.0 111.253 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 135' ' ' ALA . 96.4 mt -65.89 -40.72 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.06 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 73.5 mt-10 -65.53 -45.13 84.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.466 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.6 mmt180 -66.96 -60.78 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.92 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -77.73 -18.93 56.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.463 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 t -134.8 -175.82 4.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.472 0.653 . . . . 0.0 111.315 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -109.58 13.44 23.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.29 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -42.09 140.16 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.518 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.8 p -71.17 36.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.857 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -57.48 119.71 34.72 Favored Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 122.046 -0.409 . . . . 0.0 111.014 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.591 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 96.1 Cg_endo -87.71 167.1 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.93 2.42 . . . . 0.0 112.488 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.5 Cg_endo -66.5 146.87 81.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.699 2.266 . . . . 0.0 112.756 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' A' ' 75' ' ' GLU . 50.0 mt -73.44 158.87 85.96 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.56 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 67.6 Cg_endo -87.5 108.86 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.754 2.303 . . . . 0.0 111.466 174.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.54 38.71 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.433 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -145.28 42.24 1.28 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.63 -83.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.158 0.504 . . . . 0.0 112.181 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -52.05 -24.78 7.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.339 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -61.14 -43.53 98.74 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.16 24.64 8.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.809 0.814 . . . . 0.0 109.686 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -120.42 -40.08 2.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.045 -177.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.65 166.24 26.03 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.356 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.405 ' HG2' ' NH1' ' A' ' 104' ' ' ARG . 15.0 Cg_exo -70.4 -163.62 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.411 2.741 . . . . 0.0 112.726 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.89 -91.09 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.538 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' PRO . 73.1 mtm-85 65.31 -70.86 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.503 0.721 . . . . 0.0 111.855 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.53 77.15 0.32 Allowed Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.603 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.4 t0 67.84 -69.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 110.857 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -125.17 -7.21 7.1 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.17 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.22 8.53 35.76 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 48.5 pt -82.62 -18.25 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.78 -175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.18 -8.72 59.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.538 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.84 139.27 30.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.83 -22.59 64.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.69 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 12.5 m120 -63.25 -59.02 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -54.28 -48.37 71.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.728 0.299 . . . . 0.0 110.753 177.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.3 mt -52.77 -45.54 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.786 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -73.53 -23.32 59.98 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.327 -178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 39.4 mm-40 -70.78 -32.62 69.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.447 0.641 . . . . 0.0 109.78 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.3 ttm180 -79.89 -39.65 30.02 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -54.22 -49.91 68.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.825 -178.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -59.92 -40.36 88.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -84.08 -31.82 24.93 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.065 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.7 tp -65.61 -35.69 81.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.297 0.239 . . . . 0.0 111.063 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.737 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.9 pt-20 -76.73 -35.39 57.83 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.5 mm-40 -56.71 -55.46 33.86 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.525 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.4 t80 -51.23 -54.05 29.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.732 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.3 tp -64.35 -38.22 81.99 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.161 -170.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -64.03 -21.67 66.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 39.7 mttm -85.15 -55.03 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.757 0.789 . . . . 0.0 110.763 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.57 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.38 -12.4 15.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.816 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.33 8.81 21.51 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.332 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.6 9.24 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.658 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 47.7 t60 -100.87 140.91 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.637 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.658 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.3 Cg_endo -46.17 -48.03 13.73 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.709 2.939 . . . . 0.0 112.936 -172.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.66 -30.01 69.44 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.039 -176.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -79.08 -43.79 23.45 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.655 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.9 mm100 -66.85 -7.69 23.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.245 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.599 ' ND2' ' HE2' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -92.23 -15.37 27.61 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.632 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 45.7 mm-40 -105.73 130.84 53.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.608 -170.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HA ' HD13 ' A' ' 159' ' ' ILE . 19.2 tpt180 -56.7 -25.87 55.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.592 -172.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 143' ' ' MET . 1.2 p -60.32 -21.24 61.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.7 mp -70.01 -35.6 74.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.878 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 36.1 t60 -56.65 -35.35 68.26 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.122 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.622 ' HG3' HG13 ' A' ' 150' ' ' ILE . 3.8 ptm -82.66 -34.0 27.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.639 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.476 ' N ' ' HG2' ' A' ' 143' ' ' MET . 11.2 t80 -82.11 -26.71 33.33 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.492 HD13 ' CE1' ' A' ' 60' ' ' PHE . 2.3 mt -99.48 -46.89 5.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.37 0.605 . . . . 0.0 109.837 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 34.4 mt-30 -91.75 175.89 6.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.852 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 59.59 -168.92 0.15 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -98.31 -34.11 10.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.556 0.693 . . . . 0.0 110.768 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.72 166.1 15.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.35 -166.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.659 HD12 HH11 ' A' ' 69' ' ' ARG . 1.9 mp -85.18 119.91 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.124 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -90.52 99.48 12.5 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 31.8 mmtp -67.31 -3.21 7.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.73 0.3 . . . . 0.0 111.684 -172.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.7 m -113.79 18.59 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.417 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.5 OUTLIER -66.53 -171.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.798 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.2 m -90.64 113.06 56.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.207 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.75 83.82 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.153 2.569 . . . . 0.0 111.69 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.4 m -153.36 -145.26 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.327 -0.233 . . . . 0.0 110.801 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.599 ' HE2' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -100.67 155.6 17.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 59' ' ' ILE . 19.5 mm -57.7 -41.07 78.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.516 . . . . 0.0 109.909 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.523 175.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 . . . . . 0 CA--C 1.518 -0.264 0 CA-C-O 121.265 0.555 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.88 174.56 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.745 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.87 159.14 9.75 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.763 2.975 . . . . 0.0 111.533 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.65 -9.21 1.02 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.17 3.247 . . . . 0.0 114.569 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -73.49 -55.75 5.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.7 m120 61.48 169.94 0.11 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.7 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.49 130.9 34.71 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 57' ' ' LEU . 21.9 tp -141.69 129.31 21.5 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.501 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -137.81 99.36 3.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.024 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.696 HG12 ' HB ' ' A' ' 53' ' ' VAL . 44.4 mt -110.57 134.62 52.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.718 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -134.36 113.98 12.47 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -95.52 134.34 33.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t 178.43 -161.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 28.0 m-80 68.09 76.78 0.26 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HB3' HG21 ' A' ' 115' ' ' ILE . 57.6 Cg_endo -71.76 119.27 6.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.069 1.846 . . . . 0.0 112.981 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.4 tp60 -111.89 104.71 13.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.6 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.2 m -76.03 106.51 7.67 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -133.51 89.61 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.025 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.93 -167.5 32.94 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.513 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.5 t -101.08 146.89 8.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 119.324 -0.369 . . . . 0.0 110.409 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.72 -51.42 3.96 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.13 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -98.77 89.96 4.52 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.405 0.621 . . . . 0.0 109.554 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.14 29.81 1.43 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.791 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.2 ttt180 -82.46 143.12 31.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 35.0 p90 -137.66 156.62 47.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.695 0.283 . . . . 0.0 110.81 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.2 m -113.78 125.15 53.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.462 . . . . 0.0 110.879 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -92.79 143.85 25.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.397 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -103.89 141.58 35.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.377 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 20.1 tt0 -96.19 115.42 27.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.816 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -94.27 111.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 38.0 mtp180 -96.7 141.61 29.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -147.84 136.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.179 0.514 . . . . 0.0 112.174 177.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.97 142.22 51.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.734 167.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.447 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.0 t -171.49 164.68 6.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 111.261 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.548 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.57 21.47 13.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.766 167.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.695 HD11 HD22 ' A' ' 29' ' ' LEU . 28.6 mt -55.76 133.3 72.5 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.685 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 7.6 Cg_exo -68.83 -34.65 17.62 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.475 2.117 . . . . 0.0 111.39 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.641 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.53 -42.53 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.7 m-30 -68.29 -23.66 64.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 71.1 -61.91 0.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.545 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.8 -14.3 59.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.876 0.307 . . . . 0.0 111.021 -173.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp 71.46 -35.09 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.778 0.674 . . . . 0.0 111.302 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -144.32 145.9 32.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.0 t -169.58 153.41 5.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 7.5 m -141.11 130.56 23.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.138 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -127.1 172.9 13.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 32.5 ttp180 -138.24 109.8 7.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.963 0.411 . . . . 0.0 110.229 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 7.4 tpp180 -135.7 171.82 13.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -171.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 56.6 ttp180 -96.45 158.18 15.55 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.5 t80 -51.35 -41.16 60.42 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.539 0.336 . . . . 0.0 111.0 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.496 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 33.3 p -56.57 -29.62 62.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.8 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 28.3 m-20 -77.55 -30.39 52.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.22 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 46.1 m-85 -64.04 -38.74 92.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 109.679 173.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HA ' HD11 ' A' ' 92' ' ' LEU . 10.9 mt-10 -65.94 -47.97 72.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.633 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.469 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 6.1 t-105 -62.34 -35.29 78.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.703 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.658 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -65.64 -44.33 86.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.2 ttt180 -58.53 -61.33 2.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.24 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -60.12 -35.12 74.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.856 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 5.5 tp10 -66.54 -44.88 81.22 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.297 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.61 -42.36 96.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.858 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 30.8 mt-10 -64.53 -33.12 75.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.953 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.442 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.6 ppt_? -90.18 -23.34 21.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -172.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.32 -41.61 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.033 0.444 . . . . 0.0 111.648 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -130.67 174.87 9.5 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.532 0.682 . . . . 0.0 111.227 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -97.12 32.5 2.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.702 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 94.6 t -51.54 142.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.958 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.5 p -71.28 35.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -56.5 119.31 27.65 Favored Pre-proline 0 N--CA 1.467 0.406 0 O-C-N 121.873 -0.517 . . . . 0.0 111.167 -176.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 163.31 10.7 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.146 2.564 . . . . 0.0 112.411 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.22 135.15 39.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.886 2.391 . . . . 0.0 112.304 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 75' ' ' GLU . 81.8 mt -64.58 152.02 90.56 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.91 124.31 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.46 2.107 . . . . 0.0 110.811 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.0 175.9 47.74 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 68.91 -54.41 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.659 0.784 . . . . 0.0 112.162 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -47.57 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -172.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.524 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -65.31 -24.08 67.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.669 -170.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.747 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -67.4 -46.62 72.69 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.972 0.415 . . . . 0.0 110.602 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.1 ppt_? -95.89 27.26 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.469 0.652 . . . . 0.0 110.395 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -123.27 -42.39 2.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.12 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.79 168.51 11.1 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.471 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.8 140.45 46.47 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.252 2.635 . . . . 0.0 111.151 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -82.48 -75.47 0.3 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 69.78 -56.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.98 -175.91 48.9 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.516 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.44 -51.4 27.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.388 0.613 . . . . 0.0 110.656 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 109' ' ' ILE . 6.8 t70 -117.33 -32.97 4.79 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.53 176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.11 -6.55 7.72 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.289 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.713 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 33.5 pt -66.53 -15.15 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.176 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -78.04 -13.03 60.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.666 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 -17.45 63.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.934 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 47.6 m-80 -73.89 -57.87 3.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.713 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -48.51 -50.56 31.33 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.343 0.402 . . . . 0.0 110.911 178.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.544 HG21 ' HB3' ' A' ' 36' ' ' PRO . 49.4 mt -49.65 -54.81 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.331 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.69 -17.89 58.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.791 -175.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.546 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 67.9 mm-40 -73.27 -35.15 66.14 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.935 0.398 . . . . 0.0 110.481 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 32.7 ttp180 -81.2 -32.48 33.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.99 -50.67 71.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -60.43 -32.65 71.56 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.544 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 -33.58 10.01 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.734 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.3 tp -66.35 -33.36 75.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.206 0.203 . . . . 0.0 111.223 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 33' ' ' VAL . 11.9 pt-20 -75.29 -31.85 60.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.4 mm-40 -59.97 -59.66 5.07 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.474 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -45.84 -51.63 12.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.033 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.557 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.5 tp -65.36 -39.53 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.984 -172.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.85 -16.14 60.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -87.68 -57.8 2.81 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.914 0.864 . . . . 0.0 110.01 174.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.534 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.49 -13.12 13.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.043 -177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.75 4.68 23.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.32 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.07 10.91 2.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.71 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.678 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 51.4 t60 -101.19 141.39 22.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 117.176 0.488 . . . . 0.0 110.665 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.4 Cg_exo -40.87 -49.01 4.51 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.131 3.221 . . . . 0.0 113.822 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.84 -25.73 63.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.441 -174.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.11 -40.78 17.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.926 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -68.78 -0.13 5.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.103 176.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.482 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.9 t-20 -112.14 10.9 20.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.07 131.79 50.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.002 -0.437 . . . . 0.0 111.013 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -55.67 -17.49 5.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -175.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.725 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.2 m -55.33 -31.14 61.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.699 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.574 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.7 mp -73.63 -35.32 65.3 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.667 -0.646 . . . . 0.0 111.484 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 9.9 t60 -58.53 -39.22 79.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.725 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -76.02 -27.71 57.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.795 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t80 -81.03 -57.87 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -84.47 -26.21 28.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.149 -172.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 9.2 mt-30 -113.83 167.24 10.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.531 -166.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.07 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.885 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -175.04 -60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.577 0.703 . . . . 0.0 111.316 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG23 ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -121.9 144.49 30.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.868 -171.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.606 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -65.85 100.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.28 102.23 5.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.416 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 32.2 mmtp -69.88 6.55 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.707 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.4 m -120.81 18.19 11.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.357 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -66.74 -171.32 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.267 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.3 m -87.51 114.16 57.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.901 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -71.06 78.52 1.44 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.751 2.301 . . . . 0.0 110.951 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -155.56 -168.74 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.886 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 4.6 mmmm -80.85 157.98 25.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.92 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.641 HG21 HG13 ' A' ' 59' ' ' ILE . 15.2 mm -50.57 -42.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.155 0.502 . . . . 0.0 110.069 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 120.936 0.398 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.83 177.17 46.24 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.607 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.9 Cg_endo -52.76 153.92 13.67 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 124.098 3.198 . . . . 0.0 112.307 175.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 77.1 Cg_exo -51.92 -14.75 2.61 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.495 3.463 . . . . 0.0 115.431 -172.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -51.07 13.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 27.9 m120 61.27 176.83 0.11 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.021 175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -90.63 137.64 32.2 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -145.15 130.54 18.7 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.978 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.41 100.45 4.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.686 HG12 ' HB ' ' A' ' 53' ' ' VAL . 48.0 mt -111.76 142.27 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.487 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -132.86 119.39 20.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -101.21 130.44 50.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t 178.96 -162.35 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.9 m-80 64.93 76.22 0.33 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.25 147.26 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.86 2.373 . . . . 0.0 113.465 -171.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 43.5 tp60 -130.99 118.85 21.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.572 172.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -77.56 95.9 4.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.63 0.729 . . . . 0.0 109.341 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.02 91.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.159 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.29 -167.38 33.03 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.355 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.0 t -104.3 145.14 13.39 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -37.97 -53.63 2.01 Favored Glycine 0 N--CA 1.463 0.472 0 O-C-N 123.182 0.301 . . . . 0.0 113.445 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -100.62 89.94 4.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.498 0.666 . . . . 0.0 109.435 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.48 35.26 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.573 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -87.77 147.31 25.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 122.957 0.503 . . . . 0.0 110.67 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -140.01 167.71 21.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.5 m -123.47 131.9 53.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 22.3 p -94.67 148.84 21.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.878 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.13 146.67 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.384 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 32.8 tt0 -103.48 121.56 43.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.366 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.806 HD13 ' HD3' ' A' ' 69' ' ' ARG . 2.0 mp -94.39 118.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.227 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HG3' HG23 ' A' ' 66' ' ' THR . 27.1 mtt180 -108.97 126.08 52.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.093 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -130.66 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.035 0.445 . . . . 0.0 112.123 -177.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.67 137.23 53.85 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.65 165.18 6.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.364 0.602 . . . . 0.0 112.227 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.551 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.61 26.07 9.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.971 168.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 29' ' ' LEU . 19.9 mt -60.88 140.33 93.58 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.38 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.4 -23.21 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.824 2.349 . . . . 0.0 111.688 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.06 -41.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.375 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 145' ' ' LEU . 3.0 m-85 -67.26 -27.26 67.06 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -60.2 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.15 -11.12 59.77 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.282 -0.261 . . . . 0.0 111.301 -174.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp 70.9 -33.5 0.27 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.798 0.686 . . . . 0.0 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.22 139.11 25.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 48.5 t -155.59 154.09 31.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.665 -176.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 52' ' ' ARG . 5.8 m -140.77 129.28 22.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.147 0.498 . . . . 0.0 110.427 171.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HB ' ' NH1' ' A' ' 69' ' ' ARG . 2.7 m -139.98 145.46 26.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.04 -175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' NH1' ' HB2' ' A' ' 37' ' ' GLN . 22.1 ttm180 -115.35 116.27 28.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.806 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.13 169.02 18.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.533 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.98 170.1 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.601 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 36.9 t80 -51.76 -40.59 60.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.575 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.559 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 21.7 m -54.34 -31.87 55.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.048 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 69' ' ' ARG . 44.9 m-20 -74.38 -35.63 63.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 58.5 m-85 -66.36 -36.55 83.16 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.689 ' HA ' HD11 ' A' ' 92' ' ' LEU . 31.4 mt-10 -60.09 -56.05 26.45 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 150' ' ' ILE . 7.2 t-105 -64.7 -28.06 69.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.372 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.52 -46.03 56.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 46.3 ttt180 -57.29 -58.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.361 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.676 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 14.4 p -60.82 -37.47 82.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.472 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -63.3 -39.01 93.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.951 0.405 . . . . 0.0 110.731 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.3 mt -62.99 -34.07 76.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.63 -22.79 53.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 79' ' ' SER . 38.9 mmt180 -68.82 -62.23 1.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.01 0.433 . . . . 0.0 111.948 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -98.63 -18.05 18.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.236 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -126.61 166.37 17.45 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.49 0.662 . . . . 0.0 111.117 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -98.51 32.78 2.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.526 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.9 t -51.81 141.33 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.864 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.3 p -71.11 35.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.929 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -59.81 120.69 52.04 Favored Pre-proline 0 C--O 1.236 0.346 0 O-C-N 121.816 -0.553 . . . . 0.0 111.144 -176.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 72.9 Cg_endo -85.65 165.32 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.843 2.362 . . . . 0.0 112.249 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.86 141.51 65.44 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.6 2.2 . . . . 0.0 111.883 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 75' ' ' GLU . 86.8 mt -69.05 145.48 96.52 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 7.8 Cg_exo -71.18 109.33 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.744 2.296 . . . . 0.0 111.479 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.32 46.94 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.003 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 59.08 18.62 6.54 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.913 0.485 . . . . 0.0 111.642 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -118.62 -81.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 0.0 111.627 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.71 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.72 -23.47 67.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.165 -176.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.863 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -62.93 -48.1 80.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.942 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -94.05 20.03 8.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.138 177.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -115.22 -41.9 3.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.322 -177.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 4.5 pp -107.53 169.1 7.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.2 Cg_exo -69.47 132.07 23.01 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.482 2.788 . . . . 0.0 112.66 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 13.6 m-85 -55.92 -63.47 1.17 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.78 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 73.85 -56.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.566 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -110.98 -165.95 18.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.196 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -50.85 -47.53 60.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.22 0.533 . . . . 0.0 111.611 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 109' ' ' ILE . 4.7 t70 -120.62 -29.78 4.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.68 -13.95 6.81 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.644 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 38.2 pt -64.54 -16.31 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.571 -0.814 . . . . 0.0 112.105 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 91.5 m-85 -80.06 -9.36 59.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.677 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.33 137.29 40.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.45 -17.4 61.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.224 -173.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 53.3 m-80 -69.34 -52.43 27.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.227 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.644 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -50.1 -50.63 47.76 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.478 0.486 . . . . 0.0 111.083 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.19 -52.2 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.27 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -73.48 -20.58 60.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.359 -176.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 63.3 mm-40 -72.07 -35.47 69.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 110.036 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 36.7 ttm180 -80.92 -34.98 33.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -54.44 -50.98 66.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.24 -178.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -62.19 -37.46 85.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.481 -174.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.33 -34.94 12.86 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.594 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.4 tp -67.78 -32.39 72.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 122.14 0.176 . . . . 0.0 111.228 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.7 pt-20 -75.81 -29.79 58.82 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.2 mm-40 -64.41 -54.17 36.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -48.85 -53.7 18.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.399 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -65.57 -40.23 87.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.878 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -61.46 -16.99 52.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.109 0.48 . . . . 0.0 111.891 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.559 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 67.2 mttt -90.45 -58.75 2.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.018 0.914 . . . . 0.0 110.69 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -66.22 -11.73 13.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.337 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.59 -0.07 20.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.506 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -132.67 6.13 5.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.407 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.693 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 30.3 t60 -100.71 143.42 26.54 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 117.028 0.414 . . . . 0.0 110.921 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.693 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 4.5 Cg_exo -43.17 -50.17 6.67 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.105 3.203 . . . . 0.0 113.266 -174.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -67.91 -28.08 67.19 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.249 -174.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -81.28 -42.7 20.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.857 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 7.6 mm-40 -62.29 -6.25 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.932 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.8 t-20 -108.75 10.1 26.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.824 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.508 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 51.0 mm-40 -115.71 126.08 53.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.951 0.405 . . . . 0.0 111.206 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -56.14 -26.18 49.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.847 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.764 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.3 p -62.2 -24.72 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 145' ' ' LEU . 2.7 mp -66.52 -33.81 76.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.653 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.529 ' HA ' ' OE1' ' A' ' 146' ' ' GLN . 33.4 t-80 -62.77 -34.85 78.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.384 -175.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.764 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -85.04 -28.16 25.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.376 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.468 ' N ' ' HG2' ' A' ' 143' ' ' MET . 31.9 t80 -81.17 -44.81 17.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.532 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.0 mt -93.05 -45.41 7.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.625 0.726 . . . . 0.0 110.574 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 142' ' ' HIS . 30.6 mt-30 -97.87 -172.71 2.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.652 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.13 -132.62 1.76 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.537 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.469 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -130.01 -37.56 1.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -148.33 161.35 6.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.53 0.681 . . . . 0.0 112.515 -168.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.518 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.8 mp -87.14 105.59 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.626 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.46 109.03 20.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.802 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 10.7 mptt -76.45 10.8 1.87 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.724 0.774 . . . . 0.0 111.325 -173.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -115.19 14.61 16.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.82 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -65.74 -171.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.493 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.3 m -89.38 114.0 58.68 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 23.0 Cg_exo -67.02 95.62 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.984 2.456 . . . . 0.0 110.835 174.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 9.4 t -165.95 -155.73 0.24 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.384 0.611 . . . . 0.0 110.501 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.501 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.4 mmmt -97.92 161.94 13.49 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.654 HG21 HG13 ' A' ' 59' ' ' ILE . 22.2 mm -53.74 -47.57 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.833 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.343 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.459 ' CD2' ' HB2' ' A' ' 56' ' ' ASN . 1.9 m-85 . . . . . 0 CA--C 1.518 -0.27 0 CA-C-O 120.447 0.165 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.66 178.37 47.95 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.42 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.92 157.36 8.09 Favored 'Trans proline' 0 C--N 1.335 -0.17 0 C-N-CA 124.288 3.326 . . . . 0.0 112.392 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.96 -19.66 0.88 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.947 3.765 . . . . 0.0 115.441 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -75.22 -53.41 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.59 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.8 m120 61.11 178.4 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.588 0.355 . . . . 0.0 111.928 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -92.96 139.27 30.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 57' ' ' LEU . 18.3 tp -145.56 131.51 19.2 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.159 -176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 7.8 pt-20 -140.31 102.57 4.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.254 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.642 HG12 ' HB ' ' A' ' 53' ' ' VAL . 51.6 mt -114.05 140.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.345 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -137.12 108.91 7.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.656 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.6 m -85.85 129.52 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t 179.95 -164.3 0.06 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.4 m-80 53.34 67.81 3.42 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.51 164.51 14.42 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.96 2.44 . . . . 0.0 113.41 -168.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -142.82 116.26 9.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.797 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.494 HG22 ' NE ' ' A' ' 45' ' ' ARG . 45.6 m -80.17 89.22 5.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.561 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.1 98.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.145 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.9 -167.07 31.53 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.964 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.8 t -102.29 148.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.123 -176.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.73 -49.81 5.97 Favored Glycine 0 N--CA 1.461 0.351 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.51 85.27 3.58 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.51 36.27 0.86 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.699 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 18.0 ttt180 -81.31 150.07 28.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.82 168.64 19.31 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 m -124.61 126.57 45.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 111.143 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 p -93.62 153.84 18.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.233 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -124.02 142.01 51.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.877 0.37 . . . . 0.0 110.5 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.4 tt0 -94.26 121.45 35.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.133 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.7 mp -97.61 108.96 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 110.623 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 34.0 mtp180 -97.97 136.53 38.11 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.703 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.642 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.24 136.99 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 13.0 ttmt -125.46 138.31 54.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.812 168.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.524 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.3 t -168.5 165.53 12.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 111.834 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.495 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -119.1 24.34 10.84 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.812 169.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.67 HD11 HD22 ' A' ' 29' ' ' LEU . 28.4 mt -60.82 135.02 92.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.89 174.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.2 Cg_exo -69.85 -30.88 21.18 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.375 2.05 . . . . 0.0 111.404 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.63 HG13 HG21 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -65.22 -42.27 93.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.393 175.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.4 m-30 -68.5 -12.47 61.29 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -168.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 72.01 -66.78 0.29 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 169.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.567 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.1 -7.56 59.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 122.368 -0.208 . . . . 0.0 110.869 -173.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmpp? 70.93 -39.41 0.45 Allowed 'General case' 0 C--O 1.218 -0.592 0 O-C-N 123.873 0.733 . . . . 0.0 111.205 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.0 pp20? -157.77 141.5 15.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.094 0.473 . . . . 0.0 109.989 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.9 t -170.2 172.13 6.47 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.23 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 22.3 m -141.59 127.96 19.95 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.192 0.52 . . . . 0.0 110.492 174.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.0 m -118.61 173.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 68' ' ' ARG . 18.5 ttm180 -137.69 115.24 11.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.117 0.484 . . . . 0.0 110.511 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 3.4 mmp_? -140.92 167.44 22.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.846 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 71' ' ' TYR . 46.9 ttt180 -98.52 165.48 11.81 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.068 -173.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.524 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 40.4 t80 -50.58 -39.86 50.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.6 0.238 . . . . 0.0 111.433 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.8 p -57.03 -31.35 65.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.72 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -71.43 -38.59 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 51.2 m-85 -61.73 -42.39 98.89 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 0.0 109.949 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HA ' HD11 ' A' ' 92' ' ' LEU . 29.1 mt-10 -55.9 -55.05 37.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.321 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.447 ' CD1' HG21 ' A' ' 150' ' ' ILE . 5.8 t-105 -61.93 -33.23 73.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.312 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 2.8 tm? -71.68 -42.89 66.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.5 ttt180 -56.06 -63.95 1.02 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.139 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.596 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -59.86 -34.49 73.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.049 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.62 -43.95 96.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.098 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.51 -37.66 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.737 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 56.5 mt-10 -67.37 -33.73 75.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.277 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 79' ' ' SER . 24.4 mmt180 -76.34 -61.15 2.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.255 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -66.99 -31.51 72.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.277 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -139.16 179.68 6.37 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.67 0.748 . . . . 0.0 112.069 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -97.86 22.42 9.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.696 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 89' ' ' VAL . 84.8 t -44.54 140.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.103 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.2 p -71.42 33.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.98 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -54.88 119.8 24.42 Favored Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 122.161 -0.337 . . . . 0.0 110.697 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 93.6 Cg_endo -85.5 163.53 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.697 2.265 . . . . 0.0 112.398 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 136.05 52.55 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.841 2.36 . . . . 0.0 112.097 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 89.3 mt -69.23 149.08 97.56 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.723 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.9 Cg_exo -72.7 109.28 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.446 2.097 . . . . 0.0 110.966 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -166.45 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.559 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.58 45.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.1 -0.647 . . . . 0.0 110.35 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.8 -103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -53.54 -30.25 40.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 94' ' ' GLY . 1.8 mm? -66.74 -44.97 80.1 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.179 -0.326 . . . . 0.0 111.299 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 8.42 42.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.771 0.796 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.6 tp-100 -97.11 -38.75 9.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.328 176.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 42.5 mt -94.32 163.69 22.39 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.58 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.11 175.94 9.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.388 2.726 . . . . 0.0 111.432 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -76.07 -79.28 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 60.62 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.585 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.87 75.53 1.08 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.874 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 69.16 -63.22 0.38 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.885 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.42 -29.84 1.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.375 0.607 . . . . 0.0 110.356 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.75 15.76 3.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.966 -173.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.703 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.1 pt -83.53 -18.95 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.387 . . . . 0.0 112.037 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.24 -9.42 59.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 109.794 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.03 118.7 23.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.653 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.06 -17.01 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.835 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 85.9 m-20 -63.35 -61.58 2.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.703 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -47.78 -51.47 22.3 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.635 0.584 . . . . 0.0 111.441 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.1 mt -50.13 -50.31 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.314 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -83.74 -14.31 51.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.817 -177.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.665 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 30.2 mt-10 -80.16 -28.12 38.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -75.71 -37.6 59.32 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.98 -52.04 67.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.055 -178.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.69 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -59.13 -43.3 91.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 -36.26 38.68 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.062 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -64.01 -38.6 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.811 0.306 . . . . 0.0 111.62 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.3 pt-20 -73.0 -31.13 64.3 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.9 mm-40 -61.58 -59.36 5.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.5 t80 -48.82 -54.09 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.756 -1.565 . . . . 0.0 111.383 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -64.04 -41.03 91.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.031 -170.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.32 0.509 . . . . 0.0 111.836 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -90.49 -58.59 2.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.849 0.833 . . . . 0.0 110.248 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.75 -12.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.256 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.51 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -109.74 3.0 20.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.08 -8.01 2.44 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.327 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.641 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 58.9 t60 -82.49 139.81 44.58 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.8 Cg_endo -44.15 -47.31 10.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.096 3.197 . . . . 0.0 113.292 -172.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.436 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -68.61 -33.16 73.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.125 -176.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.74 -43.84 35.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.745 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.493 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.67 -6.41 3.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.229 172.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.619 HD22 ' HE3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -99.79 -6.35 27.1 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.164 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.442 ' C ' HG12 ' A' ' 159' ' ' ILE . 30.1 mm-40 -107.43 129.93 54.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.693 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.427 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -56.04 -20.34 16.43 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.584 -174.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.538 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.0 m -59.25 -30.31 68.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.359 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 145' ' ' LEU . 1.1 mp -69.79 -35.33 74.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.172 -0.33 . . . . 0.0 111.208 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.679 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 11.9 t-80 -54.25 -41.36 68.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.626 0.727 . . . . 0.0 109.691 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 3.3 ptm -81.0 -27.93 35.68 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.446 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.3 t80 -79.87 -59.17 2.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.154 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.619 HD11 ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -106.38 7.09 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -175.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.5 mt-30 -121.33 -176.1 3.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.65 -111.64 0.58 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.408 0.443 . . . . 0.0 110.889 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.7 pm0 -145.42 -39.13 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 112.027 175.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.06 148.69 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.161 -166.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.551 HG22 ' HE3' ' A' ' 152' ' ' LYS . 3.4 mp -72.25 102.84 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.812 172.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -89.74 102.94 15.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.25 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.551 ' HE3' HG22 ' A' ' 150' ' ' ILE . 5.4 mptt -74.74 11.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.296 0.57 . . . . 0.0 111.913 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -111.79 12.53 20.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.166 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -171.84 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.679 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.2 m -92.52 113.71 60.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.54 89.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.018 2.479 . . . . 0.0 110.941 174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 t -159.7 -154.63 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.395 0.617 . . . . 0.0 110.868 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.619 ' HE3' HD22 ' A' ' 137' ' ' ASN . 14.8 mmmt -96.8 157.78 15.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.474 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.63 HG21 HG13 ' A' ' 59' ' ' ILE . 19.6 mm -57.77 -41.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.0 109.922 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.01 -179.336 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 CA--C 1.52 -0.174 0 CA-C-O 120.909 0.385 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.7 40.15 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.041 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.38 153.45 13.4 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 124.088 3.192 . . . . 0.0 111.608 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -41.13 -30.26 0.65 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 124.6 3.533 . . . . 0.0 115.504 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -70.75 -52.21 22.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 30.9 m-80 61.53 -179.42 0.12 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 112.135 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.39 132.41 36.22 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 57' ' ' LEU . 13.2 tp -143.0 127.21 17.56 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.58 0.705 . . . . 0.0 111.188 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.15 100.79 3.79 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.688 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.682 HG12 ' HB ' ' A' ' 53' ' ' VAL . 46.7 mt -111.82 138.71 39.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.116 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -131.77 103.24 6.23 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -79.35 131.51 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -178.03 -165.13 0.09 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 63.06 81.73 0.22 Allowed Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 121.375 0.607 . . . . 0.0 110.432 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.13 119.59 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.123 2.549 . . . . 0.0 112.527 -175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 50.0 tp60 -108.81 106.47 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.541 174.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.8 m -77.84 103.15 7.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -134.07 89.9 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.05 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.42 -167.86 33.02 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.218 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 t -104.37 149.91 7.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.337 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.86 3.19 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 121.549 -0.357 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -96.67 86.9 4.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.647 . . . . 0.0 109.858 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.94 34.85 0.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.975 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 20.9 ttt180 -82.71 146.84 28.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -143.47 165.76 26.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.901 0.381 . . . . 0.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 36.5 m -121.78 129.02 52.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.481 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 44.0 p -92.73 140.86 29.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 98.6 m-85 -100.22 126.75 46.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.07 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.648 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 15.5 tt0 -86.17 120.34 27.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.289 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -93.34 106.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.691 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -95.44 112.03 23.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.424 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.682 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -122.66 140.68 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -126.86 136.87 52.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.244 168.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.532 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.1 t -170.65 164.54 8.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.31 0.576 . . . . 0.0 112.152 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.04 26.02 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.824 168.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 29' ' ' LEU . 26.5 mt -60.4 136.42 91.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.543 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -68.34 -32.87 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.227 1.952 . . . . 0.0 111.162 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 159' ' ' ILE . 1.1 tt -66.69 -37.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.411 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 4.0 m-30 -75.07 -5.37 43.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -169.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 tttt 67.16 -74.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.18 -4.38 55.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 120.518 0.199 . . . . 0.0 110.502 -171.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 5.5 mmtp 70.31 -42.38 0.52 Allowed 'General case' 0 C--O 1.221 -0.417 0 O-C-N 124.122 0.889 . . . . 0.0 111.496 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.19 127.27 5.67 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.408 0.623 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 t -166.97 176.22 7.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.547 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.648 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 21.5 m -140.68 122.74 15.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 111.947 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.49 -178.1 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.866 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 38.6 ptt180 -150.53 133.1 15.72 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.109 170.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 4.0 mmp_? -136.11 177.99 7.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.624 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' HD1' ' A' ' 74' ' ' PHE . 61.6 mtp180 -93.13 173.2 7.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.282 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.9 t80 -60.48 -40.52 91.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 p -60.49 -26.78 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB3' HD12 ' A' ' 150' ' ' ILE . 9.3 m-20 -73.23 -37.02 66.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.913 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 34.9 m-85 -65.98 -41.36 91.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 92' ' ' LEU . 21.8 mt-10 -55.91 -53.53 55.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.021 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.444 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.5 t-105 -64.07 -30.27 71.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.331 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -73.44 -43.96 59.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 35.5 ttt180 -56.59 -61.82 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.176 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 32.7 t -59.62 -38.54 81.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.586 -173.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -48.48 75.93 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.2 mt -63.79 -40.37 96.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.201 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.9 mt-10 -66.94 -41.84 86.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.824 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.3 mmm180 -74.96 -53.6 8.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.791 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -82.86 -25.83 32.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.101 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 m -130.46 175.3 9.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.717 0.77 . . . . 0.0 111.569 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -99.13 29.96 3.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.581 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' A' ' 89' ' ' VAL . 60.3 t -54.61 142.31 8.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.0 p -73.15 34.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.037 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.516 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -57.05 122.9 56.65 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 121.886 -0.509 . . . . 0.0 111.206 -175.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 88.7 Cg_endo -85.62 167.82 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.926 2.418 . . . . 0.0 111.868 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 150.31 64.66 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.478 2.119 . . . . 0.0 112.244 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 75' ' ' GLU . 92.6 mt -78.41 151.99 78.21 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.255 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.32 110.8 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.778 2.319 . . . . 0.0 111.154 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.3 43.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.724 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -153.18 58.74 0.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.492 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -165.43 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.626 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -59.47 -29.0 67.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.945 -173.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.444 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.3 ppt_? -99.81 29.33 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 0.0 110.196 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -124.83 -41.43 2.12 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.405 -177.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 54.1 mt -85.23 166.76 29.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.18 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 33.5 Cg_exo -60.06 143.07 99.58 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.986 2.457 . . . . 0.0 112.254 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 6.9 m-85 -73.65 -62.95 1.31 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 69.77 -60.49 0.47 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.886 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.31 -145.83 7.29 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.954 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.96 -42.47 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 111.432 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -127.87 -53.26 1.32 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -173.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 141.43 -12.57 2.74 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.599 -171.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 39.3 pt -56.12 -19.84 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -76.22 -7.29 54.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.434 . . . . 0.0 110.834 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.01 125.7 34.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -69.45 -17.94 63.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.122 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.9 m-80 -72.58 -47.41 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -49.03 -49.57 40.52 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.5 0.5 . . . . 0.0 110.71 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.95 -50.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.618 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -79.18 -16.31 56.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.849 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 65.4 mm-40 -73.31 -35.32 66.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.445 ' HD2' ' OH ' ' A' ' 49' ' ' TYR . 33.0 ttm180 -79.04 -31.89 44.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -58.91 -50.96 72.06 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.652 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.688 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -61.45 -37.56 84.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 -40.49 16.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.136 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -62.11 -35.43 78.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.9 0.35 . . . . 0.0 111.281 178.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 126' ' ' ILE . 15.9 pt-20 -75.52 -33.18 60.7 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.6 mm-40 -61.67 -56.1 23.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -51.15 -52.77 40.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.433 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.44 -41.06 90.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.055 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -60.41 -17.99 47.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 0.0 111.981 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.9 mttm -88.25 -59.39 2.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.111 0.957 . . . . 0.0 110.593 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 126' ' ' ILE . 1.4 m -65.35 -13.13 14.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.398 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.41 -5.64 23.89 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.443 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.36 14.3 4.82 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.004 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 45.1 t60 -100.19 139.45 20.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.796 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.1 Cg_exo -41.32 -49.53 4.84 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.516 3.477 . . . . 0.0 113.706 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.68 -26.63 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.386 -174.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.492 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -86.76 -42.16 13.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.423 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.39 -2.66 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.182 170.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t-20 -111.3 7.83 21.19 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.937 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -116.03 126.98 54.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.0 0.429 . . . . 0.0 111.199 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -52.46 -29.31 24.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.041 -173.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.666 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 15.5 t -63.75 -22.47 66.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.83 0.347 . . . . 0.0 111.434 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -68.45 -30.85 69.81 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.793 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 7.3 t60 -67.09 -38.09 85.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.666 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 6.3 ptm -79.61 -25.28 41.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.826 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 150' ' ' ILE . 24.7 t80 -80.17 -52.54 7.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.192 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.699 ' HG ' ' CZ ' ' A' ' 60' ' ' PHE . 3.2 mm? -78.36 -25.83 46.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.921 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.697 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 28.1 mt-30 -129.48 176.7 7.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.068 -164.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.49 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 149' ' ' ILE . 9.3 tp10 177.18 -58.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.656 0.741 . . . . 0.0 110.862 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -116.24 135.85 55.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.824 -171.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 144' ' ' PHE . 46.6 mt -72.98 111.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.621 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 153' ' ' SER . 10.3 t70 -91.82 99.86 12.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.0 mptt -70.85 11.64 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 151' ' ' ASP . 25.4 m -116.06 14.03 15.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.2 174.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -61.2 -170.93 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.611 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 93.7 m -91.66 112.21 53.29 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -70.57 88.7 0.62 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.325 2.683 . . . . 0.0 111.724 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 50.1 m -156.95 -159.56 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.175 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.547 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.5 mmmt -91.23 160.02 15.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.619 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.29 -44.27 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.716 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.088 0.47 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.87 45.42 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.807 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 155.24 14.42 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 C-N-CA 123.889 3.06 . . . . 0.0 112.334 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -49.35 -18.67 2.35 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.853 3.702 . . . . 0.0 114.698 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.2 m -70.84 -54.19 12.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.562 HD22 ' ND2' ' A' ' 56' ' ' ASN . 27.4 m120 61.29 163.24 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.588 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -87.07 139.06 30.96 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -143.79 129.75 19.51 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.545 -177.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -142.03 101.43 3.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.72 0.771 . . . . 0.0 110.237 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.6 mt -111.04 133.68 55.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.223 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.36 100.79 6.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.279 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -78.01 128.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 106.716 -1.586 . . . . 0.0 106.716 171.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 p -176.8 -163.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 27.3 m-80 58.26 70.76 1.15 Allowed Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.398 . . . . 0.0 110.271 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 115' ' ' ILE . 97.4 Cg_endo -77.15 132.34 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.796 2.331 . . . . 0.0 113.414 -172.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.3 tp60 -119.92 107.78 13.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.546 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.532 HG22 ' NE ' ' A' ' 45' ' ' ARG . 54.6 m -78.02 96.12 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.569 0.7 . . . . 0.0 109.896 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.2 p -123.82 94.39 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.379 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.65 -165.82 30.26 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.078 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.9 t -97.22 146.43 7.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.166 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.16 -48.18 6.59 Favored Glycine 0 N--CA 1.46 0.263 0 C-N-CA 121.521 -0.371 . . . . 0.0 113.144 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.91 89.85 3.43 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.57 0.7 . . . . 0.0 109.222 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.74 33.09 0.95 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.474 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.585 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 27.8 ttt180 -85.66 146.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.057 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.43 149.47 51.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.54 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.5 m -105.19 128.29 53.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.347 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 35.9 p -93.16 144.3 25.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.87 138.75 49.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 110.767 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 34.8 tt0 -96.79 120.79 37.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.204 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.9 mp -98.64 109.82 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -96.1 145.02 25.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.699 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.68 138.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.497 . . . . 0.0 112.175 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -127.54 143.61 51.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.009 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -171.75 164.58 6.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.022 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.562 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.62 23.94 11.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.596 167.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 29' ' ' LEU . 28.2 mt -58.57 138.58 85.87 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.713 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 2.4 Cg_endo -77.0 -24.99 9.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.5 2.134 . . . . 0.0 111.424 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.41 -42.27 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.532 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.5 m-30 -68.46 -25.59 65.07 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -170.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.63 -60.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.77 -9.02 59.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.831 0.287 . . . . 0.0 111.293 -172.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 70.0 -41.7 0.49 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.839 0.712 . . . . 0.0 110.994 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.53 144.93 36.22 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -163.81 158.12 19.7 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.5 m -142.31 136.61 29.89 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.534 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.85 176.04 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.655 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 35.2 ttp180 -137.89 113.8 9.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.03 0.443 . . . . 0.0 110.438 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 12.1 mmm180 -131.44 177.4 7.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 70' ' ' ARG . 53.7 mtm180 -100.23 172.08 7.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.29 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.6 t80 -61.81 -38.18 87.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.492 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 17.0 p -57.77 -28.62 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.248 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 150' ' ' ILE . 5.0 m-20 -70.88 -40.13 72.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.128 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.27 -40.27 95.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 109.892 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 19.9 mt-10 -61.76 -44.98 95.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.826 0.822 . . . . 0.0 110.138 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE2' ' HG3' ' A' ' 152' ' ' LYS . 7.3 t-105 -64.03 -36.31 83.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.521 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 144' ' ' PHE . 32.3 tp -70.77 -48.03 56.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.144 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 56.8 ttt180 -50.61 -60.11 3.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.2 p -61.86 -42.21 98.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.959 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.43 -49.28 64.87 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.332 0.395 . . . . 0.0 111.149 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.21 -38.4 90.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.6 mt-10 -70.89 -20.19 62.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.752 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 79' ' ' SER . 26.5 mmt180 -80.21 -61.77 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.499 . . . . 0.0 112.113 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB2' ' OE2' ' A' ' 138' ' ' GLU . 43.7 mm-40 -84.74 -22.98 29.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.054 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 m -131.98 171.88 13.04 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.687 0.756 . . . . 0.0 112.005 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -97.99 33.46 2.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.402 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 66.6 t -54.3 140.0 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.535 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.1 p -72.41 32.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.99 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 78' ' ' ARG . 1.4 t -53.56 122.36 31.88 Favored Pre-proline 0 N--CA 1.466 0.334 0 O-C-N 122.126 -0.359 . . . . 0.0 111.258 -175.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 87.2 Cg_endo -85.75 165.17 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.175 2.583 . . . . 0.0 112.514 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.8 Cg_endo -65.76 142.95 72.12 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.852 2.368 . . . . 0.0 112.285 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.7 mt -69.8 154.17 94.93 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.775 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 60.1 Cg_endo -77.52 109.11 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.506 2.137 . . . . 0.0 110.953 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.88 -177.12 37.2 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.073 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.583 ' N ' HD23 ' A' ' 98' ' ' LEU . 12.5 mptt 68.15 -63.18 0.34 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.605 0.762 . . . . 0.0 112.202 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.71 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -76.16 -22.37 55.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.542 -169.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.73 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -64.82 -42.82 94.67 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 30.11 3.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.621 0.724 . . . . 0.0 110.064 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.601 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.7 tt0 -130.06 -38.78 1.41 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.293 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG3' ' A' ' 117' ' ' GLU . 54.0 mt -90.03 169.21 12.82 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.104 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -64.34 140.43 70.21 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.636 2.224 . . . . 0.0 111.527 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 45.2 m-85 -83.15 -83.13 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.208 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 66.87 -69.4 0.13 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.862 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 110' ' ' PHE . . . -88.85 71.13 2.45 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.636 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.15 -71.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.29 1.036 . . . . 0.0 111.366 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.01 -36.4 9.03 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.827 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.73 -5.01 7.51 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.521 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.689 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.6 pt -68.92 -17.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.472 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 58.1 m-85 -81.25 -4.62 56.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.836 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -100.01 131.47 45.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.268 0.556 . . . . 0.0 109.904 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.51 -25.65 64.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.572 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.4 m-20 -64.21 -59.98 3.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.689 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.66 -47.23 58.71 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.419 0.449 . . . . 0.0 111.044 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' A' ' 36' ' ' PRO . 65.4 mt -52.72 -52.98 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.617 -174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.93 -19.52 61.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.291 -177.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 40.6 mm-40 -75.63 -31.23 59.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.437 0.637 . . . . 0.0 109.64 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.03 -39.89 32.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.7 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.64 -51.34 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.795 -178.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.8 pt20 -61.25 -41.18 96.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 93' ' ' PRO . . . -72.18 -38.67 59.02 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.563 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -67.12 -35.64 80.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.205 0.502 . . . . 0.0 111.236 178.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 126' ' ' ILE . 8.2 pt-20 -76.12 -29.04 57.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.3 mm-40 -62.52 -58.86 6.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.2 t80 -51.3 -52.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.074 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' A' ' 123' ' ' GLU . 9.7 tp -63.35 -43.8 98.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -170.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -59.78 -20.12 54.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 38.3 mttm -84.0 -58.25 2.85 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.987 0.898 . . . . 0.0 110.14 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.541 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -65.3 -11.96 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.338 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -97.16 -15.41 20.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.626 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.426 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -123.68 1.89 9.38 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.281 -0.961 . . . . 0.0 114.044 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.676 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.7 t60 -89.67 141.94 28.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 117.321 0.561 . . . . 0.0 110.758 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.676 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.3 Cg_exo -40.55 -50.57 3.76 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.356 3.37 . . . . 0.0 113.774 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.34 -23.85 62.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.422 -174.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -88.36 -42.22 12.34 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.439 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.463 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.57 -4.26 1.88 Allowed 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.523 0.678 . . . . 0.0 110.256 172.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -105.6 2.1 27.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.269 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 84' ' ' GLU . 4.9 mm-40 -114.29 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.879 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -55.48 -20.88 14.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.421 -175.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 143' ' ' MET . 6.0 t -65.51 -24.23 67.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.3 mp -71.6 -31.11 66.57 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.7 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 6.3 t60 -61.73 -34.18 75.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.1 ptm -84.43 -26.16 28.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.5 t80 -78.98 -54.13 6.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.552 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.29 -33.84 22.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 0.0 110.713 -174.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 8.5 mt-30 -107.54 -175.44 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.329 -170.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 54.75 -145.05 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -117.92 -32.83 4.66 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 111.543 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -145.42 156.76 13.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.874 0.845 . . . . 0.0 113.132 -166.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.592 HG12 ' HG3' ' A' ' 143' ' ' MET . 81.3 mt -89.12 111.99 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.02 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -99.78 106.24 18.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.781 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' CE2' ' A' ' 76' ' ' TRP . 9.5 mptt -71.39 5.55 2.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 111.773 -171.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 m -109.31 13.74 24.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.834 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.48 -172.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.499 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 99.0 m -95.45 112.83 60.19 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -69.82 50.21 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.916 3.078 . . . . 0.0 113.262 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 71.2 m -108.69 -160.59 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.82 0.343 . . . . 0.0 110.536 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HB3' HD22 ' A' ' 137' ' ' ASN . 18.5 mmmt -86.78 160.31 18.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 59' ' ' ILE . 17.5 mm -52.78 -45.87 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.547 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.306 174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.4 m-85 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.2 178.78 41.2 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.28 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.02 154.43 13.37 Favored 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 124.314 3.343 . . . . 0.0 111.866 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.39 -27.01 4.5 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 124.078 3.185 . . . . 0.0 115.354 -169.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' HD21 ' A' ' 57' ' ' LEU . 9.0 t -87.72 -33.55 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.794 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 22.0 m-80 57.41 -173.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.96 128.99 34.87 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 57' ' ' LEU . 16.7 tp -141.36 130.47 23.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.129 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 7.7 pt-20 -139.19 109.0 6.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.245 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.69 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.9 mt -120.84 137.8 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 115.75 14.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -98.08 133.79 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.2 t 179.16 -161.54 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.1 m-80 62.22 68.66 1.04 Allowed Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 0.0 110.271 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.84 134.57 23.97 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.797 2.331 . . . . 0.0 113.832 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.6 tp60 -117.36 106.52 13.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.006 170.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.569 HG22 ' HE ' ' A' ' 45' ' ' ARG . 32.4 m -78.95 97.12 5.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.0 110.037 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -125.81 90.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.973 -170.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -165.41 29.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.9 t -97.02 149.13 5.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.649 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.09 -48.1 6.48 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 121.508 -0.377 . . . . 0.0 113.299 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -101.9 87.99 3.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 34.2 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.5 ttt180 -84.36 140.27 31.7 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -125.24 157.31 36.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.938 0.399 . . . . 0.0 110.408 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 m -110.35 127.72 55.2 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.079 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.629 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.2 p -92.82 128.55 38.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 87.6 m-85 -101.9 134.84 44.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 tt0 -86.91 121.76 29.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.897 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.6 mp -95.55 116.26 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 35.0 mtt180 -109.82 119.33 39.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.55 175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -123.57 142.5 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 111.953 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 15.9 ttmt -127.49 138.16 52.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 165.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -171.12 165.24 7.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.5 0.667 . . . . 0.0 111.899 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.465 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -121.79 28.46 7.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.397 169.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 29' ' ' LEU . 17.8 mt -62.82 145.24 96.17 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.575 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD3' ' ND2' ' A' ' 27' ' ' ASN . 70.5 Cg_endo -78.8 -15.68 13.29 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.726 2.284 . . . . 0.0 112.345 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -85.06 -41.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.75 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' HD13 ' A' ' 145' ' ' LEU . 2.3 m-30 -68.51 -29.69 68.34 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 74.25 -57.52 0.61 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.421 0.451 . . . . 0.0 112.023 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.11 -12.44 59.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.648 0.204 . . . . 0.0 111.099 -173.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp 71.93 -38.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.809 0.693 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.44 146.36 26.61 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.176 0.512 . . . . 0.0 109.911 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -170.09 159.14 7.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.196 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.4 m -140.84 136.55 32.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.416 0.627 . . . . 0.0 111.462 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 4.6 m -143.71 179.92 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.765 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 7.1 ptp180 -140.31 126.01 19.26 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.446 173.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.581 HH11 HG13 ' A' ' 150' ' ' ILE . 22.2 mmt85 -125.58 161.39 27.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.487 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -82.09 159.84 23.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 24.7 t80 -55.26 -38.31 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -59.26 -28.05 66.36 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.461 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 150' ' ' ILE . 52.2 m-20 -74.72 -37.24 62.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.187 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 57.2 m-85 -65.02 -36.16 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.937 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.1 mt-10 -63.45 -51.77 64.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 5.0 t-105 -61.64 -34.93 76.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.945 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -67.79 -44.24 77.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 66.4 ttt180 -57.14 -59.61 4.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.973 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.677 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 t -62.33 -36.01 80.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.973 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -53.93 -56.45 17.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 109.758 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.16 -35.28 76.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.296 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 20.3 mt-10 -69.37 -38.84 78.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 79' ' ' SER . 33.3 mmt180 -69.29 -60.36 2.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 0.0 111.443 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.66 -22.29 29.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.929 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -126.64 175.21 8.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.208 0.528 . . . . 0.0 112.112 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -103.0 21.03 16.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.874 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.9 t -48.01 142.0 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.125 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.89 36.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.787 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -55.61 119.6 26.05 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -175.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 86.0 Cg_endo -85.9 168.37 9.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.13 2.553 . . . . 0.0 112.325 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 147.3 70.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.697 2.265 . . . . 0.0 112.554 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 75' ' ' GLU . 78.2 mt -73.97 157.67 86.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.418 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.4 109.03 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.577 2.185 . . . . 0.0 111.439 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.5 -171.46 38.07 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.602 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 68.03 -2.75 1.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.785 0.434 . . . . 0.0 111.733 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.57 -89.98 0.46 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -52.6 -23.57 6.7 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 113.296 -174.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.8 mm? -60.86 -41.55 96.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.994 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 18.24 21.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.692 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.0 tp-100 -113.71 -40.24 3.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.96 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 114' ' ' PHE . 35.8 mt -89.7 165.87 23.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.515 -175.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.02 164.15 28.57 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.081 2.521 . . . . 0.0 111.962 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -83.23 -100.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 65.78 -65.87 0.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 111.577 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.96 52.18 4.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.146 -0.55 . . . . 0.0 111.952 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 63.9 -71.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.69 1.196 . . . . 0.0 110.391 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.01 -20.06 17.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.933 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.7 14.03 20.59 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.642 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.9 pt -83.21 -16.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.989 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 70.0 m-85 -79.69 1.24 27.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.453 175.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 113' ' ' ASN . 24.9 t70 -86.45 129.92 34.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.64 -19.76 63.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.88 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB2' ' OD2' ' A' ' 111' ' ' ASP . 46.4 m-80 -74.14 -54.37 7.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -49.87 -50.05 47.11 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.748 0.655 . . . . 0.0 111.158 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.7 mt -52.26 -45.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.278 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.0 -15.24 57.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.742 -178.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 42.4 mm-40 -70.78 -34.69 72.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.302 0.573 . . . . 0.0 109.767 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.483 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 36.5 ttm180 -78.52 -36.37 45.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -55.13 -49.32 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.827 -178.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -61.46 -33.72 74.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.496 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.02 -33.66 9.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.992 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 122' ' ' LEU . 7.4 tp -66.32 -33.61 76.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.138 0.175 . . . . 0.0 111.018 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.645 ' HB3' HG22 ' A' ' 33' ' ' VAL . 10.5 pt-20 -75.22 -32.47 61.16 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.9 mm-40 -59.96 -59.85 4.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 4.7 t80 -45.63 -51.72 11.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.022 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.12 -39.05 84.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.83 -172.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.17 -12.53 28.65 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HD3' ' HG3' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -90.78 -59.46 2.17 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.734 0.778 . . . . 0.0 110.177 172.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.563 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -65.03 -12.19 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.056 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.02 1.5 22.49 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.354 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.87 12.95 2.4 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.509 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.69 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 54.8 t60 -100.26 140.32 21.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.987 0.394 . . . . 0.0 110.19 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.668 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 3.8 Cg_exo -43.94 -43.91 12.15 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.936 3.091 . . . . 0.0 113.54 -171.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.418 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.0 -28.72 61.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.454 -175.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -80.35 -41.21 25.16 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.551 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.2 mm100 -67.55 -0.67 4.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.528 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -100.71 -7.01 24.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.386 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -117.52 132.7 56.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -49.44 -31.86 10.67 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.556 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.6 p -58.83 -25.2 62.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 111.6 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -70.52 -33.88 71.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -55.51 -41.17 72.72 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.303 0.573 . . . . 0.0 109.7 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.577 ' HB3' ' HA ' ' A' ' 150' ' ' ILE . 1.8 mpp? -66.81 -56.66 9.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.61 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' HD11 ' A' ' 150' ' ' ILE . 2.4 t80 -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.053 -1.43 . . . . 0.0 112.856 -173.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.688 HD13 ' CE1' ' A' ' 60' ' ' PHE . 1.5 mt -99.2 -40.73 7.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.054 0.454 . . . . 0.0 112.117 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.4 -49.44 5.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -168.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.411 ' O ' HG11 ' A' ' 67' ' ' VAL . 74.8 m-20 -73.66 -178.67 3.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -83.74 -30.95 26.26 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.459 0.647 . . . . 0.0 110.246 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -149.5 158.86 5.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.237 -169.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 144' ' ' PHE . 70.9 mt -86.4 111.81 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.103 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' A' ' 143' ' ' MET . 52.2 t0 -82.48 113.86 20.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.018 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.4 mptt -77.13 -3.13 37.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.91 0.862 . . . . 0.0 110.234 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.5 t -108.7 19.6 19.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.342 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.546 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 6.2 p90 -61.16 -174.18 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.959 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.472 HG22 ' OG ' ' A' ' 157' ' ' SER . 73.6 m -93.02 108.26 31.14 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.404 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 35.6 Cg_exo -65.87 92.54 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.321 2.68 . . . . 0.0 111.734 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 155' ' ' THR . 4.9 p -164.68 -169.62 1.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -174.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.6 mmmm -81.61 152.2 27.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.004 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.556 HG13 HD12 ' A' ' 59' ' ' ILE . 12.1 mm -52.56 -42.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.373 0.606 . . . . 0.0 110.328 173.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.408 ' H ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.795 -173.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.3 0 CA-C-O 120.614 0.245 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.03 178.27 48.21 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.049 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.8 Cg_endo -52.17 156.2 8.02 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 124.145 3.23 . . . . 0.0 112.323 175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 88.3 Cg_exo -50.53 -17.32 2.79 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 124.496 3.464 . . . . 0.0 114.831 -173.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.9 m -76.29 -51.21 12.45 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.7 m120 60.95 176.08 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.555 0.535 . . . . 0.0 111.382 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -88.95 135.43 33.55 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.706 HD22 HD11 ' A' ' 57' ' ' LEU . 15.3 tp -142.85 132.89 24.33 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.097 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.5 99.41 3.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.147 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 53' ' ' VAL . 34.5 mt -110.67 141.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.058 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -140.43 118.26 11.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -99.5 136.6 29.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.24 -163.19 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 60.39 77.22 0.38 Allowed Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 110.574 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.29 148.18 38.36 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.633 2.222 . . . . 0.0 112.996 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.2 tp60 -134.51 108.91 8.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.688 175.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -76.7 94.1 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.407 0.623 . . . . 0.0 109.75 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -122.97 92.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.269 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.07 -165.35 29.89 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.878 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.0 t -101.99 145.42 11.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.246 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.0 -48.2 5.29 Favored Glycine 0 N--CA 1.463 0.498 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.008 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.4 86.29 2.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.69 36.11 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.492 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 11.3 ttt180 -87.34 140.95 29.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -129.19 142.25 50.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.91 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -100.48 124.32 45.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.275 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 40.4 p -93.09 152.33 19.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.545 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.07 143.89 46.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 33.6 tt0 -96.35 120.57 36.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.461 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.95 117.96 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 13.3 mtp180 -105.52 136.95 44.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.25 139.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 64' ' ' GLU . 12.5 ttmt -126.69 138.93 53.47 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.564 168.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.489 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.1 t -170.91 164.02 7.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.219 0.533 . . . . 0.0 111.48 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.54 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.93 23.42 11.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.255 168.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.706 HD11 HD22 ' A' ' 29' ' ' LEU . 27.0 mt -57.44 139.93 80.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.705 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 -25.84 13.52 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.586 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -75.84 -40.97 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.07 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.39 -18.43 64.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD3' ' NE2' ' A' ' 146' ' ' GLN . 57.4 tttt 72.22 -66.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 171.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.7 -11.8 58.9 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 122.24 -0.288 . . . . 0.0 110.314 -172.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 72.21 -42.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.053 0.845 . . . . 0.0 110.762 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -149.57 138.26 20.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.581 0.705 . . . . 0.0 110.755 176.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -171.33 162.63 6.83 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.823 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.5 m -137.95 129.95 28.69 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.116 0.484 . . . . 0.0 111.015 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -127.1 169.22 18.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.153 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -134.18 121.35 21.27 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.807 ' NH1' ' HA ' ' A' ' 144' ' ' PHE . 16.7 ptp180 -151.26 163.47 38.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 111.316 -173.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.667 ' HG3' ' H ' ' A' ' 72' ' ' SER . 30.1 tpt180 -86.6 148.0 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.127 -170.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 38.6 t80 -48.03 -37.33 14.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.004 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.667 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 5.5 m -54.13 -34.24 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 111.244 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 150' ' ' ILE . 15.7 m-20 -74.22 -33.94 63.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.123 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 33.6 m-85 -60.21 -36.24 77.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.044 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.511 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.6 mt-10 -64.9 -53.3 48.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.743 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -28.92 66.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.786 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.4 tm? -71.73 -43.84 65.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 60.0 ttt180 -59.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.631 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.551 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.1 p -62.85 -33.49 75.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.76 -47.97 82.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.56 -42.15 91.78 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.846 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 33.0 mt-10 -66.03 -32.83 74.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.616 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.1 mmt180 -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.083 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -75.67 -33.09 60.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.961 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 m -124.62 177.46 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.314 0.578 . . . . 0.0 111.037 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -101.98 29.3 5.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.491 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 57.3 t -51.13 140.18 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.038 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -71.22 31.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.279 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.555 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -51.72 123.05 23.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 111.354 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 92.6 Cg_endo -86.12 166.51 9.62 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.171 2.581 . . . . 0.0 112.192 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 43.5 Cg_endo -67.8 142.6 58.23 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.764 2.309 . . . . 0.0 112.477 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.511 HD11 ' HA ' ' A' ' 75' ' ' GLU . 91.4 mt -69.69 150.72 96.65 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.293 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -81.79 116.95 2.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.551 2.168 . . . . 0.0 110.571 173.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.38 48.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.554 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -149.95 42.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.436 0.636 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -151.48 -81.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.016 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -56.53 -26.22 54.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.087 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.883 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.63 -47.67 84.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -174.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 3.4 ppt_? -97.12 24.52 6.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.401 0.62 . . . . 0.0 110.689 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -112.84 -47.18 3.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.879 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.566 HD12 ' C ' ' A' ' 101' ' ' LEU . 3.2 pp -91.04 173.03 5.9 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.671 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.559 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.4 Cg_exo -71.93 -143.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 124.115 3.21 . . . . 0.0 113.292 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -116.95 -83.81 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 65.27 -74.42 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.834 0.708 . . . . 0.0 111.61 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -107.09 75.82 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.366 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.29 -72.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.026 0.93 . . . . 0.0 111.852 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 109' ' ' ILE . 2.8 t70 -104.21 -34.15 8.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.113 -175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.62 3.02 10.41 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.606 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.55 ' HA ' ' CD1' ' A' ' 114' ' ' PHE . 47.8 pt -70.18 -17.86 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 49.4 m-85 -76.76 -7.72 55.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.24 129.37 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.101 0.477 . . . . 0.0 110.009 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.74 -26.03 68.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.05 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.661 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 43.3 m-80 -69.56 -56.87 6.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -46.75 -47.94 20.6 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 123.673 0.608 . . . . 0.0 111.091 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 mt -53.37 -46.65 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.368 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -78.53 -19.17 53.53 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.116 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 32.1 mm-40 -72.98 -34.65 66.59 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.64 -42.35 61.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.659 174.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.85 -50.89 71.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.612 -176.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.751 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -60.28 -35.19 74.98 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.984 -173.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.62 -31.96 9.78 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.13 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.3 tp -64.86 -35.36 80.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.807 -0.231 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.528 ' HA ' HG22 ' A' ' 126' ' ' ILE . 10.5 pt-20 -69.88 -31.35 69.12 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.751 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 65.4 mm-40 -65.83 -58.78 4.82 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.511 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.2 t80 -45.45 -53.38 8.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.641 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.7 tp -64.23 -38.67 83.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.644 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -60.48 -19.34 56.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -89.6 -56.98 3.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.882 0.849 . . . . 0.0 110.449 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -63.85 -12.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.898 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.8 3.83 24.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.479 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.28 12.02 2.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.551 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.669 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 39.4 t60 -101.43 140.47 21.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 122.483 -0.422 . . . . 0.0 110.875 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 14.5 Cg_exo -40.59 -47.14 4.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.242 3.294 . . . . 0.0 114.058 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.19 -26.54 61.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.333 -174.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.16 -40.13 20.13 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.989 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.0 mm100 -67.61 -3.01 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.225 176.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.5 t-20 -112.56 12.35 19.87 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.231 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -122.67 126.53 47.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.673 0.273 . . . . 0.0 110.929 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 159' ' ' ILE . 15.7 tpt180 -57.36 -15.7 7.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.486 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 143' ' ' MET . 3.2 m -56.07 -29.39 60.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.095 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.566 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.5 mp -74.5 -28.97 61.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.199 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 60.9 t-80 -57.28 -43.29 82.99 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.913 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.75 ' SD ' HG23 ' A' ' 150' ' ' ILE . 3.9 ptp -70.89 -35.24 72.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.807 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -77.61 -46.01 23.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.601 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -88.79 -36.47 16.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.388 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.481 ' NE2' ' HD3' ' A' ' 61' ' ' LYS . 7.1 mt-30 -100.82 -174.01 2.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.394 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 57.41 -165.21 0.16 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.363 0.414 . . . . 0.0 110.274 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -100.17 -32.38 10.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.428 0.632 . . . . 0.0 110.773 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -155.44 173.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.163 -169.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.75 HG23 ' SD ' ' A' ' 143' ' ' MET . 2.1 mp -78.35 120.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.556 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 154' ' ' TYR . 9.6 t0 -96.24 99.88 11.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HG2' ' CG2' ' A' ' 150' ' ' ILE . 81.6 mttt -74.63 -2.59 26.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.624 0.726 . . . . 0.0 111.966 -170.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.8 m -108.37 18.88 20.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.318 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -62.71 -170.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.141 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 56.1 m -84.1 110.84 28.88 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.948 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.2 Cg_exo -71.06 77.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.611 2.874 . . . . 0.0 112.227 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -151.44 -162.92 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.454 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.9 mmmt -81.37 163.25 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.925 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.586 HG21 HG13 ' A' ' 59' ' ' ILE . 17.0 mm -56.25 -39.39 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.2 0.524 . . . . 0.0 109.612 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.842 -179.698 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.79 0.328 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.36 169.2 38.18 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.329 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.99 160.24 13.0 Favored 'Trans proline' 0 C--O 1.224 -0.214 0 C-N-CA 123.911 3.074 . . . . 0.0 111.282 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.14 -21.6 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 124.839 3.693 . . . . 0.0 115.571 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -70.67 -63.59 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.536 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.4 m-80 60.24 177.41 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.108 0.48 . . . . 0.0 111.709 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -91.21 134.82 34.24 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -146.46 131.82 18.58 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.368 -175.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -144.11 100.42 3.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.079 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.5 mt -109.99 140.1 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -139.29 108.21 5.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.106 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.83 133.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t 179.74 -163.15 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 56.31 64.46 4.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.315 0.578 . . . . 0.0 109.685 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.82 154.19 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.026 2.484 . . . . 0.0 113.408 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.5 tp60 -135.09 112.2 10.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.557 173.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.538 HG22 ' HE ' ' A' ' 45' ' ' ARG . 45.5 m -76.38 92.4 3.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.738 . . . . 0.0 109.9 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -119.93 94.74 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.549 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.59 -166.3 30.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.356 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.3 t -95.9 147.55 5.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.26 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.53 -48.96 5.87 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.333 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -102.25 88.63 3.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.487 0.661 . . . . 0.0 109.484 170.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.75 34.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.783 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.563 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.8 ttt180 -85.16 132.67 34.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.862 0.363 . . . . 0.0 110.449 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -117.17 174.51 6.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.993 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.4 m -129.0 133.38 47.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.282 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.6 p -92.83 129.92 38.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -105.92 133.01 51.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.978 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 35.7 tt0 -86.36 118.15 25.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.327 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.8 mp -94.39 109.45 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 42.6 mtp180 -96.02 132.41 41.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.236 173.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.4 137.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 0.0 111.262 177.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -125.32 137.0 54.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 63' ' ' LYS . 11.8 t -170.51 165.22 8.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.363 0.601 . . . . 0.0 112.394 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.89 24.4 11.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.276 166.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.761 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.09 134.48 93.0 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 173.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 12.2 Cg_exo -67.11 -39.97 12.48 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.645 2.23 . . . . 0.0 111.797 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -60.07 -41.61 87.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.285 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.3 m-30 -66.32 -16.28 63.92 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 tttt 71.77 -65.69 0.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.04 -5.68 59.17 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.415 -0.178 . . . . 0.0 110.717 -174.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 55' ' ' THR . 14.7 mmtp 71.64 -41.61 0.51 Allowed 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.849 0.718 . . . . 0.0 111.715 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -160.05 122.41 3.34 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.429 0.633 . . . . 0.0 109.896 -177.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -160.89 176.89 10.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.525 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 20.1 m -141.84 132.5 25.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.125 0.488 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.06 179.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.436 176.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 35.0 ttt180 -145.29 111.23 5.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -138.16 152.68 48.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.806 0.813 . . . . 0.0 112.716 -173.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.645 ' HG2' ' H ' ' A' ' 72' ' ' SER . 28.9 ttp180 -74.02 144.31 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.705 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 40.3 t80 -50.98 -36.47 39.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.484 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.645 ' H ' ' HG2' ' A' ' 70' ' ' ARG . 11.0 m -61.87 -21.81 65.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.767 0.318 . . . . 0.0 111.777 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -89.03 -24.49 22.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 23.6 m-85 -61.78 -34.15 75.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.535 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.8 mt-10 -64.4 -50.92 65.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.466 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 6.6 t-105 -62.02 -30.45 70.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.586 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -70.2 -45.65 66.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 47.4 ttt180 -56.83 -61.68 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.716 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 11.1 p -59.3 -34.85 72.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.043 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 3.2 mm-40 -62.36 -37.11 84.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 85' ' ' SER . 97.7 mt -75.7 -17.99 59.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.102 0.477 . . . . 0.0 110.45 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 41.2 mt-10 -88.02 -26.36 22.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.284 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 79' ' ' SER . 41.5 mmt180 -58.43 -64.2 1.0 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -118.86 5.78 11.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 33.5 t -119.54 167.5 11.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.612 0.72 . . . . 0.0 111.169 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -101.2 19.45 17.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.535 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.437 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.2 t -51.24 139.07 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.421 0.629 . . . . 0.0 111.762 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.6 p -72.25 35.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.815 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.56 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -55.45 120.26 30.06 Favored Pre-proline 0 N--CA 1.465 0.286 0 O-C-N 122.042 -0.411 . . . . 0.0 111.159 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.594 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.3 Cg_endo -87.52 165.22 7.9 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.978 2.452 . . . . 0.0 112.249 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 38.1 Cg_endo -66.23 144.75 76.01 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.76 2.307 . . . . 0.0 112.65 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 75' ' ' GLU . 74.0 mt -70.92 150.39 95.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.111 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 6.0 Cg_endo -84.93 114.55 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.8 2.333 . . . . 0.0 111.192 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.29 32.78 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.8 18.21 2.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.218 0.509 . . . . 0.0 110.935 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -110.49 -83.31 0.57 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.078 0.466 . . . . 0.0 111.891 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -58.01 -27.18 63.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.323 -173.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? -60.93 -46.94 88.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.023 0.439 . . . . 0.0 111.128 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -101.26 29.95 4.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.49 0.662 . . . . 0.0 109.948 178.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.9 tt0 -128.46 -36.83 1.85 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.432 -173.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 74.7 mt -85.08 172.17 9.4 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.947 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 Cg_exo -66.42 -157.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.929 2.419 . . . . 0.0 112.671 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -87.76 -74.65 0.44 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.43 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 64.31 -81.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.743 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.58 108.78 0.44 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.822 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.3 t70 69.43 -65.27 0.31 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 111.836 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -139.22 -5.82 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.085 0.469 . . . . 0.0 110.45 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.86 9.63 22.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.787 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 42.7 pt -76.05 -18.0 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.131 0.491 . . . . 0.0 111.182 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.48 ' CE2' ' HD3' ' A' ' 45' ' ' ARG . 84.0 m-85 -87.47 18.19 4.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.625 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.66 134.97 54.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.692 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.04 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.734 -174.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -64.67 -60.06 3.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.268 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.787 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -52.88 -46.89 68.15 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.041 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.69 -46.41 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.157 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -80.65 -18.54 47.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 56.5 mm-40 -67.55 -38.83 84.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.542 0.687 . . . . 0.0 109.177 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -67.78 -43.35 79.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.835 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -55.77 -52.54 63.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.174 -175.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -62.52 -35.24 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.581 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.71 -34.02 17.15 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.413 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.7 tp -66.76 -36.59 82.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 122.043 0.137 . . . . 0.0 111.181 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' HG22 ' A' ' 126' ' ' ILE . 5.1 pt-20 -72.23 -31.7 66.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.3 mm-40 -60.32 -59.75 4.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.5 t80 -47.22 -52.73 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.944 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.32 -40.15 87.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.918 -171.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.51 -21.06 59.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.1 0.476 . . . . 0.0 111.87 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.594 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 36.7 mttm -87.86 -55.22 3.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.719 0.771 . . . . 0.0 110.453 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -69.08 -12.58 16.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.605 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -114.35 12.15 17.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -136.23 -9.51 1.42 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.534 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.729 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.8 t60 -87.15 146.38 40.15 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.446 -0.311 . . . . 0.0 111.282 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.729 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.3 Cg_exo -43.08 -51.24 5.74 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.915 3.077 . . . . 0.0 113.337 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -66.5 -32.59 74.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.151 -174.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.16 -44.91 35.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.152 -177.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 43.2 mm-40 -61.52 -6.49 2.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.016 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -98.87 -21.44 16.31 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.066 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 13.0 mm-40 -99.91 137.38 38.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.634 0.652 . . . . 0.0 112.352 -168.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 3.5 mmt180 -50.46 -24.45 3.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.023 0.929 . . . . 0.0 112.716 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.1 m -56.86 -29.94 63.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.464 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.9 mp -75.36 -35.26 61.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 110.662 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -64.33 -35.32 80.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 150' ' ' ILE . 8.4 ptm -81.74 -31.79 31.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.529 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 22.3 t80 -80.29 -43.36 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.332 -175.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 11.0 mt -92.02 -26.46 18.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.361 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -117.16 178.3 4.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.364 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.88 -82.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.053 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 176.92 -55.01 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.797 0.808 . . . . 0.0 109.576 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -130.66 154.16 40.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.894 -175.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.811 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -71.15 113.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.855 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.78 97.71 4.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.756 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -66.46 -6.91 16.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.881 0.372 . . . . 0.0 111.322 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.2 m -112.96 19.68 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.366 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.457 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.2 OUTLIER -64.21 -170.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.997 -178.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.5 m -86.31 113.2 51.09 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.7 Cg_exo -69.83 71.94 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.42 2.747 . . . . 0.0 111.589 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -161.56 1.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -92.85 168.27 11.29 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.799 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.544 HG21 HG13 ' A' ' 59' ' ' ILE . 8.6 mm -54.71 -48.72 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 122.781 0.432 . . . . 0.0 111.076 -174.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.488 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 8.4 m-85 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 121.144 0.497 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.93 173.98 46.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.368 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.2 155.53 9.05 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 C-N-CA 124.124 3.216 . . . . 0.0 111.882 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.28 -21.08 0.36 Allowed 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.769 3.646 . . . . 0.0 115.737 -170.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.5 m -75.16 -59.44 2.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.0 m-80 62.29 -178.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 111.812 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.4 132.11 37.03 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 57' ' ' LEU . 19.2 tp -147.02 128.82 15.29 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.791 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 4.3 pt-20 -138.01 99.78 3.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.89 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 30.9 mt -113.34 142.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.801 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -142.21 111.74 6.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.646 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.9 OUTLIER -85.48 136.37 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 171.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 22.9 t 179.79 -163.08 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 38.6 m-80 62.44 79.7 0.26 Allowed Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.191 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -64.83 143.69 80.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.187 2.591 . . . . 0.0 112.574 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -134.15 108.31 8.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.905 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 m -76.11 93.11 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 109.535 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.2 89.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.04 -166.98 32.31 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.955 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 9.9 t -117.41 152.17 19.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.638 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.54 -46.63 4.66 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 121.771 -0.252 . . . . 0.0 113.019 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.18 83.06 2.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.82 40.8 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.316 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.6 ttt180 -89.17 142.05 27.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.76 162.4 36.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.916 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 22.4 m -114.56 126.08 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.9 p -92.22 154.82 18.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.78 136.24 53.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.243 0.544 . . . . 0.0 110.836 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.602 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 28.6 tt0 -93.13 119.4 32.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.769 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.75 115.37 32.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.96 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 29.6 mtp180 -102.37 128.19 49.06 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -137.49 140.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 11.4 ttmt -128.97 136.28 50.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 63' ' ' LYS . 10.4 t -170.21 164.63 9.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.401 0.619 . . . . 0.0 112.493 -175.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.29 25.21 10.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.08 164.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.796 HD11 HD22 ' A' ' 29' ' ' LEU . 30.3 mt -58.55 134.38 85.79 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.493 171.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 8.5 Cg_exo -67.79 -36.26 19.06 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.727 2.284 . . . . 0.0 111.475 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 159' ' ' ILE . 1.3 tt -61.03 -40.54 85.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.202 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.66 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 4.9 m-30 -71.1 -18.33 62.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.46 -67.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.567 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.28 -1.72 31.13 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.432 -0.167 . . . . 0.0 111.389 -171.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.538 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmtm 68.06 -45.54 0.51 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.07 0.856 . . . . 0.0 112.045 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 1.1 pp20? -159.79 138.96 10.99 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.659 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -170.52 177.54 3.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.602 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 23.9 m -142.26 127.27 18.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.63 172.09 7.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.775 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -140.83 129.1 22.32 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.646 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.1 177.06 9.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.361 179.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 85.5 mtt180 -85.54 168.5 14.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.441 -172.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 46.5 t80 -60.77 -40.56 92.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 55.0 m -61.32 -23.3 65.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 150' ' ' ILE . 6.3 m-20 -72.94 -36.7 67.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 70.9 m-85 -64.54 -40.15 95.08 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 28.9 mt-10 -59.17 -53.43 58.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.608 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -60.65 -31.32 70.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -73.23 -44.67 59.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 39.3 ttt180 -55.82 -61.04 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.017 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -59.42 -35.11 73.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.629 -174.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 6.4 tp10 -64.3 -44.77 90.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.811 0.338 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.1 mt -62.64 -40.59 97.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.581 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.39 -34.66 78.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.209 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 3.2 ppt_? -90.24 -28.76 18.62 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -172.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' HD2' ' A' ' 83' ' ' ARG . 4.8 mm-40 -95.35 -17.29 21.72 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.956 -0.465 . . . . 0.0 112.189 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 87' ' ' VAL . 22.7 t -144.95 178.71 7.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.745 0.783 . . . . 0.0 111.685 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -103.64 19.78 19.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.423 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' A' ' 89' ' ' VAL . 79.3 t -45.41 140.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.563 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.73 37.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.883 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -54.95 121.16 33.73 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.128 -0.358 . . . . 0.0 111.075 -176.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 71.9 Cg_endo -83.47 165.9 14.09 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.324 2.682 . . . . 0.0 113.188 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.19 143.92 79.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.192 2.595 . . . . 0.0 112.686 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 95.8 mt -81.55 141.43 48.72 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.769 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.0 Cg_exo -73.79 114.22 3.98 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.173 2.582 . . . . 0.0 111.998 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.83 38.26 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.72 -34.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 111.428 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.21 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -53.99 -26.78 27.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.094 0.958 . . . . 0.0 113.542 -170.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -62.7 -48.03 81.06 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.82 13.64 23.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -102.15 -29.2 11.87 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.001 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 mt -99.99 165.69 14.11 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.073 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 -153.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.542 2.828 . . . . 0.0 112.231 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -103.05 -78.79 0.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.144 172.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 68.05 -65.81 0.24 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.135 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.8 -155.51 30.92 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.053 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -62.54 -30.83 71.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 111.143 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.65 -47.08 0.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.32 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.93 -9.57 1.8 Allowed Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.406 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 30.8 pt -65.46 -17.58 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.175 -0.512 . . . . 0.0 112.169 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -86.92 39.49 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.375 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.99 136.12 54.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.76 -21.52 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -170.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 38.2 m-80 -71.05 -60.42 2.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -45.77 -49.98 14.43 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.646 0.591 . . . . 0.0 111.263 178.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.05 -46.84 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.465 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -83.42 -17.85 40.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.519 -178.329 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 28.5 mt-10 -80.51 -30.35 37.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 109.89 -176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -80.02 -29.37 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.69 -52.5 63.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.108 178.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.662 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -59.92 -38.5 82.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.312 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.44 -42.2 65.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.882 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -69.54 -30.77 68.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 117.794 0.797 . . . . 0.0 111.313 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HA ' HG13 ' A' ' 33' ' ' VAL . 10.8 pt-20 -74.05 -33.74 63.81 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 9.4 mm-40 -59.84 -60.56 3.64 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.47 ' O ' HG13 ' A' ' 129' ' ' VAL . 9.7 t80 -48.34 -52.76 20.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.577 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.2 tp -66.11 -34.76 72.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.625 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.563 ' ND2' ' HB ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -61.37 -21.23 63.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -88.02 -59.42 2.25 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.689 0.757 . . . . 0.0 110.33 175.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.623 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.75 -11.94 11.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.477 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.01 8.08 20.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.64 15.66 1.61 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.977 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 69.8 t60 -101.09 142.07 23.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.1 Cg_endo -47.93 -44.03 28.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.375 2.717 . . . . 0.0 113.193 -170.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -73.56 -25.67 60.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.161 -175.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -82.44 -42.81 18.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.632 -176.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.4 mm100 -65.21 -7.08 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.468 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -91.11 -18.87 23.81 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.969 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 36.5 mm-40 -105.01 129.81 53.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.724 -168.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.523 ' HA ' HD13 ' A' ' 159' ' ' ILE . 21.1 tpt180 -54.59 -28.54 46.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.653 -172.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' MET . 2.3 p -60.71 -18.6 55.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.512 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -72.13 -32.58 67.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.935 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 58.8 t-80 -66.33 -34.05 77.12 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.484 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -81.35 -27.31 34.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.344 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.555 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 32.5 t80 -73.91 -52.31 13.33 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 60' ' ' PHE . 4.3 mp -96.41 -24.43 16.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.438 -173.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 29.1 mt-30 -118.92 -169.79 1.79 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.015 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 61.66 -88.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.604 0.565 . . . . 0.0 110.493 -174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.464 ' HG3' HG13 ' A' ' 149' ' ' ILE . 5.8 tp10 -179.41 -58.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.687 0.756 . . . . 0.0 109.509 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.11 154.27 35.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.562 -175.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 143' ' ' MET . 90.7 mt -85.75 115.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -98.05 105.3 17.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.829 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -73.07 3.03 5.96 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.601 0.715 . . . . 0.0 111.43 -171.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.6 m -110.45 15.62 22.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.126 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.7 OUTLIER -67.65 -171.61 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.824 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 52.4 m -83.13 111.68 32.52 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.347 177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -72.83 77.01 2.36 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 123.329 2.686 . . . . 0.0 111.801 175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -147.69 -154.34 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.694 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 15.7 mmmt -95.6 161.72 13.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.594 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.563 HG21 HG13 ' A' ' 59' ' ' ILE . 19.5 mm -56.41 -48.75 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.825 0.345 . . . . 0.0 110.167 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -78.62 -50.24 11.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.141 0.496 . . . . 0.0 110.127 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -89.53 118.99 29.57 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.33 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -149.92 138.1 20.43 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.01 0.433 . . . . 0.0 110.505 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -110.3 2.59 19.25 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.475 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -101.38 138.31 38.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.514 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -157.53 133.78 9.6 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.072 0.463 . . . . 0.0 111.067 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -129.05 42.46 3.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.491 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.33 141.0 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.83 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 63.82 -147.63 50.71 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.776 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.3 p -81.31 107.45 14.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.12 127.77 32.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.934 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -134.46 -52.79 0.82 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.014 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 p -85.77 147.25 26.41 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.249 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 m -106.35 165.8 3.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.823 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.38 77.32 3.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.288 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -102.53 -164.93 1.13 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.4 p -113.42 -52.5 2.76 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.139 0.495 . . . . 0.0 109.801 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 62.23 -87.94 0.02 OUTLIER 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.274 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -157.32 -94.01 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp 64.19 -82.18 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.828 0.705 . . . . 0.0 112.623 173.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mt 71.5 146.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.527 0.679 . . . . 0.0 111.761 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.5 p -121.97 84.31 2.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.802 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.509 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -111.89 152.45 44.23 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.989 -177.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -56.58 103.17 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.551 2.834 . . . . 0.0 111.869 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -98.04 29.17 3.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.066 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 62.14 -168.65 0.19 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.473 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.52 149.13 50.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.0 110.817 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -108.03 -173.22 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.532 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -118.67 140.98 49.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.999 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -157.83 -58.96 0.08 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.782 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -114.43 -50.74 2.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.541 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.36 -179.97 45.32 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.375 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 15.4 Cg_endo -55.69 157.61 15.38 Favored 'Trans proline' 0 C--O 1.225 -0.134 0 C-N-CA 124.142 3.228 . . . . 0.0 111.963 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 48.0 Cg_exo -56.49 -9.03 3.23 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.916 3.078 . . . . 0.0 114.462 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.5 t -73.32 -54.28 8.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.632 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.6 m120 58.14 -178.37 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.434 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -97.36 138.52 34.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.694 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -148.17 132.95 17.95 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.766 -0.773 . . . . 0.0 111.552 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -146.92 106.87 3.98 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.442 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.681 HG12 ' HB ' ' A' ' 53' ' ' VAL . 36.0 mt -115.36 147.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.209 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -140.62 111.61 7.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -88.97 131.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 p -179.33 -165.7 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 37.6 m-80 58.21 67.36 2.24 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-O 121.123 0.487 . . . . 0.0 110.388 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HG3' HG21 ' A' ' 115' ' ' ILE . 72.4 Cg_endo -72.74 152.77 53.42 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.933 2.422 . . . . 0.0 113.532 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.8 tp60 -138.93 111.57 7.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.322 173.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.411 HG22 ' NE ' ' A' ' 45' ' ' ARG . 68.0 m -78.92 90.22 4.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.856 0.836 . . . . 0.0 110.25 177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.0 OUTLIER -116.9 96.82 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.353 -174.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.64 -167.53 31.97 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.525 177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 14.6 t -98.7 152.23 4.38 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-O 119.419 -0.324 . . . . 0.0 110.52 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.16 -46.57 8.15 Favored Glycine 0 N--CA 1.46 0.248 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.321 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -100.2 84.84 2.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.23 0.538 . . . . 0.0 109.852 172.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.58 37.29 0.79 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.274 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.578 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 21.1 ttt180 -83.38 130.32 35.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 120.8 0.333 . . . . 0.0 110.379 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -122.52 159.17 28.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.1 m -111.95 127.32 55.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.483 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 43.4 p -92.5 152.36 19.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.293 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -119.62 140.5 50.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.1 0.476 . . . . 0.0 110.374 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 32.9 tt0 -90.89 119.48 31.12 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.67 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.439 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.0 mp -94.39 111.98 26.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.069 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 58.9 mtp85 -104.79 134.86 47.22 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -144.64 141.57 23.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' HE2' ' HG3' ' A' ' 64' ' ' GLU . 20.1 ttmt -127.39 135.95 51.19 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.072 169.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 63' ' ' LYS . 15.0 t -171.23 163.86 7.17 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 119.965 -0.694 . . . . 0.0 112.514 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.557 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.98 27.25 9.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.836 169.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.694 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.38 139.06 94.84 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.029 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.13 -12.27 19.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.753 2.302 . . . . 0.0 112.151 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.658 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -89.67 -41.22 13.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.432 179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.528 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.3 m-85 -65.37 -13.53 58.81 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 71.35 -66.5 0.3 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.77 -2.85 58.89 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 122.174 -0.329 . . . . 0.0 110.462 -172.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmpp? 70.45 -46.18 0.61 Allowed 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.129 0.893 . . . . 0.0 111.545 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -158.41 118.98 3.33 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.893 0.854 . . . . 0.0 110.905 -179.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 t -155.58 179.33 9.28 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.517 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.477 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 14.2 m -141.36 137.02 32.04 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.7 m -125.96 175.62 7.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.452 176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -145.72 118.59 8.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.729 0.3 . . . . 0.0 110.855 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.657 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.2 OUTLIER -151.9 173.53 14.7 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' HG2' ' OD2' ' A' ' 73' ' ' ASP . 20.6 ptt180 -99.32 170.54 8.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -164.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 33.7 t80 -53.88 -38.71 65.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.488 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.606 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 29.9 m -59.38 -25.24 64.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.776 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 20.7 m-20 -80.5 -35.18 35.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.456 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 57.0 m-85 -59.48 -38.86 81.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.445 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' OE1' ' HA ' ' A' ' 72' ' ' SER . 20.1 mt-10 -61.68 -53.24 58.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.56 0.695 . . . . 0.0 110.723 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.523 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -68.25 -23.46 64.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.759 -1.109 . . . . 0.0 111.206 -178.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.749 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -71.95 -42.95 65.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -55.31 -60.58 3.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.815 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.728 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.5 p -64.2 -35.37 80.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.371 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.543 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 4.6 mm-40 -59.37 -37.25 77.44 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.408 HD13 HG11 ' A' ' 87' ' ' VAL . 95.2 mt -73.36 -27.8 61.69 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.058 0.456 . . . . 0.0 110.656 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -84.38 -18.33 36.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.355 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.0 mmm180 -58.84 -61.7 2.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -119.64 0.05 10.88 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.7 m -125.43 166.99 15.6 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.778 0.799 . . . . 0.0 111.911 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -100.51 30.41 3.93 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.47 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 97.2 t -52.49 141.65 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.873 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 88' ' ' VAL . 4.0 p -66.42 27.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.882 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.586 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.5 OUTLIER -57.88 120.33 41.31 Favored Pre-proline 0 C--O 1.234 0.259 0 O-C-N 121.809 -0.557 . . . . 0.0 111.777 -174.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.463 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 97.4 Cg_endo -88.58 168.25 5.99 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.005 2.47 . . . . 0.0 112.147 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.03 146.06 75.81 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.565 2.177 . . . . 0.0 112.184 176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 75' ' ' GLU . 80.1 mt -69.26 152.02 96.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.15 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.53 109.98 2.97 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.965 2.443 . . . . 0.0 111.932 177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.61 176.82 44.71 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.081 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.1 tttt 55.2 31.49 16.56 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.567 0.699 . . . . 0.0 110.346 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -127.7 -85.23 0.59 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.912 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -61.76 -18.19 58.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.327 -177.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.9 mm? -69.6 -44.14 71.34 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.78 -174.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -90.45 17.88 6.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 109.844 176.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 3.2 tt0 -118.5 -39.88 2.97 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.689 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.7 mt -92.83 171.76 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.998 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -68.14 -172.86 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.737 2.291 . . . . 0.0 111.732 171.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 61.5 m-85 -105.65 -86.61 0.47 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.655 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 65.19 -75.57 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.677 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.78 64.82 3.62 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.376 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.2 t70 65.93 -69.96 0.1 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.324 1.05 . . . . 0.0 110.331 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -106.53 -23.97 12.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.128 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 113.78 7.28 20.11 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.124 -174.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.764 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.8 pt -71.95 -19.73 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.944 0.402 . . . . 0.0 111.886 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -78.92 -12.04 60.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.791 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.37 135.19 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.471 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.69 -172.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 48.3 m-80 -73.52 -58.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.764 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -50.65 -48.18 58.31 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.526 0.516 . . . . 0.0 111.192 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.467 HG21 ' HG3' ' A' ' 36' ' ' PRO . 37.5 mt -51.76 -48.38 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.433 -174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.14 -20.51 59.36 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.262 -177.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 29.9 mm-40 -71.88 -32.79 67.79 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.209 0.528 . . . . 0.0 109.762 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 43.5 ttp180 -81.93 -34.34 29.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.237 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.02 -50.05 71.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.524 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.748 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -59.47 -39.97 85.42 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.166 -175.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.5 -36.54 23.08 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.443 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.656 ' HB3' HG21 ' A' ' 33' ' ' VAL . 4.6 tp -64.24 -36.61 84.65 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.435 0.16 . . . . 0.0 111.037 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.684 ' HB3' HG22 ' A' ' 33' ' ' VAL . 13.1 pt-20 -75.65 -29.99 59.29 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.7 mm-40 -64.01 -53.61 47.32 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.6 t80 -49.9 -54.55 18.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.266 -1.334 . . . . 0.0 111.287 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.1 tp -64.67 -39.18 84.72 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.755 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.865 -172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -62.21 -16.96 56.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.16 -0.338 . . . . 0.0 111.825 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.463 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.1 mttm -89.92 -58.65 2.44 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 122.038 0.923 . . . . 0.0 110.568 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 89' ' ' VAL . 1.3 m -66.05 -13.51 15.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.027 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.405 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.92 10.28 20.62 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.364 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.405 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -136.16 2.25 3.54 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.436 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.68 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 35.1 t60 -99.91 144.36 28.22 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 117.185 0.492 . . . . 0.0 111.74 -174.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.68 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.8 Cg_exo -39.64 -50.52 3.1 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.578 3.519 . . . . 0.0 113.879 -176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.37 -30.14 68.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.212 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.522 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -78.03 -39.99 40.22 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.25 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 53.8 mm-40 -65.56 -6.38 10.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.584 175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -108.7 6.07 25.39 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.974 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 138' ' ' GLU . 5.1 mm-40 -118.48 129.18 55.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.824 0.345 . . . . 0.0 111.128 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.441 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -54.21 -20.41 6.85 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.518 -176.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.5 m -53.45 -35.81 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.432 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.5 mp -69.95 -33.53 72.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.238 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 37.1 t-80 -56.88 -39.72 74.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.132 0.491 . . . . 0.0 110.249 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.571 ' HG3' HG13 ' A' ' 150' ' ' ILE . 2.5 ptm -79.96 -28.57 39.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.081 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.749 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.26 -47.81 14.01 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.528 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -93.98 -19.91 20.46 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.113 -174.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 7.6 mt-30 -119.95 -172.61 2.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.151 -168.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 53.06 -116.75 1.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.257 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -134.89 -35.15 0.87 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.701 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.98 162.65 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.75 0.786 . . . . 0.0 112.868 -167.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.571 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -74.82 115.65 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.895 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -96.32 112.89 24.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.844 0.354 . . . . 0.0 110.186 177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 27.1 mmtp -75.69 11.04 1.46 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -172.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.0 m -129.08 19.21 5.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.212 0.53 . . . . 0.0 110.297 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.57 -174.2 0.19 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.16 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 41.0 m -90.89 112.49 53.79 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.161 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.72 76.68 1.49 Allowed 'Trans proline' 0 CA--C 1.527 0.165 0 C-N-CA 123.453 2.768 . . . . 0.0 112.111 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -146.82 -161.78 1.4 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.448 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.1 mmmt -85.93 165.07 17.05 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.658 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -60.54 -40.92 85.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.217 0.532 . . . . 0.0 110.261 172.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 120.45 25.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.3 157.52 20.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.988 0.423 . . . . 0.0 111.014 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.758 177.458 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 20.8 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.214 0.53 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . 55.65 40.91 30.98 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.642 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -122.89 80.9 1.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.175 0.512 . . . . 0.0 109.797 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -129.36 165.48 21.42 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.134 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -88.64 -30.77 18.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.767 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 4.4 t60 63.82 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.359 0.664 . . . . 0.0 110.725 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -145.9 33.19 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.76 0.79 . . . . 0.0 108.912 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -123.02 112.27 17.58 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.706 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.3 p -108.0 124.88 64.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 109.835 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -79.47 -170.13 39.21 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.805 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 m -86.24 10.99 13.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 122.291 1.043 . . . . 0.0 110.182 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.37 128.42 4.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.065 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -159.29 -58.8 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.12 144.9 30.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.623 171.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.4 -157.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 124.302 1.001 . . . . 0.0 111.56 -173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 44.56 67.05 0.75 Allowed 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.238 0.542 . . . . 0.0 112.2 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.4 155.92 33.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.896 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.1 p -56.13 -54.19 48.03 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.806 0.336 . . . . 0.0 110.433 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 70.82 143.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.816 -1.084 . . . . 0.0 112.504 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.714 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 5.7 ppt_? -136.89 136.62 38.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.704 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.639 ' C ' HG13 ' A' ' 12' ' ' ILE . 16.4 tp -153.68 -71.41 0.14 Allowed 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.066 0.46 . . . . 0.0 110.732 -176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.639 HG13 ' C ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER 63.4 -159.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.712 172.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.49 ' H ' HG22 ' A' ' 12' ' ' ILE . 13.1 p 72.81 112.59 0.06 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.41 1.084 . . . . 0.0 111.682 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 10.5 mptt -76.79 170.99 13.56 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.344 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 82.9 Cg_exo -48.32 118.53 3.31 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.192 1.928 . . . . 0.0 112.448 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -100.23 144.04 29.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.94 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.8 127.88 44.05 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' HG ' ' CZ ' ' A' ' 160' ' ' ARG . 3.5 mm? -105.78 -173.32 2.27 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.148 -174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -77.51 176.15 9.17 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.97 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -159.12 162.97 36.52 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.855 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.0 -46.41 0.1 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.162 0.505 . . . . 0.0 111.061 -176.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.425 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 79.6 m-85 -121.45 -20.05 6.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.592 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.44 174.75 46.95 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.602 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.69 158.62 19.51 Favored 'Trans proline' 0 C--O 1.222 -0.276 0 C-N-CA 124.336 3.358 . . . . 0.0 111.174 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -48.63 -14.67 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.418 3.412 . . . . 0.0 115.206 -171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 p -68.63 -62.45 1.38 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 58.13 -177.37 0.07 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.262 0.553 . . . . 0.0 111.902 176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -99.47 138.17 36.94 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 57' ' ' LEU . 15.9 tp -145.58 132.33 20.02 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 119.846 -0.741 . . . . 0.0 111.057 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.73 106.05 3.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.174 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.2 mt -114.55 142.87 25.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.058 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -136.55 118.47 15.24 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 122' ' ' LEU . 1.0 OUTLIER -100.23 135.04 37.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 36.2 t 178.85 -161.97 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 31.7 m-80 62.5 73.42 0.54 Allowed Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 121.102 0.477 . . . . 0.0 110.46 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HG3' HG21 ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.01 131.85 18.81 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.802 2.335 . . . . 0.0 112.865 -173.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 47.6 tp60 -117.02 112.34 20.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.14 176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.9 m -73.17 104.04 4.1 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.42 90.66 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.268 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.22 -167.57 33.24 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.814 177.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.4 t -100.71 147.98 7.38 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.669 0 CA-C-O 119.278 -0.392 . . . . 0.0 110.134 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.34 5.55 Favored Glycine 0 N--CA 1.462 0.395 0 C-N-CA 121.59 -0.338 . . . . 0.0 113.152 -176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -103.96 88.62 3.07 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.462 0.649 . . . . 0.0 109.416 171.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.37 32.35 0.98 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.725 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.592 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 8.9 ttp180 -84.34 152.21 24.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 122.403 0.281 . . . . 0.0 110.304 -179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.14 162.3 35.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.747 0.308 . . . . 0.0 110.359 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -113.92 131.35 56.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.608 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 15.9 p -99.64 153.39 19.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.79 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -116.54 144.97 43.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.237 0.541 . . . . 0.0 110.627 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 35.9 tt0 -95.79 123.2 39.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.347 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.55 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -96.72 117.84 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.276 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 94.6 mtt180 -110.5 109.81 20.3 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.407 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -119.46 137.79 52.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.013 0.435 . . . . 0.0 111.993 -178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -125.89 134.97 51.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.307 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.513 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.4 t -170.31 165.95 8.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.288 0.566 . . . . 0.0 111.626 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.425 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -120.45 26.26 9.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.119 168.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.667 HD11 HD22 ' A' ' 29' ' ' LEU . 20.9 mt -60.62 143.36 90.54 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.192 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -76.84 -29.64 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.431 2.088 . . . . 0.0 111.711 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.545 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.29 -40.19 79.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.95 178.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.616 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.4 m-30 -69.1 -19.98 64.06 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 71.49 -64.33 0.39 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.11 -7.66 59.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 122.182 -0.324 . . . . 0.0 110.833 -172.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 5.6 mmtp 70.68 -43.43 0.55 Allowed 'General case' 0 C--O 1.218 -0.578 0 O-C-N 124.014 0.822 . . . . 0.0 111.163 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -160.58 130.82 5.25 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 109.998 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.2 t -160.43 165.85 30.32 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.609 -174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 37.7 m -140.5 130.4 24.58 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.292 0.568 . . . . 0.0 110.853 176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 147' ' ' ASP . 5.8 m -133.47 174.35 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -144.06 122.88 12.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.197 0.522 . . . . 0.0 111.567 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -145.05 -177.66 5.65 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB3' HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -100.66 167.57 10.25 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -169.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.564 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.7 t80 -55.09 -34.38 63.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.42 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.523 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 16.9 m -55.03 -33.58 62.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.738 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -75.06 -38.14 61.45 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.574 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 59.9 m-85 -60.12 -37.47 80.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.644 176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 25.7 mt-10 -62.52 -55.07 30.87 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.752 0.787 . . . . 0.0 110.348 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -64.9 -28.64 69.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.436 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.652 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -69.35 -40.73 77.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 63.9 ttt180 -57.95 -64.93 0.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.446 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.722 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -61.28 -37.17 82.22 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.014 -172.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.19 -44.73 71.83 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.373 0.42 . . . . 0.0 111.431 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.9 mt -65.37 -37.06 85.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.73 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -73.82 -24.95 59.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.138 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.722 ' HG2' ' O ' ' A' ' 79' ' ' SER . 25.1 mmt180 -67.98 -62.53 1.36 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.063 0.459 . . . . 0.0 111.816 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -85.46 -30.05 23.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.323 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.5 m -120.66 175.03 6.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.654 0.74 . . . . 0.0 112.004 -174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -105.0 23.6 13.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.738 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 89' ' ' VAL . 97.6 t -42.6 140.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.846 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -69.19 32.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.371 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.533 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.2 t -56.07 121.65 42.65 Favored Pre-proline 0 N--CA 1.464 0.268 0 O-C-N 121.945 -0.472 . . . . 0.0 110.836 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 89.0 Cg_endo -88.28 166.4 6.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.904 2.403 . . . . 0.0 112.302 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.66 150.82 87.55 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.867 2.378 . . . . 0.0 112.459 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 49.6 mt -80.51 153.39 73.59 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.436 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -88.44 109.27 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.912 2.408 . . . . 0.0 112.289 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.12 59.15 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.443 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -144.55 -25.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.778 0.323 . . . . 0.0 111.4 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.85 -82.32 0.29 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -171.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.573 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -49.94 -24.5 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.951 1.3 . . . . 0.0 114.14 -171.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.6 mm? -59.34 -45.16 92.15 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.915 0.388 . . . . 0.0 111.221 -173.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -99.53 20.65 13.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.716 0.769 . . . . 0.0 109.432 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -118.1 -28.31 5.88 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.866 -176.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.5 mt -101.67 169.16 8.04 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.752 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.25 -161.38 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.898 2.399 . . . . 0.0 112.484 173.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.443 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 37.9 m-85 -106.97 -80.35 0.56 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.608 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 68.38 -64.99 0.28 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.538 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.485 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -113.86 79.07 0.27 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.431 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.64 -71.41 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.056 0.943 . . . . 0.0 111.911 175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -109.9 -32.11 7.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.842 -175.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 123.3 4.42 8.35 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.936 -177.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 45.8 pt -73.09 -15.22 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 54.5 m-85 -79.88 -15.1 58.03 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.68 177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -78.97 134.48 36.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.992 0.425 . . . . 0.0 110.245 -178.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.97 -24.7 64.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.67 -172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.604 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 42.7 m-80 -65.64 -57.71 7.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -51.34 -51.03 58.08 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 123.661 0.601 . . . . 0.0 110.879 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HG3' ' A' ' 36' ' ' PRO . 23.7 mt -50.59 -50.35 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.995 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -75.55 -20.59 58.55 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.883 -177.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 37.3 mm-40 -74.25 -33.64 63.38 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.166 0.508 . . . . 0.0 109.95 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.556 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 37.5 ttm180 -80.63 -33.68 35.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 173.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -55.89 -50.88 69.45 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.551 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.73 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.6 -41.91 95.71 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.844 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.0 -34.5 33.47 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.439 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 4.2 tp -67.52 -36.59 81.33 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.025 -0.103 . . . . 0.0 111.243 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.588 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.8 pt-20 -72.77 -33.33 66.24 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.73 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 15.6 mm-40 -60.45 -58.44 8.48 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.573 ' O ' HG13 ' A' ' 129' ' ' VAL . 15.0 t80 -47.57 -55.43 9.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.443 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.588 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -63.93 -39.49 85.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.83 -172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -61.62 -20.27 63.19 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.017 0.437 . . . . 0.0 111.986 -176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 35.1 mttm -90.18 -56.36 3.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.939 0.876 . . . . 0.0 110.641 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 125' ' ' PHE . 1.2 m -65.84 -13.15 15.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.002 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -110.11 7.61 23.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.088 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.418 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -141.14 12.36 2.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.158 -1.02 . . . . 0.0 113.463 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 57.7 t60 -100.32 139.8 20.96 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 122.397 -0.472 . . . . 0.0 110.499 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.622 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 6.8 Cg_exo -41.38 -47.1 5.69 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 124.21 3.273 . . . . 0.0 113.888 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -70.81 -32.55 69.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.102 -176.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.55 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.62 -42.47 51.61 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.716 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -66.0 -6.57 13.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.141 175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.587 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -99.61 -10.04 22.48 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.464 179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 5.5 mm-40 -106.61 131.87 53.26 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.058 0.456 . . . . 0.0 111.967 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.464 ' HA ' HD13 ' A' ' 159' ' ' ILE . 16.3 tpt180 -58.24 -19.08 31.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.852 -173.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.629 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 0.7 OUTLIER -63.97 -24.17 67.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.329 0.585 . . . . 0.0 110.965 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.628 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.1 mp -75.55 -31.23 59.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.553 -0.717 . . . . 0.0 110.999 176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 65.0 t-80 -57.61 -38.3 74.7 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.629 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 4.0 ptm -80.47 -26.76 38.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.559 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.652 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.0 t80 -80.14 -53.74 6.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.628 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -78.78 -36.31 43.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.357 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 11.6 mt-30 -95.3 166.67 11.78 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.474 ' O ' HG11 ' A' ' 67' ' ' VAL . 46.1 m-20 61.96 -179.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.09 0.471 . . . . 0.0 110.638 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -91.17 -35.25 14.65 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.048 0.928 . . . . 0.0 110.392 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -134.8 152.62 33.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.209 -1.36 . . . . 0.0 112.182 -165.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.624 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.2 mp -81.72 116.05 25.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.64 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.19 101.58 6.24 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.054 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -71.77 11.34 0.52 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 54.0 m -130.28 19.17 5.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 110.657 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.403 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.18 -171.43 0.05 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.534 0.683 . . . . 0.0 112.122 -179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 87.4 m -88.48 113.01 53.64 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.161 177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -71.65 65.64 3.05 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.442 2.761 . . . . 0.0 112.303 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -140.59 -154.04 0.5 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.626 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.587 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 20.9 mmmt -86.24 158.98 19.59 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.475 -0.14 . . . . 0.0 110.75 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.545 HG13 HD12 ' A' ' 59' ' ' ILE . 16.7 mm -51.41 -52.44 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 120.717 0.294 . . . . 0.0 110.422 172.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -87.65 15.66 6.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.337 -178.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m170 62.15 -174.86 0.14 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.765 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.392 179.21 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.75 0.309 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -141.35 -178.57 5.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.954 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 60.89 55.74 3.08 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.396 0.617 . . . . 0.0 110.521 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -128.21 108.18 10.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.443 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -87.46 -178.95 6.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -61.45 -38.2 86.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.304 0.573 . . . . 0.0 109.639 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -156.35 148.5 23.26 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.913 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -65.99 97.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 33.3 m -69.01 131.28 34.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.524 0.678 . . . . 0.0 112.347 -171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -129.7 19.99 5.22 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.3 p -120.21 168.75 10.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.664 -0.768 . . . . 0.0 110.668 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.35 131.42 51.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.368 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.59 -172.05 1.97 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p 56.56 176.15 0.04 OUTLIER 'General case' 0 C--O 1.237 0.438 0 O-C-N 124.002 0.814 . . . . 0.0 112.256 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.7 t 70.82 -62.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.381 176.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.01 95.71 4.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.601 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.47 146.46 54.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.532 . . . . 0.0 110.58 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -71.53 -55.11 8.46 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.76 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 3.3 mmp_? 61.05 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.645 -175.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 72.91 126.27 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 123.708 0.803 . . . . 0.0 112.084 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.1 tp -136.65 144.22 43.89 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.199 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 mt -138.55 147.03 25.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.955 0.407 . . . . 0.0 110.793 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 p -122.56 79.62 1.64 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.462 0.648 . . . . 0.0 110.566 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -100.78 168.18 9.68 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.387 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 56.7 Cg_exo -52.61 120.31 7.3 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.689 2.259 . . . . 0.0 111.649 174.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -58.45 130.13 45.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -97.88 -169.95 1.91 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.822 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.39 172.99 12.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.899 0.381 . . . . 0.0 110.339 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -68.9 178.18 2.29 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.506 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -146.97 140.89 25.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.065 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -158.46 175.29 13.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.553 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 2.6 m-85 -122.2 -5.85 8.88 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.076 -172.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.52 175.5 43.91 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.425 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.33 154.71 10.73 Favored 'Trans proline' 0 C--O 1.224 -0.224 0 C-N-CA 124.0 3.133 . . . . 0.0 111.34 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -48.98 -11.82 0.18 Allowed 'Trans proline' 0 N--CA 1.482 0.8 0 C-N-CA 124.483 3.455 . . . . 0.0 115.161 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.7 t -74.06 -61.89 1.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 32.2 m-80 58.84 -178.58 0.08 Allowed 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.489 0.493 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -91.43 125.52 36.21 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.81 HD22 HD11 ' A' ' 57' ' ' LEU . 13.1 tp -138.14 129.09 27.06 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.88 -176.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -140.32 104.36 4.77 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.093 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.664 HG12 ' HB ' ' A' ' 53' ' ' VAL . 47.9 mt -114.69 141.49 31.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.182 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -136.8 117.57 14.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.996 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -98.62 132.42 43.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 173.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t 179.52 -162.56 0.04 OUTLIER 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.2 m-80 63.58 77.44 0.32 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.938 0.399 . . . . 0.0 110.042 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' HG21 ' A' ' 115' ' ' ILE . 69.5 Cg_endo -73.98 142.17 30.93 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.392 2.061 . . . . 0.0 113.051 -174.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -131.9 111.22 11.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.059 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.0 101.57 4.52 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -129.3 88.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.426 0.632 . . . . 0.0 110.235 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.44 -167.62 33.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.837 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.2 t -111.35 156.28 12.54 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.144 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.41 -49.04 6.98 Favored Glycine 0 N--CA 1.46 0.288 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.465 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -99.08 85.1 3.17 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.084 0.469 . . . . 0.0 109.744 171.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.42 38.99 0.64 Allowed Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.565 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 10.1 ttt180 -89.49 140.46 29.5 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.24 154.82 42.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.844 0.355 . . . . 0.0 110.759 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 m -110.57 122.97 49.06 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.38 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.9 p -92.55 155.91 17.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.859 0.361 . . . . 0.0 110.829 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 80.5 m-85 -119.12 141.42 48.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.728 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 31.3 tt0 -90.64 123.62 34.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.349 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -102.73 115.6 44.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.41 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 57.4 mtp180 -105.52 139.41 40.17 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.556 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -146.39 140.7 20.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 178.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -128.83 143.08 50.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.039 165.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.407 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 15.0 t -172.9 164.46 5.06 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.912 0.387 . . . . 0.0 111.964 -174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.52 31.12 6.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.628 0.728 . . . . 0.0 110.137 166.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.81 HD11 HD22 ' A' ' 29' ' ' LEU . 23.2 mt -67.86 145.2 97.83 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.273 174.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.53 -28.53 5.38 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.598 2.199 . . . . 0.0 111.777 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.558 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.94 -41.36 79.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.878 -179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.3 m-30 -69.96 -33.0 71.53 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.593 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.1 tmmm? 75.11 -58.13 0.58 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 123.582 0.551 . . . . 0.0 112.101 175.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.75 -14.83 60.76 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 122.284 -0.26 . . . . 0.0 111.039 -172.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp 73.66 -38.07 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.851 0.719 . . . . 0.0 110.857 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.62 140.25 30.04 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.411 0.624 . . . . 0.0 109.956 174.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -160.28 151.55 19.37 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.109 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.9 m -140.39 133.95 30.14 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.021 0.439 . . . . 0.0 109.935 173.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 21.0 m -129.96 179.52 4.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.624 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 36.3 ttm180 -145.96 101.83 3.57 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.585 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 mmp_? -122.95 172.61 8.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.137 -173.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -88.83 161.83 16.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.539 -174.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.552 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 38.5 t80 -55.26 -37.53 67.37 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.428 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 35.5 m -61.99 -26.17 68.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.648 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -71.8 -36.42 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.661 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 52.1 m-85 -66.46 -39.89 89.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.998 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.9 mt-10 -57.06 -56.94 15.2 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.585 0.707 . . . . 0.0 110.826 177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.45 ' CD1' HG21 ' A' ' 150' ' ' ILE . 4.7 t-105 -63.33 -34.09 76.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.733 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -69.19 -43.97 73.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 31.8 ttt180 -57.54 -59.52 5.05 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.797 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -60.58 -32.95 72.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.301 -173.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.7 mm-40 -63.14 -46.37 87.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.014 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 85' ' ' SER . 88.8 mt -71.06 -16.31 62.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.064 0.459 . . . . 0.0 110.755 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 47.5 mt-10 -87.73 -50.08 6.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.107 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 1.5 ppt_? -62.2 -21.79 65.39 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -165.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 9.5 pt-20 -138.12 -34.92 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.668 -0.813 . . . . 0.0 112.282 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -73.92 158.85 33.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.203 0.525 . . . . 0.0 110.476 -177.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -96.53 17.86 15.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.238 0.542 . . . . 0.0 109.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 135' ' ' ALA . 90.7 t -56.06 140.24 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.93 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -75.53 37.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.611 177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.528 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -51.69 118.72 12.01 Favored Pre-proline 0 N--CA 1.465 0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.411 -175.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 128' ' ' LYS . 6.3 Cg_exo -72.43 160.56 46.53 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.495 2.797 . . . . 0.0 112.525 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 142.2 42.3 Favored 'Trans proline' 0 C--O 1.237 0.468 0 C-N-CA 122.876 2.384 . . . . 0.0 111.983 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.614 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.1 mt -69.37 150.57 97.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 27.5 Cg_endo -86.49 109.65 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.881 2.388 . . . . 0.0 111.957 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.63 -174.53 27.46 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.078 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' N ' HD23 ' A' ' 98' ' ' LEU . 51.8 tttp 71.09 -55.25 0.65 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.759 0.824 . . . . 0.0 112.035 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.418 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -47.61 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.561 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -73.36 -18.17 61.2 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.482 -170.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.636 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.1 mm? -69.14 -44.34 72.52 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.772 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -95.96 26.48 4.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.536 0.684 . . . . 0.0 110.178 176.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -116.69 -41.51 3.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.696 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 62.6 mt -80.57 163.6 55.7 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.16 -178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -65.62 147.35 86.15 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.961 2.441 . . . . 0.0 111.499 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -104.76 94.82 5.49 Favored 'General case' 0 CA--C 1.488 -1.426 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -125.76 -30.88 2.99 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.094 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.65 -167.31 43.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.439 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -55.9 -47.89 76.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.273 0.558 . . . . 0.0 110.936 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -136.41 -51.96 0.71 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.997 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.36 -10.38 1.3 Allowed Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.206 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.783 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.8 pt -65.53 -16.98 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.949 0.404 . . . . 0.0 111.928 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -81.22 -16.12 53.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.357 0.599 . . . . 0.0 110.119 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.42 122.16 28.57 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.68 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -58.64 -27.0 64.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.581 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.581 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 14.3 m120 -55.09 -60.43 3.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.487 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.783 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -54.84 -47.71 73.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.51 0.506 . . . . 0.0 110.895 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 36' ' ' PRO . 47.9 mt -51.47 -51.27 25.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.275 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -73.11 -22.33 60.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.48 -177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 66.2 mm-40 -74.87 -32.45 61.87 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.37 0.605 . . . . 0.0 109.802 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 14.7 tpp180 -78.97 -35.49 42.97 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.58 -54.01 51.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.467 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.712 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -59.33 -40.41 86.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.998 -176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -34.84 32.91 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.133 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.12 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.732 0.266 . . . . 0.0 111.298 177.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.612 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 13.7 pt-20 -73.43 -32.43 64.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.712 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.4 mm-40 -62.31 -58.17 8.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 7.1 t80 -48.89 -53.27 20.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.613 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.591 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.34 -41.05 90.36 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.818 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.776 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -58.97 -19.72 45.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.086 0.47 . . . . 0.0 111.809 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.448 ' HD2' ' HG2' ' A' ' 90' ' ' PRO . 31.8 mttm -90.72 -58.83 2.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.76 0.791 . . . . 0.0 110.66 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.32 -13.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.645 -1.162 . . . . 0.0 111.023 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -111.18 10.93 21.85 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.981 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.89 8.64 1.3 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.796 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.772 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 59.2 t60 -98.42 144.97 29.06 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 117.217 0.509 . . . . 0.0 110.214 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.772 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.0 Cg_exo -41.9 -48.86 5.89 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 124.23 3.286 . . . . 0.0 113.775 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.635 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -71.09 -38.91 72.4 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.777 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -69.14 -41.49 77.26 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.359 -177.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.45 ' O ' HD12 ' A' ' 59' ' ' ILE . 6.1 mm-40 -65.93 -4.13 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.194 176.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.513 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 0.3 OUTLIER -106.46 -7.95 17.34 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.875 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.2 mm-40 -106.51 135.14 48.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.01 -0.431 . . . . 0.0 110.998 -173.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.644 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -57.02 -17.68 10.89 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -174.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.621 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.3 m -58.3 -30.0 66.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.317 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 135' ' ' ALA . 6.5 mp -74.78 -29.97 61.29 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.22 -0.3 . . . . 0.0 111.357 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -58.51 -43.57 89.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.308 0.575 . . . . 0.0 109.864 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.627 ' HE2' HG23 ' A' ' 150' ' ' ILE . 5.3 ptm -77.84 -31.22 51.42 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.188 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 5.0 t80 -77.45 -41.31 40.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.109 -176.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.445 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.9 mt -98.29 -47.5 5.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.015 0.436 . . . . 0.0 112.005 -169.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -81.03 -46.39 15.09 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.014 -171.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -87.65 154.96 20.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.182 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.7 pm0 -66.42 -29.51 69.68 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 121.739 0.781 . . . . 0.0 110.164 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.567 ' HA ' ' HD2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -134.22 132.37 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-N 113.878 -1.51 . . . . 0.0 112.07 -167.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.627 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.3 mp -70.66 105.91 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.282 174.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -83.51 99.41 10.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.048 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.424 ' HE3' HG22 ' A' ' 150' ' ' ILE . 2.0 mptt -71.86 11.61 0.5 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.266 0.555 . . . . 0.0 112.309 -173.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.1 t -111.99 11.28 20.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.665 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -171.99 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.281 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 50.4 m -94.3 114.32 63.02 Favored Pre-proline 0 N--CA 1.444 -0.771 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.784 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 21.9 Cg_exo -68.88 68.44 1.22 Allowed 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.432 2.755 . . . . 0.0 112.067 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 66.6 m -140.24 -159.39 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.626 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.644 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 6.6 mmmm -88.25 158.91 18.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.558 HG13 HD12 ' A' ' 59' ' ' ILE . 16.5 mm -50.35 -46.29 25.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-O 120.657 0.265 . . . . 0.0 110.679 176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.29 31.76 0.8 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.231 0.539 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.8 m170 63.66 -178.39 0.16 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.607 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.184 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.122 -178.642 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.201 0.524 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -85.1 76.76 10.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.119 0.485 . . . . 0.0 110.575 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -154.22 -62.87 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.739 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -146.61 116.0 7.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.504 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -89.02 130.41 35.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.845 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -81.43 125.87 30.96 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.422 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -94.29 -3.95 49.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.966 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -134.18 81.47 1.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.916 0.389 . . . . 0.0 110.796 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.29 158.83 40.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.516 177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -135.58 -143.87 4.81 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.775 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.8 p -71.75 109.3 5.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.443 0.164 . . . . 0.0 111.443 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 71.55 131.49 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 124.132 0.895 . . . . 0.0 111.774 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.03 -59.02 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.865 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 p -103.97 145.92 29.45 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.161 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -116.53 162.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.182 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.04 77.53 2.74 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.139 0.495 . . . . 0.0 110.042 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -104.35 149.47 25.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.392 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 31.2 p -67.11 -53.31 31.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.769 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 71.53 -42.68 0.54 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.738 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' N ' ' HD3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -158.06 -171.08 3.37 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.6 tp -161.56 139.19 8.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.172 0.511 . . . . 0.0 111.014 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.9 mt -140.61 168.84 16.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.4 p 57.16 74.47 0.41 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.75 0.786 . . . . 0.0 111.311 175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.642 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -75.8 158.19 83.0 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.776 -177.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 87.6 Cg_exo -45.44 128.12 9.97 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.58 2.854 . . . . 0.0 113.664 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -98.38 112.08 24.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.459 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -98.29 160.21 14.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.95 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.51 -179.04 6.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.829 0.347 . . . . 0.0 110.202 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -72.89 168.8 18.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.487 0.66 . . . . 0.0 111.137 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -161.87 149.04 14.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.224 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.39 -61.01 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.508 -173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -125.1 -65.56 1.02 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.082 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.17 172.0 15.48 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 119.976 -1.107 . . . . 0.0 112.725 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -55.04 159.43 9.68 Favored 'Trans proline' 0 C--O 1.222 -0.31 0 C-N-CA 124.201 3.267 . . . . 0.0 111.591 175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.99 -24.87 0.47 Allowed 'Trans proline' 0 N--CA 1.481 0.78 0 C-N-CA 124.421 3.414 . . . . 0.0 115.452 -170.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -70.53 -62.29 1.44 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 122.26 0.224 . . . . 0.0 110.436 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.448 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.8 m-80 61.81 -178.67 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.212 0.53 . . . . 0.0 111.632 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -97.3 140.49 31.7 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.701 HD22 HD11 ' A' ' 57' ' ' LEU . 13.4 tp -147.11 130.58 16.73 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.429 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.87 103.64 4.07 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.663 HG12 ' HB ' ' A' ' 53' ' ' VAL . 32.8 mt -115.43 143.29 25.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.01 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -138.84 115.68 10.79 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.769 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -99.25 132.52 44.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.8 t 179.31 -163.07 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 46.4 m-80 61.94 81.6 0.23 Allowed Pre-proline 0 N--CA 1.467 0.397 0 CA-C-O 121.124 0.488 . . . . 0.0 110.47 177.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.67 152.92 59.57 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.724 2.283 . . . . 0.0 113.541 -173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.1 tp60 -144.84 107.78 4.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.007 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.1 m -76.52 104.3 6.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.445 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.4 p -130.86 88.83 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.706 -172.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.5 -168.17 34.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.0 176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 21.4 t -102.11 158.32 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.068 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.91 -49.78 6.15 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.266 -0.493 . . . . 0.0 111.972 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.82 87.03 4.87 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.118 0.485 . . . . 0.0 109.803 169.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.26 34.54 0.94 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.971 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.58 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.6 ttt180 -89.46 126.12 35.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -131.76 156.7 45.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.5 m -107.72 124.74 50.46 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.368 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 70' ' ' ARG . 32.0 p -92.09 162.43 14.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -121.52 139.43 53.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 68' ' ' ARG . 32.4 tt0 -91.11 118.35 30.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.571 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.8 mp -93.0 116.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.105 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 76.0 mtp180 -105.87 131.87 52.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.971 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.663 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.99 138.39 34.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 16.4 ttmt -127.81 137.01 52.24 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.133 169.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 63' ' ' LYS . 13.3 t -170.31 163.74 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.272 0.558 . . . . 0.0 112.147 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -118.91 22.54 11.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.203 168.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.701 HD11 HD22 ' A' ' 29' ' ' LEU . 21.4 mt -56.3 146.71 51.11 Favored Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.723 171.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.26 -9.7 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.503 2.135 . . . . 0.0 111.918 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.575 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -88.49 -40.56 13.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.416 -177.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.542 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.9 m-30 -69.86 -17.36 63.37 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' HD13 ' A' ' 62' ' ' LEU . 35.7 ttpt 75.21 -71.99 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -75.91 -1.45 25.5 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -169.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.529 ' O ' HG22 ' A' ' 55' ' ' THR . 4.4 mmtm 68.31 -48.09 0.54 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.092 0.87 . . . . 0.0 111.6 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 2.7 pp20? -156.59 140.36 16.09 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.833 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -168.71 174.97 6.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.345 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.0 m -141.12 135.62 31.1 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.238 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' CG2' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -145.4 130.62 13.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.926 -173.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 31.6 ttm180 -97.93 110.89 23.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.39 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.701 HH11 HD12 ' A' ' 150' ' ' ILE . 41.4 mtt-85 -125.64 177.01 6.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.158 -172.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.428 ' HG2' HG22 ' A' ' 48' ' ' THR . 67.0 mtp180 -92.81 156.5 16.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.823 0.344 . . . . 0.0 111.779 -175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.597 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.5 t80 -59.63 -34.13 72.39 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 171.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 t -58.26 -33.4 69.36 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.924 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD1' ' HB ' ' A' ' 150' ' ' ILE . 25.5 m-20 -65.13 -45.24 85.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.419 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 60.6 m-85 -59.81 -40.55 88.75 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.514 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.615 ' HA ' HD11 ' A' ' 92' ' ' LEU . 32.1 mt-10 -57.04 -56.3 23.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.391 0.615 . . . . 0.0 111.096 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.449 ' CD1' HG21 ' A' ' 150' ' ' ILE . 0.6 OUTLIER -68.41 -28.98 67.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.525 -178.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.702 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.4 tm? -68.23 -42.77 79.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 55.8 ttt180 -57.89 -62.52 1.75 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.278 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 m -63.15 -27.42 69.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.545 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 12.0 tp10 -68.96 -42.06 77.16 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 85' ' ' SER . 97.1 mt -71.73 -15.4 62.19 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.632 176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 25.5 mt-10 -90.18 -41.44 11.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.693 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 84' ' ' GLU . 3.4 ppt_? -78.67 -35.21 45.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -170.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.549 ' N ' ' HD2' ' A' ' 83' ' ' ARG . 6.0 mm-40 -101.73 -26.82 13.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.986 0.422 . . . . 0.0 111.779 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -112.38 167.8 10.15 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.451 -169.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -105.33 21.14 17.68 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.439 177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 81' ' ' LEU . 87.3 t -53.68 144.91 4.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.907 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.4 p -72.64 31.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.081 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.492 ' HA ' HG12 ' A' ' 129' ' ' VAL . 1.4 t -52.42 119.51 15.32 Favored Pre-proline 0 N--CA 1.467 0.407 0 O-C-N 122.228 -0.295 . . . . 0.0 111.367 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.54 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.1 Cg_endo -88.21 168.37 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.868 2.379 . . . . 0.0 111.884 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.51 148.65 84.02 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.503 2.136 . . . . 0.0 112.495 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 75' ' ' GLU . 67.6 mt -77.22 154.83 82.33 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.641 177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.47 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 61.0 Cg_endo -83.06 142.12 10.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 165.73 -163.35 36.63 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.277 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 68.06 -60.53 0.41 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.74 0.816 . . . . 0.0 112.234 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.29 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.647 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -62.09 -16.1 49.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.471 -168.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.52 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.2 mm? -69.5 -37.47 77.22 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.597 -174.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.46 12.81 32.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.316 0.579 . . . . 0.0 109.931 174.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.4 tp-100 -97.58 -38.97 9.34 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.771 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 76.9 mt -83.07 166.87 32.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.859 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 27.2 Cg_exo -62.2 142.0 90.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.804 2.336 . . . . 0.0 111.553 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -87.26 5.5 37.98 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.261 0.553 . . . . 0.0 110.876 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -70.33 -14.25 62.5 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.358 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.4 -178.49 38.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.907 -0.664 . . . . 0.0 111.571 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.08 -45.3 94.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.026 0.441 . . . . 0.0 110.434 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -151.38 -27.98 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.884 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 -0.34 12.97 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -174.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.6 pt -74.81 -15.39 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 111.551 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -84.22 -7.3 59.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.382 175.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.25 135.84 36.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.275 0.56 . . . . 0.0 110.312 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -30.81 71.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.31 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.63 -58.5 6.74 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -51.5 -48.25 62.97 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.412 0.445 . . . . 0.0 111.101 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.8 mt -50.57 -51.16 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.218 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.76 -20.62 56.27 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.642 -177.296 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.566 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 21.2 mm-40 -75.09 -33.27 61.62 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.229 0.538 . . . . 0.0 109.878 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 9.8 tpp180 -78.7 -38.22 39.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.551 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.03 -52.27 59.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 -178.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -60.62 -41.65 95.25 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.111 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -80.34 -32.25 35.37 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.5 -176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.5 tp -67.55 -40.45 84.96 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.799 -0.201 . . . . 0.0 111.156 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.655 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.6 pt-20 -72.09 -32.41 66.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.776 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.7 mm-40 -61.34 -57.75 11.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.3 t80 -50.12 -52.1 37.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.758 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.568 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -64.7 -42.04 93.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.928 -170.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -60.64 -17.78 49.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.54 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -88.2 -57.98 2.73 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.869 0.842 . . . . 0.0 110.395 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -65.36 -12.83 14.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.203 -1.362 . . . . 0.0 111.181 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.32 6.25 28.26 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.366 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -147.09 15.94 1.52 Allowed Glycine 0 C--N 1.332 0.352 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.883 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 50.1 t60 -100.26 144.38 28.31 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 117.328 0.564 . . . . 0.0 110.385 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 21.2 Cg_exo -38.95 -49.12 2.8 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.403 3.402 . . . . 0.0 113.827 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.69 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.3 OUTLIER -70.94 -39.5 72.58 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.138 -175.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -68.02 -41.01 82.84 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.716 -175.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -70.8 4.82 2.27 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.735 0.779 . . . . 0.0 109.846 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 135' ' ' ALA . 1.7 t-20 -119.24 4.3 11.29 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.138 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 48.1 mm-40 -117.26 128.14 54.78 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.0 tpt180 -54.81 -16.56 2.7 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.817 -174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.694 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.9 m -55.5 -28.73 56.38 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.075 0.55 . . . . 0.0 111.461 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.613 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.0 mp -78.75 -29.42 45.19 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.341 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.515 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 52.6 t-80 -56.79 -39.55 74.3 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.694 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.7 ptm -79.59 -31.41 41.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.702 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.4 t80 -81.39 -36.12 29.93 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -174.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.613 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -94.02 -37.7 11.52 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.137 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 48.2 mt-30 -94.59 174.12 7.28 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.54 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.0 -166.92 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.4 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -102.72 -30.71 10.73 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.55 0.691 . . . . 0.0 110.666 172.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.538 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.4 OUTLIER -138.69 158.57 30.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.132 -167.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.701 HD12 HH11 ' A' ' 69' ' ' ARG . 2.2 mp -86.85 123.33 39.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.638 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.7 106.53 18.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.856 0.36 . . . . 0.0 110.215 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 9.4 mptt -77.2 11.24 1.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.213 0.53 . . . . 0.0 112.158 -171.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 t -126.33 18.01 7.63 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.95 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -170.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.277 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 85.5 m -82.26 112.65 37.8 Favored Pre-proline 0 N--CA 1.454 -0.248 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.458 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 16.9 Cg_exo -72.87 61.34 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.358 2.705 . . . . 0.0 112.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.0 m -136.86 -157.42 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 O-C-N 122.309 -0.244 . . . . 0.0 110.841 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.43 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -87.08 158.82 19.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 119.907 -0.092 . . . . 0.0 110.83 -176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.575 HG13 HD12 ' A' ' 59' ' ' ILE . 17.5 mm -52.2 -49.95 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.287 0.565 . . . . 0.0 110.539 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.5 20.52 4.51 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.875 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 7.6 m170 60.77 -178.26 0.11 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 114.428 -1.26 . . . . 0.0 112.353 173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.029 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.732 178.304 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.846 0.355 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -119.1 5.46 11.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.395 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -70.27 -32.54 70.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -111.05 155.83 22.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -78.76 36.01 0.26 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.893 0.377 . . . . 0.0 111.932 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.04 0.448 . . . . 0.0 110.447 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -83.04 -9.33 59.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.967 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -96.0 81.64 3.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.244 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 46.7 t -89.15 128.83 40.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.604 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -119.5 62.88 0.46 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.779 -0.725 . . . . 0.0 111.931 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.4 p -72.13 121.17 18.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.065 0.459 . . . . 0.0 111.503 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.42 128.15 17.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.445 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -131.24 -62.56 0.88 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.105 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.5 p -101.76 160.94 14.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.846 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 6' ' ' ALA . 2.0 m 41.53 -100.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 124.633 1.208 . . . . 0.0 113.93 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.497 ' H ' HG23 ' A' ' 5' ' ' VAL . . . -77.72 142.39 38.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.911 0.386 . . . . 0.0 111.664 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -120.63 168.94 10.85 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.9 p -76.54 -60.62 2.27 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 64.44 146.12 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.863 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -164.39 138.54 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.179 177.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.0 tp -145.3 146.65 31.73 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.869 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 7.6 mt -134.51 141.03 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.943 0.401 . . . . 0.0 110.663 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 p -125.95 138.87 53.79 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.714 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -106.47 153.33 40.59 Favored Pre-proline 0 C--N 1.322 -0.594 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.693 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -48.35 127.39 15.54 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.827 3.018 . . . . 0.0 112.772 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -77.51 154.23 32.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.894 -177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.84 -167.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.635 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.61 -175.85 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.546 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.48 168.1 15.27 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.803 0.811 . . . . 0.0 111.607 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -148.59 144.05 26.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.341 -1.3 . . . . 0.0 107.647 170.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.99 -56.26 0.42 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.176 0.513 . . . . 0.0 110.543 -175.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.426 ' CB ' ' HB2' ' A' ' 56' ' ' ASN . 38.6 m-85 -96.89 -30.2 13.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.755 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.52 172.36 45.39 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -53.88 157.47 10.34 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.859 3.039 . . . . 0.0 112.48 175.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.29 -18.36 0.73 Allowed 'Trans proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.997 3.798 . . . . 0.0 115.439 -174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.2 m -69.91 -61.58 1.72 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.563 HD22 ' ND2' ' A' ' 56' ' ' ASN . 26.8 m120 61.44 164.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.311 0.644 . . . . 0.0 112.675 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -89.65 143.43 26.81 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -147.77 126.66 12.72 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.08 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 4.2 pt-20 -133.29 100.04 4.72 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.12 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.68 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.1 mt -113.08 137.55 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.235 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -134.82 112.9 11.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.345 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.8 OUTLIER -92.68 130.97 40.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 170.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.3 t -179.9 -163.3 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.1 m-80 60.32 77.22 0.38 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-O 120.886 0.374 . . . . 0.0 110.477 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.58 150.67 86.35 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.885 2.39 . . . . 0.0 113.02 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' THR . 46.8 tp60 -135.75 110.66 8.79 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.955 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 m -74.56 98.21 3.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.421 0.629 . . . . 0.0 109.41 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -130.12 91.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.897 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.618 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.51 -167.58 32.72 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.86 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -109.77 148.89 13.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-O 119.41 -0.328 . . . . 0.0 110.36 -176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.91 -49.93 4.2 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 121.599 -0.334 . . . . 0.0 112.841 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.59 85.34 3.11 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.991 0.425 . . . . 0.0 109.89 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.92 39.02 0.67 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.914 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 7.3 ttp180 -85.94 150.01 24.8 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 122.487 0.315 . . . . 0.0 110.252 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -149.83 171.27 17.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.826 0.346 . . . . 0.0 110.798 -177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 74.0 m -124.63 126.56 45.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.711 -176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 21.1 p -92.69 161.53 14.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.66 0.267 . . . . 0.0 110.35 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -123.26 140.98 52.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.297 0.57 . . . . 0.0 110.838 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.1 tt0 -92.4 121.06 33.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.073 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -97.52 119.07 45.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.612 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 93.6 mtt180 -109.18 142.05 40.53 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.36 177.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.68 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.71 142.33 17.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 178.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -133.81 142.35 47.82 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.527 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.625 ' O ' ' HE2' ' A' ' 63' ' ' LYS . 10.1 t -170.12 163.37 9.15 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.72 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.567 ' HA ' ' CE ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -112.69 20.22 16.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.81 169.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.744 HD11 HD22 ' A' ' 29' ' ' LEU . 30.6 mt -58.71 147.85 69.67 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.4 170.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -84.6 -30.75 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.808 1.672 . . . . 0.0 112.075 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.583 HG13 HG21 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -61.26 -43.16 95.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 178.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CE1' HD13 ' A' ' 57' ' ' LEU . 2.8 m-30 -65.7 -33.56 76.17 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -171.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 75.54 -53.72 0.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 174.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.668 HD11 ' HA ' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -81.1 -12.12 59.34 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 122.017 -0.427 . . . . 0.0 110.392 -176.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.625 ' HE2' ' O ' ' A' ' 55' ' ' THR . 10.6 mmmm 68.51 -44.55 0.51 Allowed 'General case' 0 C--O 1.221 -0.411 0 O-C-N 124.094 0.871 . . . . 0.0 111.09 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -141.36 141.78 33.81 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.1 t -170.48 157.48 5.97 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.129 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 20.5 m -141.85 130.06 22.21 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.272 0.558 . . . . 0.0 110.873 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.7 173.29 11.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.599 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 51.8 ttp180 -137.26 109.93 7.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 173.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HB3' ' CG ' ' A' ' 73' ' ' ASP . 21.4 mmm180 -127.67 179.6 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.586 -175.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -100.22 165.72 11.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.787 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 47.1 t80 -53.72 -39.63 65.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.916 0.388 . . . . 0.0 110.062 174.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.418 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 34.1 m -53.18 -36.65 61.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.622 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' CG ' ' HB3' ' A' ' 69' ' ' ARG . 4.2 m-20 -64.37 -41.64 96.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -64.44 -37.79 88.77 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.411 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.654 ' HA ' HD11 ' A' ' 92' ' ' LEU . 27.6 mt-10 -60.12 -55.65 31.24 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.38 0.61 . . . . 0.0 111.19 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.455 ' CD1' HG21 ' A' ' 150' ' ' ILE . 3.5 t-105 -67.74 -27.54 66.88 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.003 -0.998 . . . . 0.0 111.25 -177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -69.04 -47.47 65.28 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.561 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 48.6 ttt180 -55.68 -61.35 2.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.359 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 t -61.63 -27.71 68.86 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.382 -172.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.618 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 1.8 tp10 -73.38 -47.23 43.82 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.339 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.5 mt -58.96 -35.65 73.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 110.751 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 37.6 mt-10 -64.61 -37.58 88.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.439 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.451 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.5 ppt_? -91.36 -28.39 17.74 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -174.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -82.39 -30.87 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.02 0.438 . . . . 0.0 110.96 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 87' ' ' VAL . 24.3 t -144.32 -175.11 4.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 110.921 -171.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -100.36 26.81 6.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.204 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 85' ' ' SER . 74.7 t -52.46 139.68 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.308 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.454 HG12 ' CG ' ' A' ' 132' ' ' HIS . 8.7 p -73.41 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.988 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.523 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -53.15 121.32 23.8 Favored Pre-proline 0 N--CA 1.464 0.236 0 O-C-N 122.023 -0.423 . . . . 0.0 110.565 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.0 Cg_endo -85.77 162.94 10.61 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.605 2.203 . . . . 0.0 112.401 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 29.6 Cg_endo -63.57 146.24 92.52 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.765 2.31 . . . . 0.0 112.191 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.654 HD11 ' HA ' ' A' ' 75' ' ' GLU . 97.6 mt -74.3 142.9 79.09 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.9 Cg_exo -73.94 117.56 5.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.885 2.39 . . . . 0.0 111.224 176.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.09 61.44 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.257 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.43 -45.35 0.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.101 0.477 . . . . 0.0 111.388 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.01 -85.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -169.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -49.45 -32.03 11.05 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.579 1.152 . . . . 0.0 113.979 -170.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -57.46 -47.3 82.21 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.24 0.543 . . . . 0.0 110.68 -173.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.07 27.83 8.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.618 0.723 . . . . 0.0 110.145 178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -122.96 -32.73 3.45 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.871 -178.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.53 168.12 12.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.027 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.31 156.26 66.96 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.865 2.376 . . . . 0.0 111.551 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -79.2 -90.42 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.498 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 41.9 ttp-105 64.97 -72.0 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.637 0.586 . . . . 0.0 111.344 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.02 65.16 4.11 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.233 -0.508 . . . . 0.0 111.888 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 66.57 -71.14 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.297 1.039 . . . . 0.0 111.326 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -112.83 -19.18 12.08 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.338 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.28 8.47 31.09 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.572 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 50.3 pt -75.56 -17.39 15.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.027 0.441 . . . . 0.0 111.819 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -79.35 -15.43 57.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.031 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.8 132.41 41.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.155 0.503 . . . . 0.0 109.884 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -62.48 -27.3 69.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.717 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 50.2 m-80 -65.83 -52.43 50.63 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -53.95 -49.4 68.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.522 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 29.6 mt -52.57 -48.7 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.925 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.13 -21.85 59.7 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.605 -178.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 46.8 mm-40 -73.66 -33.86 64.67 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.621 0.724 . . . . 0.0 109.634 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.79 -35.82 43.75 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.433 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -57.24 -53.12 61.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.11 -178.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -61.17 -45.0 96.42 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.605 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.17 -43.41 95.52 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.804 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.4 OUTLIER -69.51 -32.14 70.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.629 0.715 . . . . 0.0 111.599 179.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.615 ' HA ' HG22 ' A' ' 126' ' ' ILE . 14.9 pt-20 -74.92 -33.3 61.98 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.0 mm-40 -59.88 -57.64 12.01 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.513 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.2 t80 -51.68 -53.31 40.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.499 179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.9 tp -64.41 -39.95 87.35 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.018 -170.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -60.58 -20.49 60.65 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 112.026 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.0 mttm -88.46 -56.26 3.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.667 0.746 . . . . 0.0 110.899 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.651 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -66.9 -11.73 14.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.025 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.07 -11.7 16.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.499 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -122.65 -6.17 8.04 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.312 -0.946 . . . . 0.0 113.936 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.72 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.6 t60 -84.09 143.55 42.85 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 117.328 0.564 . . . . 0.0 110.633 -176.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.72 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 17.2 Cg_exo -39.33 -50.03 2.95 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 124.514 3.476 . . . . 0.0 113.813 -175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.42 -30.71 66.38 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.352 -174.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.651 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -77.0 -44.54 30.55 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.45 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.14 -0.76 0.57 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.421 176.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.581 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 2.5 t30 -104.11 -21.13 13.62 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.409 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 17.9 mm-40 -102.11 143.12 32.34 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.905 0.775 . . . . 0.0 112.627 -166.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 139' ' ' ARG . 6.7 tpp85 -62.85 -21.25 65.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.513 -166.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.566 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 1.9 t -60.41 -26.15 66.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.23 0.538 . . . . 0.0 110.076 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.549 HD22 ' O ' ' A' ' 135' ' ' ALA . 4.6 mp -71.48 -28.51 63.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.342 176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.82 -47.18 86.24 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 2.5 ptm -72.44 -30.64 64.77 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.927 -176.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.7 t80 -75.92 -48.37 21.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.651 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.46 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 1.6 mt -96.97 -43.68 7.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.271 0.558 . . . . 0.0 111.545 -171.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.668 ' HA ' HD11 ' A' ' 62' ' ' LEU . 54.4 mt-30 -91.43 -15.51 28.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.573 -166.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -111.43 174.64 5.77 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -79.15 -32.72 44.43 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 122.089 0.947 . . . . 0.0 110.013 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.506 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -139.9 143.87 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 112.132 -167.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 2.9 mp -71.58 106.67 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.036 173.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -88.96 104.02 16.58 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.897 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -69.16 -1.01 6.74 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -172.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.9 p -113.24 18.03 18.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.471 0.653 . . . . 0.0 110.596 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.434 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -64.3 -171.48 0.06 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.604 178.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 50.7 m -86.45 112.12 44.06 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.14 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 22.1 Cg_exo -69.38 82.43 0.67 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.403 2.735 . . . . 0.0 111.621 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 m -156.73 -153.58 0.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -105.02 177.65 4.79 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.697 177.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.583 HG21 HG13 ' A' ' 59' ' ' ILE . 17.1 mm -66.78 -36.16 76.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.589 178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.7 mmt180 -76.34 7.04 4.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.496 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.7 m170 68.02 -179.83 0.23 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.184 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.362 -178.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.079 0.466 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.28 112.92 24.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.205 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -134.95 46.83 2.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.175 0.512 . . . . 0.0 110.02 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 48.7 m80 59.26 49.06 9.48 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.545 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -118.21 83.76 2.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -64.25 116.82 6.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.589 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -97.73 67.11 1.98 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.679 0.752 . . . . 0.0 110.006 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -108.81 157.41 18.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.903 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.1 m -76.6 82.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.559 0.695 . . . . 0.0 111.364 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 108.96 -93.55 0.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.142 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.6 p 49.66 97.26 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.99 0.916 . . . . 0.0 112.831 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.44 142.7 28.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.678 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -82.09 -46.79 13.4 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.417 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 p -107.74 151.8 25.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.585 175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.5 t -119.02 -46.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.763 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.39 123.87 30.1 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.32 148.61 46.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.8 m -54.62 -49.75 69.74 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 122.499 0.32 . . . . 0.0 110.936 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 6.0 mmp_? 64.44 154.76 0.06 Allowed 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.785 0.678 . . . . 0.0 111.589 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -169.06 -82.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.2 tp 72.22 137.42 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.553 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mt -136.3 143.25 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.917 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.9 p -136.13 130.11 32.82 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.306 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -83.8 157.72 63.29 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.324 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.55 127.11 13.26 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.275 2.65 . . . . 0.0 112.386 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -67.86 134.47 50.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.656 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -115.19 -166.78 1.15 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.814 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.76 -164.6 0.94 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 20' ' ' ASP . 1.3 p-10 -43.56 -67.65 0.26 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.075 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.525 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 5.5 p-10 -133.36 134.61 43.96 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.223 172.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -179.07 168.04 1.58 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.133 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -143.55 -53.75 0.37 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.185 0.517 . . . . 0.0 110.147 -171.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -171.89 -179.68 43.01 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 9.4 Cg_endo -51.44 154.92 7.82 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.531 2.821 . . . . 0.0 111.499 173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 51.7 Cg_exo -56.49 -7.71 2.27 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.798 2.998 . . . . 0.0 113.953 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.4 p -77.12 -53.58 7.59 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 28.7 m120 62.85 170.88 0.14 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.671 0.607 . . . . 0.0 111.494 175.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.65 134.9 33.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.727 HD22 HD11 ' A' ' 57' ' ' LEU . 14.9 tp -142.17 130.25 22.01 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.114 -177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -141.46 101.11 3.92 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.824 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.679 HG12 ' HB ' ' A' ' 53' ' ' VAL . 42.9 mt -115.07 140.55 35.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.708 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -132.59 106.92 8.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.938 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -84.6 130.64 35.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 170.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -179.1 -164.71 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.4 m-80 59.2 71.75 0.9 Allowed Pre-proline 0 C--O 1.234 0.283 0 CA-C-O 120.983 0.421 . . . . 0.0 110.284 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.39 133.37 37.15 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.088 2.525 . . . . 0.0 113.487 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.454 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 44.0 tp60 -117.65 106.96 13.64 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.686 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.5 m -78.22 90.1 4.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.554 0.692 . . . . 0.0 109.953 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' HE21 ' A' ' 37' ' ' GLN . 1.8 p -117.29 91.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.612 -174.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.45 -166.28 31.53 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.399 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.1 t -101.2 146.94 8.74 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.346 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.34 -48.13 4.6 Favored Glycine 0 N--CA 1.465 0.584 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.245 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -102.22 88.21 3.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.39 0.614 . . . . 0.0 109.713 170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.13 33.9 0.93 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.603 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.62 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 13.8 ttt180 -85.31 139.86 31.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.602 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 39.3 p90 -129.72 153.57 48.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 86.7 m -111.31 124.08 51.5 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.0 p -92.74 153.58 18.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.117 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.26 136.45 51.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.02 0.438 . . . . 0.0 110.765 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.57 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 29.3 tt0 -90.58 116.6 28.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.791 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.6 mp -94.27 113.75 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.865 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HG2' ' OG1' ' A' ' 66' ' ' THR . 66.4 mtt180 -105.53 121.98 45.08 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.843 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -128.9 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.0 111.882 -177.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -127.92 133.74 49.29 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 168.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.429 ' OG1' ' HG ' ' A' ' 57' ' ' LEU . 7.1 t -168.27 165.44 12.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.595 0.712 . . . . 0.0 112.121 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.94 21.63 12.73 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.752 167.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.727 HD11 HD22 ' A' ' 29' ' ' LEU . 26.7 mt -56.14 131.96 74.81 Favored Pre-proline 0 CA--C 1.521 -0.163 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.801 174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 11.7 Cg_exo -66.82 -37.94 18.97 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.413 2.076 . . . . 0.0 111.186 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -58.2 -42.43 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.448 176.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.87 -23.69 64.24 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -170.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.47 -64.57 0.34 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD12 ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -73.44 -25.68 60.61 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -174.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' O ' HG22 ' A' ' 55' ' ' THR . 19.2 mmtp 82.02 -34.24 0.1 Allowed 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.822 171.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -165.32 125.19 1.82 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.546 0.688 . . . . 0.0 110.08 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.468 ' CB ' HD12 ' A' ' 62' ' ' LEU . 16.7 t -170.71 176.13 4.34 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.751 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.57 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 27.9 m -141.73 133.19 26.72 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 178.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.5 m -121.3 178.35 2.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.301 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -143.24 106.08 4.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -127.41 167.59 16.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.449 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.602 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 58.0 ttp180 -94.82 165.13 12.63 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.002 -172.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.526 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.2 t80 -52.52 -40.73 62.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.621 0.248 . . . . 0.0 110.809 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -54.17 -35.5 62.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.7 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.65 -41.51 96.07 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 69.1 m-85 -64.97 -38.02 89.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.3 mt-10 -60.71 -52.12 66.44 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.376 0.607 . . . . 0.0 110.935 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.519 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 8.3 t-105 -67.26 -27.53 67.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.283 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -71.32 -46.58 60.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 53.5 ttt180 -58.17 -58.63 7.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.266 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 p -62.74 -32.28 73.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.453 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 1.1 tm-20 -59.4 -48.0 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.0 110.264 176.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 92.5 mt -65.4 -30.05 70.82 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.942 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 40.0 mt-10 -82.03 -35.53 28.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.988 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 2.6 ppt_? -69.59 -25.14 63.82 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -169.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.401 ' HG3' ' HD2' ' A' ' 83' ' ' ARG . 4.0 mt-10 -119.53 -55.06 2.14 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.056 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.7 m -87.21 171.09 10.91 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.754 0.787 . . . . 0.0 112.221 -172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -102.66 30.61 4.57 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.474 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -50.8 142.23 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.699 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.5 p -72.01 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.726 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HA ' HG12 ' A' ' 129' ' ' VAL . 0.2 OUTLIER -58.74 119.66 39.06 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.435 . . . . 0.0 110.882 -176.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 91.9 Cg_endo -85.5 162.12 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.882 2.388 . . . . 0.0 112.288 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.73 135.03 40.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.988 2.458 . . . . 0.0 112.661 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 93.5 mt -66.19 151.26 95.92 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.401 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 5.6 Cg_exo -73.49 113.01 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.635 2.223 . . . . 0.0 111.248 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.48 166.57 37.08 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.635 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 56.59 25.7 10.22 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.536 0.684 . . . . 0.0 110.925 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -116.63 -74.79 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.296 -0.865 . . . . 0.0 111.016 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -69.96 -22.29 63.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.02 -176.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -66.83 -47.0 73.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.517 -174.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -92.98 28.74 2.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.842 0.829 . . . . 0.0 110.051 176.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.6 tp-100 -124.7 -41.29 2.14 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.854 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.74 165.63 20.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.08 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 179.54 3.72 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.2 2.6 . . . . 0.0 111.966 172.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.94 -75.92 0.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.009 0.433 . . . . 0.0 110.2 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 104' ' ' ARG . 29.2 mtm180 68.06 -57.48 0.47 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.063 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -103.31 -159.26 25.1 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.717 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -59.09 -48.24 82.34 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.407 0.622 . . . . 0.0 110.719 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -130.88 -21.85 2.67 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.438 -175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.82 11.15 38.4 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.581 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 49.8 pt -90.96 -17.93 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.723 -173.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -82.9 10.44 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.357 0.599 . . . . 0.0 109.789 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -94.88 126.94 40.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.332 177.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -68.0 -21.16 65.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.628 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.582 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.4 m-80 -71.45 -55.14 8.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.9 OUTLIER -50.82 -50.06 57.31 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.616 0.572 . . . . 0.0 111.129 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.6 mt -50.96 -48.99 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.653 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -81.69 -14.84 56.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.913 -177.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 35.7 mm-40 -69.44 -35.13 75.37 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.3 0.571 . . . . 0.0 109.698 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.573 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.6 ttp180 -79.44 -34.32 41.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.212 175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -57.41 -51.29 70.0 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.631 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.779 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -61.2 -37.63 83.67 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.311 -174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.6 -33.3 25.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.388 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.8 tp -66.6 -38.02 86.11 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 122.181 0.192 . . . . 0.0 110.945 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.59 ' HA ' HG22 ' A' ' 126' ' ' ILE . 9.8 pt-20 -71.28 -30.87 66.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.779 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 22.0 mm-40 -61.16 -59.64 5.01 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 2.5 t80 -48.47 -52.52 21.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.963 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -64.08 -40.28 88.48 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.636 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.79 -172.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.09 -18.02 44.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -89.1 -59.24 2.28 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.827 0.822 . . . . 0.0 110.396 175.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 81' ' ' LEU . 1.3 m -63.45 -12.46 10.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.071 -177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.64 -0.89 27.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.436 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.456 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -140.73 11.94 2.91 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.685 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.695 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 38.3 t60 -101.57 141.34 22.39 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.474 -0.427 . . . . 0.0 110.82 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.695 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 7.9 Cg_exo -41.27 -50.47 4.42 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 124.365 3.377 . . . . 0.0 113.79 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -69.64 -26.24 64.32 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.16 -174.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.47 -41.67 16.36 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.166 -176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.659 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.3 mm100 -66.29 -4.68 8.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.201 176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.481 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.9 t-20 -106.26 0.77 25.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.438 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 138' ' ' GLU . 5.1 mm-40 -112.26 127.46 55.98 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.999 -0.438 . . . . 0.0 110.986 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.454 ' HA ' HD13 ' A' ' 159' ' ' ILE . 13.7 tpp85 -57.98 -21.53 45.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.42 -172.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.814 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 4.3 t -61.88 -22.78 65.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 110.537 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.539 ' O ' HD22 ' A' ' 145' ' ' LEU . 7.3 mp -72.76 -32.46 65.66 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.096 -0.378 . . . . 0.0 111.441 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 18.8 t60 -58.0 -44.1 87.0 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 121.363 0.602 . . . . 0.0 109.643 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.814 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -77.83 -24.4 48.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.174 -177.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.503 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.4 t80 -80.37 -57.18 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.83 -24.81 26.59 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.686 -173.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.4 mt-30 -109.16 158.76 17.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.375 -168.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 62.51 -107.06 0.22 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.258 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.418 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.6 pm0 -146.26 -39.78 0.22 Allowed 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.597 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -139.85 151.78 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -161.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -77.59 109.11 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.314 172.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.59 102.3 15.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.931 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 31.6 mmtp -66.25 -5.42 10.32 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 111.691 -174.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -106.9 18.19 22.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.311 0.577 . . . . 0.0 110.123 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.447 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -66.32 -170.8 0.1 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.951 -179.048 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 70.6 m -87.84 111.6 43.41 Favored Pre-proline 0 N--CA 1.451 -0.407 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.136 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.7 Cg_exo -70.72 81.68 1.03 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.247 2.631 . . . . 0.0 111.785 175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 60.6 m -155.56 -159.24 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.264 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.481 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 18.1 mmmt -84.92 167.31 16.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.77 -45.17 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 120.94 0.4 . . . . 0.0 110.661 173.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.19 125.72 28.4 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -75.19 174.07 9.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.588 0.709 . . . . 0.0 110.71 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.684 -179.298 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . 62.39 84.65 0.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.238 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -129.13 132.29 47.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.086 0.469 . . . . 0.0 110.264 172.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -139.35 56.67 1.66 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.289 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 71.34 -77.89 0.05 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.468 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -152.97 156.01 38.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.771 0.32 . . . . 0.0 110.531 -175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -90.35 -32.37 16.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.935 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -80.05 93.63 5.8 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.821 0.343 . . . . 0.0 111.064 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.7 t 62.15 89.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.832 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -83.37 -85.75 0.84 Allowed Glycine 0 C--N 1.314 -0.657 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.629 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 m -79.49 148.34 31.89 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.96 124.0 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.103 0.478 . . . . 0.0 110.955 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.62 -50.05 4.87 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.979 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -79.61 138.74 37.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.74 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -154.81 -41.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.257 -173.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -55.01 127.49 29.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.449 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.12 -167.88 1.73 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.456 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.4 p -58.14 -67.73 0.32 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 56.86 -171.13 0.09 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.891 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -169.45 -177.54 2.82 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.1 tp -160.39 146.32 15.21 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mt -121.26 143.4 33.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.139 0.495 . . . . 0.0 110.812 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.4 p -138.35 121.98 17.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.46 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -69.67 162.43 67.52 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.18 104.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.935 2.423 . . . . 0.0 112.118 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -98.48 167.11 11.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.919 -175.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -123.3 153.69 39.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.763 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.81 151.47 29.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.521 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -86.09 -179.66 6.79 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.712 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 4.8 m-20 -86.9 143.83 27.24 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . 71.91 168.4 0.31 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 124.154 0.909 . . . . 0.0 110.849 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.3 m-85 -122.15 -13.62 8.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.636 -171.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.66 172.23 38.18 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.753 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -51.92 156.56 6.93 Favored 'Trans proline' 0 C--O 1.224 -0.207 0 C-N-CA 124.16 3.24 . . . . 0.0 112.223 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -42.64 -22.51 0.25 Allowed 'Trans proline' 0 N--CA 1.484 0.933 0 C-N-CA 124.81 3.673 . . . . 0.0 115.728 -171.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -72.0 -61.51 1.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.507 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.1 m-80 60.95 -178.26 0.11 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.932 0.396 . . . . 0.0 111.523 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -89.42 130.52 35.76 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.735 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -145.1 129.56 17.89 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.041 -174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -143.04 100.09 3.58 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.9 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.689 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.8 mt -111.07 146.05 16.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.442 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.2 114.99 11.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.719 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -97.14 132.36 41.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.53 -161.73 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 61.94 71.87 0.7 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.738 0.304 . . . . 0.0 110.524 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.19 132.66 28.39 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.777 2.318 . . . . 0.0 113.183 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 46.1 tp60 -122.25 111.65 17.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.569 174.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.9 m -75.87 98.14 4.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.268 0.556 . . . . 0.0 109.541 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -130.04 94.45 2.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.873 -175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -170.64 -167.77 31.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.03 -1.081 . . . . 0.0 112.515 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 4.0 t -110.23 151.48 12.44 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.655 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.171 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.27 -49.1 4.58 Favored Glycine 0 N--CA 1.46 0.272 0 C-N-CA 121.296 -0.478 . . . . 0.0 112.465 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.23 78.68 3.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.06 0.457 . . . . 0.0 110.351 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.61 41.12 0.54 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.945 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.572 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 6.2 ttp180 -82.28 145.85 29.77 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -146.95 159.67 43.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.069 0.462 . . . . 0.0 111.072 -175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.6 m -112.36 128.79 56.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.928 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 20.1 p -92.29 146.22 23.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.002 0.429 . . . . 0.0 110.502 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 78.9 m-85 -108.18 132.56 53.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.996 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 32.0 tt0 -87.14 119.06 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.73 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.541 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.1 mp -94.09 111.67 25.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.104 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 91.6 mtt180 -104.66 132.64 50.67 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.141 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.689 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.9 138.44 34.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 7.1 ttmt -125.74 133.91 51.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.596 168.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.0 t -166.3 164.24 17.6 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.422 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.84 25.78 10.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.682 167.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.735 HD11 HD22 ' A' ' 29' ' ' LEU . 29.4 mt -61.42 133.58 93.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.496 172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.8 Cg_exo -70.66 -32.01 15.56 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.462 2.108 . . . . 0.0 111.262 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -63.62 -40.23 88.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.963 177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.523 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 3.8 m-30 -71.07 -19.16 62.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -172.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB3' HD13 ' A' ' 62' ' ' LEU . 54.5 tttp 71.19 -64.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' N ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.29 -5.52 56.41 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -174.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 55' ' ' THR . 4.9 mmpp? 71.22 -38.41 0.42 Allowed 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.769 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -160.35 135.94 8.22 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.014 0.435 . . . . 0.0 110.038 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -170.08 175.45 5.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.585 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.8 m -140.83 141.67 34.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.776 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.6 m -138.86 -179.9 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 40.7 ptt180 -150.37 126.97 10.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.14 0.495 . . . . 0.0 111.106 171.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.0 mmp_? -139.36 167.24 22.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.802 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.41 156.6 20.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 -174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 43.3 t80 -51.72 -39.34 58.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.723 0.297 . . . . 0.0 110.744 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.9 m -54.17 -32.77 56.34 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.863 176.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -73.13 -35.85 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.541 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 51.5 m-85 -64.52 -39.59 94.06 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HA ' HD11 ' A' ' 92' ' ' LEU . 15.7 mt-10 -60.09 -51.6 68.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.822 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' HG21 ' A' ' 150' ' ' ILE . 6.8 t-105 -65.44 -27.46 68.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.256 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.594 HD22 ' CD2' ' A' ' 144' ' ' PHE . 34.4 tp -72.08 -48.46 43.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 43.3 ttt180 -53.98 -59.38 4.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.839 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.632 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 p -60.06 -40.3 89.01 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.033 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.6 -52.57 59.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 0.0 110.594 176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 87.6 mt -65.51 -34.8 79.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.383 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 35.0 mt-10 -70.06 -43.96 70.12 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 79' ' ' SER . 20.6 mmt180 -76.73 -48.07 19.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.177 -175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -83.81 -23.07 31.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.044 -171.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.6 t -132.79 -177.52 4.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.408 0.623 . . . . 0.0 111.237 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -108.54 18.24 21.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.217 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.433 ' CG1' HG22 ' A' ' 89' ' ' VAL . 90.1 t -48.89 141.13 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.287 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.1 p -71.91 38.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.466 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -55.99 118.88 22.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.163 -0.335 . . . . 0.0 110.774 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.419 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 91.6 Cg_endo -83.79 161.62 14.17 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.845 2.363 . . . . 0.0 111.976 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.62 139.22 62.77 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.716 2.277 . . . . 0.0 112.223 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.9 mt -70.27 154.96 94.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.857 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 3.2 Cg_exo -79.06 110.07 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 0.0 110.919 175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.3 171.32 39.8 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.297 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 56.91 51.28 10.92 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.445 0.64 . . . . 0.0 110.125 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.29 -83.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.543 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.599 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -64.1 -17.96 63.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.814 -174.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.698 ' H ' HD22 ' A' ' 98' ' ' LEU . 2.0 mm? -65.85 -41.58 91.53 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.983 -175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 24.97 7.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.882 178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.599 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -96.64 -48.92 5.32 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.446 -177.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.595 ' C ' HD22 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -92.85 165.34 19.04 Favored Pre-proline 0 N--CA 1.437 -1.099 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.696 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -59.96 -78.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.489 2.793 . . . . 0.0 113.217 -175.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -149.36 -88.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.457 -175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 104' ' ' ARG . 17.6 tpt180 67.3 -56.12 0.45 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.694 0.798 . . . . 0.0 112.632 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -128.68 170.01 20.02 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.546 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.71 -53.52 24.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.049 0.54 . . . . 0.0 111.051 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -106.61 -4.86 19.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.323 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.38 4.94 58.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.782 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.4 pt -73.57 -14.79 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.205 -0.498 . . . . 0.0 111.673 -175.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -84.34 1.07 46.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.756 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -103.8 136.59 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -68.27 -25.57 65.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.638 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.469 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -61.85 -61.4 2.52 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.782 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -49.2 -50.43 38.19 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.354 177.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 55.5 mt -51.59 -53.89 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.18 -20.1 60.32 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.494 -177.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.529 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 65.2 mm-40 -74.26 -33.62 63.34 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.27 0.557 . . . . 0.0 109.639 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.1 tpp180 -76.64 -40.12 50.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -53.02 -51.44 61.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.273 -1.33 . . . . 0.0 110.859 -176.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.756 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -61.46 -36.26 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.819 -173.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.65 -33.1 10.4 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.699 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' HB3' HG21 ' A' ' 33' ' ' VAL . 8.1 tp -67.39 -36.35 81.15 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.978 -0.13 . . . . 0.0 111.083 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.644 ' OE2' ' HA ' ' A' ' 120' ' ' GLN . 9.7 pt-20 -72.37 -28.84 63.27 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.756 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 18.2 mm-40 -65.18 -61.34 2.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.462 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.5 t80 -44.01 -52.98 6.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.89 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.4 tp -62.81 -41.15 91.4 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.476 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -59.29 -17.42 28.77 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -90.47 -58.08 2.61 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.734 0.778 . . . . 0.0 110.452 175.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.0 OUTLIER -64.47 -12.5 12.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.884 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -105.63 0.45 26.44 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.376 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.476 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.33 13.89 2.29 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.933 -1.127 . . . . 0.0 114.026 -177.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.67 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 55.2 t60 -101.21 141.83 23.41 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 117.156 0.478 . . . . 0.0 110.138 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.72 -49.49 5.36 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 124.014 3.143 . . . . 0.0 113.523 -173.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -33.17 73.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.331 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -74.08 -41.29 61.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.822 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.5 mm100 -70.3 0.13 7.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.187 0.994 . . . . 0.0 109.36 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.482 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.6 t-20 -117.28 14.86 14.85 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.242 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.58 130.52 47.47 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.798 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 139' ' ' ARG . 4.3 mmt180 -49.51 -22.38 1.22 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.795 0.838 . . . . 0.0 113.002 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.712 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 2.8 m -55.4 -28.0 51.28 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.21 0.604 . . . . 0.0 112.13 -174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.51 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.2 mp -78.26 -34.39 49.06 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 121.784 -0.573 . . . . 0.0 111.735 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 81.8 t60 -63.12 -35.69 81.11 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.45 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.712 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 8.6 ptm -77.47 -28.94 52.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.452 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.594 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.1 t80 -80.7 -58.57 3.04 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.199 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.51 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.5 OUTLIER -83.12 -22.71 33.28 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.077 -172.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 42.6 mt-30 -120.98 179.19 4.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.711 -169.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 21.5 t70 65.73 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.831 0.707 . . . . 0.0 110.542 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.81 -56.04 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.68 0.752 . . . . 0.0 110.044 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.582 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.49 143.29 40.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.05 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.668 HG23 ' HE2' ' A' ' 143' ' ' MET . 2.9 mp -65.44 119.35 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.585 173.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -89.4 106.68 18.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.874 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -73.89 10.0 1.32 Allowed 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -129.93 19.22 5.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -63.71 -172.31 0.06 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.015 -177.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 89.7 m -87.31 112.24 46.66 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -69.94 77.92 1.11 Allowed 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 123.167 2.578 . . . . 0.0 111.105 176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.1 m -153.73 -161.61 1.29 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.388 -0.195 . . . . 0.0 110.554 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 4.5 mmmm -86.83 158.72 19.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.414 -174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.572 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -57.16 -39.63 68.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.209 0.528 . . . . 0.0 110.524 172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.1 mmt85 -67.92 113.06 5.32 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.681 -173.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -82.87 174.16 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.508 0.671 . . . . 0.0 110.483 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.825 -179.286 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.452 0.168 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -146.11 36.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.926 0.393 . . . . 0.0 111.368 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -134.69 54.52 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.258 0.551 . . . . 0.0 109.747 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -142.68 105.95 4.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.561 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -173.26 151.57 2.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.214 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -136.96 -56.45 0.72 Allowed 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.364 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 63.65 86.8 0.12 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.241 0.543 . . . . 0.0 110.102 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -81.06 -36.58 30.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.979 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.0 m -126.62 162.21 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.231 177.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 78.99 -79.59 1.58 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.828 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.6 m -91.84 147.89 22.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.63 132.77 46.83 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.9 -55.99 1.48 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.991 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 p -94.45 144.14 25.82 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.451 0.643 . . . . 0.0 111.489 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.5 m -131.57 163.37 37.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.0 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.54 123.88 42.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.245 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -113.05 160.81 17.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 177.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.3 p -63.68 -57.09 11.09 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.769 0.319 . . . . 0.0 110.407 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 58.0 -89.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.313 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -139.95 127.5 21.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 109.957 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.428 ' C ' HG13 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -107.64 -62.14 1.47 Allowed 'General case' 0 N--CA 1.426 -1.662 0 CA-C-O 122.213 1.006 . . . . 0.0 108.703 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.428 HG13 ' C ' ' A' ' 11' ' ' LEU . 5.7 mt 70.52 146.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 112.258 -2.246 . . . . 0.0 112.294 169.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 p -106.11 107.72 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.521 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 7.1 mptt -98.42 168.73 9.39 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.827 -177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 47.3 Cg_exo -57.48 111.5 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.375 2.05 . . . . 0.0 111.371 174.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.4 147.39 47.99 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.592 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.68 159.3 21.54 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.404 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.8 mm? -91.57 154.69 18.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.349 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 20' ' ' ASP . 3.5 p-10 -50.87 -60.76 2.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.558 0.694 . . . . 0.0 110.37 176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 4.6 m-20 -123.33 149.72 44.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.769 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.08 175.96 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.927 0.767 . . . . 0.0 111.783 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 5.2 m-85 -124.97 -9.57 7.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.757 -173.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.14 174.25 46.61 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.244 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -54.33 154.27 19.57 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 123.988 3.126 . . . . 0.0 111.486 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -46.47 -19.25 0.63 Allowed 'Trans proline' 0 N--CA 1.479 0.625 0 C-N-CA 124.42 3.413 . . . . 0.0 115.379 -170.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -70.46 -57.44 4.79 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 36.9 m-80 59.07 -178.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.469 0.481 . . . . 0.0 111.765 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -95.46 136.4 35.88 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.746 HD22 HD11 ' A' ' 57' ' ' LEU . 13.9 tp -145.79 131.28 18.73 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.09 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 5.9 pt-20 -140.81 99.72 3.68 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.063 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.665 HG12 ' HB ' ' A' ' 53' ' ' VAL . 22.4 mt -112.06 138.81 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.24 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -138.09 107.72 6.23 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -83.89 136.75 22.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 172.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 p -179.9 -167.17 0.09 Allowed 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 55.2 84.88 0.2 Allowed Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.61 0.569 . . . . 0.0 111.479 173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.478 ' HB3' HG21 ' A' ' 115' ' ' ILE . 94.4 Cg_endo -76.35 119.9 5.44 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.515 2.143 . . . . 0.0 113.738 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -102.55 106.26 16.93 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.386 171.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' HE ' ' A' ' 45' ' ' ARG . 28.5 m -78.75 89.28 4.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.685 0.755 . . . . 0.0 110.115 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -115.36 94.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.7 -173.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.61 -167.48 32.67 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.558 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 10.1 t -104.32 152.59 6.53 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 CA-C-O 119.293 -0.384 . . . . 0.0 110.177 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.1 -51.81 6.01 Favored Glycine 0 N--CA 1.461 0.347 0 C-N-CA 121.261 -0.495 . . . . 0.0 112.188 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.56 83.15 4.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.884 0.373 . . . . 0.0 110.171 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.29 39.73 0.72 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.384 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.593 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 23.5 ttt180 -84.09 141.12 31.35 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 43.5 p90 -131.1 164.3 25.75 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.167 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.6 m -117.45 127.14 53.72 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.232 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.594 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 16.6 p -92.15 128.22 37.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 91.8 m-85 -90.63 131.87 36.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.458 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 29.6 tt0 -81.74 116.37 21.41 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.314 -178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.504 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.9 mp -92.83 109.47 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.707 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 27.5 mtp180 -100.29 136.09 40.72 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.765 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.665 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.49 135.67 12.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.184 0.516 . . . . 0.0 112.337 -178.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 15.5 ttmt -124.39 139.82 53.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.024 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -170.55 164.32 8.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.4 0.619 . . . . 0.0 112.317 -177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.55 27.35 8.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.949 167.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.746 HD11 HD22 ' A' ' 29' ' ' LEU . 23.0 mt -60.98 141.88 93.19 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.751 172.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.5 Cg_exo -76.04 -33.04 3.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.569 2.179 . . . . 0.0 111.524 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -63.05 -41.91 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.807 177.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CE2' HD22 ' A' ' 145' ' ' LEU . 3.5 m-30 -68.95 -26.52 65.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -170.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HD2' ' C ' ' A' ' 61' ' ' LYS . 1.9 tmmm? 73.81 -60.64 0.52 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.69 -7.83 58.84 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 122.126 -0.359 . . . . 0.0 110.684 -173.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 55' ' ' THR . 5.4 mmtp 70.25 -40.83 0.48 Allowed 'General case' 0 C--O 1.216 -0.708 0 O-C-N 124.063 0.852 . . . . 0.0 111.24 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.9 pp20? -161.16 136.48 7.72 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 167.79 13.86 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.476 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 19.0 m -141.81 137.17 31.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.191 0.52 . . . . 0.0 111.559 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -132.74 -176.39 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.088 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 8.3 ptp180 -150.33 116.21 5.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.372 0.606 . . . . 0.0 110.929 173.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 24.4 mmm180 -135.01 160.44 38.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.874 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 32.9 ptt180 -89.8 172.63 8.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -169.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.491 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 26.7 t80 -54.46 -41.88 69.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.247 -176.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.6 t -55.42 -33.98 64.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.314 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -70.66 -37.47 73.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.504 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 61.7 m-85 -64.86 -38.74 91.98 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.621 ' HA ' HD11 ' A' ' 92' ' ' LEU . 22.0 mt-10 -60.08 -53.48 57.32 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.754 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.444 ' NE1' ' HD3' ' A' ' 152' ' ' LYS . 3.1 t-105 -67.57 -27.9 67.33 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.403 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.0 tm? -70.49 -41.71 72.34 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 57.2 ttt180 -59.06 -60.46 3.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.733 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 7.5 p -61.45 -37.13 82.44 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.373 -175.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.96 -49.99 72.01 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.132 0.27 . . . . 0.0 110.755 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.6 mt -61.44 -34.36 75.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.909 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 32.2 mt-10 -75.22 -18.54 60.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.805 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HG2' ' O ' ' A' ' 79' ' ' SER . 31.7 mmt180 -80.28 -62.99 1.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.208 0.528 . . . . 0.0 111.81 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -88.73 -21.52 23.8 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.264 -171.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.648 ' HB2' HG23 ' A' ' 87' ' ' VAL . 16.2 m -123.75 169.39 11.57 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 121.314 0.578 . . . . 0.0 111.263 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -100.45 32.36 3.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.219 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 85' ' ' SER . 80.8 t -53.08 142.04 6.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.145 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.7 p -71.21 36.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.737 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.55 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.5 OUTLIER -59.51 116.37 16.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 O-C-N 122.055 -0.403 . . . . 0.0 110.953 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.565 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 88.3 Cg_endo -85.36 162.72 11.2 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.783 2.322 . . . . 0.0 112.606 -177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.25 131.86 33.94 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.898 2.399 . . . . 0.0 112.112 178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD11 ' HA ' ' A' ' 75' ' ' GLU . 62.5 mt -63.99 152.0 88.41 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.555 -178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 2.8 Cg_exo -75.52 129.74 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.689 2.26 . . . . 0.0 111.202 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.45 -179.23 48.29 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.3 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' N ' HD23 ' A' ' 98' ' ' LEU . 10.6 mptt 66.58 -58.12 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.088 0.955 . . . . 0.0 112.185 -176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.45 -77.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.553 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -71.75 -22.03 61.66 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.499 -170.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.696 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -65.71 -45.61 82.08 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.005 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.98 22.19 8.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.388 0.613 . . . . 0.0 110.38 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.553 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.7 OUTLIER -115.97 -45.56 2.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.638 -177.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 46.5 mt -82.26 169.4 18.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.521 -174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.04 145.41 73.49 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.743 2.295 . . . . 0.0 111.054 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -75.5 -71.19 0.38 Allowed 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.005 0.431 . . . . 0.0 110.075 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 68.83 -56.37 0.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.887 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.27 -169.15 37.57 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -53.0 -50.33 64.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.34 0.59 . . . . 0.0 111.246 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -120.92 -26.44 5.19 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.62 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.26 -13.8 8.92 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.731 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 24.9 pt -68.75 -16.53 21.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.743 -0.729 . . . . 0.0 111.44 -178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -80.94 2.15 27.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.913 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -116.08 145.31 43.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.13 0.491 . . . . 0.0 110.421 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -75.84 -17.5 59.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.513 -172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 93.2 m-20 -66.73 -60.28 2.82 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.475 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.731 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -51.42 -48.29 62.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 36' ' ' PRO . 39.0 mt -50.94 -53.32 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.355 -175.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.58 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -74.24 -20.14 60.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.768 -176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.613 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 45.4 mm-40 -73.36 -32.96 64.81 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.057 0.456 . . . . 0.0 110.301 -178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 33.4 ttm180 -80.8 -36.45 31.71 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -53.48 -49.83 66.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.144 -178.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.739 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.4 pt20 -58.0 -36.75 73.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 -174.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.41 -32.67 9.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.96 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.496 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.7 tp -66.35 -35.45 80.38 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.1 pt-20 -72.46 -35.54 68.27 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.739 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 17.8 mm-40 -56.49 -53.84 52.81 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.56 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -53.39 -52.71 58.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.296 178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.0 tp -64.41 -40.68 89.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.836 -171.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.403 ' HA ' HD12 ' A' ' 31' ' ' ILE . 20.8 m-80 -62.11 -23.56 66.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.995 0.426 . . . . 0.0 111.668 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.565 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 42.9 mttm -81.35 -56.19 4.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.943 0.878 . . . . 0.0 110.367 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.564 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.5 m -68.24 -11.84 14.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.332 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.21 -2.75 19.1 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.832 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -129.29 -1.12 5.75 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.125 -1.036 . . . . 0.0 113.166 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.69 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 42.6 t60 -89.64 142.03 29.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 O-C-N 122.65 -0.323 . . . . 0.0 110.736 -175.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.69 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.7 Cg_exo -41.52 -48.86 5.38 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.436 3.424 . . . . 0.0 113.659 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.92 -26.63 64.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.347 -174.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.67 -47.75 10.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.86 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.71 -6.16 1.11 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.236 172.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -83.54 -33.72 25.41 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.519 179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 7.8 pt-20 -113.57 149.98 33.69 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 117.622 -1.631 . . . . 0.0 114.547 -164.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 159' ' ' ILE . 20.1 tpt180 -58.14 -21.38 46.62 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 113.138 -1.846 . . . . 0.0 112.026 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 143' ' ' MET . 7.8 t -60.97 -27.68 68.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.545 0.688 . . . . 0.0 109.896 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' C ' ' A' ' 135' ' ' ALA . 1.2 tp -71.56 -31.64 67.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.251 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.492 ' HA ' ' CD ' ' A' ' 146' ' ' GLN . 57.3 t60 -69.52 -29.57 67.22 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.636 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.6 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.7 ptm -79.68 -29.08 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.661 -176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.467 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 12.8 t80 -80.15 -53.62 6.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.954 -175.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.478 HD22 ' CE2' ' A' ' 60' ' ' PHE . 1.2 mp -105.41 -27.74 11.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.174 0.512 . . . . 0.0 111.792 -172.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.492 ' CD ' ' HA ' ' A' ' 142' ' ' HIS . 31.2 mt-30 -106.43 9.7 31.64 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.357 -164.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.487 ' O ' HG11 ' A' ' 67' ' ' VAL . 3.2 t70 -137.86 -177.56 4.86 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -83.5 -33.74 25.48 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 119.475 1.034 . . . . 0.0 110.257 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -143.62 143.86 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.319 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.643 -167.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.6 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.4 mp -75.04 108.85 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.924 172.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.8 108.36 18.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 28.8 mmtp -73.53 10.68 0.98 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.2 m -130.92 19.71 5.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.032 0.444 . . . . 0.0 110.142 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -174.28 0.16 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.308 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 96.4 m -79.46 112.47 29.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 155' ' ' THR . 22.7 Cg_exo -71.56 43.94 0.57 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.762 2.975 . . . . 0.0 113.143 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 31.9 m -115.01 -158.96 0.69 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 23.3 mmmt -101.07 170.02 8.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.216 -176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 59' ' ' ILE . 20.1 mm -60.15 -42.2 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 174.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.35 75.0 7.76 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 161' ' ' HIS . 2.7 p80 -85.37 160.75 19.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.251 -177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.164 175.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.398 0.142 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -77.78 77.73 4.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.132 0.491 . . . . 0.0 110.851 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -168.47 148.04 4.49 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -63.92 94.77 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.275 0.359 . . . . 0.0 110.482 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -103.33 -37.2 7.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.013 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -71.65 130.91 42.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.442 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -88.76 132.95 34.4 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . 0.42 ' O ' ' HB ' ' A' ' -1' ' ' VAL . 95.6 m-70 -61.74 108.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' -2' ' ' HIS . 84.4 t 72.11 125.33 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 O-C-N 123.98 0.8 . . . . 0.0 110.483 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 98.88 -164.81 20.77 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.953 -178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 43.2 p 51.36 98.16 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.74 0.816 . . . . 0.0 112.306 -176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.97 121.58 41.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -169.44 -59.47 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 p -92.7 151.46 20.06 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.185 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t 67.98 -66.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 O-C-N 124.06 0.85 . . . . 0.0 111.623 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.93 117.07 28.26 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.256 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 9' ' ' ARG . 26.4 t70 -95.09 153.03 17.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.425 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.9 p -64.97 -70.28 0.24 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.239 0.337 . . . . 0.0 111.429 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HG2' ' OD2' ' A' ' 7' ' ' ASP . 37.5 mmt180 61.88 140.1 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.737 -172.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -166.2 -83.13 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.292 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.6 tp 71.2 142.14 0.05 Allowed 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 124.027 0.829 . . . . 0.0 110.866 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.32 145.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 p 68.72 126.22 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.354 1.034 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.464 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 11.1 mptt -71.56 164.92 53.83 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.688 -177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 85.6 Cg_exo -47.98 128.05 15.83 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.871 2.381 . . . . 0.0 111.927 175.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.88 140.86 54.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.06 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.98 150.01 32.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.812 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -98.06 172.55 7.54 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -69.9 -177.49 1.32 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.762 0.792 . . . . 0.0 111.349 -176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -143.96 148.66 35.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.25 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -137.1 -79.4 0.39 Allowed 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.613 ' CG ' ' HB2' ' A' ' 56' ' ' ASN . 32.5 m-85 -72.92 -37.87 67.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -159.66 175.29 36.54 Favored Glycine 0 N--CA 1.433 -1.52 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.74 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.51 158.92 21.53 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.823 3.015 . . . . 0.0 110.792 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.45 -19.42 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.722 0 C-N-CA 124.635 3.557 . . . . 0.0 115.49 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.6 p -71.97 -59.94 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.441 0.296 . . . . 0.0 110.446 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.477 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 45.7 m-80 61.7 -178.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.357 0.598 . . . . 0.0 112.153 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -98.35 145.37 26.76 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.657 HD22 HD11 ' A' ' 57' ' ' LEU . 16.6 tp -150.02 130.19 13.61 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.835 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.8 pt-20 -139.06 112.39 8.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.987 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.634 HG12 ' HB ' ' A' ' 53' ' ' VAL . 35.7 mt -122.27 135.81 61.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.793 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.31 117.37 18.07 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.334 178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -95.45 138.23 21.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t 178.98 -162.11 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.5 m-80 63.87 83.5 0.2 Allowed Pre-proline 0 N--CA 1.468 0.439 0 CA-C-O 120.969 0.414 . . . . 0.0 110.322 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HB3' ' CG2' ' A' ' 115' ' ' ILE . 63.7 Cg_endo -72.6 123.76 9.29 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.424 2.082 . . . . 0.0 113.329 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.566 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 27.2 tp60 -110.63 102.71 11.26 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.453 HG22 ' NE ' ' A' ' 45' ' ' ARG . 27.9 m -77.5 102.06 6.75 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.342 0.591 . . . . 0.0 109.748 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 37' ' ' GLN . 2.0 p -132.36 89.83 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.735 -170.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.01 -166.76 31.96 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.883 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.5 t -98.69 154.96 3.91 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.664 0 CA-C-O 119.414 -0.327 . . . . 0.0 110.442 -176.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.61 -54.3 4.93 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.508 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -95.01 85.38 4.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.133 0.492 . . . . 0.0 110.183 172.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 32.04 1.1 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.588 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 15.5 ttt180 -77.42 136.91 38.44 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.71 167.09 17.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.724 0.297 . . . . 0.0 110.41 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.5 m -119.56 132.3 55.71 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.373 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 23.4 p -92.52 127.66 38.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -93.74 131.33 39.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.976 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.592 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 20.3 tt0 -91.2 120.77 32.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.719 -173.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.38 118.21 38.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.672 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 37.7 mtp180 -107.24 130.04 54.79 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.168 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.634 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.96 138.14 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 112.439 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -118.69 140.38 50.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.693 167.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.422 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.36 164.29 7.04 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 121.243 0.544 . . . . 0.0 111.328 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.613 ' HB2' ' CG ' ' A' ' 22' ' ' TYR . 0.3 OUTLIER -122.36 26.75 8.25 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.872 168.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 29' ' ' LEU . 18.8 mt -62.63 139.22 96.89 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.973 173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD3' ' ND2' ' A' ' 27' ' ' ASN . 11.5 Cg_exo -68.76 -41.68 5.51 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.427 2.085 . . . . 0.0 111.408 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.587 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.5 OUTLIER -57.26 -42.7 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 177.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.428 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.3 m-85 -69.33 -22.44 63.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -171.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.24 -60.14 0.54 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 171.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.62 -11.06 57.77 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 118.239 0.472 . . . . 0.0 111.448 -171.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp 71.46 -43.05 0.55 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.001 0.813 . . . . 0.0 110.957 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -153.23 135.16 14.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.061 178.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -170.57 172.47 5.9 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.658 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.592 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 8.0 m -140.79 136.38 32.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.203 0.525 . . . . 0.0 111.079 176.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 26.4 m -135.12 175.15 11.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.294 -0.867 . . . . 0.0 108.692 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 22.1 ptt180 -148.84 133.05 17.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.544 0.688 . . . . 0.0 111.864 172.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.487 ' HB3' ' CB ' ' A' ' 73' ' ' ASP . 3.1 mmp_? -136.69 158.02 45.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.4 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.698 ' HG2' ' OD1' ' A' ' 73' ' ' ASP . 13.6 ptm180 -79.27 167.41 20.97 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.65 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 34.7 t80 -52.32 -42.65 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.534 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 15.0 m -58.24 -29.62 65.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.038 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.698 ' OD1' ' HG2' ' A' ' 70' ' ' ARG . 2.2 m-20 -68.46 -38.91 81.51 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.518 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 52.6 m-85 -66.65 -36.97 83.83 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.969 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.8 mt-10 -61.83 -51.46 68.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.947 0.88 . . . . 0.0 110.071 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 8.4 t-105 -63.56 -29.54 70.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.406 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.646 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -74.18 -44.71 52.35 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 45.8 ttt180 -55.59 -57.07 13.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.752 178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.717 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 25.0 p -62.89 -40.66 98.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.142 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.659 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 5.9 mm-40 -57.41 -38.61 74.6 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.0 mt -72.63 -34.34 67.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.839 0.352 . . . . 0.0 110.586 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 36.2 mt-10 -73.49 -26.33 60.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.197 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 79' ' ' SER . 28.0 mmm180 -55.24 -62.52 1.62 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.73 -2.82 10.35 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 26.5 t -114.02 173.97 6.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.411 0.624 . . . . 0.0 111.162 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -107.55 20.36 18.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.222 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.439 ' CG1' HG22 ' A' ' 89' ' ' VAL . 93.6 t -51.77 141.59 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.476 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 88' ' ' VAL . 10.0 p -73.48 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.532 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.594 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -56.38 120.18 33.73 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.873 -0.517 . . . . 0.0 110.9 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.473 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 92.3 Cg_endo -85.62 163.03 10.83 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.354 2.703 . . . . 0.0 112.269 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.55 138.18 44.95 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.793 2.329 . . . . 0.0 112.339 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD11 ' HA ' ' A' ' 75' ' ' GLU . 90.8 mt -67.33 156.42 88.38 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.558 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -90.26 109.37 0.38 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.146 2.564 . . . . 0.0 111.876 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.43 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . 177.81 70.51 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.226 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -143.01 -8.59 0.8 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.78 0.324 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -115.21 -84.92 0.62 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -171.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.438 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -48.79 -32.85 9.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.518 1.127 . . . . 0.0 113.688 -171.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.806 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -57.64 -49.42 76.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.832 0.349 . . . . 0.0 111.568 -172.665 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -102.31 20.24 17.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.49 0.662 . . . . 0.0 110.483 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.7 tp60 -113.61 -34.3 5.58 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.446 -177.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 86.5 mt -83.95 176.74 3.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -66.27 -146.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.654 2.236 . . . . 0.0 112.238 172.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 79.9 m-85 -121.0 -89.26 0.61 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.141 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HD2' ' OD1' ' A' ' 111' ' ' ASP . 63.1 mtt180 68.35 -48.63 0.55 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.799 0.687 . . . . 0.0 111.429 -175.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -119.2 -150.01 8.64 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -90.08 -30.87 17.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.134 0.492 . . . . 0.0 110.177 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB2' HG23 ' A' ' 109' ' ' ILE . 12.4 m-20 -111.99 -27.76 8.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.733 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 105.37 25.34 6.71 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.743 -0.742 . . . . 0.0 111.398 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.585 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 26.3 pt -73.23 -14.43 16.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.113 0.482 . . . . 0.0 111.749 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -77.61 -8.15 57.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.771 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.406 ' OD1' ' HD2' ' A' ' 104' ' ' ARG . 0.7 OUTLIER -93.32 119.9 32.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.392 172.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -60.32 -33.03 71.8 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.949 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.595 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 94.4 m-20 -55.38 -56.16 23.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 123.236 0.335 . . . . 0.0 110.354 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.7 t80 -46.75 -50.75 17.62 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.564 0.54 . . . . 0.0 111.057 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 36' ' ' PRO . 38.3 mt -50.66 -51.57 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.07 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.54 -18.81 47.31 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.78 -177.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.595 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 33.4 mt-10 -76.36 -30.94 57.78 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.133 0.492 . . . . 0.0 109.713 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 16.3 tpp180 -74.81 -42.57 57.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 170.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.549 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -53.95 -52.06 61.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.328 -175.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.762 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -59.11 -36.93 76.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 -175.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 124' ' ' GLN . . . -88.85 -32.92 10.33 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.051 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' HB3' HG21 ' A' ' 33' ' ' VAL . 7.4 tp -67.74 -34.9 77.75 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 122.864 -0.198 . . . . 0.0 110.945 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.2 pt-20 -71.79 -31.93 67.1 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.762 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 21.1 mm-40 -59.07 -58.21 9.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.432 ' CE1' HG11 ' A' ' 129' ' ' VAL . 1.8 t80 -51.08 -51.86 49.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.011 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -62.92 -39.68 86.03 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -170.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -62.5 -19.91 64.07 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 128' ' ' LYS . 2.9 mptp? -83.36 -58.69 2.73 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 121.834 0.826 . . . . 0.0 110.063 173.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.652 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -64.84 -11.84 11.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.281 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -107.17 -12.12 15.45 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.435 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -128.85 3.92 6.47 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.964 -174.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.716 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 46.9 t60 -91.89 142.42 26.49 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 117.133 0.466 . . . . 0.0 110.216 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.716 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.1 Cg_exo -41.23 -47.34 5.36 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.173 3.248 . . . . 0.0 113.364 -174.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -70.41 -34.25 72.31 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.098 -175.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.652 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.8 -45.9 33.56 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.348 -176.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.587 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -59.49 -6.53 1.1 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.721 173.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.776 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t30 -95.9 -20.01 19.11 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.869 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 29.7 mm-40 -103.49 136.79 42.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -165.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.436 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -56.98 -20.18 22.41 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.854 -171.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 4.3 m -54.76 -33.99 62.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.891 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.583 ' O ' HD22 ' A' ' 145' ' ' LEU . 8.0 mp -73.43 -34.03 65.24 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.109 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 27.9 t-80 -57.45 -34.9 69.46 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.185 0.517 . . . . 0.0 110.345 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.686 ' HE2' HG23 ' A' ' 150' ' ' ILE . 4.2 ptm -83.24 -30.03 28.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.438 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.646 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 2.0 t80 -72.7 -49.49 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -94.02 -42.74 8.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.079 -175.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 21.1 mp0 -88.01 0.75 55.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.849 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.53 ' OD1' HD12 ' A' ' 149' ' ' ILE . 8.8 t70 -141.8 150.89 42.27 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.909 0.385 . . . . 0.0 110.138 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.611 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 1.9 pm0 -75.11 -31.85 61.25 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.108 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.611 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.2 OUTLIER -136.73 120.78 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.645 -170.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.686 HG23 ' HE2' ' A' ' 143' ' ' MET . 11.0 mt -63.82 122.47 14.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.356 -177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.31 99.57 12.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.697 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HD3' HG22 ' A' ' 150' ' ' ILE . 33.4 mmtp -68.27 -3.98 12.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.866 0.365 . . . . 0.0 111.516 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.4 m -116.58 20.62 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.69 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.471 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -64.42 -171.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.93 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 69.3 m -82.26 111.72 30.15 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.448 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 19.2 Cg_exo -71.62 73.85 2.25 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.579 2.853 . . . . 0.0 111.987 176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -152.36 -148.62 0.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.776 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -99.73 -178.0 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.93 0.871 . . . . 0.0 112.091 -176.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.582 HG21 HG13 ' A' ' 59' ' ' ILE . 12.1 mm -76.71 -35.23 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.616 175.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -75.19 -1.07 21.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.173 -171.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.8 m80 68.78 -175.77 0.2 Allowed 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.502 0.668 . . . . 0.0 111.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.162 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.247 -179.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 94.8 mmm . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 121.045 0.45 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.17 151.35 19.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.452 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -127.57 48.07 2.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.915 0.388 . . . . 0.0 110.707 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -75.81 113.94 13.85 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.703 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -88.06 122.89 32.18 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.246 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -73.16 123.06 22.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.815 177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.41 -3.11 21.38 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -99.58 -61.15 1.4 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.159 176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.22 156.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -87.43 53.51 4.38 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.601 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 34.7 p -101.71 104.11 14.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.119 0.485 . . . . 0.0 110.63 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.48 137.81 17.54 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.801 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -148.57 -66.81 0.23 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 p 52.71 131.25 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 122.324 1.059 . . . . 0.0 112.762 -171.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.03 157.35 41.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.427 -169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.59 143.88 32.17 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.895 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -71.86 159.96 33.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.7 p -51.86 -46.36 64.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.241 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 65.86 147.46 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.981 176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.577 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 8.0 ppt_? -150.93 141.79 22.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.044 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.3 tp -146.83 146.22 30.15 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.5 mt -142.77 140.97 27.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.107 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.3 p -104.29 117.96 35.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.607 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 9.1 mptt -76.9 159.18 79.27 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.019 -171.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.71 144.92 84.92 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.463 2.775 . . . . 0.0 112.728 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -81.16 138.3 35.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.579 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -106.12 150.41 25.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.203 0.525 . . . . 0.0 111.403 -175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.86 175.04 11.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.683 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 38.55 -104.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 O-C-N 124.059 0.849 . . . . 0.0 112.667 -176.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -131.02 135.22 47.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.8 0.273 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 58' ' ' PRO . . . 174.16 172.17 0.2 Allowed 'General case' 0 C--N 1.331 -0.199 0 O-C-N 124.058 0.849 . . . . 0.0 110.631 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.536 ' CE1' ' HD2' ' A' ' 63' ' ' LYS . 7.6 m-85 -126.26 -9.49 6.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.48 -172.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.54 173.54 43.99 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.678 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.3 Cg_endo -50.89 156.23 4.96 Favored 'Trans proline' 0 CA--C 1.526 0.103 0 C-N-CA 124.32 3.347 . . . . 0.0 112.33 177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 73.1 Cg_exo -51.29 -8.87 0.24 Allowed 'Trans proline' 0 N--CA 1.482 0.82 0 C-N-CA 124.504 3.469 . . . . 0.0 115.213 -174.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -71.42 -63.92 1.02 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.601 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.1 m120 59.54 172.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.669 0.605 . . . . 0.0 111.979 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -95.63 140.93 29.75 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 57' ' ' LEU . 13.5 tp -144.88 131.26 19.68 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.343 0.592 . . . . 0.0 110.956 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -141.23 102.4 4.22 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.024 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.672 HG12 ' HB ' ' A' ' 53' ' ' VAL . 54.8 mt -113.49 140.01 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 -177.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -139.05 112.8 8.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.174 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.1 m -96.99 133.45 38.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 16.3 t 178.75 -161.64 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 66.96 78.87 0.24 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.187 0.518 . . . . 0.0 110.227 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.48 119.44 5.23 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.688 2.258 . . . . 0.0 113.355 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' THR . 43.7 tp60 -107.73 113.58 26.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.964 175.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 m -76.04 98.56 4.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.411 0.624 . . . . 0.0 109.478 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.34 91.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.976 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.41 -167.04 31.91 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.702 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 8.4 t -110.71 154.67 12.25 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 CA-C-O 119.28 -0.391 . . . . 0.0 109.996 -177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.6 3.24 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 121.488 -0.387 . . . . 0.0 112.625 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.86 88.53 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.283 0.563 . . . . 0.0 109.837 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.64 36.35 0.79 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.497 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.584 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 5.5 ttp180 -86.23 130.45 34.51 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -136.38 171.72 14.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.054 0.454 . . . . 0.0 111.361 -173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 98.3 m -121.79 129.64 52.81 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.576 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.2 p -92.57 130.0 38.34 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -93.43 131.5 38.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.789 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.588 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 9.8 tt0 -88.29 118.02 27.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.562 -175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.7 mp -93.18 108.48 20.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 66.7 mtp180 -92.96 135.88 33.76 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.069 173.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.672 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.56 135.36 11.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.076 0.465 . . . . 0.0 111.868 177.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -123.88 134.87 53.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 169.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.3 t -169.48 164.45 10.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.499 0.666 . . . . 0.0 112.01 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.54 HD22 ' C ' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -118.76 23.19 11.6 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.285 171.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 29' ' ' LEU . 24.7 mt -57.91 141.11 81.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.955 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' A' ' 21' ' ' ALA . 51.5 Cg_endo -74.56 -16.25 21.49 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.709 2.272 . . . . 0.0 111.463 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.821 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -86.12 -40.99 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.557 -178.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.415 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.2 m-85 -70.05 -8.31 48.29 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -166.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER 70.87 -69.79 0.17 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 167.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -84.25 -5.81 59.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.968 -0.457 . . . . 0.0 110.682 -174.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.536 ' HD2' ' CE1' ' A' ' 22' ' ' TYR . 5.0 mmtp 70.68 -43.89 0.57 Allowed 'General case' 0 N--CA 1.467 0.397 0 O-C-N 124.122 0.889 . . . . 0.0 111.418 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -158.86 130.03 6.27 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.231 0.538 . . . . 0.0 110.063 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.7 t -170.24 173.74 5.65 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.486 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.588 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 28.6 m -141.86 123.05 14.72 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.416 0.627 . . . . 0.0 111.469 177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 23.6 m -114.17 179.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.105 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 30.9 ptt180 -150.45 126.85 10.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.25 0.548 . . . . 0.0 111.204 171.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -138.53 177.25 8.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.247 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -83.65 167.34 17.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.258 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.562 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 32.6 t80 -60.29 -39.66 87.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.527 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 18.5 m -58.55 -27.08 64.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.679 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -77.31 -34.22 55.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.621 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 35.8 m-85 -63.95 -38.79 92.37 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 172.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' HD11 ' A' ' 92' ' ' LEU . 26.2 mt-10 -57.12 -56.25 24.16 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.158 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -65.15 -28.39 69.38 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.392 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 2.9 tm? -71.63 -38.99 70.71 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.559 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 49.6 ttt180 -62.16 -61.47 2.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.042 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.544 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 8.8 p -57.52 -38.03 73.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.278 -173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.622 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 1.0 OUTLIER -58.31 -47.62 83.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.138 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.33 -36.67 84.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.186 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 62.5 mt-10 -69.04 -30.74 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.145 0.497 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 79' ' ' SER . 27.8 mmt180 -80.26 -58.93 2.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.661 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -69.85 -25.48 63.75 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.338 -0.847 . . . . 0.0 112.511 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.52 -178.72 6.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.725 0.774 . . . . 0.0 112.323 -177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -97.86 23.38 8.05 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.526 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.5 t -45.89 139.71 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.685 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.6 p -70.09 33.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.231 -0.895 . . . . 0.0 112.074 177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.559 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -54.86 120.55 29.29 Favored Pre-proline 0 CA--C 1.531 0.241 0 O-C-N 122.134 -0.354 . . . . 0.0 111.0 -176.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.61 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 90.1 Cg_endo -85.85 164.29 10.38 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.953 2.435 . . . . 0.0 112.584 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.6 132.1 29.86 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.918 2.412 . . . . 0.0 112.467 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 75' ' ' GLU . 84.5 mt -66.97 143.81 98.18 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.452 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 10.5 Cg_exo -72.11 108.63 2.52 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.416 2.077 . . . . 0.0 111.014 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' HD21 ' A' ' 98' ' ' LEU . . . -172.68 30.12 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.814 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -131.89 7.64 4.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.898 0.38 . . . . 0.0 110.503 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -111.16 -90.48 0.48 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -53.7 -29.64 40.06 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -170.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -60.85 -49.13 78.71 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.041 0.448 . . . . 0.0 110.58 -174.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.58 26.18 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.496 0.665 . . . . 0.0 109.922 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.3 tt0 -123.02 -36.91 2.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.077 -176.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 24.9 mt -92.49 165.39 19.52 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.28 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.58 164.31 35.98 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.328 2.685 . . . . 0.0 111.257 170.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -72.17 -76.93 0.1 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.697 0.284 . . . . 0.0 111.474 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 69.13 -63.21 0.38 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.205 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.07 -150.61 26.84 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.514 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.23 -41.79 96.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.941 0.401 . . . . 0.0 110.389 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -138.28 -17.45 1.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.692 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.9 10.92 23.72 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.324 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 46.2 pt -83.34 -18.8 10.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.807 0.337 . . . . 0.0 111.872 -175.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -85.8 -2.01 57.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.252 0.549 . . . . 0.0 110.439 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.47 127.45 34.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.851 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.34 -30.83 67.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.1 m-20 -56.1 -60.29 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.559 176.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.1 t80 -53.78 -47.82 70.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.092 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 37.6 mt -52.52 -47.33 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.105 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.4 OUTLIER -75.05 -21.89 58.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -178.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 73.5 mm-40 -71.53 -35.57 70.74 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.262 0.553 . . . . 0.0 109.761 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 10.9 tpp180 -76.89 -35.8 57.16 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -57.4 -53.8 54.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.458 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -58.75 -40.79 84.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.067 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.16 -37.34 28.85 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.963 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -65.6 -34.19 77.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.564 0.182 . . . . 0.0 111.272 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.698 ' HB3' HG22 ' A' ' 33' ' ' VAL . 7.4 pt-20 -78.09 -31.47 50.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.441 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 16.3 mm-40 -59.59 -58.58 7.98 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.523 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.5 t80 -49.2 -53.32 21.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.906 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.585 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.0 tp -65.04 -40.75 90.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -61.19 -19.91 62.15 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 111.65 -175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.61 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 40.3 mttm -87.21 -56.61 3.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.661 0.743 . . . . 0.0 110.731 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.578 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.24 -11.65 14.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.974 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.402 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -106.93 -6.29 17.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.291 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.42 10.58 5.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.307 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.2 t60 -98.19 140.62 21.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 122.511 -0.405 . . . . 0.0 110.41 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 5.7 Cg_exo -41.51 -48.86 5.36 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 124.306 3.337 . . . . 0.0 113.672 -173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.83 -33.16 73.37 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.323 -175.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -75.74 -44.41 41.92 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.912 -177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -63.82 -0.74 1.13 Allowed 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.005 173.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.506 ' ND2' ' HE3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -111.16 -2.87 15.64 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.819 -179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 47.1 mm-40 -112.84 132.31 55.33 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.111 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.435 ' HA ' HD13 ' A' ' 159' ' ' ILE . 6.4 tpp85 -53.82 -25.81 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.418 -172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 m -51.26 -34.46 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.459 -177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -67.4 -33.1 74.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.413 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 146' ' ' GLN . 9.5 t60 -62.5 -40.12 95.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.098 0.475 . . . . 0.0 109.748 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.568 ' HG3' HG13 ' A' ' 150' ' ' ILE . 5.6 ptm -77.95 -26.18 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.975 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.481 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 21.4 t80 -79.75 -63.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.116 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.566 HD12 ' HG3' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -110.83 -4.29 15.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -171.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.566 ' HG3' HD12 ' A' ' 145' ' ' LEU . 12.0 mt-30 -117.92 23.59 11.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.853 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -148.55 -142.16 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.527 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.457 ' HG3' HG13 ' A' ' 149' ' ' ILE . 7.3 tp10 -121.08 -56.76 1.91 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.85 0.834 . . . . 0.0 109.511 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -129.65 139.77 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.107 -176.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.568 HG13 ' HG3' ' A' ' 143' ' ' MET . 3.1 mp -66.26 112.77 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.513 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 100.73 13.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -64.21 -7.96 10.92 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.1 m -108.91 17.88 21.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.164 0.507 . . . . 0.0 110.294 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.405 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.3 OUTLIER -66.49 -172.1 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.658 178.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.4 m -92.06 114.82 63.3 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.023 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.68 83.1 1.12 Allowed 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.923 2.415 . . . . 0.0 111.251 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 89.3 p -145.85 -150.17 0.32 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 121.157 -0.217 . . . . 0.0 110.636 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.506 ' HE3' ' ND2' ' A' ' 137' ' ' ASN . 13.1 mmmt -95.4 164.07 12.98 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.821 HG21 HG13 ' A' ' 59' ' ' ILE . 15.4 mm -63.89 -34.56 69.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.056 172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.49 87.92 5.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.44 -172.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -109.96 165.5 11.67 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.961 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.556 178.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -129.28 30.42 4.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.206 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 66.98 172.2 0.26 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.107 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -134.19 94.22 3.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.726 0.298 . . . . 0.0 111.116 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -138.41 136.36 36.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.406 177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -87.51 125.69 34.46 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -84.6 78.35 9.86 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.996 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -90.96 -37.67 13.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.619 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.6 m -90.77 157.23 2.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.316 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -133.83 174.61 20.72 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.585 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 41.3 p -70.58 115.99 10.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.29 119.09 10.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.125 0.488 . . . . 0.0 110.518 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -165.18 -65.33 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.046 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -81.48 155.61 25.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.979 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 6' ' ' ALA . 15.6 t 67.18 163.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.865 0.728 . . . . 0.0 110.527 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' N ' HG12 ' A' ' 5' ' ' VAL . . . -115.32 106.58 14.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.857 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.54 162.98 28.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.14 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 p -63.57 -69.55 0.27 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 9' ' ' ARG . 33.5 mmt180 59.96 160.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.178 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -141.77 140.26 33.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.51 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.7 tp -149.76 145.41 26.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.6 mt -132.89 155.41 41.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.2 p 69.26 109.78 0.05 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.22 1.008 . . . . 0.0 111.807 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 38.4 mmtm -76.29 168.0 31.83 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 41.8 Cg_exo -56.53 111.26 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.321 2.014 . . . . 0.0 111.814 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 14' ' ' LYS . 70.8 mt-30 -94.15 98.4 10.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.448 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' C ' HD22 ' A' ' 18' ' ' LEU . 71.8 m-20 67.64 154.18 0.1 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.08 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.408 HD22 ' C ' ' A' ' 17' ' ' ASN . 3.7 mm? -123.57 -170.06 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.538 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -89.52 -179.71 5.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.234 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -106.46 132.83 52.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -171.79 167.81 6.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.342 -176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 7.5 m-85 -133.26 -24.87 1.8 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.474 -171.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.01 174.98 45.42 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.162 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.14 158.37 14.99 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 124.304 3.336 . . . . 0.0 111.696 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -43.82 -24.99 0.89 Allowed 'Trans proline' 0 N--CA 1.481 0.786 0 C-N-CA 124.704 3.602 . . . . 0.0 115.267 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.2 m -68.81 -58.51 4.08 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.7 m-80 57.96 -170.59 0.11 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.953 0.406 . . . . 0.0 111.663 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -103.34 139.41 38.79 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD22 HD11 ' A' ' 57' ' ' LEU . 16.9 tp -150.3 131.88 14.85 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.675 -175.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -142.48 99.43 3.49 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.015 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.687 HG12 ' HB ' ' A' ' 53' ' ' VAL . 29.1 mt -111.81 140.74 29.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.605 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -136.92 129.15 29.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.653 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.6 m -112.96 134.13 56.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.6 t 179.32 -162.58 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 43.3 m-80 62.77 68.86 0.94 Allowed Pre-proline 0 N--CA 1.467 0.41 0 CA-C-O 121.132 0.491 . . . . 0.0 109.837 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.25 138.04 21.94 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.794 2.329 . . . . 0.0 113.162 -171.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.534 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.4 tp60 -121.93 108.34 13.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.8 m -75.25 95.27 3.12 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.52 0.676 . . . . 0.0 109.646 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -121.9 92.8 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.232 -173.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -167.23 32.14 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.524 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.9 t -101.34 150.17 6.06 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.589 -176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.05 -48.38 5.35 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 121.516 -0.373 . . . . 0.0 112.673 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -97.96 83.36 3.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.126 0.489 . . . . 0.0 110.01 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.35 35.97 0.83 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.468 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 19.7 ttt180 -83.35 127.89 34.04 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.679 0.276 . . . . 0.0 110.367 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -117.38 169.74 9.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.266 -178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.3 m -125.88 129.11 48.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.742 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.534 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 34.2 p -92.92 146.44 23.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.267 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.427 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 83.7 m-85 -118.5 142.64 47.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.133 0.492 . . . . 0.0 110.403 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 33' ' ' VAL . 38.5 tt0 -90.15 117.96 29.31 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.565 -177.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.4 mp -93.06 120.47 42.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.864 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 51.7 mtp180 -109.53 131.73 54.8 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.936 174.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.687 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.82 136.71 43.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.848 0.356 . . . . 0.0 111.575 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.434 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 10.9 ttmt -125.93 135.07 51.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.9 t -169.62 165.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.701 0.762 . . . . 0.0 112.763 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.11 26.16 9.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.768 167.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.712 HD11 HD22 ' A' ' 29' ' ' LEU . 18.6 mt -61.06 135.89 93.52 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.379 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -68.79 -38.01 10.88 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.405 2.07 . . . . 0.0 111.351 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.533 HD12 HG13 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.49 -40.82 87.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.14 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.0 m-85 -68.77 -25.26 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.1 tttt 73.25 -64.04 0.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 ' HG2' ' A' ' 146' ' ' GLN . 0.0 OUTLIER -76.77 -6.03 50.6 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.899 -0.501 . . . . 0.0 110.282 -175.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.0 mmpp? 70.91 -37.94 0.41 Allowed 'General case' 0 C--O 1.22 -0.487 0 O-C-N 123.936 0.772 . . . . 0.0 111.452 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 62' ' ' LEU . 1.8 pp20? -162.04 142.93 10.57 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -170.24 169.2 7.86 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 13.6 m -141.4 135.57 30.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.706 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.569 HG21 HH21 ' A' ' 69' ' ' ARG . 0.5 OUTLIER -147.09 134.87 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.408 -171.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 41.0 ttp180 -99.1 111.25 23.69 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.936 0.398 . . . . 0.0 110.139 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.659 HH11 HD12 ' A' ' 150' ' ' ILE . 56.2 mtt-85 -124.99 178.1 5.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.476 -173.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -95.23 155.98 16.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.754 0.311 . . . . 0.0 111.306 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.409 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 32.5 t80 -59.59 -37.98 79.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.979 0.419 . . . . 0.0 109.924 174.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.467 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 34.4 t -59.64 -30.06 68.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.854 178.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -67.87 -39.51 83.72 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.53 ' CE2' ' HG ' ' A' ' 122' ' ' LEU . 51.4 m-85 -60.7 -32.87 72.09 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.351 177.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HG2' HD13 ' A' ' 92' ' ' LEU . 12.8 mt-10 -71.97 -49.11 40.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.503 0.668 . . . . 0.0 110.539 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.487 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.8 t-105 -65.82 -28.27 68.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.71 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.49 -42.0 59.73 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 64.2 ttt180 -57.72 -59.2 5.58 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.669 176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 6.4 p -60.04 -41.47 92.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.573 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.09 -45.99 79.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.674 0.273 . . . . 0.0 111.253 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 135' ' ' ALA . 96.4 mt -65.89 -40.72 91.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.06 177.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 73.5 mt-10 -65.53 -45.13 84.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.466 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 79' ' ' SER . 29.6 mmt180 -66.96 -60.78 2.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.92 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -77.73 -18.93 56.02 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.463 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 t -134.8 -175.82 4.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.472 0.653 . . . . 0.0 111.315 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -109.58 13.44 23.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.29 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.468 ' CG1' HG22 ' A' ' 89' ' ' VAL . 99.0 t -42.09 140.16 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.518 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.8 p -71.17 36.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.857 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -57.48 119.71 34.72 Favored Pre-proline 0 N--CA 1.464 0.245 0 O-C-N 122.046 -0.409 . . . . 0.0 111.014 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.591 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 96.1 Cg_endo -87.71 167.1 7.32 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.93 2.42 . . . . 0.0 112.488 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.5 Cg_endo -66.5 146.87 81.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.699 2.266 . . . . 0.0 112.756 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' A' ' 75' ' ' GLU . 50.0 mt -73.44 158.87 85.96 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.467 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.56 ' HG3' ' N ' ' A' ' 122' ' ' LEU . 67.6 Cg_endo -87.5 108.86 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.754 2.303 . . . . 0.0 111.466 174.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.54 38.71 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.433 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -145.28 42.24 1.28 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.63 -83.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.158 0.504 . . . . 0.0 112.181 -174.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.641 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -52.05 -24.78 7.26 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.339 -173.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -61.14 -43.53 98.74 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 -174.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.16 24.64 8.41 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.809 0.814 . . . . 0.0 109.686 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.8 OUTLIER -120.42 -40.08 2.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.045 -177.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.9 mt -87.65 166.24 26.03 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.356 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.405 ' HG2' ' NH1' ' A' ' 104' ' ' ARG . 15.0 Cg_exo -70.4 -163.62 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 123.411 2.741 . . . . 0.0 112.726 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -99.89 -91.09 0.3 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.538 175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 102' ' ' PRO . 73.1 mtm-85 65.31 -70.86 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.503 0.721 . . . . 0.0 111.855 -179.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.53 77.15 0.32 Allowed Glycine 0 CA--C 1.506 -0.528 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.603 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.4 t0 67.84 -69.96 0.13 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.21 1.004 . . . . 0.0 110.857 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -125.17 -7.21 7.1 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.17 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.22 8.53 35.76 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.71 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 48.5 pt -82.62 -18.25 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.314 -0.443 . . . . 0.0 111.78 -175.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -79.18 -8.72 59.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.538 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -87.84 139.27 30.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.238 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -68.83 -22.59 64.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.69 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.591 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 12.5 m120 -63.25 -59.02 5.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -54.28 -48.37 71.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.728 0.299 . . . . 0.0 110.753 177.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 30.3 mt -52.77 -45.54 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.786 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -73.53 -23.32 59.98 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.327 -178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.591 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 39.4 mm-40 -70.78 -32.62 69.8 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.447 0.641 . . . . 0.0 109.78 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 33.3 ttm180 -79.89 -39.65 30.02 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -54.22 -49.91 68.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.825 -178.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.706 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -59.92 -40.36 88.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.933 -176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 93' ' ' PRO . . . -84.08 -31.82 24.93 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.065 -176.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.639 ' HB3' HG21 ' A' ' 33' ' ' VAL . 6.7 tp -65.61 -35.69 81.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 122.297 0.239 . . . . 0.0 111.063 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.737 ' HB3' HG22 ' A' ' 33' ' ' VAL . 12.9 pt-20 -76.73 -35.39 57.83 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.706 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.5 mm-40 -56.71 -55.46 33.86 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.525 ' O ' HG13 ' A' ' 129' ' ' VAL . 7.4 t80 -51.23 -54.05 29.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.969 -1.469 . . . . 0.0 111.732 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.636 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.3 tp -64.35 -38.22 81.99 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.737 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.161 -170.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -64.03 -21.67 66.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.591 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 39.7 mttm -85.15 -55.03 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.757 0.789 . . . . 0.0 110.763 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.57 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -68.38 -12.4 15.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.816 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.33 8.81 21.51 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.332 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.6 9.24 3.43 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.613 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.658 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 47.7 t60 -100.87 140.91 21.71 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.637 -177.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.658 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.3 Cg_endo -46.17 -48.03 13.73 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.709 2.939 . . . . 0.0 112.936 -172.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.568 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -67.66 -30.01 69.44 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.287 -1.324 . . . . 0.0 111.039 -176.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -79.08 -43.79 23.45 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.655 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.9 mm100 -66.85 -7.69 23.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.245 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.599 ' ND2' ' HE2' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -92.23 -15.37 27.61 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.632 179.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 45.7 mm-40 -105.73 130.84 53.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.608 -170.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' HA ' HD13 ' A' ' 159' ' ' ILE . 19.2 tpt180 -56.7 -25.87 55.33 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.592 -172.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 143' ' ' MET . 1.2 p -60.32 -21.24 61.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.7 mp -70.01 -35.6 74.49 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.878 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 36.1 t60 -56.65 -35.35 68.26 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.158 0.504 . . . . 0.0 110.122 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.622 ' HG3' HG13 ' A' ' 150' ' ' ILE . 3.8 ptm -82.66 -34.0 27.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.639 -177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.476 ' N ' ' HG2' ' A' ' 143' ' ' MET . 11.2 t80 -82.11 -26.71 33.33 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.492 HD13 ' CE1' ' A' ' 60' ' ' PHE . 2.3 mt -99.48 -46.89 5.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.37 0.605 . . . . 0.0 109.837 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 34.4 mt-30 -91.75 175.89 6.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.852 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 59.59 -168.92 0.15 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -98.31 -34.11 10.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.556 0.693 . . . . 0.0 110.768 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.539 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.72 166.1 15.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.35 -166.22 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.659 HD12 HH11 ' A' ' 69' ' ' ARG . 1.9 mp -85.18 119.91 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.124 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -90.52 99.48 12.5 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HD3' ' NE1' ' A' ' 76' ' ' TRP . 31.8 mmtp -67.31 -3.21 7.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.73 0.3 . . . . 0.0 111.684 -172.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.7 m -113.79 18.59 17.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 110.604 -178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.417 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.5 OUTLIER -66.53 -171.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.798 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.2 m -90.64 113.06 56.48 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.207 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.75 83.82 1.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 123.153 2.569 . . . . 0.0 111.69 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 48.4 m -153.36 -145.26 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.327 -0.233 . . . . 0.0 110.801 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.599 ' HE2' ' ND2' ' A' ' 137' ' ' ASN . 5.5 mmmm -100.67 155.6 17.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.569 -0.16 . . . . 0.0 110.569 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.533 HG13 HD12 ' A' ' 59' ' ' ILE . 19.5 mm -57.7 -41.07 78.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.183 0.516 . . . . 0.0 109.909 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.39 94.95 10.08 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.523 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -103.9 169.48 8.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.053 0.454 . . . . 0.0 110.986 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.673 178.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -129.97 47.54 2.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.782 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -75.94 88.21 2.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -101.44 -4.36 26.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.767 -177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -83.87 66.76 9.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.89 0.376 . . . . 0.0 110.411 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -99.77 -29.3 12.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.406 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -65.72 148.07 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.415 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -143.52 140.71 30.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.118 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.48 131.05 30.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.233 0.54 . . . . 0.0 111.04 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 118.75 -113.53 2.6 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.685 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 65.21 127.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.328 0.651 . . . . 0.0 111.716 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.38 124.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.013 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -108.75 -44.77 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.349 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.6 p -74.25 156.96 36.66 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.345 168.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t 72.42 -54.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 123.889 0.743 . . . . 0.0 111.19 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.38 83.82 7.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.951 0.405 . . . . 0.0 110.418 177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 11.5 t70 -69.38 139.41 54.14 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.354 0.597 . . . . 0.0 111.144 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -88.87 -39.26 13.96 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.314 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -46.48 -56.43 5.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.51 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -147.47 -84.48 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 24.7 tp 73.52 136.41 0.05 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.215 1.007 . . . . 0.0 111.566 174.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 mt -138.93 147.64 24.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.187 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -120.52 107.31 12.71 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.818 0.342 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -105.55 160.56 25.63 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -62.54 130.67 30.7 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.971 2.447 . . . . 0.0 111.859 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -89.24 109.13 20.04 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.837 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -78.18 150.15 33.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.185 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.24 144.64 35.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.451 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -124.23 -171.42 2.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.622 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -111.4 137.89 48.59 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.217 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.98 -65.13 0.06 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.972 0.415 . . . . 0.0 110.878 -174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -75.08 -43.26 54.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.931 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.88 174.56 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.745 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.87 159.14 9.75 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.763 2.975 . . . . 0.0 111.533 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.65 -9.21 1.02 Allowed 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 124.17 3.247 . . . . 0.0 114.569 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 t -73.49 -55.75 5.94 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.617 ' OD1' HD23 ' A' ' 57' ' ' LEU . 29.7 m120 61.48 169.94 0.11 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.7 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -84.49 130.9 34.71 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.695 HD22 HD11 ' A' ' 57' ' ' LEU . 21.9 tp -141.69 129.31 21.5 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.501 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -137.81 99.36 3.89 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.024 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.696 HG12 ' HB ' ' A' ' 53' ' ' VAL . 44.4 mt -110.57 134.62 52.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.718 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -134.36 113.98 12.47 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.0 OUTLIER -95.52 134.34 33.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.1 t 178.43 -161.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 28.0 m-80 68.09 76.78 0.26 Allowed Pre-proline 0 N--CA 1.468 0.43 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HB3' HG21 ' A' ' 115' ' ' ILE . 57.6 Cg_endo -71.76 119.27 6.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.069 1.846 . . . . 0.0 112.981 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' O ' HG12 ' A' ' 39' ' ' VAL . 49.4 tp60 -111.89 104.71 13.03 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.6 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.2 m -76.03 106.51 7.67 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -133.51 89.61 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.025 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.93 -167.5 32.94 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.513 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 17.5 t -101.08 146.89 8.75 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 119.324 -0.369 . . . . 0.0 110.409 -177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.72 -51.42 3.96 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.13 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -98.77 89.96 4.52 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.405 0.621 . . . . 0.0 109.554 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.14 29.81 1.43 Allowed Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.791 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.507 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.2 ttt180 -82.46 143.12 31.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -177.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' ' HD3' ' A' ' 70' ' ' ARG . 35.0 p90 -137.66 156.62 47.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.695 0.283 . . . . 0.0 110.81 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.2 m -113.78 125.15 53.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.071 0.462 . . . . 0.0 110.879 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -92.79 143.85 25.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.397 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 90.4 m-85 -103.89 141.58 35.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.377 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 20.1 tt0 -96.19 115.42 27.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.816 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.5 mp -94.27 111.71 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.892 -176.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 38.0 mtp180 -96.7 141.61 29.72 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -147.84 136.35 15.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.179 0.514 . . . . 0.0 112.174 177.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -127.97 142.22 51.31 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.734 167.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.447 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.0 t -171.49 164.68 6.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.321 0.581 . . . . 0.0 111.261 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.548 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.57 21.47 13.44 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.766 167.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.695 HD11 HD22 ' A' ' 29' ' ' LEU . 28.6 mt -55.76 133.3 72.5 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.685 174.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 7.6 Cg_exo -68.83 -34.65 17.62 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.475 2.117 . . . . 0.0 111.39 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.641 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -61.53 -42.53 94.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 176.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.7 m-30 -68.29 -23.66 64.78 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 71.1 -61.91 0.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 174.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.545 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.8 -14.3 59.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 117.876 0.307 . . . . 0.0 111.021 -173.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp 71.46 -35.09 0.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.778 0.674 . . . . 0.0 111.302 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -144.32 145.9 32.26 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.0 t -169.58 153.41 5.07 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 -174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 7.5 m -141.11 130.56 23.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.138 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 17.9 m -127.1 172.9 13.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 32.5 ttp180 -138.24 109.8 7.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.963 0.411 . . . . 0.0 110.229 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 7.4 tpp180 -135.7 171.82 13.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -171.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' HD3' ' CD2' ' A' ' 46' ' ' PHE . 56.6 ttp180 -96.45 158.18 15.55 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 59.5 t80 -51.35 -41.16 60.42 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.539 0.336 . . . . 0.0 111.0 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.496 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 33.3 p -56.57 -29.62 62.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.8 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 69' ' ' ARG . 28.3 m-20 -77.55 -30.39 52.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.22 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.516 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 46.1 m-85 -64.04 -38.74 92.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.181 0.515 . . . . 0.0 109.679 173.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HA ' HD11 ' A' ' 92' ' ' LEU . 10.9 mt-10 -65.94 -47.97 72.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.633 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.469 ' CD1' ' HE2' ' A' ' 152' ' ' LYS . 6.1 t-105 -62.34 -35.29 78.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.703 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.658 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.3 tm? -65.64 -44.33 86.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.2 ttt180 -58.53 -61.33 2.67 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.24 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.1 t -60.12 -35.12 74.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.856 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 5.5 tp10 -66.54 -44.88 81.22 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.939 -0.305 . . . . 0.0 110.297 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.61 -42.36 96.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.858 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 30.8 mt-10 -64.53 -33.12 75.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.953 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.442 ' C ' ' HD2' ' A' ' 83' ' ' ARG . 4.6 ppt_? -90.18 -23.34 21.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -172.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -93.32 -41.61 9.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.033 0.444 . . . . 0.0 111.648 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -130.67 174.87 9.5 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.532 0.682 . . . . 0.0 111.227 -174.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.7 mtmt -97.12 32.5 2.15 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.702 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 94.6 t -51.54 142.11 4.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.958 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.5 p -71.28 35.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.985 176.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -56.5 119.31 27.65 Favored Pre-proline 0 N--CA 1.467 0.406 0 O-C-N 121.873 -0.517 . . . . 0.0 111.167 -176.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -85.69 163.31 10.7 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.146 2.564 . . . . 0.0 112.411 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.22 135.15 39.05 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.886 2.391 . . . . 0.0 112.304 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 75' ' ' GLU . 81.8 mt -64.58 152.02 90.56 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -75.91 124.31 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.46 2.107 . . . . 0.0 110.811 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.0 175.9 47.74 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 68.91 -54.41 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.659 0.784 . . . . 0.0 112.162 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -47.57 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -172.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.524 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -65.31 -24.08 67.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.669 -170.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.747 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.3 mm? -67.4 -46.62 72.69 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 120.972 0.415 . . . . 0.0 110.602 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.1 ppt_? -95.89 27.26 3.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.469 0.652 . . . . 0.0 110.395 176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -123.27 -42.39 2.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.12 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.79 168.51 11.1 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.471 -176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.8 140.45 46.47 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.252 2.635 . . . . 0.0 111.151 169.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -82.48 -75.47 0.3 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.188 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 69.78 -56.54 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.495 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.98 -175.91 48.9 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.516 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.44 -51.4 27.03 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.388 0.613 . . . . 0.0 110.656 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 109' ' ' ILE . 6.8 t70 -117.33 -32.97 4.79 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.53 176.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.11 -6.55 7.72 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.289 -175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.713 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 33.5 pt -66.53 -15.15 18.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.176 -177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -78.04 -13.03 60.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.666 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -92.1 135.2 34.16 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.317 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -69.1 -17.45 63.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.934 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 47.6 m-80 -73.89 -57.87 3.68 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.713 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -48.51 -50.56 31.33 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.343 0.402 . . . . 0.0 110.911 178.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.544 HG21 ' HB3' ' A' ' 36' ' ' PRO . 49.4 mt -49.65 -54.81 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.331 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.597 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -76.69 -17.89 58.85 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.791 -175.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.546 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 67.9 mm-40 -73.27 -35.15 66.14 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.935 0.398 . . . . 0.0 110.481 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 32.7 ttp180 -81.2 -32.48 33.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 174.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.597 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -56.99 -50.67 71.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.1 pt20 -60.43 -32.65 71.56 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.544 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.63 -33.58 10.01 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.734 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.3 tp -66.35 -33.36 75.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 122.206 0.203 . . . . 0.0 111.223 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 33' ' ' VAL . 11.9 pt-20 -75.29 -31.85 60.83 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.4 mm-40 -59.97 -59.66 5.07 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 174.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.474 ' O ' HG13 ' A' ' 129' ' ' VAL . 2.6 t80 -45.84 -51.63 12.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.033 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.557 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.5 tp -65.36 -39.53 85.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.984 -172.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -63.85 -16.14 60.62 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.447 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -87.68 -57.8 2.81 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.914 0.864 . . . . 0.0 110.01 174.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.534 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.49 -13.12 13.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.043 -177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.75 4.68 23.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.32 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.454 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -143.07 10.91 2.31 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.71 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.678 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 51.4 t60 -101.19 141.39 22.53 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 117.176 0.488 . . . . 0.0 110.665 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 13.4 Cg_exo -40.87 -49.01 4.51 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 124.131 3.221 . . . . 0.0 113.822 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.84 -25.73 63.89 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.316 -0.857 . . . . 0.0 111.441 -174.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -84.11 -40.78 17.83 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.926 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 2.4 mm100 -68.78 -0.13 5.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.103 176.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.482 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.9 t-20 -112.14 10.9 20.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.817 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.07 131.79 50.81 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.002 -0.437 . . . . 0.0 111.013 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 0.1 OUTLIER -55.67 -17.49 5.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.063 -175.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.725 ' O ' ' HG2' ' A' ' 143' ' ' MET . 4.2 m -55.33 -31.14 61.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.699 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.574 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.7 mp -73.63 -35.32 65.3 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.667 -0.646 . . . . 0.0 111.484 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 9.9 t60 -58.53 -39.22 79.55 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.725 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -76.02 -27.71 57.46 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.795 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' ' HG ' ' A' ' 77' ' ' LEU . 3.5 t80 -81.03 -57.87 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.574 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.4 OUTLIER -84.47 -26.21 28.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.98 0.419 . . . . 0.0 111.149 -172.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 9.2 mt-30 -113.83 167.24 10.81 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.531 -166.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 68.07 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.885 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -175.04 -60.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.577 0.703 . . . . 0.0 111.316 -175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG23 ' CZ ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -121.9 144.49 30.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.868 -171.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.606 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -65.85 100.61 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.28 102.23 5.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.416 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.469 ' HE2' ' CD1' ' A' ' 76' ' ' TRP . 32.2 mmtp -69.88 6.55 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.707 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.4 m -120.81 18.19 11.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.12 0.486 . . . . 0.0 110.357 176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.418 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.4 OUTLIER -66.74 -171.32 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.267 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 88.3 m -87.51 114.16 57.52 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.901 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -71.06 78.52 1.44 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.751 2.301 . . . . 0.0 110.951 173.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.1 m -155.56 -168.74 2.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.886 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 4.6 mmmm -80.85 157.98 25.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.92 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.641 HG21 HG13 ' A' ' 59' ' ' ILE . 15.2 mm -50.57 -42.17 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 121.155 0.502 . . . . 0.0 110.069 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 100.92 4.14 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 174.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -73.67 175.47 7.13 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.483 0.658 . . . . 0.0 111.616 -171.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.171 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.559 -175.404 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -128.27 34.99 4.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.134 0.492 . . . . 0.0 110.663 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -83.51 72.18 10.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.239 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -75.73 113.47 13.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.161 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -133.85 101.74 5.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.802 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -87.87 97.53 10.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.224 0.535 . . . . 0.0 111.049 -175.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -130.9 167.94 18.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.573 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 63.68 98.63 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.664 0.603 . . . . 0.0 110.7 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 31.0 m -66.74 162.15 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.445 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 116.92 58.15 0.31 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.397 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.8 p -84.13 149.07 26.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.672 0.272 . . . . 0.0 110.753 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.66 132.31 44.41 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.2 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -159.44 -62.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.197 0.522 . . . . 0.0 109.614 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.2 p -94.27 154.05 17.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.411 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t 65.37 -74.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 124.058 0.849 . . . . 0.0 111.019 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.15 68.8 10.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.298 0.57 . . . . 0.0 109.786 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.49 154.62 40.75 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.837 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 p -59.46 -43.73 93.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.247 0.546 . . . . 0.0 110.726 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 52.5 mmt-85 66.2 -172.9 0.19 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.496 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 9' ' ' ARG . 17.0 mmt180 75.24 130.89 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.826 0.822 . . . . 0.0 111.51 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.569 ' HG ' ' H ' ' A' ' 12' ' ' ILE . 12.5 tp -120.8 -169.99 1.92 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.057 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.569 ' H ' ' HG ' ' A' ' 11' ' ' LEU . 8.2 mt 67.57 152.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.739 0.78 . . . . 0.0 113.048 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.5 p -114.75 88.57 2.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.655 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -58.77 156.78 22.65 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.913 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -48.46 121.18 5.95 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.397 2.732 . . . . 0.0 112.188 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -94.1 18.16 11.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.151 -176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.17 150.75 43.48 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.766 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.49 169.65 8.72 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.778 -171.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 12.5 p-10 -50.93 -69.19 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.034 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 4.4 p-10 -155.4 143.43 20.01 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 175.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 64.28 163.91 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.484 0.659 . . . . 0.0 111.919 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -144.94 -38.11 0.28 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.258 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.83 177.17 46.24 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.607 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.9 Cg_endo -52.76 153.92 13.67 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 124.098 3.198 . . . . 0.0 112.307 175.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 77.1 Cg_exo -51.92 -14.75 2.61 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 124.495 3.463 . . . . 0.0 115.431 -172.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -75.62 -51.07 13.66 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' OD1' HD23 ' A' ' 57' ' ' LEU . 27.9 m120 61.27 176.83 0.11 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.021 175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -90.63 137.64 32.2 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 172.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 57' ' ' LEU . 18.8 tp -145.15 130.54 18.7 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.978 -177.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -138.41 100.45 4.11 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.686 HG12 ' HB ' ' A' ' 53' ' ' VAL . 48.0 mt -111.76 142.27 24.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.487 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -132.86 119.39 20.16 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -101.21 130.44 50.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 173.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t 178.96 -162.35 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.9 m-80 64.93 76.22 0.33 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -82.25 147.26 14.41 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.86 2.373 . . . . 0.0 113.465 -171.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 43.5 tp60 -130.99 118.85 21.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.572 172.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.6 m -77.56 95.9 4.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.63 0.729 . . . . 0.0 109.341 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.1 p -124.02 91.65 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.159 -174.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.29 -167.38 33.03 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.355 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.0 t -104.3 145.14 13.39 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -37.97 -53.63 2.01 Favored Glycine 0 N--CA 1.463 0.472 0 O-C-N 123.182 0.301 . . . . 0.0 113.445 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -100.62 89.94 4.09 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.498 0.666 . . . . 0.0 109.435 170.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.48 35.26 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.573 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -87.77 147.31 25.24 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 122.957 0.503 . . . . 0.0 110.67 -178.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -140.01 167.71 21.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.5 m -123.47 131.9 53.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 22.3 p -94.67 148.84 21.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.878 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.13 146.67 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.384 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 32.8 tt0 -103.48 121.56 43.09 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.366 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.806 HD13 ' HD3' ' A' ' 69' ' ' ARG . 2.0 mp -94.39 118.27 40.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.227 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HG3' HG23 ' A' ' 66' ' ' THR . 27.1 mtt180 -108.97 126.08 52.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.093 175.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -130.66 139.49 51.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.035 0.445 . . . . 0.0 112.123 -177.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -125.67 137.23 53.85 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.9 t -171.65 165.18 6.75 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.364 0.602 . . . . 0.0 112.227 -174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.551 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.61 26.07 9.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.971 168.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 29' ' ' LEU . 19.9 mt -60.88 140.33 93.58 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.38 176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.4 -23.21 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.824 2.349 . . . . 0.0 111.688 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.654 HG13 HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.06 -41.53 38.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.375 178.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.732 ' CZ ' HD13 ' A' ' 145' ' ' LEU . 3.0 m-85 -67.26 -27.26 67.06 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -172.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -60.2 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.15 -11.12 59.77 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 122.282 -0.261 . . . . 0.0 111.301 -174.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp 70.9 -33.5 0.27 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.798 0.686 . . . . 0.0 111.331 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.22 139.11 25.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 175.103 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD2' ' A' ' 62' ' ' LEU . 48.5 t -155.59 154.09 31.13 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.665 -176.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 52' ' ' ARG . 5.8 m -140.77 129.28 22.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.147 0.498 . . . . 0.0 110.427 171.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 ' HB ' ' NH1' ' A' ' 69' ' ' ARG . 2.7 m -139.98 145.46 26.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.04 -175.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' NH1' ' HB2' ' A' ' 37' ' ' GLN . 22.1 ttm180 -115.35 116.27 28.0 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -177.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.806 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -140.13 169.02 18.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.533 -179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -96.98 170.1 9.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -172.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.601 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 36.9 t80 -51.76 -40.59 60.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.575 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.559 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 21.7 m -54.34 -31.87 55.43 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.048 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 69' ' ' ARG . 44.9 m-20 -74.38 -35.63 63.5 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 58.5 m-85 -66.36 -36.55 83.16 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.689 ' HA ' HD11 ' A' ' 92' ' ' LEU . 31.4 mt-10 -60.09 -56.05 26.45 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.409 ' CD1' HG21 ' A' ' 150' ' ' ILE . 7.2 t-105 -64.7 -28.06 69.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.75 -1.113 . . . . 0.0 111.372 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.52 -46.03 56.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 46.3 ttt180 -57.29 -58.6 7.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.361 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.676 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 14.4 p -60.82 -37.47 82.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.472 -173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -63.3 -39.01 93.39 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.951 0.405 . . . . 0.0 110.731 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 98.3 mt -62.99 -34.07 76.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.465 176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -76.63 -22.79 53.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 79' ' ' SER . 38.9 mmt180 -68.82 -62.23 1.47 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.01 0.433 . . . . 0.0 111.948 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -98.63 -18.05 18.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.236 -169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.2 m -126.61 166.37 17.45 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.49 0.662 . . . . 0.0 111.117 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.1 mtmt -98.51 32.78 2.43 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.526 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.528 ' CG1' HG22 ' A' ' 89' ' ' VAL . 94.9 t -51.81 141.33 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.864 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.3 p -71.11 35.89 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.929 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -59.81 120.69 52.04 Favored Pre-proline 0 C--O 1.236 0.346 0 O-C-N 121.816 -0.553 . . . . 0.0 111.144 -176.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 72.9 Cg_endo -85.65 165.32 10.54 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.843 2.362 . . . . 0.0 112.249 178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.86 141.51 65.44 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.6 2.2 . . . . 0.0 111.883 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.689 HD11 ' HA ' ' A' ' 75' ' ' GLU . 86.8 mt -69.05 145.48 96.52 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.205 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 7.8 Cg_exo -71.18 109.33 2.55 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.744 2.296 . . . . 0.0 111.479 177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.32 46.94 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.003 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.2 mttm 59.08 18.62 6.54 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 122.913 0.485 . . . . 0.0 111.642 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -118.62 -81.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.165 0.507 . . . . 0.0 111.627 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.71 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.72 -23.47 67.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.165 -176.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.863 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -62.93 -48.1 80.39 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.942 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -94.05 20.03 8.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.138 177.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -115.22 -41.9 3.25 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.322 -177.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 4.5 pp -107.53 169.1 7.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.032 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.2 Cg_exo -69.47 132.07 23.01 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.482 2.788 . . . . 0.0 112.66 -178.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 13.6 m-85 -55.92 -63.47 1.17 Allowed 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.78 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 73.85 -56.82 0.64 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.566 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -110.98 -165.95 18.78 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.196 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -50.85 -47.53 60.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.22 0.533 . . . . 0.0 111.611 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' HB3' HG23 ' A' ' 109' ' ' ILE . 4.7 t70 -120.62 -29.78 4.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.68 -13.95 6.81 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 -173.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.644 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 38.2 pt -64.54 -16.31 19.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.571 -0.814 . . . . 0.0 112.105 -177.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 91.5 m-85 -80.06 -9.36 59.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.677 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -102.33 137.29 40.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.45 -17.4 61.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.224 -173.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 53.3 m-80 -69.34 -52.43 27.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.227 178.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.644 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -50.1 -50.63 47.76 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.478 0.486 . . . . 0.0 111.083 179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.19 -52.2 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.27 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -73.48 -20.58 60.65 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.359 -176.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 63.3 mm-40 -72.07 -35.47 69.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.181 0.515 . . . . 0.0 110.036 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 36.7 ttm180 -80.92 -34.98 33.0 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -54.44 -50.98 66.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.24 -178.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.2 pt20 -62.19 -37.46 85.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.481 -174.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.33 -34.94 12.86 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.594 -177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 8.4 tp -67.78 -32.39 72.94 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 122.14 0.176 . . . . 0.0 111.228 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.641 ' HA ' HG22 ' A' ' 126' ' ' ILE . 13.7 pt-20 -75.81 -29.79 58.82 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.696 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 11.2 mm-40 -64.41 -54.17 36.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 173.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -48.85 -53.7 18.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.399 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.6 tp -65.57 -40.23 87.43 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.878 -171.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -61.46 -16.99 52.35 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.109 0.48 . . . . 0.0 111.891 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.559 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 67.2 mttt -90.45 -58.75 2.38 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 122.018 0.914 . . . . 0.0 110.69 177.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.603 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -66.22 -11.73 13.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.337 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.59 -0.07 20.48 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.506 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -132.67 6.13 5.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.354 -0.927 . . . . 0.0 113.407 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.693 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 30.3 t60 -100.71 143.42 26.54 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 117.028 0.414 . . . . 0.0 110.921 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.693 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 4.5 Cg_exo -43.17 -50.17 6.67 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.105 3.203 . . . . 0.0 113.266 -174.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -67.91 -28.08 67.19 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.249 -174.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -81.28 -42.7 20.26 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.857 -176.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 7.6 mm-40 -62.29 -6.25 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.932 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.8 t-20 -108.75 10.1 26.83 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.824 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.508 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 51.0 mm-40 -115.71 126.08 53.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.951 0.405 . . . . 0.0 111.206 177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.47 ' O ' ' HD2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -56.14 -26.18 49.18 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.847 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.764 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.3 p -62.2 -24.72 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 145' ' ' LEU . 2.7 mp -66.52 -33.81 76.52 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.653 178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.529 ' HA ' ' OE1' ' A' ' 146' ' ' GLN . 33.4 t-80 -62.77 -34.85 78.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.384 -175.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.764 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 0.9 OUTLIER -85.04 -28.16 25.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.376 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.468 ' N ' ' HG2' ' A' ' 143' ' ' MET . 31.9 t80 -81.17 -44.81 17.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.532 -176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 4.0 mt -93.05 -45.41 7.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.625 0.726 . . . . 0.0 110.574 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.529 ' OE1' ' HA ' ' A' ' 142' ' ' HIS . 30.6 mt-30 -97.87 -172.71 2.43 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.652 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 55.13 -132.62 1.76 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.537 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.469 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -130.01 -37.56 1.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.469 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -148.33 161.35 6.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.53 0.681 . . . . 0.0 112.515 -168.2 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.518 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.8 mp -87.14 105.59 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.626 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -90.46 109.03 20.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.802 175.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.496 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 10.7 mptt -76.45 10.8 1.87 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.724 0.774 . . . . 0.0 111.325 -173.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.5 m -115.19 14.61 16.98 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.82 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.2 OUTLIER -65.74 -171.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.493 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 45.3 m -89.38 114.0 58.68 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.838 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 23.0 Cg_exo -67.02 95.62 0.36 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.984 2.456 . . . . 0.0 110.835 174.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 9.4 t -165.95 -155.73 0.24 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.384 0.611 . . . . 0.0 110.501 -176.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.501 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.4 mmmt -97.92 161.94 13.49 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.847 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.654 HG21 HG13 ' A' ' 59' ' ' ILE . 22.2 mm -53.74 -47.57 62.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 171.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.0 95.11 10.19 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.343 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -70.95 174.38 6.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.202 -169.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.813 177.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 52.0 tpp . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.981 0.419 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -109.8 102.11 10.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.044 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -78.31 123.63 27.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.466 . . . . 0.0 110.059 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -87.94 143.36 27.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.815 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -95.16 -37.14 11.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.268 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 -152.22 148.93 28.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.468 175.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 -150.35 157.23 42.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.597 0.237 . . . . 0.0 111.038 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -131.54 74.22 1.58 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.987 0.899 . . . . 0.0 109.924 177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.89 168.17 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.846 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 100.25 29.92 6.53 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.092 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.8 p 46.63 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.783 0.833 . . . . 0.0 112.933 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.12 129.05 36.45 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.469 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -162.77 -60.44 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.071 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -71.57 140.33 49.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.18 0.514 . . . . 0.0 111.482 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.5 m -132.11 164.38 34.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.217 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.27 140.53 51.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.774 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.19 137.62 38.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.514 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 9' ' ' ARG . 22.4 p -88.42 -44.5 10.69 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.037 -172.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 9' ' ' ARG . 11.6 mmt180 72.03 -56.79 0.64 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.238 0.961 . . . . 0.0 110.238 -175.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HD2' ' C ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -149.87 139.97 22.08 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 172.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.01 145.16 49.21 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.407 -174.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.7 mt -138.46 153.58 26.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.0 p 67.54 130.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.015 0.926 . . . . 0.0 111.426 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.497 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 2.9 mptp? -78.58 157.74 76.86 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.971 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 87.4 Cg_exo -45.2 116.54 1.29 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.46 2.773 . . . . 0.0 112.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.94 151.62 24.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.606 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -87.0 155.84 20.0 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.66 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.12 122.58 37.94 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.831 0.348 . . . . 0.0 110.319 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 HD22 ' C ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -79.87 176.61 9.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.235 -178.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 1.6 m-20 -80.2 141.67 35.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 20' ' ' ASP . . . 71.8 165.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.129 0.893 . . . . 0.0 109.498 -171.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.459 ' CD2' ' HB2' ' A' ' 56' ' ' ASN . 1.9 m-85 -133.39 -60.4 0.84 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.261 -169.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.66 178.37 47.95 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.42 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -52.92 157.36 8.09 Favored 'Trans proline' 0 C--N 1.335 -0.17 0 C-N-CA 124.288 3.326 . . . . 0.0 112.392 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -46.96 -19.66 0.88 Allowed 'Trans proline' 0 N--CA 1.482 0.796 0 C-N-CA 124.947 3.765 . . . . 0.0 115.441 -173.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 m -75.22 -53.41 8.85 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.59 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.8 m120 61.11 178.4 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.588 0.355 . . . . 0.0 111.928 174.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -92.96 139.27 30.7 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD22 HD11 ' A' ' 57' ' ' LEU . 18.3 tp -145.56 131.51 19.2 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.159 -176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 7.8 pt-20 -140.31 102.57 4.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.254 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.642 HG12 ' HB ' ' A' ' 53' ' ' VAL . 51.6 mt -114.05 140.54 34.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.345 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -137.12 108.91 7.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.308 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.656 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.6 m -85.85 129.52 37.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 168.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t 179.95 -164.3 0.06 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -175.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 42.4 m-80 53.34 67.81 3.42 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.51 164.51 14.42 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.96 2.44 . . . . 0.0 113.41 -168.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -142.82 116.26 9.08 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.797 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.494 HG22 ' NE ' ' A' ' 45' ' ' ARG . 45.6 m -80.17 89.22 5.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.561 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.1 98.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.145 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -171.9 -167.07 31.53 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.09 -1.052 . . . . 0.0 112.964 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.8 t -102.29 148.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 CA-C-O 119.309 -0.377 . . . . 0.0 110.123 -176.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.73 -49.81 5.97 Favored Glycine 0 N--CA 1.461 0.351 0 C-N-CA 121.27 -0.49 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -97.51 85.27 3.58 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 171.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.51 36.27 0.86 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.699 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.611 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 18.0 ttt180 -81.31 150.07 28.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -140.82 168.64 19.31 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 m -124.61 126.57 45.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 111.143 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 p -93.62 153.84 18.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.233 178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -124.02 142.01 51.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.877 0.37 . . . . 0.0 110.5 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 35.4 tt0 -94.26 121.45 35.79 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.133 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.7 mp -97.61 108.96 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.022 0.439 . . . . 0.0 110.623 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 34.0 mtp180 -97.97 136.53 38.11 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.703 177.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.642 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.24 136.99 15.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 64' ' ' GLU . 13.0 ttmt -125.46 138.31 54.0 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.812 168.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.524 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.3 t -168.5 165.53 12.44 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 111.834 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.495 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -119.1 24.34 10.84 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.812 169.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.67 HD11 HD22 ' A' ' 29' ' ' LEU . 28.4 mt -60.82 135.02 92.54 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.89 174.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 3.2 Cg_exo -69.85 -30.88 21.18 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.375 2.05 . . . . 0.0 111.404 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG13 HG21 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -65.22 -42.27 93.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.393 175.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CD2' HG21 ' A' ' 55' ' ' THR . 3.4 m-30 -68.5 -12.47 61.29 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -168.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HB3' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER 72.01 -66.78 0.29 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 169.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.567 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.1 -7.56 59.63 Favored 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 122.368 -0.208 . . . . 0.0 110.869 -173.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 mmpp? 70.93 -39.41 0.45 Allowed 'General case' 0 C--O 1.218 -0.592 0 O-C-N 123.873 0.733 . . . . 0.0 111.205 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 62' ' ' LEU . 3.0 pp20? -157.77 141.5 15.67 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-O 121.094 0.473 . . . . 0.0 109.989 177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.9 t -170.2 172.13 6.47 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.23 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 22.3 m -141.59 127.96 19.95 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.192 0.52 . . . . 0.0 110.492 174.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 148' ' ' GLU . 27.0 m -118.61 173.89 4.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.462 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 68' ' ' ARG . 18.5 ttm180 -137.69 115.24 11.22 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.117 0.484 . . . . 0.0 110.511 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.44 ' HG3' ' CD1' ' A' ' 150' ' ' ILE . 3.4 mmp_? -140.92 167.44 22.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.846 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 71' ' ' TYR . 46.9 ttt180 -98.52 165.48 11.81 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.068 -173.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' N ' ' HG2' ' A' ' 70' ' ' ARG . 40.4 t80 -50.58 -39.86 50.85 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.6 0.238 . . . . 0.0 111.433 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.8 p -57.03 -31.35 65.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.72 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -71.43 -38.59 71.37 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 51.2 m-85 -61.73 -42.39 98.89 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 0.0 109.949 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HA ' HD11 ' A' ' 92' ' ' LEU . 29.1 mt-10 -55.9 -55.05 37.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.321 177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.447 ' CD1' HG21 ' A' ' 150' ' ' ILE . 5.8 t-105 -61.93 -33.23 73.87 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.312 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 2.8 tm? -71.68 -42.89 66.89 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 57.5 ttt180 -56.06 -63.95 1.02 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.139 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.596 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.3 m -59.86 -34.49 73.2 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.049 -173.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.62 -43.95 96.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.098 178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.51 -37.66 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.737 176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 56.5 mt-10 -67.37 -33.73 75.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.277 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.596 ' HG2' ' O ' ' A' ' 79' ' ' SER . 24.4 mmt180 -76.34 -61.15 2.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.255 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -66.99 -31.51 72.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.277 -171.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.5 m -139.16 179.68 6.37 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.67 0.748 . . . . 0.0 112.069 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -97.86 22.42 9.24 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.696 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' A' ' 89' ' ' VAL . 84.8 t -44.54 140.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.103 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.2 p -71.42 33.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.98 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.3 t -54.88 119.8 24.42 Favored Pre-proline 0 N--CA 1.465 0.294 0 O-C-N 122.161 -0.337 . . . . 0.0 110.697 -176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.548 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 93.6 Cg_endo -85.5 163.53 10.96 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.697 2.265 . . . . 0.0 112.398 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 136.05 52.55 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.841 2.36 . . . . 0.0 112.097 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 75' ' ' GLU . 89.3 mt -69.23 149.08 97.56 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.723 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.9 Cg_exo -72.7 109.28 2.75 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.446 2.097 . . . . 0.0 110.966 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -166.45 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.559 -177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -77.58 45.64 0.5 Allowed 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.1 -0.647 . . . . 0.0 110.35 175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.8 -103.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.628 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.3 OUTLIER -53.54 -30.25 40.8 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 94' ' ' GLY . 1.8 mm? -66.74 -44.97 80.1 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.179 -0.326 . . . . 0.0 111.299 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.76 8.42 42.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.771 0.796 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.6 tp-100 -97.11 -38.75 9.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.328 176.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 97' ' ' PHE . 42.5 mt -94.32 163.69 22.39 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.58 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.11 175.94 9.17 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.388 2.726 . . . . 0.0 111.432 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -76.07 -79.28 0.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 60.62 -79.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.585 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.87 75.53 1.08 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.874 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 69.16 -63.22 0.38 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.823 0.849 . . . . 0.0 111.885 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.42 -29.84 1.75 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.375 0.607 . . . . 0.0 110.356 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 124.75 15.76 3.16 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.966 -173.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.703 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 47.1 pt -83.53 -18.95 9.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.387 . . . . 0.0 112.037 -174.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -79.24 -9.42 59.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.291 0.567 . . . . 0.0 109.794 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -82.03 118.7 23.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.653 175.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -64.06 -17.01 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.835 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 85.9 m-20 -63.35 -61.58 2.25 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.703 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -47.78 -51.47 22.3 Favored 'General case' 0 C--O 1.232 0.153 0 O-C-N 123.635 0.584 . . . . 0.0 111.441 -178.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 58.1 mt -50.13 -50.31 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.314 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -83.74 -14.31 51.86 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.817 -177.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.665 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 30.2 mt-10 -80.16 -28.12 38.87 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.238 0.542 . . . . 0.0 109.697 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.516 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -75.71 -37.6 59.32 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -58.98 -52.04 67.46 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.055 -178.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.69 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.3 pt20 -59.13 -43.3 91.97 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 -36.26 38.68 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.062 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -64.01 -38.6 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.811 0.306 . . . . 0.0 111.62 179.119 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 126' ' ' ILE . 12.3 pt-20 -73.0 -31.13 64.3 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 14.9 mm-40 -61.58 -59.36 5.32 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 173.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.543 ' O ' HG13 ' A' ' 129' ' ' VAL . 8.5 t80 -48.82 -54.09 16.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.756 -1.565 . . . . 0.0 111.383 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -64.04 -41.03 91.17 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.031 -170.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -61.95 -17.69 57.77 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.32 0.509 . . . . 0.0 111.836 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.548 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 34.6 mttm -90.49 -58.59 2.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.849 0.833 . . . . 0.0 110.248 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.598 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -64.75 -12.67 13.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.256 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.51 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -109.74 3.0 20.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.434 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.08 -8.01 2.44 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.327 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.641 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 58.9 t60 -82.49 139.81 44.58 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.641 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 2.8 Cg_endo -44.15 -47.31 10.61 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 124.096 3.197 . . . . 0.0 113.292 -172.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.436 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -68.61 -33.16 73.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.125 -176.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.74 -43.84 35.61 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.745 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.67 -6.41 3.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.229 172.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.619 HD22 ' HE3' ' A' ' 158' ' ' LYS . 0.9 OUTLIER -99.79 -6.35 27.1 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.164 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.442 ' C ' HG12 ' A' ' 159' ' ' ILE . 30.1 mm-40 -107.43 129.93 54.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.693 -174.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.427 ' HA ' HD13 ' A' ' 159' ' ' ILE . 0.0 OUTLIER -56.04 -20.34 16.43 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.584 -174.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.538 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.0 m -59.25 -30.31 68.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.359 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 145' ' ' LEU . 1.1 mp -69.79 -35.33 74.77 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.172 -0.33 . . . . 0.0 111.208 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.679 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 11.9 t-80 -54.25 -41.36 68.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.626 0.727 . . . . 0.0 109.691 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 3.3 ptm -81.0 -27.93 35.68 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.446 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.609 ' HB3' HD13 ' A' ' 145' ' ' LEU . 20.3 t80 -79.87 -59.17 2.83 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.154 -173.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.619 HD11 ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -106.38 7.09 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -175.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.679 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 12.5 mt-30 -121.33 -176.1 3.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 51.65 -111.64 0.58 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.408 0.443 . . . . 0.0 110.889 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HA ' HG12 ' A' ' 67' ' ' VAL . 1.7 pm0 -145.42 -39.13 0.25 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.219 0.533 . . . . 0.0 112.027 175.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -142.06 148.69 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.161 -166.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.551 HG22 ' HE3' ' A' ' 152' ' ' LYS . 3.4 mp -72.25 102.84 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.812 172.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -89.74 102.94 15.63 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.25 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.551 ' HE3' HG22 ' A' ' 150' ' ' ILE . 5.4 mptt -74.74 11.79 0.97 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.296 0.57 . . . . 0.0 111.913 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.3 t -111.79 12.53 20.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.166 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.24 -171.84 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.679 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 91.2 m -92.52 113.71 60.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.039 176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -67.54 89.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.018 2.479 . . . . 0.0 110.941 174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.1 t -159.7 -154.63 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.395 0.617 . . . . 0.0 110.868 -175.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.619 ' HE3' HD22 ' A' ' 137' ' ' ASN . 14.8 mmmt -96.8 157.78 15.74 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.474 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.63 HG21 HG13 ' A' ' 59' ' ' ILE . 19.6 mm -57.77 -41.11 78.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.385 0.612 . . . . 0.0 109.922 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -66.15 -25.26 66.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.01 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' A' ' 162' ' ' ALA . 19.2 t-80 64.03 -176.12 0.16 Allowed 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.753 172.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.498 ' H ' ' CG ' ' A' ' 161' ' ' HIS . . . . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.994 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 2.8 ppp? . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.744 0.307 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -108.3 4.89 25.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.733 0.301 . . . . 0.0 111.228 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 -109.13 110.59 21.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.847 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -72.88 129.5 38.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -110.75 -6.98 14.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.122 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -114.84 130.59 56.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.555 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -98.99 -22.72 15.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -66.97 128.39 36.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.4 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.82 129.63 51.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.474 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.66 -33.61 18.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.582 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 32.1 p -129.59 109.11 10.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.533 -0.333 . . . . 0.0 110.289 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.33 129.51 9.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.898 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -172.51 -44.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.803 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 p -70.8 152.52 43.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.664 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.12 -49.91 4.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.989 -177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.71 70.82 0.73 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.978 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -67.61 145.41 54.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.842 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.54 ' HB ' ' O ' ' A' ' 11' ' ' LEU . 26.6 p -100.24 -54.14 2.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.667 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 64.59 -60.78 0.21 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.62 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -133.45 -37.48 0.95 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.713 0.768 . . . . 0.0 110.679 -172.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 12' ' ' ILE . 5.4 tt -72.57 135.02 45.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.37 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.713 ' N ' HD23 ' A' ' 11' ' ' LEU . 1.7 mt -144.43 172.31 5.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.278 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.526 ' H ' HG22 ' A' ' 12' ' ' ILE . 40.0 p 58.46 80.94 0.17 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.861 0.839 . . . . 0.0 110.291 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 8.8 mptt -78.22 165.59 49.24 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.642 -172.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 84.5 Cg_exo -49.07 136.22 29.79 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.697 2.265 . . . . 0.0 111.358 173.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.0 173.42 7.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.266 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -62.59 146.25 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.325 0.583 . . . . 0.0 111.137 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -100.69 -166.48 1.32 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.644 -178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.43 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 4.6 p30 -53.43 -71.68 0.07 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.062 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 9.9 m-20 -129.66 129.46 44.32 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 170.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 178.82 158.61 0.55 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.911 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -133.97 -45.51 0.79 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.909 0.385 . . . . 0.0 110.746 -168.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.07 175.7 40.15 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.041 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.38 153.45 13.4 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 124.088 3.192 . . . . 0.0 111.608 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -41.13 -30.26 0.65 Allowed 'Trans proline' 0 N--CA 1.476 0.447 0 C-N-CA 124.6 3.533 . . . . 0.0 115.504 -170.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -70.75 -52.21 22.23 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -176.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 30.9 m-80 61.53 -179.42 0.12 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.098 0.475 . . . . 0.0 112.135 175.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.39 132.41 36.22 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.737 HD22 HD11 ' A' ' 57' ' ' LEU . 13.2 tp -143.0 127.21 17.56 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.58 0.705 . . . . 0.0 111.188 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -142.15 100.79 3.79 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.688 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.682 HG12 ' HB ' ' A' ' 53' ' ' VAL . 46.7 mt -111.82 138.71 39.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.116 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -131.77 103.24 6.23 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG21 ' HB3' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -79.35 131.51 34.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 p -178.03 -165.13 0.09 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 63.06 81.73 0.22 Allowed Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 121.375 0.607 . . . . 0.0 110.432 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -69.13 119.59 6.56 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.123 2.549 . . . . 0.0 112.527 -175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 50.0 tp60 -108.81 106.47 16.48 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.541 174.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.8 m -77.84 103.15 7.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 p -134.07 89.9 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.05 -173.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.42 -167.86 33.02 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.218 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 13.3 t -104.37 149.91 7.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.792 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.337 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -40.36 -54.86 3.19 Favored Glycine 0 N--CA 1.46 0.247 0 C-N-CA 121.549 -0.357 . . . . 0.0 112.508 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -96.67 86.9 4.2 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.458 0.647 . . . . 0.0 109.858 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.94 34.85 0.87 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.975 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.538 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 20.9 ttt180 -82.71 146.84 28.81 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -143.47 165.76 26.66 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.901 0.381 . . . . 0.0 110.874 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 36.5 m -121.78 129.02 52.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.481 -177.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 44.0 p -92.73 140.86 29.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' OH ' ' HD2' ' A' ' 118' ' ' ARG . 98.6 m-85 -100.22 126.75 46.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.07 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.648 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 15.5 tt0 -86.17 120.34 27.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.289 -176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.4 mp -93.34 106.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.691 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -95.44 112.03 23.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.424 176.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.682 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -122.66 140.68 45.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -126.86 136.87 52.92 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.244 168.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.532 HG21 ' CD2' ' A' ' 60' ' ' PHE . 13.1 t -170.65 164.54 8.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.31 0.576 . . . . 0.0 112.152 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.04 26.02 10.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.824 168.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.737 HD11 HD22 ' A' ' 29' ' ' LEU . 26.5 mt -60.4 136.42 91.86 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.543 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -68.34 -32.87 25.11 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.227 1.952 . . . . 0.0 111.162 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.619 HG13 HG21 ' A' ' 159' ' ' ILE . 1.1 tt -66.69 -37.17 78.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.411 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CZ ' ' HG ' ' A' ' 145' ' ' LEU . 4.0 m-30 -75.07 -5.37 43.77 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -169.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.7 tttt 67.16 -74.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 169.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.18 -4.38 55.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 120.518 0.199 . . . . 0.0 110.502 -171.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 5.5 mmtp 70.31 -42.38 0.52 Allowed 'General case' 0 C--O 1.221 -0.417 0 O-C-N 124.122 0.889 . . . . 0.0 111.496 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -158.19 127.27 5.67 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.408 0.623 . . . . 0.0 110.121 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 t -166.97 176.22 7.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.547 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.648 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 21.5 m -140.68 122.74 15.64 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.534 0.683 . . . . 0.0 111.947 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.4 m -113.49 -178.1 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.866 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.466 ' HB3' ' HA ' ' A' ' 50' ' ' GLU . 38.6 ptt180 -150.53 133.1 15.72 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.109 170.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 4.0 mmp_? -136.11 177.99 7.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.624 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.42 ' O ' ' HD1' ' A' ' 74' ' ' PHE . 61.6 mtp180 -93.13 173.2 7.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.577 0.227 . . . . 0.0 111.282 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.9 t80 -60.48 -40.52 91.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.7 p -60.49 -26.78 67.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.405 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB3' HD12 ' A' ' 150' ' ' ILE . 9.3 m-20 -73.23 -37.02 66.54 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.913 176.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 122' ' ' LEU . 34.9 m-85 -65.98 -41.36 91.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HA ' HD11 ' A' ' 92' ' ' LEU . 21.8 mt-10 -55.91 -53.53 55.73 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.021 175.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.444 ' CD1' HG21 ' A' ' 150' ' ' ILE . 8.5 t-105 -64.07 -30.27 71.35 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.331 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.2 tm? -73.44 -43.96 59.21 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 35.5 ttt180 -56.59 -61.82 2.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.176 178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 32.7 t -59.62 -38.54 81.59 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.586 -173.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -48.48 75.93 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.067 0.461 . . . . 0.0 110.235 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 89.2 mt -63.79 -40.37 96.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.201 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.9 mt-10 -66.94 -41.84 86.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.824 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.3 mmm180 -74.96 -53.6 8.69 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.791 -174.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -82.86 -25.83 32.2 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.101 -170.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.1 m -130.46 175.3 9.08 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.717 0.77 . . . . 0.0 111.569 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -99.13 29.96 3.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.581 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' A' ' 89' ' ' VAL . 60.3 t -54.61 142.31 8.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.351 -1.295 . . . . 0.0 112.036 -178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 88' ' ' VAL . 8.0 p -73.15 34.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.037 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.516 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -57.05 122.9 56.65 Favored Pre-proline 0 C--O 1.234 0.267 0 O-C-N 121.886 -0.509 . . . . 0.0 111.206 -175.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 88.7 Cg_endo -85.62 167.82 9.98 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.926 2.418 . . . . 0.0 111.868 178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.31 150.31 64.66 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.478 2.119 . . . . 0.0 112.244 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 75' ' ' GLU . 92.6 mt -78.41 151.99 78.21 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.255 -178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.32 110.8 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.778 2.319 . . . . 0.0 111.154 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.3 43.16 0.11 Allowed Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.724 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 tttm -153.18 58.74 0.78 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.492 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -165.43 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.626 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.507 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -59.47 -29.0 67.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.945 -173.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.1 mm? -60.12 -48.01 83.51 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.444 -173.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 2.3 ppt_? -99.81 29.33 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.453 0.644 . . . . 0.0 110.196 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.9 OUTLIER -124.83 -41.43 2.12 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.405 -177.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 54.1 mt -85.23 166.76 29.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.18 -177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 33.5 Cg_exo -60.06 143.07 99.58 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.986 2.457 . . . . 0.0 112.254 175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.614 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 6.9 m-85 -73.65 -62.95 1.31 Allowed 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mtt-85 69.77 -60.49 0.47 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.742 -1.572 . . . . 0.0 111.886 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -121.31 -145.83 7.29 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.954 -174.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -55.96 -42.47 76.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.105 0.478 . . . . 0.0 111.432 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -127.87 -53.26 1.32 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -173.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 141.43 -12.57 2.74 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.599 -171.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.641 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 39.3 pt -56.12 -19.84 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -76.22 -7.29 54.54 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.01 0.434 . . . . 0.0 110.834 -178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -88.01 125.7 34.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -69.45 -17.94 63.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.122 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.481 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 44.9 m-80 -72.58 -47.41 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.641 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.7 OUTLIER -49.03 -49.57 40.52 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.5 0.5 . . . . 0.0 110.71 177.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.95 -50.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.618 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -79.18 -16.31 56.77 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.849 -177.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 65.4 mm-40 -73.31 -35.32 66.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 120.906 0.384 . . . . 0.0 110.057 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.445 ' HD2' ' OH ' ' A' ' 49' ' ' TYR . 33.0 ttm180 -79.04 -31.89 44.75 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -58.91 -50.96 72.06 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.652 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.688 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -61.45 -37.56 84.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 -40.49 16.31 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.136 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 74' ' ' PHE . 0.7 OUTLIER -62.11 -35.43 78.7 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.9 0.35 . . . . 0.0 111.281 178.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' A' ' 126' ' ' ILE . 15.9 pt-20 -75.52 -33.18 60.7 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.688 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 8.6 mm-40 -61.67 -56.1 23.37 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.1 t80 -51.15 -52.77 40.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.172 -1.376 . . . . 0.0 111.433 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.44 -41.06 90.19 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.055 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -60.41 -17.99 47.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.946 0.403 . . . . 0.0 111.981 -175.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 32.9 mttm -88.25 -59.39 2.25 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 122.111 0.957 . . . . 0.0 110.593 177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.508 HG22 ' HA ' ' A' ' 126' ' ' ILE . 1.4 m -65.35 -13.13 14.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.398 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -102.41 -5.64 23.89 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.443 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.36 14.3 4.82 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.262 -0.971 . . . . 0.0 113.004 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.65 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 45.1 t60 -100.19 139.45 20.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.796 -0.361 . . . . 0.0 110.796 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.1 Cg_exo -41.32 -49.53 4.84 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 124.516 3.477 . . . . 0.0 113.706 -173.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -69.68 -26.63 64.46 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.386 -174.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.492 ' O ' HD22 ' A' ' 141' ' ' LEU . . . -86.76 -42.16 13.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.423 -175.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.419 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.39 -2.66 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.536 0.684 . . . . 0.0 110.182 170.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.7 t-20 -111.3 7.83 21.19 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.937 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -116.03 126.98 54.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.0 0.429 . . . . 0.0 111.199 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -52.46 -29.31 24.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.041 -173.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.666 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 15.5 t -63.75 -22.47 66.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.83 0.347 . . . . 0.0 111.434 -177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -68.45 -30.85 69.81 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.793 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 7.3 t60 -67.09 -38.09 85.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.666 ' SD ' ' HA ' ' A' ' 140' ' ' CYS . 6.3 ptm -79.61 -25.28 41.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.826 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.604 ' CD2' HD11 ' A' ' 150' ' ' ILE . 24.7 t80 -80.17 -52.54 7.64 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.192 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.699 ' HG ' ' CZ ' ' A' ' 60' ' ' PHE . 3.2 mm? -78.36 -25.83 46.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.921 -174.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.697 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 28.1 mt-30 -129.48 176.7 7.76 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.068 -164.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.49 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.792 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 149' ' ' ILE . 9.3 tp10 177.18 -58.65 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.656 0.741 . . . . 0.0 110.862 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.615 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -116.24 135.85 55.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.824 -171.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.604 HD11 ' CD2' ' A' ' 144' ' ' PHE . 46.6 mt -72.98 111.62 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.621 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 153' ' ' SER . 10.3 t70 -91.82 99.86 12.65 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.0 mptt -70.85 11.64 0.36 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -172.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 151' ' ' ASP . 25.4 m -116.06 14.03 15.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.2 174.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -61.2 -170.93 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.611 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 93.7 m -91.66 112.21 53.29 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 20.8 Cg_exo -70.57 88.7 0.62 Allowed 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.325 2.683 . . . . 0.0 111.724 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 50.1 m -156.95 -159.56 0.87 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.175 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.547 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 19.5 mmmt -91.23 160.02 15.75 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.619 HG21 HG13 ' A' ' 59' ' ' ILE . 16.0 mm -56.29 -44.27 79.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.716 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.45 96.11 9.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 160.64 22.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.066 0.46 . . . . 0.0 110.47 -176.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.129 179.497 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.978 0.418 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -157.21 148.63 22.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.534 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -142.42 100.78 3.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.418 . . . . 0.0 110.826 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -151.02 71.0 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.423 0.63 . . . . 0.0 110.536 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -108.76 106.43 16.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -105.02 -10.13 17.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.133 0.492 . . . . 0.0 110.199 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -81.95 74.43 8.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -75.12 90.75 2.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.385 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.55 153.31 38.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.664 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -110.92 80.2 0.27 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.852 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 m -94.28 143.65 26.21 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 120.93 0.395 . . . . 0.0 110.822 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.83 125.02 50.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.848 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -120.88 -59.63 1.72 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.442 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 p -113.38 143.48 44.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.0 111.092 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 t -132.4 -46.89 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.926 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.04 162.44 14.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.243 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -113.8 156.77 23.27 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.0 p -80.08 -66.67 0.85 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.583 0.23 . . . . 0.0 110.558 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 54.4 -172.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.796 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.497 ' N ' ' HD3' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -170.15 -177.02 2.4 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.9 tp -156.36 144.25 19.52 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.5 mt -131.52 144.0 38.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.143 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.5 p -133.59 122.36 23.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.736 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 27.5 mmtp -79.76 163.58 57.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 87.1 Cg_exo -46.98 113.02 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.647 2.231 . . . . 0.0 111.442 174.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -70.53 93.88 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.305 0.574 . . . . 0.0 111.202 -174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 17' ' ' ASN . 0.9 OUTLIER -102.46 170.19 8.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.209 179.112 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.57 119.07 38.2 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -68.71 -46.43 68.99 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.054 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -145.6 160.07 42.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.396 171.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 74.79 170.87 0.28 Allowed 'General case' 0 C--O 1.234 0.245 0 O-C-N 123.864 0.728 . . . . 0.0 111.033 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.63 -49.03 0.89 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.555 -169.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.08 172.87 45.42 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.807 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.74 155.24 14.42 Favored 'Trans proline' 0 C--N 1.332 -0.319 0 C-N-CA 123.889 3.06 . . . . 0.0 112.334 176.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -49.35 -18.67 2.35 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 124.853 3.702 . . . . 0.0 114.698 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.2 m -70.84 -54.19 12.47 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.562 HD22 ' ND2' ' A' ' 56' ' ' ASN . 27.4 m120 61.29 163.24 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.588 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -87.07 139.06 30.96 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 57' ' ' LEU . 18.6 tp -143.79 129.75 19.51 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.545 -177.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -142.03 101.43 3.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.72 0.771 . . . . 0.0 110.237 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.695 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.6 mt -111.04 133.68 55.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.223 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -127.36 100.79 6.19 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.279 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -78.01 128.3 38.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 106.716 -1.586 . . . . 0.0 106.716 171.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 p -176.8 -163.65 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 27.3 m-80 58.26 70.76 1.15 Allowed Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.398 . . . . 0.0 110.271 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 115' ' ' ILE . 97.4 Cg_endo -77.15 132.34 12.58 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.796 2.331 . . . . 0.0 113.414 -172.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.3 tp60 -119.92 107.78 13.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.546 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.532 HG22 ' NE ' ' A' ' 45' ' ' ARG . 54.6 m -78.02 96.12 5.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.569 0.7 . . . . 0.0 109.896 177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.2 p -123.82 94.39 2.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.379 -171.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.65 -165.82 30.26 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.078 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.9 t -97.22 146.43 7.6 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.166 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.16 -48.18 6.59 Favored Glycine 0 N--CA 1.46 0.263 0 C-N-CA 121.521 -0.371 . . . . 0.0 113.144 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -103.91 89.85 3.43 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.57 0.7 . . . . 0.0 109.222 170.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.74 33.09 0.95 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.474 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.585 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 27.8 ttt180 -85.66 146.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.057 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -133.43 149.47 51.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.54 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 80.5 m -105.19 128.29 53.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.347 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 35.9 p -93.16 144.3 25.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.959 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -113.87 138.75 49.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 110.767 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 34.8 tt0 -96.79 120.79 37.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.204 -178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 3.9 mp -98.64 109.82 24.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 0.0 111.109 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -96.1 145.02 25.84 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.699 173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.695 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -149.68 138.46 15.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.143 0.497 . . . . 0.0 112.175 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -127.54 143.61 51.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.009 167.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.519 HG21 ' CD2' ' A' ' 60' ' ' PHE . 15.1 t -171.75 164.58 6.58 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.022 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.562 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -117.62 23.94 11.41 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.596 167.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 29' ' ' LEU . 28.2 mt -58.57 138.58 85.87 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.713 174.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 2.4 Cg_endo -77.0 -24.99 9.29 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.5 2.134 . . . . 0.0 111.424 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.775 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -69.41 -42.27 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 175.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.532 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.5 m-30 -68.46 -25.59 65.07 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -170.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.63 -60.47 0.53 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -80.77 -9.02 59.84 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 117.831 0.287 . . . . 0.0 111.293 -172.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 70.0 -41.7 0.49 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.839 0.712 . . . . 0.0 110.994 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.53 144.93 36.22 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -163.81 158.12 19.7 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.144 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 6.5 m -142.31 136.61 29.89 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.534 171.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.85 176.04 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.655 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 35.2 ttp180 -137.89 113.8 9.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.03 0.443 . . . . 0.0 110.438 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 12.1 mmm180 -131.44 177.4 7.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -177.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 70' ' ' ARG . 53.7 mtm180 -100.23 172.08 7.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.708 0.29 . . . . 0.0 111.11 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.643 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 28.6 t80 -61.81 -38.18 87.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.492 ' HA ' ' OE2' ' A' ' 75' ' ' GLU . 17.0 p -57.77 -28.62 64.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.248 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.556 ' HB3' HD12 ' A' ' 150' ' ' ILE . 5.0 m-20 -70.88 -40.13 72.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.128 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -62.27 -40.27 95.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 109.892 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.643 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 19.9 mt-10 -61.76 -44.98 95.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.826 0.822 . . . . 0.0 110.138 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.514 ' CE2' ' HG3' ' A' ' 152' ' ' LYS . 7.3 t-105 -64.03 -36.31 83.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.521 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 144' ' ' PHE . 32.3 tp -70.77 -48.03 56.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.913 0.387 . . . . 0.0 110.144 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 56.8 ttt180 -50.61 -60.11 3.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.976 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.729 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.2 p -61.86 -42.21 98.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.959 -176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -52.43 -49.28 64.87 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.332 0.395 . . . . 0.0 111.149 177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.21 -38.4 90.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 38.6 mt-10 -70.89 -20.19 62.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.752 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 79' ' ' SER . 26.5 mmt180 -80.21 -61.77 1.88 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.147 0.499 . . . . 0.0 112.113 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' HB2' ' OE2' ' A' ' 138' ' ' GLU . 43.7 mm-40 -84.74 -22.98 29.47 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.054 -170.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.7 m -131.98 171.88 13.04 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.687 0.756 . . . . 0.0 112.005 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -97.99 33.46 2.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.402 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 66.6 t -54.3 140.0 12.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.535 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.1 p -72.41 32.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.99 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 78' ' ' ARG . 1.4 t -53.56 122.36 31.88 Favored Pre-proline 0 N--CA 1.466 0.334 0 O-C-N 122.126 -0.359 . . . . 0.0 111.258 -175.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 87.2 Cg_endo -85.75 165.17 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 123.175 2.583 . . . . 0.0 112.514 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 37.8 Cg_endo -65.76 142.95 72.12 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.852 2.368 . . . . 0.0 112.285 177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 75' ' ' GLU . 96.7 mt -69.8 154.17 94.93 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.775 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 60.1 Cg_endo -77.52 109.11 2.71 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.506 2.137 . . . . 0.0 110.953 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.88 -177.12 37.2 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.073 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.583 ' N ' HD23 ' A' ' 98' ' ' LEU . 12.5 mptt 68.15 -63.18 0.34 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.605 0.762 . . . . 0.0 112.202 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -47.71 -73.25 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.601 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -76.16 -22.37 55.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.542 -169.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.73 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.7 mm? -64.82 -42.82 94.67 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.147 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 30.11 3.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.621 0.724 . . . . 0.0 110.064 175.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.601 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.7 tt0 -130.06 -38.78 1.41 Allowed 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.293 -174.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG3' ' A' ' 117' ' ' GLU . 54.0 mt -90.03 169.21 12.82 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.104 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 24.0 Cg_exo -64.34 140.43 70.21 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.636 2.224 . . . . 0.0 111.527 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.491 ' O ' ' HA2' ' A' ' 108' ' ' GLY . 45.2 m-85 -83.15 -83.13 0.14 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.208 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 66.87 -69.4 0.13 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.862 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 110' ' ' PHE . . . -88.85 71.13 2.45 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.636 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.2 t70 65.15 -71.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.29 1.036 . . . . 0.0 111.366 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -101.01 -36.4 9.03 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.827 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 103' ' ' PHE . . . 126.73 -5.01 7.51 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.521 -173.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.689 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 43.6 pt -68.92 -17.9 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.472 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 58.1 m-85 -81.25 -4.62 56.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.836 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -100.01 131.47 45.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.268 0.556 . . . . 0.0 109.904 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.51 -25.65 64.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.018 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.572 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 89.4 m-20 -64.21 -59.98 3.76 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.689 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -50.66 -47.23 58.71 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 123.419 0.449 . . . . 0.0 111.044 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' A' ' 36' ' ' PRO . 65.4 mt -52.72 -52.98 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.617 -174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -71.93 -19.52 61.9 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.291 -177.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 40.6 mm-40 -75.63 -31.23 59.79 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.437 0.637 . . . . 0.0 109.64 -177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.03 -39.89 32.79 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.7 172.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -54.64 -51.34 65.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.795 -178.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.652 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.8 pt20 -61.25 -41.18 96.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.851 -176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 93' ' ' PRO . . . -72.18 -38.67 59.02 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.563 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -67.12 -35.64 80.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.205 0.502 . . . . 0.0 111.236 178.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.589 ' HA ' HG22 ' A' ' 126' ' ' ILE . 8.2 pt-20 -76.12 -29.04 57.7 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 12.3 mm-40 -62.52 -58.86 6.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 129' ' ' VAL . 6.2 t80 -51.3 -52.44 45.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.074 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.589 HG22 ' HA ' ' A' ' 123' ' ' GLU . 9.7 tp -63.35 -43.8 98.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -170.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -59.78 -20.12 54.71 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 38.3 mttm -84.0 -58.25 2.85 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.987 0.898 . . . . 0.0 110.14 178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.541 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -65.3 -11.96 12.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.14 -1.391 . . . . 0.0 111.338 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' A' ' 141' ' ' LEU . . . -97.16 -15.41 20.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.626 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.426 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -123.68 1.89 9.38 Favored Glycine 0 CA--C 1.517 0.198 0 C-N-CA 120.281 -0.961 . . . . 0.0 114.044 -172.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.676 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.7 t60 -89.67 141.94 28.9 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 117.321 0.561 . . . . 0.0 110.758 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.676 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 16.3 Cg_exo -40.55 -50.57 3.76 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 124.356 3.37 . . . . 0.0 113.774 -175.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.34 -23.85 62.88 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.422 -174.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -88.36 -42.22 12.34 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.439 -175.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.463 ' O ' HD12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -62.57 -4.26 1.88 Allowed 'General case' 0 C--O 1.23 0.067 0 CA-C-O 121.523 0.678 . . . . 0.0 110.256 172.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -105.6 2.1 27.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.269 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.493 ' OE2' ' HB2' ' A' ' 84' ' ' GLU . 4.9 mm-40 -114.29 129.19 56.63 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.879 -175.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 157' ' ' SER . 0.0 OUTLIER -55.48 -20.88 14.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.421 -175.111 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 143' ' ' MET . 6.0 t -65.51 -24.23 67.08 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.33 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.597 ' O ' HD22 ' A' ' 145' ' ' LEU . 5.3 mp -71.6 -31.11 66.57 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.7 177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.528 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 6.3 t60 -61.73 -34.18 75.36 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.65 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 5.1 ptm -84.43 -26.16 28.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.668 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.682 ' CD2' HD22 ' A' ' 77' ' ' LEU . 2.5 t80 -78.98 -54.13 6.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.552 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 141' ' ' LEU . 0.3 OUTLIER -85.29 -33.84 22.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.18 0.514 . . . . 0.0 110.713 -174.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 142' ' ' HIS . 8.5 mt-30 -107.54 -175.44 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.329 -170.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 54.75 -145.05 0.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -117.92 -32.83 4.66 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.291 0.567 . . . . 0.0 111.543 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.487 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.5 OUTLIER -145.42 156.76 13.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.874 0.845 . . . . 0.0 113.132 -166.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.592 HG12 ' HG3' ' A' ' 143' ' ' MET . 81.3 mt -89.12 111.99 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.02 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -99.78 106.24 18.11 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.781 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' CE2' ' A' ' 76' ' ' TRP . 9.5 mptt -71.39 5.55 2.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 111.773 -171.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.4 m -109.31 13.74 24.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.834 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.48 -172.45 0.05 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.499 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 99.0 m -95.45 112.83 60.19 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -69.82 50.21 0.8 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.916 3.078 . . . . 0.0 113.262 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 139' ' ' ARG . 71.2 m -108.69 -160.59 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.82 0.343 . . . . 0.0 110.536 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HB3' HD22 ' A' ' 137' ' ' ASN . 18.5 mmmt -86.78 160.31 18.84 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.775 HG21 HG13 ' A' ' 59' ' ' ILE . 17.5 mm -52.78 -45.87 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 171.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 89.62 1.96 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.306 174.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -74.46 178.2 5.43 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-O 122.347 1.07 . . . . 0.0 111.611 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.562 0 CA-C-N 113.55 -1.659 . . . . 0.0 108.918 174.531 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 63.1 mtm . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' -5' ' ' HIS . . . -83.09 86.03 7.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.919 0.39 . . . . 0.0 110.983 -178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -62.02 -37.95 86.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.238 -177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -111.4 16.29 20.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.778 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . 0.474 ' HA ' ' HB1' ' A' ' -8' ' ' ALA . 16.4 t-80 54.29 41.64 31.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.744 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -122.78 36.9 4.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.3 m80 66.79 -95.89 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.868 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -172.24 23.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.602 0.715 . . . . 0.0 109.302 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.3 150.05 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.118 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -114.19 -157.03 11.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.532 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.0 p -63.76 144.61 56.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.961 0.41 . . . . 0.0 111.332 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.33 137.93 32.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.435 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 4' ' ' THR . 7.7 tt0 -151.02 -169.06 3.28 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.401 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 61.6 p 60.21 175.6 0.09 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.011 0.924 . . . . 0.0 113.296 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 t 67.99 -82.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 113.841 -1.527 . . . . 0.0 112.075 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.85 140.47 36.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.861 0.362 . . . . 0.0 111.332 -175.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.41 164.61 19.83 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 173.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 p -58.05 -63.02 1.4 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 59.55 -179.6 0.09 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.564 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -168.57 170.22 9.75 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.6 tp -145.27 143.85 30.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 120.864 0.364 . . . . 0.0 110.357 -176.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.6 mt -137.92 153.06 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p 67.06 137.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.003 0.921 . . . . 0.0 112.577 174.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 9.6 mptt -79.65 168.68 24.48 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.455 175.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 69.1 Cg_exo -45.59 147.55 2.81 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.746 2.298 . . . . 0.0 112.313 175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -55.18 127.4 29.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.373 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -68.98 155.27 40.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.6 mm? -97.04 -171.49 2.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.39 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -67.37 -171.61 0.18 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.404 0.621 . . . . 0.0 111.06 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -116.29 126.93 54.23 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.992 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -145.12 150.14 36.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.838 -173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 4.4 m-85 -130.1 -9.76 4.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.309 -170.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.2 178.78 41.2 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.28 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.02 154.43 13.37 Favored 'Trans proline' 0 C--O 1.218 -0.513 0 C-N-CA 124.314 3.343 . . . . 0.0 111.866 175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.39 -27.01 4.5 Favored 'Trans proline' 0 N--CA 1.478 0.576 0 C-N-CA 124.078 3.185 . . . . 0.0 115.354 -169.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' HD21 ' A' ' 57' ' ' LEU . 9.0 t -87.72 -33.55 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.794 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 22.0 m-80 57.41 -173.35 0.08 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 174.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -84.96 128.99 34.87 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 57' ' ' LEU . 16.7 tp -141.36 130.47 23.35 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.129 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 7.7 pt-20 -139.19 109.0 6.27 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.245 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.69 HG12 ' HB ' ' A' ' 53' ' ' VAL . 43.9 mt -120.84 137.8 53.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -133.76 115.75 14.92 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.394 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.645 HG22 ' HB3' ' A' ' 123' ' ' GLU . 1.2 m -98.08 133.79 38.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.2 t 179.16 -161.54 0.03 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 33.1 m-80 62.22 68.66 1.04 Allowed Pre-proline 0 N--CA 1.47 0.528 0 CA-C-O 120.882 0.372 . . . . 0.0 110.271 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.84 134.57 23.97 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.797 2.331 . . . . 0.0 113.832 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.629 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.6 tp60 -117.36 106.52 13.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.006 170.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.569 HG22 ' HE ' ' A' ' 45' ' ' ARG . 32.4 m -78.95 97.12 5.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.651 0.739 . . . . 0.0 110.037 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -125.81 90.81 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.973 -170.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.39 -165.41 29.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 16.9 t -97.02 149.13 5.04 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.625 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.649 -177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -43.09 -48.1 6.48 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 121.508 -0.377 . . . . 0.0 113.299 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -101.9 87.99 3.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 170.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.23 34.2 0.9 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.013 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.586 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.5 ttt180 -84.36 140.27 31.7 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -125.24 157.31 36.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.938 0.399 . . . . 0.0 110.408 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 m -110.35 127.72 55.2 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.079 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.629 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 41.2 p -92.82 128.55 38.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' ARG . 87.6 m-85 -101.9 134.84 44.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.413 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 37.2 tt0 -86.91 121.76 29.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.897 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.6 mp -95.55 116.26 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.452 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HG3' ' CG2' ' A' ' 66' ' ' THR . 35.0 mtt180 -109.82 119.33 39.01 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.55 175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -123.57 142.5 40.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.948 0.404 . . . . 0.0 111.953 -178.314 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 15.9 ttmt -127.49 138.16 52.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 165.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -171.12 165.24 7.41 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.5 0.667 . . . . 0.0 111.899 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.465 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -121.79 28.46 7.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.397 169.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 29' ' ' LEU . 17.8 mt -62.82 145.24 96.17 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.575 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD3' ' ND2' ' A' ' 27' ' ' ASN . 70.5 Cg_endo -78.8 -15.68 13.29 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.726 2.284 . . . . 0.0 112.345 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 159' ' ' ILE . 0.3 OUTLIER -85.06 -41.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.75 -177.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.688 ' CE1' HD13 ' A' ' 145' ' ' LEU . 2.3 m-30 -68.51 -29.69 68.34 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -172.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 74.25 -57.52 0.61 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.421 0.451 . . . . 0.0 112.023 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.11 -12.44 59.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 117.648 0.204 . . . . 0.0 111.099 -173.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp 71.93 -38.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.809 0.693 . . . . 0.0 110.927 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.44 146.36 26.61 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.176 0.512 . . . . 0.0 109.911 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.2 t -170.09 159.14 7.38 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.196 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 9.4 m -140.84 136.55 32.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.416 0.627 . . . . 0.0 111.462 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 4.6 m -143.71 179.92 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.765 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 49' ' ' TYR . 7.1 ptp180 -140.31 126.01 19.26 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.446 173.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.581 HH11 HG13 ' A' ' 150' ' ' ILE . 22.2 mmt85 -125.58 161.39 27.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.487 -176.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -82.09 159.84 23.31 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 24.7 t80 -55.26 -38.31 68.37 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.5 m -59.26 -28.05 66.36 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.461 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.581 ' HB3' HD12 ' A' ' 150' ' ' ILE . 52.2 m-20 -74.72 -37.24 62.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.187 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.434 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 57.2 m-85 -65.02 -36.16 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.937 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 71' ' ' TYR . 21.1 mt-10 -63.45 -51.77 64.26 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.539 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 5.0 t-105 -61.64 -34.93 76.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.945 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.656 ' HG ' ' CD2' ' A' ' 144' ' ' PHE . 3.5 tm? -67.79 -44.24 77.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 66.4 ttt180 -57.14 -59.61 4.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.973 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.677 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 20.2 t -62.33 -36.01 80.88 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.973 -173.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.3 OUTLIER -53.93 -56.45 17.67 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.251 0.548 . . . . 0.0 109.758 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.16 -35.28 76.68 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.296 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 20.3 mt-10 -69.37 -38.84 78.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.514 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 79' ' ' SER . 33.3 mmt180 -69.29 -60.36 2.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.189 0.519 . . . . 0.0 111.443 -176.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -84.66 -22.29 29.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.929 -170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -126.64 175.21 8.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.208 0.528 . . . . 0.0 112.112 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -103.0 21.03 16.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.874 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.9 t -48.01 142.0 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.125 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.89 36.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.787 176.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.0 OUTLIER -55.61 119.6 26.05 Favored Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 122.062 -0.399 . . . . 0.0 111.203 -175.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.428 ' HG3' ' HD3' ' A' ' 128' ' ' LYS . 86.0 Cg_endo -85.9 168.37 9.42 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.13 2.553 . . . . 0.0 112.325 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 147.3 70.75 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.697 2.265 . . . . 0.0 112.554 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 75' ' ' GLU . 78.2 mt -73.97 157.67 86.78 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.418 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.4 109.03 1.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.577 2.185 . . . . 0.0 111.439 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.5 -171.46 38.07 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.602 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.8 tttp 68.03 -2.75 1.38 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.785 0.434 . . . . 0.0 111.733 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -108.57 -89.98 0.46 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.642 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -52.6 -23.57 6.7 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.982 0.913 . . . . 0.0 113.296 -174.41 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.8 mm? -60.86 -41.55 96.13 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.994 -173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 18.24 21.12 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.664 0.745 . . . . 0.0 109.692 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 2.0 tp-100 -113.71 -40.24 3.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.96 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 114' ' ' PHE . 35.8 mt -89.7 165.87 23.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.515 -175.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.02 164.15 28.57 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.081 2.521 . . . . 0.0 111.962 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -83.23 -100.36 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.553 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttp85 65.78 -65.87 0.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.122 0.569 . . . . 0.0 111.577 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -82.96 52.18 4.69 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.146 -0.55 . . . . 0.0 111.952 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 63.9 -71.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.69 1.196 . . . . 0.0 110.391 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.01 -20.06 17.62 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.933 174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.7 14.03 20.59 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.642 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 36.9 pt -83.21 -16.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.989 -175.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CZ ' ' HD3' ' A' ' 45' ' ' ARG . 70.0 m-85 -79.69 1.24 27.16 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.453 175.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 113' ' ' ASN . 24.9 t70 -86.45 129.92 34.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.64 -19.76 63.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.88 -175.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HB2' ' OD2' ' A' ' 111' ' ' ASP . 46.4 m-80 -74.14 -54.37 7.94 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.642 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 1.5 t80 -49.87 -50.05 47.11 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.748 0.655 . . . . 0.0 111.158 176.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.7 mt -52.26 -45.55 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.278 -175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -80.0 -15.24 57.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.742 -178.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HA ' ' NE2' ' A' ' 120' ' ' GLN . 42.4 mm-40 -70.78 -34.69 72.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.302 0.573 . . . . 0.0 109.767 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.483 ' HD3' ' CD1' ' A' ' 71' ' ' TYR . 36.5 ttm180 -78.52 -36.37 45.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 116' ' ' GLU . 0.2 OUTLIER -55.13 -49.32 72.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.827 -178.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.715 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 5.6 pt20 -61.46 -33.72 74.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.496 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.02 -33.66 9.48 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.992 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 122' ' ' LEU . 7.4 tp -66.32 -33.61 76.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.138 0.175 . . . . 0.0 111.018 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.645 ' HB3' HG22 ' A' ' 33' ' ' VAL . 10.5 pt-20 -75.22 -32.47 61.16 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.9 mm-40 -59.96 -59.85 4.76 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 4.7 t80 -45.63 -51.72 11.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.022 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.8 tp -65.12 -39.05 84.28 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.83 -172.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -63.17 -12.53 28.65 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HD3' ' HG3' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -90.78 -59.46 2.17 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.734 0.778 . . . . 0.0 110.177 172.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.563 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.1 m -65.03 -12.19 12.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.056 -176.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -108.02 1.5 22.49 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.354 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.87 12.95 2.4 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.196 -1.002 . . . . 0.0 113.509 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.69 ' O ' ' HG2' ' A' ' 136' ' ' GLN . 54.8 t60 -100.26 140.32 21.38 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.987 0.394 . . . . 0.0 110.19 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.668 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 3.8 Cg_exo -43.94 -43.91 12.15 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.936 3.091 . . . . 0.0 113.54 -171.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.418 ' CB ' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.0 -28.72 61.59 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.454 -175.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -80.35 -41.21 25.16 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.551 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.69 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.2 mm100 -67.55 -0.67 4.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.528 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.602 ' O ' ' HA ' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -100.71 -7.01 24.22 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.386 -178.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -117.52 132.7 56.49 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -49.44 -31.86 10.67 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.269 -1.332 . . . . 0.0 113.556 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.458 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 3.6 p -58.83 -25.2 62.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.738 0.304 . . . . 0.0 111.6 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.481 HD22 ' O ' ' A' ' 135' ' ' ALA . 3.8 mp -70.52 -33.88 71.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.859 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -55.51 -41.17 72.72 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.303 0.573 . . . . 0.0 109.7 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.577 ' HB3' ' HA ' ' A' ' 150' ' ' ILE . 1.8 mpp? -66.81 -56.66 9.43 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.61 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CD2' HD11 ' A' ' 150' ' ' ILE . 2.4 t80 -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.053 -1.43 . . . . 0.0 112.856 -173.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.688 HD13 ' CE1' ' A' ' 60' ' ' PHE . 1.5 mt -99.2 -40.73 7.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.054 0.454 . . . . 0.0 112.117 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.4 -49.44 5.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.645 -168.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.411 ' O ' HG11 ' A' ' 67' ' ' VAL . 74.8 m-20 -73.66 -178.67 3.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.779 0.323 . . . . 0.0 110.944 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.543 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.1 pm0 -83.74 -30.95 26.26 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.459 0.647 . . . . 0.0 110.246 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.543 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -149.5 158.86 5.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.237 -169.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' A' ' 144' ' ' PHE . 70.9 mt -86.4 111.81 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.103 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' A' ' 143' ' ' MET . 52.2 t0 -82.48 113.86 20.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.018 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.418 ' HE3' ' CG2' ' A' ' 150' ' ' ILE . 8.4 mptt -77.13 -3.13 37.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.91 0.862 . . . . 0.0 110.234 -178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.5 t -108.7 19.6 19.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.342 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.546 ' CD1' ' HE1' ' A' ' 143' ' ' MET . 6.2 p90 -61.16 -174.18 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.959 178.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.472 HG22 ' OG ' ' A' ' 157' ' ' SER . 73.6 m -93.02 108.26 31.14 Favored Pre-proline 0 N--CA 1.447 -0.618 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.404 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 35.6 Cg_exo -65.87 92.54 0.26 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 123.321 2.68 . . . . 0.0 111.734 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 155' ' ' THR . 4.9 p -164.68 -169.62 1.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 -174.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 4.6 mmmm -81.61 152.2 27.29 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.004 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.556 HG13 HD12 ' A' ' 59' ' ' ILE . 12.1 mm -52.56 -42.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.373 0.606 . . . . 0.0 110.328 173.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.408 ' H ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -84.01 10.82 9.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.795 -173.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.2 m170 63.63 -176.82 0.16 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.644 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.685 176.322 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -133.6 123.34 24.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.244 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 37.3 m80 67.34 122.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.992 0.807 . . . . 0.0 111.877 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -81.55 91.33 6.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.347 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -79.84 167.65 20.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.677 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -103.78 56.73 0.73 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.024 0.44 . . . . 0.0 111.806 -174.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -111.41 19.29 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.646 173.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -90.49 67.44 6.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.802 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.03 132.22 27.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.011 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -93.95 147.72 18.71 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 177.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.7 p -65.38 119.01 10.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.688 0.244 . . . . 0.0 110.767 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.32 119.26 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.787 0.803 . . . . 0.0 111.506 -175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -94.72 -58.09 2.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 -177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.6 p -99.92 147.07 25.95 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.143 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -116.46 -47.4 4.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.303 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.19 66.38 2.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.404 0.621 . . . . 0.0 109.778 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 165.38 18.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.959 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.8 p -62.24 -68.81 0.29 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.614 0.245 . . . . 0.0 110.36 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 56.99 -173.01 0.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -167.56 176.26 6.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.4 tp -152.17 147.34 26.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.6 mt -134.78 150.63 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.825 0.345 . . . . 0.0 110.438 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 p -119.86 93.99 4.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.081 0.467 . . . . 0.0 111.01 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -76.4 171.66 11.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 -178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 54.8 Cg_exo -54.52 150.97 32.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.475 2.117 . . . . 0.0 112.063 173.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -68.8 137.33 53.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.54 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.19 165.21 24.83 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.39 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.88 -171.91 1.78 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.721 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -45.42 -57.51 4.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.79 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -162.47 134.38 5.39 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.638 171.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 171.65 172.55 0.09 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.338 -175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 -57.9 0.6 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.913 -171.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.03 178.27 48.21 Favored Glycine 0 N--CA 1.44 -1.083 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.049 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 10.8 Cg_endo -52.17 156.2 8.02 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 124.145 3.23 . . . . 0.0 112.323 175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 24' ' ' PRO . 88.3 Cg_exo -50.53 -17.32 2.79 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 124.496 3.464 . . . . 0.0 114.831 -173.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.9 m -76.29 -51.21 12.45 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 57' ' ' LEU . 26.7 m120 60.95 176.08 0.1 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.555 0.535 . . . . 0.0 111.382 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -88.95 135.43 33.55 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.706 HD22 HD11 ' A' ' 57' ' ' LEU . 15.3 tp -142.85 132.89 24.33 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.097 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.5 99.41 3.42 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.147 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.647 HG12 ' HB ' ' A' ' 53' ' ' VAL . 34.5 mt -110.67 141.58 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.058 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -140.43 118.26 11.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 1.1 m -99.5 136.6 29.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.9 t 179.24 -163.19 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 60.39 77.22 0.38 Allowed Pre-proline 0 N--CA 1.466 0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 110.574 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.29 148.18 38.36 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.633 2.222 . . . . 0.0 112.996 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.532 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 51.2 tp60 -134.51 108.91 8.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.688 175.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 m -76.7 94.1 3.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.407 0.623 . . . . 0.0 109.75 176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -122.97 92.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.269 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.07 -165.35 29.89 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.878 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 20.0 t -101.99 145.42 11.82 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.921 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.246 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.0 -48.2 5.29 Favored Glycine 0 N--CA 1.463 0.498 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.008 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -101.4 86.29 2.95 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.69 36.11 0.8 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.492 -176.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.579 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 11.3 ttt180 -87.34 140.95 29.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -129.19 142.25 50.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.032 0.444 . . . . 0.0 110.91 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -100.48 124.32 45.87 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.275 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 40.4 p -93.09 152.33 19.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.545 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -118.07 143.89 46.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.03 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 33.6 tt0 -96.35 120.57 36.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.461 -176.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.95 117.96 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.721 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 13.3 mtp180 -105.52 136.95 44.16 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.016 174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -148.25 139.29 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 64' ' ' GLU . 12.5 ttmt -126.69 138.93 53.47 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.564 168.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.489 HG21 ' CD2' ' A' ' 60' ' ' PHE . 14.1 t -170.91 164.02 7.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.219 0.533 . . . . 0.0 111.48 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.54 ' ND2' HD22 ' A' ' 27' ' ' ASN . 0.2 OUTLIER -116.93 23.42 11.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.255 168.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.706 HD11 HD22 ' A' ' 29' ' ' LEU . 27.0 mt -57.44 139.93 80.11 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.705 174.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 -25.84 13.52 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.549 2.166 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.586 HG13 HG21 ' A' ' 159' ' ' ILE . 0.4 OUTLIER -75.84 -40.97 39.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.07 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CE2' ' HG ' ' A' ' 145' ' ' LEU . 3.8 m-30 -68.39 -18.43 64.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' HD3' ' NE2' ' A' ' 146' ' ' GLN . 57.4 tttt 72.22 -66.62 0.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 171.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -81.7 -11.8 58.9 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 122.24 -0.288 . . . . 0.0 110.314 -172.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp 72.21 -42.44 0.53 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.053 0.845 . . . . 0.0 110.762 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -149.57 138.26 20.95 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.581 0.705 . . . . 0.0 110.755 176.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 t -171.33 162.63 6.83 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.823 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' ILE . 8.5 m -137.95 129.95 28.69 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-O 121.116 0.484 . . . . 0.0 111.015 178.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -127.1 169.22 18.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.153 -179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -134.18 121.35 21.27 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.807 ' NH1' ' HA ' ' A' ' 144' ' ' PHE . 16.7 ptp180 -151.26 163.47 38.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 111.316 -173.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.667 ' HG3' ' H ' ' A' ' 72' ' ' SER . 30.1 tpt180 -86.6 148.0 25.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.435 0.636 . . . . 0.0 112.127 -170.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' H ' ' HD2' ' A' ' 70' ' ' ARG . 38.6 t80 -48.03 -37.33 14.64 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.004 176.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.667 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 5.5 m -54.13 -34.24 59.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.969 0.414 . . . . 0.0 111.244 177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 150' ' ' ILE . 15.7 m-20 -74.22 -33.94 63.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.123 178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 33.6 m-85 -60.21 -36.24 77.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.055 0.455 . . . . 0.0 110.044 175.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.511 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.6 mt-10 -64.9 -53.3 48.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.743 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -28.92 66.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.786 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.4 tm? -71.73 -43.84 65.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 60.0 ttt180 -59.06 -62.98 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.631 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.551 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.1 p -62.85 -33.49 75.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.912 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.76 -47.97 82.8 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.56 -42.15 91.78 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.846 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 33.0 mt-10 -66.03 -32.83 74.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.616 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 79' ' ' SER . 30.1 mmt180 -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.083 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -75.67 -33.09 60.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.961 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.8 m -124.62 177.46 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.314 0.578 . . . . 0.0 111.037 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -101.98 29.3 5.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.491 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 57.3 t -51.13 140.18 5.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.038 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 88' ' ' VAL . 5.6 p -71.22 31.07 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.279 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.555 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 1.4 t -51.72 123.05 23.11 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 122.222 -0.299 . . . . 0.0 111.354 -174.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 125' ' ' PHE . 92.6 Cg_endo -86.12 166.51 9.62 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.171 2.581 . . . . 0.0 112.192 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 43.5 Cg_endo -67.8 142.6 58.23 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.764 2.309 . . . . 0.0 112.477 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.511 HD11 ' HA ' ' A' ' 75' ' ' GLU . 91.4 mt -69.69 150.72 96.65 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.293 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 1.7 Cg_endo -81.79 116.95 2.91 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.551 2.168 . . . . 0.0 110.571 173.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.38 48.83 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.554 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -149.95 42.81 0.87 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.436 0.636 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . -151.48 -81.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.016 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -56.53 -26.22 54.08 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.087 -174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.883 ' H ' HD22 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -59.63 -47.67 84.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.051 -174.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 96' ' ' ALA . 3.4 ppt_? -97.12 24.52 6.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.401 0.62 . . . . 0.0 110.689 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 0.6 OUTLIER -112.84 -47.18 3.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.879 -178.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.566 HD12 ' C ' ' A' ' 101' ' ' LEU . 3.2 pp -91.04 173.03 5.9 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.671 -174.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.559 ' CD ' ' HB2' ' A' ' 101' ' ' LEU . 14.4 Cg_exo -71.93 -143.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 124.115 3.21 . . . . 0.0 113.292 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -116.95 -83.81 0.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.544 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 65.27 -74.42 0.05 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.834 0.708 . . . . 0.0 111.61 -177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.455 ' HA3' ' CD1' ' A' ' 110' ' ' PHE . . . -107.09 75.82 0.22 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.366 -177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.29 -72.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.026 0.93 . . . . 0.0 111.852 176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' HG23 ' A' ' 109' ' ' ILE . 2.8 t70 -104.21 -34.15 8.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.113 -175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.62 3.02 10.41 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.606 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.55 ' HA ' ' CD1' ' A' ' 114' ' ' PHE . 47.8 pt -70.18 -17.86 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.079 0.399 . . . . 0.0 112.079 -176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' HA3' ' A' ' 105' ' ' GLY . 49.4 m-85 -76.76 -7.72 55.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.911 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -80.24 129.37 34.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.101 0.477 . . . . 0.0 110.009 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -62.74 -26.03 68.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.05 -173.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.661 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 43.3 m-80 -69.56 -56.87 6.12 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -46.75 -47.94 20.6 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 123.673 0.608 . . . . 0.0 111.091 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 mt -53.37 -46.65 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.368 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -78.53 -19.17 53.53 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.116 -178.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 32.1 mm-40 -72.98 -34.65 66.59 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -73.64 -42.35 61.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.659 174.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -56.85 -50.89 71.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.612 -176.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.751 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.4 pt20 -60.28 -35.19 74.98 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.984 -173.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.62 -31.96 9.78 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.13 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.3 tp -64.86 -35.36 80.88 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.807 -0.231 . . . . 0.0 111.099 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.528 ' HA ' HG22 ' A' ' 126' ' ' ILE . 10.5 pt-20 -69.88 -31.35 69.12 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.751 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 65.4 mm-40 -65.83 -58.78 4.82 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' O ' HG13 ' A' ' 129' ' ' VAL . 5.2 t80 -45.45 -53.38 8.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.641 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 123' ' ' GLU . 10.7 tp -64.23 -38.67 83.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.644 -173.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -60.48 -19.34 56.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -89.6 -56.98 3.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.882 0.849 . . . . 0.0 110.449 175.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -63.85 -12.63 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.898 -177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.8 3.83 24.88 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.479 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.438 ' HA2' ' NE2' ' A' ' 136' ' ' GLN . . . -142.28 12.02 2.53 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.551 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.669 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 39.4 t60 -101.43 140.47 21.28 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 122.483 -0.422 . . . . 0.0 110.875 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 14.5 Cg_exo -40.59 -47.14 4.57 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.242 3.294 . . . . 0.0 114.058 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -73.19 -26.54 61.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.333 -174.185 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -83.16 -40.13 20.13 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.989 -176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.64 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.0 mm100 -67.61 -3.01 7.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.225 176.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 158' ' ' LYS . 1.5 t-20 -112.56 12.35 19.87 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.231 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -122.67 126.53 47.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.673 0.273 . . . . 0.0 110.929 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.514 ' HA ' HD13 ' A' ' 159' ' ' ILE . 15.7 tpt180 -57.36 -15.7 7.13 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.486 -176.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 143' ' ' MET . 3.2 m -56.07 -29.39 60.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.095 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.566 ' O ' HD22 ' A' ' 145' ' ' LEU . 6.5 mp -74.5 -28.97 61.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.199 178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 60.9 t-80 -57.28 -43.29 82.99 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.913 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.75 ' SD ' HG23 ' A' ' 150' ' ' ILE . 3.9 ptp -70.89 -35.24 72.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.807 ' HA ' ' NH1' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -77.61 -46.01 23.41 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.601 ' HG ' ' CE2' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -88.79 -36.47 16.06 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.388 -178.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.481 ' NE2' ' HD3' ' A' ' 61' ' ' LYS . 7.1 mt-30 -100.82 -174.01 2.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.394 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 57.41 -165.21 0.16 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.363 0.414 . . . . 0.0 110.274 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 149' ' ' ILE . 2.4 pm0 -100.17 -32.38 10.93 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.428 0.632 . . . . 0.0 110.773 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 148' ' ' GLU . 0.7 OUTLIER -155.44 173.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.163 -169.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.75 HG23 ' SD ' ' A' ' 143' ' ' MET . 2.1 mp -78.35 120.19 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.556 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 154' ' ' TYR . 9.6 t0 -96.24 99.88 11.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 170.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HG2' ' CG2' ' A' ' 150' ' ' ILE . 81.6 mttt -74.63 -2.59 26.76 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.624 0.726 . . . . 0.0 111.966 -170.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 69.8 m -108.37 18.88 20.51 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.318 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' O ' ' HD3' ' A' ' 156' ' ' PRO . 0.5 OUTLIER -62.71 -170.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.141 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 56.1 m -84.1 110.84 28.88 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.948 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.2 Cg_exo -71.06 77.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 123.611 2.874 . . . . 0.0 112.227 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.5 m -151.44 -162.92 1.64 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.454 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 16.9 mmmt -81.37 163.25 22.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.925 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.586 HG21 HG13 ' A' ' 59' ' ' ILE . 17.0 mm -56.25 -39.39 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.2 0.524 . . . . 0.0 109.612 169.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -79.61 11.76 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.842 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.8 m170 65.08 179.84 0.18 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.533 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.228 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.437 -179.367 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.621 0.248 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -74.39 150.81 39.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.762 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 50.3 m80 72.69 116.68 0.05 Allowed 'General case' 0 N--CA 1.465 0.319 0 O-C-N 124.083 0.865 . . . . 0.0 111.116 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -74.97 126.41 30.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.074 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -98.42 102.99 14.89 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.817 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -78.78 83.81 4.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.51 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -111.77 -45.08 3.38 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.956 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -87.56 132.42 34.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.68 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 29.8 m -105.01 141.72 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.057 0.456 . . . . 0.0 110.823 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -150.3 90.12 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.709 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p -62.54 101.49 0.25 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.246 0.546 . . . . 0.0 111.177 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.96 125.18 5.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.348 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -98.65 -62.46 1.24 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.189 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.2 p -107.9 152.39 24.49 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.164 0.507 . . . . 0.0 111.565 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.3 m -119.84 -162.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.116 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.63 117.08 3.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.033 0.444 . . . . 0.0 111.559 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.6 169.17 10.22 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.507 ' HB ' HG12 ' A' ' 12' ' ' ILE . 41.1 p -63.78 -46.83 83.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.416 0.627 . . . . 0.0 109.789 176.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 63.67 -103.57 0.12 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.497 -1.228 . . . . 0.0 111.52 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 10' ' ' ARG . 21.7 mmt180 -125.15 -46.1 1.82 Allowed 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.038 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 ' C ' HG13 ' A' ' 12' ' ' ILE . 12.7 tp -43.36 -76.82 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.419 -1.719 . . . . 0.0 112.128 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 13' ' ' THR . 3.9 mt 62.27 -178.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.981 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.588 ' H ' HG22 ' A' ' 12' ' ' ILE . 6.7 p 70.88 109.14 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.779 0.8 . . . . 0.0 112.019 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 11.1 mptt -70.64 164.94 50.67 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.64 175.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 14' ' ' LYS . 94.0 Cg_exo -42.96 108.27 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.216 2.611 . . . . 0.0 113.076 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -85.6 149.5 25.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.449 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 13.8 m120 65.8 160.45 0.13 Allowed 'General case' 0 C--O 1.232 0.141 0 O-C-N 123.814 0.696 . . . . 0.0 110.558 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -108.56 134.05 51.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.937 0.399 . . . . 0.0 110.521 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.6 -167.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -102.83 134.2 46.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.575 0.702 . . . . 0.0 110.425 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.51 159.59 16.94 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.152 -178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.13 -42.2 0.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.382 -167.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.36 169.2 38.18 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.329 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.99 160.24 13.0 Favored 'Trans proline' 0 C--O 1.224 -0.214 0 C-N-CA 123.911 3.074 . . . . 0.0 111.282 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -43.14 -21.6 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 124.839 3.693 . . . . 0.0 115.571 -171.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.8 m -70.67 -63.59 1.07 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.536 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 38.4 m-80 60.24 177.41 0.09 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.108 0.48 . . . . 0.0 111.709 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -91.21 134.82 34.24 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 57' ' ' LEU . 14.2 tp -146.46 131.82 18.58 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.368 -175.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -144.11 100.42 3.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.079 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 53.5 mt -109.99 140.1 30.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.597 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -139.29 108.21 5.99 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.106 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -85.83 133.69 29.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.2 t 179.74 -163.15 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 56.31 64.46 4.92 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.315 0.578 . . . . 0.0 109.685 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.82 154.19 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.026 2.484 . . . . 0.0 113.408 -171.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 45.5 tp60 -135.09 112.2 10.35 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.557 173.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.538 HG22 ' HE ' ' A' ' 45' ' ' ARG . 45.5 m -76.38 92.4 3.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.649 0.738 . . . . 0.0 109.9 177.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 37' ' ' GLN . 1.5 p -119.93 94.74 3.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.549 -173.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -172.59 -166.3 30.93 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.356 178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 18.3 t -95.9 147.55 5.93 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.26 -177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.53 -48.96 5.87 Favored Glycine 0 N--CA 1.465 0.568 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.333 -177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -102.25 88.63 3.35 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.487 0.661 . . . . 0.0 109.484 170.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.75 34.0 0.89 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.783 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.563 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.8 ttt180 -85.16 132.67 34.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.862 0.363 . . . . 0.0 110.449 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -117.17 174.51 6.07 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.993 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.4 m -129.0 133.38 47.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.282 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.6 p -92.83 129.92 38.6 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.036 176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -105.92 133.01 51.32 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.978 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 35.7 tt0 -86.36 118.15 25.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.327 -178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.571 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 3.8 mp -94.39 109.45 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.038 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 42.6 mtp180 -96.02 132.41 41.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.236 173.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -139.4 137.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.82 0.343 . . . . 0.0 111.262 177.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ttmt -125.32 137.0 54.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 170.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 63' ' ' LYS . 11.8 t -170.51 165.22 8.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.363 0.601 . . . . 0.0 112.394 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -115.89 24.4 11.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.276 166.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.761 HD11 HD22 ' A' ' 29' ' ' LEU . 23.1 mt -61.09 134.48 93.0 Favored Pre-proline 0 N--CA 1.462 0.161 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.891 173.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 12.2 Cg_exo -67.11 -39.97 12.48 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.645 2.23 . . . . 0.0 111.797 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -60.07 -41.61 87.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.285 179.168 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' CE1' HD13 ' A' ' 57' ' ' LEU . 3.3 m-30 -66.32 -16.28 63.92 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.4 tttt 71.77 -65.69 0.33 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -86.04 -5.68 59.17 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 122.415 -0.178 . . . . 0.0 110.717 -174.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' HG22 ' A' ' 55' ' ' THR . 14.7 mmtp 71.64 -41.61 0.51 Allowed 'General case' 0 C--O 1.218 -0.556 0 O-C-N 123.849 0.718 . . . . 0.0 111.715 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -160.05 122.41 3.34 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.429 0.633 . . . . 0.0 109.896 -177.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -160.89 176.89 10.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.525 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 20.1 m -141.84 132.5 25.54 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.125 0.488 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 m -119.06 179.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.436 176.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 35.0 ttt180 -145.29 111.23 5.52 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -138.16 152.68 48.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.806 0.813 . . . . 0.0 112.716 -173.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.645 ' HG2' ' H ' ' A' ' 72' ' ' SER . 28.9 ttp180 -74.02 144.31 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.705 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.44 ' HA ' ' CD1' ' A' ' 74' ' ' PHE . 40.3 t80 -50.98 -36.47 39.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.484 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.645 ' H ' ' HG2' ' A' ' 70' ' ' ARG . 11.0 m -61.87 -21.81 65.0 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.767 0.318 . . . . 0.0 111.777 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -89.03 -24.49 22.33 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 23.6 m-85 -61.78 -34.15 75.36 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 171.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.535 ' HA ' HD11 ' A' ' 92' ' ' LEU . 18.8 mt-10 -64.4 -50.92 65.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.606 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.466 ' O ' ' HB2' ' A' ' 80' ' ' GLU . 6.6 t-105 -62.02 -30.45 70.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.586 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -70.2 -45.65 66.19 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 47.4 ttt180 -56.83 -61.68 2.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.054 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.716 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 11.1 p -59.3 -34.85 72.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.043 -176.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 140' ' ' CYS . 3.2 mm-40 -62.36 -37.11 84.43 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 85' ' ' SER . 97.7 mt -75.7 -17.99 59.76 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.102 0.477 . . . . 0.0 110.45 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 78' ' ' ARG . 41.2 mt-10 -88.02 -26.36 22.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.284 177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HG2' ' O ' ' A' ' 79' ' ' SER . 41.5 mmt180 -58.43 -64.2 1.0 Allowed 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -118.86 5.78 11.45 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.641 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' LEU . 33.5 t -119.54 167.5 11.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.612 0.72 . . . . 0.0 111.169 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -101.2 19.45 17.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.535 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.437 ' CG1' HG22 ' A' ' 89' ' ' VAL . 89.2 t -51.24 139.07 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 121.421 0.629 . . . . 0.0 111.762 -176.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.6 p -72.25 35.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.815 177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.56 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -55.45 120.26 30.06 Favored Pre-proline 0 N--CA 1.465 0.286 0 O-C-N 122.042 -0.411 . . . . 0.0 111.159 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.594 ' HG3' ' HD2' ' A' ' 128' ' ' LYS . 92.3 Cg_endo -87.52 165.22 7.9 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.978 2.452 . . . . 0.0 112.249 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 38.1 Cg_endo -66.23 144.75 76.01 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.76 2.307 . . . . 0.0 112.65 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.535 HD11 ' HA ' ' A' ' 75' ' ' GLU . 74.0 mt -70.92 150.39 95.06 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.111 178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 6.0 Cg_endo -84.93 114.55 1.65 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.8 2.333 . . . . 0.0 111.192 174.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.29 32.78 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.864 -1.16 . . . . 0.0 113.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -138.8 18.21 2.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.218 0.509 . . . . 0.0 110.935 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 99' ' ' ARG . . . -110.49 -83.31 0.57 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.078 0.466 . . . . 0.0 111.891 -176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -58.01 -27.18 63.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 113.323 -173.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.76 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? -60.93 -46.94 88.68 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.023 0.439 . . . . 0.0 111.128 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -101.26 29.95 4.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.49 0.662 . . . . 0.0 109.948 178.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 1.9 tt0 -128.46 -36.83 1.85 Allowed 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.432 -173.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HD2' ' A' ' 102' ' ' PRO . 74.7 mt -85.08 172.17 9.4 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.947 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 Cg_exo -66.42 -157.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.929 2.419 . . . . 0.0 112.671 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -87.76 -74.65 0.44 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.43 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 64.31 -81.05 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.743 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.58 108.78 0.44 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.822 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.3 t70 69.43 -65.27 0.31 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 111.836 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -139.22 -5.82 1.42 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.085 0.469 . . . . 0.0 110.45 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 110.86 9.63 22.41 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.787 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 42.7 pt -76.05 -18.0 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.131 0.491 . . . . 0.0 111.182 -177.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' CE2' ' HD3' ' A' ' 45' ' ' ARG . 84.0 m-85 -87.47 18.19 4.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.625 175.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.66 134.97 54.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.692 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.04 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.734 -174.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 117' ' ' GLU . 55.0 m-80 -64.67 -60.06 3.55 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.268 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.787 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -52.88 -46.89 68.15 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.416 0.448 . . . . 0.0 111.041 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.5 mt -52.69 -46.41 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.157 -175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -80.65 -18.54 47.74 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.578 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.561 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 56.5 mm-40 -67.55 -38.83 84.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.542 0.687 . . . . 0.0 109.177 177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 13.4 tpp180 -67.78 -43.35 79.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.835 174.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -55.77 -52.54 63.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.174 -175.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.5 pt20 -62.52 -35.24 78.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.581 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.71 -34.02 17.15 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.413 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 118' ' ' ARG . 6.7 tp -66.76 -36.59 82.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 122.043 0.137 . . . . 0.0 111.181 178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.57 ' HA ' HG22 ' A' ' 126' ' ' ILE . 5.1 pt-20 -72.23 -31.7 66.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.685 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 13.3 mm-40 -60.32 -59.75 4.92 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' HG13 ' A' ' 129' ' ' VAL . 3.5 t80 -47.22 -52.73 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.944 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.1 tp -65.32 -40.15 87.6 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.837 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.918 -171.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.51 -21.06 59.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.1 0.476 . . . . 0.0 111.87 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.594 ' HD2' ' HG3' ' A' ' 90' ' ' PRO . 36.7 mttm -87.86 -55.22 3.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.719 0.771 . . . . 0.0 110.453 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.591 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.3 m -69.08 -12.58 16.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.605 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' O ' HD21 ' A' ' 29' ' ' LEU . . . -114.35 12.15 17.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -136.23 -9.51 1.42 Allowed Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.534 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.729 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 44.8 t60 -87.15 146.38 40.15 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.446 -0.311 . . . . 0.0 111.282 -174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.729 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 12.3 Cg_exo -43.08 -51.24 5.74 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 123.915 3.077 . . . . 0.0 113.337 -176.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.539 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -66.5 -32.59 74.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.151 -174.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -76.16 -44.91 35.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.152 -177.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 59' ' ' ILE . 43.2 mm-40 -61.52 -6.49 2.43 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.016 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -98.87 -21.44 16.31 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.066 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 13.0 mm-40 -99.91 137.38 38.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.634 0.652 . . . . 0.0 112.352 -168.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 158' ' ' LYS . 3.5 mmt180 -50.46 -24.45 3.13 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.023 0.929 . . . . 0.0 112.716 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.669 ' HA ' ' SD ' ' A' ' 143' ' ' MET . 8.1 m -56.86 -29.94 63.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.464 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 135' ' ' ALA . 5.9 mp -75.36 -35.26 61.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.906 0.384 . . . . 0.0 110.662 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -64.33 -35.32 80.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.389 0.614 . . . . 0.0 109.667 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.811 ' HE2' HG23 ' A' ' 150' ' ' ILE . 8.4 ptm -81.74 -31.79 31.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.063 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.529 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 22.3 t80 -80.29 -43.36 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.332 -175.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.456 HD13 ' CZ ' ' A' ' 60' ' ' PHE . 11.0 mt -92.02 -26.46 18.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.361 -171.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -117.16 178.3 4.41 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.364 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 66.88 -82.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.053 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 176.92 -55.01 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.797 0.808 . . . . 0.0 109.576 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -130.66 154.16 40.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.894 -175.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.811 HG23 ' HE2' ' A' ' 143' ' ' MET . 3.0 mp -71.15 113.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.855 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.78 97.71 4.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.756 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -66.46 -6.91 16.41 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.881 0.372 . . . . 0.0 111.322 -175.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.2 m -112.96 19.68 17.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.366 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.457 ' CG ' ' HE3' ' A' ' 143' ' ' MET . 0.2 OUTLIER -64.21 -170.08 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.997 -178.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 95.5 m -86.31 113.2 51.09 Favored Pre-proline 0 N--CA 1.447 -0.62 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.82 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 21.7 Cg_exo -69.83 71.94 1.51 Allowed 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 123.42 2.747 . . . . 0.0 111.589 175.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.4 m -153.18 -161.56 1.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -92.85 168.27 11.29 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.799 178.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.544 HG21 HG13 ' A' ' 59' ' ' ILE . 8.6 mm -54.71 -48.72 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 122.781 0.432 . . . . 0.0 111.076 -174.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 120.45 20.83 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.488 -177.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -80.97 171.22 15.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.053 0.454 . . . . 0.0 110.039 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.228 -179.808 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -9' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -8' ' ' ALA . . . . . . . . . . . . . . . -95.64 27.26 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 69.93 -73.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.632 0.773 . . . . 0.0 111.452 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -150.31 20.06 0.85 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 109.843 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -95.86 153.18 17.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.822 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -160.34 161.69 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.596 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 17.2 t60 56.45 71.5 0.56 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.355 0.598 . . . . 0.0 109.58 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -114.4 105.48 13.17 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.661 -174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.42 151.97 6.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 91.39 174.4 43.35 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.769 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 56.3 p 50.56 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.62 0.768 . . . . 0.0 112.091 -176.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.43 130.85 22.35 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.584 -177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.75 -48.04 7.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.42 0.629 . . . . 0.0 109.336 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 p -120.49 152.47 37.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.243 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.04 -45.18 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.721 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.78 48.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.544 169.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -54.34 134.42 45.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.46 0.648 . . . . 0.0 110.964 -176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -70.41 -46.79 63.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.131 -174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -54.67 144.38 22.11 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.749 175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -125.65 130.27 51.25 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.6 tp -140.67 140.5 34.97 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.867 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 13' ' ' THR . 15.6 mt -140.02 167.93 18.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -173.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 12' ' ' ILE . 30.4 p 64.04 99.83 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.844 0.831 . . . . 0.0 111.224 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' H ' ' HD3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -94.51 166.41 15.35 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.526 -174.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 14' ' ' LYS . 65.5 Cg_exo -42.82 134.54 5.33 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.056 2.504 . . . . 0.0 112.804 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -53.02 138.19 31.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -117.28 -161.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.682 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -74.13 -173.33 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.469 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 6.4 p-10 -60.45 -73.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.795 174.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' A' ' 19' ' ' ASN . 15.4 m-20 -139.21 141.54 37.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 70.49 165.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.941 0.776 . . . . 0.0 111.32 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 22' ' ' TYR . 8.4 m-85 -132.35 -23.98 2.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.308 -170.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.93 173.98 46.1 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.368 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.2 155.53 9.05 Favored 'Trans proline' 0 C--O 1.223 -0.228 0 C-N-CA 124.124 3.216 . . . . 0.0 111.882 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.28 -21.08 0.36 Allowed 'Trans proline' 0 N--CA 1.482 0.832 0 C-N-CA 124.769 3.646 . . . . 0.0 115.737 -170.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 46.5 m -75.16 -59.44 2.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' HB2' ' CD2' ' A' ' 57' ' ' LEU . 33.0 m-80 62.29 -178.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.036 0.446 . . . . 0.0 111.812 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.4 132.11 37.03 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.796 HD22 HD11 ' A' ' 57' ' ' LEU . 19.2 tp -147.02 128.82 15.29 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.761 -0.776 . . . . 0.0 111.791 -173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' CG ' ' HB3' ' A' ' 54' ' ' LYS . 4.3 pt-20 -138.01 99.78 3.98 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.89 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.685 HG12 ' HB ' ' A' ' 53' ' ' VAL . 30.9 mt -113.34 142.04 27.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.801 -179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -142.21 111.74 6.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.646 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 123' ' ' GLU . 0.9 OUTLIER -85.48 136.37 22.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 171.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 22.9 t 179.79 -163.08 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' GLU . 38.6 m-80 62.44 79.7 0.26 Allowed Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.191 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -64.83 143.69 80.81 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.187 2.591 . . . . 0.0 112.574 -174.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 53.8 tp60 -134.15 108.31 8.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.905 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 m -76.11 93.11 3.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 109.535 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.2 89.96 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.773 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 45' ' ' ARG . . . -173.04 -166.98 32.31 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.955 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 9.9 t -117.41 152.17 19.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.76 0 CA-C-O 119.439 -0.315 . . . . 0.0 110.638 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -41.54 -46.63 4.66 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 121.771 -0.252 . . . . 0.0 113.019 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.18 83.06 2.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.306 0.574 . . . . 0.0 109.985 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 120.82 40.8 0.55 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.316 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 16.6 ttt180 -89.17 142.05 27.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.76 162.4 36.12 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.162 0.506 . . . . 0.0 110.916 -176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 22.4 m -114.56 126.08 54.51 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.524 ' OG1' ' HB3' ' A' ' 37' ' ' GLN . 30.9 p -92.22 154.82 18.4 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.78 136.24 53.12 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.243 0.544 . . . . 0.0 110.836 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.602 ' HG2' ' CG2' ' A' ' 66' ' ' THR . 28.6 tt0 -93.13 119.4 32.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.769 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 74' ' ' PHE . 2.5 mp -93.75 115.37 32.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.96 -176.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 29.6 mtp180 -102.37 128.19 49.06 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.809 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.685 ' HB ' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -137.49 140.22 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.568 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CG ' ' A' ' 30' ' ' GLU . 11.4 ttmt -128.97 136.28 50.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 63' ' ' LYS . 10.4 t -170.21 164.63 9.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.401 0.619 . . . . 0.0 112.493 -175.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' HD3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.29 25.21 10.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.08 164.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.796 HD11 HD22 ' A' ' 29' ' ' LEU . 30.3 mt -58.55 134.38 85.79 Favored Pre-proline 0 C--O 1.235 0.322 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.493 171.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 57' ' ' LEU . 8.5 Cg_exo -67.79 -36.26 19.06 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.727 2.284 . . . . 0.0 111.475 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.563 HG13 HG21 ' A' ' 159' ' ' ILE . 1.3 tt -61.03 -40.54 85.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.202 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.66 ' HA ' ' NE2' ' A' ' 146' ' ' GLN . 4.9 m-30 -71.1 -18.33 62.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.46 -67.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.567 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -77.28 -1.72 31.13 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 122.432 -0.167 . . . . 0.0 111.389 -171.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.538 ' O ' HG22 ' A' ' 55' ' ' THR . 4.5 mmtm 68.06 -45.54 0.51 Allowed 'General case' 0 C--O 1.22 -0.452 0 O-C-N 124.07 0.856 . . . . 0.0 112.045 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' HB3' ' HA ' ' A' ' 54' ' ' LYS . 1.1 pp20? -159.79 138.96 10.99 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.659 -177.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -170.52 177.54 3.97 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.602 ' CG2' ' HG2' ' A' ' 50' ' ' GLU . 23.9 m -142.26 127.27 18.4 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.117 0.484 . . . . 0.0 111.095 177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 m -119.63 172.09 7.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.775 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -140.83 129.1 22.32 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.646 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' HD3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.1 177.06 9.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.361 179.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 73' ' ' ASP . 85.5 mtt180 -85.54 168.5 14.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.441 -172.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 46.5 t80 -60.77 -40.56 92.96 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.531 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 55.0 m -61.32 -23.3 65.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 150' ' ' ILE . 6.3 m-20 -72.94 -36.7 67.25 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 70.9 m-85 -64.54 -40.15 95.08 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HA ' HD11 ' A' ' 92' ' ' LEU . 28.9 mt-10 -59.17 -53.43 58.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.608 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -60.65 -31.32 70.54 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.555 ' HG ' ' CD1' ' A' ' 144' ' ' PHE . 3.1 tm? -73.23 -44.67 59.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 89' ' ' VAL . 39.3 ttt180 -55.82 -61.04 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.017 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.4 p -59.42 -35.11 73.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.069 -0.968 . . . . 0.0 111.629 -174.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 80' ' ' GLU . 6.4 tp10 -64.3 -44.77 90.58 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.811 0.338 . . . . 0.0 110.089 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' CD1' ' HB ' ' A' ' 129' ' ' VAL . 95.1 mt -62.64 -40.59 97.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.581 176.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -65.39 -34.66 78.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.209 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.473 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 3.2 ppt_? -90.24 -28.76 18.62 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -172.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HG2' ' HD2' ' A' ' 83' ' ' ARG . 4.8 mm-40 -95.35 -17.29 21.72 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.956 -0.465 . . . . 0.0 112.189 177.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 87' ' ' VAL . 22.7 t -144.95 178.71 7.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.745 0.783 . . . . 0.0 111.685 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -103.64 19.78 19.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.423 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' A' ' 89' ' ' VAL . 79.3 t -45.41 140.35 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.563 -179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 88' ' ' VAL . 9.8 p -72.73 37.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.883 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.515 ' CG1' ' HG3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -54.95 121.16 33.73 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.128 -0.358 . . . . 0.0 111.075 -176.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HD2' ' CG1' ' A' ' 129' ' ' VAL . 71.9 Cg_endo -83.47 165.9 14.09 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.324 2.682 . . . . 0.0 113.188 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.19 143.92 79.42 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.192 2.595 . . . . 0.0 112.686 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 75' ' ' GLU . 95.8 mt -81.55 141.43 48.72 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.769 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 92' ' ' LEU . 8.0 Cg_exo -73.79 114.22 3.98 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 123.173 2.582 . . . . 0.0 111.998 177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.83 38.26 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.169 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -138.72 -34.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.342 . . . . 0.0 111.428 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.21 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -53.99 -26.78 27.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.094 0.958 . . . . 0.0 113.542 -170.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.793 ' H ' HD22 ' A' ' 98' ' ' LEU . 1.2 mm? -62.7 -48.03 81.06 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.36 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.82 13.64 23.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.771 0.796 . . . . 0.0 110.135 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.594 ' HB3' ' HA ' ' A' ' 97' ' ' PHE . 4.3 tp60 -102.15 -29.2 11.87 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.001 177.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 mt -99.99 165.69 14.11 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.073 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.57 -153.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.542 2.828 . . . . 0.0 112.231 172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -103.05 -78.79 0.54 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.144 172.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 68.05 -65.81 0.24 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.135 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.8 -155.51 30.92 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.053 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -62.54 -30.83 71.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.051 0.453 . . . . 0.0 111.143 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -143.65 -47.08 0.28 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.32 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.93 -9.57 1.8 Allowed Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.406 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.418 ' HA ' ' CD2' ' A' ' 114' ' ' PHE . 30.8 pt -65.46 -17.58 22.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.175 -0.512 . . . . 0.0 112.169 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -86.92 39.49 0.85 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.375 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -122.99 136.12 54.74 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.76 -21.52 64.36 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -170.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.596 ' O ' ' HG3' ' A' ' 117' ' ' GLU . 38.2 m-80 -71.05 -60.42 2.24 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CD2' ' HA ' ' A' ' 109' ' ' ILE . 0.8 OUTLIER -45.77 -49.98 14.43 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.646 0.591 . . . . 0.0 111.263 178.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 64.5 mt -53.05 -46.84 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.211 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.465 ' O ' ' HE3' ' A' ' 119' ' ' LYS . 0.7 OUTLIER -83.42 -17.85 40.72 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.519 -178.329 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 28.5 mt-10 -80.51 -30.35 37.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 109.89 -176.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -80.02 -29.37 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 173.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -62.69 -52.5 63.04 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.108 178.082 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.662 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 6.0 pt20 -59.92 -38.5 82.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.312 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.44 -42.2 65.07 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.882 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -69.54 -30.77 68.66 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 117.794 0.797 . . . . 0.0 111.313 179.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.625 ' HA ' HG13 ' A' ' 33' ' ' VAL . 10.8 pt-20 -74.05 -33.74 63.81 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 120' ' ' GLN . 9.4 mm-40 -59.84 -60.56 3.64 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 173.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.47 ' O ' HG13 ' A' ' 129' ' ' VAL . 9.7 t80 -48.34 -52.76 20.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.577 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.61 HG22 ' HA ' ' A' ' 123' ' ' GLU . 11.2 tp -66.11 -34.76 72.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.603 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.625 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.563 ' ND2' ' HB ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -61.37 -21.23 63.86 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -88.02 -59.42 2.25 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.689 0.757 . . . . 0.0 110.33 175.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.623 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 1.2 m -64.75 -11.94 11.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.477 -175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.01 8.08 20.05 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.522 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -146.64 15.66 1.61 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.977 177.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.672 ' CG ' ' HD2' ' A' ' 133' ' ' PRO . 69.8 t60 -101.09 142.07 23.88 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.672 ' HD2' ' CG ' ' A' ' 132' ' ' HIS . 1.1 Cg_endo -47.93 -44.03 28.45 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.375 2.717 . . . . 0.0 113.193 -170.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.497 ' O ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -73.56 -25.67 60.48 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.161 -175.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 129' ' ' VAL . . . -82.44 -42.81 18.07 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.632 -176.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.643 ' HG2' ' O ' ' A' ' 132' ' ' HIS . 3.4 mm100 -65.21 -7.08 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.468 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 158' ' ' LYS . 0.2 OUTLIER -91.11 -18.87 23.81 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.969 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 134' ' ' LEU . 36.5 mm-40 -105.01 129.81 53.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.724 -168.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.523 ' HA ' HD13 ' A' ' 159' ' ' ILE . 21.1 tpt180 -54.59 -28.54 46.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.653 -172.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . 0.637 ' O ' ' HG2' ' A' ' 143' ' ' MET . 2.3 p -60.71 -18.6 55.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.512 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.522 HD22 ' O ' ' A' ' 135' ' ' ALA . 1.3 tp -72.13 -32.58 67.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.935 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.552 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 58.8 t-80 -66.33 -34.05 77.12 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.484 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.637 ' HG2' ' O ' ' A' ' 140' ' ' CYS . 7.2 ptm -81.35 -27.31 34.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.344 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.555 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 32.5 t80 -73.91 -52.31 13.33 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.57 HD22 ' CE2' ' A' ' 60' ' ' PHE . 4.3 mp -96.41 -24.43 16.14 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.184 0.516 . . . . 0.0 111.438 -173.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 60' ' ' PHE . 29.1 mt-30 -118.92 -169.79 1.79 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.015 -168.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 61.66 -88.71 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.604 0.565 . . . . 0.0 110.493 -174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.464 ' HG3' HG13 ' A' ' 149' ' ' ILE . 5.8 tp10 -179.41 -58.2 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.687 0.756 . . . . 0.0 109.509 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -126.11 154.27 35.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.562 -175.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.551 HG12 ' HG3' ' A' ' 143' ' ' MET . 90.7 mt -85.75 115.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -98.05 105.3 17.42 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.829 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -73.07 3.03 5.96 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.601 0.715 . . . . 0.0 111.43 -171.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.6 m -110.45 15.62 22.06 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.126 176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 140' ' ' CYS . 0.7 OUTLIER -67.65 -171.61 0.21 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.824 -179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 156' ' ' PRO . 52.4 m -83.13 111.68 32.52 Favored Pre-proline 0 N--CA 1.452 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.347 177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 154' ' ' TYR . 16.3 Cg_exo -72.83 77.01 2.36 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 123.329 2.686 . . . . 0.0 111.801 175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 49.5 m -147.69 -154.34 0.55 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.694 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 15.7 mmmt -95.6 161.72 13.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 121.208 -0.197 . . . . 0.0 110.594 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.563 HG21 HG13 ' A' ' 59' ' ' ILE . 19.5 mm -56.41 -48.75 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 120.825 0.345 . . . . 0.0 110.167 173.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.424 ' HD3' ' H ' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -88.17 103.27 15.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -69.53 170.91 9.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -171.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.118 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.142 -176.677 . . . . . . . . 0 0 . 1 stop_ save_